Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific A4GALT A14GALT, Gb3S, P(k) ENSG00000128274 Alpha 1,4-galactosyltransferase 22 42692121-42721298 Enzymes, Predicted membrane proteins Evidence at protein level HPA001141, HPA076542 Supported Mitochondria Cervical cancer:2.48e-4 (favourable) Expressed in all Mixed seminal vesicle: 30.1 A4GNT alpha4GnT ENSG00000118017 Alpha-1,4-N-acetylglucosaminyltransferase 3 138123718-138132387 Predicted secreted proteins Evidence at protein level HPA008017 Supported Group enriched Tissue enriched 8 stomach: 24.6 gallbladder: 3.2 AADACL2 MGC72001 ENSG00000197953 Arylacetamide deacetylase-like 2 3 151733916-151761339 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 14 skin: 31.2 breast: 2.2 AADACL3 ENSG00000188984 Arylacetamide deacetylase-like 3 1 12716115-12728759 Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced placenta: 1.3 skin: 0.7 AAED1 C9orf21 ENSG00000158122 AhpC/TSA antioxidant enzyme domain containing 1 9 96639577-96655303 Predicted intracellular proteins Evidence at protein level HPA021294 Approved Renal cancer:3.26e-5 (unfavourable) Expressed in all Expressed in all smooth muscle: 15.9 AARD C8orf85, LOC441376 ENSG00000205002 Alanine and arginine rich domain containing protein 8 116938199-116944487 Predicted intracellular proteins Evidence at protein level HPA068290 Approved Lipid droplets Tissue enriched Tissue enriched 8 testis: 42.4 breast: 5.5 ABCA10 EST698739 ENSG00000154263 ATP-binding cassette, sub-family A (ABC1), member 10 17 69147214-69244846 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA014535 Uncertain Mixed Mixed ovary: 13.7 ABCA5 EST90625 ENSG00000154265 ATP-binding cassette, sub-family A (ABC1), member 5 17 69244311-69327244 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA022032 Approved Pancreatic cancer:9.97e-5 (favourable) Expressed in all Expressed in all skin: 28.0 ABHD12B BEM46L3, C14orf29 ENSG00000131969 Abhydrolase domain containing 12B 14 50872160-50904970 Predicted intracellular proteins Evidence at transcript level HPA002873 Uncertain Uncertain Nucleus Tissue enriched Tissue enriched 6 skin: 16.3 breast: 2.5 ABHD13 bA153I24.2, BEM46L1, C13orf6, FLJ14906 ENSG00000139826 Abhydrolase domain containing 13 13 108218379-108234255 Predicted membrane proteins Evidence at protein level HPA032143, HPA032144 Approved Approved Cytosol Expressed in all Mixed thyroid gland: 12.6 ABHD14A DKFZP564O243, DORZ1 ENSG00000248487 Abhydrolase domain containing 14A 3 51971426-51981199 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA038153, HPA038154, HPA056913 Approved Supported Vesicles Lung cancer:4.72e-4 (favourable) Expressed in all Expressed in all thyroid gland: 50.8 ABHD15 ENSG00000168792 Abhydrolase domain containing 15 17 29560547-29567137 Predicted secreted proteins Evidence at protein level HPA014470 Approved Approved Nucleoplasm
Cytosol Expressed in all Mixed adipose tissue: 20.5 ABHD17C FAM108C1 ENSG00000136379 Abhydrolase domain containing 17C 15 80679684-80755621 Predicted intracellular proteins Evidence at protein level HPA048890 Uncertain Expressed in all Mixed colon: 65.2 ABHD18 C4orf29, FLJ21106 ENSG00000164074 Abhydrolase domain containing 18 4 127965306-128039711 Predicted intracellular proteins Evidence at protein level HPA050168, HPA051676 Approved Approved Nuclear membrane Colorectal cancer:5.35e-4 (favourable), Urothelial cancer:9.13e-4 (favourable) Expressed in all Expressed in all heart muscle: 9.5 ABHD2 LABH2 ENSG00000140526 Abhydrolase domain containing 2 15 89087459-89202360 Predicted membrane proteins Evidence at protein level HPA005999 Approved Approved Nucleoplasm
Cytosol Renal cancer:2.18e-7 (favourable) Expressed in all Expressed in all testis: 99.6 ABHD4 FLJ12816 ENSG00000100439 Abhydrolase domain containing 4 14 22598237-22613215 Enzymes, Predicted intracellular proteins Evidence at protein level HPA000600 Uncertain Approved Nucleus Expressed in all Expressed in all testis: 62.6 ABHD8 FLJ11743, MGC14280, MGC2512 ENSG00000127220 Abhydrolase domain containing 8 19 17292131-17310236 Predicted intracellular proteins Evidence at protein level HPA037658, HPA058209 Approved Approved Nucleoplasm
Nuclear bodies Pancreatic cancer:3.04e-5 (favourable), Colorectal cancer:5.25e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 28.6 ABR MDB ENSG00000159842 Active BCR-related 17 1003518-1229021 Predicted intracellular proteins Evidence at protein level HPA053618, HPA054824 Approved Approved Nucleoplasm
Cytosol Renal cancer:2.21e-4 (favourable), Cervical cancer:4.03e-4 (favourable) Expressed in all Mixed smooth muscle: 12.4 ABRA STARS ENSG00000174429 Actin binding Rho activating protein 8 106759483-106770245 Predicted intracellular proteins Evidence at transcript level HPA017724 Uncertain Not detected Group enriched 9 heart muscle: 11.2;skeletal muscle: 49.8 esophagus: 3.3 ABTB2 ABTB2A, BTBD22, DKFZP586C1619 ENSG00000166016 Ankyrin repeat and BTB (POZ) domain containing 2 11 34150988-34358008 Predicted intracellular proteins Evidence at protein level HPA020065, HPA030699 Approved Supported Nucleus Renal cancer:3.51e-5 (favourable), Cervical cancer:5.70e-5 (unfavourable) Expressed in all Mixed adrenal gland: 13.1 AC004381.6 ENSG00000005189 Putative RNA exonuclease NEF-sp 16 20806429-20849668 Predicted intracellular proteins Evidence at protein level HPA040755, HPA040868 Supported Approved Nuclear membrane
Nucleoli
Endoplasmic reticulum Expressed in all Tissue enriched 33 testis: 615.7 parathyroid gland: 18.5 AC113404.1 ENSG00000254893 Ras-related protein Rap-1b-like protein 5 76170093-76174331 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enriched 8 small intestine: 3.4 adrenal gland: 0.4 ACCSL ENSG00000205126 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like 11 44047981-44059977 Predicted intracellular proteins Evidence at transcript level HPA046163 Uncertain Tissue enriched Not detected skin,testis: 0.4 ACER1 ASAH3 ENSG00000167769 Alkaline ceramidase 1 19 6306142-6333629 Enzymes, Predicted membrane proteins Evidence at transcript level Group enriched Tissue enriched 6 skin: 68.0 esophagus: 11.4 ACOXL FLJ11042 ENSG00000153093 Acyl-CoA oxidase-like 2 110732573-111118222 Predicted intracellular proteins Evidence at protein level HPA035392, HPA035393 Uncertain Supported Nucleoli
Cytosol Urothelial cancer:6.48e-4 (favourable) Group enriched Group enriched 5 epididymis: 9.2;lung: 14.6;parathyroid gland: 7.4;prostate: 5.5;testis: 5.3;urinary bladder: 8.0 thyroid gland: 1.6 ACR ENSG00000100312 Acrosin 22 50738196-50745334 Enzymes, Predicted secreted proteins Evidence at protein level HPA048687 Supported Not detected Tissue enriched 56 testis: 115.9 spleen: 2.0 ACRBP CT23, OY-TES-1, SP32 ENSG00000111644 Acrosin binding protein 12 6638075-6647460 Predicted secreted proteins Evidence at protein level HPA039081, HPA039082 Supported Approved Nucleoplasm
Vesicles Mixed Tissue enriched 19 testis: 432.6 thyroid gland: 22.6 ACRC ENSG00000147174 Acidic repeat containing X 71578411-71613583 Predicted intracellular proteins Evidence at protein level HPA023476 Supported Approved Vesicles Mixed Group enriched 5 adrenal gland: 5.9;testis: 20.6 spleen: 2.5 ACSBG1 BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352 ENSG00000103740 Acyl-CoA synthetase bubblegum family member 1 15 78167468-78245688 Enzymes, Predicted intracellular proteins Evidence at protein level HPA041642, CAB045955, HPA058869 Approved Approved Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 25.7;skin: 13.3 adrenal gland: 8.1 ACSL6 ACS2, FACL6, KIAA0837, LACS2, LACS5 ENSG00000164398 Acyl-CoA synthetase long-chain family member 6 5 131949973-132012243 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA040470 Uncertain Group enriched Group enriched 6 bone marrow: 18.0;cerebral cortex: 62.1;parathyroid gland: 22.1;seminal vesicle: 28.7;testis: 51.2 adrenal gland: 6.5 ACSM4 ENSG00000215009 Acyl-CoA synthetase medium-chain family member 4 12 7304284-7328724 Enzymes, Predicted membrane proteins Evidence at transcript level HPA049895 Uncertain Not detected Tissue enhanced ovary: 2.5;testis: 2.6 spleen: 1.2 ACSM6 bA310E22.3, C10orf129 ENSG00000173124 Acyl-CoA synthetase medium-chain family member 6 10 95194200-95228928 Enzymes, Predicted membrane proteins Evidence at protein level HPA044593 Uncertain Urothelial cancer:7.71e-4 (favourable) Tissue enriched Tissue enhanced stomach: 1.7 urinary bladder: 0.6 ACTL10 C20orf134 ENSG00000182584 Actin-like 10 20 33666498-33668525 Predicted secreted proteins Evidence at transcript level Mixed Tissue enriched 16 testis: 22.2 prostate: 1.4 ACTL7B Tact1 ENSG00000148156 Actin-like 7B 9 108854589-108856967 Predicted intracellular proteins Evidence at protein level HPA021803, HPA024664 Supported Not detected Tissue enriched 593 testis: 59.3 all non-specific tissues: 0.0 ACTR3B ARP11, ARP3beta ENSG00000133627 ARP3 actin-related protein 3 homolog B (yeast) 7 152759749-152855378 Predicted intracellular proteins Evidence at protein level HPA047016, HPA051683 Uncertain Renal cancer:1.66e-4 (favourable), Stomach cancer:4.53e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 51.0 ACTR3C ARP11 ENSG00000106526 ARP3 actin-related protein 3 homolog C (yeast) 7 150243916-150323725 Predicted intracellular proteins Evidence at transcript level HPA055957 Uncertain Mixed Tissue enriched 5 parathyroid gland: 85.6 adrenal gland: 15.9 ACTRT1 AIP1, ARIP1, Arp-T1, KIAA0705 ENSG00000123165 Actin-related protein T1 X 128050962-128052398 Predicted intracellular proteins Evidence at protein level HPA003119 Supported Not detected Tissue enriched 36 testis: 3.6 all non-specific tissues: 0.0 ACTRT2 Arp-T2, ARPM2, FLJ25424 ENSG00000169717 Actin-related protein T2 1 3021483-3022903 Predicted intracellular proteins Evidence at protein level HPA006480, HPA025079 Supported Not detected Tissue enriched 1023 testis: 102.2 all non-specific tissues: 0.0 ACTRT3 ARPM1 ENSG00000184378 Actin-related protein T3 3 169766921-169769895 Predicted intracellular proteins Evidence at protein level HPA035817, HPA035818 Approved Approved Nucleoplasm Endometrial cancer:4.11e-4 (unfavourable) Mixed Tissue enriched 21 testis: 60.8 fallopian tube: 2.9 ADAD1 Tenr ENSG00000164113 Adenosine deaminase domain containing 1 (testis-specific) 4 122378966-122429802 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 2108 testis: 210.7 all non-specific tissues: 0.0 ADAD2 FLJ00337, TENRL ENSG00000140955 Adenosine deaminase domain containing 2 16 84191138-84197168 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 43 testis: 32.4 cerebral cortex,skin: 0.7 ADAL ENSG00000168803 Adenosine deaminase-like 15 43330674-43354555 Predicted intracellular proteins Evidence at protein level HPA046215, HPA048175 Approved Approved Microtubules Renal cancer:7.64e-9 (favourable) Expressed in all Mixed testis: 24.8 ADAM11 MDC ENSG00000073670 ADAM metallopeptidase domain 11 17 44759031-44781846 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Mixed Tissue enhanced cerebral cortex: 19.8 heart muscle: 4.5 ADAM18 ADAM27, tMDCIII ENSG00000168619 ADAM metallopeptidase domain 18 8 39584489-39730064 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 84 testis: 8.3 all non-specific tissues: 0.0 ADAM2 CT15, FTNB, PH-30b, PH30 ENSG00000104755 ADAM metallopeptidase domain 2 8 39743735-39838289 Enzymes, Predicted membrane proteins Evidence at protein level CAB022390, HPA024621, HPA026581 Supported Tissue enhanced Tissue enriched 288 testis: 41.7 breast: 0.1 ADAM20 ENSG00000134007 ADAM metallopeptidase domain 20 14 70522358-70535015 Enzymes, Predicted membrane proteins Evidence at protein level HPA059377 Supported Not detected Tissue enriched 76 testis: 9.2 cerebral cortex,endometrium,skin: 0.1 ADAM21 ADAM31 ENSG00000139985 ADAM metallopeptidase domain 21 14 70452157-70459899 Enzymes, Predicted membrane proteins Evidence at protein level HPA059016 Uncertain Not detected Tissue enriched 31 testis: 15.4 cerebral cortex: 0.5 ADAM28 ADAM23, eMDCII, MDC-Lm, MDC-Ls ENSG00000042980 ADAM metallopeptidase domain 28 8 24294040-24359018 Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA074034 Approved Plasma membrane
Mitochondria Endometrial cancer:3.17e-4 (favourable) Mixed Tissue enhanced epididymis: 428.3 stomach: 104.5 ADAM30 svph4 ENSG00000134249 ADAM metallopeptidase domain 30 1 119893533-119896495 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA026080 Uncertain Not detected Tissue enriched 468 testis: 46.8 all non-specific tissues: 0.0 ADAMTS14 ENSG00000138316 ADAM metallopeptidase with thrombospondin type 1 motif, 14 10 70672803-70762441 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level HPA034605 Uncertain Cytosol Mixed Tissue enhanced gallbladder: 10.9;placenta: 11.0 urinary bladder: 4.5 ADAMTS15 ENSG00000166106 ADAM metallopeptidase with thrombospondin type 1 motif, 15 11 130448974-130476641 Enzymes, Predicted secreted proteins Evidence at transcript level HPA042867 Uncertain Approved Cytosol Urothelial cancer:5.63e-5 (unfavourable), Glioma:9.00e-4 (favourable), Lung cancer:9.72e-4 (unfavourable) Mixed Tissue enhanced adipose tissue: 30.2;placenta: 23.5 breast: 11.0 ADAMTS16 ADAMTS16s ENSG00000145536 ADAM metallopeptidase with thrombospondin type 1 motif, 16 5 5140330-5320304 Enzymes, Predicted secreted proteins Evidence at protein level Renal cancer:3.29e-5 (favourable) Mixed Tissue enhanced gallbladder: 10.0;ovary: 11.4 adipose tissue: 6.3 ADAMTS17 FLJ16363, FLJ32769 ENSG00000140470 ADAM metallopeptidase with thrombospondin type 1 motif, 17 15 99971589-100342005 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA062487 Approved Nucleus Mixed Mixed endometrium: 3.5 ADAMTS19 ENSG00000145808 ADAM metallopeptidase with thrombospondin type 1 motif, 19 5 129460265-129738683 Enzymes, Predicted secreted proteins Evidence at transcript level HPA056171, HPA058438 Uncertain Approved Vesicles
Midbody Tissue enhanced Group enriched 13 cervix, uterine: 16.4;endometrium: 16.4;placenta: 5.2;smooth muscle: 8.9 adrenal gland: 0.9 ADAMTS2 ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP ENSG00000087116 ADAM metallopeptidase with thrombospondin type 1 motif, 2 5 179110851-179345430 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level HPA028444 Uncertain Approved Vesicles
Plasma membrane Renal cancer:1.71e-8 (unfavourable) Expressed in all Mixed placenta: 27.2 ADAMTS20 GON-1 ENSG00000173157 ADAM metallopeptidase with thrombospondin type 1 motif, 20 12 43353866-43551921 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA027608, HPA027609 Uncertain Not detected Not detected placenta: 0.8 ADAMTS3 ADAMTS-4, KIAA0366 ENSG00000156140 ADAM metallopeptidase with thrombospondin type 1 motif, 3 4 72280969-72568799 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level HPA021368, HPA021369 Uncertain Approved Intermediate filaments Mixed Tissue enhanced parathyroid gland: 7.9 testis: 3.7 ADAMTS6 ADAM-TS6 ENSG00000049192 ADAM metallopeptidase with thrombospondin type 1 motif, 6 5 65148736-65481920 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level HPA043441 Supported Mixed Tissue enhanced placenta: 2.7 gallbladder: 2.3 ADAMTS8 ADAM-TS8, FLJ41712, METH2 ENSG00000134917 ADAM metallopeptidase with thrombospondin type 1 motif, 8 11 130404925-130428993 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at transcript level HPA066349 Approved Endometrial cancer:1.38e-4 (favourable) Tissue enhanced Tissue enhanced appendix: 11.2;lung: 15.6 seminal vesicle: 5.5 ADCK1 FLJ39600 ENSG00000063761 AarF domain containing kinase 1 14 77800083-77935012 Enzymes, Predicted secreted proteins Evidence at protein level HPA051012, HPA055014 Uncertain Approved Nucleoplasm Renal cancer:5.82e-6 (favourable), Lung cancer:4.11e-5 (favourable), Liver cancer:1.70e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 9.0 ADCK2 MGC20727 ENSG00000133597 AarF domain containing kinase 2 7 140673153-140696261 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036036 Approved Uncertain Centrosome
Cytosol Renal cancer:9.75e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 26.7 ADCY7 AC7, KIAA0037 ENSG00000121281 Adenylate cyclase 7 16 50246137-50318135 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA041218, HPA048241 Uncertain Approved Cytosol Cervical cancer:5.31e-4 (unfavourable) Mixed Mixed spleen: 42.9 ADGB C6orf103, CAPN16, dJ408K24.1, FLJ23121 ENSG00000118492 Androglobin 6 146598965-146815462 Enzymes, Predicted intracellular proteins Evidence at protein level HPA036340, HPA036341 Supported Uncertain Nucleoplasm
Mitochondria Not detected Group enriched 24 fallopian tube: 14.6;testis: 58.0 lung: 1.4 ADGRA1 GPR123, KIAA1828 ENSG00000197177 Adhesion G protein-coupled receptor A1 10 133070929-133131675 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA042773 Approved Tissue enriched Tissue enhanced adrenal gland: 4.9;cerebral cortex: 22.5 fallopian tube: 3.1 ADGRD2 GPR144, PGR24 ENSG00000180264 Adhesion G protein-coupled receptor D2 9 124451600-124478589 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced epididymis: 2.3;seminal vesicle: 5.6 breast,parathyroid gland: 1.4 ADGRE1 EMR1, TM7LN3 ENSG00000174837 Adhesion G protein-coupled receptor E1 19 6887566-6940459 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level HPA052809 Uncertain Mixed Tissue enhanced appendix: 10.2;spleen: 20.1 lung: 6.8 ADGRE3 EMR3 ENSG00000131355 Adhesion G protein-coupled receptor E3 19 14619117-14690027 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA015638 Uncertain Not detected Tissue enhanced appendix: 8.9;spleen: 8.8 lung: 3.9 ADGRF2 GPR111, hGPCR35, PGR20 ENSG00000164393 Adhesion G protein-coupled receptor F2 6 47656436-47697797 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA035507 Uncertain Not detected Tissue enhanced fallopian tube: 1.5;skin: 1.4 esophagus: 0.3 ADGRF3 GPR113, hGPCR37, PGR23 ENSG00000173567 Adhesion G protein-coupled receptor F3 2 26308173-26346817 G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA044500 Uncertain Not detected Not detected kidney: 0.9 ADGRF4 FLJ38076, GPR115, PGR18 ENSG00000153294 Adhesion G protein-coupled receptor F4 6 47685864-47722021 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA007131, HPA007158 Supported Uncertain Mitochondria Pancreatic cancer:5.52e-4 (unfavourable) Mixed Group enriched 7 esophagus: 12.1;skin: 45.9 tonsil: 3.9 ADGRG4 GPR112, PGR17, RP1-299I16 ENSG00000156920 Adhesion G protein-coupled receptor G4 X 136300963-136416888 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA035324 Uncertain Not detected Tissue enhanced duodenum: 2.6;small intestine: 1.7 fallopian tube: 0.5 ADGRG5 GPR114, PGR27 ENSG00000159618 Adhesion G protein-coupled receptor G5 16 57542421-57591681 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA007133 Supported Approved Nucleoplasm
Nuclear membrane
Vesicles Cervical cancer:4.25e-4 (favourable) Mixed Tissue enhanced lymph node: 11.3;tonsil: 8.9 appendix: 6.2 ADM2 AM2, FLJ21135 ENSG00000128165 Adrenomedullin 2 22 50481556-50486440 Predicted secreted proteins Evidence at transcript level Thyroid cancer:2.72e-4 (unfavourable) Mixed Tissue enhanced thyroid gland: 19.2 kidney: 5.9 ADM5 AM5, C19orf76 ENSG00000224420 Adrenomedullin 5 (putative) 19 49688664-49690575 Predicted secreted proteins Evidence at transcript level Urothelial cancer:6.74e-4 (favourable) Mixed Mixed skin: 2.6 ADORA2B ENSG00000170425 Adenosine A2b receptor 17 15944917-15975746 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA073747 Uncertain Cytosol Mixed Mixed colon: 8.3 ADORA3 AD026 ENSG00000282608 Adenosine A3 receptor 1 111499429-111503760 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Mixed adrenal gland: 18.5 ADPRHL1 ARH2 ENSG00000153531 ADP-ribosylhydrolase like 1 13 113399610-113453524 Predicted intracellular proteins Evidence at protein level HPA066478 Supported Approved Nucleoplasm Liver cancer:2.55e-5 (unfavourable), Head and neck cancer:4.88e-4 (unfavourable) Mixed Group enriched 14 heart muscle: 252.1;skeletal muscle: 114.3 fallopian tube: 13.2 ADRA1D ADRA1, ADRA1A, ADRA1R ENSG00000171873 Adrenoceptor alpha 1D 20 4220631-4249074 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level HPA038789 Uncertain Mixed Tissue enhanced cervix, uterine: 4.3;prostate: 4.2 seminal vesicle: 2.5 ADRA2C ADRA2L2, ADRA2RL2, ADRARL2 ENSG00000184160 Adrenoceptor alpha 2C 4 3766348-3768526 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA057688 Uncertain Mixed Tissue enhanced cervix, uterine: 21.0;endometrium: 26.0;seminal vesicle: 26.7 fallopian tube: 7.9 ADTRP AIG1L, C6orf105, dJ413H6.1 ENSG00000111863 Androgen-dependent TFPI-regulating protein 6 11712054-11807046 Predicted membrane proteins Evidence at transcript level HPA048113 Uncertain Uncertain Nucleoli Renal cancer:1.13e-5 (unfavourable) Mixed Tissue enhanced small intestine: 81.0 duodenum: 62.8 AFMID DKFZp686F03259, KF ENSG00000183077 Arylformamidase 17 78187317-78207701 Enzymes, Predicted intracellular proteins Evidence at protein level HPA023861, HPA026536 Uncertain Approved Mitochondria Expressed in all Expressed in all kidney: 87.0 AGAP4 AGAP8, CTGLF1, CTGLF5, Em:AC012044.1, MRIP2 ENSG00000188234 ArfGAP with GTPase domain, ankyrin repeat and PH domain 4 10 45825594-45853875 Predicted intracellular proteins Evidence at transcript level HPA042490 Uncertain Mixed Expressed in all skin: 24.6 AGAP5 CTGLF2, Em:AC073389.1 ENSG00000172650 ArfGAP with GTPase domain, ankyrin repeat and PH domain 5 10 73674285-73698159 Predicted intracellular proteins Evidence at transcript level HPA042490 Uncertain Not detected Mixed testis: 11.8 AGAP6 bA324H6.1, CTGLF3 ENSG00000204149 ArfGAP with GTPase domain, ankyrin repeat and PH domain 6 10 49982190-50010499 Predicted intracellular proteins Evidence at transcript level HPA042490 Uncertain Renal cancer:9.70e-10 (unfavourable), Urothelial cancer:1.83e-7 (favourable), Pancreatic cancer:2.66e-4 (favourable) Expressed in all Expressed in all skin: 21.9 AGBL3 CCP3, MGC32955 ENSG00000146856 ATP/GTP binding protein-like 3 7 134986508-135147963 Enzymes, Predicted intracellular proteins Evidence at protein level HPA020397, HPA024150 Uncertain Uncertain Nuclear speckles
Mitochondria
Cytosol Renal cancer:4.02e-4 (unfavourable) Mixed Mixed testis: 9.3 AGBL4 CCP6, FLJ14442 ENSG00000186094 ATP/GTP binding protein-like 4 1 48532855-50023913 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA037994 Approved Not detected Tissue enhanced cerebral cortex: 7.9 fallopian tube: 4.6 AGBL5 CCP5, FLJ21839 ENSG00000084693 ATP/GTP binding protein-like 5 2 27042364-27070622 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA030981 Uncertain Approved Cytosol Liver cancer:6.87e-5 (unfavourable) Expressed in all Tissue enriched 6 testis: 357.5 parathyroid gland: 57.3 AIM1L CRYBG2, FLJ38020 ENSG00000176092 Absent in melanoma 1-like 1 26321859-26354130 Predicted intracellular proteins Evidence at protein level HPA029629, HPA029631 Uncertain Approved Nucleoplasm Endometrial cancer:5.11e-6 (unfavourable), Pancreatic cancer:3.53e-4 (unfavourable) Mixed Tissue enhanced esophagus: 50.7;skin: 21.6 placenta: 9.7 AKNAD1 C1orf62, MGC26989 ENSG00000162641 AKNA domain containing 1 1 108815898-108858228 Predicted intracellular proteins Evidence at transcript level HPA030270, HPA030271, HPA030272 Uncertain Tissue enhanced Tissue enriched 41 testis: 4.2 skin: 0.1 ALDH3B2 ALDH8 ENSG00000132746 Aldehyde dehydrogenase 3 family, member B2 11 67662162-67681200 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA045132 Approved Mixed Group enriched 5 breast: 88.2;esophagus: 103.8;skin: 122.4 tonsil: 19.7 ALG10 ALG10A, DIE2, FLJ14751 ENSG00000139133 ALG10, alpha-1,2-glucosyltransferase 12 34022281-34029694 Enzymes, Predicted membrane proteins Evidence at protein level HPA043329, HPA063387 Approved Approved Endoplasmic reticulum Mixed Mixed parathyroid gland: 4.6 ALG1L ALG1L1 ENSG00000189366 ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like 3 125929275-125937039 Predicted intracellular proteins Evidence at transcript level HPA036108 Uncertain Glioma:1.82e-4 (favourable), Urothelial cancer:6.24e-4 (favourable) Expressed in all Tissue enhanced epididymis: 12.5;urinary bladder: 15.4 skin: 6.8 ALPK1 FLJ22670, KIAA1527, Lak ENSG00000073331 Alpha-kinase 1 4 112285509-112442620 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA027435, HPA027443 Approved Approved Centrosome Renal cancer:5.82e-7 (unfavourable), Urothelial cancer:1.17e-4 (favourable) Expressed in all Mixed parathyroid gland: 9.2 ALPK2 HAK ENSG00000198796 Alpha-kinase 2 18 58481247-58628957 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level HPA027377, HPA027976, HPA028084, HPA029801 Uncertain Approved Cytosol Renal cancer:8.20e-5 (unfavourable) Tissue enriched Tissue enhanced heart muscle: 28.3;skeletal muscle: 14.1 lymph node: 6.9 ALPK3 KIAA1330, MAK, Midori ENSG00000136383 Alpha-kinase 3 15 84816680-84873482 Enzymes, Predicted intracellular proteins Evidence at protein level HPA026558 Uncertain Approved Nucleus Renal cancer:3.95e-7 (favourable) Mixed Tissue enhanced heart muscle: 32.4;parathyroid gland: 35.6;skeletal muscle: 47.6 adipose tissue: 12.3 ALPPL2 ENSG00000163286 Alkaline phosphatase, placental-like 2 2 232406843-232410714 Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level CAB020698, HPA038764, HPA038765, HPA051699 Supported Approved Plasma membrane Tissue enhanced Tissue enhanced cervix, uterine: 1.1;fallopian tube: 1.9 lung: 0.7 AMBN ENSG00000178522 Ameloblastin (enamel matrix protein) 4 70592256-70607288 Disease related genes, Predicted secreted proteins Evidence at protein level Group enriched Not detected cerebral cortex: 0.3 AMELY AMGL ENSG00000099721 Amelogenin, Y-linked Y 6865918-6874027 Predicted secreted proteins Evidence at transcript level Not detected Not detected thyroid gland: 0.2 AMIGO3 ENSG00000176020 Adhesion molecule with Ig-like domain 3 3 49716834-49719695 Predicted membrane proteins Evidence at transcript level HPA026673 Uncertain Not detected Mixed skeletal muscle: 1.0 AMN1 ENSG00000151743 Antagonist of mitotic exit network 1 homolog 12 31671137-31729174 Predicted intracellular proteins Evidence at protein level HPA046157, HPA062290 Uncertain Approved Centrosome Expressed in all Expressed in all testis: 99.3 ANGEL1 Ccr4e, KIAA0759 ENSG00000013523 Angel homolog 1 (Drosophila) 14 76786178-76826246 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA000948 Uncertain Approved Nucleoplasm Lung cancer:3.43e-4 (favourable), Pancreatic cancer:5.46e-4 (favourable) Expressed in all Expressed in all testis: 68.0 ANGEL2 Ccr4d, FLJ12793, KIAA0759L ENSG00000174606 Angel homolog 2 (Drosophila) 1 212992182-213015826 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA030796 Uncertain Approved Nucleoplasm
Mitochondria Renal cancer:8.39e-6 (unfavourable), Urothelial cancer:1.20e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 17.0 ANGPTL1 ANG3, ANGPT3, AngY, ARP1 ENSG00000116194 Angiopoietin-like 1 1 178849705-178871052 Predicted secreted proteins Evidence at protein level HPA009976 Approved Renal cancer:5.11e-4 (favourable), Liver cancer:8.73e-4 (favourable) Mixed Tissue enhanced placenta: 188.3 smooth muscle: 95.5 ANGPTL2 ARP2, HARP ENSG00000136859 Angiopoietin-like 2 9 127087332-127122883 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA040933, HPA041299 Approved Renal cancer:3.32e-5 (unfavourable) Expressed in all Mixed adipose tissue: 114.6 ANGPTL5 ENSG00000187151 Angiopoietin-like 5 11 101890674-101916522 Predicted secreted proteins Evidence at protein level HPA038516 Uncertain Not detected Tissue enhanced ovary: 27.2 breast: 7.2 ANHX ENSG00000227059 Anomalous homeobox 12 133218312-133236095 Predicted intracellular proteins Evidence at protein level Tissue enriched Tissue enriched 76 testis: 7.5 all non-specific tissues: 0.0 ANKAR FLJ25415 ENSG00000151687 Ankyrin and armadillo repeat containing 2 189674290-189761193 Predicted intracellular proteins Evidence at transcript level HPA036168 Uncertain Approved Nucleus
Microtubule organizing center Mixed Tissue enriched 7 testis: 10.2 parathyroid gland: 1.4 ANKDD1A FLJ25870 ENSG00000166839 Ankyrin repeat and death domain containing 1A 15 64911902-64958700 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA040757 Approved Approved Nucleoplasm Mixed Mixed spleen: 15.6 ANKEF1 ANKRD5, dJ839B4.6, FLJ21669 ENSG00000132623 Ankyrin repeat and EF-hand domain containing 1 20 9986126-10058303 Predicted intracellular proteins Evidence at protein level HPA041151 Approved Approved Nucleoli fibrillar center
Plasma membrane
Cytosol Thyroid cancer:1.58e-4 (unfavourable), Lung cancer:1.81e-4 (unfavourable), Renal cancer:4.44e-4 (favourable) Mixed Tissue enhanced testis: 33.7 thyroid gland: 11.3 ANKFN1 FLJ38335 ENSG00000153930 Ankyrin-repeat and fibronectin type III domain containing 1 17 56110958-56511659 Predicted intracellular proteins Evidence at protein level HPA021566, HPA022538 Uncertain Mixed Tissue enhanced cervix, uterine: 14.1;fallopian tube: 8.3 cerebral cortex: 3.1 ANKK1 X-kinase ENSG00000170209 Ankyrin repeat and kinase domain containing 1 11 113387791-113400418 Enzymes, Predicted intracellular proteins Evidence at protein level HPA012813 Uncertain Mixed Tissue enhanced skin: 4.2 fallopian tube: 1.3 ANKLE1 ANKRD41, FLJ39369, LEMD6 ENSG00000160117 Ankyrin repeat and LEM domain containing 1 19 17281645-17287646 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA026789, HPA073498 Approved Approved Nucleoplasm
Cytosol Endometrial cancer:4.86e-5 (unfavourable) Mixed Tissue enhanced bone marrow: 13.8 lymph node: 3.7 ANKMY1 FLJ20499, ZMYND13 ENSG00000144504 Ankyrin repeat and MYND domain containing 1 2 240479422-240569209 Predicted intracellular proteins Evidence at protein level HPA026620 Uncertain Approved Nucleus
Nuclear bodies
Cytosol Urothelial cancer:3.20e-4 (favourable) Expressed in all Group enriched 7 fallopian tube: 39.0;testis: 118.1 parathyroid gland: 11.0 ANKRD13C dJ677H15.3, DKFZP566D1346 ENSG00000118454 Ankyrin repeat domain 13C 1 70260588-70354734 Predicted intracellular proteins Evidence at protein level HPA026766 Uncertain Expressed in all Expressed in all parathyroid gland: 18.8 ANKRD18A FLJ35740, KIAA2015 ENSG00000180071 Ankyrin repeat domain 18A 9 38571358-38620660 Predicted intracellular proteins Evidence at protein level HPA046346, HPA046695, HPA049923, HPA051288 Uncertain Supported Nucleoli
Cytosol Mixed Tissue enhanced bone marrow: 12.0;testis: 11.5 thyroid gland: 3.8 ANKRD20A1 ANKRD20A, DKFZp434A171 ENSG00000260691 Ankyrin repeat domain 20 family, member A1 9 67859147-67902094 Predicted intracellular proteins Evidence at transcript level HPA043239, HPA047112, HPA047167, HPA047766, HPA051753 Uncertain Not detected Tissue enriched 7 testis: 5.1 cerebral cortex,spleen: 0.7 ANKRD22 MGC22805 ENSG00000152766 Ankyrin repeat domain 22 10 88822132-88851818 Predicted intracellular proteins Evidence at protein level HPA012922 Approved Approved Nucleus Endometrial cancer:8.73e-6 (favourable), Pancreatic cancer:6.15e-4 (unfavourable) Expressed in all Tissue enhanced skin: 38.6;stomach: 48.9 esophagus: 27.1 ANKRD24 KIAA1981 ENSG00000089847 Ankyrin repeat domain 24 19 4183354-4224814 Predicted intracellular proteins Evidence at protein level HPA041534, HPA048498 Uncertain Uncertain Microtubules
Cytosol Liver cancer:9.13e-5 (favourable) Mixed Tissue enhanced cerebral cortex: 13.6;testis: 7.0 prostate: 2.8 ANKRD29 FLJ25053 ENSG00000154065 Ankyrin repeat domain 29 18 23598926-23662885 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA041272, HPA049419 Uncertain Approved Nucleoplasm
Nuclear bodies Head and neck cancer:1.92e-5 (favourable), Lung cancer:5.98e-5 (favourable), Renal cancer:7.20e-5 (favourable) Mixed Mixed lung: 47.5 ANKRD30A NY-BR-1 ENSG00000148513 Ankyrin repeat domain 30A 10 37125788-37384111 Predicted intracellular proteins Evidence at protein level Tissue enriched Tissue enriched 15 breast: 49.0 testis: 3.3 ANKRD30B NY-BR-1.1 ENSG00000180777 Ankyrin repeat domain 30B 18 14728272-14852738 Predicted intracellular proteins Evidence at protein level HPA060455 Uncertain Tissue enhanced Tissue enriched 11 testis: 14.3 breast: 1.3 ANKRD30BL ANKRD30BP3, NCRNA00164 ENSG00000163046 Ankyrin repeat domain 30B-like 2 132147591-132257969 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 30 testis: 3.0 appendix: 0.1 ANKRD33 C12orf7, DKFZp686O1689, PANKY ENSG00000167612 Ankyrin repeat domain 33 12 51887960-51891664 Predicted intracellular proteins Evidence at transcript level HPA040013, HPA058753 Uncertain Not detected Not detected placenta: 0.5 ANKRD34A ANKRD34 ENSG00000272031 Ankyrin repeat domain 34A 1 145959442-145964582 Predicted intracellular proteins Evidence at protein level HPA029642, HPA029643 Uncertain Validated Cytosol Mixed Tissue enriched 5 cerebral cortex: 12.7 parathyroid gland: 2.4 ANKRD34B DP58 ENSG00000189127 Ankyrin repeat domain 34B 5 80556755-80570488 Predicted intracellular proteins Evidence at protein level HPA043327, HPA061740 Uncertain Approved Lipid droplets Tissue enhanced Tissue enhanced bone marrow: 1.1;lymph node: 1.0;tonsil: 1.2 kidney: 0.7 ANKRD35 FLJ25124 ENSG00000198483 Ankyrin repeat domain 35 1 145866560-145885866 Predicted intracellular proteins Evidence at protein level HPA035452, HPA035453 Approved Approved Plasma membrane Cervical cancer:2.90e-4 (favourable), Breast cancer:9.35e-4 (favourable) Mixed Group enriched 6 cervix, uterine: 30.6;esophagus: 16.7;skin: 69.9 tonsil: 6.3 ANKRD36 UNQ2430 ENSG00000135976 Ankyrin repeat domain 36 2 97113496-97264521 Predicted intracellular proteins Evidence at protein level HPA051757, HPA057661 Approved Nucleus
Cytosol Mixed Mixed testis: 12.7 ANKRD36C DKFZp667P0924 ENSG00000174501 Ankyrin repeat domain 36C 2 95836919-95991831 Predicted intracellular proteins Evidence at protein level HPA051757, HPA057661 Approved Nucleus
Cytosol Mixed Tissue enhanced testis: 21.9 bone marrow: 10.7 ANKRD37 Lrp2bp ENSG00000186352 Ankyrin repeat domain 37 4 185396021-185400628 Predicted intracellular proteins Evidence at protein level HPA036626, HPA058127 Uncertain Supported Nucleus
Mitochondria
Cytosol Expressed in all Mixed prostate: 31.3 ANKRD42 FLJ37874, PPP1R79, SARP ENSG00000137494 Ankyrin repeat domain 42 11 83193739-83260694 Predicted intracellular proteins Evidence at protein level HPA039917 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Expressed in all Tissue enhanced testis: 71.7 epididymis: 28.4 ANKRD53 FLJ12056, FLJ36160 ENSG00000144031 Ankyrin repeat domain 53 2 70978380-70985499 Predicted intracellular proteins Evidence at transcript level HPA049574 Approved Mixed Tissue enhanced testis: 17.5 adipose tissue: 4.3 ANKRD55 FLJ11795 ENSG00000164512 Ankyrin repeat domain 55 5 56099678-56233359 Predicted intracellular proteins Evidence at protein level HPA051049 Approved Tissue enriched Group enriched 5 lymph node: 4.2;testis: 17.2 tonsil: 1.9 ANKRD62 DKFZp779B1634 ENSG00000181626 Ankyrin repeat domain 62 18 12093853-12129749 Predicted intracellular proteins Evidence at protein level HPA059835 Supported Not detected Tissue enriched 11 testis: 4.1 pancreas: 0.3 ANKRD65 ENSG00000235098 Ankyrin repeat domain 65 1 1418420-1421769 Predicted intracellular proteins Evidence at protein level HPA065720 Approved Approved Nucleoplasm Lung cancer:1.08e-5 (favourable) Expressed in all Tissue enhanced fallopian tube: 60.1 seminal vesicle: 31.8 ANKRD66 ENSG00000230062 Ankyrin repeat domain 66 6 46746917-46759506 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enriched 13 fallopian tube: 63.1 lung: 4.9 ANKRD7 TSA806 ENSG00000106013 Ankyrin repeat domain 7 7 118214669-118496171 Predicted intracellular proteins Evidence at protein level HPA043489 Approved Nucleus Tissue enhanced Tissue enriched 569 testis: 1533.6 epididymis: 2.6 ANKRD9 ENSG00000156381 Ankyrin repeat domain 9 14 102501760-102509799 Predicted intracellular proteins Evidence at protein level HPA055985 Uncertain Renal cancer:1.17e-7 (favourable) Expressed in all Expressed in all duodenum: 51.8 ANKUB1 C3orf16 ENSG00000206199 Ankyrin repeat and ubiquitin domain containing 1 3 149761105-149968385 Predicted intracellular proteins Evidence at transcript level HPA053749 Uncertain Not detected Tissue enriched 5 fallopian tube: 8.7 lung: 1.6 ANO4 FLJ34221, FLJ34272, FLJ35277, TMEM16D ENSG00000151572 Anoctamin 4 12 100717526-101128641 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA053412 Uncertain Renal cancer:5.48e-5 (favourable) Mixed Group enriched 6 adrenal gland: 17.6;cerebral cortex: 10.0;cervix, uterine: 12.5;endometrium: 8.3;ovary: 10.9;prostate: 10.9;seminal vesicle: 11.3 testis: 2.0 ANO9 PIG5, TMEM16J, TP53I5 ENSG00000185101 Anoctamin 9 11 417933-442011 Predicted membrane proteins, Transporters Evidence at protein level HPA039948, HPA040112 Approved Uncertain Golgi apparatus Urothelial cancer:8.81e-4 (favourable) Tissue enhanced Tissue enhanced duodenum: 32.4;small intestine: 31.6 skin: 21.6 ANP32D PP32R2 ENSG00000139223 Acidic (leucine-rich) nuclear phosphoprotein 32 family, member D 12 48472665-48473624 Predicted intracellular proteins Evidence at protein level HPA063133, HPA067561 Uncertain Approved Nucleoplasm
Centrosome
Cytosol Not detected Not detected testis,thyroid gland: 0.1 ANXA8L1 ANXA8L2, bA145E20.2, bA301J7.3 ENSG00000264230 Annexin A8-like 1 10 46375627-46537864 Predicted intracellular proteins Evidence at protein level HPA045246, HPA047451 Approved Nucleoplasm Mixed Group enriched 7 esophagus: 200.1;skin: 461.5 urinary bladder: 45.9 AP3M2 AP47B, CLA20 ENSG00000070718 Adaptor-related protein complex 3, mu 2 subunit 8 42152946-42171673 Predicted intracellular proteins Evidence at protein level CAB014876, HPA045591, HPA048380 Approved Urothelial cancer:2.38e-4 (favourable), Endometrial cancer:3.46e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 47.0 AP3S2 sigma3b ENSG00000157823 Adaptor-related protein complex 3, sigma 2 subunit 15 89830599-89894638 Predicted intracellular proteins Evidence at transcript level HPA049270 Uncertain Approved Vesicles Renal cancer:5.55e-16 (favourable) Expressed in all Expressed in all parathyroid gland: 76.2 AP4S1 AP47B, CLA20, SPG52 ENSG00000100478 Adaptor-related protein complex 4, sigma 1 subunit 14 31025106-31096450 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA039963 Approved Renal cancer:2.87e-6 (favourable), Lung cancer:7.44e-4 (favourable) Expressed in all Expressed in all testis: 33.2 APCDD1L FLJ90166 ENSG00000198768 Adenomatosis polyposis coli down-regulated 1-like 20 58459101-58515131 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA067015 Uncertain Uncertain Mitochondria Mixed Tissue enhanced breast: 6.5;salivary gland: 11.7 kidney: 2.9 APELA ELA, Ende, tdl ENSG00000248329 Apelin receptor early endogenous ligand 4 164877004-164898965 Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced prostate: 6.6 kidney: 2.1 APLN apelin, XNPEP2 ENSG00000171388 Apelin X 129645259-129654937 Predicted secreted proteins Evidence at transcript level Renal cancer:9.61e-5 (unfavourable), Cervical cancer:2.92e-4 (unfavourable), Lung cancer:6.09e-4 (unfavourable), Liver cancer:9.32e-4 (unfavourable) Group enriched Tissue enhanced placenta: 79.3 lung: 20.9 APOBEC4 C1orf169, FLJ25691, MGC26594, RP1-127C7.4 ENSG00000173627 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative) 1 183646404-183653316 Predicted intracellular proteins Evidence at transcript level HPA015636, HPA015637 Approved Endometrial cancer:2.65e-4 (favourable) Tissue enhanced Group enriched 10 fallopian tube: 19.3;testis: 18.4 lung: 1.9 APOL4 APOLIV ENSG00000100336 Apolipoprotein L, 4 22 36189124-36204840 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA049797, HPA055435 Approved Supported Vesicles Urothelial cancer:2.40e-6 (favourable), Renal cancer:2.00e-5 (unfavourable), Ovarian cancer:3.45e-4 (favourable) Expressed in all Tissue enhanced prostate: 27.8 lung: 19.8 APOL5 APOLV ENSG00000128313 Apolipoprotein L, 5 22 35717872-35729483 Plasma proteins, Predicted intracellular proteins Evidence at transcript level HPA040968 Uncertain Tissue enriched Not detected skeletal muscle,testis: 0.5 APOL6 APOL-VI, APOLVI ENSG00000221963 Apolipoprotein L, 6 22 35648395-35668409 Predicted membrane proteins Evidence at protein level CAB028574, HPA029165, HPA029167 Approved Supported Nucleoplasm
Nuclear bodies
Cytosol Urothelial cancer:6.61e-4 (favourable) Expressed in all Mixed spleen: 25.5 APOLD1 DKFZP434F0318, FLJ25138 ENSG00000178878 Apolipoprotein L domain containing 1 12 12725917-12829975 Predicted membrane proteins Evidence at protein level HPA052462, HPA058882 Approved Validated Nucleoplasm
Cytosol Expressed in all Tissue enhanced adipose tissue: 142.0 placenta: 121.8 APOPT1 APOP-1, C14orf153, MGC2562 ENSG00000256053 Apoptogenic 1, mitochondrial 14 103562962-103607523 Predicted intracellular proteins Evidence at transcript level Liver cancer:6.34e-5 (unfavourable), Ovarian cancer:4.78e-4 (favourable) Expressed in all Expressed in all testis: 89.3 AQP10 ENSG00000143595 Aquaporin 10 1 154321090-154325325 Predicted membrane proteins, Transporters Evidence at protein level HPA065947 Supported Not detected Group enriched 8 duodenum: 70.3;small intestine: 50.1 fallopian tube: 7.1 AQP11 ENSG00000178301 Aquaporin 11 11 77589391-77610355 Predicted membrane proteins, Transporters Evidence at protein level HPA042879 Approved Approved Nucleoplasm
Vesicles Ovarian cancer:9.89e-4 (favourable) Mixed Tissue enhanced duodenum: 24.8;small intestine: 23.6 adrenal gland: 10.1 AQP12A AQP12 ENSG00000184945 Aquaporin 12A 2 240691845-240698483 Predicted membrane proteins, Transporters Evidence at protein level HPA042216 Supported Not detected Tissue enriched 67 pancreas: 27.7 duodenum,small intestine: 0.4 AQP12B INSSA3 ENSG00000185176 Aquaporin 12B 2 240676418-240682906 Predicted membrane proteins Evidence at protein level HPA042216 Supported Not detected Tissue enriched 56 pancreas: 35.7 duodenum: 0.6 AQP3 GIL ENSG00000165272 Aquaporin 3 (Gill blood group) 9 33441154-33447611 Blood group antigen proteins, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA014924 Supported Supported Nucleus
Plasma membrane Cervical cancer:5.31e-4 (favourable) Expressed in all Expressed in all esophagus: 975.2 AQP6 AQP2L ENSG00000086159 Aquaporin 6, kidney specific 12 49967194-49977139 Predicted membrane proteins, Transporters Evidence at protein level HPA015278 Supported Tissue enriched Tissue enriched 9 kidney: 20.8 cerebral cortex: 2.3 AQP8 ENSG00000103375 Aquaporin 8 16 25215731-25228940 Predicted membrane proteins, Transporters Evidence at protein level HPA046259 Approved Group enriched Group enriched 132 colon: 325.1;pancreas: 269.4;rectum: 169.2 smooth muscle: 1.9 AQP9 HsT17287, SSC1 ENSG00000103569 Aquaporin 9 15 58138169-58185911 Predicted membrane proteins Evidence at transcript level Renal cancer:5.72e-11 (unfavourable) Tissue enriched Tissue enhanced appendix: 104.4;liver: 352.6 epididymis: 49.4 ARC Arg3.1, KIAA0278 ENSG00000198576 Activity-regulated cytoskeleton-associated protein 8 142611044-142614472 Predicted intracellular proteins Evidence at protein level HPA056430 Approved Vesicles
Microtubules Tissue enriched Group enriched 7 adipose tissue: 14.1;adrenal gland: 13.4;cerebral cortex: 14.4;gallbladder: 3.3;seminal vesicle: 5.5 placenta: 1.4 ARGFX ENSG00000186103 Arginine-fifty homeobox 3 121570704-121586634 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043049 Uncertain Tissue enriched Not detected testis: 0.6 ARHGAP11B B'-T, FAM7B1 ENSG00000187951 Rho GTPase activating protein 11B 15 30624494-30772993 Predicted intracellular proteins Evidence at protein level HPA064479 Uncertain Approved Vesicles Mixed Tissue enhanced bone marrow: 2.0 lymph node,testis: 1.1 ARHGAP36 FLJ30058 ENSG00000147256 Rho GTPase activating protein 36 X 131058242-131089883 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA002064 Supported Approved Nucleus
Vesicles
Plasma membrane Tissue enriched Tissue enriched 19 adrenal gland: 138.4 cerebral cortex: 7.4 ARHGEF33 ENSG00000214694 Rho guanine nucleotide exchange factor (GEF) 33 2 38889880-38975449 Predicted intracellular proteins Evidence at protein level HPA034661, HPA041051 Supported Supported Vesicles Mixed Tissue enhanced testis: 10.7 ovary: 4.3 ARHGEF37 FLJ41603 ENSG00000183111 Rho guanine nucleotide exchange factor (GEF) 37 5 149551947-149634968 Predicted intracellular proteins Evidence at protein level HPA043885, HPA053487 Uncertain Approved Cytosol Renal cancer:6.85e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 67.1 ARHGEF38 FLJ20184 ENSG00000236699 Rho guanine nucleotide exchange factor (GEF) 38 4 105552620-105708093 Predicted intracellular proteins Evidence at protein level HPA036510, HPA045484 Approved Approved Nucleoplasm
Centrosome Tissue enhanced Tissue enhanced breast: 9.9 prostate: 8.4 ARIH2OS C3orf71 ENSG00000221883 Ariadne homolog 2 opposite strand 3 48917788-48919385 Predicted membrane proteins Evidence at transcript level Mixed Mixed testis: 4.2 ARL10 ARL10A ENSG00000175414 ADP-ribosylation factor-like 10 5 176365468-176401865 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA047044 Approved Mixed Mixed skin: 17.0 ARL13A ARL13 ENSG00000174225 ADP-ribosylation factor-like 13A X 100969708-100990829 Predicted intracellular proteins Evidence at transcript level HPA037377, HPA037378 Uncertain Not detected Tissue enriched 7 testis: 7.5 parathyroid gland: 1.1 ARL17A ARF1P2, ARL17P1 ENSG00000185829 ADP-ribosylation factor-like 17A 17 46516702-46579722 Predicted intracellular proteins Evidence at protein level HPA046814 Uncertain Not detected Mixed endometrium: 13.3 ARL17B ARL17 ENSG00000228696 ADP-ribosylation factor-like 17B 17 46274784-46361797 Predicted intracellular proteins Evidence at protein level HPA046814 Uncertain Not detected Mixed ovary: 7.6 ARL9 ENSG00000196503 ADP-ribosylation factor-like 9 4 56505343-56524448 Predicted intracellular proteins Evidence at protein level HPA072942 Supported Approved Nucleoli
Mitochondria Mixed Tissue enhanced testis: 12.6 seminal vesicle: 3.1 ARMC12 C6orf81, FLJ25390 ENSG00000157343 Armadillo repeat containing 12 6 35737032-35749079 Predicted intracellular proteins Evidence at protein level HPA030895 Approved Nucleoplasm
Plasma membrane Mixed Tissue enriched 8 testis: 62.9 epididymis: 7.4 ARMC2 bA787I22.1, DKFZp434P0714 ENSG00000118690 Armadillo repeat containing 2 6 108848416-108974472 Predicted intracellular proteins Evidence at protein level HPA025809, HPA053696 Uncertain Approved Nucleus Mixed Tissue enhanced testis: 61.6 fallopian tube: 33.3 ARMC3 CT81, FLJ32827 ENSG00000165309 Armadillo repeat containing 3 10 22928024-23038523 Predicted intracellular proteins Evidence at protein level HPA037823, HPA037824 Supported Tissue enhanced Group enriched 12 fallopian tube: 73.4;testis: 60.7 lung: 5.5 ARMCX2 ALEX2, GASP9, KIAA0512 ENSG00000184867 Armadillo repeat containing, X-linked 2 X 101655281-101659891 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA005761 Supported Approved Nucleus
Mitochondria Pancreatic cancer:3.45e-5 (favourable), Stomach cancer:2.69e-4 (unfavourable) Expressed in all Tissue enhanced epididymis: 199.2 thyroid gland: 107.0 ARMCX6 FLJ20811, GASP10 ENSG00000198960 Armadillo repeat containing, X-linked 6 X 101615118-101618001 Predicted membrane proteins Evidence at protein level HPA043030, HPA048125 Approved Supported Nucleus
Nuclear membrane
Cytosol Expressed in all Expressed in all parathyroid gland: 33.6 ARMS2 ARMD8, LOC387715 ENSG00000254636 Age-related maculopathy susceptibility 2 10 122454653-122457352 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA067225 Approved Not detected Tissue enhanced placenta: 2.1;testis: 2.8 ovary: 1.2 ARRDC2 CLONE24945, PP2703 ENSG00000105643 Arrestin domain containing 2 19 18001132-18014102 Predicted intracellular proteins Evidence at transcript level HPA053788 Uncertain Approved Nucleoplasm
Cytosol Urothelial cancer:2.92e-4 (favourable), Ovarian cancer:5.84e-4 (unfavourable), Cervical cancer:5.93e-4 (favourable), Thyroid cancer:6.91e-4 (favourable) Expressed in all Expressed in all bone marrow: 51.1 ARSH ENSG00000205667 Arylsulfatase family, member H X 3006613-3033571 Predicted membrane proteins Evidence at transcript level Not detected Not detected epididymis: 0.9 ARSJ FLJ23548 ENSG00000180801 Arylsulfatase family, member J 4 113900284-113979727 Predicted intracellular proteins Evidence at protein level HPA036481, HPA036482 Uncertain Supported Nucleoli
Actin filaments Renal cancer:2.97e-6 (favourable), Head and neck cancer:6.08e-4 (unfavourable) Mixed Mixed parathyroid gland: 12.5 ART1 ART2, CD296 ENSG00000129744 ADP-ribosyltransferase 1 11 3645128-3664416 CD markers, Enzymes, Predicted membrane proteins Evidence at transcript level HPA051148 Uncertain Not detected Tissue enriched 21 skeletal muscle: 16.4 esophagus: 0.7 ART4 CD297, DO, DOK1 ENSG00000111339 ADP-ribosyltransferase 4 (Dombrock blood group) 12 14825569-14843495 Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA075664 Uncertain Rods & Rings Tissue enhanced Tissue enhanced liver: 27.1;spleen: 27.3 gallbladder: 15.2 ART5 ENSG00000167311 ADP-ribosyltransferase 5 11 3638503-3642316 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA041637, HPA044099 Uncertain Renal cancer:1.85e-4 (favourable) Tissue enhanced Tissue enhanced ovary: 10.2;testis: 22.6 endometrium: 5.1 ARV1 ENSG00000173409 ARV1 homolog, fatty acid homeostasis modulator 1 230978981-231000595 Predicted membrane proteins, Transporters Evidence at protein level HPA035709 Approved Approved Vesicles Lung cancer:3.27e-5 (favourable), Colorectal cancer:1.33e-4 (favourable) Expressed in all Expressed in all testis: 61.6 ASAH2B ASAH2C, ASAH2L, bA449O16.3, bA98I6.3 ENSG00000204147 N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B 10 50739318-50816495 Predicted intracellular proteins Evidence at protein level HPA061171 Supported Approved Focal adhesion sites Mixed Mixed duodenum: 20.1 ASB14 DKFZp313L0121 ENSG00000239388 Ankyrin repeat and SOCS box containing 14 3 57268347-57292682 Predicted intracellular proteins Evidence at protein level Not detected Tissue enhanced skeletal muscle: 9.9 heart muscle: 2.2 ASB15 FLJ43370 ENSG00000146809 Ankyrin repeat and SOCS box containing 15 7 123567010-123639481 Predicted intracellular proteins Evidence at protein level Not detected Tissue enhanced heart muscle: 19.6;skeletal muscle: 43.9 kidney: 7.4 ASB17 ENSG00000154007 Ankyrin repeat and SOCS box containing 17 1 75918873-75932431 Plasma proteins, Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 381 testis: 84.0 kidney: 0.2 ASB18 ENSG00000182177 Ankyrin repeat and SOCS box containing 18 2 236194872-236264409 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA068447 Approved Not detected Group enriched 7 heart muscle: 3.9;skeletal muscle: 3.6;testis: 1.0 cerebral cortex: 0.4 ASB4 ASB-4 ENSG00000005981 Ankyrin repeat and SOCS box containing 4 7 95478444-95540232 Predicted intracellular proteins Evidence at transcript level HPA055240 Uncertain Tissue enhanced Group enriched 10 adrenal gland: 50.4;skeletal muscle: 11.5 placenta: 2.9 ASB5 ENSG00000164122 Ankyrin repeat and SOCS box containing 5 4 176213673-176277571 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA028870 Uncertain Plasma membrane Head and neck cancer:5.67e-4 (unfavourable) Tissue enhanced Tissue enhanced skeletal muscle: 75.7 prostate: 18.1 ASB8 FLJ21255, MGC5540 ENSG00000177981 Ankyrin repeat and SOCS box containing 8 12 48147788-48181213 Predicted intracellular proteins Evidence at protein level HPA003299 Approved Renal cancer:6.57e-6 (favourable) Expressed in all Expressed in all skeletal muscle: 98.2 ASCL3 bHLHa42, HASH3, Sgn1 ENSG00000176009 Achaete-scute family bHLH transcription factor 3 11 8937579-8938211 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027032 Uncertain Not detected Tissue enriched 9 salivary gland: 3.3 prostate,testis: 0.3 ASNSD1 FLJ20752, NBLA00058, NS3TP1 ENSG00000138381 Asparagine synthetase domain containing 1 2 189661385-189670831 Predicted intracellular proteins Evidence at protein level HPA036132, HPA036133, HPA075042 Uncertain Approved Cytosol Glioma:5.68e-4 (favourable), Liver cancer:8.66e-4 (unfavourable) Expressed in all Expressed in all placenta: 50.9 ASPG C14orf76 ENSG00000166183 Asparaginase 14 104085679-104115581 Enzymes, Predicted intracellular proteins Evidence at protein level HPA069761 Approved Tissue enhanced Tissue enhanced liver: 29.4 heart muscle: 18.8 ASPHD2 FLJ39838 ENSG00000128203 Aspartate beta-hydroxylase domain containing 2 22 26429273-26445015 Predicted membrane proteins Evidence at protein level HPA000820 Uncertain Renal cancer:4.06e-5 (unfavourable) Mixed Tissue enhanced cerebral cortex: 12.9 stomach: 7.9 ASTN1 ASTN ENSG00000152092 Astrotactin 1 1 176857302-177164973 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA074112 Approved Golgi apparatus
Vesicles Tissue enriched Group enriched 6 adrenal gland: 19.7;cerebral cortex: 67.0 ovary: 7.4 ASTN2 KIAA0634 ENSG00000148219 Astrotactin 2 9 116425225-117415070 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA027035 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:6.66e-16 (favourable) Expressed in all Expressed in all prostate: 42.3 ASXL3 KIAA1713 ENSG00000141431 Additional sex combs like transcriptional regulator 3 18 33578615-33751192 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA039539, HPA040034 Uncertain Not detected Tissue enhanced ovary: 3.6 cerebral cortex: 2.8 ASZ1 ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3 ENSG00000154438 Ankyrin repeat, SAM and basic leucine zipper domain containing 1 7 117363222-117428123 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA020558 Supported Approved Nucleoplasm
Cytosol Not detected Tissue enriched 195 testis: 19.5 all non-specific tissues: 0.0 ATAD3C FLJ34599 ENSG00000215915 ATPase family, AAA domain containing 3C 1 1449689-1470158 Predicted intracellular proteins Evidence at protein level HPA065305 Approved Mitochondria Lung cancer:5.15e-4 (favourable) Mixed Mixed thyroid gland: 3.4 ATG9B APG9L2, FLJ14885, NOS3AS, SONE ENSG00000181652 Autophagy related 9B 7 151012209-151024499 Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced esophagus: 1.5;placenta: 2.0;skin: 1.2 testis: 0.8 ATOH1 bHLHa14, HATH1, MATH-1, Math1 ENSG00000172238 Atonal bHLH transcription factor 1 4 93828753-93830964 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level Colorectal cancer:3.26e-5 (favourable) Tissue enhanced Group enriched 9 colon: 18.0;duodenum: 11.4;rectum: 20.1;small intestine: 22.8 appendix: 2.0 ATOH8 bHLHa21, FLJ14708, HATH6 ENSG00000168874 Atonal bHLH transcription factor 8 2 85751344-85788066 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028406 Supported Nucleoplasm Pancreatic cancer:8.98e-6 (favourable), Renal cancer:3.80e-5 (favourable) Tissue enhanced Tissue enhanced adipose tissue: 31.6 lung: 17.1 ATP10A ATP10C, ATPVA, ATPVC, KIAA0566 ENSG00000206190 ATPase, class V, type 10A 15 25677273-25865172 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level HPA041496, HPA042509 Uncertain Renal cancer:6.60e-5 (unfavourable) Expressed in all Mixed lung: 10.5 ATP10B ATPVB, FLJ21477, KIAA0715 ENSG00000118322 ATPase, class V, type 10B 5 160563120-160852214 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA034574 Uncertain Group enriched Tissue enhanced colon: 36.7;rectum: 40.8 gallbladder: 21.5 ATP10D ATPVD, KIAA1487 ENSG00000145246 ATPase, class V, type 10D 4 47485288-47593486 Enzymes, Predicted membrane proteins Evidence at protein level HPA050808 Approved Supported Nucleoplasm
Plasma membrane Renal cancer:5.00e-8 (favourable) Expressed in all Mixed parathyroid gland: 22.1 ATP13A4 DKFZp761I1011, FLJ37958 ENSG00000127249 ATPase type 13A4 3 193402077-193593111 Disease related genes, Predicted membrane proteins Evidence at protein level HPA051932 Approved Nucleoplasm Head and neck cancer:3.91e-4 (favourable) Tissue enhanced Tissue enhanced epididymis: 89.1;parathyroid gland: 129.5;thyroid gland: 68.2 lung: 56.5 ATP13A5 FLJ16025 ENSG00000187527 ATPase type 13A5 3 193274790-193378843 Predicted membrane proteins Evidence at transcript level HPA031771, HPA031774 Uncertain Tissue enhanced Tissue enhanced breast: 17.8 salivary gland: 4.0 ATP1B4 ENSG00000101892 ATPase, Na+/K+ transporting, beta 4 polypeptide X 120362085-120383249 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 11 skeletal muscle: 20.5 prostate: 1.9 ATP4A ATP6A ENSG00000105675 ATPase, H+/K+ exchanging, alpha polypeptide 19 35550043-35563658 Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA039154 Supported Tissue enriched Tissue enriched 250 stomach: 537.7 pancreas: 2.1 ATP5G2 ENSG00000135390 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) 12 53632726-53677408 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA051469 Approved Expressed in all Expressed in all fallopian tube: 769.8 ATP5G3 ENSG00000154518 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) 2 175176258-175184607 Predicted membrane proteins Evidence at transcript level Renal cancer:2.31e-6 (favourable), Head and neck cancer:6.01e-4 (unfavourable), Colorectal cancer:9.90e-4 (favourable) Expressed in all Expressed in all heart muscle: 525.2 ATP6AP1L ENSG00000205464 ATPase, H+ transporting, lysosomal accessory protein 1-like 5 82279462-82386977 Predicted membrane proteins Evidence at transcript level HPA053771 Approved Approved Nucleoli
Cytosol Mixed Mixed testis: 10.3 ATP6V0B ATP6F, HATPL, VMA16 ENSG00000117410 ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b 1 43974487-43978295 Predicted membrane proteins Evidence at transcript level HPA044281 Approved Cytosol Renal cancer:3.62e-6 (favourable), Pancreatic cancer:3.24e-4 (favourable), Liver cancer:4.79e-4 (unfavourable), Urothelial cancer:8.87e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 181.8 ATP6V0D2 ATP6D2, FLJ38708, VMA6 ENSG00000147614 ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 8 85987323-86154228 Predicted intracellular proteins Evidence at protein level HPA055327, HPA058496 Supported Approved Vesicles Renal cancer:2.20e-6 (favourable) Tissue enriched Tissue enriched 15 kidney: 59.1 lung: 3.8 ATP6V0E1 ATP6H, ATP6V0E, M9.2 ENSG00000113732 ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 5 172983757-173035445 Predicted membrane proteins Evidence at transcript level Expressed in all Expressed in all epididymis: 758.5 ATP6V0E2 ATP6V0E2L, C7orf32 ENSG00000171130 ATPase, H+ transporting V0 subunit e2 7 149872968-149880698 Predicted membrane proteins Evidence at transcript level Renal cancer:8.26e-7 (favourable), Pancreatic cancer:5.80e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 261.8 ATP6V1G2 ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10 ENSG00000213760 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 6 31544462-31548427 Predicted intracellular proteins Evidence at protein level CAB004616 Supported Tissue enriched Tissue enriched 12 cerebral cortex: 16.8 lymph node: 1.4 ATP6V1G3 ATP6G3, Vma10 ENSG00000151418 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 1 198523222-198540945 Predicted intracellular proteins, Transporters Evidence at protein level HPA028701 Supported Tissue enriched Tissue enriched 11 kidney: 21.1 epididymis,seminal vesicle: 1.9 ATP8B3 ATPIK ENSG00000130270 ATPase, aminophospholipid transporter, class I, type 8B, member 3 19 1782075-1812276 Enzymes, Predicted membrane proteins Evidence at transcript level Renal cancer:4.80e-9 (unfavourable) Mixed Tissue enriched 7 testis: 28.7 bone marrow: 4.0 ATP9B ATPIIB ENSG00000166377 ATPase, class II, type 9B 18 79069285-79378283 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA029364 Approved Expressed in all Expressed in all testis: 39.0 ATRNL1 ALP, FLJ45344, KIAA0534 ENSG00000107518 Attractin-like 1 10 115093365-115948992 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA038070 Uncertain Approved Nucleus
Mitochondria Mixed Tissue enhanced cerebral cortex: 34.0 testis: 22.6 AVPR1B AVPR3 ENSG00000198049 Arginine vasopressin receptor 1B 1 206109692-206117699 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Tissue enhanced Not detected stomach: 0.3 AXDND1 C1orf125, FLJ32940 ENSG00000162779 Axonemal dynein light chain domain containing 1 1 179365720-179554735 Predicted intracellular proteins Evidence at protein level HPA071114 Supported Not detected Tissue enriched 52 testis: 24.4 epididymis,fallopian tube: 0.4 B3GALNT1 B3GALT3, beta3Gal-T3, galT3, GLOB, P1 ENSG00000169255 Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) 3 161083883-161105384 Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA041204 Approved Vesicles Expressed in all Mixed thyroid gland: 47.6 B3GALT1 beta3Gal-T1 ENSG00000172318 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 2 167868948-167874041 Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enhanced cerebral cortex: 5.2;colon: 3.8;rectum: 4.1 skeletal muscle: 1.8 B3GALT2 beta3Gal-T2 ENSG00000162630 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 1 193179045-193186654 Predicted membrane proteins Evidence at transcript level HPA078659 Approved Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 29.0;gallbladder: 26.0 heart muscle: 16.2 B3GALT4 beta3Gal-T4, GalT4 ENSG00000235863 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 6 33277132-33284832 Enzymes, Predicted secreted proteins Evidence at transcript level HPA043001 Approved Expressed in all Mixed testis: 3.8 B3GALT5 B3GalT-V, B3T5, beta3Gal-T5, GLCT5 ENSG00000183778 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 21 39556442-39673137 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA054092, HPA054684 Approved Endometrial cancer:6.36e-4 (favourable) Mixed Group enriched 5 colon: 23.1;duodenum: 28.2;gallbladder: 8.6;rectum: 41.3;small intestine: 37.9 stomach: 5.1 B3GNT7 beta3GnT7 ENSG00000156966 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 2 231395543-231401164 Predicted secreted proteins Evidence at protein level HPA035625, HPA035626 Supported Thyroid cancer:6.00e-4 (favourable) Expressed in all Tissue enhanced rectum: 74.0 colon: 55.3 B3GNT9 MGC4655 ENSG00000237172 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 16 67148105-67151214 Predicted secreted proteins Evidence at protein level HPA052743, HPA062734 Approved Supported Nucleoli fibrillar center
Golgi apparatus Expressed in all Tissue enhanced parathyroid gland: 47.3 thyroid gland: 27.9 B3GNTL1 B3GNT8 ENSG00000175711 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 17 82942155-83051810 Predicted intracellular proteins Evidence at protein level HPA023585, HPA024547 Supported Approved Nucleoli Mixed Mixed bone marrow: 5.0 B4GALT5 beta4GalT-V ENSG00000158470 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 20 49632945-49713878 Predicted secreted proteins Evidence at protein level Pancreatic cancer:1.87e-5 (unfavourable), Liver cancer:2.69e-5 (unfavourable) Expressed in all Expressed in all bone marrow: 59.9 B9D1 B9, EPPB9, MKS9 ENSG00000108641 B9 protein domain 1 17 19337554-19378182 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA022957 Approved Renal cancer:4.14e-4 (favourable) Expressed in all Expressed in all fallopian tube: 101.0 BAALC ENSG00000164929 Brain and acute leukemia, cytoplasmic 8 103140710-103230305 Predicted intracellular proteins Evidence at protein level HPA027132, HPA068307 Approved Supported Nucleus
Cytosol Tissue enriched Tissue enriched 16 cerebral cortex: 248.4 adrenal gland: 15.7 BARHL1 ENSG00000125492 BarH-like homeobox 1 9 132582185-132590266 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA004809 Approved Not detected Not detected all non-specific tissues: 0.0 BARX2 ENSG00000043039 BARX homeobox 2 11 129375940-129452279 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB033311, HPA068414 Supported Supported Nucleoplasm
Cytosol Urothelial cancer:3.06e-4 (unfavourable) Mixed Tissue enhanced esophagus: 104.2;salivary gland: 60.6 fallopian tube: 28.0 BBC3 JFY1, PUMA ENSG00000105327 BCL2 binding component 3 19 47220822-47232766 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB007752, HPA070403 Approved Approved Cytosol Urothelial cancer:2.62e-5 (favourable), Endometrial cancer:1.31e-4 (favourable) Expressed in all Mixed cerebral cortex,skin: 4.7 BBOF1 C14orf45, CCDC176 ENSG00000119636 Basal body orientation factor 1 14 74019353-74082863 Predicted intracellular proteins Evidence at protein level HPA003090, HPA003136 Uncertain Approved Nucleus
Plasma membrane
Microtubule organizing center Endometrial cancer:6.34e-4 (favourable) Expressed in all Tissue enhanced testis: 69.7 fallopian tube: 35.6 BCL6B BAZF, ZBTB28, ZNF62 ENSG00000161940 B-cell CLL/lymphoma 6, member B 17 7023020-7030290 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059147 Uncertain Head and neck cancer:8.56e-5 (favourable), Renal cancer:4.04e-4 (unfavourable) Expressed in all Mixed adipose tissue: 34.5 BEAN1 SCA31 ENSG00000166546 Brain expressed, associated with NEDD4, 1 16 66427297-66493529 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA053851 Uncertain Uncertain Nucleoplasm
Centrosome Mixed Mixed cerebral cortex: 2.2 BEND2 CXorf20, MGC33653 ENSG00000177324 BEN domain containing 2 X 18162931-18220883 Predicted intracellular proteins Evidence at protein level HPA009420, HPA013142 Supported Not detected Tissue enriched 30 testis: 9.9 spleen: 0.3 BEND4 CCDC4, FLJ35632, FLJ43965 ENSG00000188848 BEN domain containing 4 4 42110938-42152878 Predicted intracellular proteins Evidence at protein level HPA036850 Uncertain Approved Nucleus
Nucleoli fibrillar center
Cytosol Group enriched Tissue enhanced prostate: 5.2;testis: 17.7 lymph node: 2.5 BEST2 FLJ20132, VMD2L1 ENSG00000039987 Bestrophin 2 19 12751702-12758458 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level HPA046229 Approved Tissue enhanced Tissue enhanced colon: 15.8;rectum: 15.4 tonsil: 4.9 BEST3 MGC13168, MGC40411, VMD2L3 ENSG00000127325 Bestrophin 3 12 69643360-69699476 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA054582 Approved Tissue enriched Tissue enhanced cerebral cortex: 16.4;skeletal muscle: 12.2 testis: 5.9 BEST4 VMD2L2 ENSG00000142959 Bestrophin 4 1 44783585-44787705 Predicted membrane proteins Evidence at protein level HPA058564 Uncertain Mixed Tissue enhanced colon: 26.7;rectum: 21.9 duodenum: 11.6 BEX4 BEXL1, FLJ10097 ENSG00000102409 Brain expressed, X-linked 4 X 103215092-103217246 Predicted intracellular proteins Evidence at transcript level HPA045105, HPA051935 Uncertain Approved Nucleus
Cytosol Renal cancer:2.54e-14 (favourable), Pancreatic cancer:9.41e-4 (favourable) Expressed in all Expressed in all epididymis: 318.7 BHLHB9 GASP3, KIAA1701, p60TRP ENSG00000198908 Basic helix-loop-helix domain containing, class B, 9 X 102720688-102753540 Predicted intracellular proteins Evidence at transcript level HPA000887 Approved Cytosol Expressed in all Tissue enhanced cerebral cortex: 18.8 parathyroid gland: 8.3 BHLHE22 Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20 ENSG00000180828 Basic helix-loop-helix family, member e22 8 64580367-64583628 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064128, HPA064872, HPA067500 Supported Mixed Tissue enhanced cerebral cortex: 12.2 seminal vesicle: 3.3 BHLHE23 bA305P22.3, Beta4, BHLHB4, bHLHe23 ENSG00000125533 Basic helix-loop-helix family, member e23 20 63005927-63007035 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030575 Uncertain Tissue enriched Not detected testis: 0.1 BIVM FLJ20159 ENSG00000134897 Basic, immunoglobulin-like variable motif containing 13 102799049-102841535 Predicted intracellular proteins Evidence at protein level HPA050126 Approved Supported Nucleoplasm Expressed in all Expressed in all kidney: 17.8 BLACE ENSG00000204960 B-cell acute lymphoblastic leukemia expressed 7 155356985-155367934 Predicted intracellular proteins Evidence at transcript level HPA041918 Uncertain Tissue enriched Not detected bone marrow: 0.3 BMP5 ENSG00000112175 Bone morphogenetic protein 5 6 55753645-55875564 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enriched 5 placenta: 101.7 prostate: 20.2 BMP8A ENSG00000183682 Bone morphogenetic protein 8a 1 39491646-39525935 Predicted secreted proteins Evidence at transcript level Mixed Tissue enriched 19 thyroid gland: 80.6 testis: 4.2 BMP8B BMP8, OP-2 ENSG00000116985 Bone morphogenetic protein 8b 1 39757182-39788861 Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced thyroid gland: 35.7 adrenal gland: 8.0 BOD1L2 BOD1P, FAM44C, MGC33608 ENSG00000228075 Biorientation of chromosomes in cell division 1-like 2 18 57147062-57150300 Predicted intracellular proteins Evidence at transcript level HPA036293 Uncertain Not detected Tissue enriched 4237 testis: 423.7 all non-specific tissues: 0.0 BPIFA3 bA49G10.4, C20orf71, SPLUNC3 ENSG00000131059 BPI fold containing family A, member 3 20 33217310-33227758 Predicted secreted proteins Evidence at protein level HPA062708 Supported Not detected Tissue enriched 533 testis: 53.2 all non-specific tissues: 0.0 BPIFB3 C20orf185, dJ726C3.4, LPLUNC3, RYA3 ENSG00000186190 BPI fold containing family B, member 3 20 33055424-33073628 Plasma proteins, Predicted secreted proteins Evidence at transcript level HPA045741 Uncertain Tissue enriched Tissue enhanced testis: 1.0 salivary gland: 0.2 BPIFB4 C20orf186, dJ726C3.5, LPLUNC4 ENSG00000186191 BPI fold containing family B, member 4 20 33079644-33111751 Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced parathyroid gland: 1.3 testis: 0.7 BPIFC BPIL2, dJ149A16.7 ENSG00000184459 BPI fold containing family C 22 32413847-32464484 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA037665, HPA043306 Uncertain Group enriched Tissue enriched 19 skin: 75.7 breast: 4.0 BRI3 ENSG00000164713 Brain protein I3 7 98252379-98310441 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA042215 Uncertain Head and neck cancer:3.35e-4 (unfavourable) Expressed in all Expressed in all lung: 119.5 BRINP2 DBCCR1L2, FAM5B ENSG00000198797 Bone morphogenetic protein/retinoic acid inducible neural-specific 2 1 177171497-177282422 Predicted secreted proteins Evidence at transcript level HPA050681, HPA061920 Uncertain Approved Nucleoli
Vesicles Tissue enriched Group enriched 9 adrenal gland: 11.5;cerebral cortex: 35.5 testis: 2.4 BSN ZNF231 ENSG00000164061 Bassoon presynaptic cytomatrix protein 3 49554489-49671545 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA034757 Approved Mixed Tissue enriched 6 cerebral cortex: 28.3 epididymis: 4.7 BSPH1 BSP1, ELSPBP2 ENSG00000188334 Binder of sperm protein homolog 1 19 47968046-47992170 Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 2756 epididymis: 461.3 testis: 0.1 BSPRY FLJ20150 ENSG00000119411 B-box and SPRY domain containing 9 113349541-113371233 Predicted intracellular proteins Evidence at protein level HPA042889 Approved Approved Nucleoplasm
Cytosol Renal cancer:4.56e-14 (favourable) Mixed Tissue enhanced parathyroid gland: 250.1 thyroid gland: 50.2 BSX BSX1 ENSG00000188909 Brain-specific homeobox 11 122977570-122981720 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA015654 Uncertain Not detected Not detected testis: 0.2 BTBD11 ABTB2B, FLJ33957 ENSG00000151136 BTB (POZ) domain containing 11 12 107318413-107659642 Predicted intracellular proteins Evidence at protein level HPA055898 Approved Nucleoplasm Mixed Tissue enhanced parathyroid gland: 128.0 thyroid gland: 31.6 BTBD16 C10orf87, Em:AC061711.1, FLJ25359 ENSG00000138152 BTB (POZ) domain containing 16 10 122271306-122338162 Predicted intracellular proteins Evidence at protein level HPA040529, HPA057638 Uncertain Uncertain Nucleoli
Cytosol Renal cancer:1.50e-4 (unfavourable) Tissue enriched Group enriched 7 skin: 9.9;testis: 14.1;urinary bladder: 19.7 liver: 2.1 BTBD18 ENSG00000233436 BTB (POZ) domain containing 18 11 57743514-57751781 Predicted intracellular proteins Evidence at protein level HPA049325 Uncertain Not detected Tissue enriched 8 testis: 4.1 epididymis,skin: 0.5 BTBD19 ENSG00000222009 BTB (POZ) domain containing 19 1 44808482-44815585 Predicted intracellular proteins Evidence at protein level HPA042633, HPA076404 Uncertain Approved Cytosol Renal cancer:4.18e-8 (unfavourable) Mixed Mixed endometrium: 4.4 BTBD3 dJ742J24.1, KIAA0952 ENSG00000132640 BTB (POZ) domain containing 3 20 11890723-11926609 Predicted intracellular proteins Evidence at protein level HPA041424, HPA042048 Uncertain Supported Vesicles Liver cancer:2.51e-5 (unfavourable), Lung cancer:6.94e-4 (unfavourable) Expressed in all Expressed in all placenta: 59.7 BTBD8 ENSG00000189195 BTB (POZ) domain containing 8 1 92080305-92147836 Predicted intracellular proteins Evidence at protein level HPA035311, HPA035312 Uncertain Supported Nucleoplasm Not detected Mixed parathyroid gland: 4.0 BTBD9 dJ322I12.1, KIAA1880 ENSG00000183826 BTB (POZ) domain containing 9 6 38168451-38640148 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA041930 Uncertain Approved Nucleoplasm Renal cancer:4.20e-13 (favourable) Expressed in all Mixed parathyroid gland: 38.2 BTG4 PC3B ENSG00000137707 B-cell translocation gene 4 11 111467526-111512354 Predicted intracellular proteins Evidence at transcript level HPA057157 Approved Endoplasmic reticulum
Golgi apparatus Not detected Tissue enriched 17 testis: 47.2 fallopian tube: 2.7 BTNL2 BTL-II, BTN7, HSBLMHC1 ENSG00000204290 Butyrophilin-like 2 6 32393963-32407128 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Not detected prostate: 0.6 BTNL3 BTN9.1, BTNLR ENSG00000168903 Butyrophilin-like 3 5 180988845-181006727 Predicted membrane proteins Evidence at transcript level Group enriched Group enriched 25 colon: 25.0;duodenum: 118.3;rectum: 26.8;small intestine: 90.9 gallbladder: 2.5 BTNL9 BTN8, FLJ32535 ENSG00000165810 Butyrophilin-like 9 5 181040225-181061523 Predicted membrane proteins Evidence at protein level HPA043429 Approved Nuclear membrane
Vesicles Liver cancer:1.55e-9 (favourable), Endometrial cancer:7.51e-4 (unfavourable) Mixed Tissue enhanced adipose tissue: 166.7 lung: 56.0 C10orf105 FLJ00245 ENSG00000214688 Chromosome 10 open reading frame 105 10 71711701-71737824 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enhanced cerebral cortex: 2.3;spleen: 3.3 testis: 1.4 C10orf107 bA63A2.1, Em:AC022398.2, MGC44593 ENSG00000183346 Chromosome 10 open reading frame 107 10 61662961-61766766 Predicted intracellular proteins Evidence at protein level HPA041398 Supported Uncertain Nucleoplasm
Centrosome
Cytosol Endometrial cancer:1.79e-4 (favourable), Glioma:3.99e-4 (unfavourable) Mixed Tissue enhanced fallopian tube: 43.7;testis: 30.2 parathyroid gland: 12.4 C10orf113 bA165O3.1 ENSG00000204683 Chromosome 10 open reading frame 113 10 21125763-21146559 Predicted intracellular proteins Evidence at transcript level HPA037013 Uncertain Not detected Tissue enriched 13 testis: 1.8 gallbladder,salivary gland: 0.1 C10orf120 bA318C4.1 ENSG00000183559 Chromosome 10 open reading frame 120 10 122697709-122699822 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 379 testis: 49.1 epididymis: 0.1 C10orf131 bA690P14.3 ENSG00000173088 Chromosome 10 open reading frame 131 10 95907603-95938723 Predicted intracellular proteins Evidence at transcript level HPA072122 Approved Nucleoli Not detected Mixed testis: 10.2 C10orf142 ENSG00000277288 Chromosome 10 open reading frame 142 10 44292569-44294649 Predicted intracellular proteins Evidence at transcript level Not detected Mixed testis: 2.8 C10orf55 bA417O11.3 ENSG00000222047 Chromosome 10 open reading frame 55 10 73909969-73922777 Predicted intracellular proteins Evidence at transcript level HPA045739 Uncertain Approved Nucleus Mixed Not detected kidney: 0.3 C10orf67 MGC46732 ENSG00000179133 Chromosome 10 open reading frame 67 10 23267195-23344845 Predicted intracellular proteins Evidence at transcript level HPA038130, HPA038131 Approved Approved Nucleoplasm
Nucleoli Not detected Tissue enhanced fallopian tube: 9.3;testis: 30.5 lung: 5.1 C10orf71 FLJ45913 ENSG00000177354 Chromosome 10 open reading frame 71 10 49299193-49327487 Predicted intracellular proteins Evidence at protein level HPA037962, HPA057556 Uncertain Tissue enhanced Group enriched 40 heart muscle: 28.8;parathyroid gland: 73.6;skeletal muscle: 97.7 esophagus,prostate: 1.6 C10orf76 FLJ13114 ENSG00000120029 Chromosome 10 open reading frame 76 10 101845599-102056193 Predicted intracellular proteins Evidence at protein level HPA050913, HPA053580 Approved Approved Vesicles Expressed in all Expressed in all parathyroid gland: 25.9 C10orf82 Em:AC016825.4, MGC33547 ENSG00000165863 Chromosome 10 open reading frame 82 10 116663696-116670264 Predicted intracellular proteins Evidence at transcript level HPA043022 Approved Mitochondria Mixed Tissue enriched 25 testis: 111.2 ovary: 4.4 C10orf90 bA422P15.2, FATS, FLJ32938 ENSG00000154493 Chromosome 10 open reading frame 90 10 126424997-126670446 Predicted intracellular proteins Evidence at protein level HPA038648, HPA057599 Uncertain Uncertain Nucleoplasm
Plasma membrane
Cytosol Tissue enriched Group enriched 13 breast: 5.6;cerebral cortex: 15.3;salivary gland: 4.4;testis: 12.4 adipose tissue,skin,tonsil: 0.7 C11orf1 FLJ23499 ENSG00000137720 Chromosome 11 open reading frame 1 11 111878935-111885975 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA038410, HPA057519 Uncertain Validated Nucleoplasm Renal cancer:1.39e-4 (favourable), Endometrial cancer:9.32e-4 (favourable) Expressed in all Expressed in all testis: 103.8 C11orf16 ENSG00000176029 Chromosome 11 open reading frame 16 11 8920076-8933006 Predicted intracellular proteins Evidence at transcript level Endometrial cancer:3.32e-4 (favourable) Tissue enhanced Tissue enhanced fallopian tube: 20.4;lung: 4.1 testis: 2.5 C11orf21 ENSG00000110665 Chromosome 11 open reading frame 21 11 2295645-2303049 Predicted intracellular proteins Evidence at transcript level HPA037607 Approved Mixed Tissue enhanced bone marrow: 32.4;spleen: 17.9 lymph node: 16.1 C11orf24 DM4E3 ENSG00000171067 Chromosome 11 open reading frame 24 11 68261335-68272001 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA012748 Uncertain Uncertain Nucleoplasm
Vesicles Renal cancer:1.60e-9 (unfavourable), Lung cancer:6.05e-4 (unfavourable), Glioma:9.83e-4 (unfavourable) Expressed in all Expressed in all small intestine: 67.2 C11orf40 NOV1 ENSG00000171987 Chromosome 11 open reading frame 40 11 4571423-4577820 Predicted intracellular proteins Evidence at transcript level Not detected Not detected epididymis: 0.2 C11orf42 MGC34805 ENSG00000180878 Chromosome 11 open reading frame 42 11 6205566-6211132 Predicted intracellular proteins Evidence at protein level HPA063404 Supported Not detected Tissue enriched 11 testis: 20.4 skin: 1.8 C11orf45 FLJ43646, MGC35558 ENSG00000174370 Chromosome 11 open reading frame 45 11 128899565-128906035 Predicted secreted proteins Evidence at transcript level HPA039716 Uncertain Approved Cytosol Mixed Mixed skin: 7.5 C11orf53 MGC50104 ENSG00000150750 Chromosome 11 open reading frame 53 11 111255982-111286401 Predicted intracellular proteins Evidence at transcript level HPA056128 Uncertain Mixed Tissue enhanced testis: 4.2 gallbladder: 2.1 C11orf63 FLJ23554 ENSG00000109944 Chromosome 11 open reading frame 63 11 122882528-122959798 Predicted intracellular proteins Evidence at protein level HPA039612, HPA040344 Supported Nucleoplasm
Golgi apparatus Endometrial cancer:7.94e-5 (favourable), Thyroid cancer:2.58e-4 (unfavourable), Renal cancer:8.77e-4 (favourable) Mixed Tissue enhanced testis: 63.4 parathyroid gland: 14.4 C11orf70 MGC13040 ENSG00000137691 Chromosome 11 open reading frame 70 11 102047443-102084560 Predicted intracellular proteins Evidence at protein level HPA038585 Supported Approved Centrosome Mixed Tissue enhanced fallopian tube: 45.9;testis: 54.5 epididymis: 12.9 C11orf71 FLJ20010 ENSG00000180425 Chromosome 11 open reading frame 71 11 114391443-114400550 Predicted intracellular proteins Evidence at transcript level HPA063943, HPA074787 Approved Nucleoplasm Renal cancer:7.01e-9 (favourable), Endometrial cancer:6.94e-4 (favourable) Expressed in all Tissue enriched 518 testis: 53.6 liver: 0.1 C11orf71 FLJ20010 ENSG00000282682 Chromosome 11 open reading frame 71 11 114399960-114400331 Predicted intracellular proteins Evidence at transcript level HPA063943, HPA074787 Approved Nucleoplasm Tissue enriched 11 testis: 44.1 skeletal muscle: 4.1 C11orf74 FLJ38678, HEPIS ENSG00000166352 Chromosome 11 open reading frame 74 11 36594493-36659290 Predicted intracellular proteins Evidence at protein level HPA044880 Uncertain Approved Aggresome
Cytosol Expressed in all Expressed in all thyroid gland: 177.0 C11orf80 FLJ22531 ENSG00000173715 Chromosome 11 open reading frame 80 11 66744451-66843328 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA038932, HPA038933 Approved Approved Centrosome Expressed in all Mixed skin: 48.3 C11orf85 ENSG00000168070 Chromosome 11 open reading frame 85 11 64937517-64972085 Predicted intracellular proteins Evidence at protein level Mixed Tissue enriched 9 testis: 41.3 gallbladder: 4.5 C11orf88 FLJ46266 ENSG00000183644 Chromosome 11 open reading frame 88 11 111514785-111537031 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enhanced fallopian tube: 140.3;testis: 39.5 lung: 18.0 C11orf91 ENSG00000205177 Chromosome 11 open reading frame 91 11 33698261-33700801 Predicted intracellular proteins Evidence at protein level HPA047064, HPA050487 Uncertain Validated Vesicles Not detected Tissue enhanced gallbladder: 7.8;testis: 6.9 adipose tissue: 5.7 C11orf95 MGC3032 ENSG00000188070 Chromosome 11 open reading frame 95 11 63759892-63768775 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA045002 Approved Intermediate filaments Expressed in all Expressed in all endometrium: 24.5 C12orf4 ENSG00000047621 Chromosome 12 open reading frame 4 12 4487728-4538508 Predicted intracellular proteins Evidence at protein level HPA037871 Uncertain Approved Nuclear bodies Expressed in all Mixed testis: 16.8 C12orf42 FLJ25323 ENSG00000179088 Chromosome 12 open reading frame 42 12 103237591-103496010 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 16 testis: 25.1 spleen: 1.5 C12orf54 MGC35033 ENSG00000177627 Chromosome 12 open reading frame 54 12 48482503-48496512 Predicted intracellular proteins Evidence at transcript level HPA039919 Uncertain Group enriched Tissue enriched 63 testis: 85.7 tonsil: 1.3 C12orf56 ENSG00000185306 Chromosome 12 open reading frame 56 12 64264762-64391192 Predicted intracellular proteins Evidence at protein level HPA056986 Supported Mixed Tissue enriched 21 testis: 15.2 skin: 0.7 C12orf60 MGC47869 ENSG00000182993 Chromosome 12 open reading frame 60 12 14803572-14906586 Predicted intracellular proteins Evidence at protein level HPA043911 Uncertain Approved Nucleus
Cytosol Mixed Tissue enhanced testis: 23.8 adrenal gland: 6.0 C12orf65 FLJ38663, SPG55 ENSG00000130921 Chromosome 12 open reading frame 65 12 123232916-123257959 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA038194, HPA057595 Uncertain Approved Nucleus
Mitochondria
Cytosol Liver cancer:4.29e-9 (unfavourable), Urothelial cancer:7.82e-5 (favourable) Expressed in all Expressed in all testis: 26.7 C12orf66 FLJ32549 ENSG00000174206 Chromosome 12 open reading frame 66 12 64186316-64222296 Predicted intracellular proteins Evidence at protein level HPA046743, HPA052855 Uncertain Validated Microtubules
Cytokinetic bridge
Mitotic spindle Expressed in all Expressed in all parathyroid gland: 12.1 C12orf74 ENSG00000214215 Chromosome 12 open reading frame 74 12 92702843-92708549 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enhanced fallopian tube: 1.9 urinary bladder: 0.9 C12orf76 FLJ40142 ENSG00000174456 Chromosome 12 open reading frame 76 12 110027028-110073686 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA039713, HPA042013 Uncertain Approved Plasma membrane
Actin filaments Renal cancer:5.74e-5 (unfavourable), Lung cancer:6.44e-5 (favourable) Expressed in all Expressed in all cerebral cortex: 106.1 C14orf105 FLJ10650 ENSG00000100557 Chromosome 14 open reading frame 105 14 57469301-57493867 Predicted intracellular proteins Evidence at transcript level HPA029202 Uncertain Nucleus
Cytosol Renal cancer:1.92e-4 (favourable), Liver cancer:5.61e-4 (unfavourable) Tissue enhanced Tissue enhanced fallopian tube: 43.3;gallbladder: 27.2;kidney: 63.2 liver: 11.3 C14orf177 FLJ25773 ENSG00000176605 Chromosome 14 open reading frame 177 14 98711613-98717761 Predicted intracellular proteins Evidence at transcript level HPA018091 Uncertain Not detected Tissue enriched 23 testis: 2.2 all non-specific tissues: 0.0 C14orf178 FLJ25976 ENSG00000197734 Chromosome 14 open reading frame 178 14 77760830-77769742 Predicted intracellular proteins Evidence at transcript level HPA062581 Uncertain Not detected Mixed testis: 2.1 C14orf180 C14orf77, NRAC ENSG00000184601 Chromosome 14 open reading frame 180 14 104579684-104590515 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Tissue enhanced Group enriched 19 adipose tissue: 34.6;heart muscle: 28.7 adrenal gland: 1.6 C14orf28 DRIP-1 ENSG00000179476 Chromosome 14 open reading frame 28 14 44897295-44907257 Predicted intracellular proteins Evidence at transcript level HPA059635 Approved Cytosol Expressed in all Mixed testis: 15.5 C14orf39 SIX6OS1 ENSG00000179008 Chromosome 14 open reading frame 39 14 60396469-60515543 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA059518 Uncertain Approved Nucleus
Nucleoli Mixed Tissue enriched 8 testis: 19.6 adrenal gland: 2.4 C14orf79 ENSG00000140104 Chromosome 14 open reading frame 79 14 104985775-105010482 Predicted intracellular proteins Evidence at transcript level HPA042052, HPA061117 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Expressed in all Mixed fallopian tube: 23.9 C14orf80 ENSG00000185347 Chromosome 14 open reading frame 80 14 105489855-105499575 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039049, HPA039050 Uncertain Approved Nucleoplasm
Golgi apparatus
Cytosol Liver cancer:3.54e-4 (unfavourable) Expressed in all Mixed appendix: 6.8 C15orf43 MGC33951 ENSG00000167014 Chromosome 15 open reading frame 43 15 44956702-44979229 Predicted intracellular proteins Evidence at protein level HPA041780, HPA041941 Uncertain Nucleus
Nucleoli
Centrosome Not detected Tissue enriched 22 testis: 39.9 breast: 1.7 C15orf48 NMES1 ENSG00000166920 Chromosome 15 open reading frame 48 15 45430529-45448761 Predicted intracellular proteins Evidence at protein level HPA012677, HPA012943 Approved Uncertain Mitochondria Expressed in all Tissue enhanced colon: 728.9;rectum: 845.4 small intestine: 336.3 C15orf53 FLJ35695 ENSG00000175779 Chromosome 15 open reading frame 53 15 38696598-38700038 Predicted intracellular proteins Evidence at transcript level HPA041914 Uncertain Not detected Not detected lung,urinary bladder: 0.1 C15orf59 LOC388135, MGC131524 ENSG00000205363 Chromosome 15 open reading frame 59 15 73735431-73752747 Predicted intracellular proteins Evidence at transcript level HPA041563 Approved Approved Nucleoplasm
Cytosol Renal cancer:5.38e-9 (favourable) Tissue enhanced Tissue enhanced cerebral cortex: 56.1 seminal vesicle: 19.5 C15orf61 LOC145853 ENSG00000189227 Chromosome 15 open reading frame 61 15 67521068-67530143 Predicted intracellular proteins Evidence at protein level HPA062820 Approved Nucleoli
Vesicles
Cytosol Renal cancer:5.31e-5 (favourable) Expressed in all Mixed cerebral cortex: 11.0 C15orf62 LOC643338 ENSG00000188277 Chromosome 15 open reading frame 62 15 40770080-40772449 Predicted intracellular proteins Evidence at protein level HPA044636 Approved Mixed Tissue enhanced esophagus: 15.0;skin: 12.6 tonsil: 6.4 C15orf65 FLJ27352 ENSG00000261652 Chromosome 15 open reading frame 65 15 55408548-55418764 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level HPA067189 Approved Approved Nucleus
Cytosol Endometrial cancer:3.18e-7 (favourable) Expressed in all Mixed testis: 16.8 C16orf46 FLJ32702 ENSG00000166455 Chromosome 16 open reading frame 46 16 81053497-81077267 Predicted intracellular proteins Evidence at protein level HPA041136, HPA041379 Uncertain Supported Nucleoplasm
Cytosol Mixed Tissue enhanced testis: 16.3;thyroid gland: 12.4 fallopian tube: 8.8 C16orf52 ENSG00000185716 Chromosome 16 open reading frame 52 16 22007638-22087534 Predicted membrane proteins Evidence at transcript level Expressed in all Expressed in all parathyroid gland: 39.5 C16orf71 DKFZp686H2240, FLJ43261 ENSG00000166246 Chromosome 16 open reading frame 71 16 4734272-4749396 Predicted intracellular proteins Evidence at protein level HPA049468 Supported Uncertain Nuclear speckles Endometrial cancer:7.49e-4 (favourable) Mixed Group enriched 16 fallopian tube: 36.2;testis: 113.1 epididymis: 4.5 C16orf78 MGC33367 ENSG00000166152 Chromosome 16 open reading frame 78 16 49373823-49399431 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 347 testis: 70.4 lung: 0.2 C16orf86 FLJ41802 ENSG00000159761 Chromosome 16 open reading frame 86 16 67666816-67668758 Predicted intracellular proteins Evidence at protein level HPA073475 Supported Renal cancer:2.12e-7 (favourable), Pancreatic cancer:1.47e-4 (favourable) Expressed in all Tissue enriched 7 testis: 27.5 parathyroid gland: 4.0 C16orf90 LOC646174 ENSG00000215131 Chromosome 16 open reading frame 90 16 3493484-3495480 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 215 testis: 21.4 all non-specific tissues: 0.0 C16orf91 CCSMST1, gs103 ENSG00000174109 Chromosome 16 open reading frame 91 16 1419744-1420800 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Renal cancer:1.11e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 16.6 C16orf92 FLJ25404 ENSG00000167194 Chromosome 16 open reading frame 92 16 30023334-30027736 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 7 testis: 24.0 cerebral cortex: 3.5 C16orf95 ENSG00000260456 Chromosome 16 open reading frame 95 16 87083562-87317420 Predicted intracellular proteins Evidence at protein level HPA040850, HPA067924 Supported Approved Endoplasmic reticulum Mixed Tissue enriched 25 testis: 80.4 cerebral cortex: 3.2 C17orf104 FLJ35848 ENSG00000180336 Chromosome 17 open reading frame 104 17 44656404-44690308 Predicted intracellular proteins Evidence at protein level HPA027266 Uncertain Uncertain Cell Junctions Not detected Tissue enriched 51 testis: 85.8 cerebral cortex: 1.6 C17orf105 ENSG00000231256 Chromosome 17 open reading frame 105 17 43780435-43787612 Predicted intracellular proteins Evidence at transcript level HPA053028 Approved Not detected Tissue enriched 46 testis: 20.2 skin,thyroid gland: 0.4 C17orf107 ENSG00000205710 Chromosome 17 open reading frame 107 17 4899418-4902932 Predicted intracellular proteins Evidence at transcript level HPA069713 Uncertain Approved Nucleus Breast cancer:5.06e-5 (favourable), Renal cancer:2.68e-4 (favourable), Pancreatic cancer:8.61e-4 (favourable) Mixed Mixed salivary gland: 5.7 C17orf47 FLJ40121 ENSG00000181013 Chromosome 17 open reading frame 47 17 58541587-58544368 Predicted intracellular proteins Evidence at protein level HPA028424 Approved Not detected Tissue enriched 12 testis: 16.4 placenta: 1.3 C17orf50 ENSG00000270806 Chromosome 17 open reading frame 50 17 35760897-35765079 Predicted intracellular proteins Evidence at protein level HPA043184, HPA063464 Supported Nucleoplasm Not detected Tissue enriched 52 testis: 39.2 fallopian tube: 0.7 C17orf51 FLJ12977, FLJ31874, FLJ33618 ENSG00000212719 Chromosome 17 open reading frame 51 17 21524790-21574458 Predicted intracellular proteins Evidence at transcript level HPA052106 Approved Approved Nucleoplasm
Nuclear bodies
Vesicles Mixed Tissue enhanced cerebral cortex: 16.7 testis: 8.6 C17orf64 ENSG00000141371 Chromosome 17 open reading frame 64 17 60392429-60431421 Predicted intracellular proteins Evidence at protein level HPA044415 Supported Approved Nucleoplasm
Vesicles Not detected Tissue enriched 227 testis: 184.8 spleen: 0.8 C17orf74 ENSG00000184560 Chromosome 17 open reading frame 74 17 7425615-7427568 Predicted membrane proteins Evidence at transcript level HPA023649 Uncertain Not detected Tissue enriched 618 testis: 61.7 all non-specific tissues: 0.0 C17orf78 FLJ39647 ENSG00000278505 Chromosome 17 open reading frame 78 17 37375986-37392708 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Group enriched Group enriched 75 duodenum: 101.8;small intestine: 51.9 testis: 1.0 C17orf80 FLJ20721, HLC-8, MIG3, SPEP1 ENSG00000141219 Chromosome 17 open reading frame 80 17 73232233-73248947 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA012896 Uncertain Approved Nucleoplasm
Vesicles Liver cancer:9.02e-6 (unfavourable), Colorectal cancer:1.43e-4 (favourable) Expressed in all Expressed in all testis: 71.6 C17orf97 LOC400566 ENSG00000187624 Chromosome 17 open reading frame 97 17 410327-431062 Predicted intracellular proteins Evidence at protein level HPA023583 Approved Approved Nucleoli
Cytosol Expressed in all Tissue enhanced testis: 56.7 fallopian tube: 21.4 C18orf54 LAS2, MGC33382 ENSG00000166845 Chromosome 18 open reading frame 54 18 54357917-54385218 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA040704, HPA041098 Supported Nucleoplasm Mixed Tissue enriched 8 testis: 30.2 placenta: 3.7 C18orf63 DKFZP781G0119 ENSG00000206043 Chromosome 18 open reading frame 63 18 74315813-74359187 Predicted intracellular proteins Evidence at protein level HPA042233 Approved Mitochondria Not detected Tissue enriched 61 testis: 17.7 breast: 0.2 C18orf8 HsT2591, MIC-1, MIC1 ENSG00000141452 Chromosome 18 open reading frame 8 18 23503470-23531807 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA043589 Uncertain Uncertain Nucleus Liver cancer:3.94e-4 (unfavourable) Expressed in all Expressed in all testis: 33.0 C19orf18 MGC41906 ENSG00000177025 Chromosome 19 open reading frame 18 19 57958437-57974534 Predicted membrane proteins Evidence at transcript level HPA014527 Uncertain Approved Golgi apparatus Endometrial cancer:5.07e-4 (favourable) Mixed Tissue enhanced testis: 16.9 epididymis: 4.8 C19orf35 FLJ45778 ENSG00000188305 Chromosome 19 open reading frame 35 19 2274622-2282176 Predicted intracellular proteins Evidence at protein level HPA057806 Uncertain Mixed Mixed appendix: 1.8 C19orf38 HIDE1 ENSG00000214212 Chromosome 19 open reading frame 38 19 10836575-10869790 Predicted membrane proteins Evidence at protein level HPA012150, HPA055027 Uncertain Golgi apparatus
Plasma membrane
Cytosol Renal cancer:1.75e-7 (unfavourable), Cervical cancer:2.43e-4 (favourable) Expressed in all Tissue enhanced bone marrow: 62.9 spleen: 17.8 C19orf45 FLJ35784 ENSG00000198723 Chromosome 19 open reading frame 45 19 7492976-7508450 Predicted intracellular proteins Evidence at transcript level HPA066278 Uncertain Mixed Tissue enhanced testis: 17.0 seminal vesicle: 4.2 C1orf100 ENSG00000173728 Chromosome 1 open reading frame 100 1 244352635-244389663 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 52 testis: 70.9 parathyroid gland: 1.3 C1orf101 MGC33370 ENSG00000179397 Chromosome 1 open reading frame 101 1 244454377-244641177 Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 12 testis: 38.3 epididymis: 3.1 C1orf106 FLJ10901 ENSG00000163362 Chromosome 1 open reading frame 106 1 200891048-200915735 Predicted intracellular proteins Evidence at protein level HPA027499, HPA027511 Uncertain Endometrial cancer:1.78e-5 (unfavourable) Expressed in all Tissue enhanced small intestine: 71.1 duodenum: 55.8 C1orf115 FLJ14146 ENSG00000162817 Chromosome 1 open reading frame 115 1 220689845-220699157 Predicted intracellular proteins Evidence at transcript level Ovarian cancer:5.12e-5 (favourable), Endometrial cancer:6.52e-4 (favourable) Expressed in all Mixed small intestine: 113.1 C1orf141 ENSG00000203963 Chromosome 1 open reading frame 141 1 67092165-67231853 Predicted intracellular proteins Evidence at transcript level HPA035316 Approved Not detected Group enriched 13 fallopian tube: 15.4;testis: 28.1 lung: 1.6 C1orf146 ENSG00000203910 Chromosome 1 open reading frame 146 1 92217940-92245813 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 14 testis: 14.5 skin: 1.0 C1orf158 MGC35194 ENSG00000157330 Chromosome 1 open reading frame 158 1 12746215-12763699 Predicted intracellular proteins Evidence at transcript level HPA028396 Uncertain Uncertain Cytosol Group enriched Group enriched 15 fallopian tube: 42.0;testis: 47.2 lung: 2.9 C1orf159 FLJ20584 ENSG00000131591 Chromosome 1 open reading frame 159 1 1081818-1116361 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA010019 Approved Approved Nucleoli fibrillar center
Cytosol Renal cancer:1.77e-6 (unfavourable), Liver cancer:9.58e-6 (unfavourable), Urothelial cancer:1.62e-4 (favourable) Expressed in all Mixed skin: 15.2 C1orf162 MGC24133 ENSG00000143110 Chromosome 1 open reading frame 162 1 111473792-111478512 Predicted membrane proteins Evidence at protein level HPA026988 Approved Renal cancer:3.14e-6 (unfavourable) Expressed in all Expressed in all spleen: 131.2 C1orf167 DKFZp434E1410, RP11-56N19.2 ENSG00000215910 Chromosome 1 open reading frame 167 1 11761787-11789585 Predicted intracellular proteins Evidence at transcript level HPA039114 Uncertain Not detected Tissue enriched 33 testis: 14.7 lung: 0.4 C1orf168 FLJ43208, RP4-758N20.2 ENSG00000187889 Chromosome 1 open reading frame 168 1 56718804-56819696 Predicted intracellular proteins Evidence at protein level Mixed Tissue enhanced fallopian tube: 21.2;liver: 8.6 cervix, uterine: 5.0 C1orf185 FLJ27485 ENSG00000204006 Chromosome 1 open reading frame 185 1 51102234-51148086 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 241 testis: 42.7 adipose tissue,gallbladder,parathyroid gland: 0.1 C1orf186 FLJ16052 ENSG00000263961 Chromosome 1 open reading frame 186 1 206037231-206102459 Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced cervix, uterine: 37.8 seminal vesicle: 28.6 C1orf194 ENSG00000179902 Chromosome 1 open reading frame 194 1 109105951-109113857 Predicted intracellular proteins Evidence at protein level HPA031144, HPA049684 Supported Uncertain Nuclear speckles
Cytosol Endometrial cancer:1.36e-4 (favourable) Group enriched Group enriched 30 fallopian tube: 195.3;testis: 197.5 lung: 6.5 C1orf204 FLJ39187 ENSG00000188004 Chromosome 1 open reading frame 204 1 159834474-159855347 Predicted intracellular proteins Evidence at protein level HPA045602, HPA051028 Approved Uncertain Nucleoplasm Mixed Mixed ovary,parathyroid gland: 8.1 C1orf228 MGC33556, NCRNA00082, p40 ENSG00000198520 Chromosome 1 open reading frame 228 1 44674692-44725591 Predicted intracellular proteins Evidence at protein level HPA034769 Uncertain Uncertain Cytosol Endometrial cancer:8.64e-4 (favourable) Mixed Tissue enhanced fallopian tube: 13.4;testis: 21.5 epididymis: 5.1 C1orf234 ENSG00000227868 Chromosome 1 open reading frame 234 1 23010834-23015850 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 109 testis: 97.5 epididymis,skin: 0.8 C1orf43 DKFZp586G1722, NICE-3 ENSG00000143612 Chromosome 1 open reading frame 43 1 154206706-154220628 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA010725 Approved Liver cancer:6.57e-4 (unfavourable) Expressed in all Expressed in all kidney: 194.2 C1orf53 ENSG00000203724 Chromosome 1 open reading frame 53 1 197902647-197907367 Predicted intracellular proteins Evidence at transcript level HPA065352 Approved Vesicles
Aggresome Breast cancer:1.63e-4 (favourable), Endometrial cancer:3.78e-4 (unfavourable) Expressed in all Mixed adrenal gland: 6.3 C1orf54 FLJ23221 ENSG00000118292 Chromosome 1 open reading frame 54 1 150268200-150280916 Predicted secreted proteins Evidence at transcript level HPA026518 Approved Approved Vesicles Renal cancer:2.43e-4 (unfavourable) Expressed in all Expressed in all spleen: 77.4 C1orf56 FLJ20519, MENT ENSG00000143443 Chromosome 1 open reading frame 56 1 151047740-151051986 Predicted secreted proteins Evidence at protein level HPA037429, HPA037430 Supported Expressed in all Tissue enhanced testis: 48.6 parathyroid gland: 12.7 C1orf61 CROC4 ENSG00000125462 Chromosome 1 open reading frame 61 1 156404250-156430701 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 131 cerebral cortex: 505.2 testis: 3.8 C1orf64 ERRF, MGC24047 ENSG00000183888 Chromosome 1 open reading frame 64 1 16004236-16008807 Predicted intracellular proteins Evidence at transcript level HPA026676 Uncertain Approved Nucleoplasm Endometrial cancer:1.68e-6 (favourable) Tissue enhanced Tissue enhanced breast: 7.0 cervix, uterine: 3.7 C1orf74 FLJ25078 ENSG00000162757 Chromosome 1 open reading frame 74 1 209779208-209784559 Predicted intracellular proteins Evidence at protein level HPA028496 Uncertain Approved Plasma membrane
Cytosol Cervical cancer:8.52e-6 (unfavourable) Expressed in all Mixed lymph node: 5.1 C1orf87 CREF, MGC34837 ENSG00000162598 Chromosome 1 open reading frame 87 1 59987269-60073770 Predicted intracellular proteins Evidence at protein level HPA031366, HPA031368 Supported Tissue enhanced Tissue enriched 10 fallopian tube: 47.2 lung: 4.9 C1orf95 DKFZp761P211 ENSG00000203685 Chromosome 1 open reading frame 95 1 226548800-226609214 Predicted membrane proteins Evidence at protein level Renal cancer:6.40e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 35.8 smooth muscle: 8.3 C1QL2 C1QTNF10, CTRP10 ENSG00000144119 Complement component 1, q subcomponent-like 2 2 119156243-119158889 Predicted secreted proteins Evidence at protein level HPA057934 Uncertain Mixed Tissue enriched 17 cerebral cortex: 2.5 lymph node,testis: 0.1 C1QL3 C1ql, C1QTNF13, CTRP13, K100 ENSG00000165985 Complement component 1, q subcomponent-like 3 10 16513743-16522005 Predicted secreted proteins Evidence at protein level Renal cancer:6.29e-5 (favourable) Mixed Tissue enriched 20 cerebral cortex: 43.5 kidney: 2.2 C1QL4 C1QTNF11, CTRP11 ENSG00000186897 Complement component 1, q subcomponent-like 4 12 49332411-49337188 Predicted secreted proteins Evidence at transcript level Renal cancer:3.03e-5 (unfavourable) Mixed Tissue enhanced testis: 2.1;thyroid gland: 1.2 cerebral cortex: 0.7 C1QTNF7 CTRP7 ENSG00000163145 C1q and tumor necrosis factor related protein 7 4 15339818-15446166 Plasma proteins, Predicted secreted proteins Evidence at protein level CAB007055, HPA051797 Uncertain Mixed Mixed cervix, uterine: 36.3 C20orf141 dJ860F19.4 ENSG00000258713 Chromosome 20 open reading frame 141 20 2814987-2815833 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 106 testis: 96.9 placenta: 0.9 C20orf144 bclt, dJ63M2.6 ENSG00000149609 Chromosome 20 open reading frame 144 20 33662284-33665619 Predicted intracellular proteins Evidence at protein level HPA019029 Supported Not detected Tissue enriched 431 testis: 43.0 all non-specific tissues: 0.0 C20orf173 dJ477O4.4 ENSG00000125975 Chromosome 20 open reading frame 173 20 35523186-35529652 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 137 testis: 34.3 skin: 0.2 C20orf196 FLJ25067 ENSG00000171984 Chromosome 20 open reading frame 196 20 5750393-5863912 Predicted intracellular proteins Evidence at transcript level HPA040749 Approved Approved Endoplasmic reticulum
Golgi apparatus
Vesicles Urothelial cancer:4.05e-5 (favourable) Expressed in all Mixed lymph node: 18.8 C20orf202 ENSG00000215595 Chromosome 20 open reading frame 202 20 1203454-1208274 Predicted intracellular proteins Evidence at transcript level HPA042786 Uncertain Mixed Tissue enhanced placenta: 4.8 lung: 1.9 C20orf24 PNAS-11, RIP5 ENSG00000101084 Chromosome 20 open reading frame 24 20 36605734-36612557 Predicted membrane proteins Evidence at protein level HPA057387 Uncertain Approved Cytosol Liver cancer:4.56e-6 (unfavourable), Renal cancer:2.46e-4 (unfavourable) Expressed in all Expressed in all esophagus: 83.3 C20orf85 bA196N14.1, LLC1 ENSG00000124237 Chromosome 20 open reading frame 85 20 58150904-58161150 Predicted intracellular proteins Evidence at protein level HPA058271, HPA065540 Supported Tissue enhanced Tissue enriched 8 fallopian tube: 719.2 testis: 91.4 C20orf96 dJ1103G7.2 ENSG00000196476 Chromosome 20 open reading frame 96 20 270863-290778 Predicted intracellular proteins Evidence at transcript level HPA048649 Uncertain Approved Nucleus
Golgi apparatus Pancreatic cancer:4.12e-5 (favourable), Liver cancer:6.12e-5 (unfavourable), Urothelial cancer:1.05e-4 (favourable) Expressed in all Expressed in all fallopian tube: 52.9 C21orf140 ENSG00000222018 Chromosome 21 open reading frame 140 21 34400317-34401072 Predicted intracellular proteins Evidence at transcript level HPA045123 Uncertain Not detected Mixed testis: 10.5 C21orf58 ENSG00000160298 Chromosome 21 open reading frame 58 21 46300181-46323875 Predicted intracellular proteins Evidence at protein level HPA035110, HPA035111 Uncertain Supported Nucleoplasm
Nuclear bodies Pancreatic cancer:4.20e-4 (favourable), Head and neck cancer:7.00e-4 (favourable), Melanoma:7.48e-4 (unfavourable) Expressed in all Tissue enhanced fallopian tube: 41.7 testis: 9.0 C21orf62 B37, C21orf120, PRED81 ENSG00000205929 Chromosome 21 open reading frame 62 21 32790674-32813743 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA016899, CAB034173 Approved Renal cancer:1.14e-4 (favourable) Tissue enriched Tissue enhanced epididymis: 7.0;kidney: 5.4;ovary: 12.5 prostate: 3.7 C21orf91 C21orf14, C21orf38, CSSG1, EURL, YG81 ENSG00000154642 Chromosome 21 open reading frame 91 21 17788967-17819386 Predicted intracellular proteins Evidence at protein level HPA018288, HPA049030 Approved Approved Microtubules
Cytokinetic bridge Expressed in all Mixed testis: 44.2 C22orf15 FLJ36561, N27C7-3 ENSG00000169314 Chromosome 22 open reading frame 15 22 23763021-23765861 Predicted secreted proteins Evidence at transcript level HPA018006, HPA019494 Uncertain Endometrial cancer:8.53e-5 (favourable) Tissue enhanced Tissue enriched 15 fallopian tube: 29.0 testis: 1.9 C22orf31 bK747E2.1, HS747E2A ENSG00000100249 Chromosome 22 open reading frame 31 22 29058672-29061844 Predicted intracellular proteins Evidence at transcript level HPA000604 Uncertain Not detected Tissue enriched 12 testis: 13.9 epididymis: 1.1 C22orf42 ENSG00000205856 Chromosome 22 open reading frame 42 22 32149006-32159322 Predicted intracellular proteins Evidence at transcript level HPA019531 Approved Group enriched Tissue enriched 10 testis: 10.7 prostate: 1.0 C22orf46 CTA-216E10.6, FLJ23584 ENSG00000184208 Chromosome 22 open reading frame 46 22 41688939-41698136 Predicted secreted proteins Evidence at transcript level HPA052741, HPA057048 Uncertain Approved Nucleus
Nucleoli Endometrial cancer:4.70e-4 (favourable) Expressed in all Mixed parathyroid gland: 17.4 C2CD4A FAM148A, NLF1 ENSG00000198535 C2 calcium-dependent domain containing 4A 15 62066977-62070917 Predicted intracellular proteins Evidence at transcript level Renal cancer:4.15e-4 (unfavourable) Mixed Mixed endometrium: 2.3 C2CD4B FAM148B, NLF2 ENSG00000205502 C2 calcium-dependent domain containing 4B 15 62163535-62165283 Predicted intracellular proteins Evidence at transcript level HPA046880 Uncertain Cervical cancer:4.22e-4 (favourable) Mixed Tissue enhanced adipose tissue: 15.3 pancreas: 8.1 C2CD4D FAM148D ENSG00000225556 C2 calcium-dependent domain containing 4D 1 151837819-151840557 Predicted intracellular proteins Evidence at transcript level Mixed Mixed skin: 1.9 C2orf15 MGC29762 ENSG00000273045 Chromosome 2 open reading frame 15 2 99141485-99151487 Predicted intracellular proteins Evidence at protein level HPA042990 Uncertain Renal cancer:1.23e-4 (favourable), Ovarian cancer:4.95e-4 (favourable) Mixed Mixed thyroid gland: 9.9 C2orf16 DKFZp434G118 ENSG00000221843 Chromosome 2 open reading frame 16 2 27576522-27582720 Predicted intracellular proteins Evidence at protein level HPA052136, HPA056962 Uncertain Uncertain Nuclear bodies Mixed Tissue enriched 15 testis: 15.3 thyroid gland: 1.0 C2orf40 augurin, ECRG4 ENSG00000119147 Chromosome 2 open reading frame 40 2 106063246-106078159 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA008546 Uncertain Breast cancer:4.58e-4 (favourable) Tissue enriched Tissue enhanced seminal vesicle: 115.1;thyroid gland: 127.1 prostate: 57.6 C2orf54 FLJ22671 ENSG00000172478 Chromosome 2 open reading frame 54 2 240886048-240896889 Predicted intracellular proteins Evidence at protein level HPA052722 Approved Nucleoplasm
Golgi apparatus Endometrial cancer:2.77e-4 (unfavourable) Mixed Tissue enhanced esophagus: 112.6;skin: 51.5 tonsil: 26.7 C2orf61 FLJ40172 ENSG00000239605 Chromosome 2 open reading frame 61 2 47045538-47155378 Predicted intracellular proteins Evidence at transcript level HPA047366, HPA052691 Approved Approved Nucleoplasm
Cytosol Not detected Tissue enriched 67 testis: 23.4 gallbladder: 0.3 C2orf68 ENSG00000168887 Chromosome 2 open reading frame 68 2 85606654-85612066 Predicted intracellular proteins Evidence at protein level HPA051143 Uncertain Approved Nucleus
Nuclear membrane
Nucleoli
Mitochondria Renal cancer:1.11e-6 (unfavourable), Endometrial cancer:1.12e-6 (unfavourable), Liver cancer:6.76e-6 (unfavourable) Expressed in all Expressed in all endometrium: 26.2 C2orf73 FLJ40298 ENSG00000177994 Chromosome 2 open reading frame 73 2 54330034-54383742 Predicted intracellular proteins Evidence at transcript level HPA055221, HPA059596 Uncertain Not detected Tissue enriched 7 testis: 83.2 fallopian tube: 12.0 C2orf78 COG5373, FLJ43987, hCG1989538 ENSG00000187833 Chromosome 2 open reading frame 78 2 73784189-73817147 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 147 testis: 14.7 all non-specific tissues: 0.0 C2orf80 GONDA1, LOC389073 ENSG00000188674 Chromosome 2 open reading frame 80 2 208165343-208190073 Predicted intracellular proteins Evidence at transcript level HPA042639 Approved Golgi apparatus Tissue enriched Tissue enriched 27 cerebral cortex: 37.7 testis: 1.4 C2orf82 ASCL830, UNQ830 ENSG00000182600 Chromosome 2 open reading frame 82 2 232857270-232878708 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA052824 Uncertain Approved Nucleus
Nucleoli Endometrial cancer:3.56e-4 (unfavourable) Mixed Tissue enhanced breast: 5.2;testis: 4.1 cerebral cortex: 2.6 C2orf83 DKFZp547H025 ENSG00000042304 Chromosome 2 open reading frame 83 2 227610090-227633320 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA030319 Approved Not detected Tissue enhanced placenta: 2.9 testis: 1.0 C2orf91 ENSG00000205086 Chromosome 2 open reading frame 91 2 41935368-41954266 Predicted intracellular proteins Evidence at transcript level HPA042517 Uncertain Tissue enriched Tissue enhanced lung: 2.4 adrenal gland: 1.0 C3orf14 HT021 ENSG00000114405 Chromosome 3 open reading frame 14 3 62318973-62336213 Predicted intracellular proteins Evidence at transcript level HPA048286 Approved Approved Plasma membrane
Cytosol Renal cancer:4.33e-5 (favourable) Expressed in all Mixed breast: 61.4 C3orf18 G20 ENSG00000088543 Chromosome 3 open reading frame 18 3 50558025-50571027 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA012105 Approved Approved Cytosol Renal cancer:2.80e-9 (favourable) Expressed in all Mixed parathyroid gland: 27.8 C3orf20 DKFZP434N1817 ENSG00000131379 Chromosome 3 open reading frame 20 3 14675099-14773034 Predicted intracellular proteins Evidence at protein level HPA039584 Uncertain Not detected Tissue enriched 28 testis: 10.3 lymph node,tonsil: 0.3 C3orf22 MGC34728 ENSG00000180697 Chromosome 3 open reading frame 22 3 126526999-126558965 Predicted intracellular proteins Evidence at protein level HPA059199 Supported Not detected Tissue enriched 326 testis: 32.5 all non-specific tissues: 0.0 C3orf30 FLJ32859 ENSG00000163424 Chromosome 3 open reading frame 30 3 119146150-119160042 Predicted intracellular proteins Evidence at protein level HPA062468 Supported Not detected Tissue enriched 365 testis: 93.6 epididymis,kidney: 0.2 C3orf36 FLJ22173 ENSG00000221972 Chromosome 3 open reading frame 36 3 133928145-133929812 Predicted intracellular proteins Evidence at transcript level HPA046432 Uncertain Mixed Tissue enriched 7 seminal vesicle: 11.7 appendix,parathyroid gland: 1.5 C3orf49 ENSG00000163632 Chromosome 3 open reading frame 49 3 63819362-63848636 Predicted intracellular proteins Evidence at transcript level HPA053582 Uncertain Not detected Tissue enhanced testis: 2.1 cerebral cortex: 1.2 C3orf67 FLJ42117, FLJ42930 ENSG00000163689 Chromosome 3 open reading frame 67 3 58717365-59050084 Predicted intracellular proteins Evidence at protein level HPA069696 Approved Nucleus
Golgi apparatus Mixed Tissue enhanced esophagus: 13.3;testis: 46.8 fallopian tube: 6.2 C3orf70 ENSG00000187068 Chromosome 3 open reading frame 70 3 185078050-185153014 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA041861 Uncertain Approved Cytosol Renal cancer:6.40e-6 (unfavourable) Tissue enhanced Tissue enhanced smooth muscle: 25.7 cerebral cortex: 19.2 C3orf80 ENSG00000180044 Chromosome 3 open reading frame 80 3 160225636-160228213 Predicted membrane proteins Evidence at transcript level HPA047439 Uncertain Mixed Tissue enhanced cerebral cortex: 1.9 duodenum: 0.5 C3orf84 ENSG00000236980 Chromosome 3 open reading frame 84 3 49177632-49191858 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 32 testis: 7.6 epididymis: 0.2 C4orf17 DKFZP434G072 ENSG00000138813 Chromosome 4 open reading frame 17 4 99511004-99542303 Predicted intracellular proteins Evidence at protein level HPA060374, HPA060564 Uncertain Not detected Tissue enriched 341 testis: 34.0 all non-specific tissues: 0.0 C4orf22 ENSG00000197826 Chromosome 4 open reading frame 22 4 80335720-80963756 Predicted intracellular proteins Evidence at transcript level HPA043383 Approved Approved Plasma membrane
Cytosol Not detected Group enriched 23 fallopian tube: 30.3;testis: 47.2 lung: 1.7 C4orf32 FLJ39370 ENSG00000174749 Chromosome 4 open reading frame 32 4 112145397-112195256 Predicted membrane proteins Evidence at protein level HPA062443, HPA069294 Approved Approved Golgi apparatus Stomach cancer:8.87e-4 (unfavourable) Mixed Mixed adipose tissue: 19.3 C4orf45 FLJ25371 ENSG00000164123 Chromosome 4 open reading frame 45 4 158893134-159038760 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 49 testis: 19.9 bone marrow: 0.4 C4orf47 LOC441054 ENSG00000205129 Chromosome 4 open reading frame 47 4 185426249-185449826 Predicted intracellular proteins Evidence at transcript level HPA043662 Uncertain Approved Vesicles Renal cancer:4.75e-4 (unfavourable) Mixed Tissue enhanced fallopian tube: 21.3;testis: 24.2 thyroid gland: 7.8 C4orf50 FLJ46481 ENSG00000181215 Chromosome 4 open reading frame 50 4 5897591-5989818 Predicted intracellular proteins Evidence at transcript level HPA058292 Uncertain Not detected Tissue enriched 10 cerebral cortex: 3.6 adrenal gland,prostate,testis: 0.3 C5orf15 HTGN29, KCT2 ENSG00000113583 Chromosome 5 open reading frame 15 5 133955502-133968787 Predicted membrane proteins Evidence at protein level HPA011951, HPA039165 Uncertain Approved Golgi apparatus Expressed in all Expressed in all thyroid gland: 81.4 C5orf28 FLJ21657 ENSG00000151881 Chromosome 5 open reading frame 28 5 43444252-43483893 Predicted membrane proteins Evidence at protein level HPA059946 Approved Nucleoplasm Liver cancer:1.59e-4 (unfavourable), Renal cancer:2.85e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 64.8 C5orf34 FLJ32363 ENSG00000172244 Chromosome 5 open reading frame 34 5 43486701-43515145 Predicted intracellular proteins Evidence at protein level HPA045386 Approved Endometrial cancer:2.65e-6 (unfavourable) Expressed in all Tissue enhanced testis: 7.9 prostate: 3.8 C5orf38 CEI, IRX2NB ENSG00000186493 Chromosome 5 open reading frame 38 5 2752131-2755397 Predicted intracellular proteins Evidence at protein level HPA073667 Validated Golgi apparatus
Vesicles Mixed Tissue enhanced lung: 13.8;salivary gland: 13.0 skin: 8.5 C5orf45 DKFZp686L2452, LOC51149, MGC65027, MGC78537 ENSG00000161010 Chromosome 5 open reading frame 45 5 179835133-179862173 Predicted intracellular proteins Evidence at protein level HPA043975 Uncertain Approved Plasma membrane
Cytosol Renal cancer:2.64e-5 (unfavourable) Expressed in all Mixed fallopian tube: 21.2 C5orf47 LOC133491 ENSG00000185056 Chromosome 5 open reading frame 47 5 173973779-174006140 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 253 testis: 39.1 cerebral cortex,parathyroid gland: 0.1 C5orf49 LOC134121 ENSG00000215217 Chromosome 5 open reading frame 49 5 7830378-7851490 Predicted intracellular proteins Evidence at transcript level HPA043759 Uncertain Tissue enhanced Group enriched 10 fallopian tube: 118.9;testis: 30.8 lung: 7.8 C5orf52 ENSG00000187658 Chromosome 5 open reading frame 52 5 157671553-157680143 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enriched 20 testis: 38.6 colon: 1.9 C5orf56 ENSG00000197536 Chromosome 5 open reading frame 56 5 132410636-132476044 Predicted intracellular proteins Evidence at transcript level HPA043790 Approved Mitochondria Renal cancer:3.13e-6 (unfavourable) Mixed Mixed spleen: 29.1 C5orf63 FLJ44606, YDR286C ENSG00000164241 Chromosome 5 open reading frame 63 5 127042558-127073492 Predicted intracellular proteins Evidence at transcript level HPA043240 Approved Approved Mitochondria Mixed Mixed cerebral cortex: 36.9 C6orf1 LBH, MGC57858 ENSG00000186577 Chromosome 6 open reading frame 1 6 34246380-34249470 Predicted intracellular proteins Evidence at transcript level HPA037659, HPA037660 Uncertain Renal cancer:4.38e-4 (unfavourable), Pancreatic cancer:7.98e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 70.1 C6orf10 TSBP ENSG00000204296 Chromosome 6 open reading frame 10 6 32288526-32371912 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enriched 72 testis: 15.7 lymph node,ovary: 0.2 C6orf118 bA85G2.1, MGC23884 ENSG00000112539 Chromosome 6 open reading frame 118 6 165279664-165309607 Predicted intracellular proteins Evidence at transcript level HPA029787, HPA029789 Approved Uncertain Mitochondria Tissue enhanced Group enriched 6 fallopian tube: 25.9;testis: 12.8 lung: 3.2 C6orf136 Em:AB023049.8 ENSG00000204564 Chromosome 6 open reading frame 136 6 30647039-30653210 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA046804 Uncertain Renal cancer:9.16e-8 (favourable), Urothelial cancer:7.51e-4 (favourable) Expressed in all Mixed parathyroid gland: 8.0 C6orf141 MGC46457 ENSG00000197261 Chromosome 6 open reading frame 141 6 49550646-49561907 Predicted intracellular proteins Evidence at protein level HPA036199 Uncertain Approved Nuclear membrane Breast cancer:3.92e-6 (favourable), Endometrial cancer:1.15e-4 (favourable) Mixed Tissue enhanced gallbladder: 9.3 duodenum: 6.4 C6orf15 STG ENSG00000204542 Chromosome 6 open reading frame 15 6 31111223-31112559 Predicted secreted proteins Evidence at transcript level HPA001436 Uncertain Mixed Tissue enhanced cervix, uterine: 1.9 skin,tonsil: 0.8 C6orf201 dJ1013A10.5 ENSG00000185689 Chromosome 6 open reading frame 201 6 4079209-4130951 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 23 testis: 29.9 fallopian tube: 1.2 C6orf223 MGC45491 ENSG00000181577 Chromosome 6 open reading frame 223 6 44000580-44005958 Predicted intracellular proteins Evidence at transcript level HPA035765, HPA046117 Uncertain Uncertain Nucleoli fibrillar center Renal cancer:9.38e-5 (unfavourable), Liver cancer:4.59e-4 (unfavourable) Mixed Group enriched 10 breast: 22.3;lung: 5.6 duodenum: 1.4 C6orf47 D6S53E, G4 ENSG00000204439 Chromosome 6 open reading frame 47 6 31658298-31660772 Predicted membrane proteins Evidence at protein level HPA045281, HPA053373 Uncertain Approved Cytosol Expressed in all Mixed skin: 5.4 C6orf52 ENSG00000137434 Chromosome 6 open reading frame 52 6 10671418-10694797 Predicted intracellular proteins Evidence at transcript level HPA051142 Uncertain Approved Nuclear speckles Endometrial cancer:6.50e-5 (favourable) Mixed Tissue enhanced testis: 17.9 fallopian tube: 10.5 C6orf62 DKFZP564G182, FLJ12619, XTP12 ENSG00000112308 Chromosome 6 open reading frame 62 6 24704861-24720836 Predicted intracellular proteins Evidence at protein level HPA030564, HPA030566 Supported Approved Cytosol Urothelial cancer:3.62e-6 (favourable), Liver cancer:5.77e-5 (unfavourable), Ovarian cancer:4.04e-4 (favourable) Expressed in all Expressed in all testis: 173.7 C7orf26 MGC2718 ENSG00000146576 Chromosome 7 open reading frame 26 7 6590017-6608726 Predicted intracellular proteins Evidence at protein level HPA042899, HPA052175 Uncertain Approved Nucleus
Nucleoli
Intermediate filaments
Cytosol Pancreatic cancer:6.95e-5 (favourable) Expressed in all Expressed in all spleen: 26.2 C7orf33 ENSG00000170279 Chromosome 7 open reading frame 33 7 148590565-148615860 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.3 C7orf34 CTM-1 ENSG00000165131 Chromosome 7 open reading frame 34 7 142939343-142940868 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 47 testis: 48.7 bone marrow: 1.0 C7orf57 ENSG00000164746 Chromosome 7 open reading frame 57 7 48035511-48061304 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA021286 Supported Mixed Tissue enhanced fallopian tube: 21.7;testis: 6.8 lung: 3.4 C7orf60 DKFZp762M126, FLJ31818 ENSG00000164603 Chromosome 7 open reading frame 60 7 112819147-112939916 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA044405, HPA050733 Uncertain Approved Cytosol Expressed in all Mixed testis: 14.8 C7orf61 IMAGE:4839025 ENSG00000185955 Chromosome 7 open reading frame 61 7 100456615-100464271 Predicted intracellular proteins Evidence at protein level HPA060395 Supported Approved Vesicles Tissue enhanced Tissue enriched 10 testis: 53.2 cerebral cortex: 5.2 C7orf62 MGC26647 ENSG00000164645 Chromosome 7 open reading frame 62 7 88794106-88795721 Predicted intracellular proteins Evidence at transcript level HPA023817, HPA024163 Uncertain Nucleoplasm
Mitochondria Not detected Tissue enriched 458 testis: 51.4 thyroid gland: 0.1 C8orf34 vest-1, VEST1 ENSG00000165084 Chromosome 8 open reading frame 34 8 68330722-68819022 Predicted intracellular proteins Evidence at protein level HPA044420, HPA053065 Uncertain Supported Nucleus
Nucleoli
Golgi apparatus Mixed Tissue enhanced fallopian tube: 15.1;parathyroid gland: 19.7 cerebral cortex: 6.1 C8orf44 FLJ11267 ENSG00000213865 Chromosome 8 open reading frame 44 8 66667615-66685564 Predicted intracellular proteins Evidence at protein level HPA043660, HPA054753 Uncertain Validated Nucleoplasm Renal cancer:1.08e-7 (unfavourable), Urothelial cancer:2.68e-6 (favourable), Pancreatic cancer:4.21e-4 (favourable) Expressed in all Mixed epididymis: 20.9 C8orf46 MGC33510 ENSG00000169085 Chromosome 8 open reading frame 46 8 66460003-66518524 Predicted intracellular proteins Evidence at protein level HPA075134 Approved Nuclear speckles Tissue enriched Tissue enriched 15 cerebral cortex: 65.3 seminal vesicle: 4.4 C8orf58 FLJ34715 ENSG00000241852 Chromosome 8 open reading frame 58 8 22599601-22604150 Predicted intracellular proteins Evidence at transcript level HPA024667, HPA028286 Uncertain Approved Nuclear bodies Renal cancer:3.58e-6 (unfavourable) Expressed in all Mixed testis: 28.1 C8orf76 FLJ14825 ENSG00000189376 Chromosome 8 open reading frame 76 8 123219957-123241398 Predicted intracellular proteins Evidence at transcript level HPA023708 Uncertain Uncertain Nucleoplasm
Cytosol Renal cancer:5.95e-11 (unfavourable), Endometrial cancer:1.61e-4 (unfavourable), Breast cancer:9.95e-4 (unfavourable) Expressed in all Expressed in all placenta: 16.0 C8orf86 FLJ43582 ENSG00000196166 Chromosome 8 open reading frame 86 8 38510834-38528662 Predicted intracellular proteins Evidence at transcript level HPA025066 Uncertain Not detected Tissue enhanced duodenum: 1.0 small intestine: 0.5 C8orf89 ENSG00000274443 Chromosome 8 open reading frame 89 8 73241329-73259502 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 8 testis: 13.2 cervix, uterine: 1.5 C9orf131 MGC41945 ENSG00000174038 Chromosome 9 open reading frame 131 9 35041095-35045991 Predicted intracellular proteins Evidence at transcript level HPA022029 Approved Mitochondria Not detected Tissue enriched 12 testis: 61.8 endometrium: 5.1 C9orf152 bA470J20.2 ENSG00000188959 Chromosome 9 open reading frame 152 9 110190048-110208189 Predicted intracellular proteins Evidence at protein level HPA050769 Approved Supported Nucleus Endometrial cancer:7.22e-5 (favourable) Mixed Tissue enhanced rectum: 45.4 colon: 33.1 C9orf173 FLJ40246 ENSG00000197768 Chromosome 9 open reading frame 173 9 137251261-137253483 Predicted intracellular proteins Evidence at transcript level HPA044352 Uncertain Uncertain Vesicles Mixed Tissue enhanced testis: 28.2 epididymis: 5.9 C9orf47 bA791O21.3, C9orf108, FLJ37523 ENSG00000186354 Chromosome 9 open reading frame 47 9 88990863-88996140 Predicted secreted proteins Evidence at transcript level CAB009902 Approved Not detected Mixed adrenal gland: 2.1 C9orf50 FLJ35803 ENSG00000179058 Chromosome 9 open reading frame 50 9 129612225-129620776 Predicted intracellular proteins Evidence at protein level HPA026743 Supported Mixed Tissue enhanced testis: 8.1 cerebral cortex: 1.8 C9orf57 ENSG00000204669 Chromosome 9 open reading frame 57 9 72051376-72072721 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 228 testis: 25.9 parathyroid gland: 0.1 C9orf66 FLJ31158 ENSG00000183784 Chromosome 9 open reading frame 66 9 212824-215741 Predicted intracellular proteins Evidence at transcript level HPA035652 Uncertain Renal cancer:1.32e-5 (favourable) Tissue enhanced Tissue enhanced kidney: 17.7 adrenal gland: 4.1 C9orf84 FLJ32779 ENSG00000165181 Chromosome 9 open reading frame 84 9 111686173-111795008 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA032108 Approved Vesicles
Cytosol Mixed Tissue enriched 10 testis: 30.9 adrenal gland: 3.1 C9orf91 DKFZp547P234, FLJ38045 ENSG00000157693 Chromosome 9 open reading frame 91 9 114611206-114646422 Predicted membrane proteins Evidence at transcript level HPA017199 Approved Approved Plasma membrane
Cytosol Endometrial cancer:3.61e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 22.4 CA10 CA-RPX, CARPX, HUCEP-15 ENSG00000154975 Carbonic anhydrase X 17 51630313-52160017 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA054825, HPA057837 Supported Approved Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 56.9;cervix, uterine: 31.9 testis: 10.6 CABS1 C4orf35, CLPH, FLJ32897, NYD-SP26 ENSG00000145309 Calcium-binding protein, spermatid-specific 1 4 70334966-70337116 Predicted intracellular proteins Evidence at protein level HPA044016, HPA055352 Supported Not detected Tissue enriched 591 testis: 150.7 salivary gland: 0.2 CACNA1G Cav3.1, NBR13 ENSG00000006283 Calcium channel, voltage-dependent, T type, alpha 1G subunit 17 50561068-50627474 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA004714 Uncertain Mixed Tissue enhanced cerebral cortex: 10.6;cervix, uterine: 8.5 endometrium: 5.2 CACNB1 CACNLB1 ENSG00000067191 Calcium channel, voltage-dependent, beta 1 subunit 17 39173456-39197703 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level HPA023343 Approved Endometrial cancer:3.80e-4 (unfavourable) Mixed Group enriched 6 cerebral cortex: 46.9;skeletal muscle: 108.5 skin: 12.3 CACNG3 ENSG00000006116 Calcium channel, voltage-dependent, gamma subunit 3 16 24255553-24362801 Predicted membrane proteins, Transporters Evidence at protein level HPA059010 Approved Tissue enriched Tissue enriched 28 cerebral cortex: 42.6 adrenal gland: 1.5 CACNG4 MGC11138, MGC24983 ENSG00000075461 Calcium channel, voltage-dependent, gamma subunit 4 17 66964910-67033398 Predicted membrane proteins, Transporters Evidence at transcript level HPA005803, HPA065370 Approved Approved Cytosol Mixed Tissue enhanced cerebral cortex: 48.7;prostate: 18.8 lung: 9.3 CACNG5 ENSG00000075429 Calcium channel, voltage-dependent, gamma subunit 5 17 66835117-66885486 Predicted membrane proteins Evidence at protein level HPA050115 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 1.2 lymph node: 0.6 CACNG6 ENSG00000130433 Calcium channel, voltage-dependent, gamma subunit 6 19 53992288-54012669 Predicted membrane proteins, Transporters Evidence at transcript level HPA056615 Approved Nucleoli fibrillar center
Cytosol Mixed Group enriched 11 fallopian tube: 17.8;skeletal muscle: 33.9 lung: 2.3 CACNG7 ENSG00000105605 Calcium channel, voltage-dependent, gamma subunit 7 19 53909335-53943941 Predicted membrane proteins, Transporters Evidence at protein level Tissue enriched Tissue enriched 101 cerebral cortex: 63.9 adrenal gland: 0.6 CACNG8 ENSG00000142408 Calcium channel, voltage-dependent, gamma subunit 8 19 53963040-53990215 Predicted membrane proteins, Transporters Evidence at protein level HPA041351 Supported Tissue enriched Tissue enriched 32 cerebral cortex: 23.8 testis: 0.7 CADM2 IGSF4D, Necl-3, NECL3, SynCAM2 ENSG00000175161 Cell adhesion molecule 2 3 84958981-86074429 Predicted membrane proteins Evidence at protein level HPA010024 Supported Tissue enriched Tissue enriched 14 cerebral cortex: 86.4 seminal vesicle: 6.2 CALB2 CAL2 ENSG00000172137 Calbindin 2 16 71358713-71390438 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB000106, HPA007305, HPA007306 Supported Supported Validated Cytosol Colorectal cancer:5.78e-5 (unfavourable) Mixed Tissue enhanced adipose tissue: 54.5;testis: 24.9 adrenal gland: 12.7 CALHM2 FAM26B ENSG00000138172 Calcium homeostasis modulator 2 10 103446786-103452402 Predicted membrane proteins, Transporters Evidence at protein level HPA014706 Approved Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:3.03e-6 (unfavourable) Expressed in all Mixed ovary: 44.9 CALHM3 bA225H22.7, FAM26A ENSG00000183128 Calcium homeostasis modulator 3 10 103472804-103479240 Predicted membrane proteins, Transporters Evidence at transcript level HPA018205 Uncertain Approved Nucleoplasm Tissue enhanced Not detected testis: 0.4 CALML4 MGC4809, NY-BR-20 ENSG00000129007 Calmodulin-like 4 15 68190705-68206110 Predicted intracellular proteins Evidence at protein level HPA051109 Supported Approved Nucleoplasm
Golgi apparatus
Cytosol Mixed Tissue enhanced duodenum: 82.7;small intestine: 76.5 colon: 58.6 CALML6 CAGLP ENSG00000169885 Calmodulin-like 6 1 1914827-1917296 Predicted intracellular proteins, RAS pathway related proteins Evidence at transcript level Not detected Tissue enriched 9 skeletal muscle: 37.6 esophagus: 4.2 CALN1 ENSG00000183166 Calneuron 1 7 71779491-72447151 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036278, HPA036708 Approved Uncertain Vesicles
Plasma membrane Mixed Group enriched 5 adrenal gland: 14.8;cerebral cortex: 46.5 testis: 6.0 CAMK2N2 CaM-KIIN ENSG00000163888 Calcium/calmodulin-dependent protein kinase II inhibitor 2 3 184259213-184261463 Predicted intracellular proteins Evidence at protein level HPA050835 Supported Nucleus
Centrosome Cervical cancer:9.77e-4 (favourable) Mixed Tissue enhanced adrenal gland: 12.3;cerebral cortex: 40.5 pancreas: 5.6 CAMKV MGC8407, VACAMKL ENSG00000164076 CaM kinase-like vesicle-associated 3 49857988-49870222 Enzymes, Predicted intracellular proteins Evidence at protein level HPA007656, CAB034931 Supported Approved Nucleoplasm
Cytokinetic bridge Group enriched Tissue enriched 55 cerebral cortex: 86.5 testis: 1.5 CAPN11 ENSG00000137225 Calpain 11 6 44158811-44184402 Enzymes, Predicted intracellular proteins Evidence at protein level CAB018070, HPA030955 Supported Not detected Tissue enriched 32 testis: 54.7 adipose tissue,breast: 1.6 CAPN12 ENSG00000182472 Calpain 12 19 38730187-38769904 Enzymes, Predicted intracellular proteins Evidence at protein level HPA043492, HPA053322 Uncertain Approved Nucleoplasm
Focal adhesion sites Renal cancer:5.90e-6 (unfavourable) Mixed Tissue enriched 7 gallbladder: 35.0 cervix, uterine: 4.7 CAPN14 ENSG00000214711 Calpain 14 2 31173056-31233858 Enzymes, Predicted intracellular proteins Evidence at protein level Group enriched Tissue enriched 25 esophagus: 88.6 tonsil: 3.4 CAPN8 nCL-2 ENSG00000203697 Calpain 8 1 223538007-223665734 Enzymes, Predicted intracellular proteins Evidence at protein level HPA073939 Approved Nucleoplasm
Nuclear membrane
Vesicles Tissue enhanced Tissue enriched 8 stomach: 288.4 rectum: 37.8 CAPNS2 MGC12536, MGC14804 ENSG00000256812 Calpain, small subunit 2 16 55566672-55567687 Predicted intracellular proteins Evidence at protein level Group enriched Tissue enhanced esophagus: 60.1;skin: 109.5 urinary bladder: 31.5 CAPS2 ENSG00000180881 Calcyphosine 2 12 75275979-75390928 Predicted intracellular proteins Evidence at transcript level HPA040004 Uncertain Approved Nucleus
Nucleoli
Centrosome Mixed Tissue enhanced fallopian tube: 15.6 testis,thyroid gland: 6.8 CAPSL MGC26610 ENSG00000152611 Calcyphosine-like 5 35904295-35938779 Predicted intracellular proteins Evidence at protein level HPA046811, HPA058495 Supported Approved Nucleus
Microtubules Group enriched Tissue enriched 10 fallopian tube: 173.5 testis: 17.3 CARD10 BIMP1, CARMA3 ENSG00000100065 Caspase recruitment domain family, member 10 22 37490362-37519542 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA029359, HPA055612 Approved Approved Vesicles
Intermediate filaments
Cytosol Liver cancer:7.73e-6 (unfavourable), Endometrial cancer:3.47e-4 (favourable) Expressed in all Mixed small intestine: 40.7 CASC1 FLJ10921, LAS1, PPP1R54 ENSG00000118307 Cancer susceptibility candidate 1 12 25108420-25195162 Predicted intracellular proteins Evidence at protein level HPA039662 Supported Renal cancer:3.13e-4 (favourable) Mixed Tissue enhanced fallopian tube: 22.4;testis: 41.6 parathyroid gland: 7.5 CASC10 bA418C1.3, C10orf114 ENSG00000204682 Cancer susceptibility candidate 10 10 21492658-21497262 Predicted intracellular proteins Evidence at transcript level HPA064131 Uncertain Approved Nucleoplasm Glioma:5.81e-4 (unfavourable), Urothelial cancer:5.86e-4 (unfavourable) Mixed Mixed placenta: 4.0 CASD1 C7orf12, FLJ21213, FLJ21879 ENSG00000127995 CAS1 domain containing 1 7 94509219-94557019 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA044404 Uncertain Approved Nucleoplasm Expressed in all Expressed in all cerebral cortex: 38.9 CATSPERB C14orf161, FLJ14298 ENSG00000133962 Catsper channel auxiliary subunit beta 14 91580696-91780707 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA035134 Uncertain Uncertain Vesicles Mixed Mixed skin: 2.7 CATSPERG C19orf15, DKFZp434A1022, FLJ46353 ENSG00000099338 Catsper channel auxiliary subunit gamma 19 38335775-38370943 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA052777 Approved Nucleus
Nucleoli
Cytosol Mixed Tissue enriched 41 testis: 48.5 skin: 1.1 CBLN2 ENSG00000141668 Cerebellin 2 precursor 18 72536680-72638521 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA056335 Uncertain Endoplasmic reticulum Tissue enriched Group enriched 7 cerebral cortex: 30.3;seminal vesicle: 7.2 small intestine: 2.8 CBWD3 bA561O23.1 ENSG00000196873 COBW domain containing 3 9 68232003-68300015 Predicted intracellular proteins Evidence at transcript level HPA042759, HPA042813 Uncertain Approved Plasma membrane Not detected Expressed in all appendix: 25.9 CBWD5 ENSG00000147996 COBW domain containing 5 9 65668805-65734041 Predicted intracellular proteins Evidence at transcript level HPA042759, HPA042813 Approved Approved Plasma membrane Mixed Expressed in all breast: 21.6 CC2D2B bA248J23.4, C10orf130 ENSG00000188649 Coiled-coil and C2 domain containing 2B 10 96000091-96032684 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 5 testis: 17.8 endometrium: 3.4 CCDC102B ACY1L, AN, C18orf14, FLJ23594, HsT1731 ENSG00000150636 Coiled-coil domain containing 102B 18 68715209-69055189 Predicted intracellular proteins Evidence at protein level HPA040623, HPA048194 Approved Approved Mitochondria
Cytosol Renal cancer:2.90e-6 (unfavourable) Mixed Tissue enhanced placenta: 40.6 gallbladder: 21.7 CCDC105 FLJ40365 ENSG00000160994 Coiled-coil domain containing 105 19 15010744-15023269 Predicted intracellular proteins Evidence at protein level HPA058585 Approved Not detected Tissue enriched 104 testis: 11.7 skin: 0.1 CCDC107 MGC31967 ENSG00000159884 Coiled-coil domain containing 107 9 35658290-35661511 Predicted membrane proteins Evidence at protein level HPA016857, HPA050442 Validated Nucleoplasm
Plasma membrane Expressed in all Expressed in all adipose tissue: 63.0 CCDC122 FLJ31846 ENSG00000151773 Coiled-coil domain containing 122 13 43823909-43879727 Predicted intracellular proteins Evidence at protein level CAB034233, HPA054995, HPA061456 Approved Approved Nucleus
Vesicles Mixed Mixed thyroid gland: 7.8 CCDC126 FLJ23031 ENSG00000169193 Coiled-coil domain containing 126 7 23597379-23644708 Predicted intracellular proteins Evidence at protein level HPA026883 Uncertain Approved Nucleoplasm Expressed in all Expressed in all testis: 61.6 CCDC129 FLJ38344 ENSG00000180347 Coiled-coil domain containing 129 7 31514071-31658720 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA024103 Uncertain Uncertain Nucleoplasm Not detected Tissue enhanced cervix, uterine: 2.6;salivary gland: 2.4 testis: 2.1 CCDC140 FLJ32447 ENSG00000163081 Coiled-coil domain containing 140 2 222298147-222305217 Predicted intracellular proteins Evidence at transcript level HPA042500, HPA048166 Uncertain Tissue enriched Not detected skin: 0.3 CCDC142 FLJ14397 ENSG00000135637 Coiled-coil domain containing 142 2 74471986-74483408 Predicted intracellular proteins Evidence at transcript level HPA056946 Approved Renal cancer:3.71e-7 (unfavourable), Endometrial cancer:1.87e-4 (unfavourable), Liver cancer:4.46e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 5.7 CCDC149 DKFZp761B107 ENSG00000181982 Coiled-coil domain containing 149 4 24806117-24980204 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA044158, HPA047913 Uncertain Supported Nucleoli Endometrial cancer:6.63e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 24.1 CCDC15 FLJ13215 ENSG00000149548 Coiled-coil domain containing 15 11 124954121-125041489 Predicted intracellular proteins Evidence at transcript level HPA040450, HPA041738 Uncertain Approved Plasma membrane
Cytosol Mixed Tissue enriched 5 testis: 18.8 breast: 3.5 CCDC152 LOC100129792 ENSG00000198865 Coiled-coil domain containing 152 5 42756801-42802360 Predicted intracellular proteins Evidence at protein level HPA036240 Approved Approved Nucleoplasm
Cytosol Mixed Mixed liver: 16.2 CCDC154 C16orf29, LOC645811 ENSG00000197599 Coiled-coil domain containing 154 16 1434383-1444556 Predicted intracellular proteins Evidence at protein level HPA041158, HPA043535, HPA048237 Uncertain Approved Golgi apparatus
Plasma membrane Mixed Tissue enhanced testis: 6.5 prostate: 3.7 CCDC157 ENSG00000187860 Coiled-coil domain containing 157 22 30356635-30378658 Predicted intracellular proteins Evidence at protein level HPA042943 Uncertain Mixed Group enriched 5 fallopian tube: 11.8;testis: 28.5 thyroid gland: 3.9 CCDC159 ENSG00000183401 Coiled-coil domain containing 159 19 11344684-11354944 Predicted intracellular proteins Evidence at protein level HPA047126, HPA054655 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Endometrial cancer:1.87e-7 (favourable), Pancreatic cancer:1.42e-4 (favourable), Urothelial cancer:8.62e-4 (favourable), Ovarian cancer:9.46e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 64.3 CCDC168 C13orf40, FLJ40176 ENSG00000175820 Coiled-coil domain containing 168 13 102729369-102759070 Predicted membrane proteins Evidence at protein level HPA048184, HPA058793 Uncertain Not detected Tissue enriched 12 testis: 7.5 epididymis: 0.6 CCDC169 C13orf38, LOC728591, RP11-251J8.1 ENSG00000242715 Coiled-coil domain containing 169 13 36222008-36297840 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enriched 15 testis: 78.1 parathyroid gland: 5.0 CCDC171 bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740 ENSG00000164989 Coiled-coil domain containing 171 9 15552897-16061663 Predicted intracellular proteins Evidence at protein level HPA019803, HPA019806, HPA024133 Uncertain Approved Nucleus Mixed Tissue enhanced testis: 21.3 endometrium: 9.7 CCDC173 C2orf77, LOC129881 ENSG00000154479 Coiled-coil domain containing 173 2 169645425-169694433 Predicted intracellular proteins Evidence at protein level HPA042995, HPA048454 Uncertain Mixed Tissue enriched 6 testis: 143.0 fallopian tube: 23.2 CCDC174 C3orf19, FLJ33839 ENSG00000154781 Coiled-coil domain containing 174 3 14651746-14672659 Predicted intracellular proteins Evidence at protein level HPA043468, HPA060129 Approved Validated Nucleoplasm Urothelial cancer:3.81e-5 (favourable), Prostate cancer:4.75e-4 (unfavourable) Expressed in all Expressed in all ovary: 17.9 CCDC177 C14orf162, PLPL ENSG00000267909 Coiled-coil domain containing 177 14 69569816-69574837 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced cerebral cortex: 2.3 epididymis: 0.7 CCDC178 C18orf34, FLJ44050 ENSG00000166960 Coiled-coil domain containing 178 18 32937402-33441101 Predicted intracellular proteins Evidence at protein level HPA053265 Approved Nucleoplasm
Cytosol Not detected Tissue enhanced testis: 30.7 spleen: 10.8 CCDC18 NY-SAR-41 ENSG00000122483 Coiled-coil domain containing 18 1 93179919-93278730 Predicted intracellular proteins Evidence at protein level HPA028035 Uncertain Approved Nucleoplasm
Cytosol Mixed Tissue enhanced testis: 17.2 lymph node: 10.9 CCDC180 BDAG1, C9orf174, DKFZp434I2420, KIAA1529 ENSG00000197816 Coiled-coil domain containing 180 9 97307304-97378524 Predicted intracellular proteins Evidence at protein level Not detected Group enriched 5 fallopian tube: 15.6;testis: 37.7 lung: 4.8 CCDC181 C1orf114, FLJ25846 ENSG00000117477 Coiled-coil domain containing 181 1 169394870-169460669 Predicted intracellular proteins Evidence at protein level HPA027189, HPA027275, HPA027281, HPA027312 Supported Approved Nuclear speckles Mixed Tissue enhanced parathyroid gland: 22.7;testis: 49.4 fallopian tube: 19.6 CCDC182 ENSG00000166329 Coiled-coil domain containing 182 17 57744481-57745312 Predicted intracellular proteins Evidence at transcript level HPA023446 Uncertain Not detected Tissue enriched 212 testis: 21.1 all non-specific tissues: 0.0 CCDC183 bA216L13.7, KIAA1984, MGC15438 ENSG00000213213 Coiled-coil domain containing 183 9 136796350-136807741 Predicted intracellular proteins Evidence at transcript level HPA043812 Uncertain Mixed Tissue enriched 81 testis: 11.7 pancreas,placenta,prostate,rectum: 0.1 CCDC189 C16orf93, MGC104706 ENSG00000196118 Coiled-coil domain containing 189 16 30757423-30762710 Predicted intracellular proteins Evidence at protein level HPA041806, HPA046289 Approved Supported Cytosol Mixed Tissue enhanced fallopian tube: 13.0 testis: 8.1 CCDC190 C1orf110, MGC48998 ENSG00000185860 Coiled-coil domain containing 190 1 162824458-162868815 Predicted intracellular proteins Evidence at transcript level HPA028579, HPA028584, HPA028592 Uncertain Approved Vesicles Mixed Tissue enhanced esophagus: 3.7;lung: 2.8 fallopian tube: 0.8 CCDC191 KIAA1407 ENSG00000163617 Coiled-coil domain containing 191 3 113964137-114056613 Predicted intracellular proteins Evidence at protein level HPA047833 Approved Approved Mitochondria Urothelial cancer:3.45e-4 (favourable) Expressed in all Mixed fallopian tube: 18.6 CCDC27 FLJ32825 ENSG00000162592 Coiled-coil domain containing 27 1 3752398-3771645 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 54 testis: 18.4 seminal vesicle: 0.3 CCDC3 DKFZp761F241 ENSG00000151468 Coiled-coil domain containing 3 10 12896625-13099652 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA062425 Approved Nucleus
Cytosol Renal cancer:1.38e-5 (unfavourable) Expressed in all Mixed skin: 158.8 CCDC30 FLJ20972, LOC728621, PFD6L ENSG00000186409 Coiled-coil domain containing 30 1 42463330-42654664 Predicted intracellular proteins Evidence at protein level HPA036344, HPA036345 Approved Mixed Tissue enhanced testis: 6.8 fallopian tube: 4.9 CCDC34 L15, NY-REN-41, RAMA3 ENSG00000109881 Coiled-coil domain containing 34 11 27330827-27363868 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA037574 Uncertain Approved Nuclear membrane
Nucleoli fibrillar center Liver cancer:1.32e-7 (unfavourable), Renal cancer:1.82e-4 (unfavourable), Ovarian cancer:8.52e-4 (favourable) Expressed in all Tissue enhanced testis: 54.6 fallopian tube: 13.4 CCDC38 FLJ40089 ENSG00000165972 Coiled-coil domain containing 38 12 95867048-95942974 Predicted intracellular proteins Evidence at protein level HPA039726 Approved Nucleus
Nucleoli Not detected Tissue enriched 18 testis: 26.2 liver: 1.4 CCDC39 CILD14, DKFZp434A128, FAP59 ENSG00000145075 Coiled-coil domain containing 39 3 180602858-180871005 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA035363, HPA035364 Supported Mixed Mixed parathyroid gland: 27.7 CCDC40 CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640 ENSG00000141519 Coiled-coil domain containing 40 17 80036632-80100613 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA022974 Uncertain Approved Microtubules Renal cancer:2.45e-4 (unfavourable), Endometrial cancer:2.95e-4 (favourable) Mixed Tissue enhanced fallopian tube: 23.5 testis: 12.9 CCDC63 FLJ35843, ODA5 ENSG00000173093 Coiled-coil domain containing 63 12 110846769-110907535 Predicted intracellular proteins Evidence at protein level HPA061568 Approved Nucleoplasm
Nuclear bodies
Vesicles Tissue enriched Tissue enriched 31 testis: 29.4 skeletal muscle: 0.9 CCDC64 FLJ26450 ENSG00000135127 Coiled-coil domain containing 64 12 119989869-120094494 Predicted intracellular proteins Evidence at protein level HPA061116 Approved Approved Nucleoplasm
Vesicles
Cytosol Stomach cancer:1.21e-5 (favourable), Renal cancer:3.93e-5 (favourable), Head and neck cancer:3.15e-4 (favourable), Cervical cancer:6.50e-4 (favourable), Liver cancer:6.84e-4 (unfavourable) Expressed in all Tissue enhanced kidney: 73.5;skin: 58.8 epididymis: 45.0 CCDC7 BIOT2, C10orf68, FLJ13031, FLJ32762 ENSG00000150076 Coiled-coil domain containing 7 10 32567723-32882874 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 45 testis: 93.5 epididymis: 2.0 CCDC7 BIOT2, C10orf68, FLJ13031, FLJ32762 ENSG00000216937 Coiled-coil domain containing 7 10 32446140-32574564 Predicted intracellular proteins Evidence at transcript level HPA075536 Approved Nucleoli
Cytosol Not detected Tissue enriched 38 testis: 131.0 thyroid gland: 3.4 CCDC71 FLJ12800 ENSG00000177352 Coiled-coil domain containing 71 3 49162535-49166321 Predicted intracellular proteins Evidence at protein level HPA047547 Uncertain Approved Nuclear membrane Renal cancer:9.65e-9 (favourable) Expressed in all Expressed in all thyroid gland: 27.2 CCDC71L C7orf74, FLJ36031 ENSG00000253276 Coiled-coil domain containing 71-like 7 106656765-106660996 Predicted intracellular proteins Evidence at protein level HPA067925 Approved Approved Golgi apparatus
Actin filaments
Cytosol Renal cancer:2.53e-6 (unfavourable), Cervical cancer:9.08e-4 (unfavourable) Expressed in all Mixed adipose tissue: 30.8 CCDC73 NY-SAR-79 ENSG00000186714 Coiled-coil domain containing 73 11 32602246-32794658 Predicted intracellular proteins Evidence at protein level HPA038668, HPA038669 Uncertain Not detected Tissue enriched 11 testis: 6.6 spleen: 0.5 CCDC74A FLJ40345 ENSG00000163040 Coiled-coil domain containing 74A 2 131527675-131533666 Predicted intracellular proteins Evidence at transcript level HPA060727 Uncertain Vesicles Renal cancer:1.70e-7 (unfavourable), Glioma:1.82e-4 (unfavourable), Testis cancer:4.92e-4 (favourable), Breast cancer:5.11e-4 (favourable) Mixed Tissue enhanced fallopian tube: 54.5;testis: 79.2 parathyroid gland: 26.7 CCDC74B DKFZp434E2321 ENSG00000152076 Coiled-coil domain containing 74B 2 130139287-130145134 Predicted intracellular proteins Evidence at transcript level HPA060727 Uncertain Vesicles Renal cancer:1.55e-4 (unfavourable), Breast cancer:4.46e-4 (favourable) Mixed Tissue enhanced fallopian tube: 22.9;testis: 52.1 cervix, uterine: 13.9 CCDC77 MGC13183 ENSG00000120647 Coiled-coil domain containing 77 12 389273-442645 Predicted intracellular proteins Evidence at protein level HPA038854 Approved Approved Nuclear membrane Liver cancer:8.11e-7 (unfavourable) Expressed in all Mixed testis: 23.3 CCDC78 C16orf25, FLJ34512 ENSG00000162004 Coiled-coil domain containing 78 16 722582-726954 Disease related genes, Predicted intracellular proteins Evidence at protein level Tissue enhanced Tissue enriched 11 fallopian tube: 95.2 lung: 8.5 CCDC79 FLJ35894 ENSG00000249961 Coiled-coil domain containing 79 16 66754976-66801620 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 22 testis: 25.1 bone marrow: 1.1 CCDC81 FLJ16339, FLJ23514 ENSG00000149201 Coiled-coil domain containing 81 11 86374736-86423109 Predicted intracellular proteins Evidence at protein level HPA040745, HPA040827 Uncertain Uncertain Plasma membrane Tissue enhanced Group enriched 11 fallopian tube: 45.5;testis: 10.9 endometrium: 2.6 CCDC83 CT148, FLJ42119, MGC34732 ENSG00000150676 Coiled-coil domain containing 83 11 85855101-85920021 Predicted intracellular proteins Evidence at transcript level HPA039707, HPA039882 Uncertain Nucleus
Plasma membrane
Cytosol Not detected Tissue enriched 132 testis: 63.3 cerebral cortex,endometrium,parathyroid gland: 0.4 CCDC84 DLNB14 ENSG00000186166 Coiled-coil domain containing 84 11 118998142-119015791 Predicted intracellular proteins Evidence at protein level HPA039906, HPA071715 Uncertain Approved Nucleus Renal cancer:2.93e-5 (unfavourable) Expressed in all Mixed skin: 4.6 CCDC85A KIAA1912 ENSG00000055813 Coiled-coil domain containing 85A 2 56184123-56386173 Predicted secreted proteins Evidence at protein level HPA043106, HPA057020 Uncertain Mixed Tissue enhanced cerebral cortex: 21.1 thyroid gland: 15.8 CCDC89 FLJ38159 ENSG00000179071 Coiled-coil domain containing 89 11 85684866-85686277 Predicted intracellular proteins Evidence at transcript level HPA039351, HPA040628 Uncertain Approved Nucleoplasm Mixed Tissue enhanced fallopian tube: 19.1;testis: 53.2 ovary: 8.1 CCDC96 FLJ90575 ENSG00000173013 Coiled-coil domain containing 96 4 7040849-7042939 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA047546 Approved Renal cancer:3.80e-5 (favourable), Endometrial cancer:4.05e-4 (favourable), Pancreatic cancer:4.87e-4 (favourable) Expressed in all Group enriched 14 fallopian tube: 17.6;testis: 61.6 cerebral cortex,lung: 2.7 CCIN BTBD20, KBTBD14 ENSG00000185972 Calicin 9 36169394-36171334 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 41 testis: 111.6 smooth muscle: 2.7 CCM2L C20orf160, dJ310O13.5 ENSG00000101331 Cerebral cavernous malformation 2-like 20 32010450-32032180 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA008434, HPA071063 Uncertain Approved Nucleoplasm Expressed in all Tissue enriched 8 spleen: 124.7 placenta: 14.9 CCNG2 ENSG00000138764 Cyclin G2 4 77157151-77433388 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level HPA034684 Approved Approved Nucleoplasm
Cytosol Renal cancer:2.47e-5 (favourable), Pancreatic cancer:8.57e-4 (unfavourable) Expressed in all Expressed in all esophagus: 151.2 CCNI CCNI1 ENSG00000118816 Cyclin I 4 77047158-77076005 Predicted intracellular proteins Evidence at protein level CAB010206, HPA039853, HPA061470 Uncertain Supported Nucleoplasm
Nuclear bodies
Golgi apparatus Renal cancer:2.10e-4 (favourable) Expressed in all Expressed in all thyroid gland: 451.7 CCNI2 FLJ16793 ENSG00000205089 Cyclin I family, member 2 5 132747445-132754403 Predicted intracellular proteins Evidence at protein level HPA056288 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Colorectal cancer:8.21e-4 (favourable) Tissue enhanced Mixed duodenum: 3.9 CCNJ bA690P14.1, FLJ10895 ENSG00000107443 Cyclin J 10 96043394-96060870 Predicted intracellular proteins Evidence at transcript level HPA036531, HPA058151 Approved Approved Nucleoplasm
Golgi apparatus Expressed in all Expressed in all parathyroid gland: 9.8 CCNJL FLJ14166 ENSG00000135083 Cyclin J-like 5 160251652-160345396 Predicted intracellular proteins Evidence at protein level HPA049970 Approved Approved Nuclear speckles Thyroid cancer:7.10e-4 (favourable), Colorectal cancer:7.31e-4 (favourable), Urothelial cancer:8.02e-4 (favourable) Mixed Tissue enhanced testis: 19.4 lung: 10.3 CCR6 BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22 ENSG00000112486 Chemokine (C-C motif) receptor 6 6 167111807-167139696 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level CAB006820, HPA014488 Approved Not detected Tissue enhanced lymph node: 20.6;tonsil: 33.8 spleen: 17.3 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level CAB003796, HPA031383, HPA074467 Supported Supported Mitochondria Head and neck cancer:7.61e-7 (favourable), Cervical cancer:8.03e-6 (favourable), Breast cancer:3.84e-4 (favourable), Testis cancer:7.72e-4 (unfavourable) Mixed Group enriched 6 appendix: 91.9;lymph node: 98.3;spleen: 39.9;tonsil: 80.2 urinary bladder: 12.9 CCSER1 FAM190A, KIAA1680 ENSG00000184305 Coiled-coil serine-rich protein 1 4 90127535-91601913 Predicted intracellular proteins Evidence at transcript level HPA041880, HPA054709 Uncertain Mixed Tissue enhanced testis: 4.6 adrenal gland: 1.7 CCSER2 FAM190B, KIAA1128 ENSG00000107771 Coiled-coil serine-rich protein 2 10 84328586-84518521 Predicted intracellular proteins Evidence at protein level HPA037481, HPA037482 Approved Approved Nucleoplasm
Cytosol Expressed in all Expressed in all cerebral cortex: 39.6 CCT8L2 CESK1 ENSG00000198445 Chaperonin containing TCP1, subunit 8 (theta)-like 2 22 16590751-16592810 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 171 testis: 17.1 all non-specific tissues: 0.0 CD200R1L CD200R2, CD200RLa ENSG00000206531 CD200 receptor 1-like 3 112815709-112846856 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 46 testis: 4.9 epididymis: 0.1 CD300C CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR ENSG00000167850 CD300c molecule 17 74541108-74546143 CD markers, Predicted membrane proteins Evidence at transcript level HPA014523 Approved Testis cancer:8.53e-5 (unfavourable) Mixed Tissue enhanced lung: 12.5 appendix: 9.7 CD72 CD72b, LYB2 ENSG00000137101 CD72 molecule 9 35609533-35646810 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB002505, HPA044658 Supported Approved Nucleus
Mitochondria Renal cancer:2.49e-8 (unfavourable) Expressed in all Group enriched 8 appendix: 26.2;lymph node: 72.0;spleen: 65.9;tonsil: 44.3 gallbladder,urinary bladder: 6.2 CD8B CD8B1 ENSG00000172116 CD8b molecule 2 86815339-86861924 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level CAB004353, HPA029164 Approved Supported Plasma membrane Endometrial cancer:7.88e-7 (favourable), Renal cancer:7.11e-6 (unfavourable) Mixed Tissue enhanced cervix, uterine: 60.5;lymph node: 40.2 parathyroid gland: 22.4 CDADC1 NYD-SP15 ENSG00000102543 Cytidine and dCMP deaminase domain containing 1 13 49247925-49293485 Predicted intracellular proteins Evidence at transcript level HPA047615, HPA058314 Uncertain Approved Nucleoplasm Renal cancer:1.19e-5 (favourable), Lung cancer:6.03e-4 (favourable) Expressed in all Mixed thyroid gland: 15.7 CDC42EP5 Borg3, CEP5 ENSG00000167617 CDC42 effector protein (Rho GTPase binding) 5 19 54465026-54473264 Predicted intracellular proteins Evidence at protein level HPA043449 Approved Renal cancer:2.79e-5 (unfavourable), Urothelial cancer:1.36e-4 (favourable) Expressed in all Tissue enhanced colon: 3.2;prostate: 2.0 adipose tissue: 0.9 CDCP2 ENSG00000157211 CUB domain containing protein 2 1 54133074-54153770 Predicted secreted proteins Evidence at transcript level HPA031143 Uncertain Not detected Not detected cervix, uterine,spleen: 0.1 CDH11 CAD11, OB ENSG00000140937 Cadherin 11, type 2, OB-cadherin (osteoblast) 16 64943753-65126112 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level CAB013072 Approved Renal cancer:2.48e-9 (unfavourable) Expressed in all Tissue enhanced ovary: 223.0 placenta: 172.7 CDH12 Br-cadherin, CDHB ENSG00000154162 Cadherin 12, type 2 (N-cadherin 2) 5 21750673-22853622 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA029325 Uncertain Approved Vesicles Mixed Group enriched 5 adrenal gland: 2.5;cerebral cortex: 3.8;cervix, uterine: 5.3;fallopian tube: 4.0;skin: 1.1;testis: 2.7 breast,urinary bladder: 0.6 CDH16 ENSG00000166589 Cadherin 16, KSP-cadherin 16 66908122-66918984 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB013526, HPA036260 Supported Renal cancer:1.02e-7 (favourable) Tissue enriched Group enriched 8 kidney: 230.2;thyroid gland: 57.6 fallopian tube: 16.9 CDH17 cadherin, HPT-1 ENSG00000079112 Cadherin 17, LI cadherin (liver-intestine) 8 94127171-94217303 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA023614, HPA023616, CAB025143, HPA026556 Supported Supported Cell Junctions Group enriched Group enriched 7 colon: 261.7;duodenum: 323.0;rectum: 272.5;small intestine: 300.5 appendix: 39.2 CDH18 CDH14, EY-CADHERIN ENSG00000145526 Cadherin 18, type 2 5 19472951-20575873 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA014416 Uncertain Mixed Tissue enhanced adrenal gland: 5.9;cerebral cortex: 19.1 testis: 3.2 CDH19 CDH7 ENSG00000071991 Cadherin 19, type 2 18 66501083-66604138 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA056332 Uncertain Tissue enriched Mixed heart muscle: 9.6 CDH20 Cdh7, CDH7L3 ENSG00000101542 Cadherin 20, type 2 18 61333582-61555773 Predicted membrane proteins Evidence at protein level HPA015490 Uncertain Tissue enriched Tissue enriched 5 cerebral cortex: 26.9 adipose tissue: 4.9 CDH22 C20orf25, dJ998H6.1 ENSG00000149654 Cadherin 22, type 2 20 46173733-46308498 Predicted membrane proteins Evidence at transcript level HPA012164 Uncertain Mixed Group enriched 6 adrenal gland: 2.0;cerebral cortex: 10.3;fallopian tube: 2.3;skin: 5.2 testis: 0.8 CDH26 VR20 ENSG00000124215 Cadherin 26 20 59958427-60034011 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015722, HPA047578 Uncertain Approved Plasma membrane
Microtubules Lung cancer:3.75e-4 (favourable), Cervical cancer:7.62e-4 (favourable) Group enriched Tissue enhanced prostate: 19.8 urinary bladder: 6.3 CDH4 ENSG00000179242 Cadherin 4, type 1, R-cadherin (retinal) 20 61252426-61940617 Predicted membrane proteins Evidence at protein level HPA015613 Validated Plasma membrane Group enriched Tissue enhanced cerebral cortex: 6.0;spleen: 4.9 seminal vesicle: 1.3 CDH7 ENSG00000081138 Cadherin 7, type 2 18 65750252-65890341 Predicted membrane proteins Evidence at protein level HPA061419 Approved Tissue enhanced Tissue enhanced cerebral cortex: 2.8;prostate: 1.2 testis: 0.7 CDH8 ENSG00000150394 Cadherin 8, type 2 16 61647242-62037035 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014908, HPA058444 Approved Supported Plasma membrane Tissue enhanced Group enriched 8 cerebral cortex: 27.9;seminal vesicle: 6.9 ovary: 2.1 CDH9 ENSG00000113100 Cadherin 9, type 2 (T1-cadherin) 5 26880600-27121150 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA007167 Uncertain Not detected Tissue enhanced breast: 16.7;cerebral cortex: 11.4 testis: 6.6 CDHR4 CDH29, VLLR9392 ENSG00000187492 Cadherin-related family member 4 3 49790732-49799835 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Tissue enriched Tissue enriched 9 fallopian tube: 103.8 lung: 11.5 CDKL4 ENSG00000205111 Cyclin-dependent kinase-like 4 2 39175646-39229588 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA067895 Uncertain Not detected Tissue enriched 8 testis: 5.3 placenta: 0.6 CDRT1 FBXW10B, FBXW10P1, HREP, SM25H2 ENSG00000241322 CMT1A duplicated region transcript 1 17 15565483-15619704 Predicted intracellular proteins Evidence at transcript level HPA013332, HPA047457 Approved Nucleus
Nucleoli Not detected Tissue enriched 5 testis: 27.0 esophagus: 5.3 CDRT15 ENSG00000223510 CMT1A duplicated region transcript 15 17 14235673-14236862 Predicted intracellular proteins Evidence at protein level HPA055952 Uncertain Approved Cell Junctions Not detected Tissue enhanced testis: 11.6 skin: 4.0 CDRT15L2 ENSG00000214819 CMT1A duplicated region transcript 15-like 2 17 20579724-20580911 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 11 testis: 13.2 epididymis: 1.1 CDS1 ENSG00000163624 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 4 84582979-84651338 Enzymes, Predicted membrane proteins Evidence at protein level HPA036187 Uncertain Approved Nucleus
Nuclear membrane Renal cancer:0.00e+0 (favourable), Colorectal cancer:5.22e-4 (favourable) Expressed in all Mixed fallopian tube: 49.0 CDX2 CDX3 ENSG00000165556 Caudal type homeobox 2 13 27962137-27971139 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002221, HPA045669, HPA049580 Supported Supported Nucleoplasm Tissue enriched Group enriched 6 colon: 31.4;duodenum: 22.9;rectum: 25.3;small intestine: 30.8 appendix: 4.9 CEACAM21 FLJ13540, R29124_1 ENSG00000007129 Carcinoembryonic antigen-related cell adhesion molecule 21 19 41549518-41586844 Predicted membrane proteins Evidence at transcript level HPA043411 Uncertain Endometrial cancer:1.89e-5 (favourable) Mixed Tissue enhanced bone marrow: 11.0 spleen: 6.6 CECR6 ENSG00000183307 Cat eye syndrome chromosome region, candidate 6 22 17116299-17121367 Predicted membrane proteins Evidence at protein level HPA068790 Approved Nucleoplasm
Vesicles
Plasma membrane Tissue enhanced Group enriched 7 cerebral cortex: 15.0;prostate: 10.9 testis: 1.9 CELA2B ELA2B, RP11-265F14.2 ENSG00000215704 Chymotrypsin-like elastase family, member 2B 1 15465909-15491400 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Tissue enriched Tissue enriched 258 pancreas: 4260.7 ovary: 16.4 CEMP1 CP-23 ENSG00000205923 Cementum protein 1 16 2530035-2531417 Predicted intracellular proteins Evidence at transcript level HPA057658 Approved Not detected Mixed skin: 5.7 CEND1 BM88, FLJ90066 ENSG00000184524 Cell cycle exit and neuronal differentiation 1 11 787104-790123 Predicted membrane proteins Evidence at protein level HPA042527 Supported Approved Mitochondria Glioma:6.10e-5 (unfavourable) Tissue enriched Tissue enriched 16 cerebral cortex: 114.3 adrenal gland: 7.1 CENPBD1 MGC16385 ENSG00000177946 CENPB DNA-binding domains containing 1 16 89969791-89972534 Predicted intracellular proteins Evidence at transcript level HPA052759, HPA060522 Uncertain Approved Nucleoli
Vesicles Renal cancer:5.27e-11 (favourable) Expressed in all Mixed parathyroid gland: 11.0 CEP295 KIAA1731 ENSG00000166004 Centrosomal protein 295kDa 11 93661639-93730358 Predicted intracellular proteins Evidence at protein level HPA038595, HPA038596, HPA038597 Approved Supported Plasma membrane
Cytosol Expressed in all Expressed in all testis: 22.2 CEP295NL DDC8, KIAA1731NL ENSG00000178404 CEP295 N-terminal like 17 78870910-78903217 Predicted intracellular proteins Evidence at transcript level HPA023609, HPA024619, HPA025717 Uncertain Approved Vesicles Not detected Tissue enriched 46 testis: 40.4 bone marrow: 0.8 CERCAM CEECAM1, CerCAM, GLT25D3 ENSG00000167123 Cerebral endothelial cell adhesion molecule 9 128411751-128437351 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA021657, HPA051595 Uncertain Approved Nucleus
Nucleoli
Cell Junctions Renal cancer:3.33e-16 (unfavourable), Urothelial cancer:3.30e-5 (unfavourable), Ovarian cancer:5.22e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 156.0 CERS5 FLJ25304, LASS5, MGC45411, Trh4 ENSG00000139624 Ceramide synthase 5 12 50129306-50167533 Enzymes, Predicted membrane proteins Evidence at protein level HPA026589 Approved Approved Nucleus
Nucleoli Renal cancer:9.33e-11 (unfavourable), Liver cancer:4.63e-5 (unfavourable), Thyroid cancer:5.76e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 37.9 CES4A CES8, FLJ37464 ENSG00000172824 Carboxylesterase 4A 16 66988589-67009758 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA035701 Approved Approved Cytosol Renal cancer:2.35e-6 (unfavourable) Mixed Group enriched 7 fallopian tube: 28.2;skin: 9.2 epididymis: 2.7 CES5A CAUXIN, CES4C1, CES5, CES7, FLJ31547 ENSG00000159398 Carboxylesterase 5A 16 55846154-55956031 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA047635 Uncertain Tissue enhanced Tissue enriched 40 epididymis: 78.9 liver: 1.9 CFAP100 CCDC37, FLJ40083, MIA1 ENSG00000163885 Cilia and flagella associated protein 100 3 126394939-126436556 Predicted intracellular proteins Evidence at protein level HPA046354 Approved Tissue enhanced Group enriched 5 fallopian tube: 43.0;testis: 34.3 lung: 7.5 CFAP126 C1orf192, Flattop, Fltp ENSG00000188931 Cilia and flagella associated protein 126 1 161364731-161367874 Predicted intracellular proteins Evidence at protein level HPA045904 Supported Not detected Tissue enriched 9 fallopian tube: 224.9 testis: 24.8 CFAP157 C9orf117 ENSG00000160401 Cilia and flagella associated protein 157 9 127706989-127716002 Predicted intracellular proteins Evidence at protein level HPA021474, HPA021786 Supported Validated Plasma membrane
Cytosol Endometrial cancer:1.45e-4 (favourable) Mixed Tissue enriched 8 fallopian tube: 93.9 lung: 12.2 CFAP161 C15orf26, FLJ38615 ENSG00000156206 Cilia and flagella associated protein 161 15 81007033-81149175 Predicted intracellular proteins Evidence at protein level HPA041807 Uncertain Endometrial cancer:3.05e-4 (favourable) Tissue enhanced Tissue enhanced fallopian tube: 24.5;testis: 11.4 lung: 4.1 CFAP43 bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96 ENSG00000197748 Cilia and flagella associated protein 43 10 104129888-104232362 Predicted intracellular proteins Evidence at protein level HPA038128 Approved Nucleus Mixed Group enriched 7 fallopian tube: 77.1;testis: 102.7 lung: 12.6 CFAP45 CCDC19, NESG1 ENSG00000213085 Cilia and flagella associated protein 45 1 159872364-159900163 Predicted intracellular proteins Evidence at protein level HPA042204, HPA043618 Supported Validated Nucleoplasm Tissue enhanced Group enriched 7 fallopian tube: 70.6;testis: 38.8 lung: 7.7 CFAP46 bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40 ENSG00000171811 Cilia and flagella associated protein 46 10 132808392-132942823 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA037786, HPA038034, HPA038867, HPA038868 Uncertain Mixed Tissue enhanced fallopian tube: 8.4;testis: 17.6 skeletal muscle: 5.8 CFAP54 C12orf55, C12orf63, FLJ31514, FLJ44112 ENSG00000188596 Cilia and flagella associated 54 12 96489571-96875555 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039897 Supported Approved Microtubules
Cytosol Not detected Mixed testis: 10.6 CFAP57 FLJ32000, WDR65 ENSG00000243710 Cilia and flagella associated protein 57 1 43172149-43254358 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA002736, HPA028623 Supported Uncertain Cytosol Endometrial cancer:6.02e-4 (favourable) Mixed Group enriched 8 fallopian tube: 35.3;testis: 27.6 liver: 3.8 CFAP61 C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156 ENSG00000089101 Cilia and flagella associated protein 61 20 20052514-20360702 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA009079 Uncertain Mixed Group enriched 6 fallopian tube: 20.0;heart muscle: 6.9;testis: 30.1 skeletal muscle: 3.3 CFAP69 C7orf63, FAP69, FLJ21062 ENSG00000105792 Cilia and flagella associated protein 69 7 90245174-90311063 Predicted intracellular proteins Evidence at protein level HPA062883 Uncertain Tissue enhanced Tissue enhanced prostate: 24.6 fallopian tube: 17.4 CFAP70 FLJ25765, TTC18 ENSG00000156042 Cilia and flagella associated protein 70 10 73253759-73358859 Predicted intracellular proteins Evidence at protein level HPA037582 Approved Mixed Tissue enhanced fallopian tube: 23.4;testis: 38.3 epididymis: 14.3 CFAP73 CCDC42B, MIA2 ENSG00000186710 Cilia and flagella associated protein 73 12 113149858-113159276 Predicted intracellular proteins Evidence at protein level HPA048539 Supported Cervical cancer:1.29e-4 (favourable), Endometrial cancer:5.52e-4 (favourable) Tissue enhanced Tissue enriched 8 fallopian tube: 59.6 lung: 7.0 CFAP74 C1orf222, FLJ45476, KIAA1751 ENSG00000142609 Cilia and flagella associated protein 74 1 1921951-2003837 Predicted intracellular proteins Evidence at protein level HPA028521, HPA029274 Supported Tissue enhanced Tissue enhanced fallopian tube: 10.4;testis: 9.0 skin: 4.4 CGB1 ENSG00000267631 Chorionic gonadotropin, beta polypeptide 1 19 49035610-49036895 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA038925, HPA038934 Supported Approved Cytosol Not detected Not detected pancreas: 0.6 CGREF1 CGR11 ENSG00000138028 Cell growth regulator with EF-hand domain 1 2 27098889-27119115 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA008241 Uncertain Endometrial cancer:3.18e-4 (unfavourable), Liver cancer:7.57e-4 (unfavourable) Mixed Tissue enhanced cerebral cortex: 44.9 stomach: 11.6 CHAC2 ENSG00000143942 ChaC, cation transport regulator homolog 2 (E. coli) 2 53767792-53775196 Predicted intracellular proteins Evidence at protein level HPA049235 Approved Approved Cytosol Liver cancer:3.80e-7 (unfavourable) Expressed in all Mixed testis: 9.9 CHAD SLRR4A ENSG00000136457 Chondroadherin 17 50464496-50468966 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA018241 Supported Liver cancer:1.59e-4 (favourable), Breast cancer:7.68e-4 (favourable) Tissue enhanced Tissue enhanced cervix, uterine: 33.1 breast: 14.0 CHIC1 BRX ENSG00000204116 Cysteine-rich hydrophobic domain 1 X 73563200-73687102 Predicted membrane proteins Evidence at protein level HPA026782, HPA052062 Uncertain Approved Nuclear speckles
Vesicles
Cytosol Renal cancer:2.75e-4 (favourable) Mixed Mixed cerebral cortex: 14.2 CHODL C21orf68, FLJ12627, MT75, PRED12 ENSG00000154645 Chondrolectin 21 17901263-18267373 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017282 Approved Supported Endometrial cancer:1.18e-6 (unfavourable) Mixed Tissue enhanced spleen: 19.7;testis: 57.3 prostate: 8.2 CHPF2 ChSy-3, CSGlcA-T, KIAA1402 ENSG00000033100 Chondroitin polymerizing factor 2 7 151232489-151238827 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA020992 Approved Approved Nucleoplasm
Cytosol Pancreatic cancer:2.51e-4 (favourable), Liver cancer:9.47e-4 (unfavourable) Expressed in all Expressed in all appendix: 24.0 CHRFAM7A CHRNA7-DR1, D-10 ENSG00000166664 CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion 15 30357766-30393849 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced testis: 6.1 parathyroid gland: 4.9 CHRM4 ENSG00000180720 Cholinergic receptor, muscarinic 4 11 46385098-46386608 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level CAB022444, HPA072083 Uncertain Uncertain Nucleus
Golgi apparatus Mixed Tissue enhanced cerebral cortex: 8.1;small intestine: 7.9;spleen: 21.9 testis: 6.9 CHRM5 ENSG00000184984 Cholinergic receptor, muscarinic 5 15 33968720-34067457 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA013172 Uncertain Not detected Tissue enhanced cerebral cortex: 3.1;testis: 4.1 placenta: 2.5 CHRNA6 ENSG00000147434 Cholinergic receptor, nicotinic, alpha 6 (neuronal) 8 42752620-42796392 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Mixed Not detected fallopian tube: 0.6 CHRNB3 ENSG00000147432 Cholinergic receptor, nicotinic, beta 3 (neuronal) 8 42697376-42737407 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA045555 Uncertain Tissue enriched Tissue enriched 6 testis: 3.7 cerebral cortex: 0.6 CHST5 FLJ22167, I-GLCNAC-6-ST ENSG00000135702 Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 16 75528535-75535247 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA043804 Approved Group enriched Group enriched 14 colon: 46.8;duodenum: 88.4;rectum: 60.8;small intestine: 85.3 stomach: 4.9 CHST9 GALNAC-4-ST2, GALNAC4ST-2 ENSG00000154080 Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 18 26906481-27185317 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA011393 Uncertain Mixed Tissue enhanced fallopian tube: 16.5;testis: 12.7 spleen: 8.0 CHSY3 CHSY-2, CSS3 ENSG00000198108 Chondroitin sulfate synthase 3 5 129904472-130186634 Enzymes, Predicted secreted proteins Evidence at protein level HPA044612 Uncertain Mixed Tissue enhanced cervix, uterine: 7.1 gallbladder: 4.5 CILP2 MGC45771 ENSG00000160161 Cartilage intermediate layer protein 2 19 19538248-19546659 Predicted secreted proteins Evidence at protein level HPA041847 Uncertain Endometrial cancer:3.22e-6 (unfavourable), Ovarian cancer:2.50e-4 (unfavourable) Mixed Tissue enhanced gallbladder: 2.5;testis: 4.2 adipose tissue: 0.8 CKLF C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1 ENSG00000217555 Chemokine-like factor 16 66552563-66566251 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA062779 Approved Vesicles Renal cancer:1.06e-9 (unfavourable), Liver cancer:5.67e-5 (unfavourable), Thyroid cancer:2.22e-4 (favourable) Expressed in all Expressed in all testis: 91.2 CLDN10 CPETRL3, OSP-L ENSG00000134873 Claudin 10 13 95433604-95579759 Predicted membrane proteins Evidence at protein level CAB012969, HPA042348 Supported Renal cancer:7.46e-5 (favourable), Thyroid cancer:2.13e-4 (favourable) Mixed Tissue enhanced kidney: 161.8 gallbladder: 111.0 CLDN11 OSP, OTM ENSG00000013297 Claudin 11 3 170418865-170860380 Predicted membrane proteins Evidence at protein level CAB009789, HPA013166 Supported Breast cancer:6.31e-4 (favourable) Tissue enhanced Tissue enhanced cerebral cortex: 89.2;testis: 184.3 ovary: 61.8 CLDN17 MGC126552, MGC126554 ENSG00000156282 Claudin 17 21 30165564-30166756 Predicted membrane proteins, Transporters Evidence at protein level HPA045903 Supported Tissue enhanced Tissue enriched 5 esophagus: 6.6 tonsil: 1.3 CLDN18 SFTPJ ENSG00000066405 Claudin 18 3 137998735-138033655 Predicted membrane proteins Evidence at protein level CAB013010, CAB013243, HPA018446 Supported Group enriched Group enriched 99 lung: 362.1;stomach: 695.3 gallbladder: 5.3 CLDN20 ENSG00000171217 Claudin 20 6 155264013-155276548 Predicted membrane proteins Evidence at transcript level Mixed Mixed skin: 1.0 CLDN22 CLDN21 ENSG00000177300 Claudin 22 4 183318194-183320774 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Not detected epididymis,esophagus: 0.1 CLDN23 CLDNL ENSG00000253958 Claudin 23 8 8701938-8704106 Predicted membrane proteins, Transporters Evidence at protein level HPA070578 Uncertain Nucleus
Plasma membrane Renal cancer:9.65e-8 (favourable), Colorectal cancer:3.46e-4 (favourable) Expressed in all Tissue enhanced colon: 24.1;stomach: 24.9 small intestine: 16.9 CLDN5 AWAL, BEC1, CPETRL1, TMVCF ENSG00000184113 Claudin 5 22 19523024-19527545 Predicted membrane proteins, Transporters Evidence at protein level CAB002607 Approved Expressed in all Tissue enhanced adipose tissue: 128.2 lung: 53.8 CLDND2 MGC33839 ENSG00000160318 Claudin domain containing 2 19 51367098-51369003 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA056971 Uncertain Approved Nucleoplasm Mixed Tissue enhanced testis: 22.3 spleen: 6.4 CLEC10A CD301, CLECSF13, CLECSF14, HML, HML2 ENSG00000132514 C-type lectin domain family 10, member A 17 7074537-7080307 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA021937 Approved Head and neck cancer:1.26e-5 (favourable), Testis cancer:4.22e-4 (unfavourable), Lung cancer:9.24e-4 (favourable) Expressed in all Mixed appendix: 40.3 CLEC16A Gop-1, KIAA0350 ENSG00000038532 C-type lectin domain family 16, member A 16 10944488-11182189 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA035814, HPA035815, HPA061385 Approved Approved Nucleus
Vesicles Renal cancer:2.92e-6 (favourable) Expressed in all Expressed in all testis: 60.2 CLEC18B ENSG00000140839 C-type lectin domain family 18, member B 16 74408270-74421953 Predicted secreted proteins Evidence at transcript level HPA048976 Uncertain Glioma:1.55e-4 (unfavourable) Group enriched Group enriched 10 kidney: 30.8;testis: 8.2 cerebral cortex: 2.0 CLEC18C MGC34761 ENSG00000157335 C-type lectin domain family 18, member C 16 70173322-70187361 Predicted secreted proteins Evidence at transcript level HPA048976 Uncertain Tissue enriched Group enriched 23 kidney: 12.2;testis: 3.6 duodenum: 0.3 CLEC19A ENSG00000261210 C-type lectin domain family 19, member A 16 19285739-19322145 Predicted secreted proteins Evidence at transcript level HPA042113 Uncertain Not detected Tissue enriched 6 cerebral cortex: 2.6 skin: 0.4 CLEC1A CLEC1, MGC34328 ENSG00000150048 C-type lectin domain family 1, member A 12 10069554-10111627 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 6 placenta: 70.5 lung: 12.7 CLEC4F CLECSF13, FLJ39110, KCLR ENSG00000152672 C-type lectin domain family 4, member F 2 70808643-70820600 Predicted membrane proteins Evidence at transcript level Mixed Mixed small intestine: 5.0 CLEC6A CLECSF10, dectin-2 ENSG00000205846 C-type lectin domain family 6, member A 12 8455926-8478330 Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enhanced appendix: 1.6;lung: 1.5 lymph node: 0.8 CLECL1 DCAL1 ENSG00000184293 C-type lectin-like 1 12 9715860-9733299 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced lymph node: 29.1;spleen: 23.2;tonsil: 29.6 appendix: 13.7 CLIC6 CLIC1L, CLIC5 ENSG00000159212 Chloride intracellular channel 6 21 34669389-34718227 Predicted intracellular proteins, Transporters Evidence at protein level HPA055123, HPA065285 Approved Lung cancer:3.15e-5 (favourable), Breast cancer:6.11e-5 (favourable) Mixed Tissue enhanced stomach: 76.8 cervix, uterine: 24.3 CLLU1 ENSG00000257127 Chronic lymphocytic leukemia up-regulated 1 12 92421531-92431002 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 CLPSL1 C6orf127, dJ510O8.6 ENSG00000204140 Colipase-like 1 6 35781017-35793675 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA073155 Approved Group enriched Tissue enriched 37 epididymis: 719.8 pancreas: 19.3 CLRN2 ENSG00000249581 Clarin 2 4 17515165-17527104 Predicted membrane proteins, Transporters Evidence at transcript level HPA042407 Uncertain Not detected Not detected testis: 0.3 CLRN3 MGC32871, TMEM12, USH3AL1 ENSG00000180745 Clarin 3 10 127877841-127892947 Predicted membrane proteins, Transporters Evidence at protein level HPA014482 Approved Stomach cancer:8.98e-4 (favourable) Group enriched Group enriched 8 colon: 71.2;duodenum: 75.4;gallbladder: 23.7;kidney: 43.9;liver: 40.2;rectum: 77.5;small intestine: 99.5 appendix: 7.5 CLUL1 ENSG00000079101 Clusterin-like 1 (retinal) 18 596988-650334 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB025264, HPA044243 Uncertain Approved Vesicles Mixed Mixed prostate: 14.6 CLVS2 bA160A10.4, C6orf212, C6orf213, RLBP1L2 ENSG00000146352 Clavesin 2 6 122995971-123072927 Predicted intracellular proteins Evidence at protein level HPA043764 Uncertain Tissue enhanced Group enriched 6 cerebral cortex: 15.5;prostate: 4.4 endometrium: 1.6 CMTM1 CKLFH, CKLFH1a, CKLFSF1 ENSG00000089505 CKLF-like MARVEL transmembrane domain containing 1 16 66566393-66579137 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA013801, HPA017136 Uncertain Approved Nucleoplasm Pancreatic cancer:5.68e-5 (unfavourable) Mixed Tissue enriched 6 testis: 28.8 spleen: 4.5 CMTM2 CKLFSF2, FLJ25732, MGC39436 ENSG00000140932 CKLF-like MARVEL transmembrane domain containing 2 16 66579448-66588275 Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 1014 testis: 711.4 bone marrow: 0.7 CMTM7 CKLFSF7, FLJ30992 ENSG00000153551 CKLF-like MARVEL transmembrane domain containing 7 3 32391671-32483067 Predicted membrane proteins, Transporters Evidence at protein level HPA077409 Approved Plasma membrane Renal cancer:1.00e-6 (unfavourable), Liver cancer:3.21e-4 (unfavourable) Expressed in all Mixed fallopian tube: 60.9 CNBD1 FLJ35802 ENSG00000176571 Cyclic nucleotide binding domain containing 1 8 86866442-87615219 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA025037, HPA027469, HPA027786 Uncertain Not detected Tissue enriched 12 testis: 11.6 spleen: 0.9 CNBD2 C20orf152, CNMPD1, dJ954P9.1 ENSG00000149646 Cyclic nucleotide binding domain containing 2 20 35954564-36030700 Predicted intracellular proteins Evidence at protein level HPA043182 Uncertain Not detected Tissue enhanced testis: 37.8 epididymis: 14.8 CNGA2 CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA ENSG00000183862 Cyclic nucleotide gated channel alpha 2 X 151738451-151745304 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA015065 Uncertain Not detected Not detected testis: 0.4 CNIH3 CNIH-3, FLJ38993 ENSG00000143786 Cornichon family AMPA receptor auxiliary protein 3 1 224434660-224740549 Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced cerebral cortex: 14.8 testis: 4.2 CNNM1 ACDP1 ENSG00000119946 Cyclin and CBS domain divalent metal cation transport mediator 1 10 99329099-99394330 Predicted membrane proteins Evidence at protein level HPA040408 Approved Uncertain Plasma membrane
Cytosol Mixed Tissue enhanced cerebral cortex: 10.2;testis: 16.7 ovary: 3.0 CNPPD1 C2orf24, CGI-57 ENSG00000115649 Cyclin Pas1/PHO80 domain containing 1 2 219171897-219178106 Predicted membrane proteins Evidence at transcript level HPA049303 Uncertain Renal cancer:1.62e-10 (favourable), Liver cancer:2.04e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 86.9 CNPY4 MGC40499, PRAT4B ENSG00000166997 Canopy FGF signaling regulator 4 7 100119613-100125511 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA014166, HPA025240 Uncertain Approved Vesicles Renal cancer:3.59e-5 (unfavourable), Liver cancer:3.99e-4 (unfavourable) Expressed in all Mixed endometrium: 34.7 CNTD1 CNTD, FLJ40137 ENSG00000176563 Cyclin N-terminal domain containing 1 17 42798792-42811587 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA023324 Uncertain Nucleoplasm
Plasma membrane
Focal adhesion sites Mixed Tissue enriched 32 testis: 72.3 stomach: 2.2 CNTD2 CCNP, FLJ13265 ENSG00000105219 Cyclin N-terminal domain containing 2 19 40222208-40226690 Predicted intracellular proteins Evidence at transcript level HPA045615 Uncertain Mixed Not detected adipose tissue: 0.9 CNTNAP3 CASPR3, CNTNAP3A, FLJ14195, KIAA1714 ENSG00000106714 Contactin associated protein-like 3 9 39072767-39288315 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA015604, HPA047731 Approved Mixed Mixed esophagus: 8.3 CNTNAP3B ENSG00000154529 Contactin associated protein-like 3B 9 41890314-42129510 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA015604, HPA047731 Uncertain Not detected Mixed esophagus,skin: 10.4 CNTNAP5 caspr5, FLJ31966 ENSG00000155052 Contactin associated protein-like 5 2 124025287-124915287 Predicted membrane proteins Evidence at protein level HPA069095, HPA069356 Supported Nucleus
Nucleoli fibrillar center
Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 5.8;gallbladder: 1.6 adrenal gland: 0.7 COL21A1 ENSG00000124749 Collagen, type XXI, alpha 1 6 56056590-56394094 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA031210, HPA031212, HPA031213 Uncertain Supported Cytosol Mixed Tissue enhanced cervix, uterine: 36.5;placenta: 38.7 endometrium: 19.5 COL22A1 ENSG00000169436 Collagen, type XXII, alpha 1 8 138588235-138914006 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA024830 Approved Supported Endoplasmic reticulum
Vesicles Lung cancer:2.13e-6 (unfavourable), Glioma:3.62e-4 (unfavourable) Mixed Tissue enhanced adrenal gland: 9.8 prostate: 4.8 COL28A1 ENSG00000215018 Collagen, type XXVIII, alpha 1 7 7356203-7535853 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA060468 Uncertain Tissue enhanced Tissue enhanced epididymis: 17.9 fallopian tube,salivary gland: 7.9 COLCA2 C11orf93, CASC13 ENSG00000214290 Colorectal cancer associated 2 11 111298546-111308735 Predicted intracellular proteins Evidence at transcript level Renal cancer:8.97e-6 (favourable) Mixed Mixed epididymis: 35.0 COLEC10 CL-L1 ENSG00000184374 Collectin sub-family member 10 (C-type lectin) 8 118995452-119106582 Plasma proteins, Predicted secreted proteins Evidence at protein level Liver cancer:5.79e-4 (favourable) Mixed Group enriched 8 liver: 51.1;placenta: 25.7 thyroid gland: 4.9 COPZ2 MGC23008 ENSG00000005243 Coatomer protein complex, subunit zeta 2 17 48026167-48038030 Predicted intracellular proteins Evidence at protein level HPA055999 Uncertain Renal cancer:3.45e-9 (unfavourable), Thyroid cancer:2.89e-6 (unfavourable), Urothelial cancer:4.66e-4 (unfavourable) Expressed in all Mixed adipose tissue: 73.0 COQ10A FLJ32452 ENSG00000135469 Coenzyme Q10A 12 56266858-56270966 Predicted intracellular proteins Evidence at protein level HPA068931 Approved Endoplasmic reticulum
Golgi apparatus
Cytosol Pancreatic cancer:2.06e-4 (favourable), Renal cancer:3.44e-4 (favourable), Colorectal cancer:5.46e-4 (unfavourable) Expressed in all Expressed in all skeletal muscle: 97.2 COQ10B FLJ13448 ENSG00000115520 Coenzyme Q10B 2 197453423-197475308 Predicted intracellular proteins Evidence at protein level HPA046057 Approved Approved Cytosol Expressed in all Expressed in all adrenal gland: 49.9 CORO2A IR10, WDR2 ENSG00000106789 Coronin, actin binding protein, 2A 9 98120975-98192640 Predicted intracellular proteins Evidence at protein level HPA041161, HPA041302 Supported Approved Plasma membrane
Cytosol Renal cancer:6.56e-4 (unfavourable) Mixed Mixed small intestine: 39.4 CORT MGC32686 ENSG00000241563 Cortistatin 1 10449719-10451902 Predicted secreted proteins Evidence at transcript level Mixed Tissue enriched 23 cerebral cortex: 24.9 placenta: 1.1 COX18 FLJ38991 ENSG00000163626 COX18 cytochrome c oxidase assembly factor 4 73052362-73069755 Predicted membrane proteins Evidence at protein level HPA046772, HPA049489 Approved Renal cancer:8.22e-7 (favourable), Colorectal cancer:6.31e-4 (favourable) Expressed in all Mixed thyroid gland: 5.5 COX6A2 ENSG00000156885 Cytochrome c oxidase subunit VIa polypeptide 2 16 31427731-31428428 Predicted intracellular proteins, Transporters Evidence at protein level Group enriched Group enriched 23 heart muscle: 681.3;skeletal muscle: 1847.0 esophagus: 55.1 COX8C COX8-3 ENSG00000187581 Cytochrome c oxidase subunit VIIIC 14 93347191-93348356 Predicted membrane proteins, Transporters Evidence at transcript level HPA003127 Approved Group enriched Tissue enriched 52 testis: 29.6 fallopian tube: 0.5 CPA5 ENSG00000158525 Carboxypeptidase A5 7 130344816-130368730 Enzymes, Predicted intracellular proteins Evidence at protein level HPA020322 Approved Nucleus Not detected Tissue enriched 11 testis: 47.1 spleen: 4.2 CPEB2 ENSG00000137449 Cytoplasmic polyadenylation element binding protein 2 4 15002674-15070153 Predicted intracellular proteins Evidence at protein level HPA072513 Supported Nucleoplasm
Cytosol Expressed in all Tissue enhanced testis: 41.5 parathyroid gland: 23.7 CPED1 C7orf58, FLJ21986 ENSG00000106034 Cadherin-like and PC-esterase domain containing 1 7 120988677-121297444 Predicted intracellular proteins Evidence at transcript level HPA012058 Uncertain Approved Nucleus Lung cancer:3.00e-4 (favourable), Renal cancer:4.87e-4 (unfavourable) Mixed Mixed ovary: 96.3 CPLX2 CPX-2, DKFZp547D155 ENSG00000145920 Complexin 2 5 175796310-175884020 Predicted intracellular proteins Evidence at protein level HPA071191 Uncertain Vesicles Mixed Tissue enhanced cerebral cortex: 237.1;epididymis: 143.5 adrenal gland: 44.6 CPLX3 CPX-III ENSG00000213578 Complexin 3 15 74826547-74831802 Predicted intracellular proteins Evidence at protein level Not detected Group enriched 8 prostate: 127.7;spleen: 75.8 cerebral cortex: 12.9 CPLX4 CPX-IV ENSG00000166569 Complexin 4 18 59275156-59318649 Predicted intracellular proteins Evidence at protein level Not detected Not detected skin,testis: 0.4 CPO ENSG00000144410 Carboxypeptidase O 2 206939554-206969474 Enzymes, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 15 small intestine: 133.7 epididymis: 9.2 CPSF4L ENSG00000187959 Cleavage and polyadenylation specific factor 4-like 17 73248449-73262352 Predicted intracellular proteins Evidence at transcript level HPA044047 Uncertain Not detected Tissue enhanced testis: 1.0 breast: 0.5 CPXCR1 CT77 ENSG00000147183 CPX chromosome region, candidate 1 X 88747225-88754785 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 57 testis: 11.4 fallopian tube: 0.2 CPXM1 CPX-1, CPX1, CPXM ENSG00000088882 Carboxypeptidase X (M14 family), member 1 20 2794069-2800637 Enzymes, Predicted secreted proteins Evidence at protein level Renal cancer:4.62e-10 (unfavourable) Expressed in all Tissue enhanced endometrium: 130.2;gallbladder: 132.9 urinary bladder: 77.4 CPXM2 CPX2, UNQ676 ENSG00000121898 Carboxypeptidase X (M14 family), member 2 10 123706207-123940267 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA048375 Uncertain Renal cancer:9.02e-4 (favourable) Expressed in all Tissue enhanced epididymis: 71.4;smooth muscle: 79.7 urinary bladder: 35.5 CRIP3 bA480N24.2, TLP, TLP-A ENSG00000146215 Cysteine-rich protein 3 6 43299710-43308797 Predicted intracellular proteins Evidence at protein level HPA036198 Uncertain Approved Nuclear speckles Tissue enhanced Tissue enhanced testis: 15.4 heart muscle: 13.0 CRISPLD1 Cocoacrisp, DKFZp762F133, LCRISP1 ENSG00000121005 Cysteine-rich secretory protein LCCL domain containing 1 8 74984515-75034558 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA024725 Uncertain Tissue enhanced Tissue enhanced prostate: 40.7 breast: 34.9 CRISPLD2 DKFZP434B044, LCRISP2 ENSG00000103196 Cysteine-rich secretory protein LCCL domain containing 2 16 84819984-84920768 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA030055 Approved Approved Nucleoplasm
Cytosol Renal cancer:1.97e-6 (unfavourable) Expressed in all Expressed in all placenta: 173.0 CRYGA CRY-g-A, CRYG1, CRYG5 ENSG00000168582 Crystallin, gamma A 2 208160740-208163576 Predicted intracellular proteins Evidence at protein level Not detected Not detected cerebral cortex,testis: 0.1 CRYGN ENSG00000127377 Crystallin, gamma N 7 151428835-151440813 Predicted intracellular proteins Evidence at transcript level HPA050788 Uncertain Tissue enriched Tissue enhanced seminal vesicle: 3.3;thyroid gland: 12.8 parathyroid gland: 1.9 CSAG1 CSAGE, CT24.1 ENSG00000198930 Chondrosarcoma associated gene 1 X 152727484-152733735 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced testis: 2.2 lymph node: 0.8 CSHL1 CS-5, CSHP1, CSL, hCS-L, MGC149868 ENSG00000204414 Chorionic somatomammotropin hormone-like 1 17 63909597-63918838 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB025646, HPA043715 Supported Not detected Tissue enriched 356 placenta: 216.4 smooth muscle: 0.6 CSMD3 ENSG00000164796 CUB and Sushi multiple domains 3 8 112222928-113437099 Predicted membrane proteins Evidence at transcript level HPA029007 Uncertain Not detected Group enriched 7 cerebral cortex: 4.9;testis: 1.8 fallopian tube,prostate,spleen: 0.4 CSNK1A1L MGC33182 ENSG00000180138 Casein kinase 1, alpha 1-like 13 37103259-37105664 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA051334 Uncertain Cytosol Not detected Tissue enriched 16 testis: 6.4 bone marrow: 0.3 CSRNP3 FAM130A2, FLJ32093, PPP1R73, TAIP-2 ENSG00000178662 Cysteine-serine-rich nuclear protein 3 2 165469647-165689407 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017905 Supported Approved Nucleus
Nucleoli Mixed Tissue enhanced cerebral cortex: 16.2 endometrium: 4.6 CST9 CLM, CTES7A ENSG00000173335 Cystatin 9 (testatin) 20 23602410-23605876 Predicted secreted proteins Evidence at transcript level HPA029190 Uncertain Tissue enriched Tissue enriched 12 breast: 2.2 kidney: 0.1 CSTL1 CTES1, dJ322G13.4 ENSG00000125823 Cystatin-like 1 20 23439685-23444930 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 37 testis: 4.6 placenta,seminal vesicle,skin,small intestine,stomach: 0.1 CT45A1 CT45-1, CT45.1 ENSG00000268940 Cancer/testis antigen family 45, member A1 X 135713453-135723539 Predicted intracellular proteins Evidence at protein level HPA044735, HPA044757, HPA046872, HPA046987 Supported Approved Nucleus
Nucleoli Mixed Tissue enriched 42 testis: 12.4 cerebral cortex,lung: 0.2 CT45A10 ENSG00000269586 Cancer/testis antigen family 45, member A10 X 135881063-135889086 Predicted intracellular proteins Evidence at protein level HPA044735, HPA044757, HPA046872, HPA046987 Supported Approved Nucleus
Nucleoli Mixed Tissue enriched 23 testis: 16.4 cerebral cortex: 0.7 CT45A2 CT45-2, CT45.2 ENSG00000271449 Cancer/testis antigen family 45, member A2 X 135811668-135820012 Predicted intracellular proteins Evidence at protein level HPA044735, HPA044757, HPA046872, HPA046987 Supported Approved Nucleus
Nucleoli Not detected Tissue enriched 14 testis: 1.3 all non-specific tissues: 0.0 CT45A5 CT45-5, CT45.5 ENSG00000228836 Cancer/testis antigen family 45, member A5 X 135777130-135785298 Predicted intracellular proteins Evidence at protein level HPA044735, HPA044757, HPA046872, HPA046987 Supported Approved Nucleus
Nucleoli Not detected Tissue enriched 62 testis: 8.6 cerebral cortex: 0.1 CT45A6 CT45-6, CT45.6 ENSG00000278289 Cancer/testis antigen family 45, member A6 X 135794706-135802656 Predicted intracellular proteins Evidence at protein level HPA044735, HPA044757, HPA046872, HPA046987 Supported Approved Nucleus
Nucleoli Not detected Not detected testis: 0.6 CT47A1 CT47.1 ENSG00000236371 Cancer/testis antigen family 47, member A1 X 120982466-120985788 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 11 testis: 1.1 all non-specific tissues: 0.0 CT47A10 CT47.10 ENSG00000224089 Cancer/testis antigen family 47, member A10 X 120938701-120942023 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 21 testis: 2.0 all non-specific tissues: 0.0 CT47A11 CT47.11 ENSG00000226929 Cancer/testis antigen family 47, member A11 X 120933840-120937158 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 36 testis: 3.5 all non-specific tissues: 0.0 CT47A12 CT47.12 ENSG00000226685 Cancer/testis antigen family 47, member A12 X 120930250-120932301 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 24 testis: 2.3 all non-specific tissues: 0.0 CT47A2 CT47.2 ENSG00000242362 Cancer/testis antigen family 47, member A2 X 120977606-120980928 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 21 testis: 2.0 all non-specific tissues: 0.0 CT47A3 CT47.3 ENSG00000236126 Cancer/testis antigen family 47, member A3 X 120972746-120976068 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 21 testis: 2.0 all non-specific tissues: 0.0 CT47A4 CT47.4 ENSG00000230594 Cancer/testis antigen family 47, member A4 X 120967886-120971208 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 21 testis: 2.0 all non-specific tissues: 0.0 CT47A5 CT47.5 ENSG00000237957 Cancer/testis antigen family 47, member A5 X 120958165-120966348 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 24 testis: 2.3 all non-specific tissues: 0.0 CT47A6 CT47.6 ENSG00000226023 Cancer/testis antigen family 47, member A6 X 120953282-120961487 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Not detected testis: 0.5 CT47A7 CT47.7 ENSG00000228517 Cancer/testis antigen family 47, member A7 X 120953288-120956600 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Not detected all non-specific tissues: 0.0 CT47A8 CT47.8 ENSG00000230347 Cancer/testis antigen family 47, member A8 X 120877490-120951744 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 21 testis: 2.0 all non-specific tissues: 0.0 CT47A9 CT47.9 ENSG00000226600 Cancer/testis antigen family 47, member A9 X 120943561-120946883 Predicted intracellular proteins Evidence at transcript level HPA042483 Approved Not detected Tissue enriched 21 testis: 2.0 all non-specific tissues: 0.0 CT62 ENSG00000225362 Cancer/testis antigen 62 15 71110244-71115494 Predicted intracellular proteins Evidence at transcript level HPA045306 Uncertain Group enriched Tissue enriched 16 testis: 49.8 breast: 3.2 CTAGE1 CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2 ENSG00000212710 Cutaneous T-cell lymphoma-associated antigen 1 18 22413601-22417915 Predicted membrane proteins Evidence at protein level HPA000387, HPA000922, CAB016204 Uncertain Not detected Tissue enriched 50 testis: 5.0 all non-specific tissues: 0.0 CTAGE15 CTAGE15P ENSG00000271079 CTAGE family, member 15 7 143571801-143574387 Predicted membrane proteins Evidence at protein level HPA000387, HPA000922 Uncertain Not detected Tissue enhanced testis: 7.2 thyroid gland: 1.9 CTAGE4 cTAGE-4, FLJ43692 ENSG00000225932 CTAGE family, member 4 7 144183466-144186053 Predicted membrane proteins Evidence at protein level HPA000387, HPA000922 Uncertain Not detected Mixed thyroid gland: 16.7 CTAGE6 CTAGE6P, MGC41943 ENSG00000271321 CTAGE family, member 6 7 143755089-143757696 Predicted membrane proteins Evidence at protein level HPA000387, HPA000922 Uncertain Not detected Tissue enriched 38 testis: 9.9 skin: 0.2 CTAGE9 ENSG00000236761 CTAGE family, member 9 6 131708684-131711017 Predicted membrane proteins Evidence at protein level HPA000387, HPA000922 Uncertain Not detected Tissue enriched 40 testis: 7.6 duodenum,seminal vesicle,small intestine: 0.1 CTB-55O6.8 ENSG00000141854 Uncharacterized protein LOC113230 19 14072536-14075062 Predicted intracellular proteins Evidence at protein level HPA042225 Uncertain Stomach cancer:3.11e-5 (favourable), Renal cancer:9.52e-4 (favourable) Expressed in all Mixed small intestine: 8.7 CTRB1 CTRB ENSG00000168925 Chymotrypsinogen B1 16 75219000-75224924 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Tissue enriched Tissue enriched 375 pancreas: 48914.0 ovary: 130.3 CTRB2 ENSG00000168928 Chymotrypsinogen B2 16 75204096-75207185 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Tissue enriched Tissue enriched 391 pancreas: 29051.6 ovary: 74.2 CTRL ENSG00000141086 Chymotrypsin-like 16 67927640-67932414 Enzymes, Predicted secreted proteins Evidence at protein level HPA034504, HPA034505 Supported Uncertain Nucleoplasm Not detected Tissue enriched 209 pancreas: 1630.5 ovary: 7.8 CTSO CTSO1 ENSG00000256043 Cathepsin O 4 155924118-155953917 Enzymes, Predicted secreted proteins Evidence at protein level HPA002041 Approved Expressed in all Expressed in all gallbladder: 32.5 CUZD1 ERG-1, UO-44 ENSG00000138161 CUB and zona pellucida-like domains 1 10 122832149-122850793 Predicted membrane proteins Evidence at protein level HPA068479, HPA068660, HPA074117 Supported Approved Nucleoli
Vesicles Tissue enriched Tissue enriched 170 pancreas: 380.4 testis: 2.2 CWH43 CWH43-C, FLJ21511 ENSG00000109182 Cell wall biogenesis 43 C-terminal homolog 4 48986247-49062081 Predicted membrane proteins Evidence at protein level HPA042814, HPA048140 Uncertain Renal cancer:2.29e-11 (favourable), Endometrial cancer:1.32e-4 (favourable) Tissue enhanced Tissue enhanced prostate: 69.1 skin: 29.7 CXCL16 CXCLG16, SR-PSOX, SRPSOX ENSG00000161921 Chemokine (C-X-C motif) ligand 16 17 4733526-4739922 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA053253, HPA066315 Approved Approved Golgi apparatus
Vesicles Expressed in all Mixed lung: 106.3 CXCR6 BONZO, CD186, STRL33, TYMSTR ENSG00000172215 Chemokine (C-X-C motif) receptor 6 3 45940933-45948353 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA047591 Uncertain Endometrial cancer:6.74e-6 (favourable), Renal cancer:2.42e-5 (unfavourable), Head and neck cancer:2.16e-4 (favourable), Cervical cancer:4.92e-4 (favourable) Mixed Mixed lymph node: 17.6 CXorf21 FLJ11577 ENSG00000120280 Chromosome X open reading frame 21 X 30558824-30577844 Predicted intracellular proteins Evidence at protein level HPA001185 Uncertain Mixed Mixed appendix: 14.8 CXorf36 DIA1R, FLJ14103 ENSG00000147113 Chromosome X open reading frame 36 X 45148374-45200901 Disease related genes, Predicted secreted proteins Evidence at transcript level HPA002806 Uncertain Expressed in all Tissue enhanced placenta: 58.0 adipose tissue: 36.2 CXorf40B ENSG00000197021 Chromosome X open reading frame 40B X 149929527-149938811 Predicted intracellular proteins Evidence at transcript level HPA060897 Approved Thyroid cancer:1.02e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 79.8 CXorf49 ENSG00000215115 Chromosome X open reading frame 49 X 71714371-71718151 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 51 testis: 5.0 all non-specific tissues: 0.0 CXorf49B ENSG00000215113 Chromosome X open reading frame 49B X 71763424-71767204 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 51 testis: 5.0 all non-specific tissues: 0.0 CXorf58 FLJ25444 ENSG00000165182 Chromosome X open reading frame 58 X 23907801-23939507 Predicted intracellular proteins Evidence at protein level HPA031542, HPA031543, HPA031544 Uncertain Not detected Tissue enriched 10 testis: 6.2 fallopian tube: 0.6 CXorf66 RP11-35F15.2, SGPX ENSG00000203933 Chromosome X open reading frame 66 X 139955725-139965520 Predicted membrane proteins Evidence at protein level HPA048517 Approved Not detected Tissue enriched 76 testis: 24.1 liver: 0.3 CXorf67 ENSG00000187690 Chromosome X open reading frame 67 X 51406915-51408843 Predicted intracellular proteins Evidence at protein level HPA004003, HPA006128 Supported Validated Nucleoplasm Tissue enriched Group enriched 20 placenta: 1.3;testis: 4.7 cerebral cortex,epididymis,ovary,spleen: 0.1 CYB561D1 FLJ39035, FLJ44753 ENSG00000174151 Cytochrome b561 family, member D1 1 109494052-109502932 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA027028 Uncertain Pancreatic cancer:5.16e-6 (favourable), Renal cancer:2.22e-4 (favourable), Head and neck cancer:4.68e-4 (favourable) Expressed in all Mixed skin: 21.4 CYB5D1 FLJ32499 ENSG00000182224 Cytochrome b5 domain containing 1 17 7857746-7862282 Predicted intracellular proteins Evidence at protein level HPA021632 Uncertain Approved Nucleoli
Golgi apparatus Mixed Expressed in all fallopian tube: 42.0 CYB5D2 MGC32124 ENSG00000167740 Cytochrome b5 domain containing 2 17 4143168-4187310 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042299 Approved Approved Nuclear membrane
Nucleoli
Centrosome Renal cancer:2.03e-10 (favourable), Liver cancer:4.98e-6 (favourable), Pancreatic cancer:7.76e-5 (favourable), Endometrial cancer:6.19e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 51.5 CYB5RL LOC606495 ENSG00000215883 Cytochrome b5 reductase-like 1 54172336-54200036 Enzymes, Predicted intracellular proteins Evidence at protein level HPA042671, HPA060463 Approved Validated Nucleoplasm Mixed Mixed thyroid gland: 3.3 CYLC1 ENSG00000183035 Cylicin, basic protein of sperm head cytoskeleton 1 X 83861126-83886699 Predicted intracellular proteins Evidence at protein level HPA070355 Supported Not detected Tissue enriched 428 testis: 42.7 all non-specific tissues: 0.0 CYLC2 ENSG00000155833 Cylicin, basic protein of sperm head cytoskeleton 2 9 102995311-103018488 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 395 testis: 79.9 epididymis: 0.2 CYP26A1 CP26, CYP26, P450RAI, P450RAI1 ENSG00000095596 Cytochrome P450, family 26, subfamily A, polypeptide 1 10 93073475-93077890 Predicted intracellular proteins Evidence at protein level Tissue enhanced Tissue enriched 9 liver: 9.7 cerebral cortex: 1.0 CYP26C1 ENSG00000187553 Cytochrome P450, family 26, subfamily C, polypeptide 1 10 93060808-93069536 Disease related genes, Predicted membrane proteins Evidence at transcript level Not detected Not detected spleen: 0.2 CYP27C1 FLJ16008 ENSG00000186684 Cytochrome P450, family 27, subfamily C, polypeptide 1 2 127184120-127220078 Predicted intracellular proteins Evidence at protein level HPA068731 Approved Vesicles Mixed Tissue enhanced skin: 7.0 cervix, uterine: 2.4 CYP2A7 CYP2A ENSG00000198077 Cytochrome P450, family 2, subfamily A, polypeptide 7 19 40875439-40882752 Enzymes, Predicted secreted proteins Evidence at protein level CAB033510, HPA046713, HPA047262 Supported Group enriched Tissue enriched 113 liver: 60.8 breast: 0.5 CYP39A1 ENSG00000146233 Cytochrome P450, family 39, subfamily A, polypeptide 1 6 46549580-46652830 Enzymes, Predicted membrane proteins Evidence at protein level Renal cancer:1.86e-4 (favourable) Tissue enhanced Tissue enhanced liver: 56.7 epididymis: 28.4 CYP4F22 FLJ39501 ENSG00000171954 Cytochrome P450, family 4, subfamily F, polypeptide 22 19 15508493-15552317 Disease related genes, Predicted membrane proteins Evidence at protein level HPA058960 Uncertain Group enriched Tissue enhanced esophagus: 14.1;skin: 34.3 seminal vesicle: 9.0 CYP4X1 MGC40051 ENSG00000186377 Cytochrome P450, family 4, subfamily X, polypeptide 1 1 47023568-47050751 Enzymes, Predicted membrane proteins Evidence at protein level HPA017661 Approved Mixed Tissue enhanced cervix, uterine: 52.7 breast: 18.6 CYP4Z1 CYP4A20 ENSG00000186160 Cytochrome P450, family 4, subfamily Z, polypeptide 1 1 47067488-47118319 Enzymes, Predicted membrane proteins Evidence at protein level Tissue enriched Tissue enhanced breast: 7.0 lung: 1.7 CYTH4 CYT4, cytohesin-4, PSCD4 ENSG00000100055 Cytohesin 4 22 37282027-37315345 Predicted intracellular proteins Evidence at protein level HPA071573 Approved Renal cancer:2.41e-8 (unfavourable) Expressed in all Tissue enhanced appendix: 92.0 spleen: 71.0 CYYR1 C21orf95 ENSG00000166265 Cysteine/tyrosine-rich 1 21 26466209-26573284 Predicted membrane proteins Evidence at transcript level CAB034921, HPA067685 Uncertain Approved Nucleoplasm Expressed in all Expressed in all adrenal gland: 60.4 DACH2 ENSG00000126733 Dachshund family transcription factor 2 X 86148458-86832604 Predicted intracellular proteins Evidence at transcript level HPA000258 Uncertain Not detected Group enriched 8 cerebral cortex: 11.9;epididymis: 4.4;fallopian tube: 5.0 kidney: 0.8 DACT2 bA503C24.7, C6orf116, DAPPER2 ENSG00000164488 Dishevelled-binding antagonist of beta-catenin 2 6 168292830-168319754 Predicted intracellular proteins Evidence at transcript level HPA030251, HPA030252 Approved Endometrial cancer:1.07e-5 (favourable), Renal cancer:5.76e-5 (favourable) Tissue enhanced Tissue enhanced placenta: 18.7 prostate: 6.7 DAND5 CER2, CKTSF1B3, DANTE, DTE, FLJ38607, GREM3 ENSG00000179284 DAN domain family member 5, BMP antagonist 19 12965159-12974762 Predicted secreted proteins Evidence at transcript level HPA049472 Uncertain Mixed Tissue enhanced heart muscle: 5.3 bone marrow,cerebral cortex: 1.3 DBX2 FLJ16139 ENSG00000185610 Developing brain homeobox 2 12 45014672-45051099 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA066053 Uncertain Tissue enriched Group enriched 5 cerebral cortex: 4.1;testis: 1.2 skin: 0.5 DCAF12L2 WDR40C ENSG00000198354 DDB1 and CUL4 associated factor 12-like 2 X 126164531-126165951 Predicted intracellular proteins Evidence at transcript level HPA044737, HPA048981, HPA053138 Approved Approved Cytosol Mixed Tissue enhanced epididymis: 17.8;testis: 9.2 seminal vesicle: 6.5 DCAF4L1 WDR21B ENSG00000182308 DDB1 and CUL4 associated factor 4-like 1 4 41981696-41986467 Predicted intracellular proteins Evidence at protein level CAB073535 Supported Tissue enriched Tissue enriched 122 testis: 45.7 appendix,skin: 0.3 DCAF8L1 WDR42B ENSG00000226372 DDB1 and CUL4 associated factor 8-like 1 X 27977993-27981355 Predicted intracellular proteins Evidence at transcript level HPA043787 Approved Not detected Tissue enriched 57 testis: 5.6 all non-specific tissues: 0.0 DCAF8L2 WDR42C ENSG00000189186 DDB1 and CUL4 associated factor 8-like 2 X 27590382-27748821 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 52 testis: 40.4 ovary: 0.7 DCDC1 ENSG00000170959 Doublecortin domain containing 1 11 30830369-31369810 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Not detected Tissue enhanced fallopian tube: 6.4;testis: 4.3 gallbladder: 2.8 DCHS2 CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ ENSG00000197410 Dachsous cadherin-related 2 4 154232037-154491716 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA064159 Uncertain Approved Vesicles
Plasma membrane Not detected Mixed endometrium: 4.0 DCLK2 DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428 ENSG00000170390 Doublecortin-like kinase 2 4 150078274-150257457 Enzymes, Predicted intracellular proteins Evidence at protein level HPA015770 Supported Pancreatic cancer:2.48e-4 (favourable), Ovarian cancer:3.25e-4 (favourable) Tissue enriched Tissue enriched 11 cerebral cortex: 82.8 heart muscle: 7.4 DCLK3 DCAMKL3, DCDC3C, KIAA1765 ENSG00000163673 Doublecortin-like kinase 3 3 36712422-36739861 Enzymes, Predicted membrane proteins Evidence at protein level CAB015207 Uncertain Tissue enhanced Tissue enhanced testis: 4.9 cerebral cortex: 1.1 DCST1 FLJ32785 ENSG00000163357 DC-STAMP domain containing 1 1 155033824-155050930 Predicted membrane proteins Evidence at protein level HPA060314 Uncertain Not detected Group enriched 5 skin: 3.7;testis: 6.2 small intestine: 0.9 DCST2 FLJ32934 ENSG00000163354 DC-STAMP domain containing 2 1 155018520-155033781 Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced skin: 5.1;testis: 4.2 duodenum,fallopian tube: 1.3 DDIAS C11orf82, FLJ25416, FLJ38838, noxin ENSG00000165490 DNA damage-induced apoptosis suppressor 11 82899975-82958277 Predicted secreted proteins Evidence at protein level HPA038540, HPA038541 Approved Approved Plasma membrane
Cytosol Mixed Tissue enhanced testis: 20.1 skeletal muscle: 6.4 DDO ENSG00000203797 D-aspartate oxidase 6 110391771-110415562 Enzymes, Predicted membrane proteins Evidence at protein level HPA037525, HPA037526 Supported Supported Cytosol Renal cancer:8.69e-5 (favourable) Mixed Tissue enhanced parathyroid gland: 24.0 heart muscle: 11.7 DDTL ENSG00000099974 D-dopachrome tautomerase-like 22 23966901-23972532 Predicted intracellular proteins Evidence at transcript level Liver cancer:5.98e-4 (favourable) Expressed in all Mixed liver: 6.5 DDX43 CT13, DKFZp434H2114, HAGE ENSG00000080007 DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 6 73394748-73417569 Enzymes, Predicted intracellular proteins Evidence at protein level HPA031380, HPA031381 Approved Tissue enriched Tissue enriched 5 testis: 34.5 placenta: 6.8 DDX60L FLJ31033 ENSG00000181381 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like 4 168356735-168537786 Enzymes, Predicted intracellular proteins Evidence at protein level HPA043211, HPA055501 Approved Approved Plasma membrane
Cytosol Pancreatic cancer:3.04e-5 (unfavourable), Renal cancer:2.94e-4 (unfavourable) Expressed in all Mixed bone marrow: 33.7 DEC1 CTS9 ENSG00000173077 Deleted in esophageal cancer 1 9 115141818-115402644 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.5 DEFB104A DEFB-4, DEFB104, DEFB4 ENSG00000176782 Defensin, beta 104A 8 7836471-7841242 Predicted secreted proteins Evidence at protein level HPA045292 Supported Not detected Tissue enriched 598 epididymis: 572.3 esophagus: 0.9 DEFB104B ENSG00000177023 Defensin, beta 104B 8 7470308-7475082 Predicted secreted proteins Evidence at protein level HPA045292 Supported Not detected Tissue enriched 598 epididymis: 572.3 esophagus: 0.9 DEFB105A DEFB-5, DEFB105 ENSG00000186562 Defensin, beta 105A 8 7821966-7823889 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 6001 epididymis: 2329.8 esophagus: 0.3 DEFB105B ENSG00000186599 Defensin, beta 105B 8 7487669-7489593 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 12711 epididymis: 1768.6 testis: 0.1 DEFB107A DEFB-7, DEFB107 ENSG00000186572 Defensin, beta 107A 8 7811720-7815716 Predicted secreted proteins Evidence at transcript level HPA045626 Approved Not detected Tissue enriched 2765 epididymis: 478.6 endometrium: 0.1 DEFB107B HsT21816 ENSG00000198129 Defensin, beta 107B 8 7495846-7509311 Predicted secreted proteins Evidence at transcript level HPA045626 Approved Not detected Tissue enriched 2765 epididymis: 478.6 endometrium: 0.1 DEFB108B ENSG00000184276 Defensin, beta 108B 11 71833200-71837710 Predicted secreted proteins Evidence at transcript level HPA042588 Uncertain Not detected Not detected all non-specific tissues: 0.0 DEFB118 C20orf63, DEFB-18, dJ1018D12.3, ESC42 ENSG00000131068 Defensin, beta 118 20 31368618-31373923 Predicted secreted proteins Evidence at transcript level HPA042634 Approved Not detected Tissue enriched 12100 epididymis: 1209.9 all non-specific tissues: 0.0 DEFB119 DEFB-19, DEFB-20, DEFB120 ENSG00000180483 Defensin, beta 119 20 31377164-31390603 Predicted secreted proteins Evidence at protein level HPA043059 Approved Tissue enriched Group enriched 3354 epididymis: 2302.6;testis: 469.2 duodenum: 0.4 DEFB123 DEFB-23 ENSG00000180424 Defensin, beta 123 20 31440519-31450257 Predicted secreted proteins Evidence at protein level Tissue enriched Group enriched 426 epididymis: 106.1;testis: 176.9 small intestine: 0.3 DEFB125 DEFB-25 ENSG00000178591 Defensin, beta 125 20 87250-97094 Predicted secreted proteins Evidence at transcript level HPA043095 Uncertain Not detected Group enriched 13 epididymis: 1.7;seminal vesicle: 1.4 testis: 0.1 DEFB126 bA530N10.1, C20orf8, DEFB-26 ENSG00000125788 Defensin, beta 126 20 142369-145751 Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enriched 233 epididymis: 653.9 seminal vesicle: 2.8 DEFB129 bA530N10.3, C20orf87, DEFB-29 ENSG00000125903 Defensin, beta 129 20 227258-229886 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 492 epididymis: 2327.0 seminal vesicle: 4.7 DEFB131 DEFB-31 ENSG00000186146 Defensin, beta 131 4 9444534-9450514 Predicted secreted proteins Evidence at transcript level Tissue enriched Tissue enriched 9 epididymis: 203.3 seminal vesicle: 21.7 DENND2A FAM31D, KIAA1277 ENSG00000146966 DENN/MADD domain containing 2A 7 140518420-140673993 Predicted intracellular proteins Evidence at protein level HPA021778, HPA026718 Approved Renal cancer:3.05e-6 (unfavourable), Glioma:4.97e-4 (unfavourable), Colorectal cancer:9.35e-4 (favourable) Tissue enriched Mixed endometrium: 31.8 DENND6B AFI1B, FAM116B, MGC33692 ENSG00000205593 DENN/MADD domain containing 6B 22 50309030-50327060 Predicted intracellular proteins Evidence at protein level HPA018934, HPA021653, HPA029570 Uncertain Uncertain Plasma membrane Endometrial cancer:5.93e-5 (favourable), Colorectal cancer:1.41e-4 (unfavourable) Expressed in all Tissue enhanced fallopian tube: 21.3 cerebral cortex: 12.0 DEPDC4 DEP.4, FLJ33505 ENSG00000166153 DEP domain containing 4 12 100203669-100267079 Predicted intracellular proteins Evidence at protein level HPA039323 Uncertain Approved Microtubules Mixed Tissue enhanced testis: 7.2 kidney: 1.7 DEPDC7 ENSG00000121690 DEP domain containing 7 11 33015864-33033582 Predicted intracellular proteins Evidence at protein level HPA015800 Approved Nucleus
Nucleoli
Cytosol Liver cancer:7.26e-4 (favourable) Mixed Tissue enhanced liver: 37.5;testis: 50.4 small intestine: 31.9 DEXI MYLE ENSG00000182108 Dexi homolog (mouse) 16 10928891-10942460 Predicted membrane proteins Evidence at transcript level HPA041511 Approved Approved Nuclear speckles
Cytosol Pancreatic cancer:4.23e-4 (favourable) Expressed in all Expressed in all skeletal muscle: 45.0 DGAT2L6 DC3, FLJ25989 ENSG00000184210 Diacylglycerol O-acyltransferase 2-like 6 X 70177483-70205545 Predicted membrane proteins Evidence at transcript level Tissue enhanced Group enriched 23 breast: 2.8;skin: 1.6 all non-specific tissues: 0.0 DGCR2 DGS-C, IDD, KIAA0163, LAN, SEZ-12 ENSG00000070413 DiGeorge syndrome critical region gene 2 22 19036282-19122454 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA000873, HPA075929 Uncertain Approved Nucleoplasm
Nuclear bodies Renal cancer:8.72e-7 (favourable) Expressed in all Expressed in all cerebral cortex: 58.4 DGKB DAGK2, DGK, DGK-BETA, KIAA0718 ENSG00000136267 Diacylglycerol kinase, beta 90kDa 7 14145049-14974777 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA020321 Supported Tissue enriched Tissue enriched 6 cerebral cortex: 34.3 endometrium: 5.6 DGKG DAGK3 ENSG00000058866 Diacylglycerol kinase, gamma 90kDa 3 186105668-186362237 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA036577 Approved Approved Vesicles
Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 21.3 placenta: 11.1 DHRS12 FLJ13639, SDR40C1 ENSG00000102796 Dehydrogenase/reductase (SDR family) member 12 13 51767993-51804157 Predicted intracellular proteins Evidence at protein level CAB034238, HPA057028, HPA058315 Uncertain Supported Nucleoplasm
Golgi apparatus
Vesicles Renal cancer:2.22e-16 (favourable), Breast cancer:1.41e-4 (favourable) Expressed in all Expressed in all epididymis: 22.6 DHRS13 MGC23280, SDR7C5 ENSG00000167536 Dehydrogenase/reductase (SDR family) member 13 17 28897781-28903071 Predicted intracellular proteins Evidence at protein level HPA022991 Uncertain Approved Vesicles Liver cancer:3.39e-6 (unfavourable) Expressed in all Mixed bone marrow: 25.2 DHRS4L2 SDR25C3 ENSG00000187630 Dehydrogenase/reductase (SDR family) member 4 like 2 14 23969874-24006408 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA023972 Uncertain Uncertain Nuclear membrane
Vesicles Ovarian cancer:3.21e-4 (favourable) Expressed in all Expressed in all kidney: 121.8 DHRS7C SDR32C2 ENSG00000184544 Dehydrogenase/reductase (SDR family) member 7C 17 9771434-9791297 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Not detected Group enriched 16 heart muscle: 71.2;skeletal muscle: 122.8 esophagus: 5.9 DHRSX DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6 ENSG00000169084 Dehydrogenase/reductase (SDR family) X-linked X 2219516-2502805 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA003035 Approved Approved Actin filaments
Cytosol Expressed in all Expressed in all thyroid gland: 17.0 DIO1 TXDI1 ENSG00000211452 Deiodinase, iodothyronine, type I 1 53891239-53911086 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Thyroid cancer:5.44e-4 (unfavourable) Group enriched Group enriched 30 kidney: 146.4;liver: 94.7;thyroid gland: 433.9 fallopian tube: 7.5 DIRC1 ENSG00000174325 Disrupted in renal carcinoma 1 2 188734155-188790104 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA056566 Approved Cytosol Not detected Not detected epididymis,gallbladder: 0.4 DISP2 DISPB, HsT16908, KIAA1742 ENSG00000140323 Dispatched homolog 2 (Drosophila) 15 40358235-40378639 Predicted membrane proteins Evidence at protein level HPA059903 Uncertain Approved Nucleoplasm
Vesicles Mixed Tissue enhanced cerebral cortex: 7.5 thyroid gland: 1.9 DKK2 ENSG00000155011 Dickkopf WNT signaling pathway inhibitor 2 4 106921802-107283806 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB009727, HPA052611 Uncertain Uncertain Golgi apparatus Mixed Tissue enhanced cervix, uterine: 23.9 lung: 8.2 DKKL1 CT34, SGY-1 ENSG00000104901 Dickkopf-like 1 19 49361783-49375116 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB025410, HPA047194 Supported Approved Vesicles Tissue enhanced Tissue enriched 137 testis: 265.5 endometrium,fallopian tube: 1.9 DLEC1 CFAP81, DLC1 ENSG00000008226 Deleted in lung and esophageal cancer 1 3 38039205-38124025 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA019077 Supported Supported Cytosol Mixed Tissue enhanced fallopian tube: 29.4;testis: 17.3 lung: 6.0 DLEU7 FLJ44882 ENSG00000186047 Deleted in lymphocytic leukemia, 7 13 50711008-50843939 Predicted intracellular proteins Evidence at transcript level HPA053750 Uncertain Mixed Tissue enriched 6 cerebral cortex: 6.3 epididymis: 1.0 DLK2 EGFL9, MGC2487 ENSG00000171462 Delta-like 2 homolog (Drosophila) 6 43450352-43456632 Predicted membrane proteins Evidence at transcript level HPA061223, HPA068672 Uncertain Approved Nucleus Mixed Tissue enhanced skin: 14.5 prostate: 8.1 DLX1 ENSG00000144355 Distal-less homeobox 1 2 172084740-172089677 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035666, HPA045884 Approved Approved Nucleus
Vesicles
Cell Junctions Tissue enhanced Tissue enhanced adrenal gland: 1.6;cerebral cortex: 5.0 prostate: 0.7 DLX6 ENSG00000006377 Distal-less homeobox 6 7 97005548-97011039 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030608, HPA061460 Uncertain Approved Nuclear bodies Tissue enriched Tissue enhanced endometrium: 4.4;placenta: 4.3;testis: 5.4 cervix, uterine: 3.0 DMRT2 ENSG00000173253 Doublesex and mab-3 related transcription factor 2 9 1049858-1057552 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at transcript level HPA029297 Uncertain Tissue enhanced Tissue enriched 7 parathyroid gland: 106.9 kidney: 16.0 DMRTA1 ENSG00000176399 DMRT-like family A1 9 22446841-22455740 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044764, HPA062253 Uncertain Approved Vesicles Renal cancer:1.14e-6 (favourable) Mixed Tissue enhanced parathyroid gland: 6.4 liver: 4.3 DMRTA2 ENSG00000142700 DMRT-like family A2 1 50417550-50423500 Predicted secreted proteins, Transcription factors Evidence at protein level HPA043098, HPA062958 Uncertain Approved Mitochondria Tissue enhanced Not detected testis: 0.7 DMRTB1 ENSG00000143006 DMRT-like family B with proline-rich C-terminal, 1 1 53459399-53467488 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036490, HPA058553 Supported Tissue enhanced Tissue enriched 68 testis: 69.6 epididymis: 1.0 DMRTC1 ENSG00000269502 DMRT-like family C1 X 72872025-72943814 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA046874, HPA046992 Uncertain Not detected Tissue enhanced cerebral cortex: 2.3 thyroid gland: 1.4 DMRTC1B ENSG00000184911 DMRT-like family C1B X 72777009-72848802 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA046874, HPA046992 Uncertain Not detected Tissue enhanced cerebral cortex: 16.7 ovary: 10.3 DMRTC2 ENSG00000142025 DMRT-like family C2 19 41844743-41852333 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045016 Uncertain Not detected Tissue enriched 127 testis: 48.7 lymph node,parathyroid gland,thyroid gland: 0.3 DNAH1 DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1 ENSG00000114841 Dynein, axonemal, heavy chain 1 3 52316319-52400491 Predicted intracellular proteins Evidence at protein level HPA036805, HPA036806 Uncertain Mixed Mixed testis: 7.8 DNAH10OS FLJ45278 ENSG00000250091 Dynein, axonemal, heavy chain 10 opposite strand 12 123926424-123934984 Predicted intracellular proteins Evidence at transcript level HPA039786 Uncertain Mixed Tissue enhanced cerebral cortex: 4.0 kidney: 1.5 DNAH12 DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19 ENSG00000174844 Dynein, axonemal, heavy chain 12 3 57293699-57544344 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA037493, HPA058203, HPA061365 Supported Tissue enhanced Tissue enhanced fallopian tube: 16.0;testis: 11.0 lung: 2.7 DNAH14 C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277 ENSG00000185842 Dynein, axonemal, heavy chain 14 1 224896262-225399292 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA027718, HPA028545, HPA031379 Uncertain Approved Centrosome Mixed Tissue enhanced testis: 21.5 thyroid gland: 7.3 DNAH2 DNHD3, FLJ46675, KIAA1503 ENSG00000183914 Dynein, axonemal, heavy chain 2 17 7717354-7833744 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA067103 Supported Approved Microtubules Mixed Group enriched 8 fallopian tube: 20.7;parathyroid gland: 28.1;testis: 11.0 placenta: 2.5 DNAH3 DKFZp434N074, DLP3, Dnahc3b, Hsadhc3 ENSG00000158486 Dynein, axonemal, heavy chain 3 16 20933111-21159441 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA062493 Approved Nuclear membrane
Intermediate filaments Mixed Group enriched 5 fallopian tube: 8.0;testis: 5.9 lung: 1.3 DNAH6 Dnahc6, DNHL1, FLJ37357, HL-2 ENSG00000115423 Dynein, axonemal, heavy chain 6 2 84516455-84819589 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA036391 Supported Mixed Tissue enhanced fallopian tube: 9.7;testis: 5.8 parathyroid gland: 3.6 DNAJB13 RSPH16A, TSARG6 ENSG00000187726 DnaJ (Hsp40) homolog, subfamily B, member 13 11 73950319-73970366 Predicted intracellular proteins Evidence at protein level HPA052465 Approved Renal cancer:2.10e-6 (unfavourable) Tissue enhanced Group enriched 7 fallopian tube: 75.7;testis: 19.0 cervix, uterine: 6.5 DNAJB7 HSC3 ENSG00000172404 DnaJ (Hsp40) homolog, subfamily B, member 7 22 40859549-40862126 Predicted intracellular proteins Evidence at transcript level HPA000534 Approved Not detected Tissue enriched 17 testis: 10.2 duodenum,small intestine: 0.5 DNAJC14 DNAJ, DRIP78, FLJ32792, HDJ3, LIP6 ENSG00000135392 DnaJ (Hsp40) homolog, subfamily C, member 14 12 55820960-55830824 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017653 Approved Expressed in all Expressed in all parathyroid gland: 49.6 DNAJC16 KIAA0962 ENSG00000116138 DnaJ (Hsp40) homolog, subfamily C, member 16 1 15526813-15592379 Predicted membrane proteins Evidence at protein level HPA043643 Approved Approved Vesicles Colorectal cancer:6.77e-4 (favourable), Renal cancer:7.24e-4 (favourable) Expressed in all Expressed in all kidney: 20.8 DNAJC18 MGC29463 ENSG00000170464 DnaJ (Hsp40) homolog, subfamily C, member 18 5 139408588-139444491 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036538, HPA060154 Approved Supported Cell Junctions Pancreatic cancer:5.89e-4 (favourable) Mixed Group enriched 5 cerebral cortex: 30.2;testis: 115.2 ovary: 13.8 DNAJC22 FLJ13236, wus ENSG00000178401 DnaJ (Hsp40) homolog, subfamily C, member 22 12 49346917-49357546 Predicted membrane proteins Evidence at protein level HPA039953 Approved Vesicles Endometrial cancer:4.56e-5 (favourable), Melanoma:7.54e-4 (unfavourable) Mixed Mixed thyroid gland: 17.9 DNAJC5G CSP-gamma, FLJ40417 ENSG00000163793 DnaJ (Hsp40) homolog, subfamily C, member 5 gamma 2 27275421-27281499 Predicted membrane proteins Evidence at transcript level HPA041445 Approved Not detected Group enriched 40 epididymis: 63.9;testis: 42.6 cerebral cortex: 1.3 DNASE2B DLAD ENSG00000137976 Deoxyribonuclease II beta 1 84398532-84415018 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enriched 6 salivary gland: 73.5 prostate: 11.3 DNHD1 C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184 ENSG00000179532 Dynein heavy chain domain 1 11 6497260-6593758 Predicted intracellular proteins Evidence at protein level HPA039698, HPA040267, HPA057639 Uncertain Approved Nucleoplasm
Cytokinetic bridge Mixed Tissue enriched 6 testis: 19.5 bone marrow: 3.5 DOLPP1 LSFR2 ENSG00000167130 Dolichyldiphosphatase 1 9 129081100-129090438 Enzymes, Predicted membrane proteins Evidence at protein level HPA019179 Approved Approved Vesicles
Intermediate filaments Expressed in all Expressed in all duodenum: 26.5 DOPEY1 dJ202D23.2, KIAA1117 ENSG00000083097 Dopey family member 1 6 83067666-83171350 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA027902, HPA027904 Approved Approved Nucleus Pancreatic cancer:7.36e-4 (favourable) Expressed in all Mixed parathyroid gland: 25.0 DPCR1 bCX105N19.6, PBLT ENSG00000168631 Diffuse panbronchiolitis critical region 1 6 30940972-30954221 Predicted membrane proteins Evidence at transcript level HPA014036 Approved Pancreatic cancer:6.58e-4 (unfavourable) Group enriched Tissue enriched 12 stomach: 191.9 gallbladder: 16.1 DPEP3 ENSG00000141096 Dipeptidase 3 16 67975663-67980829 Enzymes, Predicted secreted proteins Evidence at protein level HPA031870, HPA058607 Supported Group enriched Tissue enriched 24 testis: 56.8 spleen: 2.3 DPF1 BAF45b, NEUD4, neuro-d4 ENSG00000011332 D4, zinc and double PHD fingers family 1 19 38211006-38229714 Predicted intracellular proteins Evidence at protein level HPA049148 Supported Approved Nucleoplasm
Mitochondria
Cytosol Tissue enhanced Tissue enriched 15 cerebral cortex: 27.5 testis: 1.8 DPPA2 CT100, PESCRG1 ENSG00000163530 Developmental pluripotency associated 2 3 109293788-109316517 Predicted intracellular proteins Evidence at protein level HPA036134 Uncertain Approved Nucleus Tissue enriched Tissue enriched 11 testis: 6.5 placenta: 0.5 DPPA3 Stella ENSG00000187569 Developmental pluripotency associated 3 12 7711454-7717559 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enhanced testis: 1.4 lung: 0.6 DPPA5 Esg1 ENSG00000203909 Developmental pluripotency associated 5 6 73353062-73354295 Predicted intracellular proteins Evidence at transcript level HPA064505 Uncertain Tissue enriched Tissue enhanced testis: 3.8 lung: 0.9 DPY19L1 KIAA0877 ENSG00000173852 Dpy-19-like 1 (C. elegans) 7 34928876-35038271 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA059139 Uncertain Approved Vesicles Pancreatic cancer:2.99e-4 (unfavourable) Expressed in all Expressed in all testis: 69.2 DPY19L3 ENSG00000178904 Dpy-19-like 3 (C. elegans) 19 32405543-32485895 Predicted membrane proteins Evidence at protein level HPA008325 Approved Approved Microtubules Pancreatic cancer:1.70e-4 (favourable), Head and neck cancer:5.55e-4 (favourable) Expressed in all Mixed cerebral cortex: 20.4 DQX1 FLJ23757 ENSG00000144045 DEAQ box RNA-dependent ATPase 1 2 74518131-74526336 Enzymes, Predicted intracellular proteins Evidence at protein level HPA039158 Supported Approved Plasma membrane
Cytosol Mixed Tissue enhanced duodenum: 14.8;small intestine: 13.8 colon: 5.6 DRC1 C2orf39, CCDC164, CILD21, FLJ32660, MGC16372 ENSG00000157856 Dynein regulatory complex subunit 1 2 26401916-26456711 Disease related genes, Predicted intracellular proteins Evidence at protein level Tissue enhanced Group enriched 10 fallopian tube: 61.8;testis: 36.7 lung: 4.8 DRC3 CFAP134, DKFZP586M1120, LRRC48 ENSG00000171962 Dynein regulatory complex subunit 3 17 17972813-18016889 Predicted intracellular proteins Evidence at transcript level HPA036040, HPA036041 Approved Endometrial cancer:4.05e-5 (favourable), Breast cancer:1.51e-4 (favourable) Mixed Tissue enhanced fallopian tube: 98.0 testis: 21.8 DRP2 ENSG00000102385 Dystrophin related protein 2 X 101219769-101264497 Predicted intracellular proteins Evidence at protein level HPA002949 Supported Tissue enhanced Tissue enriched 6 cerebral cortex: 12.3 prostate: 2.1 DSCR3 DCRA ENSG00000157538 Down syndrome critical region 3 21 37223420-37267919 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA023288 Uncertain Approved Mitochondria Renal cancer:8.54e-4 (favourable) Expressed in all Expressed in all kidney: 32.0 DSCR4 DCRB ENSG00000184029 Down syndrome critical region 4 21 37951425-38121360 Predicted intracellular proteins Evidence at transcript level HPA018460 Uncertain Tissue enriched Group enriched 18 placenta: 2.0;testis: 1.4 all non-specific tissues: 0.0 DSEL C18orf4, FLJ11477, NCAG1 ENSG00000171451 Dermatan sulfate epimerase-like 18 67506582-67516980 Predicted membrane proteins Evidence at protein level HPA060942 Approved Nucleoplasm
Plasma membrane Tissue enhanced Mixed cerebral cortex: 5.3 DTD2 C14orf126, MGC9912 ENSG00000129480 D-tyrosyl-tRNA deacylase 2 (putative) 14 31446036-31457510 Predicted intracellular proteins Evidence at protein level HPA001117 Approved Approved Vesicles Urothelial cancer:5.74e-6 (unfavourable), Head and neck cancer:9.33e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 10.9 DTHD1 FLJ16686 ENSG00000197057 Death domain containing 1 4 36281622-36345756 Predicted intracellular proteins Evidence at protein level Mixed Tissue enhanced fallopian tube: 22.8 lung: 5.3 DUS4L DUS4, PP35 ENSG00000105865 Dihydrouridine synthase 4-like 7 107563484-107578464 Predicted intracellular proteins Evidence at protein level HPA044301 Approved Approved Cytosol Expressed in all Mixed thyroid gland: 4.8 DUSP27 ENSG00000198842 Dual specificity phosphatase 27 (putative) 1 167094045-167129165 Predicted intracellular proteins Evidence at protein level HPA012608, HPA012912 Uncertain Approved Nucleoplasm Group enriched Group enriched 15 heart muscle: 39.9;skeletal muscle: 39.7 placenta: 2.6 DUSP28 DUSP26, VHP ENSG00000188542 Dual specificity phosphatase 28 2 240560054-240564014 Enzymes, Predicted intracellular proteins Evidence at protein level HPA047456, CAB069448 Uncertain Uncertain Nuclear speckles
Cytosol Pancreatic cancer:1.84e-4 (favourable) Expressed in all Mixed skeletal muscle: 3.9 DXO DOM3Z ENSG00000204348 Decapping exoribonuclease 6 31969810-31972292 Predicted intracellular proteins Evidence at protein level HPA046708 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Renal cancer:4.77e-6 (unfavourable), Pancreatic cancer:5.87e-4 (favourable) Expressed in all Mixed testis: 5.7 DYDC2 bA36D19.6, MGC16186 ENSG00000133665 DPY30 domain containing 2 10 80344745-80368073 Predicted intracellular proteins Evidence at protein level HPA038006, HPA038007 Supported Ovarian cancer:3.54e-4 (favourable) Tissue enhanced Tissue enriched 10 fallopian tube: 151.1 testis: 14.9 DYRK3 hYAK3-2, RED, REDK ENSG00000143479 Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 1 206635536-206684419 Enzymes, Predicted intracellular proteins Evidence at protein level HPA075041 Supported Nucleoplasm
Cytosol Renal cancer:9.41e-7 (unfavourable) Expressed in all Tissue enhanced testis: 86.3 gallbladder: 23.2 DYTN ENSG00000232125 Dystrotelin 2 206651621-206718396 Predicted intracellular proteins Evidence at protein level Not detected Not detected bone marrow,testis: 0.1 EBF2 COE2, FLJ11500 ENSG00000221818 Early B-cell factor 2 8 25841730-26045397 Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:2.51e-6 (unfavourable) Mixed Tissue enhanced adipose tissue: 20.6 heart muscle: 6.7 EBF4 COE4, KIAA1442, O/E-4, RP5-860F19.3 ENSG00000088881 Early B-cell factor 4 20 2692878-2760108 Predicted intracellular proteins, Transcription factors Evidence at transcript level Pancreatic cancer:2.47e-5 (favourable), Colorectal cancer:6.59e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 23.4 EBLN1 ENSG00000223601 Endogenous Bornavirus-like nucleoprotein 1 10 22208814-22210021 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 43 testis: 4.2 all non-specific tissues: 0.0 EBLN2 ENSG00000255423 Endogenous Bornavirus-like nucleoprotein 2 3 73061659-73063337 Predicted intracellular proteins Evidence at protein level HPA062510, HPA068795 Uncertain Approved Nucleoplasm
Nuclear bodies Mixed Mixed bone marrow: 10.2 ECM2 ENSG00000106823 Extracellular matrix protein 2, female organ and adipocyte specific 9 92493554-92536655 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA035347 Approved Renal cancer:4.09e-6 (unfavourable), Liver cancer:4.50e-5 (favourable) Expressed in all Mixed adipose tissue: 128.3 ECT2L ARHGEF32, C6orf91, FBXO49, LFDH ENSG00000203734 Epithelial cell transforming 2 like 6 138795926-138904070 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA035488 Uncertain Not detected Tissue enriched 6 fallopian tube: 18.0 lung: 2.7 EDDM3A FAM12A, HE3-ALPHA ENSG00000181562 Epididymal protein 3A 14 20731699-20748380 Predicted secreted proteins Evidence at protein level HPA049952 Approved Not detected Tissue enriched 15 epididymis: 768.9 seminal vesicle: 50.1 EFCAB1 FLJ11767 ENSG00000034239 EF-hand calcium binding domain 1 8 48710789-48735311 Predicted intracellular proteins Evidence at protein level HPA023527, HPA069955 Supported Approved Nucleoplasm
Plasma membrane Tissue enhanced Tissue enhanced fallopian tube: 148.1;testis: 46.9 ovary: 23.8 EFCAB10 ENSG00000185055 EF-hand calcium binding domain 10 7 105565120-105600875 Predicted intracellular proteins Evidence at transcript level HPA019751 Uncertain Mixed Group enriched 9 fallopian tube: 43.3;testis: 39.8 lung: 4.6 EFCAB11 C14orf143 ENSG00000140025 EF-hand calcium binding domain 11 14 89794669-89954777 Predicted intracellular proteins Evidence at transcript level HPA051209 Approved Cell Junctions
Cytosol Expressed in all Tissue enhanced testis: 59.8 fallopian tube: 17.1 EFCAB13 C17orf57, FLJ40342 ENSG00000178852 EF-hand calcium binding domain 13 17 47323290-47441312 Predicted intracellular proteins Evidence at protein level CAB002501, HPA021633, HPA023249, HPA026561 Uncertain Mixed Tissue enhanced testis: 40.7 thyroid gland: 23.6 EFCAB14 KIAA0494 ENSG00000159658 EF-hand calcium binding domain 14 1 46675159-46719064 Predicted membrane proteins Evidence at protein level HPA011224, HPA011938 Supported Approved Nucleoli
Golgi apparatus
Cytosol Expressed in all Expressed in all parathyroid gland: 299.7 EFCAB2 CFAP200, DRC8, MGC12458 ENSG00000203666 EF-hand calcium binding domain 2 1 244969705-245127164 Predicted intracellular proteins Evidence at protein level HPA031206, HPA031207 Approved Approved Plasma membrane
Cytosol Thyroid cancer:6.51e-4 (unfavourable) Mixed Expressed in all fallopian tube: 57.4 EFCAB3 FLJ25818 ENSG00000172421 EF-hand calcium binding domain 3 17 62370218-62416476 Predicted intracellular proteins Evidence at protein level HPA046862 Uncertain Not detected Tissue enriched 24 testis: 10.5 adipose tissue: 0.4 EFCAB7 KIAA1799, RP4-534K7.1 ENSG00000203965 EF-hand calcium binding domain 7 1 63523372-63572693 Predicted intracellular proteins Evidence at protein level HPA029611, HPA029612, HPA029613 Supported Approved Nucleus
Nucleoli
Plasma membrane
Cytosol Glioma:4.84e-4 (favourable) Mixed Mixed testis: 24.5 EFCC1 C3orf73, CCDC48, FLJ12057 ENSG00000114654 EF-hand and coiled-coil domain containing 1 3 129001629-129040742 Predicted intracellular proteins Evidence at transcript level HPA042798, HPA050888 Uncertain Pancreatic cancer:9.70e-4 (favourable) Mixed Tissue enhanced lung: 4.9 spleen: 3.6 EFHB CFAP21, FLJ25200 ENSG00000163576 EF-hand domain family, member B 3 19879472-19947025 Predicted intracellular proteins Evidence at protein level Mixed Group enriched 6 fallopian tube: 25.3;testis: 25.7 cerebral cortex: 4.3 EGFL6 MAEG ENSG00000198759 EGF-like-domain, multiple 6 X 13569605-13633575 Predicted secreted proteins Evidence at transcript level HPA001838 Approved Ovarian cancer:4.95e-4 (favourable), Head and neck cancer:9.73e-4 (favourable) Mixed Tissue enriched 34 placenta: 913.7 lung: 26.8 EGR3 PILOT ENSG00000179388 Early growth response 3 8 22687659-22693302 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006206, CAB009373 Uncertain Uncertain Nucleus
Vesicles Breast cancer:1.83e-4 (favourable), Melanoma:4.78e-4 (favourable) Mixed Mixed gallbladder: 49.7 EGR4 NGFI-C, PAT133 ENSG00000135625 Early growth response 4 2 73290929-73293705 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028983 Approved Mixed Group enriched 29 cerebral cortex: 9.7;testis: 3.2 adipose tissue,appendix: 0.2 EHF ESE3, ESEJ ENSG00000135373 Ets homologous factor 11 34621093-34661057 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA050923, HPA060734 Approved Supported Nucleoplasm
Golgi apparatus Colorectal cancer:5.81e-4 (favourable), Pancreatic cancer:6.94e-4 (unfavourable) Mixed Mixed esophagus: 229.2 EIF4E3 MGC39820 ENSG00000163412 Eukaryotic translation initiation factor 4E family member 3 3 71675416-71754773 Predicted intracellular proteins Evidence at protein level HPA058649 Approved Nucleoli fibrillar center Ovarian cancer:4.64e-5 (favourable), Renal cancer:6.99e-5 (favourable), Lung cancer:6.63e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 54.8 EIF5AL1 bA342M3.3, EIF5AP1 ENSG00000253626 Eukaryotic translation initiation factor 5A-like 1 10 79512601-79516440 Predicted intracellular proteins, Transporters Evidence at transcript level Cervical cancer:4.23e-4 (favourable) Expressed in all Tissue enriched 10 testis: 20.0 parathyroid gland: 2.0 ELAVL3 DKFZp547J036, HUC, HUCL, MGC20653, PLE21 ENSG00000196361 ELAV like neuron-specific RNA binding protein 3 19 11451326-11481046 Predicted intracellular proteins Evidence at protein level CAB013066, HPA045610 Supported Approved Vesicles Tissue enriched Tissue enriched 45 cerebral cortex: 73.0 adrenal gland: 1.6 ELMOD1 DKFZp547C176 ENSG00000110675 ELMO/CED-12 domain containing 1 11 107591091-107666779 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA038434, HPA038435 Supported Nucleoplasm
Cytosol Tissue enriched Group enriched 15 cerebral cortex: 71.6;skin: 36.8 adrenal gland,fallopian tube: 3.5 EMID1 EMI5, EMU1, hEmu1 ENSG00000186998 EMI domain containing 1 22 29205851-29259597 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA000592 Uncertain Expressed in all Mixed spleen: 31.1 EMILIN3 C20orf130, dJ620E11.4, EMILIN5 ENSG00000183798 Elastin microfibril interfacer 3 20 41359966-41366827 Predicted secreted proteins Evidence at protein level HPA044034, HPA059912 Approved Tissue enhanced Tissue enhanced epididymis: 59.6 seminal vesicle: 13.4 EML5 EMAP-2, HuEMAP-2 ENSG00000165521 Echinoderm microtubule associated protein like 5 14 88612431-88792752 Predicted intracellular proteins Evidence at protein level HPA054019, HPA055379 Uncertain Not detected Tissue enhanced ovary: 24.4 prostate: 10.6 EML6 FLJ42562 ENSG00000214595 Echinoderm microtubule associated protein like 6 2 54723499-54972025 Predicted intracellular proteins Evidence at protein level HPA062808, HPA068759 Uncertain Approved Vesicles
Mitochondria Mixed Tissue enhanced lymph node: 7.6;tonsil: 8.7 appendix: 4.6 EN2 ENSG00000164778 Engrailed homeobox 2 7 155458129-155464831 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025088, HPA045646, HPA069809 Uncertain Supported Nucleus
Nucleoli fibrillar center Glioma:2.82e-6 (unfavourable) Tissue enhanced Tissue enhanced parathyroid gland: 1.9;testis: 1.1 endometrium: 0.6 ENHO C9orf165, UNQ470 ENSG00000168913 Energy homeostasis associated 9 34521040-34523041 Predicted secreted proteins Evidence at transcript level HPA042575 Approved Endometrial cancer:3.71e-4 (unfavourable) Tissue enhanced Tissue enriched 12 cerebral cortex: 140.7 testis: 11.6 ENKUR C10orf63, CFAP106, enkurin, MGC26778 ENSG00000151023 Enkurin, TRPC channel interacting protein 10 24981979-25062279 Predicted intracellular proteins Evidence at protein level HPA037593, HPA037594, HPA061503 Supported Tissue enhanced Tissue enhanced fallopian tube: 68.9 cerebral cortex: 15.2 ENO4 AC023283.3, C10orf134 ENSG00000188316 Enolase family member 4 10 116849512-116911788 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA037937, HPA037938, HPA061509 Supported Approved Mitochondria Mixed Tissue enhanced fallopian tube: 14.6 parathyroid gland,testis: 9.6 ENPP5 ENSG00000112796 Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) 6 46159187-46170971 Predicted membrane proteins Evidence at protein level HPA016902 Approved Renal cancer:4.44e-13 (favourable), Pancreatic cancer:4.04e-4 (favourable), Lung cancer:4.57e-4 (favourable) Expressed in all Tissue enhanced epididymis: 291.6 thyroid gland: 85.2 ENTHD1 FLJ25421 ENSG00000176177 ENTH domain containing 1 22 39743044-39893864 Predicted intracellular proteins Evidence at protein level HPA019800 Uncertain Tissue enriched Tissue enriched 24 testis: 19.6 lymph node: 0.8 ENTPD7 FLJ30978, LALP1 ENSG00000198018 Ectonucleoside triphosphate diphosphohydrolase 7 10 99659506-99706240 Predicted membrane proteins Evidence at protein level HPA014351 Uncertain Approved Nucleoplasm Expressed in all Mixed small intestine: 24.2 EP400NL FLJ33915 ENSG00000185684 EP400 N-terminal like 12 132084283-132131639 Predicted intracellular proteins Evidence at protein level HPA068417 Approved Expressed in all Tissue enriched 9 testis: 28.7 spleen: 3.2 EPB41L4B EHM2 ENSG00000095203 Erythrocyte membrane protein band 4.1 like 4B 9 109171975-109320964 Predicted intracellular proteins Evidence at protein level HPA042862 Approved Approved Plasma membrane
Cytosol Breast cancer:1.02e-4 (unfavourable) Mixed Mixed thyroid gland: 74.5 EPG5 hEPG5, KIAA1632 ENSG00000152223 Ectopic P-granules autophagy protein 5 homolog (C. elegans) 18 45847609-45967274 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA031689 Approved Approved Nuclear speckles Renal cancer:4.04e-5 (favourable) Expressed in all Mixed parathyroid gland: 12.2 EPHA6 FLJ35246 ENSG00000080224 EPH receptor A6 3 96814581-97752460 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA007397, HPA058047 Uncertain Validated Nucleoplasm Mixed Tissue enhanced ovary: 7.7;testis: 15.1 cerebral cortex: 3.6 EPHX3 ABHD9, FLJ22408 ENSG00000105131 Epoxide hydrolase 3 19 15226919-15233435 Predicted secreted proteins Evidence at transcript level HPA012842 Uncertain Head and neck cancer:2.27e-5 (favourable) Tissue enhanced Group enriched 7 esophagus: 35.3;skin: 62.9;tonsil: 25.2 urinary bladder: 5.5 EPHX4 ABHD7, EPHXRP, FLJ90341 ENSG00000172031 Epoxide hydrolase 4 1 92029982-92063536 Predicted intracellular proteins Evidence at protein level HPA035067 Uncertain Approved Vesicles Pancreatic cancer:2.00e-4 (unfavourable) Mixed Tissue enhanced cerebral cortex: 14.6 thyroid gland: 3.0 EPN3 FLJ20778, MGC129899 ENSG00000049283 Epsin 3 17 50532543-50543750 Predicted intracellular proteins Evidence at protein level HPA055546, HPA063224 Approved Supported Nucleoplasm
Vesicles Renal cancer:1.53e-5 (favourable) Mixed Mixed stomach: 27.4 EPSTI1 BRESI1, MGC29634 ENSG00000133106 Epithelial stromal interaction 1 (breast) 13 42886388-42992271 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017362 Approved Approved Cytosol Renal cancer:1.02e-5 (unfavourable), Pancreatic cancer:1.66e-4 (unfavourable) Expressed in all Mixed appendix: 44.1 EPYC DSPG3, Pg-Lb, SLRR3B ENSG00000083782 Epiphycan 12 90963679-91005026 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA038212, HPA045455 Approved Pancreatic cancer:1.85e-4 (unfavourable) Tissue enhanced Tissue enriched 6 placenta: 8.8 endometrium: 1.5 EQTN AFAF, C9orf11, equatorin, SPACA8 ENSG00000120160 Equatorin, sperm acrosome associated 9 27284659-27297139 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA015089, HPA015504 Supported Not detected Tissue enriched 86 testis: 67.2 ovary: 0.7 ERAS HRAS2, HRASP ENSG00000187682 ES cell expressed Ras X 48828873-48830138 Predicted intracellular proteins Evidence at transcript level Mixed Not detected cerebral cortex,testis: 0.4 ERI2 EXOD1, KIAA1504, MGC16943, ZGRF5 ENSG00000196678 ERI1 exoribonuclease family member 2 16 20780193-20900349 Predicted intracellular proteins Evidence at protein level HPA035384, HPA035385 Uncertain Supported Nucleus
Golgi apparatus Expressed in all Expressed in all testis: 22.9 ERICH3 C1orf173, DKFZp547I048, RP11-653A5.1 ENSG00000178965 Glutamate-rich 3 1 74568111-74673738 Predicted intracellular proteins Evidence at protein level HPA028655 Approved Endometrial cancer:1.56e-5 (favourable) Tissue enhanced Tissue enhanced cerebral cortex: 18.9;fallopian tube: 27.5;testis: 44.0 cervix, uterine: 8.6 ERICH5 C8orf47, FLJ39553 ENSG00000177459 Glutamate-rich 5 8 98064311-98093610 Predicted intracellular proteins Evidence at protein level HPA025070, HPA025293, HPA027233 Supported Approved Nucleoplasm
Golgi apparatus
Cytosol Renal cancer:3.76e-4 (favourable), Urothelial cancer:9.38e-4 (favourable) Tissue enhanced Tissue enhanced fallopian tube: 13.6;gallbladder: 13.8 stomach: 9.1 ERICH6 C3orf44, ERICH6A, FAM194A, MGC39662 ENSG00000163645 Glutamate-rich 6 3 150659885-150703971 Predicted intracellular proteins Evidence at protein level HPA048373 Supported Not detected Tissue enriched 24 testis: 51.4 thyroid gland: 2.1 ERICH6B FAM194B, FLJ32682 ENSG00000165837 Glutamate-rich 6B 13 45534522-45615739 Predicted intracellular proteins Evidence at transcript level CAB034242, HPA040358, HPA043559 Uncertain Not detected Tissue enriched 35 testis: 3.4 all non-specific tissues: 0.0 ERMN ERMIN, JN, KIAA1189 ENSG00000136541 Ermin, ERM-like protein 2 157318625-157327713 Predicted intracellular proteins Evidence at protein level HPA038295, HPA038296 Supported Endometrial cancer:6.93e-6 (favourable) Group enriched Tissue enriched 27 cerebral cortex: 228.3 bone marrow: 8.4 ERV3-1 envR, ERV-R, ERV3, H-PLK, HERV-R ENSG00000213462 Endogenous retrovirus group 3, member 1 7 64990809-65006743 Predicted secreted proteins Evidence at protein level HPA017209 Approved Vesicles Expressed in all Mixed adrenal gland: 40.0 ERVMER34-1 ENSG00000226887 Endogenous retrovirus group MER34, member 1 4 52722618-52751640 Predicted membrane proteins Evidence at protein level HPA011423, HPA024053 Uncertain Approved Nucleus
Cytosol Head and neck cancer:3.55e-4 (unfavourable) Mixed Group enriched 8 parathyroid gland: 47.3;placenta: 15.5 kidney: 3.7 ERVV-1 ENVV1, FLJ32214, HERV-V1 ENSG00000269526 Endogenous retrovirus group V, member 1 19 53013921-53016122 Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 65 placenta: 21.9 prostate,urinary bladder: 0.3 ERVV-2 ENSG00000268964 Endogenous retrovirus group V, member 2 19 53044738-53051076 Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 99 placenta: 13.5 kidney,testis,thyroid gland: 0.1 ESPNL FLJ42568 ENSG00000144488 Espin-like 2 238100157-238133287 Predicted intracellular proteins Evidence at protein level HPA055103 Uncertain Mixed Mixed seminal vesicle: 1.2 ETNK2 EKI2, FLJ10761 ENSG00000143845 Ethanolamine kinase 2 1 204131062-204152003 Enzymes, Predicted intracellular proteins Evidence at protein level HPA057167 Supported Glioma:3.43e-4 (unfavourable), Renal cancer:6.50e-4 (favourable) Expressed in all Tissue enhanced kidney: 109.8;liver: 119.6;testis: 142.1 ovary: 43.3 ETV2 ER71 ENSG00000105672 Ets variant 2 19 35641745-35644871 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced testis: 8.8 duodenum: 2.1 ETV3L FLJ16478 ENSG00000253831 Ets variant 3-like 1 157092044-157099808 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Not detected breast: 0.9 EVA1C B18, B19, C21orf63, C21orf64, FAM176C, PRED34 ENSG00000166979 Eva-1 homolog C (C. elegans) 21 32412006-32515397 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015720, HPA029944, CAB034174 Approved Head and neck cancer:5.06e-4 (favourable) Expressed in all Mixed fallopian tube: 24.9 EVI2A EVDA, EVI2 ENSG00000126860 Ecotropic viral integration site 2A 17 31317560-31321884 Predicted membrane proteins Evidence at protein level HPA045033, HPA057051 Uncertain Approved Nucleoplasm
Nuclear bodies Renal cancer:2.63e-6 (unfavourable), Melanoma:7.55e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 83.2 EVPLL ENSG00000214860 Envoplakin-like 17 18377662-18389647 Predicted intracellular proteins Evidence at transcript level HPA045728 Uncertain Approved Nucleoplasm
Nuclear bodies Not detected Tissue enhanced esophagus: 3.5;skin: 6.1;testis: 4.1 lung: 1.8 EVX1 ENSG00000106038 Even-skipped homeobox 1 7 27242700-27250493 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055132 Approved Nucleoplasm Mixed Tissue enhanced adrenal gland: 3.7;prostate: 4.6;seminal vesicle: 4.3 testis: 1.5 EVX2 ENSG00000174279 Even-skipped homeobox 2 2 176077472-176083913 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA041576 Uncertain Not detected Tissue enhanced prostate: 2.0;seminal vesicle: 2.2;testis: 2.7 cervix, uterine: 1.1 EXD3 FLJ20433, LOC54932, mut-7 ENSG00000187609 Exonuclease 3'-5' domain containing 3 9 137306896-137423262 Predicted intracellular proteins Evidence at transcript level HPA047395 Approved Approved Actin filaments
Focal adhesion sites Endometrial cancer:4.30e-4 (favourable) Expressed in all Mixed duodenum,small intestine,spleen: 10.2 EXOC3L1 EXOC3L, FLJ35539, FLJ35587 ENSG00000179044 Exocyst complex component 3-like 1 16 67184366-67190204 Predicted intracellular proteins Evidence at transcript level HPA029574 Uncertain Approved Vesicles
Plasma membrane Expressed in all Tissue enhanced spleen: 30.6 placenta: 8.4 EXOC3L2 FLJ36147, XTP7 ENSG00000130201 Exocyst complex component 3-like 2 19 45212621-45234211 Predicted intracellular proteins Evidence at protein level HPA041595, HPA061110 Approved Approved Nucleus
Vesicles Liver cancer:4.01e-5 (favourable), Head and neck cancer:1.27e-4 (favourable), Pancreatic cancer:2.10e-4 (favourable) Expressed in all Mixed spleen: 13.5 EXTL1 EXTL, MGC70794 ENSG00000158008 Exostosin-like glycosyltransferase 1 1 26019884-26036464 Enzymes, Predicted secreted proteins Evidence at protein level HPA037749 Approved Tissue enriched Tissue enhanced cerebral cortex: 11.2 skeletal muscle: 4.3 FAAH2 AMDD, FAAH-2, FLJ31204, RP11-479E16.1 ENSG00000165591 Fatty acid amide hydrolase 2 X 57286706-57489196 Enzymes, Predicted intracellular proteins Evidence at protein level Renal cancer:2.47e-13 (favourable), Urothelial cancer:6.83e-5 (favourable), Thyroid cancer:2.66e-4 (favourable), Ovarian cancer:5.99e-4 (favourable) Mixed Mixed parathyroid gland: 19.8 FABP12 ENSG00000197416 Fatty acid binding protein 12 8 81524981-81531378 Predicted intracellular proteins Evidence at protein level HPA044041 Approved Tissue enhanced Group enriched 13 esophagus: 4.4;testis: 15.2 lung: 0.7 FADS3 CYB5RP, LLCDL3 ENSG00000221968 Fatty acid desaturase 3 11 61873519-61892051 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA045224 Approved Renal cancer:1.50e-9 (unfavourable), Head and neck cancer:9.54e-5 (unfavourable) Expressed in all Expressed in all adipose tissue: 98.7 FAM105A FLJ11127, NET20 ENSG00000145569 Family with sequence similarity 105, member A 5 14581775-14615007 Enzymes, Predicted membrane proteins Evidence at protein level HPA046638 Uncertain Approved Nucleoli
Cytosol Pancreatic cancer:1.02e-4 (favourable), Testis cancer:7.62e-4 (unfavourable) Expressed in all Mixed bone marrow: 35.6 FAM106A FLJ11800 ENSG00000213077 Family with sequence similarity 106, member A 17 18524566-18526846 Predicted intracellular proteins Evidence at transcript level HPA056425 Uncertain Not detected Tissue enhanced testis: 7.3 bone marrow,placenta: 1.6 FAM110D FLJ14050, GRRP1 ENSG00000197245 Family with sequence similarity 110, member D 1 26159020-26163962 Predicted intracellular proteins Evidence at transcript level HPA013664 Approved Expressed in all Mixed adipose tissue: 4.8 FAM120C CXorf17, FLJ20506, ORF34 ENSG00000184083 Family with sequence similarity 120C X 54068324-54183281 Predicted intracellular proteins Evidence at protein level HPA047677 Uncertain Approved Nuclear speckles Head and neck cancer:4.48e-4 (favourable) Expressed in all Mixed cerebral cortex: 9.6 FAM122C RP3-473B4.1 ENSG00000156500 Family with sequence similarity 122C X 134796789-134854610 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA059961 Approved Uncertain Nucleoplasm Mixed Mixed testis: 7.8 FAM131A C3orf40, MGC21688 ENSG00000175182 Family with sequence similarity 131, member A 3 184335926-184346275 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042800 Uncertain Approved Nucleus
Nucleoli Endometrial cancer:2.22e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 101.5 FAM132B C1QTNF15, CTRP15, FLJ37034 ENSG00000178752 Family with sequence similarity 132, member B 2 238158982-238168900 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA077259 Approved Endoplasmic reticulum
Microtubule organizing center Renal cancer:2.46e-4 (unfavourable), Endometrial cancer:3.75e-4 (unfavourable) Tissue enhanced Group enriched 8 testis: 17.1;thyroid gland: 40.6 appendix: 3.5 FAM135B C8ORFK32 ENSG00000147724 Family with sequence similarity 135, member B 8 138130023-138496822 Predicted intracellular proteins Evidence at transcript level HPA023911, HPA023950, HPA024815 Uncertain Approved Nucleoplasm
Nuclear membrane Tissue enhanced Group enriched 7 adrenal gland: 3.6;cerebral cortex: 8.3;testis: 7.2 colon: 0.8 FAM13B ARHGAP49, C5orf5, FAM13B1, KHCHP, N61 ENSG00000031003 Family with sequence similarity 13, member B 5 137937960-138051961 Predicted intracellular proteins Evidence at protein level HPA036525, HPA041819, HPA071936 Uncertain Approved Nucleoplasm Renal cancer:3.55e-5 (favourable) Expressed in all Expressed in all testis: 66.0 FAM149A DKFZP564J102, MST119, MSTP119 ENSG00000109794 Family with sequence similarity 149, member A 4 186104419-186172667 Predicted intracellular proteins Evidence at protein level HPA055004 Uncertain Approved Nucleus Endometrial cancer:2.67e-6 (favourable) Mixed Mixed kidney: 36.8 FAM149B1 KIAA0974 ENSG00000138286 Family with sequence similarity 149, member B1 10 73168166-73244504 Predicted intracellular proteins Evidence at transcript level HPA039189, HPA039859 Uncertain Approved Nucleoplasm Pancreatic cancer:7.81e-4 (unfavourable) Expressed in all Expressed in all testis: 38.1 FAM150A UNQ9433 ENSG00000196711 Family with sequence similarity 150, member A 8 52534037-52565507 Predicted secreted proteins Evidence at transcript level HPA027368 Uncertain Mixed Tissue enhanced gallbladder: 3.5;thyroid gland: 3.7 cervix, uterine: 1.7 FAM150B ENSG00000189292 Family with sequence similarity 150, member B 2 279558-288851 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Mixed Tissue enhanced adrenal gland: 258.3 ovary: 82.8 FAM151A C1orf179, MGC27169 ENSG00000162391 Family with sequence similarity 151, member A 1 54609182-54623556 Predicted intracellular proteins Evidence at protein level HPA016840 Approved Uncertain Nucleoplasm Renal cancer:4.09e-5 (favourable) Group enriched Group enriched 14 kidney: 175.6;small intestine: 68.0 liver: 8.5 FAM153A NY-REN-7 ENSG00000170074 Family with sequence similarity 153, member A 5 177707981-177783398 Predicted intracellular proteins Evidence at transcript level HPA042585, HPA044022, HPA046691, HPA052337, HPA055498 Uncertain Not detected Tissue enriched 5 testis: 14.3 ovary: 2.8 FAM153B ENSG00000182230 Family with sequence similarity 153, member B 5 176060689-176132258 Predicted intracellular proteins Evidence at transcript level HPA042585, HPA044022, HPA046691, HPA052337, HPA055498 Uncertain Not detected Tissue enhanced ovary: 8.3;testis: 14.6 cerebral cortex: 4.1 FAM155A ENSG00000204442 Family with sequence similarity 155, member A 13 107163510-107866735 Predicted membrane proteins Evidence at protein level HPA039453, HPA058768 Supported Approved Nucleus
Vesicles
Centrosome Mixed Tissue enriched 6 cerebral cortex: 15.6 seminal vesicle: 2.4 FAM155B CXorf63, TED, TMEM28 ENSG00000130054 Family with sequence similarity 155, member B X 69505241-69532508 Predicted membrane proteins Evidence at transcript level HPA036093 Uncertain Breast cancer:4.61e-5 (unfavourable), Prostate cancer:1.83e-4 (unfavourable), Renal cancer:6.63e-4 (favourable) Mixed Tissue enhanced heart muscle: 12.9;seminal vesicle: 8.5;thyroid gland: 16.6 cerebral cortex: 2.5 FAM159A MGC52498 ENSG00000182183 Family with sequence similarity 159, member A 1 52633344-52669683 Predicted membrane proteins Evidence at transcript level HPA030744 Uncertain Mixed Tissue enhanced lymph node: 8.9;tonsil: 6.9 spleen: 4.6 FAM160A1 FLJ43373 ENSG00000164142 Family with sequence similarity 160, member A1 4 151409216-151663632 Predicted intracellular proteins Evidence at protein level HPA046348 Approved Approved Cytosol Mixed Mixed parathyroid gland: 16.6 FAM160B2 FLJ21801, RAI16 ENSG00000158863 Family with sequence similarity 160, member B2 8 22089159-22104898 Predicted intracellular proteins Evidence at protein level HPA025040 Approved Approved Nucleoplasm
Cytosol Head and neck cancer:4.56e-4 (favourable) Expressed in all Expressed in all seminal vesicle: 18.4 FAM162B bA86F4.2, C6orf189 ENSG00000183807 Family with sequence similarity 162, member B 6 116752197-116765723 Predicted membrane proteins Evidence at protein level HPA036112, HPA060342 Uncertain Renal cancer:2.48e-4 (unfavourable) Tissue enriched Tissue enhanced placenta: 93.2 lung: 27.0 FAM163A C1orf76, MGC16664 ENSG00000143340 Family with sequence similarity 163, member A 1 179743163-179816198 Predicted membrane proteins Evidence at transcript level HPA010778 Uncertain Mixed Tissue enhanced adrenal gland: 7.7;testis: 9.7 appendix,gallbladder: 1.8 FAM163B C9orf166 ENSG00000196990 Family with sequence similarity 163, member B 9 133578415-133586197 Predicted membrane proteins Evidence at transcript level HPA067336 Approved Approved Nuclear bodies
Plasma membrane
Cytosol Tissue enriched Tissue enriched 6 cerebral cortex: 103.9 adrenal gland: 16.5 FAM166A ENSG00000188163 Family with sequence similarity 166, member A 9 137243584-137247770 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA023307 Supported Not detected Tissue enriched 42 testis: 58.6 epididymis: 1.3 FAM166B ENSG00000215187 Family with sequence similarity 166, member B 9 35561831-35563899 Predicted intracellular proteins Evidence at protein level HPA045540 Uncertain Ovarian cancer:6.20e-6 (favourable), Endometrial cancer:2.61e-5 (favourable) Group enriched Group enriched 13 adrenal gland: 371.3;fallopian tube: 157.1;skeletal muscle: 82.6 epididymis: 15.9 FAM167B C1orf90, MGC10820 ENSG00000183615 Family with sequence similarity 167, member B 1 32247233-32248856 Predicted intracellular proteins Evidence at protein level HPA029398, HPA062074 Approved Approved Actin filaments Colorectal cancer:1.11e-4 (unfavourable) Expressed in all Mixed thyroid gland: 9.4 FAM169B FLJ39743, KIAA0888L ENSG00000185087 Family with sequence similarity 169, member B 15 98437162-98514382 Predicted intracellular proteins Evidence at transcript level HPA055979 Uncertain Not detected Mixed gallbladder,testis: 1.5 FAM170A ENSG00000164334 Family with sequence similarity 170, member A 5 119629559-119635822 Predicted intracellular proteins Evidence at protein level HPA037900, HPA037901, HPA037902 Approved Not detected Tissue enriched 103 testis: 20.8 skin: 0.2 FAM170B C10orf73, Em:AC084727.4 ENSG00000172538 Family with sequence similarity 170, member B 10 49131154-49134008 Predicted intracellular proteins Evidence at transcript level HPA043899, HPA050610 Uncertain Not detected Tissue enriched 75 testis: 7.4 all non-specific tissues: 0.0 FAM171B FLJ34104, KIAA1946 ENSG00000144369 Family with sequence similarity 171, member B 2 186693971-186765965 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA010639, HPA013434 Approved Approved Nucleus
Mitochondria Renal cancer:9.51e-7 (unfavourable), Urothelial cancer:5.03e-4 (unfavourable) Tissue enriched Tissue enriched 6 cerebral cortex: 114.9 parathyroid gland: 19.0 FAM172A C5orf21, DKFZP564D172 ENSG00000113391 Family with sequence similarity 172, member A 5 93618069-94111699 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA012299, HPA045505 Approved Supported Nucleoplasm
Cytosol Renal cancer:4.43e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 26.9 FAM173A C16orf24, MGC2494 ENSG00000103254 Family with sequence similarity 173, member A 16 720581-722601 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA046262 Approved Approved Cytosol Renal cancer:4.24e-5 (favourable), Head and neck cancer:8.88e-4 (favourable) Expressed in all Mixed spleen: 9.5 FAM174A TMEM157, UNQ1912 ENSG00000174132 Family with sequence similarity 174, member A 5 100535305-100586741 Predicted membrane proteins Evidence at protein level HPA019539 Approved Approved Golgi apparatus
Cytosol Glioma:3.85e-6 (unfavourable), Renal cancer:5.48e-4 (favourable) Expressed in all Expressed in all fallopian tube: 51.2 FAM174B LOC400451, MGC102891 ENSG00000185442 Family with sequence similarity 174, member B 15 92617443-92809884 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015306 Approved Approved Intermediate filaments Endometrial cancer:9.03e-5 (favourable) Expressed in all Mixed thyroid gland: 61.6 FAM177B FLJ43505, RP11-452F19.2 ENSG00000197520 Family with sequence similarity 177, member B 1 222737207-222750805 Predicted intracellular proteins Evidence at transcript level HPA063059 Uncertain Mixed Tissue enhanced stomach: 47.6 gallbladder: 15.9 FAM178B LOC51252 ENSG00000168754 Family with sequence similarity 178, member B 2 96875882-96986592 Predicted intracellular proteins Evidence at transcript level HPA042516, HPA062110 Uncertain Uncertain Nuclear speckles
Golgi apparatus Tissue enriched Group enriched 5 bone marrow: 11.4;epididymis: 6.6;spleen: 17.0;testis: 7.4 fallopian tube: 2.0 FAM179A FLJ43249, LOC165186 ENSG00000189350 Family with sequence similarity 179, member A 2 28956611-29061373 Predicted intracellular proteins Evidence at protein level HPA037561, HPA037562 Uncertain Not detected Tissue enriched 5 fallopian tube: 13.5 lung,testis: 2.6 FAM180A HWKM1940, UNQ1940 ENSG00000189320 Family with sequence similarity 180, member A 7 135728348-135748846 Predicted secreted proteins Evidence at protein level HPA021224 Uncertain Mixed Tissue enhanced gallbladder: 25.6 ovary: 9.9 FAM181A C14orf152 ENSG00000140067 Family with sequence similarity 181, member A 14 93918894-93929608 Predicted intracellular proteins Evidence at protein level HPA001603 Supported Group enriched Group enriched 5 cerebral cortex: 3.4;fallopian tube: 3.2;testis: 13.9 thyroid gland: 1.3 FAM181B LOC220382, MGC33846 ENSG00000182103 Family with sequence similarity 181, member B 11 82729941-82733864 Predicted intracellular proteins Evidence at transcript level HPA066861 Approved Approved Nuclear membrane
Mitochondria Endometrial cancer:8.07e-4 (favourable) Tissue enriched Tissue enriched 20 cerebral cortex: 17.5 adrenal gland,fallopian tube: 0.8 FAM182B ENSG00000175170 Family with sequence similarity 182, member B 20 25763466-25868225 Predicted intracellular proteins Evidence at transcript level CAB034235, HPA050100 Uncertain Approved Nucleoplasm Tissue enhanced Tissue enhanced testis: 11.8 fallopian tube: 6.7 FAM184A C6orf60, FLJ13942 ENSG00000111879 Family with sequence similarity 184, member A 6 118959763-119149387 Predicted intracellular proteins Evidence at protein level HPA034571, HPA034572, HPA041955 Uncertain Supported Nucleoplasm
Golgi apparatus
Cytosol Mixed Tissue enhanced placenta: 45.6;testis: 45.0 cerebral cortex: 25.2 FAM184B KIAA1276 ENSG00000047662 Family with sequence similarity 184, member B 4 17629306-17781512 Predicted intracellular proteins Evidence at protein level HPA044119, HPA048458 Uncertain Mixed Tissue enhanced cerebral cortex: 2.6;skeletal muscle: 1.4 epididymis: 0.5 FAM185A MGC35361 ENSG00000222011 Family with sequence similarity 185, member A 7 102748971-102809225 Predicted intracellular proteins Evidence at protein level HPA020470, HPA029883 Uncertain Validated Cytosol Renal cancer:9.36e-5 (favourable) Expressed in all Mixed parathyroid gland: 4.3 FAM186A LOC121006 ENSG00000185958 Family with sequence similarity 186, member A 12 50326230-50396622 Predicted intracellular proteins Evidence at protein level HPA047128 Uncertain Not detected Tissue enriched 12 testis: 11.0 epididymis: 0.9 FAM186B C12orf25, DKFZP434J0113 ENSG00000135436 Family with sequence similarity 186, member B 12 49582885-49605639 Predicted intracellular proteins Evidence at protein level HPA039736, HPA040028 Uncertain Not detected Tissue enriched 32 testis: 75.9 parathyroid gland: 2.3 FAM187B FLJ25660, TMEM162 ENSG00000177558 Family with sequence similarity 187, member B 19 35224800-35228729 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 200 testis: 44.3 spleen: 0.2 FAM188B C7orf67, FLJ22374 ENSG00000106125 Family with sequence similarity 188, member B 7 30771417-30892387 Predicted intracellular proteins Evidence at protein level HPA019475, HPA030129, HPA030130 Approved Supported Vesicles
Cytosol Mixed Mixed fallopian tube: 18.4 FAM189A1 KIAA0574, TMEM228 ENSG00000104059 Family with sequence similarity 189, member A1 15 29120254-29570723 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA009410, HPA010637 Uncertain Supported Nucleus Mixed Tissue enhanced cerebral cortex: 2.2;parathyroid gland: 2.0 colon,testis: 0.8 FAM196A C10orf141, FLJ45557 ENSG00000188916 Family with sequence similarity 196, member A 10 127135426-127196158 Predicted intracellular proteins Evidence at protein level HPA035898, HPA035899 Uncertain Group enriched Tissue enhanced cerebral cortex: 3.2 testis: 1.2 FAM196B C5orf57 ENSG00000204767 Family with sequence similarity 196, member B 5 169864264-169980740 Predicted intracellular proteins Evidence at transcript level HPA047227 Uncertain Mixed Tissue enhanced breast: 7.6;cerebral cortex: 7.0 ovary: 2.1 FAM198B C4orf18, DKFZp434L142, FLJ38155 ENSG00000164125 Family with sequence similarity 198, member B 4 158124474-158173318 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA007227 Uncertain Approved Nucleoplasm
Nucleoli fibrillar center
Golgi apparatus Expressed in all Expressed in all adrenal gland: 272.9 FAM19A2 TAFA-2 ENSG00000198673 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 12 61708259-62279150 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced cerebral cortex: 26.4 seminal vesicle: 9.9 FAM19A3 TAFA-3 ENSG00000184599 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 1 112720419-112727235 Predicted secreted proteins Evidence at transcript level HPA055927 Approved Glioma:8.24e-4 (unfavourable) Mixed Group enriched 16 adrenal gland: 20.0;testis: 8.7 epididymis: 0.9 FAM19A5 TAFA-5 ENSG00000219438 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 22 48489460-48850912 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level CAB025629 Approved Expressed in all Tissue enhanced cerebral cortex: 50.1 cervix, uterine: 12.9 FAM204A bA319I23.1, C10orf84, FLJ13188 ENSG00000165669 Family with sequence similarity 204, member A 10 118297930-118342328 Predicted intracellular proteins Evidence at protein level HPA038182, HPA062025 Approved Supported Nucleus
Nucleoli Renal cancer:8.59e-4 (unfavourable) Expressed in all Expressed in all testis: 89.0 FAM205A C9orf144B ENSG00000205108 Family with sequence similarity 205, member A 9 34723055-34729467 Predicted membrane proteins Evidence at protein level HPA071267 Supported Not detected Tissue enriched 319 testis: 39.3 parathyroid gland,skin: 0.1 FAM209A C20orf106, dJ1153D9.3 ENSG00000124103 Family with sequence similarity 209, member A 20 56517187-56526142 Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 10 testis: 100.2 bone marrow: 9.7 FAM209B C20orf107, dJ1153D9.4 ENSG00000213714 Family with sequence similarity 209, member B 20 56533246-56536520 Predicted membrane proteins Evidence at protein level HPA042144 Supported Mixed Tissue enriched 22 testis: 111.9 bone marrow: 5.0 FAM212B C1orf183, FLJ31105 ENSG00000197852 Family with sequence similarity 212, member B 1 111680630-111755824 Predicted intracellular proteins Evidence at transcript level HPA027809, HPA027811 Approved Approved Nucleus Head and neck cancer:4.51e-5 (favourable) Tissue enhanced Mixed cerebral cortex: 16.7 FAM213B C1orf93, MGC26818 ENSG00000157870 Family with sequence similarity 213, member B 1 2586491-2591469 Enzymes, Predicted intracellular proteins Evidence at protein level HPA006403 Approved Approved Approved Nucleoplasm
Plasma membrane
Cytosol Renal cancer:1.28e-4 (favourable), Liver cancer:1.62e-4 (unfavourable) Expressed in all Mixed small intestine: 14.9 FAM216A C12orf24, HSU79274 ENSG00000204856 Family with sequence similarity 216, member A 12 110468364-110490385 Predicted intracellular proteins Evidence at protein level HPA038286 Approved Approved Actin filaments Renal cancer:4.18e-10 (unfavourable), Liver cancer:4.49e-5 (unfavourable) Expressed in all Group enriched 7 cerebral cortex: 16.2;testis: 60.9 appendix: 5.7 FAM216B C13orf30, FLJ40919 ENSG00000179813 Family with sequence similarity 216, member B 13 42781550-42791549 Predicted intracellular proteins Evidence at transcript level HPA040118 Uncertain Endometrial cancer:9.77e-4 (favourable) Group enriched Tissue enriched 8 fallopian tube: 121.7 lung: 15.2 FAM217A C6orf146, MGC43581 ENSG00000145975 Family with sequence similarity 217, member A 6 4049434-4087344 Predicted intracellular proteins Evidence at transcript level HPA035455 Uncertain Not detected Tissue enriched 128 testis: 20.9 gallbladder,pancreas: 0.1 FAM217B C20orf177, dJ551D2.5 ENSG00000196227 Family with sequence similarity 217, member B 20 59933764-59948680 Predicted intracellular proteins Evidence at protein level HPA041021, HPA056698 Approved Supported Nucleoplasm Expressed in all Mixed cerebral cortex: 35.0 FAM220A C7orf70, MGC12966, SIPAR ENSG00000178397 Family with sequence similarity 220, member A 7 6329409-6348981 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA055050 Approved Vesicles Liver cancer:5.17e-6 (unfavourable), Thyroid cancer:3.47e-4 (unfavourable) Expressed in all Expressed in all testis: 102.0 FAM221A C7orf46, DKFZp686F0810, FLJ45875, MGC72075 ENSG00000188732 Family with sequence similarity 221, member A 7 23680130-23703249 Predicted intracellular proteins Evidence at protein level HPA019719, HPA026748, HPA026752 Approved Approved Cytosol Mixed Tissue enhanced testis: 34.4 fallopian tube: 14.3 FAM221B C9orf128 ENSG00000204930 Family with sequence similarity 221, member B 9 35816391-35828747 Predicted intracellular proteins Evidence at transcript level HPA023011, HPA026577 Uncertain Not detected Group enriched 6 bone marrow: 2.4;testis: 10.4 prostate: 1.1 FAM222A C12orf34, FLJ14721 ENSG00000139438 Family with sequence similarity 222, member A 12 109714228-109770507 Predicted intracellular proteins Evidence at protein level HPA040181 Uncertain Approved Nucleoplasm
Plasma membrane
Focal adhesion sites
Mitochondria Cervical cancer:1.82e-5 (favourable), Pancreatic cancer:4.81e-4 (favourable), Stomach cancer:8.59e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 20.1;testis: 16.6 adrenal gland: 9.9 FAM222B C17orf63, FLJ10700 ENSG00000173065 Family with sequence similarity 222, member B 17 28755978-28855232 Predicted intracellular proteins Evidence at protein level HPA051840, HPA062239 Approved Validated Nucleoplasm Liver cancer:3.45e-4 (unfavourable) Expressed in all Expressed in all testis: 50.8 FAM227B C15orf33, FLJ32800 ENSG00000166262 Family with sequence similarity 227, member B 15 49326962-49620931 Predicted intracellular proteins Evidence at protein level HPA049774, HPA061695 Uncertain Approved Nuclear speckles Mixed Expressed in all testis: 21.3 FAM228A C2orf84, FLJ30851 ENSG00000186453 Family with sequence similarity 228, member A 2 24175069-24200849 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 19 testis: 42.1 cerebral cortex: 2.2 FAM231D ENSG00000272058 Family with sequence similarity 231, member D 1 149702328-149705721 Predicted intracellular proteins Evidence at transcript level HPA043267, HPA043292, HPA077864 Uncertain Approved Cytosol Not detected Mixed thyroid gland: 9.6 FAM26D C6orf78, FLJ32239 ENSG00000164451 Family with sequence similarity 26, member D 6 116529013-116558868 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Not detected Tissue enriched 46 placenta: 33.6 testis: 0.7 FAM26E C6orf188, dJ493F7.3, MGC45451 ENSG00000178033 Family with sequence similarity 26, member E 6 116511646-116524792 Predicted membrane proteins Evidence at protein level HPA034969, HPA034970 Uncertain Approved Golgi apparatus Mixed Mixed placenta: 6.4 FAM26F C6orf187, dJ93H18.5, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5 ENSG00000188820 Family with sequence similarity 26, member F 6 116461370-116463779 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Renal cancer:9.31e-10 (unfavourable) Expressed in all Tissue enhanced spleen: 173.5 appendix: 83.3 FAM35A bA163M19.1, FAM35A1, MGC5560 ENSG00000122376 Family with sequence similarity 35, member A 10 87094161-87191468 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036582 Uncertain Approved Nucleoplasm
Actin filaments Glioma:5.44e-4 (favourable), Colorectal cancer:6.06e-4 (favourable) Expressed in all Expressed in all thyroid gland: 38.6 FAM43A FLJ90022 ENSG00000185112 Family with sequence similarity 43, member A 3 194686544-194689037 Predicted intracellular proteins Evidence at protein level HPA048345 Uncertain Approved Vesicles Urothelial cancer:9.96e-4 (unfavourable) Expressed in all Tissue enhanced spleen: 34.6 placenta: 18.2 FAM43B FLJ44952 ENSG00000183114 Family with sequence similarity 43, member B 1 20552439-20555010 Predicted intracellular proteins Evidence at protein level HPA050813 Approved Approved Cytosol Tissue enhanced Tissue enhanced adrenal gland: 10.4 epididymis: 3.4 FAM45A ENSG00000119979 Family with sequence similarity 45, member A 10 119104086-119137984 Predicted intracellular proteins Evidence at protein level HPA041159 Approved Plasma membrane
Centrosome
Cytosol Expressed in all Expressed in all thyroid gland: 31.7 FAM47A MGC27003 ENSG00000185448 Family with sequence similarity 47, member A X 34129756-34132314 Predicted intracellular proteins Evidence at protein level HPA000610 Uncertain Not detected Tissue enriched 55 testis: 5.5 all non-specific tissues: 0.0 FAM47B FLJ35782 ENSG00000189132 Family with sequence similarity 47, member B X 34942796-34944915 Predicted intracellular proteins Evidence at protein level HPA046829, HPA050996 Uncertain Not detected Tissue enriched 133 testis: 13.2 all non-specific tissues: 0.0 FAM47C ENSG00000198173 Family with sequence similarity 47, member C X 37008397-37011666 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 28 testis: 4.8 parathyroid gland: 0.1 FAM47E FLJ42946, LOC100129583 ENSG00000189157 Family with sequence similarity 47, member E 4 76214040-76283780 Predicted intracellular proteins Evidence at transcript level HPA053331 Uncertain Uncertain Plasma membrane
Cytosol Mixed Tissue enhanced fallopian tube: 26.5 thyroid gland: 13.8 FAM49A DKFZP566A1524, FLJ11080 ENSG00000197872 Family with sequence similarity 49, member A 2 16549459-16666331 Predicted intracellular proteins Evidence at protein level CAB017847, HPA060398 Approved Approved Nucleoplasm Renal cancer:1.83e-6 (unfavourable), Urothelial cancer:4.46e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 81.7 thyroid gland: 68.0 FAM53A DNTNP ENSG00000174137 Family with sequence similarity 53, member A 4 1617915-1684302 Predicted intracellular proteins Evidence at protein level HPA036452, HPA058138 Supported Uncertain Nucleoplasm Mixed Tissue enhanced testis: 17.5 thyroid gland: 7.8 FAM57B DKFZP434I2117 ENSG00000149926 Family with sequence similarity 57, member B 16 30024427-30052978 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA030837 Uncertain Tissue enriched Group enriched 12 cerebral cortex: 18.7;testis: 77.3 skeletal muscle: 3.9 FAM65C C20orf175, C20orf176, dJ530I15.2, dJ530I15.3 ENSG00000042062 Family with sequence similarity 65, member C 20 50586108-50691528 Predicted intracellular proteins Evidence at protein level HPA051823, HPA054759 Uncertain Approved Nucleoplasm Head and neck cancer:1.66e-5 (favourable) Mixed Mixed endometrium: 18.2 FAM69A FLJ23493 ENSG00000154511 Family with sequence similarity 69, member A 1 92832737-92961522 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015718, HPA017281 Approved Approved Nucleus
Cytosol Renal cancer:1.45e-7 (unfavourable), Breast cancer:8.96e-4 (favourable) Expressed in all Mixed cerebral cortex: 44.8 FAM69C C18orf51 ENSG00000187773 Family with sequence similarity 69, member C 18 74434099-74457944 Predicted intracellular proteins Evidence at protein level HPA048928 Supported Group enriched Tissue enhanced cerebral cortex: 28.9;testis: 8.4 skin: 4.9 FAM71A FLJ32796 ENSG00000162771 Family with sequence similarity 71, member A 1 212624474-212626778 Predicted intracellular proteins Evidence at protein level HPA028462 Supported Not detected Tissue enriched 96 testis: 78.7 fallopian tube: 0.8 FAM71D C14orf54 ENSG00000172717 Family with sequence similarity 71, member D 14 67189393-67228550 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 16 testis: 24.0 epididymis: 1.4 FAM71E1 ENSG00000142530 Family with sequence similarity 71, member E1 19 50466785-50476753 Predicted intracellular proteins Evidence at transcript level HPA048111 Approved Nucleoli fibrillar center Renal cancer:5.35e-7 (favourable) Expressed in all Tissue enriched 11 testis: 38.5 cerebral cortex: 3.4 FAM71E2 C19orf16, DKFZp434G1729 ENSG00000180043 Family with sequence similarity 71, member E2 19 55354908-55363260 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 237 testis: 23.6 all non-specific tissues: 0.0 FAM71F1 FAM137A, NYD-SP18 ENSG00000135248 Family with sequence similarity 71, member F1 7 128709061-128731743 Predicted intracellular proteins Evidence at transcript level HPA020636 Uncertain Cytosol Tissue enriched Tissue enriched 147 testis: 82.4 cerebral cortex,epididymis: 0.5 FAM71F2 FAM137B ENSG00000205085 Family with sequence similarity 71, member F2 7 128672288-128687872 Predicted intracellular proteins Evidence at protein level HPA020513, HPA024248 Supported Approved Nucleoplasm Mixed Tissue enriched 7 testis: 9.1 epididymis,skin: 1.3 FAM72B RP11-439A17.6 ENSG00000188610 Family with sequence similarity 72, member B 1 121167646-121185539 Predicted intracellular proteins Evidence at transcript level HPA043271, HPA067321 Uncertain Approved Vesicles
Plasma membrane
Cytosol Mixed Tissue enhanced lymph node: 9.8 tonsil: 6.4 FAM72D ENSG00000215784 Family with sequence similarity 72, member D 1 145096000-145112696 Predicted intracellular proteins Evidence at transcript level HPA043271, HPA067321 Uncertain Approved Vesicles
Plasma membrane
Cytosol Mixed Tissue enhanced lymph node: 5.7 tonsil: 4.2 FAM76A MGC34648 ENSG00000009780 Family with sequence similarity 76, member A 1 27725979-27763122 Predicted intracellular proteins Evidence at protein level HPA044762, HPA077897 Uncertain Approved Nucleus
Cytosol Renal cancer:2.26e-4 (favourable) Expressed in all Expressed in all testis: 32.4 FAM78A C9orf59, FLJ00024 ENSG00000126882 Family with sequence similarity 78, member A 9 131258076-131276547 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA021472, HPA023914 Uncertain Uncertain Nucleus
Vesicles Head and neck cancer:2.00e-4 (favourable), Cervical cancer:3.67e-4 (favourable) Expressed in all Mixed lymph node: 27.8 FAM78B ENSG00000188859 Family with sequence similarity 78, member B 1 166057426-166166969 Predicted intracellular proteins Evidence at transcript level HPA052789, HPA073246 Uncertain Approved Golgi apparatus
Vesicles Mixed Not detected adipose tissue,cerebral cortex,duodenum,stomach,testis: 0.2 FAM81A MGC26690 ENSG00000157470 Family with sequence similarity 81, member A 15 59372693-59523549 Predicted intracellular proteins Evidence at protein level HPA001847, HPA065797 Supported Approved Nucleoplasm
Cytosol Mixed Tissue enhanced cerebral cortex: 33.4 fallopian tube: 9.8 FAM84A FLJ35392, NSE1 ENSG00000162981 Family with sequence similarity 84, member A 2 14632686-14650814 Predicted intracellular proteins Evidence at protein level HPA047703 Uncertain Approved Nucleus Mixed Mixed colon: 41.1 FAM86B1 MGC16279 ENSG00000186523 Family with sequence similarity 86, member B1 8 12182096-12194133 Predicted intracellular proteins Evidence at transcript level HPA041610, HPA055718 Uncertain Uncertain Vesicles Mixed Tissue enhanced epididymis: 9.2 cerebral cortex: 4.5 FAM92B FLJ44299 ENSG00000153789 Family with sequence similarity 92, member B 16 85098358-85112508 Predicted intracellular proteins Evidence at protein level HPA041022 Supported Group enriched Tissue enriched 9 fallopian tube: 134.5 lung: 14.2 FAM98C FLJ44669 ENSG00000130244 Family with sequence similarity 98, member C 19 38403135-38409088 Predicted intracellular proteins Evidence at protein level HPA040930, HPA041730 Approved Approved Nucleus
Nucleoli
Cytosol Ovarian cancer:8.51e-5 (unfavourable), Urothelial cancer:5.53e-4 (favourable) Expressed in all Mixed small intestine: 15.5 FANCD2OS C3orf24, MGC40179 ENSG00000163705 FANCD2 opposite strand 3 10081317-10108231 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 17 testis: 54.7 parathyroid gland: 3.3 FANK1 ENSG00000203780 Fibronectin type III and ankyrin repeat domains 1 10 125896539-126009592 Predicted intracellular proteins Evidence at protein level HPA037557, HPA038413 Uncertain Supported Nucleoplasm Endometrial cancer:3.83e-4 (favourable) Mixed Group enriched 5 fallopian tube: 54.6;testis: 92.1 epididymis: 14.0 FAR2 FLJ10462, MLSTD1, SDR10E2 ENSG00000064763 Fatty acyl CoA reductase 2 12 29149103-29340980 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015884 Approved Approved Nucleoli
Golgi apparatus Renal cancer:4.93e-4 (unfavourable) Expressed in all Mixed epididymis: 52.9 FAT3 CDHF15, CDHR10, KIAA1989 ENSG00000165323 FAT atypical cadherin 3 11 92352096-92896470 Predicted membrane proteins Evidence at protein level HPA026878 Uncertain Tissue enriched Tissue enhanced cerebral cortex: 3.9;seminal vesicle: 2.6 prostate: 1.6 FAXC C6orf168, dJ273F20, MGC2817 ENSG00000146267 Failed axon connections homolog 6 99271169-99350062 Predicted intracellular proteins Evidence at protein level HPA039106 Uncertain Approved Nucleoplasm Mixed Tissue enhanced cerebral cortex: 23.6 seminal vesicle: 14.7 FAXDC2 C5orf4, FLJ13758 ENSG00000170271 Fatty acid hydroxylase domain containing 2 5 154818491-154859252 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Renal cancer:9.71e-10 (favourable), Liver cancer:3.87e-5 (favourable) Expressed in all Tissue enriched 6 parathyroid gland: 381.3 ovary: 66.6 FBLN7 FLJ37440, TM14 ENSG00000144152 Fibulin 7 2 112138385-112188216 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA034992 Uncertain Approved Plasma membrane
Cell Junctions Mixed Mixed parathyroid gland: 18.3 FBN3 ENSG00000142449 Fibrillin 3 19 8065402-8149846 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA049482 Uncertain Endometrial cancer:5.15e-4 (unfavourable) Tissue enhanced Tissue enhanced lung: 2.1;thyroid gland: 1.7 cerebral cortex,salivary gland: 1.1 FBXL13 DRC6, Fbl13, MGC21636 ENSG00000161040 F-box and leucine-rich repeat protein 13 7 102813230-103074843 Predicted intracellular proteins Evidence at protein level HPA057232 Uncertain Mixed Group enriched 5 fallopian tube: 7.8;testis: 37.2 stomach: 4.3 FBXL16 C16orf22, Fbl16, MGC33974 ENSG00000127585 F-box and leucine-rich repeat protein 16 16 692498-705829 Predicted intracellular proteins Evidence at protein level HPA039504, HPA056354 Supported Endometrial cancer:6.24e-5 (unfavourable), Pancreatic cancer:7.34e-5 (favourable), Renal cancer:1.87e-4 (favourable) Expressed in all Tissue enriched 23 cerebral cortex: 187.0 testis: 8.0 FBXL17 DKFZP434C1715, Fbl17, Fbx13, FBXO13 ENSG00000145743 F-box and leucine-rich repeat protein 17 5 107859035-108382098 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036410, HPA036411 Uncertain Approved Nucleus Renal cancer:4.60e-8 (favourable), Thyroid cancer:3.27e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 43.5 FBXL6 FBL6 ENSG00000182325 F-box and leucine-rich repeat protein 6 8 144355431-144359376 Predicted intracellular proteins Evidence at protein level HPA008867 Approved Nucleus Renal cancer:4.49e-10 (unfavourable) Expressed in all Mixed duodenum: 9.2 FBXL7 FBL6, FBL7, KIAA0840 ENSG00000183580 F-box and leucine-rich repeat protein 7 5 15500196-15939795 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA055464 Uncertain Liver cancer:1.29e-4 (unfavourable), Thyroid cancer:6.69e-4 (unfavourable) Expressed in all Mixed endometrium: 36.3 FBXO15 FBX15, MGC39671 ENSG00000141665 F-box protein 15 18 74073353-74147865 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enhanced fallopian tube: 4.8;testis: 6.6 cerebral cortex,epididymis: 2.0 FBXO16 FBX16 ENSG00000214050 F-box protein 16 8 28348287-28490318 Predicted intracellular proteins Evidence at transcript level HPA053955, HPA058676 Uncertain Approved Nucleoplasm
Vesicles
Plasma membrane
Cytosol Ovarian cancer:6.70e-5 (favourable) Mixed Tissue enhanced epididymis: 26.9 thyroid gland: 12.6 FBXO21 FBX21, KIAA0875 ENSG00000135108 F-box protein 21 12 117141988-117190531 Predicted intracellular proteins Evidence at protein level HPA062411, HPA071452 Approved Approved Mitochondria Renal cancer:2.05e-8 (favourable) Expressed in all Expressed in all fallopian tube: 202.3 FBXO36 Fbx36, FLJ37592 ENSG00000153832 F-box protein 36 2 229922302-230013109 Predicted intracellular proteins Evidence at protein level HPA053865 Approved Nucleus
Nucleoli Endometrial cancer:2.28e-4 (favourable) Expressed in all Tissue enhanced fallopian tube: 17.4 thyroid gland: 12.4 FBXO39 CT144, Fbx39, MGC35179 ENSG00000177294 F-box protein 39 17 6776223-6797101 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 62 testis: 53.2 ovary: 0.8 FBXO40 Fbx40, KIAA1195 ENSG00000163833 F-box protein 40 3 121593119-121630295 Plasma proteins, Predicted intracellular proteins Evidence at protein level Not detected Group enriched 47 heart muscle: 62.3;skeletal muscle: 54.0 esophagus,prostate: 1.2 FBXO41 Fbx41, KIAA1940 ENSG00000163013 F-box protein 41 2 73254682-73284431 Predicted intracellular proteins Evidence at protein level HPA055246, HPA058386 Approved Nucleus
Plasma membrane
Cytosol Renal cancer:1.08e-5 (unfavourable), Endometrial cancer:5.76e-4 (unfavourable) Mixed Tissue enhanced cerebral cortex: 38.4 parathyroid gland: 11.0 FBXO47 ENSG00000204952 F-box protein 47 17 38936432-38967402 Predicted intracellular proteins Evidence at transcript level HPA057438 Uncertain Not detected Tissue enriched 72 testis: 7.2 all non-specific tissues: 0.0 FBXO48 ENSG00000204923 F-box protein 48 2 68459419-68467258 Predicted intracellular proteins Evidence at transcript level HPA049775, HPA054782 Uncertain Approved Nuclear bodies Expressed in all Mixed skin: 3.0 FBXO8 FBS, FBX8 ENSG00000164117 F-box protein 8 4 174236658-174284264 Predicted intracellular proteins Evidence at transcript level HPA002885 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:1.29e-7 (favourable) Expressed in all Expressed in all placenta: 44.1 FBXW10 C17orf1, C17orf1A, Fbw10, HREP, SM2SH2 ENSG00000171931 F-box and WD repeat domain containing 10 17 18744024-18779349 Predicted intracellular proteins Evidence at transcript level HPA047457 Approved Nucleoplasm Not detected Tissue enriched 20 testis: 17.4 epididymis: 0.8 FBXW12 Fbw12, FBXO35 ENSG00000164049 F-box and WD repeat domain containing 12 3 48372219-48401259 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA037491, HPA037492 Uncertain Not detected Group enriched 5 pancreas: 1.2;testis: 1.1 cerebral cortex: 0.2 FBXW4 dactylin, Fbw4, SHFM3 ENSG00000107829 F-box and WD repeat domain containing 4 10 101610664-101695295 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA043496 Approved Approved Golgi apparatus Renal cancer:3.41e-5 (favourable), Pancreatic cancer:4.67e-4 (favourable), Endometrial cancer:4.91e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 79.6 FCF1 Bka, C14orf111, CGI-35, UTP24 ENSG00000119616 FCF1 rRNA-processing protein 14 74713144-74738620 Predicted intracellular proteins Evidence at protein level HPA046681 Approved Approved Nucleoplasm Liver cancer:5.54e-6 (unfavourable), Renal cancer:2.26e-4 (favourable), Pancreatic cancer:3.54e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 72.5 FCGR1B CD64b ENSG00000198019 Fc fragment of IgG, high affinity Ib, receptor (CD64) 1 121087345-121096310 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enhanced appendix: 28.1;epididymis: 61.7 placenta: 17.2 FER1L5 DKFZp434I0121 ENSG00000249715 Fer-1-like family member 5 2 96642737-96704887 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 14 testis: 7.5 seminal vesicle: 0.5 FER1L6 C8ORFK23 ENSG00000214814 Fer-1-like family member 6 8 123851987-124120061 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA054117 Uncertain Group enriched Group enriched 5 rectum: 12.6;stomach: 44.3 small intestine: 5.4 FEZF2 FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312 ENSG00000153266 FEZ family zinc finger 2 3 62369681-62374324 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enriched 29 cerebral cortex: 11.8 colon: 0.4 FGF11 FHF3, FLJ16061, MGC102953, MGC45269 ENSG00000161958 Fibroblast growth factor 11 17 7438273-7444937 Predicted intracellular proteins, RAS pathway related proteins Evidence at transcript level HPA066605 Approved Centrosome Mixed Tissue enhanced adrenal gland: 34.8;skin: 27.6 cerebral cortex: 20.7 FHAD1 KIAA1937 ENSG00000142621 Forkhead-associated (FHA) phosphopeptide binding domain 1 1 15247272-15400283 Predicted intracellular proteins Evidence at protein level HPA054284 Approved Mixed Group enriched 6 fallopian tube: 24.0;lung: 5.3;testis: 24.6 cervix, uterine: 3.1 FITM1 FIT1 ENSG00000139914 Fat storage-inducing transmembrane protein 1 14 24131275-24132849 Predicted membrane proteins Evidence at protein level HPA019842 Uncertain Liver cancer:1.00e-3 (favourable) Mixed Group enriched 14 heart muscle: 45.3;skeletal muscle: 113.0 spleen: 5.5 FITM2 C20orf142, dJ881L22.2, FIT2 ENSG00000197296 Fat storage-inducing transmembrane protein 2 20 44302838-44311169 Predicted membrane proteins Evidence at protein level Renal cancer:8.98e-12 (favourable) Expressed in all Tissue enhanced heart muscle: 40.2 parathyroid gland: 23.7 FJX1 FLJ22416, FLJ25593 ENSG00000179431 Four jointed box 1 11 35618419-35620868 Predicted secreted proteins Evidence at protein level HPA059220 Uncertain Approved Vesicles Renal cancer:9.24e-9 (unfavourable), Urothelial cancer:6.56e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 22.4 endometrium: 8.8 FMO1 ENSG00000010932 Flavin containing monooxygenase 1 1 171248471-171285978 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA023680 Uncertain Renal cancer:2.81e-4 (favourable) Tissue enriched Tissue enriched 8 kidney: 218.3 small intestine: 25.7 FMR1NB CT37, FLJ25736, NY-SAR-35 ENSG00000176988 Fragile X mental retardation 1 neighbor X 147981329-148026667 Predicted membrane proteins Evidence at protein level HPA011284, CAB026403 Supported Tissue enhanced Tissue enriched 420 testis: 86.4 epididymis: 0.2 FNDC1 bA243O10.1, dJ322A24.1, FNDC2, KIAA1866 ENSG00000164694 Fibronectin type III domain containing 1 6 159169397-159272109 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA030962, HPA030963 Approved Supported Nuclear speckles Renal cancer:1.93e-6 (unfavourable), Endometrial cancer:6.10e-5 (favourable) Tissue enhanced Tissue enhanced gallbladder: 23.0;thyroid gland: 33.8 smooth muscle: 16.3 FNDC4 FLJ22362, FRCP1 ENSG00000115226 Fibronectin type III domain containing 4 2 27491883-27495245 Predicted membrane proteins Evidence at transcript level HPA051804, HPA063581 Uncertain Approved Nucleoplasm
Aggresome
Cytosol Endometrial cancer:5.07e-4 (unfavourable), Urothelial cancer:6.11e-4 (unfavourable) Expressed in all Tissue enhanced adrenal gland: 72.9 cerebral cortex: 36.0 FNDC7 FLJ35838 ENSG00000143107 Fibronectin type III domain containing 7 1 108712657-108742740 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA028079, HPA054297 Approved Approved Nucleoplasm
Actin filaments Not detected Tissue enriched 12 testis: 2.0 bone marrow,cerebral cortex: 0.1 FNDC8 DKFZp434H2215 ENSG00000073598 Fibronectin type III domain containing 8 17 35121579-35130732 Predicted intracellular proteins Evidence at protein level HPA026521 Supported Not detected Tissue enriched 391 testis: 107.9 endometrium,esophagus,ovary,parathyroid gland: 0.2 FNDC9 C5orf40, MGC27121 ENSG00000172568 Fibronectin type III domain containing 9 5 157341600-157345721 Predicted membrane proteins Evidence at transcript level HPA011115, HPA017291 Approved Tissue enriched Group enriched 17 adrenal gland: 6.3;cerebral cortex: 20.7 appendix: 0.7 FOSB AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291 ENSG00000125740 FBJ murine osteosarcoma viral oncogene homolog B 19 45467995-45475179 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB010267, HPA054663 Approved Supported Nucleoplasm
Vesicles Expressed in all Mixed gallbladder: 560.0 FOXD1 FKHL8, FREAC4 ENSG00000251493 Forkhead box D1 5 73444827-73448362 Predicted intracellular proteins, Transcription factors Evidence at transcript level Head and neck cancer:2.73e-4 (unfavourable), Urothelial cancer:9.65e-4 (unfavourable) Mixed Tissue enhanced testis: 4.8 adrenal gland: 2.9 FOXD2 FKHL17, FREAC9 ENSG00000186564 Forkhead box D2 1 47436017-47440691 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced colon: 3.8;rectum: 3.5 prostate: 1.1 FOXD4 FKHL9, FOXD4a, FREAC5 ENSG00000170122 Forkhead box D4 9 116231-118204 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Mixed Tissue enhanced testis: 1.0 cerebral cortex: 0.3 FOXD4L1 FOXD5 ENSG00000184492 Forkhead box D4-like 1 2 113498665-113501155 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Not detected Not detected testis: 0.7 FOXD4L3 FOXD6 ENSG00000187559 Forkhead box D4-like 3 9 68302867-68304905 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Not detected Not detected spleen: 0.3 FOXD4L4 bA460E7.2, FOXD4L2 ENSG00000184659 Forkhead box D4-like 4 9 65736555-65738784 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Not detected Not detected appendix,cerebral cortex,fallopian tube: 0.1 FOXI2 FLJ46831 ENSG00000186766 Forkhead box I2 10 127737235-127741186 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:4.23e-7 (favourable) Tissue enriched Tissue enhanced cervix, uterine: 2.6 kidney: 1.6 FOXI3 ENSG00000214336 Forkhead box I3 2 88446787-88452656 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enriched 8 placenta: 7.3 testis: 0.8 FOXJ1 FKHL13, HFH-4, HFH4 ENSG00000129654 Forkhead box J1 17 76136333-76141299 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005714 Supported Renal cancer:2.03e-5 (unfavourable), Breast cancer:9.39e-4 (favourable) Tissue enhanced Tissue enriched 8 fallopian tube: 82.8 lung: 10.4 FOXL1 FKH6, FKHL11, FREAC7 ENSG00000176678 Forkhead box L1 16 86576368-86582160 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced gallbladder: 8.4 duodenum: 3.2 FOXL2NB C3orf72, FLJ43329 ENSG00000206262 FOXL2 neighbor 3 138947234-138953451 Predicted intracellular proteins Evidence at protein level HPA061017, HPA071790 Supported Nucleoli fibrillar center Mixed Tissue enhanced endometrium: 29.1;ovary: 50.7;parathyroid gland: 63.1 fallopian tube: 19.5 FOXN1 FKHL20, RONU, WHN ENSG00000109101 Forkhead box N1 17 28506243-28538896 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Head and neck cancer:5.00e-4 (favourable), Cervical cancer:6.43e-4 (favourable) Tissue enhanced Tissue enhanced esophagus: 7.2;skin: 35.3 tonsil: 5.3 FOXN4 ENSG00000139445 Forkhead box N4 12 109277979-109309220 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050018 Uncertain Approved Nucleus
Mitochondria
Cytosol Tissue enhanced Tissue enriched 13 testis: 10.7 cervix, uterine: 0.7 FOXQ1 HFH1 ENSG00000164379 Forkhead box Q1 6 1312473-1314187 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059700 Supported Nucleus Prostate cancer:6.68e-4 (favourable) Expressed in all Tissue enhanced stomach: 102.1;urinary bladder: 41.0 skin: 28.3 FOXS1 FKHL18, FREAC10 ENSG00000179772 Forkhead box S1 20 31844301-31845619 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042475 Approved Approved Nucleoplasm
Cytosol Renal cancer:1.10e-8 (unfavourable) Expressed in all Mixed placenta: 7.0 FP325331.1 ENSG00000278881 Uncharacterized protein UNQ6126/PRO20091 22 47115838-47117217 Predicted secreted proteins Evidence at transcript level HPA003644 Approved Nucleus
Cytosol Not detected Not detected cervix, uterine,skin: 0.1 FPR2 ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R ENSG00000171049 Formyl peptide receptor 2 19 51752026-51770526 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA029154 Approved Mixed Tissue enhanced appendix: 71.3 spleen: 20.0 FPR3 FMLPY, FPRH1, FPRL2, RMLP-R-I ENSG00000187474 Formyl peptide receptor 3 19 51795163-51826189 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Testis cancer:9.13e-4 (unfavourable) Expressed in all Mixed lung: 41.3 FRAT2 ENSG00000181274 Frequently rearranged in advanced T-cell lymphomas 2 10 97332497-97334709 Predicted intracellular proteins Evidence at transcript level HPA049763 Uncertain Approved Nucleus
Mitochondria Renal cancer:2.55e-4 (favourable), Liver cancer:3.02e-4 (unfavourable) Expressed in all Expressed in all duodenum: 26.2 FRG2 FRG2A ENSG00000205097 FSHD region gene 2 4 190024351-190027257 Predicted intracellular proteins Evidence at transcript level HPA039264, HPA047769 Uncertain Not detected Not detected parathyroid gland: 0.8 FRG2B ENSG00000225899 FSHD region gene 2 family, member B 10 133623895-133626795 Predicted intracellular proteins Evidence at transcript level HPA039264, HPA047769 Uncertain Not detected Tissue enriched 6 parathyroid gland: 1.3 kidney,placenta: 0.2 FRMD1 bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260 ENSG00000153303 FERM domain containing 1 6 168055745-168081557 Predicted intracellular proteins Evidence at transcript level HPA030346, HPA030347 Uncertain Approved Actin filaments Tissue enriched Tissue enhanced colon: 5.9;stomach: 6.2;testis: 5.9 rectum: 4.6 FRMD3 EPB41L4O, MGC20553 ENSG00000172159 FERM domain containing 3 9 83242990-83538546 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017285 Approved Approved Nucleoplasm
Golgi apparatus
Plasma membrane Thyroid cancer:1.79e-4 (favourable), Renal cancer:7.24e-4 (favourable) Tissue enhanced Tissue enhanced heart muscle: 51.7 skeletal muscle: 28.6 FRMPD3 KIAA1817, RP5-1070B1.1 ENSG00000147234 FERM and PDZ domain containing 3 X 107522450-107605251 Predicted intracellular proteins Evidence at transcript level HPA003164 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 5.9;ovary: 6.7;thyroid gland: 5.5 seminal vesicle: 1.9 FRRS1 SDFR2, SDR2 ENSG00000156869 Ferric-chelate reductase 1 1 99708703-99766631 Predicted membrane proteins Evidence at protein level HPA017883 Approved Renal cancer:6.53e-4 (unfavourable) Expressed in all Mixed placenta: 15.7 FRRS1L C9orf4, CG-6 ENSG00000260230 Ferric-chelate reductase 1-like 9 109130293-109167291 Predicted membrane proteins Evidence at protein level HPA071086 Supported Mixed Tissue enhanced cerebral cortex: 47.9 ovary: 14.1 FSCB C14orf155, DKFZP434F1017 ENSG00000189139 Fibrous sheath CABYR binding protein 14 44504342-44507279 Predicted intracellular proteins Evidence at protein level HPA003546 Supported Not detected Tissue enriched 516 testis: 51.6 all non-specific tissues: 0.0 FSCN3 ENSG00000106328 Fascin actin-bundling protein 3, testicular 7 127591409-127602144 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 244 testis: 105.3 skin: 0.4 FSIP1 FLJ35989 ENSG00000150667 Fibrous sheath interacting protein 1 15 39600031-39782830 Predicted intracellular proteins Evidence at protein level HPA041002 Uncertain Uncertain Nucleoplasm Tissue enriched Group enriched 7 colon: 11.3;rectum: 18.6;testis: 13.5 breast: 2.1 FSIP2 FLJ34780 ENSG00000188738 Fibrous sheath interacting protein 2 2 185738628-185833290 Predicted intracellular proteins Evidence at protein level HPA036139 Approved Microtubules
Mitochondria Not detected Tissue enriched 9 testis: 21.2 stomach: 2.4 FSTL4 KIAA1061 ENSG00000053108 Follistatin-like 4 5 133196455-133612564 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA045920 Uncertain Approved Mitochondria Mixed Tissue enhanced cerebral cortex: 9.6 urinary bladder: 7.6 FSTL5 DKFZp566D234, KIAA1263 ENSG00000168843 Follistatin-like 5 4 161383897-162164035 Predicted secreted proteins Evidence at protein level HPA045909, HPA046724 Uncertain Tissue enriched Group enriched 10 adrenal gland: 7.8;cerebral cortex: 16.3 testis: 1.1 FTCDNL1 FONG ENSG00000226124 Formiminotransferase cyclodeaminase N-terminal like 2 199760544-199851173 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA065748 Uncertain Vesicles Renal cancer:3.31e-4 (favourable), Thyroid cancer:5.74e-4 (unfavourable) Mixed Mixed thyroid gland: 11.9 FTHL17 CT38 ENSG00000132446 Ferritin, heavy polypeptide-like 17 X 31071241-31072053 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enriched 14 testis: 3.5 skin: 0.2 FUK FLJ39408 ENSG00000157353 Fucokinase 16 70454421-70480274 Enzymes, Predicted intracellular proteins Evidence at protein level HPA041971 Approved Approved Vesicles Urothelial cancer:8.38e-4 (favourable), Renal cancer:8.91e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 14.2 FUT1 H, HSC ENSG00000174951 Fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) 19 48748011-48755390 Blood group antigen proteins, Enzymes, Predicted membrane proteins Evidence at transcript level Renal cancer:3.99e-4 (favourable) Mixed Mixed stomach: 7.1 FUT10 ENSG00000172728 Fucosyltransferase 10 (alpha (1,3) fucosyltransferase) 8 33370824-33473422 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA053970, HPA058655 Uncertain Approved Nucleoplasm
Endoplasmic reticulum
Golgi apparatus Mixed Mixed parathyroid gland: 8.6 FUT2 SE, Se2, SEC2, sej ENSG00000176920 Fucosyltransferase 2 (secretor status included) 19 48695971-48705950 Blood group antigen proteins, Enzymes, Predicted membrane proteins Evidence at transcript level HPA014402 Uncertain Uncertain Plasma membrane
Cytosol Head and neck cancer:5.83e-4 (favourable) Mixed Tissue enhanced duodenum: 52.9 stomach: 32.5 FUT3 CD174, LE ENSG00000171124 Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) 19 5842888-5851474 Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA046966 Supported Renal cancer:8.22e-7 (favourable), Breast cancer:6.86e-4 (unfavourable) Tissue enhanced Tissue enhanced colon: 69.4;esophagus: 83.4;small intestine: 64.4 duodenum,rectum: 50.3 FUT4 CD15, ELFT, FCT3A, FUC-TIV ENSG00000196371 Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) 11 94543840-94549898 Predicted membrane proteins Evidence at protein level CAB000014, CAB016129 Supported Validated Vesicles Lung cancer:3.64e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 63.0 duodenum: 12.7 FUT5 FUC-TV ENSG00000130383 Fucosyltransferase 5 (alpha (1,3) fucosyltransferase) 19 5865826-5870540 Enzymes, Predicted membrane proteins Evidence at transcript level HPA046966 Uncertain Not detected Not detected bone marrow,testis: 0.3 FUT9 Fuc-TIX ENSG00000172461 Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) 6 96015984-96215612 Predicted membrane proteins Evidence at protein level HPA070923 Approved Nucleoplasm
Microtubules
Cytokinetic bridge
Cytosol Tissue enhanced Group enriched 12 cerebral cortex: 28.2;stomach: 22.2 duodenum: 2.1 FUZ FLJ22688, Fy ENSG00000010361 Fuzzy planar cell polarity protein 19 49806869-49817376 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA041779, HPA042196 Uncertain Approved Cytosol Renal cancer:1.50e-5 (favourable) Expressed in all Expressed in all testis: 52.6 FXYD3 MAT-8, PLML ENSG00000089356 FXYD domain containing ion transport regulator 3 19 35115879-35124324 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA010856 Supported Supported Plasma membrane Renal cancer:1.15e-6 (unfavourable) Expressed in all Tissue enhanced colon: 1480.8;rectum: 1982.1 prostate: 686.5 FZD9 CD349, FZD3 ENSG00000188763 Frizzled class receptor 9 7 73433783-73436120 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced testis: 1.5 skeletal muscle: 1.5 GAB3 ENSG00000160219 GRB2-associated binding protein 3 X 154675249-154751583 Predicted intracellular proteins Evidence at protein level HPA010090 Approved Renal cancer:5.07e-4 (unfavourable) Mixed Mixed spleen: 18.0 GAB4 ENSG00000215568 GRB2-associated binding protein family, member 4 22 16961936-17008222 Predicted intracellular proteins Evidence at transcript level HPA044621 Uncertain Not detected Tissue enriched 38 testis: 3.7 all non-specific tissues: 0.0 GABRA2 ENSG00000151834 Gamma-aminobutyric acid (GABA) A receptor, alpha 2 4 46248427-46475230 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Tissue enhanced Tissue enriched 6 cerebral cortex: 74.5 epididymis: 13.3 GABRA3 ENSG00000011677 Gamma-aminobutyric acid (GABA) A receptor, alpha 3 X 152166234-152451358 FDA approved drug targets, Predicted membrane proteins Evidence at protein level HPA000839 Approved Supported Tissue enriched Tissue enriched 7 cerebral cortex: 28.9 placenta: 4.1 GABRA4 ENSG00000109158 Gamma-aminobutyric acid (GABA) A receptor, alpha 4 4 46918900-46994407 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 12 cerebral cortex: 15.1 heart muscle: 1.2 GABRA6 ENSG00000145863 Gamma-aminobutyric acid (GABA) A receptor, alpha 6 5 161547063-161702593 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA019188, CAB022462, HPA058329 Uncertain Not detected Tissue enhanced testis: 1.2 cerebral cortex: 0.3 GABRB1 ENSG00000163288 Gamma-aminobutyric acid (GABA) A receptor, beta 1 4 46993723-47426444 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA051297 Uncertain Tissue enhanced Tissue enriched 15 cerebral cortex: 19.8 heart muscle: 1.3 GABRE ENSG00000102287 Gamma-aminobutyric acid (GABA) A receptor, epsilon X 151953124-151974680 FDA approved drug targets, Predicted membrane proteins Evidence at transcript level HPA045918 Uncertain Renal cancer:4.05e-11 (unfavourable) Mixed Tissue enhanced adipose tissue: 10.1 heart muscle: 5.5 GABRG1 ENSG00000163285 Gamma-aminobutyric acid (GABA) A receptor, gamma 1 4 46035769-46124081 FDA approved drug targets, Predicted membrane proteins Evidence at transcript level HPA035622 Approved Tissue enriched Tissue enriched 17 cerebral cortex: 26.1 ovary: 1.5 GABRG3 ENSG00000182256 Gamma-aminobutyric acid (GABA) A receptor, gamma 3 15 26971282-27541991 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA054010 Supported Tissue enhanced Tissue enhanced prostate: 10.6;testis: 16.4 cerebral cortex: 4.2 GABRP ENSG00000094755 Gamma-aminobutyric acid (GABA) A receptor, pi 5 170763350-170814047 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level CAB014883 Uncertain Cervical cancer:3.37e-4 (favourable) Mixed Expressed in all breast: 186.6 GABRQ THETA ENSG00000268089 Gamma-aminobutyric acid (GABA) A receptor, theta X 152638183-152657534 FDA approved drug targets, Predicted membrane proteins Evidence at transcript level HPA002063 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 6.6;cervix, uterine: 12.8 adrenal gland: 3.0 GABRR1 ENSG00000146276 Gamma-aminobutyric acid (GABA) A receptor, rho 1 6 89177501-89231278 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 6 testis: 1.8 placenta: 0.3 GABRR2 ENSG00000111886 Gamma-aminobutyric acid (GABA) A receptor, rho 2 6 89257208-89315299 FDA approved drug targets, Predicted membrane proteins Evidence at transcript level Not detected Not detected adrenal gland,appendix,cerebral cortex,endometrium,gallbladder,lymph node,skin,spleen,testis,thyroid gland: 0.1 GAGE12F ENSG00000236362 G antigen 12F X 49560876-49568205 Predicted intracellular proteins Evidence at protein level HPA043232 Supported Uncertain Golgi apparatus
Cytosol Not detected Tissue enriched 12 testis: 124.2 stomach: 10.2 GAGE12G ENSG00000215269 G antigen 12G X 49570434-49577754 Predicted intracellular proteins Evidence at protein level HPA043232 Supported Uncertain Golgi apparatus
Plasma membrane
Cytosol Not detected Tissue enriched 12 testis: 124.2 stomach: 10.2 GALNT13 GalNAc-T13, KIAA1918 ENSG00000144278 Polypeptide N-acetylgalactosaminyltransferase 13 2 153871913-154453849 Enzymes, Predicted intracellular proteins Evidence at protein level HPA060775 Approved Tissue enriched Group enriched 6 adrenal gland: 6.6;cerebral cortex: 32.8 lung: 3.2 GALNT15 GALNT7, GALNTL2, pp-GalNAc-T15 ENSG00000131386 Polypeptide N-acetylgalactosaminyltransferase 15 3 16174649-16231992 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA017076, HPA051551 Uncertain Approved Vesicles
Plasma membrane Tissue enriched Tissue enhanced adipose tissue: 36.2;cerebral cortex: 41.4;placenta: 42.6 breast: 18.3 GALNT18 GalNAc-T18, GALNT15, GALNTL4, MGC71806 ENSG00000110328 Polypeptide N-acetylgalactosaminyltransferase 18 11 11270876-11622005 Enzymes, Predicted membrane proteins Evidence at protein level HPA012955 Approved Approved Mitochondria Endometrial cancer:1.29e-4 (unfavourable) Expressed in all Tissue enhanced thyroid gland: 59.0 lung: 43.2 GALNT6 GalNAc-T6 ENSG00000139629 Polypeptide N-acetylgalactosaminyltransferase 6 12 51351247-51392867 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA011762, HPA017086 Supported Approved Nucleoplasm
Golgi apparatus Ovarian cancer:5.40e-4 (favourable), Endometrial cancer:9.85e-4 (favourable) Mixed Tissue enhanced stomach: 61.9 cervix, uterine: 49.2 GALNT8 GALNAC-T8 ENSG00000130035 Polypeptide N-acetylgalactosaminyltransferase 8 12 4720341-4851927 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA012638, HPA014418, HPA073461 Approved Approved Vesicles Tissue enhanced Group enriched 7 cerebral cortex: 19.5;colon: 18.0;duodenum: 8.4;rectum: 41.3;small intestine: 19.3;testis: 26.3 appendix: 3.3 GALNT9 GALNAC-T9 ENSG00000182870 Polypeptide N-acetylgalactosaminyltransferase 9 12 132196372-132329349 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA075016 Approved Vesicles Mixed Group enriched 7 cerebral cortex: 29.5;epididymis: 7.8;thyroid gland: 6.4 kidney: 1.9 GALNTL5 GalNAc-T5L, GALNT15 ENSG00000106648 Polypeptide N-acetylgalactosaminyltransferase-like 5 7 151956379-152019934 Disease related genes, Predicted membrane proteins Evidence at protein level HPA011140 Supported Not detected Tissue enriched 14 testis: 11.1 cerebral cortex: 0.8 GALNTL6 GalNAc-T6L, GALNT17 ENSG00000174473 Polypeptide N-acetylgalactosaminyltransferase-like 6 4 171812254-173041559 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA031019 Uncertain Not detected Tissue enhanced cerebral cortex: 5.5;testis: 4.8 spleen: 2.1 GALP ENSG00000197487 Galanin-like peptide 19 56176020-56185775 Predicted secreted proteins Evidence at transcript level HPA053938 Uncertain Tissue enhanced Not detected liver: 0.3 GANC ENSG00000214013 Glucosidase, alpha; neutral C 15 42273233-42356935 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level HPA016949 Approved Approved Nucleoplasm
Actin filaments Lung cancer:9.76e-4 (favourable) Expressed in all Expressed in all lung: 42.6 GAREML FAM59B, FLJ00375, KIAA2038 ENSG00000157833 GRB2 associated, regulator of MAPK1-like 2 26173091-26189663 Predicted intracellular proteins Evidence at protein level HPA071575 Approved Cytosol Mixed Group enriched 6 cerebral cortex: 23.1;parathyroid gland: 17.5 smooth muscle: 3.4 GARNL3 bA356B19.1, DKFZp761J1523 ENSG00000136895 GTPase activating Rap/RanGAP domain-like 3 9 127224265-127393660 Predicted intracellular proteins Evidence at protein level HPA022433, HPA028757 Uncertain Approved Vesicles Mixed Mixed parathyroid gland: 15.2 GAS1 ENSG00000180447 Growth arrest-specific 1 9 86944363-86947189 Cancer-related genes, Predicted secreted proteins Evidence at protein level CAB024164, HPA036085, HPA066902 Approved Approved Nuclear speckles Thyroid cancer:1.13e-5 (unfavourable), Renal cancer:1.96e-5 (unfavourable), Colorectal cancer:1.55e-4 (unfavourable), Stomach cancer:8.26e-4 (unfavourable) Expressed in all Tissue enhanced endometrium: 110.4 smooth muscle: 73.6 GAS2L2 GAR17 ENSG00000270765 Growth arrest-specific 2 like 2 17 35744511-35752878 Predicted intracellular proteins Evidence at protein level HPA044370 Supported Endometrial cancer:7.00e-4 (favourable) Tissue enhanced Tissue enriched 11 fallopian tube: 27.8 epididymis,lung: 2.6 GATSL2 GATSL1 ENSG00000274070 GATS protein-like 2 7 74964818-75024798 Predicted intracellular proteins Evidence at transcript level HPA057229 Uncertain Expressed in all Tissue enhanced cerebral cortex: 15.0 skeletal muscle: 13.8 GBGT1 A3GALNT, FS, MGC44848, UDP-GalNAc ENSG00000148288 Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 9 133152948-133163945 Predicted secreted proteins Evidence at protein level HPA051298 Approved Renal cancer:3.46e-5 (unfavourable), Colorectal cancer:6.22e-4 (unfavourable) Expressed in all Mixed placenta: 15.5 GBP4 Mpa2 ENSG00000162654 Guanylate binding protein 4 1 89181148-89198932 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA030101, HPA062039 Approved Uncertain Plasma membrane Renal cancer:1.30e-5 (unfavourable), Ovarian cancer:9.29e-5 (favourable) Expressed in all Mixed lung: 47.2 GBP6 DKFZp686G0786 ENSG00000183347 Guanylate binding protein family, member 6 1 89364058-89386461 Predicted intracellular proteins Evidence at protein level HPA027744 Supported Group enriched Tissue enriched 7 esophagus: 450.3 tonsil: 68.6 GBP7 FLJ38822, GBP4L ENSG00000213512 Guanylate binding protein 7 1 89131751-89176040 Predicted intracellular proteins Evidence at protein level HPA051245 Uncertain Tissue enriched Tissue enriched 89 liver: 48.3 adrenal gland: 0.5 GBX2 ENSG00000168505 Gastrulation brain homeobox 2 2 236165236-236168369 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067809 Supported Nucleoplasm Group enriched Not detected cerebral cortex: 0.6 GCM1 GCMA, hGCMa ENSG00000137270 Glial cells missing homolog 1 (Drosophila) 6 53126964-53148829 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA011343 Supported Approved Vesicles Not detected Tissue enriched 21 placenta: 29.0 kidney: 1.4 GCNT2 bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3 ENSG00000111846 Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) 6 10492223-10629368 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA026776 Approved Supported Golgi apparatus Mixed Tissue enhanced prostate: 49.8 breast: 14.2 GCNT3 C2/4GnT, C2GnT-M, C2GnT2 ENSG00000140297 Glucosaminyl (N-acetyl) transferase 3, mucin type 15 59594875-59640239 Enzymes, Predicted membrane proteins Evidence at protein level HPA011154 Approved Approved Golgi apparatus
Vesicles Liver cancer:6.49e-5 (unfavourable), Endometrial cancer:1.78e-4 (favourable) Tissue enhanced Tissue enhanced colon: 144.6;gallbladder: 118.5;rectum: 136.6;small intestine: 141.0 duodenum: 100.5 GCNT4 C2GNT3 ENSG00000176928 Glucosaminyl (N-acetyl) transferase 4, core 2 5 75025346-75030899 Enzymes, Predicted intracellular proteins Evidence at protein level HPA037431 Approved Supported Nucleoplasm
Golgi apparatus Renal cancer:1.93e-7 (favourable) Mixed Tissue enhanced duodenum: 22.0 parathyroid gland: 20.7 GCNT7 C20orf105, dJ1153D9.2 ENSG00000124091 Glucosaminyl (N-acetyl) transferase family member 7 20 56491492-56525925 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA052617 Uncertain Not detected Tissue enriched 5 bone marrow: 2.8 skin,testis: 0.5 GCSAML C1orf150, FLJ44728 ENSG00000169224 Germinal center-associated, signaling and motility-like 1 247507058-247577690 Predicted intracellular proteins Evidence at protein level HPA027507, HPA027510 Uncertain Approved Cytosol Tissue enriched Tissue enhanced prostate: 8.4;testis: 7.7 lung: 3.4 GDAP1L1 ENSG00000124194 Ganglioside induced differentiation associated protein 1-like 1 20 44247099-44280917 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA054182, HPA063265 Approved Approved Endoplasmic reticulum Tissue enriched Tissue enriched 20 cerebral cortex: 55.7 adrenal gland: 2.8 GDF10 BMP-3b ENSG00000266524 Growth differentiation factor 10 10 47300386-47313547 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA015498 Uncertain Mixed Tissue enhanced lung: 19.6 testis: 9.0 GDF11 BMP-11 ENSG00000135414 Growth differentiation factor 11 12 55743280-55757278 Predicted secreted proteins Evidence at protein level HPA060985, HPA069609 Approved Approved Vesicles Pancreatic cancer:1.08e-4 (favourable) Expressed in all Mixed seminal vesicle: 13.5 GDF15 MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB ENSG00000130513 Growth differentiation factor 15 19 18374731-18389176 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA011191, CAB062554 Supported Supported Golgi apparatus Expressed in all Tissue enhanced placenta: 121.8 prostate: 63.1 GDF5OS ENSG00000204183 Growth differentiation factor 5 opposite strand 20 35433029-35435450 Predicted intracellular proteins Evidence at transcript level HPA062720 Uncertain Not detected Not detected adipose tissue,testis: 0.3 GDF7 BMP12 ENSG00000143869 Growth differentiation factor 7 2 20666664-20679245 Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced seminal vesicle: 29.2 endometrium: 11.5 GDPD2 FLJ20207, GDE3, OBDPF ENSG00000130055 Glycerophosphodiester phosphodiesterase domain containing 2 X 70423031-70433390 Enzymes, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced skin: 50.9;spleen: 61.0 small intestine: 20.5 GDPD3 MGC4171 ENSG00000102886 Glycerophosphodiester phosphodiesterase domain containing 3 16 30104810-30113856 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA041148, HPA041470 Uncertain Approved Nucleoplasm
Cytokinetic bridge
Cytosol Renal cancer:5.89e-9 (unfavourable) Expressed in all Mixed esophagus: 23.2 GDPD4 GDE6 ENSG00000178795 Glycerophosphodiester phosphodiesterase domain containing 4 11 77216558-77301687 Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enriched 7 testis: 4.8 placenta: 0.6 GFOD2 FLJ23802, MGC11335 ENSG00000141098 Glucose-fructose oxidoreductase domain containing 2 16 67674531-67719421 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA040939, HPA041112 Uncertain Supported Nucleoplasm
Cytosol Pancreatic cancer:5.95e-4 (favourable), Renal cancer:8.66e-4 (favourable) Expressed in all Expressed in all esophagus: 22.8 GFRA1 GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1 ENSG00000151892 GDNF family receptor alpha 1 10 116056925-116273467 Predicted membrane proteins Evidence at protein level HPA043829 Uncertain Approved Nucleoplasm
Golgi apparatus Tissue enriched Mixed breast: 30.1 GFRA2 GDNFRB, NTNRA, RETL2, TRNR2 ENSG00000168546 GDNF family receptor alpha 2 8 21690403-21812357 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA024704, CAB032791 Uncertain Uncertain Vesicles Tissue enriched Tissue enhanced thyroid gland: 13.3 spleen: 9.7 GFRAL bA360D14.1, C6orf144, GRAL, UNQ9356 ENSG00000187871 GDNF family receptor alpha like 6 55327469-55402493 Predicted membrane proteins Evidence at protein level HPA047372 Uncertain Not detected Not detected testis: 0.2 GGT6 FLJ90165 ENSG00000167741 Gamma-glutamyltransferase 6 17 4556927-4560818 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA023362, HPA027213 Approved Renal cancer:9.42e-7 (favourable), Lung cancer:4.35e-4 (favourable) Mixed Mixed colon: 55.8 GGTLC1 dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4 ENSG00000149435 Gamma-glutamyltransferase light chain 1 20 23985050-23988779 Predicted intracellular proteins Evidence at protein level HPA045635, HPA047534 Uncertain Tissue enriched Group enriched 14 lung: 38.8;testis: 15.7 thyroid gland: 1.9 GGTLC2 GGTL4 ENSG00000100121 Gamma-glutamyltransferase light chain 2 22 22644475-22647903 Predicted intracellular proteins Evidence at protein level HPA045635, HPA047534 Uncertain Not detected Tissue enriched 9 testis: 7.1 small intestine: 0.7 GID4 C17orf39, VID24 ENSG00000141034 GID complex subunit 4 homolog 17 18039292-18068404 Predicted intracellular proteins Evidence at protein level HPA044348 Uncertain Approved Cytosol Expressed in all Expressed in all testis: 62.5 GIMAP6 FLJ22690, IAN6 ENSG00000133561 GTPase, IMAP family member 6 7 150625375-150632648 Predicted intracellular proteins Evidence at protein level HPA026715, HPA050740 Uncertain Uncertain Nucleoplasm
Cytosol Liver cancer:1.56e-4 (favourable), Head and neck cancer:2.91e-4 (favourable), Endometrial cancer:3.12e-4 (favourable), Renal cancer:5.27e-4 (unfavourable) Expressed in all Mixed spleen: 89.4 GIMAP8 DKFZp667I133, hIAN6, IAN9 ENSG00000171115 GTPase, IMAP family member 8 7 150450630-150479392 Predicted intracellular proteins Evidence at protein level HPA014474, HPA017765 Supported Testis cancer:8.47e-4 (unfavourable) Expressed in all Mixed spleen: 56.8 GIN1 FLJ20125, GIN-1, TGIN1, ZH2C2 ENSG00000145723 Gypsy retrotransposon integrase 1 5 103086000-103120151 Predicted intracellular proteins Evidence at protein level HPA037402, HPA061362 Approved Approved Nucleus
Nucleoli Renal cancer:1.63e-4 (favourable) Expressed in all Mixed testis: 8.3 GINM1 C6orf72, dJ12G14.2 ENSG00000055211 Glycoprotein integral membrane 1 6 149566294-149591748 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017210, HPA041679 Approved Approved Nucleoli fibrillar center
Plasma membrane Expressed in all Expressed in all thyroid gland: 118.1 GJA10 CX62 ENSG00000135355 Gap junction protein, alpha 10, 62kDa 6 89894469-89896120 Predicted membrane proteins Evidence at protein level HPA021145 Uncertain Tissue enriched Not detected testis: 0.3 GJA9 CX58, CX59, GJA10 ENSG00000131233 Gap junction protein, alpha 9, 59kDa 1 38874451-38881587 Predicted membrane proteins Evidence at transcript level HPA067850 Uncertain Not detected Tissue enhanced testis: 2.2 skin: 0.5 GJB5 CX31.1 ENSG00000189280 Gap junction protein, beta 5, 31.1kDa 1 34755047-34758512 Cancer-related genes, Predicted membrane proteins Evidence at transcript level HPA038146 Uncertain Pancreatic cancer:1.54e-4 (unfavourable) Group enriched Group enriched 6 esophagus: 56.7;skin: 77.6 tonsil: 11.9 GJB7 bA136M9.1, CX25 ENSG00000164411 Gap junction protein, beta 7, 25kDa 6 87282978-87329278 Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced fallopian tube: 11.1;placenta: 3.8 testis: 1.5 GJC3 CX30.2, GJE1 ENSG00000176402 Gap junction protein, gamma 3, 30.2kDa 7 99923269-99929620 Predicted membrane proteins, Transporters Evidence at protein level HPA015024 Uncertain Group enriched Tissue enhanced breast: 8.9;prostate: 5.6 testis: 3.2 GJD4 CX40.1, FLJ90023 ENSG00000177291 Gap junction protein, delta 4, 40.1kDa 10 35605410-35608935 Predicted membrane proteins, Transporters Evidence at transcript level HPA038266 Approved Not detected Mixed cerebral cortex: 1.7 GK2 GKP2, GKTA ENSG00000196475 Glycerol kinase 2 4 79406352-79408293 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA060687 Uncertain Not detected Tissue enriched 1517 testis: 151.7 all non-specific tissues: 0.0 GK5 MGC40579 ENSG00000175066 Glycerol kinase 5 (putative) 3 142157527-142225607 Enzymes, Predicted intracellular proteins Evidence at protein level HPA042606, HPA057998 Approved Approved Nucleoplasm
Cytosol Expressed in all Mixed prostate: 12.7 GKN1 AMP18, BRICD1, CA11 ENSG00000169605 Gastrokine 1 2 68974573-68980974 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA047684 Supported Pancreatic cancer:1.54e-4 (unfavourable), Urothelial cancer:4.53e-4 (favourable) Tissue enriched Tissue enriched 1194 stomach: 31692.5 placenta: 26.5 GLB1L MGC10771 ENSG00000163521 Galactosidase, beta 1-like 2 219236606-219245478 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA043058 Supported Expressed in all Tissue enhanced testis: 95.1 fallopian tube: 36.8 GLB1L2 ENSG00000149328 Galactosidase, beta 1-like 2 11 134331874-134378341 Predicted secreted proteins Evidence at protein level HPA054808, HPA059955 Uncertain Supported Nucleus Mixed Tissue enhanced prostate: 57.3 parathyroid gland: 52.2 GLB1L3 FLJ90231 ENSG00000166105 Galactosidase, beta 1-like 3 11 134274245-134319564 Predicted intracellular proteins Evidence at protein level HPA039916 Uncertain Lung cancer:1.97e-4 (favourable) Tissue enhanced Tissue enhanced prostate: 18.8;seminal vesicle: 10.7 cerebral cortex: 4.0 GLDN CLOM, COLM, colmedin, CRG-L2, UNC-112 ENSG00000186417 Gliomedin 15 51341629-51408013 Predicted intracellular proteins Evidence at protein level HPA059441 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 24.0 adipose tissue: 12.9 GLIPR1L2 MGC39497 ENSG00000180481 GLI pathogenesis-related 1 like 2 12 75391070-75432688 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039795, HPA039866 Supported Mixed Tissue enriched 8 testis: 84.5 parathyroid gland: 11.0 GLIS1 FLJ36155 ENSG00000174332 GLIS family zinc finger 1 1 53506237-53738106 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA001409 Uncertain Tissue enhanced Tissue enhanced seminal vesicle: 10.8 prostate: 3.2 GLIS3 MGC33662, ZNF515 ENSG00000107249 GLIS family zinc finger 3 9 3824127-4348392 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA056426 Approved Supported Nucleoplasm Mixed Tissue enhanced thyroid gland: 34.8 fallopian tube: 17.0 GLP2R ENSG00000065325 Glucagon-like peptide 2 receptor 17 9822206-9892102 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level CAB022690, HPA049244 Supported Supported Plasma membrane Tissue enhanced Tissue enhanced gallbladder: 19.4 duodenum: 10.4 GLRA2 GLR ENSG00000101958 Glycine receptor, alpha 2 X 14529298-14731812 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level CAB070422 Approved Mixed Group enriched 10 cerebral cortex: 6.2;colon: 1.4;rectum: 4.3 testis: 0.3 GLT1D1 FLJ31978 ENSG00000151948 Glycosyltransferase 1 domain containing 1 12 128853427-128984968 Predicted intracellular proteins Evidence at protein level HPA039051, HPA039052 Validated Cytosol Group enriched Tissue enhanced cerebral cortex: 22.5;testis: 28.1 bone marrow: 18.6 GLT6D1 GLTDC1 ENSG00000204007 Glycosyltransferase 6 domain containing 1 9 135623656-135639540 Predicted secreted proteins Evidence at transcript level HPA023424 Uncertain Not detected Tissue enriched 41 testis: 8.3 epididymis: 0.2 GLT8D2 FLJ31494 ENSG00000120820 Glycosyltransferase 8 domain containing 2 12 103988984-104064183 Predicted intracellular proteins Evidence at protein level HPA026904 Approved Approved Cytosol Renal cancer:1.58e-6 (unfavourable), Cervical cancer:7.37e-4 (unfavourable), Stomach cancer:7.92e-4 (unfavourable) Expressed in all Mixed gallbladder: 57.3 GLYATL3 bA28H17.2, C6orf140 ENSG00000203972 Glycine-N-acyltransferase-like 3 6 49499958-49527047 Predicted intracellular proteins Evidence at transcript level HPA044044 Uncertain Tissue enhanced Not detected liver: 0.7 GML LY6DL ENSG00000104499 Glycosylphosphatidylinositol anchored molecule like 8 142834247-142916506 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 39 adrenal gland: 251.9 testis: 6.4 GNAS GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI ENSG00000087460 GNAS complex locus 20 58839718-58911192 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB010337, HPA018122, HPA027478, HPA028386 Uncertain Supported Nucleoplasm
Plasma membrane
Cytosol Renal cancer:3.49e-4 (unfavourable), Ovarian cancer:8.76e-4 (favourable) Expressed in all Expressed in all thyroid gland: 1471.9 GNAT2 ACHM4 ENSG00000134183 Guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 1 109603267-109619929 Disease related genes, Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 6 testis: 3.7 placenta: 0.6 GNAT3 GDCA, gustducin ENSG00000214415 Guanine nucleotide binding protein, alpha transducing 3 7 80458671-80512020 Predicted intracellular proteins Evidence at protein level Group enriched Tissue enhanced duodenum: 2.0;small intestine: 1.4 testis: 0.5 GNAZ ENSG00000128266 Guanine nucleotide binding protein (G protein), alpha z polypeptide 22 23070361-23125037 Predicted intracellular proteins Evidence at protein level HPA003011 Supported Approved Vesicles Endometrial cancer:4.85e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 49.8 seminal vesicle: 22.7 GNB5 GB5 ENSG00000069966 Guanine nucleotide binding protein (G protein), beta 5 15 52115105-52191369 Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level CAB032353, HPA041942, HPA044198 Uncertain Approved Nuclear speckles
Centrosome
Rods & Rings Renal cancer:3.32e-11 (favourable), Endometrial cancer:1.47e-6 (favourable) Expressed in all Mixed parathyroid gland: 73.1 GNGT2 GNG9 ENSG00000167083 Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 17 49202791-49210574 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level HPA043381 Supported Renal cancer:3.11e-4 (unfavourable) Mixed Mixed spleen: 26.7 GNRH2 ENSG00000125787 Gonadotropin-releasing hormone 2 20 3043622-3045747 Predicted secreted proteins Evidence at transcript level HPA004338 Uncertain Tissue enhanced Mixed ovary: 2.6 GOLGA6A GLP, GOLGA6 ENSG00000159289 Golgin A6 family, member A 15 74069857-74082550 Predicted intracellular proteins Evidence at protein level HPA044978, HPA050087 Supported Not detected Tissue enriched 9 testis: 21.4 liver: 2.4 GOLGA6L9 GOLGA6L20 ENSG00000197978 Golgin A6 family-like 9 15 82430018-82439153 Predicted intracellular proteins Evidence at transcript level Mixed Not detected stomach: 0.9 GOLGA7B bA451M19.3, bA459F3.4, C10orf132, C10orf133 ENSG00000155265 Golgin A7 family, member B 10 97850239-97871580 Predicted intracellular proteins Evidence at protein level HPA046878 Uncertain Mixed Group enriched 7 cerebral cortex: 18.4;epididymis: 28.1;skin: 17.4 adrenal gland: 3.1 GOLGA8A GM88, GOLGIN-67 ENSG00000175265 Golgin A8 family, member A 15 34379068-34437466 Predicted intracellular proteins Evidence at transcript level HPA051808 Approved Golgi apparatus
Cytosol Renal cancer:2.16e-6 (unfavourable), Urothelial cancer:5.68e-6 (favourable), Lung cancer:7.58e-4 (favourable) Expressed in all Mixed skin: 41.1 GOLGA8B ENSG00000215252 Golgin A8 family, member B 15 34525207-34588503 Predicted intracellular proteins Evidence at transcript level HPA051808 Approved Golgi apparatus
Cytosol Renal cancer:9.38e-6 (unfavourable), Urothelial cancer:5.79e-4 (favourable) Expressed in all Tissue enhanced thyroid gland: 47.6 testis: 23.5 GOLT1A CGI-141, FLJ42654, GOT1, MGC62027, YMR292W ENSG00000174567 Golgi transport 1A 1 204198160-204214092 Predicted membrane proteins Evidence at protein level Renal cancer:6.35e-5 (unfavourable), Urothelial cancer:1.51e-4 (favourable), Glioma:5.49e-4 (unfavourable) Tissue enriched Tissue enhanced duodenum: 41.5;liver: 78.8;small intestine: 43.2 parathyroid gland: 27.5 GOT1L1 MGC33309 ENSG00000169154 Glutamic-oxaloacetic transaminase 1-like 1 8 37934281-37940129 Predicted intracellular proteins Evidence at transcript level HPA028778 Uncertain Not detected Tissue enriched 26 testis: 21.3 ovary: 0.8 GP2 ENSG00000169347 Glycoprotein 2 (zymogen granule membrane) 16 20309572-20327808 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA015739, HPA016668 Supported Tissue enriched Tissue enriched 200 pancreas: 7528.0 duodenum: 37.5 GPAT2 CT123 ENSG00000186281 Glycerol-3-phosphate acyltransferase 2, mitochondrial 2 96021946-96039451 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036841 Uncertain Approved Mitochondria Mixed Mixed testis: 7.3 GPATCH3 FLJ12455, GPATC3 ENSG00000198746 G patch domain containing 3 1 26890488-26900466 Predicted intracellular proteins Evidence at protein level HPA032078, HPA054973 Approved Approved Nucleoplasm
Cytosol Liver cancer:1.23e-7 (unfavourable), Pancreatic cancer:6.42e-4 (favourable) Expressed in all Expressed in all bone marrow: 15.3 GPBAR1 BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5 ENSG00000179921 G protein-coupled bile acid receptor 1 2 218259496-218263859 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA062890 Approved Tissue enhanced Tissue enhanced gallbladder: 27.0;smooth muscle: 13.8 adipose tissue: 10.0 GPC2 cerebroglycan, DKFZp547M109, FLJ38962 ENSG00000213420 Glypican 2 7 100169606-100177372 Predicted secreted proteins Evidence at protein level CAB025423, HPA053945 Uncertain Uncertain Nucleus
Nucleoli
Golgi apparatus Urothelial cancer:9.94e-4 (favourable) Mixed Tissue enhanced skin: 5.7;testis: 10.1 cerebral cortex: 3.4 GPC5 ENSG00000179399 Glypican 5 13 91398607-92873682 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA040152, HPA044081 Supported Approved Nucleus
Cytosol Glioma:5.67e-4 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 15.9;kidney: 8.1;testis: 11.5 lung: 4.9 GPR108 LUSTR2 ENSG00000125734 G protein-coupled receptor 108 19 6729914-6737603 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA041924, HPA041951, HPA063863 Uncertain Supported Golgi apparatus
Vesicles Renal cancer:1.29e-9 (favourable), Endometrial cancer:1.04e-7 (favourable) Expressed in all Expressed in all parathyroid gland: 73.7 GPR135 HUMNPIIY20, PAFR ENSG00000181619 G protein-coupled receptor 135 14 59429022-59465342 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA045337 Uncertain Mixed Tissue enhanced testis: 9.1 fallopian tube: 5.0 GPR137 C11orf4, GPR137A, TM7SF1L1 ENSG00000173264 G protein-coupled receptor 137 11 64270062-64289500 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA062871 Uncertain Approved Nucleus
Nucleoli
Actin filaments Liver cancer:5.34e-4 (unfavourable), Pancreatic cancer:6.18e-4 (favourable) Expressed in all Expressed in all testis: 147.8 GPR137B TM7SF1 ENSG00000077585 G protein-coupled receptor 137B 1 236142505-236221865 Predicted membrane proteins, Transporters Evidence at protein level HPA026422 Approved Colorectal cancer:1.63e-4 (unfavourable) Expressed in all Mixed kidney: 70.2 GPR137C DKFZp762F0713, TM7SF1L2 ENSG00000180998 G protein-coupled receptor 137C 14 52553148-52637713 Predicted membrane proteins Evidence at transcript level HPA003640, HPA030763 Uncertain Approved Vesicles Mixed Tissue enhanced cerebral cortex: 18.0;epididymis: 10.5 testis: 8.2 GPR139 PGR3 ENSG00000180269 G protein-coupled receptor 139 16 20031485-20073917 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA046596 Uncertain Not detected Not detected endometrium: 0.3 GPR141 PGR13 ENSG00000187037 G protein-coupled receptor 141 7 37683796-37833788 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced bone marrow: 18.7 appendix: 5.8 GPR142 PGR2 ENSG00000257008 G protein-coupled receptor 142 17 74367407-74372622 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA031392 Uncertain Uncertain Plasma membrane
Cell Junctions
Cytosol Tissue enhanced Not detected appendix: 0.1 GPR146 PGR8 ENSG00000164849 G protein-coupled receptor 146 7 1044576-1059261 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Mixed Expressed in all adipose tissue: 35.4 GPR148 PGR6 ENSG00000173302 G protein-coupled receptor 148 2 130729070-130730336 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA060527 Uncertain Not detected Not detected stomach: 0.4 GPR149 IEDA, PGR10 ENSG00000174948 G protein-coupled receptor 149 3 154337672-154429715 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA018020 Uncertain Not detected Tissue enriched 6 seminal vesicle: 2.9 testis: 0.4 GPR15 ENSG00000154165 G protein-coupled receptor 15 3 98531899-98533150 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA013775 Approved Mixed Tissue enhanced colon: 25.7;rectum: 47.8 urinary bladder: 19.1 GPR151 GALR4, PGR7 ENSG00000173250 G protein-coupled receptor 151 5 146513103-146516190 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected cerebral cortex: 0.2 GPR152 PGR5 ENSG00000175514 G protein-coupled receptor 152 11 67451301-67452729 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA035078 Uncertain Not detected Not detected parathyroid gland: 0.2 GPR153 PGR1 ENSG00000158292 G protein-coupled receptor 153 1 6247346-6260975 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA007159 Approved Endometrial cancer:3.07e-4 (unfavourable), Lung cancer:3.75e-4 (unfavourable) Expressed in all Mixed cervix, uterine: 17.3 GPR155 DEP.7, DEPDC3, FLJ31819, PGR22 ENSG00000163328 G protein-coupled receptor 155 2 174431571-174487094 Predicted membrane proteins Evidence at protein level HPA036159, HPA057384 Approved Approved Nuclear bodies
Cytosol Expressed in all Expressed in all stomach: 44.0 GPR156 GABABL, PGR28 ENSG00000175697 G protein-coupled receptor 156 3 120164645-120285094 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA028642, HPA028644 Uncertain Supported Plasma membrane Mixed Tissue enhanced testis: 5.1 fallopian tube: 1.8 GPR157 FLJ12132 ENSG00000180758 G protein-coupled receptor 157 1 9100305-9129170 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA028697 Uncertain Uncertain Nucleoli
Plasma membrane
Cell Junctions Expressed in all Mixed parathyroid gland: 23.9 GPR160 GPCR1, GPCR150 ENSG00000173890 G protein-coupled receptor 160 3 170037929-170085403 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA006970 Approved Supported Plasma membrane Renal cancer:4.93e-7 (favourable), Lung cancer:1.21e-4 (favourable), Urothelial cancer:3.61e-4 (favourable) Expressed in all Tissue enhanced parathyroid gland: 426.5 small intestine: 111.2 GPR161 RE2 ENSG00000143147 G protein-coupled receptor 161 1 168079543-168137667 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level HPA015576, HPA072047 Uncertain Approved Nucleus
Nucleoli Mixed Tissue enhanced smooth muscle: 39.8 endometrium: 28.5 GPR162 A-2, GRCA ENSG00000250510 G protein-coupled receptor 162 12 6821545-6829972 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA055135 Supported Approved Microtubule organizing center Renal cancer:1.37e-6 (unfavourable), Pancreatic cancer:4.29e-5 (favourable) Tissue enriched Group enriched 6 cerebral cortex: 84.5;fallopian tube: 29.1 lung: 9.6 GPR17 ENSG00000144230 G protein-coupled receptor 17 2 127645864-127652639 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA029766 Approved Approved Vesicles Tissue enriched Mixed spleen: 12.3 GPR171 H963 ENSG00000174946 G protein-coupled receptor 171 3 151197832-151203201 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA062429 Approved Mixed Tissue enhanced appendix: 30.7 lymph node: 21.8 GPR173 SREB3 ENSG00000184194 G protein-coupled receptor 173 X 53049091-53080615 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA003905 Approved Plasma membrane
Cytosol Endometrial cancer:2.88e-6 (unfavourable), Pancreatic cancer:2.33e-5 (favourable), Renal cancer:2.47e-4 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 19.1 ovary: 9.0 GPR174 FKSG79 ENSG00000147138 G protein-coupled receptor 174 X 79170972-79172229 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA041025 Supported Uncertain Vesicles Mixed Tissue enhanced lymph node: 30.2;spleen: 16.9;tonsil: 17.8 appendix: 13.1 GPR176 Gm1012 ENSG00000166073 G protein-coupled receptor 176 15 39799023-39920892 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA039943, HPA039979 Approved Renal cancer:9.38e-7 (unfavourable), Stomach cancer:6.84e-5 (unfavourable) Expressed in all Mixed cerebral cortex: 19.1 GPR18 ENSG00000125245 G protein-coupled receptor 18 13 99254714-99261744 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA013873 Supported Mixed Tissue enhanced lymph node: 52.2;testis: 25.1;tonsil: 32.9 appendix: 17.0 GPR180 ITR ENSG00000152749 G protein-coupled receptor 180 13 94601903-94634645 Predicted membrane proteins Evidence at protein level HPA047250 Approved Approved Vesicles Renal cancer:3.18e-5 (unfavourable) Expressed in all Mixed adipose tissue: 6.3 GPR182 ADMR, AM-R, G10D, hrhAMR ENSG00000166856 G protein-coupled receptor 182 12 56994446-56998441 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA027037 Supported Not detected Tissue enhanced spleen: 12.4;testis: 6.6 liver: 2.0 GPR19 ENSG00000183150 G protein-coupled receptor 19 12 12660891-12696207 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA013955 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 8.5;testis: 7.7 appendix: 2.8 GPR21 ENSG00000188394 G protein-coupled receptor 21 9 123034527-123035696 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA041651 Uncertain Not detected Tissue enhanced cerebral cortex: 2.1 endometrium: 0.9 GPR22 ENSG00000172209 G protein-coupled receptor 22 7 107470018-107475659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Group enriched 13 adrenal gland: 2.4;cerebral cortex: 9.5;cervix, uterine: 6.3;endometrium: 5.0;heart muscle: 11.9 smooth muscle: 0.5 GPR27 SREB1 ENSG00000170837 G protein-coupled receptor 27 3 71754050-71756496 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA029395 Approved Approved Nucleoplasm
Plasma membrane
Actin filaments
Cytosol Ovarian cancer:1.21e-6 (favourable), Breast cancer:5.63e-4 (favourable) Mixed Tissue enhanced parathyroid gland: 45.7 cerebral cortex: 24.9 GPR31 12-HETER, HETER1 ENSG00000120436 G protein-coupled receptor 31 6 167156271-167158329 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA014014, HPA027108 Uncertain Not detected Tissue enhanced lymph node: 1.6 epididymis,spleen: 0.9 GPR32 RVDR1 ENSG00000142511 G protein-coupled receptor 32 19 50770464-50771732 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA030330 Approved Not detected Tissue enriched 98 parathyroid gland: 254.8 placenta: 2.5 GPR33 ENSG00000214943 G protein-coupled receptor 33 (gene/pseudogene) 14 31482964-31487945 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected spleen: 0.4 GPR34 ENSG00000171659 G protein-coupled receptor 34 X 41688973-41697277 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA010668, CAB025490 Uncertain Uncertain Nucleus
Cytosol Expressed in all Mixed placenta: 60.4 GPR35 ENSG00000178623 G protein-coupled receptor 35 2 240605431-240631259 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Renal cancer:2.59e-5 (unfavourable), Lung cancer:5.86e-4 (unfavourable) Tissue enhanced Tissue enhanced duodenum: 42.6;small intestine: 43.2 colon: 18.8 GPR4 ENSG00000177464 G protein-coupled receptor 4 19 45589764-45602208 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA014278 Uncertain Renal cancer:2.07e-5 (unfavourable), Lung cancer:9.19e-4 (unfavourable) Expressed in all Mixed adipose tissue: 10.3 GPR45 PSP24, PSP24A ENSG00000135973 G protein-coupled receptor 45 2 105241743-105243049 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA055940 Uncertain Not detected Tissue enhanced cerebral cortex: 1.8 testis: 0.5 GPR52 ENSG00000203737 G protein-coupled receptor 52 1 174448111-174449198 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA028575 Uncertain Not detected Tissue enriched 7 cerebral cortex: 2.7 bone marrow: 0.3 GPR61 BALGR ENSG00000156097 G protein-coupled receptor 61 1 109539872-109548406 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA007326, HPA026088 Approved Not detected Tissue enhanced cerebral cortex: 3.4;thyroid gland: 1.2 adrenal gland: 1.0 GPR62 ENSG00000180929 G protein-coupled receptor 62 3 51955314-51957504 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enriched 13 cerebral cortex: 8.0 ovary: 0.6 GPR63 PSP24(beta), PSP24B ENSG00000112218 G protein-coupled receptor 63 6 96794126-96837463 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA039103 Approved Approved Nucleus
Plasma membrane
Cytosol Mixed Mixed testis: 4.6 GPR65 hTDAG8, TDAG8 ENSG00000140030 G protein-coupled receptor 65 14 88005124-88014811 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA054454 Approved Cytosol Renal cancer:4.99e-4 (unfavourable) Mixed Mixed spleen: 13.5 GPR82 ENSG00000171657 G protein-coupled receptor 82 X 41724155-41730135 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA035914 Approved Mixed Tissue enhanced tonsil: 6.7 lymph node: 3.7 GPR83 GPR72 ENSG00000123901 G protein-coupled receptor 83 11 94377311-94401419 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Mixed Group enriched 5 adrenal gland: 1.0;cerebral cortex: 4.6;thyroid gland: 5.2 epididymis,testis: 0.6 GPR84 EX33 ENSG00000139572 G protein-coupled receptor 84 12 54362445-54364487 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA027603 Supported Mixed Tissue enhanced appendix: 11.9;bone marrow: 14.7 adipose tissue: 5.9 GPR87 GPR95 ENSG00000138271 G protein-coupled receptor 87 3 151294086-151316952 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA066313 Approved Nucleoplasm
Lipid droplets
Mitochondria Pancreatic cancer:4.62e-6 (unfavourable) Group enriched Tissue enhanced esophagus: 29.4;skin: 29.8 placenta: 11.9 GPR88 ENSG00000181656 G protein-coupled receptor 88 1 100538137-100542018 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA007488 Uncertain Approved Tissue enriched Group enriched 12 breast: 9.7;cerebral cortex: 3.1;liver: 5.1;ovary: 3.4;parathyroid gland: 7.9;spleen: 14.7 adipose tissue,prostate: 0.6 GPRC5B RAIG-2 ENSG00000167191 G protein-coupled receptor, class C, group 5, member B 16 19856691-19886167 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015247 Approved Supported Nucleus
Nucleoli
Vesicles Colorectal cancer:9.27e-5 (unfavourable), Renal cancer:6.30e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 309.2 testis: 66.5 GPRC5D ENSG00000111291 G protein-coupled receptor, class C, group 5, member D 12 12940775-12952147 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA071909 Approved Head and neck cancer:5.09e-4 (favourable) Mixed Mixed testis: 5.2 GPRIN1 GRIN1, KIAA1893 ENSG00000169258 G protein regulated inducer of neurite outgrowth 1 5 176595802-176610133 Predicted intracellular proteins Evidence at protein level HPA036478, HPA070892 Supported Supported Vesicles
Plasma membrane Renal cancer:2.79e-7 (unfavourable), Lung cancer:6.83e-6 (unfavourable) Expressed in all Tissue enriched 7 cerebral cortex: 27.9 duodenum: 3.9 GPRIN3 FLJ42625, GRIN3 ENSG00000185477 GPRIN family member 3 4 89236386-89308010 Predicted intracellular proteins Evidence at protein level HPA043148, HPA057666, HPA059092 Uncertain Approved Nucleus
Nucleoli Colorectal cancer:7.22e-5 (favourable), Renal cancer:8.33e-4 (favourable) Mixed Mixed appendix: 12.3 GPX6 GPXP3 ENSG00000198704 Glutathione peroxidase 6 6 28503296-28528215 Enzymes, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 12 epididymis: 4.1 testis: 0.3 GRAMD2 ENSG00000175318 GRAM domain containing 2 15 72159807-72197785 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA029435 Uncertain Approved Nucleoli
Nuclear speckles
Cytosol Thyroid cancer:7.01e-4 (unfavourable) Mixed Tissue enhanced epididymis: 45.7;placenta: 69.4 lung: 23.6 GREB1 KIAA0575 ENSG00000196208 Growth regulation by estrogen in breast cancer 1 2 11482341-11642788 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA024616, HPA027843, HPA028416 Uncertain Approved Mitochondria
Cytosol Endometrial cancer:1.05e-4 (favourable) Tissue enhanced Tissue enhanced ovary: 156.7 prostate: 54.3 GREB1L C18orf6, FLJ13687, KIAA1772 ENSG00000141449 Growth regulation by estrogen in breast cancer-like 18 21242242-21525417 Predicted intracellular proteins Evidence at protein level HPA041647, HPA044218 Uncertain Approved Nucleoli
Mitochondria Mixed Tissue enhanced testis: 11.4 thyroid gland: 5.8 GREM2 CKTSF1B2, DAND3, FLJ21195, Prdc ENSG00000180875 Gremlin 2, DAN family BMP antagonist 1 240489573-240612149 Predicted secreted proteins Evidence at protein level CAB009920 Approved Mixed Tissue enhanced gallbladder: 49.0;parathyroid gland: 77.1 rectum: 22.9 GRIA4 GluA4, GLUR4, GLURD ENSG00000152578 Glutamate receptor, ionotropic, AMPA 4 11 105609994-105982092 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Group enriched Tissue enriched 10 cerebral cortex: 73.4 adrenal gland: 7.4 GRID1 GluD1, KIAA1220 ENSG00000182771 Glutamate receptor, ionotropic, delta 1 10 85599555-86366493 Predicted membrane proteins Evidence at protein level Group enriched Tissue enhanced cerebral cortex: 7.7 thyroid gland: 3.4 GRID2 GluD2, GluR-delta-2 ENSG00000152208 Glutamate receptor, ionotropic, delta 2 4 92303622-93774556 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA056253, HPA058538 Approved Tissue enriched Tissue enriched 10 testis: 59.7 cerebral cortex: 5.9 GRIFIN ENSG00000275572 Galectin-related inter-fiber protein 7 2474844-2476894 Predicted intracellular proteins Evidence at transcript level Not detected Not detected skin: 0.7 GRIK3 GluK3, GLUR7 ENSG00000163873 Glutamate receptor, ionotropic, kainate 3 1 36795527-37034129 Plasma proteins, Predicted membrane proteins Evidence at protein level Tissue enhanced Tissue enriched 6 cerebral cortex: 19.8 seminal vesicle: 3.5 GRIK4 GluK4, GRIK, KA1 ENSG00000149403 Glutamate receptor, ionotropic, kainate 4 11 120511759-120988904 Predicted membrane proteins, Transporters Evidence at transcript level Tissue enriched Tissue enhanced cerebral cortex: 10.6 thyroid gland: 2.8 GRIK5 GluK5, GRIK2, KA2 ENSG00000105737 Glutamate receptor, ionotropic, kainate 5 19 41998321-42069498 Predicted membrane proteins Evidence at protein level Pancreatic cancer:7.23e-4 (favourable), Renal cancer:9.32e-4 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 30.9;parathyroid gland: 21.7 testis: 19.2 GRIN3B GluN3B ENSG00000116032 Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B 19 1000419-1009732 FDA approved drug targets, Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced fallopian tube: 2.1;spleen: 1.2 lung: 0.7 GRINA HNRGW, LFG1, NMDARA1, TMBIM3 ENSG00000178719 Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) 8 143990058-143993415 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA036980, HPA036981 Approved Approved Nucleoli fibrillar center
Cytosol Expressed in all Expressed in all seminal vesicle: 261.5 GRM4 GPRC1D, mGlu4, MGLUR4 ENSG00000124493 Glutamate receptor, metabotropic 4 6 34018645-34155622 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB022096 Supported Tissue enhanced Tissue enhanced cerebral cortex: 2.9 testis: 0.7 GRM8 GLUR8, GPRC1H, mGlu8, MGLUR8 ENSG00000179603 Glutamate receptor, metabotropic 8 7 126438598-127253294 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA051481 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 4.1 testis: 2.9 GRPR BB2 ENSG00000126010 Gastrin-releasing peptide receptor X 16123556-16153021 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA069604 Validated Plasma membrane Tissue enhanced Tissue enhanced pancreas: 4.2 breast: 2.6 GSC2 GSCL ENSG00000063515 Goosecoid homeobox 2 22 19148576-19150283 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043011 Uncertain Not detected Tissue enriched 31 testis: 3.0 all non-specific tissues: 0.0 GSDMB GSDML, PRO2521 ENSG00000073605 Gasdermin B 17 39904595-39919854 Predicted intracellular proteins Evidence at protein level CAB013681, HPA023925, HPA052407 Supported Renal cancer:5.13e-11 (unfavourable), Urothelial cancer:5.91e-9 (favourable), Cervical cancer:3.41e-5 (favourable) Expressed in all Tissue enhanced duodenum: 68.8;small intestine: 86.7 rectum: 63.5 GSDMC MLZE ENSG00000147697 Gasdermin C 8 129748196-129786888 Predicted intracellular proteins Evidence at protein level HPA023670, HPA024767, HPA026317 Supported Validated Mitochondria Group enriched Tissue enhanced esophagus: 20.1;skin: 44.4;spleen: 21.9 tonsil: 6.7 GSX1 Gsh-1, GSH1 ENSG00000169840 GS homeobox 1 13 27792643-27794768 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047096 Uncertain Tissue enriched Not detected cerebral cortex: 0.7 GSX2 Gsh2 ENSG00000180613 GS homeobox 2 4 54099523-54102505 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Not detected testis: 0.4 GTDC1 FLJ11753, Hmat-Xa ENSG00000121964 Glycosyltransferase-like domain containing 1 2 143938068-144332568 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA036694 Uncertain Approved Cytosol Renal cancer:6.60e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 29.5 GTF2H4 P52, TFB2, TFIIH ENSG00000213780 General transcription factor IIH, polypeptide 4, 52kDa 6 30908184-30914106 Predicted intracellular proteins Evidence at protein level HPA074336 Supported Nuclear speckles Renal cancer:4.08e-4 (unfavourable) Expressed in all Mixed appendix: 3.7 GTPBP8 HSPC135 ENSG00000163607 GTP-binding protein 8 (putative) 3 112990918-113015060 Predicted intracellular proteins Evidence at protein level HPA034831, HPA058631 Approved Validated Mitochondria Renal cancer:3.07e-5 (favourable) Expressed in all Expressed in all testis: 32.8 GTSF1L C20orf65, dJ1028D15.4, FAM112A ENSG00000124196 Gametocyte specific factor 1-like 20 43726164-43726998 Predicted intracellular proteins Evidence at protein level HPA054694 Supported Tissue enriched Tissue enriched 156 testis: 267.7 lymph node: 1.7 GUCY1A2 GC-SA2, GUC1A2 ENSG00000152402 Guanylate cyclase 1, soluble, alpha 2 11 106674012-107018524 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level CAB009534 Uncertain Renal cancer:3.02e-5 (unfavourable) Mixed Tissue enhanced placenta: 25.4 endometrium: 21.0 GUCY2F CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2 ENSG00000101890 Guanylate cyclase 2F, retinal X 109372906-109482072 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Not detected Not detected fallopian tube,testis: 0.4 GVQW1 bA205M20.5, TIGD1L2 ENSG00000241043 GVQW motif containing 1 9 32566789-32568621 Predicted secreted proteins Evidence at transcript level HPA074576 Approved Mitochondria Mixed Mixed parathyroid gland: 2.5 GXYLT2 GLT8D4 ENSG00000172986 Glucoside xylosyltransferase 2 3 72888073-72998138 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA068429 Uncertain Approved Nucleoplasm
Cytokinetic bridge
Midbody ring Renal cancer:1.46e-7 (unfavourable), Urothelial cancer:2.42e-5 (unfavourable) Mixed Mixed ovary: 20.5 GYPE GPE, MNS ENSG00000197465 Glycophorin E (MNS blood group) 4 143870867-143905563 Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced bone marrow: 8.1 lung: 4.5 H1FNT H1T2, HANP1 ENSG00000187166 H1 histone family, member N, testis-specific 12 48328980-48330279 Predicted intracellular proteins Evidence at protein level HPA046204 Approved Not detected Tissue enriched 352 testis: 77.7 cerebral cortex: 0.2 H1FOO ENSG00000178804 H1 histone family, member O, oocyte-specific 3 129543214-129551467 Predicted intracellular proteins Evidence at transcript level HPA037992 Uncertain Not detected Tissue enriched 59 testis: 5.8 all non-specific tissues: 0.0 H2AFB1 ENSG00000274183 H2A histone family, member B1 X 154884972-154885558 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 9 testis: 4.3 bone marrow,skin: 0.4 H2AFB2 ENSG00000277858 H2A histone family, member B2 X 155380787-155381134 Predicted intracellular proteins Evidence at transcript level Not detected Not detected duodenum: 0.6 H2AFB3 H2AFB ENSG00000277745 H2A histone family, member B3 X 155459415-155460005 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 55 testis: 18.5 spleen: 0.3 HAGHL MGC2605 ENSG00000103253 Hydroxyacylglutathione hydrolase-like 16 726936-735525 Predicted intracellular proteins Evidence at transcript level Renal cancer:1.18e-5 (favourable) Expressed in all Tissue enhanced cerebral cortex: 9.1 spleen: 4.5 HAND1 bHLHa27, eHand, Hxt, Thing1 ENSG00000113196 Heart and neural crest derivatives expressed 1 5 154474972-154478264 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA040925 Approved Uncertain Nucleus
Nuclear membrane Group enriched Tissue enhanced smooth muscle: 16.6 adrenal gland: 6.3 HAPLN1 CRTL1 ENSG00000145681 Hyaluronan and proteoglycan link protein 1 5 83637805-83721613 Predicted secreted proteins Evidence at protein level HPA019105, HPA019482 Supported Supported Vesicles Renal cancer:4.81e-9 (unfavourable) Mixed Tissue enriched 8 placenta: 102.5 cerebral cortex: 12.8 HAPLN2 BRAL1 ENSG00000132702 Hyaluronan and proteoglycan link protein 2 1 156619294-156625725 Predicted secreted proteins Evidence at protein level HPA045765 Supported Tissue enriched Tissue enriched 46 cerebral cortex: 42.2 duodenum: 0.9 HAPLN3 EXLD1, HsT19883 ENSG00000140511 Hyaluronan and proteoglycan link protein 3 15 88877288-88895626 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA039237 Uncertain Approved Plasma membrane
Cytosol Renal cancer:4.18e-13 (unfavourable) Expressed in all Tissue enhanced appendix: 14.3;lymph node: 11.0 spleen: 4.0 HAPLN4 BRAL2, KIAA1926 ENSG00000187664 Hyaluronan and proteoglycan link protein 4 19 19255641-19262796 Predicted secreted proteins Evidence at protein level HPA055856 Approved Not detected Group enriched 7 cerebral cortex: 8.5;duodenum: 15.7;small intestine: 21.7 cervix, uterine: 2.1 HAS2 ENSG00000170961 Hyaluronan synthase 2 8 121612116-121641390 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level HPA052060 Approved Nuclear speckles Mixed Tissue enhanced adipose tissue: 27.7 appendix: 12.9 HAS3 ENSG00000103044 Hyaluronan synthase 3 16 69105564-69118719 Enzymes, Predicted membrane proteins Evidence at protein level HPA031554, CAB033850 Supported Approved Microtubules Pancreatic cancer:5.36e-4 (unfavourable) Group enriched Tissue enhanced lung: 29.9;urinary bladder: 37.7 stomach: 12.1 HBM HBAP2, HBK ENSG00000206177 Hemoglobin, mu 16 153892-166768 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 30 bone marrow: 269.9 placenta: 9.1 HCN3 KIAA1535 ENSG00000143630 Hyperpolarization activated cyclic nucleotide gated potassium channel 3 1 155277583-155289848 Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level HPA026584 Approved Urothelial cancer:6.93e-4 (favourable), Renal cancer:7.49e-4 (unfavourable) Expressed in all Mixed liver,skin: 3.0 HCRTR1 OX1R ENSG00000121764 Hypocretin (orexin) receptor 1 1 31617686-31632518 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA014018 Approved Not detected Mixed adrenal gland: 1.2 HDGFL1 dJ309H15.1, PWWP1 ENSG00000112273 Hepatoma derived growth factor-like 1 6 22569493-22571666 Predicted intracellular proteins Evidence at protein level HPA045679, HPA063707 Supported Tissue enriched Tissue enriched 1391 testis: 139.0 all non-specific tissues: 0.0 HEATR4 MGC48595 ENSG00000187105 HEAT repeat containing 4 14 73478484-73558947 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 5 testis: 23.2 skin: 4.5 HEATR9 C17orf66, FLJ32830 ENSG00000270379 HEAT repeat containing 9 17 35854946-35868891 Predicted intracellular proteins Evidence at transcript level HPA023129 Uncertain Not detected Tissue enriched 34 testis: 9.9 spleen: 0.2 HECTD2 FLJ37306 ENSG00000165338 HECT domain containing E3 ubiquitin protein ligase 2 10 91409280-91514829 Predicted intracellular proteins Evidence at protein level HPA037767 Approved Approved Nucleoplasm Renal cancer:1.67e-5 (unfavourable) Mixed Mixed prostate: 26.7 HELT bHLHb44, HCM1228, HESL, MEGANE, Mgn ENSG00000187821 Helt bHLH transcription factor 4 185018841-185020804 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA036188, HPA036189 Uncertain Not detected Not detected lung: 0.5 HEPH CPL, KIAA0698 ENSG00000089472 Hephaestin X 66162549-66268867 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA005824 Approved Renal cancer:7.00e-6 (unfavourable), Glioma:6.23e-4 (unfavourable) Expressed in all Mixed smooth muscle: 117.4 HEPHL1 DKFZp686F22190 ENSG00000181333 Hephaestin-like 1 11 94021361-94113751 Predicted membrane proteins Evidence at protein level HPA031517 Uncertain Cervical cancer:4.94e-4 (unfavourable) Tissue enriched Group enriched 11 esophagus: 3.2;tonsil: 9.8 testis: 0.6 HERC6 FLJ20637 ENSG00000138642 HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 4 88378739-88443111 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA035846 Uncertain Supported Nucleus
Cytosol Renal cancer:7.14e-5 (favourable) Expressed in all Expressed in all esophagus: 22.9 HES2 bHLHb40 ENSG00000069812 Hes family bHLH transcription factor 2 1 6412418-6424670 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA039462 Uncertain Mixed Tissue enhanced skin: 17.0 placenta: 9.8 HES4 bHLHb42 ENSG00000188290 Hes family bHLH transcription factor 4 1 998962-1000172 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062465 Approved Nucleoplasm
Vesicles
Cytosol Liver cancer:2.99e-4 (unfavourable), Endometrial cancer:3.85e-4 (favourable), Renal cancer:6.27e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 7.5 HES5 bHLHb38 ENSG00000197921 Hes family bHLH transcription factor 5 1 2528745-2530245 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065458 Approved Nucleoplasm
Nuclear speckles
Cytosol Tissue enhanced Tissue enhanced cerebral cortex: 1.8 skin: 0.9 HES6 bHLHb41 ENSG00000144485 Hes family bHLH transcription factor 6 2 238238267-238240662 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA061763 Approved Nucleus
Nucleoli
Nuclear bodies
Cytosol Lung cancer:9.18e-5 (favourable), Liver cancer:2.79e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 77.0 fallopian tube: 22.1 HEXDC FLJ23825 ENSG00000169660 Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing 17 82418318-82442645 Enzymes, Predicted intracellular proteins Evidence at protein level HPA022834, HPA023379, HPA027844 Uncertain Approved Nucleoli fibrillar center
Mitochondria Urothelial cancer:2.52e-5 (favourable), Head and neck cancer:2.71e-4 (favourable), Pancreatic cancer:5.57e-4 (favourable), Cervical cancer:7.70e-4 (favourable) Expressed in all Expressed in all spleen: 25.9 HHATL C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3 ENSG00000010282 Hedgehog acyltransferase-like 3 42692663-42702827 Predicted membrane proteins Evidence at protein level HPA018174 Supported Tissue enhanced Tissue enhanced heart muscle: 333.2;skeletal muscle: 97.6 cerebral cortex: 53.4 HHIPL1 KIAA1822 ENSG00000182218 HHIP-like 1 14 99645110-99680569 Predicted secreted proteins Evidence at transcript level HPA052767 Approved Mixed Tissue enhanced cerebral cortex: 6.6 smooth muscle: 2.6 HHLA1 PLA2L ENSG00000132297 HERV-H LTR-associating 1 8 132061486-132111159 Predicted secreted proteins Evidence at transcript level Not detected Not detected placenta: 0.1 HIAT1 DKFZP564L0864 ENSG00000156875 Hippocampus abundant transcript 1 1 100038097-100083377 Predicted membrane proteins Evidence at transcript level HPA073681 Approved Vesicles Liver cancer:2.08e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 197.2 HIATL1 FLJ14753 ENSG00000148110 Hippocampus abundant transcript-like 1 9 94374551-94461042 Predicted membrane proteins, Transporters Evidence at protein level HPA017978 Approved Nucleoplasm
Cytosol Expressed in all Expressed in all parathyroid gland: 251.1 HIATL2 MGC12945 ENSG00000196312 Hippocampus abundant transcript-like 2 9 96898066-97013580 Predicted membrane proteins Evidence at transcript level Expressed in all Mixed testis: 10.4 HIST1H1T H1FT, H1t ENSG00000187475 Histone cluster 1, H1t 6 26107419-26108136 Predicted intracellular proteins Evidence at protein level HPA065718, HPA068266 Supported Not detected Tissue enriched 7 testis: 1.4 appendix,breast,prostate: 0.1 HIVEP3 FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C ENSG00000127124 Human immunodeficiency virus type I enhancer binding protein 3 1 41506365-42035925 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005728 Approved Approved Nucleoplasm Mixed Mixed skin: 5.7 HKR1 ZNF875 ENSG00000181666 HKR1, GLI-Kruppel zinc finger family member 19 37312837-37369365 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036126, HPA044855 Approved Supported Nucleoplasm
Golgi apparatus
Mitochondria Prostate cancer:5.18e-5 (unfavourable), Pancreatic cancer:4.41e-4 (favourable) Expressed in all Expressed in all thyroid gland: 54.4 HLA-F ENSG00000204642 Major histocompatibility complex, class I, F 6 29722775-29738528 Plasma proteins, Predicted membrane proteins Evidence at protein level Renal cancer:2.67e-4 (unfavourable) Expressed in all Tissue enhanced lymph node: 40.6 duodenum: 28.3 HLF MGC33822 ENSG00000108924 Hepatic leukemia factor 17 55265012-55325065 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA068156, HPA071210 Validated Nucleus Lung cancer:2.71e-7 (favourable), Renal cancer:3.55e-6 (favourable), Head and neck cancer:1.88e-4 (favourable) Tissue enhanced Mixed cerebral cortex: 65.6 HMGXB3 HMGX3, KIAA0194, SMF ENSG00000113716 HMG box domain containing 3 5 150000046-150053142 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005967 Approved Nucleoli Liver cancer:3.37e-5 (unfavourable) Expressed in all Tissue enriched 11 parathyroid gland: 278.2 prostate: 26.2 HMP19 ENSG00000170091 HMP19 protein 5 174045604-174243501 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA056191 Supported Approved Golgi apparatus Tissue enriched Tissue enriched 7 cerebral cortex: 289.3 adrenal gland: 42.2 HMSD ACC-6, ACC6, C18orf53 ENSG00000221887 Histocompatibility (minor) serpin domain containing 18 63949301-63981774 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Tissue enhanced Mixed lymph node: 1.9 HMX1 H6, NKX5-3 ENSG00000215612 H6 family homeobox 1 4 8846076-8871817 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced cerebral cortex: 1.1 testis: 0.9 HMX2 NKX5-2 ENSG00000188816 H6 family homeobox 2 10 123148122-123150672 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043379 Uncertain Tissue enhanced Tissue enriched 6 kidney: 1.2 duodenum: 0.2 HNRNPA1L2 LOC144983 ENSG00000139675 Heterogeneous nuclear ribonucleoprotein A1-like 2 13 52640786-52643796 Predicted intracellular proteins Evidence at protein level Breast cancer:2.58e-4 (favourable), Pancreatic cancer:4.26e-4 (favourable) Expressed in all Mixed ovary: 5.9 HNRNPCL1 HNRPCL1 ENSG00000179172 Heterogeneous nuclear ribonucleoprotein C-like 1 1 12847377-12947578 Predicted intracellular proteins Evidence at protein level Not detected Not detected testis: 0.1 HNRNPCL2 HNRNPCP5 ENSG00000275774 Heterogeneous nuclear ribonucleoprotein C-like 2 1 13115496-13116854 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.1 HNRNPCL3 ENSG00000277058 Heterogeneous nuclear ribonucleoprotein C-like 3 1 13060869-13062229 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 HORMAD1 CT46, DKFZP434A1315 ENSG00000143452 HORMA domain containing 1 1 150698060-150720888 Predicted intracellular proteins Evidence at protein level HPA028346, HPA037850 Supported Approved Nucleoplasm Tissue enhanced Tissue enriched 25 testis: 223.6 skin: 8.8 HOXA11 HOX1, HOX1I ENSG00000005073 Homeobox A11 7 27181510-27185223 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006770, HPA035623 Supported Supported Nucleoplasm Renal cancer:2.57e-5 (unfavourable) Mixed Tissue enhanced endometrium: 96.0;smooth muscle: 67.7 cervix, uterine: 18.3 HOXA4 HOX1, HOX1D ENSG00000197576 Homeobox A4 7 27128507-27130799 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060088 Approved Validated Nuclear bodies Endometrial cancer:6.37e-4 (unfavourable) Mixed Tissue enhanced fallopian tube: 36.8;parathyroid gland: 34.7 esophagus: 16.4 HOXA6 HOX1, HOX1B ENSG00000106006 Homeobox A6 7 27145396-27150603 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA004203 Approved Endometrial cancer:1.40e-4 (unfavourable), Renal cancer:2.03e-4 (favourable) Mixed Tissue enhanced fallopian tube: 10.1 endometrium: 9.0 HOXA7 HOX1, HOX1A ENSG00000122592 Homeobox A7 7 27153716-27157936 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074048 Approved Nucleoplasm
Nuclear membrane Renal cancer:1.15e-5 (favourable), Endometrial cancer:7.87e-5 (unfavourable) Mixed Mixed epididymis: 22.3 HOXB3 HOX2, HOX2G ENSG00000120093 Homeobox B3 17 48548870-48604912 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009860, HPA064990 Approved Supported Nucleus Urothelial cancer:8.45e-6 (favourable) Mixed Tissue enhanced epididymis: 85.0 fallopian tube: 39.8 HOXB4 HOX2, HOX2F ENSG00000182742 Homeobox B4 17 48575513-48580111 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA057432 Uncertain Approved Nucleus
Centrosome Ovarian cancer:2.23e-4 (unfavourable) Mixed Tissue enhanced epididymis: 15.9 fallopian tube: 12.4 HOXB8 HOX2, HOX2D ENSG00000120068 Homeobox B8 17 48611377-48614939 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA075905 Supported Nucleoplasm Renal cancer:1.30e-7 (favourable) Tissue enhanced Tissue enhanced epididymis: 67.4;seminal vesicle: 32.6 cervix, uterine: 16.9 HOXC6 HOX3, HOX3C ENSG00000197757 Homeobox C6 12 53990624-54030823 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054981 Supported Nucleoplasm
Cytosol Renal cancer:3.55e-6 (unfavourable) Mixed Mixed epididymis: 22.0 HOXD1 HOX4, HOX4G ENSG00000128645 Homeobox D1 2 176188579-176190907 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA040062, HPA056900 Supported Nucleoplasm Tissue enhanced Tissue enhanced epididymis: 8.6;fallopian tube: 7.4 lung: 4.6 HOXD4 HOX4, HOX4B ENSG00000170166 Homeobox D4 2 176151222-176153226 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054383, HPA070349 Approved Validated Nucleus
Cell Junctions Tissue enhanced Tissue enhanced endometrium: 23.5;epididymis: 22.6 fallopian tube: 15.4 HOXD8 HOX4, HOX4E ENSG00000175879 Homeobox D8 2 176129694-176132695 Predicted intracellular proteins, Transcription factors Evidence at transcript level Lung cancer:3.78e-4 (unfavourable) Mixed Tissue enhanced epididymis: 121.2;kidney: 83.6 ovary: 43.6 HPR ENSG00000261701 Haptoglobin-related protein 16 72063224-72077246 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA047750 Supported Approved Vesicles Tissue enriched Tissue enriched 29 liver: 443.2 heart muscle: 15.4 HRH2 ENSG00000113749 Histamine receptor H2 5 175658030-175686242 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA013770 Approved Tissue enhanced Tissue enhanced bone marrow: 26.4 placenta: 17.9 HS3ST4 3OST4 ENSG00000182601 Heparan sulfate (glucosamine) 3-O-sulfotransferase 4 16 25692026-26137688 Enzymes, Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 7 cerebral cortex: 18.7 breast: 2.7 HS6ST2 ENSG00000171004 Heparan sulfate 6-O-sulfotransferase 2 X 132626016-132961395 Predicted membrane proteins Evidence at protein level HPA034625, HPA034626 Uncertain Validated Nucleoplasm Urothelial cancer:6.03e-4 (favourable) Mixed Tissue enhanced kidney: 14.9;ovary: 17.6 placenta: 11.9 HS6ST3 ENSG00000185352 Heparan sulfate 6-O-sulfotransferase 3 13 96090839-96839562 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA051513 Approved Nucleus
Nucleoli fibrillar center Renal cancer:6.12e-5 (favourable) Mixed Tissue enhanced cerebral cortex: 27.8 urinary bladder: 6.2 HSD11B1L SCDR10, SDR26C2 ENSG00000167733 Hydroxysteroid (11-beta) dehydrogenase 1-like 19 5680604-5688523 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA049078 Approved Vesicles Head and neck cancer:4.38e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 25.7 fallopian tube: 8.0 HSF5 FLJ40311 ENSG00000176160 Heat shock transcription factor family member 5 17 58420167-58488384 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063613 Supported Not detected Tissue enriched 64 testis: 94.4 lymph node: 1.4 HTR1F 5-HT1F, HTR1EL ENSG00000179097 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled 3 87990696-87993835 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA005555 Uncertain Not detected Tissue enhanced placenta: 2.7 cerebral cortex: 1.0 HTR5A 5-HT5A ENSG00000157219 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 7 155070324-155085749 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level CAB017467 Approved Not detected Tissue enriched 11 cerebral cortex: 8.6 testis: 0.7 HTRA4 FLJ90724 ENSG00000169495 HtrA serine peptidase 4 8 38974164-38988662 Enzymes, Predicted secreted proteins Evidence at protein level HPA045402 Approved Tissue enhanced Tissue enriched 20 placenta: 94.4 bone marrow: 4.8 IER5 ENSG00000162783 Immediate early response 5 1 181088712-181092899 Predicted intracellular proteins Evidence at protein level HPA029894 Uncertain Approved Supported Nucleus
Nucleoli Endometrial cancer:2.42e-7 (favourable), Lung cancer:1.18e-4 (unfavourable), Renal cancer:2.36e-4 (unfavourable) Expressed in all Mixed bone marrow: 31.2 IER5L bA247A12.2 ENSG00000188483 Immediate early response 5-like 9 129175552-129178262 Predicted intracellular proteins Evidence at transcript level HPA021327 Approved Approved Nucleus Lung cancer:1.48e-6 (unfavourable) Expressed in all Mixed endometrium: 5.9 IFFO1 HOM-TES-103, IFFO ENSG00000010295 Intermediate filament family orphan 1 12 6538375-6556083 Predicted intracellular proteins Evidence at protein level HPA069344 Approved Renal cancer:7.47e-7 (unfavourable), Pancreatic cancer:6.53e-5 (favourable) Expressed in all Mixed spleen: 12.2 IFFO2 ENSG00000169991 Intermediate filament family orphan 2 1 18904281-18956686 Predicted intracellular proteins Evidence at protein level HPA015987, HPA064603 Approved Approved Nucleoplasm
Plasma membrane Expressed in all Expressed in all skin: 72.6 IFI27L2 FAM14A, TLH29 ENSG00000119632 Interferon, alpha-inducible protein 27-like 2 14 94127779-94130253 Predicted secreted proteins Evidence at protein level HPA049588 Approved Nucleoli
Cytosol Expressed in all Expressed in all adrenal gland: 47.7 IFI44 MTAP44, p44, TLDC5 ENSG00000137965 Interferon-induced protein 44 1 78649796-78664078 Predicted intracellular proteins Evidence at protein level HPA027148, HPA043858 Approved Approved Nucleoplasm Renal cancer:1.37e-8 (unfavourable) Expressed in all Expressed in all spleen: 90.2 IFI44L C1orf29, GS3686 ENSG00000137959 Interferon-induced protein 44-like 1 78619922-78646145 Predicted intracellular proteins Evidence at protein level HPA053247, HPA060372 Approved Approved Nucleoplasm Renal cancer:1.06e-4 (unfavourable), Endometrial cancer:2.95e-4 (unfavourable), Glioma:5.08e-4 (favourable) Expressed in all Mixed spleen: 32.9 IFI6 6-16, FAM14C, G1P3, IFI-6-16, IFI616 ENSG00000126709 Interferon, alpha-inducible protein 6 1 27666061-27672218 Predicted membrane proteins Evidence at transcript level HPA005543 Approved Approved Mitochondria Expressed in all Expressed in all placenta: 412.1 IFIT1B bA149I23.6, IFIT1L ENSG00000204010 Interferon-induced protein with tetratricopeptide repeats 1B 10 89378056-89385205 Predicted intracellular proteins Evidence at protein level HPA062924 Approved Not detected Group enriched 97 bone marrow: 15.3;placenta: 4.1 all non-specific tissues: 0.0 IFITM10 ENSG00000244242 Interferon induced transmembrane protein 10 11 1732410-1750591 Predicted membrane proteins Evidence at transcript level Expressed in all Tissue enhanced adrenal gland: 12.7;cerebral cortex: 12.0 seminal vesicle: 4.0 IFNA16 IFN-alphaO ENSG00000147885 Interferon, alpha 16 9 21216373-21217311 Predicted secreted proteins Evidence at transcript level HPA047557 Uncertain Not detected Not detected all non-specific tissues: 0.0 IFNE IFNE1 ENSG00000184995 Interferon, epsilon 9 21480839-21482313 Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced epididymis: 1.0 urinary bladder: 0.9 IFNL2 IL-28A, IL28A ENSG00000183709 Interferon, lambda 2 19 39268514-39270092 Predicted secreted proteins Evidence at transcript level CAB025489 Uncertain Not detected Not detected pancreas,testis: 0.1 IFT22 DKFZp761N0823, FLJ13225, FLJ14117, RABL5 ENSG00000128581 Intraflagellar transport 22 7 101313367-101321823 Predicted intracellular proteins Evidence at protein level HPA042930 Approved Approved Microtubules
Cytosol Expressed in all Expressed in all testis: 138.8 IFT52 C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5 ENSG00000101052 Intraflagellar transport 52 20 43590931-43647296 Predicted intracellular proteins Evidence at protein level HPA063367, HPA067423 Supported Approved Cytosol Liver cancer:3.30e-6 (unfavourable), Testis cancer:3.33e-4 (favourable) Expressed in all Expressed in all fallopian tube: 60.6 IFT88 D13S1056E, hTg737, MGC26259, Tg737, TTC10 ENSG00000032742 Intraflagellar transport 88 13 20567069-20691437 Predicted intracellular proteins Evidence at protein level Renal cancer:1.33e-4 (favourable), Pancreatic cancer:5.17e-4 (favourable) Expressed in all Expressed in all testis: 125.9 IGDCC3 HsT18880, PUNC ENSG00000174498 Immunoglobulin superfamily, DCC subclass, member 3 15 65327127-65378040 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA015246 Approved Tissue enhanced Group enriched 5 cerebral cortex: 3.3;parathyroid gland: 14.4;placenta: 8.5;testis: 5.2 thyroid gland: 1.5 IGFBPL1 bA113O24.1 ENSG00000137142 Insulin-like growth factor binding protein-like 1 9 38408994-38424447 Predicted secreted proteins Evidence at protein level HPA051354 Uncertain Approved Nucleoplasm
Vesicles Mixed Tissue enriched 8 thyroid gland: 31.3 cerebral cortex: 3.9 IGFL2 UNQ645 ENSG00000204866 IGF-like family member 2 19 46143106-46161299 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA059137 Uncertain Approved Nucleoplasm
Plasma membrane Mixed Tissue enriched 6 skin: 35.5 parathyroid gland: 5.7 IGFL4 ENSG00000204869 IGF-like family member 4 19 46039748-46077118 Predicted intracellular proteins Evidence at transcript level HPA047655 Approved Approved Cytosol Mixed Tissue enhanced skin: 8.1 parathyroid gland: 3.2 IGLL5 ENSG00000254709 Immunoglobulin lambda-like polypeptide 5 22 22887780-22896107 Predicted intracellular proteins Evidence at protein level Renal cancer:5.94e-8 (unfavourable), Head and neck cancer:3.41e-5 (favourable), Breast cancer:6.10e-4 (favourable) Expressed in all Tissue enhanced tonsil: 868.7 urinary bladder: 660.2 IGLON5 LOC402665 ENSG00000142549 IgLON family member 5 19 51311848-51330354 Predicted secreted proteins Evidence at protein level HPA041994 Approved Uncertain Nucleus Renal cancer:5.62e-7 (unfavourable) Tissue enhanced Group enriched 7 adrenal gland: 2.3;cerebral cortex: 11.1;testis: 9.5 seminal vesicle: 1.1 IGSF10 CMF608, FLJ25972 ENSG00000152580 Immunoglobulin superfamily, member 10 3 151425384-151458709 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA012921 Uncertain Approved Nucleoplasm
Intermediate filaments Mixed Tissue enhanced ovary: 18.1 gallbladder: 14.8 IGSF11 BT-IgSF, CT119, Igsf13, MGC35227, VSIG3 ENSG00000144847 Immunoglobulin superfamily, member 11 3 118900557-119146068 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA046377 Uncertain Approved Nucleus
Cell Junctions
Cytosol Group enriched Tissue enhanced cerebral cortex: 31.1;testis: 64.7 ovary: 20.0 IGSF21 MGC15730, RP11-121A23.1 ENSG00000117154 Immunoglobin superfamily, member 21 1 18107746-18378483 Predicted secreted proteins Evidence at protein level HPA044535 Approved Group enriched Tissue enhanced cerebral cortex: 29.0;spleen: 13.4 adrenal gland: 5.9 IGSF22 FLJ37794, IGFN2 ENSG00000179057 Immunoglobulin superfamily, member 22 11 18704305-18726230 Predicted intracellular proteins Evidence at protein level CAB026459 Uncertain Mixed Tissue enhanced skin: 1.2;testis: 1.0 cerebral cortex: 0.8 IGSF23 ENSG00000216588 Immunoglobulin superfamily, member 23 19 44613630-44636781 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA051811, HPA054591 Uncertain Approved Nucleus
Cell Junctions Liver cancer:7.20e-6 (favourable) Tissue enriched Group enriched 7 duodenum: 15.6;liver: 13.1;small intestine: 17.8 testis: 2.3 IGSF3 EWI-3, MGC117164, V8 ENSG00000143061 Immunoglobulin superfamily, member 3 1 116574399-116667755 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036305, HPA036306 Approved Approved Nucleoplasm
Cytosol Renal cancer:2.87e-6 (favourable), Liver cancer:4.03e-6 (unfavourable), Endometrial cancer:1.98e-4 (unfavourable), Pancreatic cancer:2.03e-4 (unfavourable) Expressed in all Mixed skin: 21.6 IGSF5 JAM4 ENSG00000183067 Immunoglobulin superfamily, member 5 21 39745407-39802096 Predicted membrane proteins Evidence at transcript level HPA057282 Uncertain Tissue enhanced Mixed placenta: 3.7 IGSF6 DORA ENSG00000140749 Immunoglobulin superfamily, member 6 16 21639537-21652660 Predicted membrane proteins Evidence at protein level HPA041023, HPA041072 Uncertain Endometrial cancer:1.54e-5 (favourable), Cervical cancer:4.92e-4 (favourable) Expressed in all Tissue enhanced spleen: 64.7 appendix: 37.2 IGSF9B KIAA1030 ENSG00000080854 Immunoglobulin superfamily, member 9B 11 133908564-133956985 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA010744, HPA010802 Uncertain Approved Cytosol Mixed Mixed cerebral cortex: 9.0 IL17B IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7 ENSG00000127743 Interleukin 17B 5 149371324-149404202 Cancer-related genes, Predicted secreted proteins Evidence at protein level HPA042441 Uncertain Mixed Tissue enhanced breast: 4.1 smooth muscle: 3.5 IL17D FLJ30846, IL-17D, IL-22, IL-27, IL27 ENSG00000172458 Interleukin 17D 13 20702127-20723098 Predicted secreted proteins Evidence at protein level Group enriched Tissue enhanced cerebral cortex: 100.5 skeletal muscle: 45.9 IL17REL FLJ41993 ENSG00000188263 Interleukin 17 receptor E-like 22 49994513-50012659 Predicted intracellular proteins Evidence at transcript level HPA045546 Approved Mixed Tissue enhanced appendix: 3.2;lymph node: 2.4;tonsil: 4.1 stomach: 2.1 IL1F10 FKSG75, IL-1F10, IL-1HY2, IL1-theta, MGC11983, MGC119832, MGC119833 ENSG00000136697 Interleukin 1 family, member 10 (theta) 2 113067970-113075850 Predicted intracellular proteins Evidence at protein level HPA059813 Approved Tissue enhanced Group enriched 5 skin: 4.8;tonsil: 2.6 breast: 0.6 IL1RAPL2 IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1 ENSG00000189108 Interleukin 1 receptor accessory protein-like 2 X 104566315-105767829 Predicted membrane proteins Evidence at protein level HPA036128, HPA036129 Uncertain Not detected Tissue enhanced parathyroid gland: 4.7 adrenal gland: 1.9 IL27RA CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1 ENSG00000104998 Interleukin 27 receptor, alpha 19 14031748-14053216 Predicted membrane proteins Evidence at protein level HPA047188 Approved Vesicles
Cytosol Renal cancer:2.58e-10 (unfavourable), Breast cancer:1.74e-6 (favourable) Expressed in all Mixed tonsil: 31.5 IL31 IL-31 ENSG00000204671 Interleukin 31 12 122172030-122174199 Predicted secreted proteins Evidence at transcript level CAB025657 Approved Not detected Not detected testis: 0.3 IL36B FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882 ENSG00000136696 Interleukin 36, beta 2 113022091-113052867 Predicted intracellular proteins Evidence at transcript level HPA035664 Uncertain Tissue enhanced Tissue enhanced esophagus: 2.2;skin: 7.4;tonsil: 3.5 breast: 1.2 IL9 HP40, IL-9, P40 ENSG00000145839 Interleukin 9 5 135892246-135895827 Cancer-related genes, Predicted secreted proteins Evidence at transcript level Not detected Tissue enhanced cerebral cortex: 1.7 skin: 0.5 IL9R CD129 ENSG00000124334 Interleukin 9 receptor X 155997581-156010817 CD markers, Predicted membrane proteins Evidence at protein level CAB010497 Uncertain Urothelial cancer:1.90e-7 (favourable) Tissue enhanced Tissue enhanced urinary bladder: 8.8 lymph node: 2.9 ILDR2 C1orf32 ENSG00000143195 Immunoglobulin-like domain containing receptor 2 1 166895711-166975482 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA012545 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 11.4;testis: 17.4 kidney: 3.0 IMMP1L FLJ25059, IMMP1 ENSG00000148950 Inner mitochondrial membrane peptidase subunit 1 11 31432401-31509645 Enzymes, Predicted intracellular proteins Evidence at protein level Pancreatic cancer:6.72e-4 (favourable), Liver cancer:7.97e-4 (unfavourable) Expressed in all Expressed in all epididymis: 44.8 IMMP2L IMMP2L-IT1, IMP2 ENSG00000184903 Inner mitochondrial membrane peptidase subunit 2 7 110663051-111562517 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA026711 Approved Approved Mitochondria Head and neck cancer:1.89e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 39.4 INHBC ENSG00000175189 Inhibin, beta C 12 57434760-57450828 Plasma proteins, Predicted secreted proteins Evidence at protein level Tissue enriched Tissue enriched 42 liver: 85.8 testis: 2.0 INPP4B ENSG00000109452 Inositol polyphosphate-4-phosphatase type II B 4 142023160-142847432 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA037681, HPA037682 Approved Approved Centrosome Pancreatic cancer:1.03e-4 (unfavourable) Mixed Mixed testis: 33.1 INS-IGF2 ENSG00000129965 INS-IGF2 readthrough 11 2132538-2161209 Predicted secreted proteins Evidence at protein level CAB019430 Supported Not detected Group enriched 5 pancreas: 1.6;placenta: 4.6 adrenal gland,endometrium,ovary: 0.5 INSL6 RIF1 ENSG00000120210 Insulin-like 6 9 5131979-5185668 Predicted secreted proteins Evidence at protein level HPA021364 Supported Not detected Tissue enriched 38 testis: 21.7 placenta: 0.5 INTU KIAA1284, PDZD6, PDZK6 ENSG00000164066 Inturned planar cell polarity protein 4 127623271-127726737 Predicted intracellular proteins Evidence at transcript level HPA036714, HPA036715 Approved Approved Vesicles Mixed Mixed epididymis: 8.3 IPP KLHL27 ENSG00000197429 Intracisternal A particle-promoted polypeptide 1 45694324-45750650 Plasma proteins, Predicted intracellular proteins Evidence at protein level Renal cancer:1.11e-4 (favourable), Liver cancer:2.27e-4 (unfavourable), Colorectal cancer:9.11e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 19.4 IQCA1 DRC11, FLJ22527, IQCA ENSG00000132321 IQ motif containing with AAA domain 1 2 236324147-236507542 Predicted intracellular proteins Evidence at transcript level HPA057320 Uncertain Nucleus Renal cancer:2.54e-4 (favourable) Tissue enhanced Tissue enhanced fallopian tube: 17.7;thyroid gland: 32.1 cerebral cortex: 11.5 IQCC FLJ10547 ENSG00000160051 IQ motif containing C 1 32205661-32208687 Predicted intracellular proteins Evidence at protein level HPA028602, HPA028686 Approved Supported Vesicles Pancreatic cancer:8.23e-5 (favourable), Testis cancer:3.79e-4 (favourable), Lung cancer:5.65e-4 (favourable) Expressed in all Mixed testis: 11.8 IQCD CFAP84, DRC10 ENSG00000166578 IQ motif containing D 12 113195441-113221094 Predicted intracellular proteins Evidence at protein level HPA046810, HPA048782 Uncertain Approved Nucleus Pancreatic cancer:3.90e-4 (favourable) Mixed Group enriched 6 fallopian tube: 34.5;testis: 65.3 parathyroid gland: 7.7 IQCF1 MGC39725 ENSG00000173389 IQ motif containing F1 3 51894876-51903335 Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enriched 573 testis: 57.2 all non-specific tissues: 0.0 IQCF3 ENSG00000229972 IQ motif containing F3 3 51817604-51830856 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 245 testis: 72.1 cerebral cortex,epididymis: 0.2 IQCF5 ENSG00000214681 IQ motif containing F5 3 51873721-51875584 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 721 testis: 72.0 all non-specific tissues: 0.0 IQCH FLJ12476 ENSG00000103599 IQ motif containing H 15 67254800-67502260 Predicted intracellular proteins Evidence at protein level HPA040845 Uncertain Approved Cytosol Mixed Tissue enhanced fallopian tube: 10.7;testis: 21.0 thyroid gland: 6.9 IQCJ ENSG00000214216 IQ motif containing J 3 158962928-159266307 Predicted intracellular proteins Evidence at transcript level HPA052835 Uncertain Not detected Not detected testis: 0.8 IQCK FLJ36575, MGC35048 ENSG00000174628 IQ motif containing K 16 19716456-19858467 Predicted intracellular proteins Evidence at transcript level HPA026792, HPA048786 Approved Approved Nuclear speckles
Cytosol Mixed Mixed testis: 34.5 IQSEC3 KIAA1110, MGC30156 ENSG00000120645 IQ motif and Sec7 domain 3 12 66765-178460 Predicted intracellular proteins Evidence at protein level Tissue enhanced Tissue enhanced cerebral cortex: 16.2 fallopian tube: 5.4 IRGC CINEMA, Iigp5, IRGC1 ENSG00000124449 Immunity-related GTPase family, cinema 19 43716010-43720021 Predicted intracellular proteins Evidence at protein level HPA046769, HPA060064 Supported Not detected Tissue enriched 629 testis: 62.9 all non-specific tissues: 0.0 IRX1 IRX-5 ENSG00000170549 Iroquois homeobox 1 5 3596054-3601403 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043160 Uncertain Supported Nucleoplasm
Golgi apparatus Group enriched Tissue enhanced breast: 7.7;kidney: 5.3;salivary gland: 5.7 lung: 3.6 IRX3 IRX-1 ENSG00000177508 Iroquois homeobox 3 16 54283304-54286763 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062522 Approved Vesicles Expressed in all Tissue enhanced breast: 95.2 skin: 70.3 IRX6 IRX-3, IRX7 ENSG00000159387 Iroquois homeobox 6 16 55323760-55330760 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA018332 Uncertain Approved Nucleus
Mitochondria Lung cancer:3.34e-4 (favourable) Tissue enhanced Tissue enhanced adipose tissue: 8.6 heart muscle: 4.0 ISLR HsT17563 ENSG00000129009 Immunoglobulin superfamily containing leucine-rich repeat 15 74173671-74176872 Predicted secreted proteins Evidence at protein level HPA040326, HPA050811 Approved Approved Golgi apparatus
Plasma membrane Renal cancer:4.89e-8 (unfavourable) Expressed in all Mixed endometrium: 198.5 ISLR2 KIAA1465 ENSG00000167178 Immunoglobulin superfamily containing leucine-rich repeat 2 15 74100311-74138540 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA012930, HPA067333 Uncertain Mixed Group enriched 5 cerebral cortex: 31.2;testis: 15.2 endometrium: 4.5 ISM1 bA149I18.1, C20orf82 ENSG00000101230 Isthmin 1, angiogenesis inhibitor 20 13221771-13300651 Predicted secreted proteins Evidence at protein level Renal cancer:9.32e-6 (unfavourable) Expressed in all Tissue enhanced thyroid gland: 74.2 placenta: 24.7 ISM2 FLJ32147, TAIL1, THSD3 ENSG00000100593 Isthmin 2 14 77474394-77498850 Predicted secreted proteins Evidence at protein level HPA039314, HPA039742 Supported Supported Nucleoplasm Mixed Tissue enriched 114 placenta: 272.7 epididymis: 2.3 ISX RAXLX ENSG00000175329 Intestine-specific homeobox 22 35066136-35087387 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060328 Approved Supported Nucleoplasm
Nuclear bodies Tissue enhanced Group enriched 37 colon: 27.9;duodenum: 38.5;rectum: 28.6;small intestine: 30.3 smooth muscle: 0.8 ITGA10 ENSG00000143127 Integrin, alpha 10 1 145891208-145910189 Plasma proteins, Predicted membrane proteins Evidence at transcript level HPA064008 Approved Endoplasmic reticulum Breast cancer:7.18e-4 (favourable) Tissue enhanced Mixed cervix, uterine: 8.1 ITGB8 ENSG00000105855 Integrin, beta 8 7 20330702-20415754 Cancer-related genes, Predicted membrane proteins Evidence at protein level HPA027796, HPA027797 Approved Approved Plasma membrane
Cytosol Renal cancer:1.77e-4 (favourable) Mixed Mixed cerebral cortex: 30.9 ITGBL1 OSCP, TIED ENSG00000198542 Integrin, beta-like 1 (with EGF-like repeat domains) 13 101452593-101720856 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA005676 Uncertain Urothelial cancer:2.70e-4 (unfavourable) Mixed Tissue enhanced gallbladder: 60.1 placenta: 46.8 ITIH6 ITIH5L, UNQ6369 ENSG00000102313 Inter-alpha-trypsin inhibitor heavy chain family, member 6 X 54748899-54798240 Predicted secreted proteins Evidence at protein level HPA000506 Uncertain Tissue enriched Not detected prostate: 0.6 ITLN2 HL-2 ENSG00000158764 Intelectin 2 1 160945025-160954799 Predicted secreted proteins Evidence at protein level HPA006683 Approved Tissue enhanced Group enriched 20 duodenum: 251.5;small intestine: 463.3 lung: 18.3 IZUMO2 C19orf41, MGC33947, SCRL ENSG00000161652 IZUMO family member 2 19 50152548-50163195 Predicted membrane proteins, Transporters Evidence at transcript level HPA042143 Uncertain Not detected Tissue enriched 255 testis: 55.9 skin,thyroid gland: 0.2 IZUMO4 C19orf36 ENSG00000099840 IZUMO family member 4 19 2096429-2099593 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA045099, HPA048496 Approved Uncertain Nucleoplasm
Vesicles Pancreatic cancer:1.69e-4 (favourable), Endometrial cancer:7.08e-4 (favourable) Mixed Tissue enriched 52 testis: 341.4 ovary: 6.5 JAKMIP3 bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2 ENSG00000188385 Janus kinase and microtubule interacting protein 3 10 132104671-132184809 Predicted membrane proteins Evidence at protein level HPA022872 Uncertain Mixed Tissue enhanced cerebral cortex: 5.8 prostate: 2.0 JKAMP C14orf100, CDA06, HSPC213, HSPC327, JAMP ENSG00000050130 JNK1/MAPK8-associated membrane protein 14 59484443-59505410 Cancer-related genes, Predicted membrane proteins Evidence at protein level HPA031172, HPA071650 Supported Approved Nucleoplasm
Vesicles Liver cancer:3.09e-6 (unfavourable), Renal cancer:1.36e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 74.7 JMJD8 C16orf20 ENSG00000161999 Jumonji domain containing 8 16 681671-684528 Predicted secreted proteins Evidence at transcript level Expressed in all Expressed in all parathyroid gland: 59.8 JPH3 CAGL237, HDL2, JP-3, JP3, TNRC22 ENSG00000154118 Junctophilin 3 16 87601835-87698156 Disease related genes, Predicted membrane proteins Evidence at protein level HPA076304 Approved Nucleoplasm
Cytosol Mixed Tissue enriched 22 cerebral cortex: 43.4 adrenal gland: 2.0 JPH4 JPHL1, KIAA1831 ENSG00000092051 Junctophilin 4 14 23568035-23578800 Predicted membrane proteins Evidence at transcript level CAB013492, HPA054232 Approved Nucleoplasm
Golgi apparatus Tissue enhanced Tissue enhanced cerebral cortex: 107.4;seminal vesicle: 51.4 endometrium: 28.0 JRKL HHMJG ENSG00000183340 JRK-like 11 96389989-96507574 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA046184 Uncertain Approved Vesicles Expressed in all Expressed in all parathyroid gland: 19.1 KAAG1 RU2, RU2AS ENSG00000146049 Kidney associated antigen 1 6 24356903-24358284 Predicted intracellular proteins Evidence at transcript level HPA036021 Approved Mixed Not detected kidney,thyroid gland: 0.5 KANK4 ANKRD38, KIAA0172 ENSG00000132854 KN motif and ankyrin repeat domains 4 1 62236979-62319414 Predicted intracellular proteins Evidence at protein level HPA014030 Uncertain Uncertain Microtubules
Cytosol Mixed Tissue enhanced parathyroid gland: 28.9;placenta: 16.3 adipose tissue: 11.8 KATNAL2 DKFZP667C165, MGC33211 ENSG00000167216 Katanin p60 subunit A-like 2 18 46917492-47102243 Enzymes, Predicted intracellular proteins Evidence at protein level HPA040712, HPA042029 Approved Approved Nucleoplasm
Intermediate filaments Renal cancer:1.24e-7 (favourable) Mixed Tissue enhanced parathyroid gland: 45.5 testis: 33.0 KBTBD12 FLJ46299, KLHDC6 ENSG00000187715 Kelch repeat and BTB (POZ) domain containing 12 3 127915232-127987671 Predicted intracellular proteins Evidence at protein level Mixed Group enriched 9 heart muscle: 8.0;skeletal muscle: 20.3 fallopian tube,stomach: 1.5 KBTBD3 BKLHD3 ENSG00000182359 Kelch repeat and BTB (POZ) domain containing 3 11 106051098-106077765 Predicted intracellular proteins Evidence at protein level HPA047385 Uncertain Renal cancer:3.42e-7 (favourable) Mixed Mixed cerebral cortex: 7.7 KBTBD8 KIAA1842, TA-KRP ENSG00000163376 Kelch repeat and BTB (POZ) domain containing 8 3 66998307-67011210 Predicted intracellular proteins Evidence at protein level HPA041285, HPA069190 Approved Mixed Tissue enhanced lymph node: 24.6;tonsil: 19.7 testis: 14.6 KCNA6 ENSG00000151079 Potassium voltage-gated channel subfamily A member 6 12 4809176-4813412 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level CAB011539, HPA014418 Approved Not detected Not detected appendix,duodenum,lymph node: 0.1 KCNA7 HAK6, Kv1.7 ENSG00000104848 Potassium channel, voltage gated shaker related subfamily A, member 7 19 49067418-49072941 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Not detected Tissue enriched 37 skeletal muscle: 26.2 esophagus: 0.7 KCNAB3 AKR6A9, KCNA3B ENSG00000170049 Potassium channel, voltage gated subfamily A regulatory beta subunit 3 17 7921859-7929803 Predicted intracellular proteins Evidence at protein level HPA077993 Approved Mitochondria Mixed Tissue enhanced endometrium: 14.5;smooth muscle: 8.5 cerebral cortex: 4.7 KCNB2 Kv2.2 ENSG00000182674 Potassium channel, voltage gated Shab related subfamily B, member 2 8 72537391-72938349 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA065970 Approved Nucleoli
Plasma membrane
Midbody Not detected Tissue enhanced cerebral cortex: 3.2;spleen: 3.4 fallopian tube,testis: 0.7 KCNH4 elk1, Kv12.3 ENSG00000089558 Potassium channel, voltage gated eag related subfamily H, member 4 17 42156891-42181278 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Not detected Tissue enhanced cerebral cortex: 1.8 appendix: 0.7 KCNH7 erg3, HERG3, Kv11.3 ENSG00000184611 Potassium channel, voltage gated eag related subfamily H, member 7 2 162371407-162838730 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA018039 Uncertain Not detected Tissue enriched 6 cerebral cortex: 4.7 testis: 0.7 KCNH8 elk3, Kv12.1 ENSG00000183960 Potassium channel, voltage gated eag related subfamily H, member 8 3 19148454-19535646 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Mixed Tissue enhanced cerebral cortex: 4.8 adrenal gland: 2.3 KCNJ16 BIR9, Kir5.1 ENSG00000153822 Potassium channel, inwardly rectifying subfamily J, member 16 17 70053429-70135608 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level HPA059563 Approved Uncertain Vesicles Renal cancer:9.61e-7 (favourable), Thyroid cancer:6.58e-4 (favourable) Group enriched Group enriched 7 kidney: 207.9;parathyroid gland: 268.8;thyroid gland: 233.9 seminal vesicle: 31.9 KCNJ9 GIRK3, Kir3.3 ENSG00000162728 Potassium channel, inwardly rectifying subfamily J, member 9 1 160081570-160090563 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA070478 Supported Tissue enriched Tissue enriched 112 cerebral cortex: 52.5 adrenal gland,testis: 0.4 KCNK12 K2p12.1, THIK-2, THIK2 ENSG00000184261 Potassium channel, two pore domain subfamily K, member 12 2 47516581-47570939 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Tissue enriched Tissue enriched 16 cerebral cortex: 5.3 placenta,testis: 0.3 KCNK13 K2p13.1, THIK-1, THIK1 ENSG00000152315 Potassium channel, two pore domain subfamily K, member 13 14 90061765-90185857 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level HPA003514 Approved Approved Nuclear speckles
Cell Junctions Mixed Tissue enhanced parathyroid gland: 14.3;testis: 14.4 kidney: 3.3 KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, two pore domain subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level HPA043892 Uncertain Mixed Tissue enhanced lung: 5.6 placenta: 5.2 KCNK7 K2p7.1 ENSG00000173338 Potassium channel, two pore domain subfamily K, member 7 11 65592855-65595996 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Voltage-gated ion channels Evidence at transcript level HPA077577 Approved Plasma membrane Tissue enhanced Tissue enriched 7 skin: 53.1 esophagus: 8.0 KCNN1 hSK1, KCa2.1 ENSG00000105642 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1 19 17951293-18000080 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA065938 Approved Actin filaments
Cytosol Tissue enhanced Tissue enriched 10 cerebral cortex: 21.5 testis: 2.0 KCNN3 hSK3, KCa2.3, SKCA3 ENSG00000143603 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 1 154697455-154870280 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA017990, HPA057127 Uncertain Approved Nucleoplasm Renal cancer:1.97e-4 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 25.4 fallopian tube: 9.4 KCTD18 6530404F10Rik, FLJ31322, FLJ37818 ENSG00000155729 Potassium channel tetramerization domain containing 18 2 200488952-200519784 Predicted intracellular proteins Evidence at protein level HPA045498, HPA058028 Approved Approved Mitochondria Expressed in all Expressed in all thyroid gland: 23.1 KCTD19 FLJ40162 ENSG00000168676 Potassium channel tetramerization domain containing 19 16 67289428-67326763 Predicted intracellular proteins Evidence at protein level HPA049310, HPA053321 Uncertain Not detected Tissue enriched 15 testis: 39.1 bone marrow: 2.7 KCTD4 bA321C24.3 ENSG00000180332 Potassium channel tetramerization domain containing 4 13 45192853-45194717 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA040734 Uncertain Approved Microtubule organizing center Group enriched Group enriched 10 cerebral cortex: 17.7;skin: 3.7 gallbladder: 1.1 KCTD8 ENSG00000183783 Potassium channel tetramerization domain containing 8 4 44173909-44448807 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA031562 Supported Approved Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 11.5;thyroid gland: 5.1 testis: 2.4 KDELR3 ENSG00000100196 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 22 38468062-38483447 Predicted membrane proteins Evidence at protein level HPA043477, HPA076405 Uncertain Validated Endoplasmic reticulum Renal cancer:6.05e-10 (unfavourable), Liver cancer:1.19e-4 (unfavourable) Expressed in all Mixed cervix, uterine: 46.3 KDF1 C1orf172, FLJ34633, RP11-344H11.3 ENSG00000175707 Keratinocyte differentiation factor 1 1 26949562-26960406 Predicted intracellular proteins Evidence at protein level HPA028639, HPA068312 Uncertain Supported Nucleoplasm
Cell Junctions
Mitotic spindle Renal cancer:3.04e-13 (favourable), Urothelial cancer:4.40e-4 (favourable) Mixed Mixed epididymis: 23.7 KHDC1 bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1 ENSG00000135314 KH homology domain containing 1 6 73241314-73310365 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA029032 Approved Approved Mitochondria
Cytosol Mixed Tissue enhanced cerebral cortex: 10.0 testis: 6.7 KHDC3L C6orf221, ECAT1 ENSG00000203908 KH domain containing 3-like, subcortical maternal complex member 6 73362677-73364171 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA043699 Uncertain Tissue enriched Tissue enhanced lung: 1.0;testis: 2.2 epididymis: 0.4 KIAA0513 ENSG00000135709 KIAA0513 16 85027751-85094230 Predicted intracellular proteins Evidence at protein level HPA012866, HPA014431 Supported Uncertain Nucleoplasm
Cytosol Pancreatic cancer:1.72e-5 (favourable) Expressed in all Tissue enriched 7 cerebral cortex: 102.9 adrenal gland: 14.9 KIAA0825 C5orf36, DKFZp686F0372, MGC34713 ENSG00000185261 KIAA0825 5 94152966-94618604 Predicted intracellular proteins Evidence at protein level HPA038030, HPA038031 Uncertain Not detected Mixed testis: 5.5 KIAA0895 ENSG00000164542 KIAA0895 7 36324221-36390125 Predicted intracellular proteins Evidence at transcript level HPA020512, HPA021036, HPA061066 Uncertain Approved Nucleus
Plasma membrane
Cell Junctions
Cytosol Expressed in all Tissue enhanced testis: 43.8 parathyroid gland: 23.4 KIAA0895L LOC653319 ENSG00000196123 KIAA0895-like 16 67175602-67184040 Predicted intracellular proteins Evidence at transcript level HPA065996 Approved Approved Nucleoplasm
Vesicles Pancreatic cancer:3.16e-4 (favourable) Expressed in all Mixed cerebral cortex: 25.4 KIAA1024 ENSG00000169330 KIAA1024 15 79432516-79472290 Predicted membrane proteins Evidence at protein level HPA011545 Uncertain Approved Golgi apparatus Mixed Tissue enriched 11 adrenal gland: 14.0 prostate,salivary gland: 1.2 KIAA1147 LCHN ENSG00000257093 KIAA1147 7 141656728-141702153 Predicted intracellular proteins Evidence at protein level HPA029467, HPA061437 Approved Approved Golgi apparatus Head and neck cancer:6.24e-4 (favourable), Renal cancer:8.01e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 21.2 KIAA1210 ENSG00000250423 KIAA1210 X 119078635-119150579 Predicted intracellular proteins Evidence at protein level HPA000551, HPA048322 Supported Tissue enhanced Tissue enhanced epididymis: 47.2;seminal vesicle: 27.1;testis: 58.1 prostate: 9.0 KIAA1211L C2orf55, MGC42367 ENSG00000196872 KIAA1211-like 2 98793846-98936259 Predicted intracellular proteins Evidence at protein level HPA051082, HPA061678 Uncertain Approved Microtubules
Cytokinetic bridge
Centrosome Renal cancer:1.13e-5 (favourable), Thyroid cancer:1.33e-5 (favourable) Expressed in all Tissue enhanced cerebral cortex: 36.9;epididymis: 38.1 fallopian tube: 35.8 KIAA1257 ENSG00000114656 KIAA1257 3 128909866-129002690 Predicted intracellular proteins Evidence at transcript level HPA042811, HPA048445 Uncertain Mixed Group enriched 10 placenta: 9.7;testis: 35.0 fallopian tube: 2.2 KIAA1324 EIG121, maba1 ENSG00000116299 KIAA1324 1 109113679-109206781 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA029869, HPA070749 Supported Supported Plasma membrane Endometrial cancer:2.14e-7 (favourable), Lung cancer:5.69e-5 (favourable), Ovarian cancer:2.16e-4 (favourable) Mixed Mixed cervix, uterine: 128.0 KIAA1324L EIG121L, FLJ31340 ENSG00000164659 KIAA1324-like 7 86876906-87059699 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA044527, HPA076093 Uncertain Approved Endoplasmic reticulum Mixed Tissue enhanced lung: 32.3 cerebral cortex: 21.8 KIAA1456 C8orf79, FLJ36980 ENSG00000250305 KIAA1456 8 12945642-13031503 Predicted intracellular proteins Evidence at transcript level HPA024673 Approved Approved Nucleus
Cytosol Renal cancer:2.77e-7 (favourable) Tissue enhanced Tissue enhanced thyroid gland: 31.4 cerebral cortex: 6.6 KIAA1549L C11orf41, C11orf69, G2, MGC34830 ENSG00000110427 KIAA1549-like 11 33542072-33674102 Predicted membrane proteins Evidence at protein level HPA051594 Approved Nucleoplasm Mixed Group enriched 40 cerebral cortex: 35.0;parathyroid gland: 143.5 skin: 2.2 KIAA1614 ENSG00000135835 KIAA1614 1 180913154-180951614 Predicted intracellular proteins Evidence at protein level HPA028227, HPA061684 Approved Approved Nuclear membrane
Vesicles Mixed Mixed thyroid gland: 3.0 KIAA1644 ENSG00000138944 KIAA1644 22 44243667-44312851 Predicted membrane proteins Evidence at transcript level HPA051178 Uncertain Approved Vesicles
Cytosol Mixed Tissue enhanced cerebral cortex: 27.6;endometrium: 42.5;smooth muscle: 44.0 cervix, uterine: 19.1 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 20 38210488-38260772 Predicted intracellular proteins Evidence at protein level HPA051064 Approved Approved Nucleoli
Golgi apparatus
Vesicles Tissue enhanced Mixed cerebral cortex: 33.7 KIAA1841 ENSG00000162929 KIAA1841 2 61065871-61138034 Predicted intracellular proteins Evidence at transcript level HPA051240 Approved Approved Nucleus
Nucleoli Expressed in all Mixed prostate: 6.9 KIAA1919 MFSD4B, MGC33953 ENSG00000173214 KIAA1919 6 111259348-111271167 Predicted membrane proteins Evidence at protein level HPA031784 Approved Uncertain Intermediate filaments Expressed in all Mixed placenta: 5.0 KIAA2012 ENSG00000182329 KIAA2012 2 202073255-202197862 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 12 fallopian tube: 8.5 testis: 0.6 KIAA2013 MGC33867, RP5-1077B9.1 ENSG00000116685 KIAA2013 1 11919591-11926428 Predicted membrane proteins Evidence at protein level HPA052677, HPA060536 Uncertain Approved Golgi apparatus
Cytosol Expressed in all Expressed in all small intestine: 69.5 KIAA2022 MRX98, XPN ENSG00000050030 KIAA2022 X 74732849-74925485 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA000407 Uncertain Uncertain Nucleoplasm
Midbody Mixed Tissue enhanced cerebral cortex: 5.4;parathyroid gland: 5.2 prostate: 1.8 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 9 5881596-6007901 Predicted intracellular proteins Evidence at protein level HPA002109 Uncertain Approved Nucleus
Vesicles
Cytosol Renal cancer:8.34e-4 (favourable) Expressed in all Expressed in all testis: 22.9 KIF17 KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3 ENSG00000117245 Kinesin family member 17 1 20664014-20718017 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA032085 Uncertain Approved Nucleoplasm
Plasma membrane Mixed Tissue enriched 6 testis: 23.7 cerebral cortex: 3.8 KIF19 FLJ37300, KIF19A ENSG00000196169 Kinesin family member 19 17 74326210-74355820 Predicted intracellular proteins Evidence at protein level HPA043638, HPA073303 Approved Approved Plasma membrane
Actin filaments
Centrosome Mixed Tissue enhanced fallopian tube: 18.7;spleen: 6.7 duodenum: 3.0 KIF25 KNSL3 ENSG00000125337 Kinesin family member 25 6 167996241-168045089 Predicted intracellular proteins Evidence at protein level HPA046153 Uncertain Tissue enhanced Tissue enhanced adipose tissue: 8.7 placenta: 1.8 KIF26A DKFZP434N178, KIAA1236 ENSG00000066735 Kinesin family member 26A 14 104138723-104180894 Predicted intracellular proteins Evidence at protein level HPA046882, HPA060346 Uncertain Approved Nucleus
Plasma membrane
Cytosol Renal cancer:7.78e-4 (unfavourable) Group enriched Mixed adipose tissue: 5.0 KIF26B FLJ10157 ENSG00000162849 Kinesin family member 26B 1 245154985-245709431 Predicted intracellular proteins Evidence at protein level HPA027709, HPA028478, HPA028561, HPA028562 Approved Approved Plasma membrane
Microtubules Ovarian cancer:1.24e-4 (unfavourable) Mixed Mixed cerebral cortex: 2.3 KIF27 DKFZp434D0917 ENSG00000165115 Kinesin family member 27 9 83836698-83921465 Predicted intracellular proteins Evidence at protein level Mixed Tissue enhanced testis: 48.5 thyroid gland: 14.3 KIF4B ENSG00000226650 Kinesin family member 4B 5 155013755-155018132 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA034745, HPA034746, HPA061583 Uncertain Validated Nucleoplasm Not detected Tissue enriched 63 testis: 6.2 all non-specific tissues: 0.0 KIFC2 ENSG00000167702 Kinesin family member C2 8 144466043-144474202 Predicted secreted proteins Evidence at protein level HPA029264 Approved Supported Nucleoplasm
Cytosol Expressed in all Expressed in all skin: 73.3 KIR3DL2 CD158K, cl-5, nkat4, nkat4a, nkat4b ENSG00000240403 Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 19 54850443-54867207 CD markers, Predicted membrane proteins Evidence at transcript level Not detected Not detected bone marrow: 0.1 KLF7 UKLF ENSG00000118263 Kruppel-like factor 7 (ubiquitous) 2 207074137-207167267 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030490 Approved Approved Golgi apparatus Renal cancer:4.26e-4 (favourable) Expressed in all Expressed in all smooth muscle: 30.6 KLHDC1 MST025 ENSG00000197776 Kelch domain containing 1 14 49693105-49753152 Predicted intracellular proteins Evidence at protein level HPA020461 Approved Supported Cytosol Pancreatic cancer:1.94e-4 (favourable) Mixed Mixed endometrium,ovary: 9.6 KLHDC3 dJ20C7.3, hPeas, PEAS ENSG00000124702 Kelch domain containing 3 6 43014103-43021298 Predicted intracellular proteins Evidence at protein level HPA030131, HPA030132, HPA030133, HPA030134 Uncertain Supported Nucleoplasm Endometrial cancer:4.52e-4 (unfavourable), Pancreatic cancer:9.08e-4 (favourable), Cervical cancer:9.15e-4 (favourable) Expressed in all Expressed in all testis: 251.3 KLHDC7B MGC16635 ENSG00000130487 Kelch domain containing 7B 22 50548033-50551023 Predicted intracellular proteins Evidence at protein level HPA000518 Uncertain Breast cancer:1.30e-4 (favourable) Tissue enhanced Tissue enhanced parathyroid gland: 12.5 thyroid gland: 3.4 KLHDC8A FLJ10748 ENSG00000162873 Kelch domain containing 8A 1 205336065-205357090 Predicted intracellular proteins Evidence at transcript level Thyroid cancer:8.01e-4 (favourable) Tissue enhanced Tissue enriched 11 ovary: 287.7 adrenal gland: 26.1 KLHDC8B MGC35097 ENSG00000185909 Kelch domain containing 8B 3 49171611-49176486 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA008463, HPA014467 Supported Validated Cytosol Lung cancer:1.47e-4 (favourable) Expressed in all Expressed in all adrenal gland: 70.3 KLHL1 FLJ30047, KIAA1490, MRP2 ENSG00000150361 Kelch-like family member 1 13 69700594-70108493 Predicted intracellular proteins Evidence at transcript level HPA021196 Uncertain Tissue enriched Tissue enhanced cerebral cortex: 1.9 prostate,testis: 0.4 KLHL17 ENSG00000187961 Kelch-like family member 17 1 960587-965715 Predicted intracellular proteins Evidence at protein level HPA031251 Approved Approved Nucleoplasm
Nuclear bodies Liver cancer:1.89e-6 (unfavourable), Renal cancer:2.70e-6 (unfavourable), Cervical cancer:4.22e-4 (unfavourable) Expressed in all Mixed skin: 9.7 KLHL24 DRE1, FLJ20059 ENSG00000114796 Kelch-like family member 24 3 183635568-183684477 Predicted intracellular proteins Evidence at transcript level HPA056337 Uncertain Expressed in all Expressed in all parathyroid gland: 73.1 KLHL28 BTBD5, FLJ20081 ENSG00000179454 Kelch-like family member 28 14 44924319-45042322 Predicted intracellular proteins Evidence at transcript level HPA000988 Approved Cytosol Expressed in all Mixed bone marrow: 17.2 KLHL29 KBTBD9, KIAA1921 ENSG00000119771 Kelch-like family member 29 2 23385217-23708611 Predicted intracellular proteins Evidence at protein level HPA049057, HPA057379 Approved Approved Mitochondria
Cytosol Pancreatic cancer:2.19e-4 (favourable), Renal cancer:6.29e-4 (unfavourable) Mixed Mixed adrenal gland: 12.0 KLHL30 FLJ43374 ENSG00000168427 Kelch-like family member 30 2 238138722-238152947 Predicted intracellular proteins Evidence at transcript level HPA062095 Approved Microtubule organizing center Mixed Tissue enhanced skeletal muscle: 22.1 heart muscle: 5.8 KLHL31 bA345L23.2, BKLHD6, KBTBD1 ENSG00000124743 Kelch-like family member 31 6 53647901-53665708 Predicted intracellular proteins Evidence at protein level Not detected Tissue enhanced heart muscle: 30.3;skeletal muscle: 51.2 adipose tissue: 9.0 KLHL32 BKLHD5, KIAA1900 ENSG00000186231 Kelch-like family member 32 6 96924620-97140754 Predicted intracellular proteins Evidence at transcript level HPA039150 Approved Mixed Group enriched 6 cerebral cortex: 25.4;fallopian tube: 10.2 testis: 3.1 KLHL34 FLJ34960, RP11-450P7.3 ENSG00000185915 Kelch-like family member 34 X 21654690-21658330 Predicted intracellular proteins Evidence at protein level HPA060287 Uncertain Not detected Tissue enriched 8 skeletal muscle: 8.8 duodenum: 1.1 KLHL5 ENSG00000109790 Kelch-like family member 5 4 39045039-39126857 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA013958 Approved Expressed in all Expressed in all seminal vesicle: 90.3 KLK13 KLK-L4 ENSG00000167759 Kallikrein-related peptidase 13 19 51056206-51065114 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level HPA062136 Supported Tissue enhanced Tissue enriched 9 esophagus: 403.9 tonsil: 46.8 KLK9 KLK-L3 ENSG00000213022 Kallikrein-related peptidase 9 19 51003111-51009634 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at transcript level CAB025049 Uncertain Tissue enriched Not detected skin,tonsil: 0.8 KLRC3 NKG2-E ENSG00000205810 Killer cell lectin-like receptor subfamily C, member 3 12 10412312-10420595 Predicted membrane proteins Evidence at transcript level HPA039910, HPA062570 Approved Uncertain Vesicles Tissue enriched Tissue enhanced cerebral cortex: 9.3;spleen: 6.3 lymph node: 2.3 KLRC4 NKG2-F ENSG00000183542 Killer cell lectin-like receptor subfamily C, member 4 12 10407382-10409757 Predicted membrane proteins Evidence at protein level Not detected Tissue enhanced spleen: 13.3 lymph node: 5.6 KNCN FLJ32011, KINO, L5 ENSG00000162456 Kinocilin 1 46545644-46551527 Predicted membrane proteins Evidence at transcript level HPA046357 Uncertain Not detected Not detected testis: 0.7 KNDC1 bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2 ENSG00000171798 Kinase non-catalytic C-lobe domain (KIND) containing 1 10 133160447-133226412 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039624 Uncertain Mixed Tissue enhanced cerebral cortex: 19.5;fallopian tube: 10.5 adrenal gland: 6.4 KRBOX1 ENSG00000240747 KRAB box domain containing 1 3 42809483-42942792 Predicted intracellular proteins Evidence at transcript level HPA046901 Approved Nucleoplasm
Golgi apparatus Mixed Tissue enriched 31 testis: 287.3 epididymis: 9.1 KRBOX4 FLJ20344, ZNF673 ENSG00000147121 KRAB box domain containing 4 X 46446857-46497422 Predicted intracellular proteins Evidence at protein level HPA065295 Approved Nucleoplasm Renal cancer:1.98e-7 (unfavourable), Liver cancer:2.87e-6 (unfavourable), Lung cancer:4.67e-5 (favourable), Urothelial cancer:2.17e-4 (favourable) Expressed in all Expressed in all endometrium: 29.3 KRCC1 FLJ22333 ENSG00000172086 Lysine-rich coiled-coil 1 2 88027205-88055729 Predicted intracellular proteins Evidence at protein level HPA045618, HPA052666 Approved Approved Nucleoli
Cytosol Expressed in all Expressed in all parathyroid gland: 58.6 KREMEN1 KREMEN, KRM1 ENSG00000183762 Kringle containing transmembrane protein 1 22 29073078-29168333 Predicted membrane proteins Evidence at protein level HPA058513 Approved Nucleoplasm
Nuclear bodies
Cytosol Not detected Mixed skin: 43.5 KREMEN2 KRM2, MGC10791 ENSG00000131650 Kringle containing transmembrane protein 2 16 2963944-2968383 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA003223 Uncertain Approved Nucleoli Lung cancer:8.98e-4 (unfavourable) Mixed Tissue enhanced skin: 6.9 cerebral cortex: 2.1 KRT222 KA21, KRT222P, MGC45562 ENSG00000213424 Keratin 222, type II 17 40654665-40665181 Predicted intracellular proteins Evidence at protein level HPA043708, HPA054586, HPA069774 Uncertain Approved Vesicles
Lipid droplets Mixed Tissue enhanced cerebral cortex: 10.0;epididymis: 3.1 gallbladder: 2.7 KRT32 Ha-2, KRTHA2 ENSG00000108759 Keratin 32, type I 17 41459811-41467429 Predicted intracellular proteins Evidence at protein level Not detected Group enriched 13 esophagus: 7.5;skin: 2.4 breast: 0.3 KRT33A Ha-3I, Krt1-3, KRTHA3A ENSG00000006059 Keratin 33A, type I 17 41346092-41350812 Predicted intracellular proteins Evidence at protein level HPA055194 Supported Tissue enhanced Group enriched 13 esophagus: 1.4;testis: 1.5 breast: 0.1 KRT34 Ha-4, KRTHA4 ENSG00000131737 Keratin 34, type I 17 41377650-41382403 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA055194, HPA072208 Supported Approved Nucleus
Vesicles Tissue enhanced Tissue enriched 8 cervix, uterine: 4.2 testis: 0.5 KRT35 Ha-5, KRTHA5 ENSG00000197079 Keratin 35, type I 17 41476689-41481140 Plasma proteins, Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 8 skin: 2.2 breast,salivary gland,spleen: 0.2 KRT36 KRTHA6 ENSG00000126337 Keratin 36, type I 17 41486136-41492546 Plasma proteins, Predicted intracellular proteins Evidence at protein level Tissue enhanced Tissue enhanced skin: 2.1;tonsil: 1.6 cervix, uterine,spleen: 0.5 KRT77 KRT1B ENSG00000189182 Keratin 77, type II 12 52689626-52703463 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA045934 Supported Approved Nuclear membrane
Plasma membrane Mixed Tissue enriched 12 skin: 309.5 breast: 25.9 KRT78 K5B ENSG00000170423 Keratin 78, type II 12 52837804-52849092 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA039724 Supported Tissue enhanced Tissue enriched 8 esophagus: 1058.9 tonsil: 132.4 KRT84 Hb-4, KRTHB4 ENSG00000161849 Keratin 84, type II 12 52377812-52385652 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA039714 Supported Tissue enhanced Not detected tonsil: 0.5 KRTAP1-1 HB2A, KAP1.1, KAP1.1A, KAP1.1B ENSG00000188581 Keratin associated protein 1-1 17 41040559-41041461 Predicted intracellular proteins Evidence at transcript level Not detected Not detected pancreas: 0.1 KRTAP1-3 KAP1.3 ENSG00000221880 Keratin associated protein 1-3 17 41033884-41034855 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP1-4 KAP1.4 ENSG00000204887 Keratin associated protein 1-4 17 41029697-41030104 Predicted intracellular proteins Evidence at transcript level Not detected Not detected skin: 0.1 KRTAP1-5 KAP1.5 ENSG00000221852 Keratin associated protein 1-5 17 41026026-41027202 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 13 cervix, uterine: 2.1 prostate,urinary bladder: 0.1 KRTAP10-1 KAP10.1, KAP18.1, KRTAP18-1 ENSG00000215455 Keratin associated protein 10-1 21 44538981-44540195 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP10-10 KAP10.10, KAP18.10, KRTAP18-10 ENSG00000221859 Keratin associated protein 10-10 21 44637356-44638455 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP10-12 KAP10.12, KRTAP18-12, KRTAP18.12 ENSG00000189169 Keratin associated protein 10-12 21 44697172-44698044 Predicted intracellular proteins Evidence at protein level Not detected Not detected all non-specific tissues: 0.0 KRTAP10-2 KAP10.2, KAP18.2, KRTAP18-2 ENSG00000205445 Keratin associated protein 10-2 21 44550357-44551505 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP10-3 KAP10.3, KAP18.3, KRTAP18-3 ENSG00000212935 Keratin associated protein 10-3 21 44557790-44558760 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP10-6 KAP10.6, KAP18.6, KRTAP18-6, KRTAP18.6 ENSG00000188155 Keratin associated protein 10-6 21 44579737-44592505 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP11-1 KAP11.1 ENSG00000182591 Keratin associated protein 11-1 21 30880644-30881555 Predicted intracellular proteins Evidence at protein level HPA054008 Supported Group enriched Not detected skin: 0.1 KRTAP12-3 KRTAP12.3 ENSG00000205439 Keratin associated protein 12-3 21 44646657-44658341 Predicted intracellular proteins Evidence at transcript level Not detected Not detected skin: 0.1 KRTAP13-1 KAP13.1 ENSG00000198390 Keratin associated protein 13-1 21 30396074-30396822 Predicted intracellular proteins Evidence at protein level Not detected Not detected testis: 0.3 KRTAP13-2 KAP13-2 ENSG00000182816 Keratin associated protein 13-2 21 30348075-30425912 Plasma proteins, Predicted intracellular proteins Evidence at protein level Tissue enhanced Group enriched 20 colon: 1.9;rectum: 2.0 all non-specific tissues: 0.0 KRTAP13-4 KAP13.4 ENSG00000186971 Keratin associated protein 13-4 21 30430230-30431026 Predicted intracellular proteins Evidence at protein level Not detected Not detected adrenal gland,parathyroid gland: 0.2 KRTAP15-1 KAP15.1 ENSG00000186970 Keratin associated protein 15-1 21 30440275-30440945 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP19-1 KAP19.1 ENSG00000184351 Keratin associated protein 19-1 21 30479699-30480344 Predicted intracellular proteins Evidence at transcript level Tissue enriched Not detected prostate: 0.1 KRTAP2-1 KAP2.1A ENSG00000212725 Keratin associated protein 2-1 17 41046541-41047316 Predicted intracellular proteins Evidence at protein level HPA059203 Supported Not detected Not detected all non-specific tissues: 0.0 KRTAP2-2 KAP2.2 ENSG00000214518 Keratin associated protein 2-2 17 41054498-41055230 Predicted intracellular proteins Evidence at protein level HPA059203 Supported Not detected Not detected all non-specific tissues: 0.0 KRTAP2-4 KAP2.4 ENSG00000213417 Keratin associated protein 2-4 17 41065116-41065879 Predicted intracellular proteins Evidence at protein level HPA059203 Supported Not detected Not detected all non-specific tissues: 0.0 KRTAP24-1 KAP24.1 ENSG00000188694 Keratin associated protein 24-1 21 30281309-30282958 Predicted intracellular proteins Evidence at protein level HPA017604 Supported Not detected Not detected all non-specific tissues: 0.0 KRTAP27-1 ENSG00000206107 Keratin associated protein 27-1 21 30337013-30337694 Predicted intracellular proteins Evidence at transcript level HPA021522, HPA048826 Approved Not detected Not detected all non-specific tissues: 0.0 KRTAP4-1 KAP4.1, KAP4.10, KRTAP4-10 ENSG00000198443 Keratin associated protein 4-1 17 41184102-41185342 Predicted intracellular proteins Evidence at transcript level Mixed Not detected colon,small intestine: 0.3 KRTAP4-3 KAP4.3 ENSG00000196156 Keratin associated protein 4-3 17 41167231-41168194 Predicted intracellular proteins Evidence at protein level Not detected Not detected all non-specific tissues: 0.0 KRTAP4-4 KAP4.13, KAP4.4, KRTAP4-13 ENSG00000171396 Keratin associated protein 4-4 17 41159651-41160731 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP4-5 KAP4.5 ENSG00000198271 Keratin associated protein 4-5 17 41148924-41149802 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP4-6 KAP4.15, KAP4.6, KRTAP4-15 ENSG00000198090 Keratin associated protein 4-6 17 41139433-41140487 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP4-8 KAP4.8 ENSG00000204880 Keratin associated protein 4-8 17 41096981-41098141 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP4-9 KAP4.9 ENSG00000212722 Keratin associated protein 4-9 17 41105332-41106488 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP5-1 KRN1L, KRTAP5.1 ENSG00000205869 Keratin associated protein 5-1 11 1584342-1585283 Predicted intracellular proteins Evidence at transcript level Colorectal cancer:2.37e-4 (unfavourable) Mixed Not detected epididymis: 0.3 KRTAP5-10 KRTAP5.10 ENSG00000204572 Keratin associated protein 5-10 11 71565563-71568934 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced epididymis: 1.9 fallopian tube,seminal vesicle,testis: 0.4 KRTAP5-11 KRTAP5-6, KRTAP5.11 ENSG00000204571 Keratin associated protein 5-11 11 71579714-71603353 Predicted intracellular proteins Evidence at transcript level Not detected Not detected duodenum: 0.1 KRTAP5-2 KRTAP5-8, KRTAP5.2 ENSG00000205867 Keratin associated protein 5-2 11 1597177-1598294 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enhanced cerebral cortex: 3.6 parathyroid gland: 1.6 KRTAP5-3 KRTAP5-9, KRTAP5.3 ENSG00000196224 Keratin associated protein 5-3 11 1607565-1608463 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP5-5 KRTAP5-11, KRTAP5.5 ENSG00000185940 Keratin associated protein 5-5 11 1629775-1630707 Predicted intracellular proteins Evidence at transcript level Not detected Not detected epididymis: 0.1 KRTAP5-7 KRTAP5-3, KRTAP5.7 ENSG00000244411 Keratin associated protein 5-7 11 71527267-71528674 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enhanced testis: 1.8 epididymis: 0.8 KRTAP5-8 KRTAP5-2, KRTAP5.8, UHSKerB ENSG00000241233 Keratin associated protein 5-8 11 71538025-71539207 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enhanced testis: 1.3 epididymis,kidney: 0.8 KRTAP7-1 KAP7.1 ENSG00000274749 Keratin associated protein 7-1 (gene/pseudogene) 21 30829039-30829759 Predicted intracellular proteins Evidence at transcript level Tissue enriched Not detected skin: 0.1 KRTAP9-3 KAP9.3 ENSG00000204873 Keratin associated protein 9-3 17 41232463-41233454 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP9-8 KAP9.8 ENSG00000187272 Keratin associated protein 9-8 17 41232475-41239004 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTAP9-9 KAP9.5, KAP9.9, KRTAP9-5 ENSG00000198083 Keratin associated protein 9-9 17 41226653-41256364 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 KRTCAP3 KCP3 ENSG00000157992 Keratinocyte associated protein 3 2 27442366-27446481 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA047136, HPA060203 Supported Approved Nucleus
Cytosol Breast cancer:2.67e-5 (favourable) Expressed in all Mixed small intestine: 35.5 LACC1 C13orf31, FLJ38725 ENSG00000179630 Laccase (multicopper oxidoreductase) domain containing 1 13 43879284-43893932 Disease related genes, Predicted intracellular proteins Evidence at protein level CAB034228, HPA040150, HPA044211 Uncertain Approved Nucleoplasm
Cytokinetic bridge
Cytosol Expressed in all Mixed testis: 17.1 LACTBL1 ENSG00000215906 Lactamase, beta-like 1 1 22953043-22965338 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.3 LAMB4 ENSG00000091128 Laminin, beta 4 7 108023548-108130356 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA020242, HPA024247 Approved Uncertain Cytosol Tissue enhanced Tissue enriched 12 skin: 46.6 placenta: 3.8 LANCL3 FLJ42925 ENSG00000147036 LanC lantibiotic synthetase component C-like 3 (bacterial) X 37571569-37684463 Predicted intracellular proteins Evidence at protein level HPA005470 Approved Not detected Mixed esophagus: 1.4 LAYN FLJ30977, FLJ31092 ENSG00000204381 Layilin 11 111540280-111561745 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA040087 Approved Approved Cytosol Expressed in all Mixed ovary: 49.5 LBX1 HPX6, LBX1H ENSG00000138136 Ladybird homeobox 1 10 101226195-101229794 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA002016, HPA002086 Uncertain Approved Nucleoplasm
Nuclear bodies Not detected Tissue enriched 65 skeletal muscle: 9.1 lung: 0.1 LBX2 ENSG00000179528 Ladybird homeobox 2 2 74497517-74503316 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044257 Uncertain Approved Nucleus
Midbody Mixed Tissue enhanced duodenum: 5.5;small intestine: 5.4 liver: 3.5 LCE1A LEP1 ENSG00000186844 Late cornified envelope 1A 1 152827473-152827894 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 10 skin: 506.0 breast: 49.7 LCE1C LEP3 ENSG00000197084 Late cornified envelope 1C 1 152804835-152806628 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 11 skin: 514.5 breast: 44.9 LCE1D LEP4 ENSG00000172155 Late cornified envelope 1D 1 152796751-152798181 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 305 skin: 101.4 skeletal muscle: 0.3 LCE1E LEP5 ENSG00000186226 Late cornified envelope 1E 1 152786214-152788426 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enriched 122 skin: 74.1 breast: 0.6 LCE1F LEP6 ENSG00000240386 Late cornified envelope 1F 1 152776372-152776728 Predicted intracellular proteins Evidence at transcript level Group enriched Tissue enriched 21 skin: 246.3 breast: 11.8 LCE2B LEP10, SPRL1B, XP5 ENSG00000159455 Late cornified envelope 2B 1 152686123-152687401 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 10 skin: 564.3 breast: 55.3 LCE2C LEP11 ENSG00000187180 Late cornified envelope 2C 1 152675295-152676574 Predicted intracellular proteins Evidence at transcript level Group enriched Tissue enriched 10 skin: 283.3 breast: 29.2 LCE3A LEP13 ENSG00000185962 Late cornified envelope 3A 1 152622834-152623103 Predicted intracellular proteins Evidence at transcript level Group enriched Tissue enriched 23 tonsil: 101.7 esophagus: 4.5 LCE3B LEP14 ENSG00000187238 Late cornified envelope 3B 1 152613811-152614098 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 30 tonsil: 2.9 all non-specific tissues: 0.0 LCE3D LEP16, SPRL6A, SPRL6B ENSG00000163202 Late cornified envelope 3D 1 152579381-152580504 Predicted intracellular proteins Evidence at protein level Group enriched Tissue enhanced skin: 26.5;tonsil: 83.1 esophagus: 11.7 LCE5A LEP18, SPRL5A ENSG00000186207 Late cornified envelope 5A 1 152510844-152512177 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enriched 6 skin: 94.0 breast: 16.5 LCN12 MGC48935 ENSG00000184925 Lipocalin 12 9 136949551-136955497 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enriched 30 epididymis: 44.4 thyroid gland: 1.4 LCN8 LCN5 ENSG00000204001 Lipocalin 8 9 136754386-136758543 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enriched 234 epididymis: 101.7 lymph node,thyroid gland: 0.4 LCN9 ENSG00000148386 Lipocalin 9 9 135663322-135666422 Predicted secreted proteins Evidence at transcript level Not detected Tissue enhanced epididymis: 1.1 cerebral cortex: 0.6 LCNL1 FLJ45224 ENSG00000214402 Lipocalin-like 1 9 136981904-136986410 Predicted intracellular proteins Evidence at transcript level HPA060268 Uncertain Mixed Not detected seminal vesicle: 0.7 LDHAL6A LDH6A, MGC23940 ENSG00000166800 Lactate dehydrogenase A-like 6A 11 18455824-18479600 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 13 testis: 17.4 skin: 1.3 LDLRAD2 ENSG00000187942 Low density lipoprotein receptor class A domain containing 2 1 21812265-21825221 Predicted secreted proteins Evidence at transcript level HPA030478 Approved Mixed Mixed adipose tissue: 2.8 LDLRAD3 LRAD3 ENSG00000179241 Low density lipoprotein receptor class A domain containing 3 11 35943981-36232136 Predicted membrane proteins Evidence at protein level HPA038251 Approved Supported Cell Junctions Renal cancer:5.05e-8 (unfavourable), Lung cancer:9.34e-6 (unfavourable), Urothelial cancer:2.14e-5 (unfavourable), Cervical cancer:2.24e-4 (unfavourable) Expressed in all Mixed breast: 22.9 LDOC1L dJ1033E15.2, DKFZp761O17121, Mar6, Mart6 ENSG00000188636 Leucine zipper, down-regulated in cancer 1-like 22 44492572-44498298 Predicted intracellular proteins Evidence at protein level HPA005697 Approved Approved Nuclear speckles
Cytosol Expressed in all Expressed in all cerebral cortex: 42.5 LEFTY1 LEFTB, LEFTYB ENSG00000243709 Left-right determination factor 1 1 225886282-225911382 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA047883, HPA056210 Approved Renal cancer:2.48e-6 (unfavourable) Tissue enhanced Tissue enhanced colon: 59.7;rectum: 35.8 pancreas: 20.4 LEKR1 FLJ16641 ENSG00000197980 Leucine, glutamate and lysine rich 1 3 156825481-157046129 Predicted intracellular proteins Evidence at protein level HPA044039 Uncertain Not detected Tissue enhanced testis: 27.1 fallopian tube: 6.6 LEMD1 CT50, LEMP-1 ENSG00000186007 LEM domain containing 1 1 205381378-205457091 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA045425 Approved Nucleoli
Cytosol Ovarian cancer:1.26e-4 (favourable), Pancreatic cancer:1.70e-4 (unfavourable) Tissue enhanced Group enriched 17 epididymis: 17.7;testis: 71.0 fallopian tube: 2.6 LENEP LEP503 ENSG00000163352 Lens epithelial protein 1 154993586-154994315 Predicted intracellular proteins Evidence at transcript level Not detected Not detected breast: 0.3 LEPROT FLJ90360, OB-RGRP, OBRGRP, VPS55 ENSG00000213625 Leptin receptor overlapping transcript 1 65420587-65436007 Predicted membrane proteins Evidence at protein level HPA069444 Approved Centrosome Expressed in all Expressed in all placenta: 79.7 LEPROTL1 my047, Vps55 ENSG00000104660 Leptin receptor overlapping transcript-like 1 8 30095398-30177208 Predicted membrane proteins Evidence at protein level HPA047911 Uncertain Renal cancer:1.94e-5 (unfavourable), Colorectal cancer:9.04e-4 (favourable) Expressed in all Expressed in all placenta: 119.4 LETM2 FLJ25409 ENSG00000165046 Leucine zipper-EF-hand containing transmembrane protein 2 8 38386207-38409527 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA025032, HPA053676 Uncertain Approved Nucleus
Nuclear bodies
Cytosol Mixed Tissue enriched 9 testis: 39.3 cerebral cortex: 4.2 LEUTX ENSG00000213921 Leucine twenty homeobox 19 39776595-39786135 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA041498 Uncertain Approved Nucleus
Nucleoli Not detected Not detected all non-specific tissues: 0.0 LEXM C1orf177, FLJ40201, LEM ENSG00000162398 Lymphocyte expansion molecule 1 54806063-54842252 Predicted intracellular proteins Evidence at protein level HPA035889, HPA035890 Uncertain Mixed Group enriched 5 esophagus: 10.5;testis: 7.0 duodenum: 1.7 LGALS16 ENSG00000249861 Lectin, galactoside-binding, soluble, 16 19 39655894-39660647 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 53 placenta: 7.6 testis: 0.1 LGI2 FLJ10675, KIAA1916 ENSG00000153012 Leucine-rich repeat LGI family, member 2 4 24998847-25030879 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA017140 Approved Approved Centrosome Mixed Tissue enriched 19 parathyroid gland: 364.8 smooth muscle: 19.4 LGI3 ENSG00000168481 Leucine-rich repeat LGI family, member 3 8 22146825-22157084 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA024826 Approved Cytosol Tissue enhanced Group enriched 7 cerebral cortex: 76.2;lung: 23.9;skin: 17.4;thyroid gland: 21.5 esophagus: 5.2 LGI4 ENSG00000153902 Leucine-rich repeat LGI family, member 4 19 35124513-35142451 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042116, HPA043556 Approved Approved Golgi apparatus Renal cancer:2.84e-7 (unfavourable) Group enriched Mixed cerebral cortex: 26.2 LHFP MGC22429 ENSG00000183722 Lipoma HMGIC fusion partner 13 39342892-39603528 Cancer-related genes, Disease related genes, Predicted membrane proteins Evidence at protein level HPA058975 Approved Approved Nucleoli Renal cancer:1.20e-7 (unfavourable), Urothelial cancer:2.30e-4 (unfavourable) Expressed in all Mixed placenta: 195.0 LHFPL1 ENSG00000182508 Lipoma HMGIC fusion partner-like 1 X 112630648-112680054 Predicted membrane proteins Evidence at transcript level HPA003029 Uncertain Mixed Tissue enhanced cerebral cortex: 1.8 seminal vesicle: 1.3 LHFPL2 KIAA0206 ENSG00000145685 Lipoma HMGIC fusion partner-like 2 5 78485215-78770021 Predicted membrane proteins Evidence at protein level HPA042402 Uncertain Approved Vesicles
Actin filaments Renal cancer:3.45e-7 (unfavourable), Liver cancer:2.73e-4 (unfavourable) Expressed in all Mixed gallbladder: 36.4 LHFPL3 LHFPL4 ENSG00000187416 Lipoma HMGIC fusion partner-like 3 7 104328656-104907232 Predicted membrane proteins Evidence at transcript level HPA069691 Approved Vesicles Tissue enriched Tissue enriched 11 cerebral cortex: 48.9 cervix, uterine: 4.6 LHFPL4 ENSG00000156959 Lipoma HMGIC fusion partner-like 4 3 9498361-9553802 Predicted membrane proteins Evidence at protein level HPA041421 Uncertain Approved Nucleus
Golgi apparatus Group enriched Tissue enriched 9 cerebral cortex: 23.1 adrenal gland: 2.6 LHX1 LIM-1, LIM1 ENSG00000273706 LIM homeobox 1 17 36936785-36944612 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level CAB002770 Uncertain Endometrial cancer:3.63e-5 (unfavourable) Tissue enhanced Tissue enriched 6 kidney: 1.3 fallopian tube: 0.2 LHX2 hLhx2, LH-2 ENSG00000106689 LIM homeobox 2 9 124001670-124033301 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA000838 Supported Approved Nucleoplasm Cervical cancer:9.52e-4 (favourable) Group enriched Tissue enriched 11 cerebral cortex: 56.4 placenta: 5.1 LHX5 ENSG00000089116 LIM homeobox 5 12 113462034-113472280 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA053908 Uncertain Mixed Tissue enhanced cerebral cortex: 1.4 stomach: 0.3 LILRA1 CD85i, LIR-6, LIR6 ENSG00000104974 Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 19 54573879-54602090 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Mixed Not detected spleen: 0.9 LILRA6 CD85b, ILT8, LILRB6 ENSG00000244482 Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 19 54236592-54242791 Predicted membrane proteins Evidence at protein level Mixed Tissue enhanced appendix: 7.7;smooth muscle: 3.3 spleen: 2.9 LILRB3 CD85a, HL9, ILT5, LIR-3, LIR3 ENSG00000204577 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 19 54216278-54223506 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Mixed Group enriched 6 adipose tissue: 5.3;appendix: 10.4;bone marrow: 8.3;lung: 8.7;spleen: 9.4;urinary bladder: 6.9 placenta: 1.3 LIMS3 ENSG00000256977 LIM and senescent cell antigen-like domains 3 2 109898428-109924868 Predicted intracellular proteins Evidence at transcript level HPA058455 Uncertain Approved Focal adhesion sites
Cytosol Not detected Tissue enhanced fallopian tube: 9.8 endometrium: 8.8 LINC01620 C20orf62, dJ1013A22.3 ENSG00000168746 Long intergenic non-protein coding RNA 1620 20 44451984-44465344 Predicted intracellular proteins Evidence at transcript level HPA041142 Uncertain Not detected Not detected skin: 0.1 LINGO2 LERN3, LRRN6C ENSG00000174482 Leucine rich repeat and Ig domain containing 2 9 27948078-28670286 Predicted membrane proteins Evidence at transcript level HPA016633, CAB025361 Approved Mixed Tissue enhanced endometrium: 11.8;smooth muscle: 12.8 thyroid gland: 4.9 LINGO4 LRRN6D ENSG00000213171 Leucine rich repeat and Ig domain containing 4 1 151800264-151806154 Predicted membrane proteins Evidence at transcript level HPA060781 Uncertain Mixed Tissue enhanced adrenal gland: 2.3;skeletal muscle: 4.1 fallopian tube: 1.0 LINS1 LINS, WINS1 ENSG00000140471 Lines homolog 1 15 100559369-100603230 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA038578, HPA038579 Approved Approved Nucleoplasm Expressed in all Expressed in all thyroid gland: 14.0 LIPJ bA425M17.2, LIPL1 ENSG00000204022 Lipase, family member J 10 88586753-88606976 Predicted intracellular proteins Evidence at transcript level HPA048594 Uncertain Not detected Tissue enriched 11 testis: 12.2 epididymis,fallopian tube: 1.1 LIPK bA186O14.2, LIPL2 ENSG00000204021 Lipase, family member K 10 88724544-88752786 Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enriched 12 skin: 37.4 breast: 3.2 LIPM bA304I5.1, LIPL3 ENSG00000173239 Lipase, family member M 10 88802730-88820546 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Pancreatic cancer:6.47e-4 (unfavourable) Mixed Tissue enriched 11 skin: 51.5 stomach: 4.8 LIPN bA186O14.3, LIPL4 ENSG00000204020 Lipase, family member N 10 88761406-88778242 Disease related genes, Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enriched 7 skin: 39.9 appendix: 5.8 LIX1 C5orf11, Lft ENSG00000145721 Limb and CNS expressed 1 5 97091867-97142872 Predicted intracellular proteins Evidence at transcript level HPA058426 Uncertain Endometrial cancer:2.48e-4 (unfavourable) Tissue enhanced Tissue enriched 6 cerebral cortex: 32.9 seminal vesicle: 5.6 LIX1L MGC46719 ENSG00000271601 Limb and CNS expressed 1 like 1 145933423-145958001 Predicted intracellular proteins Evidence at protein level HPA046996, HPA063598 Uncertain Approved Cytosol Renal cancer:3.19e-5 (unfavourable), Liver cancer:1.61e-4 (unfavourable), Urothelial cancer:5.27e-4 (unfavourable) Expressed in all Expressed in all ovary: 45.7 LKAAEAR1 C20orf201 ENSG00000171695 LKAAEAR motif containing 1 20 64083380-64084359 Predicted intracellular proteins Evidence at transcript level HPA056463 Uncertain Mixed Tissue enhanced testis: 2.8 cerebral cortex: 0.8 LMAN1L ERGIC-53L, ERGL ENSG00000140506 Lectin, mannose-binding, 1 like 15 74812716-74825758 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enhanced prostate: 81.3;spleen: 32.1 heart muscle: 15.7 LMBRD2 DKFZp434H2226 ENSG00000164187 LMBR1 domain containing 2 5 36098412-36151961 Predicted membrane proteins Evidence at protein level HPA012165 Approved Approved Nucleoplasm
Cytosol Expressed in all Expressed in all cerebral cortex: 25.5 LMLN Gp63, Msp ENSG00000185621 Leishmanolysin-like (metallopeptidase M8 family) 3 197960200-198043720 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA016481, HPA028844 Uncertain Supported Focal adhesion sites
Cytosol Endometrial cancer:6.77e-4 (favourable) Expressed in all Tissue enhanced testis: 18.7 epididymis: 12.7 LMNTD1 FLJ36004, IFLTD1, Pas1c1 ENSG00000152936 Lamin tail domain containing 1 12 25409307-25648579 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA038640, HPA045911 Uncertain Approved Nucleoplasm
Centrosome Tissue enhanced Group enriched 7 fallopian tube: 26.9;testis: 26.5 rectum: 3.9 LMNTD2 C11orf35, MGC35138 ENSG00000185522 Lamin tail domain containing 2 11 554855-560779 Predicted intracellular proteins Evidence at protein level HPA058474, HPA073912 Uncertain Approved Cytoplasmic bodies Colorectal cancer:3.75e-4 (unfavourable) Mixed Tissue enhanced epididymis: 13.5 fallopian tube: 12.1 LMO7DN C13orf45 ENSG00000178734 LMO7 downstream neighbor 13 75871038-75883811 Predicted intracellular proteins Evidence at transcript level HPA052013 Uncertain Not detected Tissue enhanced gallbladder: 1.4 esophagus,lung,testis: 0.7 LNP1 NP3 ENSG00000206535 Leukemia NUP98 fusion partner 1 3 100401193-100456319 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA047926 Approved Nuclear speckles
Vesicles
Cytosol Expressed in all Tissue enriched 6 testis: 47.7 cerebral cortex: 7.6 LONRF2 FLJ45273, RNF192 ENSG00000170500 LON peptidase N-terminal domain and ring finger 2 2 100273291-100322733 Predicted intracellular proteins Evidence at protein level HPA057366 Supported Nucleus Pancreatic cancer:6.42e-5 (favourable) Tissue enhanced Tissue enhanced epididymis: 54.9 endometrium: 44.9 LOXHD1 DFNB77, FLJ32670, LH2D1 ENSG00000167210 Lipoxygenase homology domains 1 18 46476972-46657033 Disease related genes, Predicted intracellular proteins Evidence at protein level Tissue enhanced Tissue enriched 5 testis: 41.4 epididymis: 8.2 LOXL3 ENSG00000115318 Lysyl oxidase-like 3 2 74532414-74555690 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA035281 Approved Renal cancer:7.97e-8 (unfavourable) Tissue enhanced Mixed placenta: 20.6 LPAR3 Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3 ENSG00000171517 Lysophosphatidic acid receptor 3 1 84811602-84893213 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA013421 Uncertain Supported Plasma membrane Ovarian cancer:4.31e-5 (favourable) Tissue enhanced Tissue enhanced fallopian tube: 66.2 prostate: 21.5 LPAR5 GPR92, GPR93, KPG_010, LPA5 ENSG00000184574 Lysophosphatidic acid receptor 5 12 6618835-6636447 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA013170 Approved Thyroid cancer:6.56e-5 (favourable) Mixed Mixed tonsil: 11.0 LRCH2 KIAA1495 ENSG00000130224 Leucine-rich repeats and calponin homology (CH) domain containing 2 X 115110616-115234072 Predicted intracellular proteins Evidence at protein level HPA003233 Approved Approved Nucleoli
Plasma membrane Mixed Mixed prostate: 13.3 LRCOL1 ENSG00000204583 Leucine rich colipase-like 1 12 132603150-132610543 Predicted secreted proteins Evidence at transcript level Liver cancer:7.04e-4 (favourable) Tissue enhanced Tissue enriched 61 epididymis: 53.7 lung: 0.8 LRFN3 FIGLER1, MGC2656, SALM4 ENSG00000126243 Leucine rich repeat and fibronectin type III domain containing 3 19 35935358-35945767 Predicted membrane proteins Evidence at transcript level HPA048923 Approved Renal cancer:8.46e-7 (favourable) Expressed in all Mixed cerebral cortex: 8.2 LRGUK CFAP246, FLJ32786 ENSG00000155530 Leucine-rich repeats and guanylate kinase domain containing 7 134127299-134264591 Predicted intracellular proteins Evidence at protein level HPA029505, HPA029506 Uncertain Mixed Group enriched 8 epididymis: 1.7;fallopian tube: 5.4;testis: 8.3 lung,thyroid gland: 0.6 LRIG2 KIAA0806 ENSG00000198799 Leucine-rich repeats and immunoglobulin-like domains 2 1 113073209-113132260 Disease related genes, Predicted membrane proteins Evidence at protein level HPA015538 Uncertain Supported Nucleus
Golgi apparatus Endometrial cancer:9.37e-4 (unfavourable) Expressed in all Mixed parathyroid gland,thyroid gland: 5.6 LRIG3 FLJ90440, KIAA3016 ENSG00000139263 Leucine-rich repeats and immunoglobulin-like domains 3 12 58872149-58920522 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA010773 Approved Approved Cytosol Expressed in all Tissue enhanced thyroid gland: 97.1 skin: 33.1 LRIT1 DKFZP434K091, FIGLER9, LRRC21, PAL ENSG00000148602 Leucine-rich repeat, immunoglobulin-like and transmembrane domains 1 10 84231593-84241461 Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 69 testis: 6.8 all non-specific tissues: 0.0 LRIT2 AC022389.4, LRRC22 ENSG00000204033 Leucine-rich repeat, immunoglobulin-like and transmembrane domains 2 10 84220495-84225589 Predicted membrane proteins Evidence at protein level HPA037788 Uncertain Not detected Tissue enhanced cerebral cortex: 1.0;rectum: 1.2;skin: 3.1 colon: 0.6 LRP11 bA350J20.3, MANSC3 ENSG00000120256 Low density lipoprotein receptor-related protein 11 6 149818798-149864026 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA064002 Approved Mitochondria Breast cancer:2.31e-8 (unfavourable), Liver cancer:2.01e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 88.0 LRP3 hLRp105, LRP-3 ENSG00000130881 Low density lipoprotein receptor-related protein 3 19 33177603-33208867 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Pancreatic cancer:6.12e-7 (favourable) Expressed in all Mixed ovary: 63.4 LRP5L DKFZp434O0213 ENSG00000100068 Low density lipoprotein receptor-related protein 5-like 22 25351418-25405377 Predicted intracellular proteins Evidence at transcript level HPA028717 Uncertain Approved Nucleoplasm Urothelial cancer:6.93e-6 (favourable) Expressed in all Mixed thyroid gland: 9.7 LRRC10 HRLRRP, LRRC10A ENSG00000198812 Leucine rich repeat containing 10 12 69608564-69611162 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 27 heart muscle: 21.6 lymph node: 0.8 LRRC14 KIAA0014, LRRC14A ENSG00000160959 Leucine rich repeat containing 14 8 144517992-144525178 Predicted intracellular proteins Evidence at protein level HPA021047 Uncertain Approved Nucleoplasm
Cytosol Pancreatic cancer:1.78e-4 (favourable) Expressed in all Expressed in all prostate: 25.0 LRRC15 LIB ENSG00000172061 Leucine rich repeat containing 15 3 194355247-194369743 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA035503 Uncertain Approved Vesicles
Plasma membrane Tissue enhanced Mixed cervix, uterine,tonsil: 4.7 LRRC16B BC008134, C14orf121, CARMIL3, crml-1 ENSG00000186648 Leucine rich repeat containing 16B 14 24052000-24069728 Predicted intracellular proteins Evidence at protein level HPA030596 Uncertain Mixed Tissue enhanced cerebral cortex: 6.8;skin: 6.2 testis: 3.0 LRRC17 H_RG318M05.3, P37NB ENSG00000128606 Leucine rich repeat containing 17 7 102912991-102944949 Predicted secreted proteins Evidence at protein level HPA030139 Uncertain Approved Nucleoplasm
Nuclear speckles
Plasma membrane Renal cancer:4.12e-6 (unfavourable), Urothelial cancer:6.30e-4 (unfavourable) Mixed Tissue enhanced ovary: 98.8 gallbladder: 46.9 LRRC18 MGC34773, UNQ933, UNQ9338, VKGE9338 ENSG00000165383 Leucine rich repeat containing 18 10 48909483-48935190 Predicted intracellular proteins Evidence at transcript level HPA039256 Uncertain Tissue enhanced Group enriched 8 fallopian tube: 11.9;testis: 25.1 lung: 2.3 LRRC19 FLJ21302 ENSG00000184434 Leucine rich repeat containing 19 9 26993136-27005693 Predicted membrane proteins Evidence at protein level Renal cancer:7.08e-8 (favourable) Group enriched Group enriched 8 colon: 36.8;duodenum: 24.4;gallbladder: 9.5;kidney: 45.4;rectum: 36.2;small intestine: 35.4 appendix: 3.7 LRRC2 ENSG00000163827 Leucine rich repeat containing 2 3 46515423-46580099 Predicted intracellular proteins Evidence at protein level HPA039138, HPA040096 Approved Tissue enhanced Group enriched 5 heart muscle: 27.7;skeletal muscle: 56.0;thyroid gland: 36.8 endometrium: 7.8 LRRC23 B7, LRPB7 ENSG00000010626 Leucine rich repeat containing 23 12 6873569-6914243 Predicted intracellular proteins Evidence at protein level HPA037766, HPA057533 Supported Supported Nucleoli Breast cancer:6.02e-4 (favourable) Expressed in all Group enriched 7 fallopian tube: 164.7;testis: 43.2 epididymis: 14.9 LRRC24 LRRC14OS ENSG00000254402 Leucine rich repeat containing 24 8 144522377-144527032 Predicted membrane proteins Evidence at protein level HPA028171, HPA052250 Supported Approved Vesicles Not detected Tissue enhanced cerebral cortex: 3.1;prostate: 3.0 parathyroid gland: 1.7 LRRC27 KIAA1674 ENSG00000148814 Leucine rich repeat containing 27 10 132332154-132379918 Predicted intracellular proteins Evidence at protein level HPA037595 Approved Nucleus
Golgi apparatus Mixed Tissue enhanced testis: 100.6 fallopian tube: 20.9 LRRC28 FLJ34269, FLJ45242, MGC24976 ENSG00000168904 Leucine rich repeat containing 28 15 99251362-99390729 Predicted intracellular proteins Evidence at transcript level HPA039378, HPA040784, HPA066130 Approved Approved Nucleus
Golgi apparatus
Mitochondria Ovarian cancer:9.97e-5 (favourable), Cervical cancer:1.41e-4 (favourable) Expressed in all Expressed in all testis: 50.0 LRRC31 FLJ23259 ENSG00000114248 Leucine rich repeat containing 31 3 169839179-169869930 Predicted intracellular proteins Evidence at protein level HPA037548 Uncertain Mixed Group enriched 5 colon: 18.5;duodenum: 9.1;rectum: 24.7;small intestine: 11.2;stomach: 9.8 liver: 2.8 LRRC34 MGC27085 ENSG00000171757 Leucine rich repeat containing 34 3 169793428-169812986 Predicted intracellular proteins Evidence at protein level HPA035747, HPA058105 Approved Approved Cell Junctions
Microtubules
Cytokinetic bridge Mixed Group enriched 8 fallopian tube: 12.2;testis: 26.8 cerebral cortex,thyroid gland: 2.3 LRRC36 FLJ11004 ENSG00000159708 Leucine rich repeat containing 36 16 67326798-67385203 Predicted intracellular proteins Evidence at protein level HPA055237, HPA058479 Supported Mixed Tissue enriched 7 testis: 62.1 placenta: 8.7 LRRC37A KIAA0563 ENSG00000176681 Leucine rich repeat containing 37A 17 46292733-46337794 Predicted membrane proteins Evidence at protein level HPA042121, HPA042701, HPA043056, HPA045090, HPA049080 Supported Approved Vesicles Not detected Tissue enriched 8 testis: 13.5 skeletal muscle: 1.6 LRRC37A2 FLJ45049 ENSG00000238083 Leucine rich repeat containing 37, member A2 17 46511511-46555650 Predicted membrane proteins Evidence at protein level HPA042121, HPA042701, HPA043056, HPA045090, HPA049080 Supported Approved Vesicles Mixed Tissue enriched 35 testis: 11.8 appendix,bone marrow,lymph node: 0.3 LRRC37A3 FLJ34306, KIAA0563 ENSG00000176809 Leucine rich repeat containing 37, member A3 17 64854312-64919480 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA042121, HPA042701, HPA043056, HPA045090 Supported Approved Vesicles Renal cancer:3.25e-6 (unfavourable) Mixed Tissue enhanced testis: 31.5 epididymis: 14.5 LRRC37B ENSG00000185158 Leucine rich repeat containing 37B 17 32007872-32053504 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA015134, HPA015135 Approved Approved Cytosol Mixed Tissue enhanced testis: 32.4 bone marrow: 16.5 LRRC39 MGC14816 ENSG00000122477 Leucine rich repeat containing 39 1 100148449-100178273 Predicted intracellular proteins Evidence at protein level HPA028443, HPA029724 Uncertain Mixed Group enriched 10 heart muscle: 79.5;skeletal muscle: 175.7 testis: 12.2 LRRC3B LRP15 ENSG00000179796 Leucine rich repeat containing 3B 3 26622806-26710776 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA015568 Approved Group enriched Group enriched 7 cerebral cortex: 19.2;skeletal muscle: 3.9;testis: 13.0 endometrium,ovary: 1.6 LRRC3C ENSG00000204913 Leucine rich repeat containing 3C 17 39941474-39944747 Predicted membrane proteins Evidence at protein level HPA071271 Uncertain Not detected Not detected testis: 0.9 LRRC43 MGC35140 ENSG00000158113 Leucine rich repeat containing 43 12 122167738-122203471 Predicted intracellular proteins Evidence at transcript level HPA039425, HPA047606 Uncertain Approved Golgi apparatus
Vesicles Mixed Group enriched 5 fallopian tube: 29.9;testis: 8.5 parathyroid gland: 3.5 LRRC46 MGC16309 ENSG00000141294 Leucine rich repeat containing 46 17 47831627-47837713 Predicted intracellular proteins Evidence at protein level HPA021882 Approved Cytosol Endometrial cancer:2.11e-4 (favourable) Tissue enhanced Group enriched 13 fallopian tube: 119.1;testis: 55.5 lung: 6.5 LRRC49 FLJ20156 ENSG00000137821 Leucine rich repeat containing 49 15 70853239-71053657 Predicted intracellular proteins Evidence at protein level HPA015596 Uncertain Mixed Mixed epididymis: 35.0 LRRC4B DKFZp761A179, HSM, LRIG4 ENSG00000131409 Leucine rich repeat containing 4B 19 50516892-50568045 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA058986 Uncertain Group enriched Tissue enhanced cerebral cortex: 61.6 cervix, uterine: 12.8 LRRC56 DKFZp761L1518, FLJ00101 ENSG00000161328 Leucine rich repeat containing 56 11 537527-554916 Predicted intracellular proteins Evidence at transcript level HPA038728 Uncertain Lung cancer:6.19e-4 (favourable), Pancreatic cancer:6.32e-4 (favourable), Endometrial cancer:7.39e-4 (favourable) Expressed in all Tissue enhanced testis: 3.9 epididymis,fallopian tube: 1.5 LRRC61 FLJ31392, HSPC295, MGC3036 ENSG00000127399 Leucine rich repeat containing 61 7 150322639-150338150 Predicted intracellular proteins Evidence at transcript level HPA019355 Approved Approved Nucleoplasm Glioma:2.15e-5 (unfavourable), Stomach cancer:2.85e-4 (favourable) Expressed in all Mixed fallopian tube: 22.4 LRRC66 ENSG00000188993 Leucine rich repeat containing 66 4 51993702-52017620 Predicted membrane proteins Evidence at transcript level HPA014549, HPA027839 Uncertain Mixed Tissue enhanced duodenum: 23.2;small intestine: 21.0 rectum: 6.5 LRRC69 ENSG00000214954 Leucine rich repeat containing 69 8 91101832-91219236 Predicted intracellular proteins Evidence at transcript level HPA046337 Uncertain Approved Plasma membrane Mixed Tissue enhanced testis: 5.2 skin: 2.0 LRRC70 LOC100130733, SLRN ENSG00000186105 Leucine rich repeat containing 70 5 62578735-62581448 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA013409 Uncertain Mixed Mixed thyroid gland: 6.4 LRRC71 C1orf92, FLJ32884 ENSG00000160838 Leucine rich repeat containing 71 1 156920650-156933094 Predicted intracellular proteins Evidence at protein level Tissue enriched Group enriched 9 fallopian tube: 19.9;testis: 22.2 lung: 2.3 LRRC72 ENSG00000205858 Leucine rich repeat containing 72 7 16526880-16581568 Predicted intracellular proteins Evidence at transcript level HPA020554 Uncertain Not detected Tissue enriched 29 testis: 4.3 cervix, uterine: 0.1 LRRC73 C6orf154, dJ337H4.2 ENSG00000204052 Leucine rich repeat containing 73 6 43506969-43510686 Predicted intracellular proteins Evidence at protein level HPA046698 Approved Approved Cytosol Mixed Tissue enhanced fallopian tube: 8.2;testis: 24.7 cerebral cortex: 6.6 LRRC74A C14orf166B, LRRC74 ENSG00000100565 Leucine rich repeat containing 74A 14 76826372-76870302 Predicted intracellular proteins Evidence at transcript level HPA035094 Uncertain Not detected Tissue enriched 17 testis: 7.0 spleen,stomach: 0.4 LRRC74B ENSG00000187905 Leucine rich repeat containing 74B 22 21045960-21064168 Predicted intracellular proteins Evidence at transcript level HPA049947 Uncertain Not detected Group enriched 5 fallopian tube: 6.0;testis: 1.8 lung: 0.7 LRRC75A C17orf76, FAM211A, FLJ35696 ENSG00000181350 Leucine rich repeat containing 75A 17 16441577-16492153 Predicted intracellular proteins Evidence at protein level HPA028528 Uncertain Pancreatic cancer:7.46e-5 (favourable) Mixed Tissue enhanced duodenum: 11.3;small intestine: 11.2 spleen: 5.6 LRRC75B C22orf36, FAM211B, MGC131773 ENSG00000178026 Leucine rich repeat containing 75B 22 24585620-24593208 Predicted intracellular proteins Evidence at transcript level HPA002540 Uncertain Approved Nucleus
Cytosol Expressed in all Tissue enhanced testis: 2.2 cerebral cortex: 1.3 LRRC9 FLJ46156 ENSG00000131951 Leucine rich repeat containing 9 14 59919713-60063559 Predicted intracellular proteins Evidence at transcript level HPA040965, HPA041381 Uncertain Not detected Tissue enhanced parathyroid gland: 3.4;testis: 10.8 fallopian tube: 1.9 LRRD1 IMAGE:4798971 ENSG00000240720 Leucine-rich repeats and death domain containing 1 7 92112159-92179531 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 38 testis: 30.8 epididymis: 0.8 LRRIQ1 FLJ12303, KIAA1801 ENSG00000133640 Leucine-rich repeats and IQ motif containing 1 12 85036314-85263224 Predicted intracellular proteins Evidence at protein level HPA046162 Uncertain Mixed Group enriched 7 fallopian tube: 13.5;testis: 25.4 parathyroid gland: 2.8 LRRN2 FIGLER7, GAC1, LRANK1, LRRN5 ENSG00000170382 Leucine rich repeat neuronal 2 1 204617170-204685733 Predicted membrane proteins Evidence at transcript level HPA029124 Uncertain Approved Endoplasmic reticulum Endometrial cancer:2.59e-7 (unfavourable) Group enriched Tissue enhanced cerebral cortex: 23.4;parathyroid gland: 21.0 fallopian tube: 11.9 LRRN3 FIGLER5, FLJ11129, NLRR3 ENSG00000173114 Leucine rich repeat neuronal 3 7 111091006-111125454 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA043820, HPA046792 Uncertain Approved Nucleus
Cytosol Group enriched Tissue enhanced adrenal gland: 30.9;cerebral cortex: 31.2;testis: 29.0;thyroid gland: 33.4 lung: 11.6 LRRN4 C20orf75, dJ1056H1.1, NLRR4 ENSG00000125872 Leucine rich repeat neuronal 4 20 6040778-6054049 Predicted membrane proteins Evidence at protein level HPA075974 Approved Nucleus
Nucleoli
Cytosol Group enriched Tissue enriched 11 lung: 13.6 fallopian tube: 1.3 LRRN4CL ENSG00000177363 LRRN4 C-terminal like 11 62686402-62689899 Predicted membrane proteins Evidence at protein level HPA050317 Approved Approved Nucleoplasm
Nuclear bodies Tissue enriched Mixed endometrium: 16.8 LRRTM1 FLJ32082 ENSG00000162951 Leucine rich repeat transmembrane neuronal 1 2 80288351-80304749 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA062660 Approved Group enriched Tissue enhanced cerebral cortex: 13.3;salivary gland: 4.9 thyroid gland: 2.2 LRRTM2 KIAA0416 ENSG00000146006 Leucine rich repeat transmembrane neuronal 2 5 138868923-138875368 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Tissue enriched Tissue enriched 10 cerebral cortex: 29.1 placenta: 3.0 LRRTM3 ENSG00000198739 Leucine rich repeat transmembrane neuronal 3 10 66926006-67099830 Predicted membrane proteins Evidence at protein level Tissue enriched Tissue enriched 5 cerebral cortex: 22.7 ovary: 4.2 LRRTM4 FLJ12568 ENSG00000176204 Leucine rich repeat transmembrane neuronal 4 2 76747719-77593319 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Tissue enhanced Tissue enriched 6 cerebral cortex: 21.4 epididymis: 3.8 LRTM1 HT017 ENSG00000144771 Leucine-rich repeats and transmembrane domains 1 3 54918237-54967088 Predicted membrane proteins Evidence at transcript level HPA013839 Uncertain Tissue enhanced Group enriched 5 esophagus: 4.3;skeletal muscle: 9.1;spleen: 9.0 prostate: 1.4 LRTM2 ENSG00000166159 Leucine-rich repeats and transmembrane domains 2 12 1820267-1836752 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA055094 Uncertain Not detected Tissue enriched 47 cerebral cortex: 8.3 testis: 0.1 LRTOMT CFAP111, COMT2, DFNB63, LRRC51 ENSG00000184154 Leucine rich transmembrane and O-methyltransferase domain containing 11 72080331-72110782 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039949 Approved Approved Nucleoli
Microtubules Ovarian cancer:5.36e-4 (favourable), Endometrial cancer:7.70e-4 (favourable) Expressed in all Expressed in all testis: 137.8 LTB4R2 BLT2, BLTR2, JULF2, NOP9 ENSG00000213906 Leukotriene B4 receptor 2 14 24305734-24312053 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level CAB022689, HPA029680, HPA072921 Uncertain Supported Nucleoplasm
Plasma membrane Mixed Tissue enhanced skin: 40.6 spleen: 11.2 LUZP2 ENSG00000187398 Leucine zipper protein 2 11 24496970-25082631 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039007, HPA046161 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched Group enriched 6 adrenal gland: 8.5;cerebral cortex: 33.1 prostate: 3.3 LUZP6 MPD6, MTPNUT ENSG00000267697 Leucine zipper protein 6 7 135927274-135927450 Predicted intracellular proteins Evidence at transcript level HPA077907 Approved Lipid droplets Not detected Not detected skeletal muscle: 0.1 LY6E RIG-E, SCA-2, TSA-1 ENSG00000160932 Lymphocyte antigen 6 complex, locus E 8 143017982-143023832 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Renal cancer:6.74e-8 (unfavourable) Expressed in all Expressed in all lung: 109.5 LYG1 SALW1939 ENSG00000144214 Lysozyme G-like 1 2 99284238-99304742 Predicted secreted proteins Evidence at transcript level Renal cancer:8.44e-4 (favourable) Tissue enriched Group enriched 5 kidney: 21.9;testis: 4.8 breast: 2.5 LYL1 bHLHa18 ENSG00000104903 Lymphoblastic leukemia associated hematopoiesis regulator 1 19 13099033-13103161 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA075004 Approved Golgi apparatus Renal cancer:3.89e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 22.9;spleen: 21.2 appendix: 14.8 LYPD1 LYPDC1, MGC29643 ENSG00000150551 LY6/PLAUR domain containing 1 2 132644853-132671579 Predicted secreted proteins Evidence at transcript level Tissue enhanced Group enriched 17 cerebral cortex: 27.3;fallopian tube: 125.8 salivary gland: 4.5 LYPD2 LYPDC2, RGTR430, UNQ430 ENSG00000197353 LY6/PLAUR domain containing 2 8 142750150-142752534 Predicted secreted proteins Evidence at protein level HPA028599 Uncertain Cervical cancer:2.00e-4 (favourable), Head and neck cancer:2.63e-4 (favourable) Group enriched Tissue enhanced esophagus: 99.6;tonsil: 25.0 stomach: 21.6 LYPD4 MGC42718 ENSG00000273111 LY6/PLAUR domain containing 4 19 41837074-41844697 Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 745 testis: 164.8 bone marrow: 0.2 LYPD6B CT116, LYPD7 ENSG00000150556 LY6/PLAUR domain containing 6B 2 149038107-149215262 Predicted secreted proteins, Transporters Evidence at transcript level HPA049239 Uncertain Mixed Tissue enhanced gallbladder: 58.8;skin: 56.6 testis: 42.1 LYRM1 A211C6.1 ENSG00000102897 LYR motif containing 1 16 20899868-20925006 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA059840 Supported Nucleoplasm
Midbody Endometrial cancer:7.48e-7 (favourable), Renal cancer:4.80e-4 (unfavourable), Urothelial cancer:9.50e-4 (favourable) Expressed in all Expressed in all testis: 70.0 LYSMD4 FLJ33008 ENSG00000183060 LysM, putative peptidoglycan-binding, domain containing 4 15 99715697-99733561 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA029152, HPA059824 Approved Approved Actin filaments
Cytosol Expressed in all Mixed skin: 18.4 LYZL1 LYC2, MGC33408 ENSG00000120563 Lysozyme-like 1 10 29289061-29318328 Enzymes, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 139 testis: 53.2 epididymis: 0.3 LYZL2 ENSG00000151033 Lysozyme-like 2 10 30611779-30629762 Enzymes, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 668 testis: 66.7 all non-specific tissues: 0.0 LYZL4 LYC4, MGC26768 ENSG00000157093 Lysozyme-like 4 3 42397078-42410600 Predicted secreted proteins Evidence at protein level HPA038806 Approved Not detected Tissue enriched 58 testis: 43.6 cerebral cortex: 0.7 LYZL6 LYC1, PRO1485, TKAL754 ENSG00000275722 Lysozyme-like 6 17 35934518-35943699 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA025734, HPA053073 Supported Not detected Not detected testis: 0.1 MAGEA10 CT1.10, MAGE10, MGC10599 ENSG00000124260 Melanoma antigen family A10 X 152133310-152138578 Predicted intracellular proteins Evidence at protein level HPA003333, HPA070780 Approved Supported Nucleoplasm
Cytosol Mixed Group enriched 13 placenta: 13.5;testis: 4.8 skin: 0.7 MAGEA12 CT1.12, MAGE12 ENSG00000213401 Melanoma antigen family A12 X 152733779-152737669 Predicted intracellular proteins Evidence at protein level Liver cancer:3.22e-4 (unfavourable) Tissue enhanced Tissue enriched 17 testis: 4.9 cerebral cortex: 0.2 MAGEB10 FLJ32965 ENSG00000177689 Melanoma antigen family B10 X 27807990-27823014 Predicted intracellular proteins Evidence at protein level HPA000611 Uncertain Not detected Tissue enriched 10 testis: 4.6 skin: 0.4 MAGEB3 CT3.5 ENSG00000198798 Melanoma antigen family B3 X 30230436-30237492 Predicted intracellular proteins Evidence at protein level HPA072203 Approved Not detected Group enriched 160 epididymis: 22.5;testis: 9.5 all non-specific tissues: 0.0 MAGEB5 CT3.3, MAGE-B5 ENSG00000188408 Melanoma antigen family B5 X 26216169-26218270 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level HPA052627 Uncertain Not detected Not detected testis: 0.8 MAGEE2 HCA3 ENSG00000186675 Melanoma antigen family E2 X 75782988-75785236 Predicted intracellular proteins Evidence at transcript level HPA030625 Uncertain Tissue enriched Tissue enhanced cerebral cortex: 3.3 adrenal gland: 1.0 MAMDC2 MGC21981 ENSG00000165072 MAM domain containing 2 9 70043581-70226970 Predicted secreted proteins Evidence at protein level HPA021814, HPA022249 Uncertain Thyroid cancer:7.78e-4 (unfavourable) Mixed Mixed endometrium: 60.2 MAMDC4 AEGP, DKFZp434M1411 ENSG00000177943 MAM domain containing 4 9 136850943-136860799 Predicted membrane proteins Evidence at protein level CAB026377, HPA059977 Approved Approved Nucleoplasm
Cytosol Pancreatic cancer:1.88e-6 (favourable) Expressed in all Mixed spleen: 5.7 MAMSTR FLJ36070, MASTR ENSG00000176909 MEF2 activating motif and SAP domain containing transcriptional regulator 19 48712742-48719721 Predicted intracellular proteins Evidence at transcript level HPA049765 Approved Nuclear speckles Expressed in all Tissue enhanced adrenal gland: 21.5;skeletal muscle: 31.4 fallopian tube: 10.4 MAN2A2 HsT19662, MANA2X ENSG00000196547 Mannosidase, alpha, class 2A, member 2 15 90902218-90922584 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017226 Approved Renal cancer:8.95e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 46.4 MANBA ENSG00000109323 Mannosidase, beta A, lysosomal 4 102631488-102760994 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level HPA053478 Approved Supported Vesicles Liver cancer:3.74e-6 (unfavourable), Glioma:1.06e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 36.8 MANEAL FLJ31434 ENSG00000185090 Mannosidase, endo-alpha-like 1 37793802-37801137 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA063423 Approved Golgi apparatus Liver cancer:3.32e-4 (unfavourable), Head and neck cancer:5.28e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 27.2 adrenal gland: 9.6 MANSC1 FLJ10298, LOH12CR3 ENSG00000111261 MANSC domain containing 1 12 12326056-12350541 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA007955, HPA007956 Approved Approved Golgi apparatus
Vesicles Renal cancer:3.30e-5 (favourable) Expressed in all Mixed parathyroid gland: 24.2 MAP1LC3B2 ATG8G ENSG00000258102 Microtubule-associated protein 1 light chain 3 beta 2 12 116548105-116576448 Predicted intracellular proteins Evidence at transcript level HPA043000, HPA052474, HPA052484, HPA053767 Uncertain Approved Microtubule organizing center Mixed Mixed adrenal gland: 2.7 MAP3K19 FLJ23074, RCK, YSK4 ENSG00000176601 Mitogen-activated protein kinase kinase kinase 19 2 134964491-135047468 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA011388 Uncertain Cytosol Tissue enhanced Group enriched 9 fallopian tube: 32.7;testis: 18.0 lung: 2.9 MARCH11 MARCH-XI ENSG00000183654 Membrane-associated ring finger (C3HC4) 11 5 16067139-16180762 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA077262 Uncertain Vesicles Not detected Tissue enriched 20 testis: 89.9 cerebral cortex: 4.5 MARCH3 MARCH-III, MGC48332, RNF173 ENSG00000173926 Membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase 5 126867714-127030808 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA043406 Uncertain Mixed Mixed testis: 10.9 MARCH4 KIAA1399, MARCH-IV, RNF174 ENSG00000144583 Membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase 2 216257865-216372027 Predicted membrane proteins Evidence at protein level HPA014348 Approved Mixed Tissue enriched 6 cerebral cortex: 9.1 stomach: 1.6 MARVELD3 MRVLDC3 ENSG00000140832 MARVEL domain containing 3 16 71626161-71642114 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA043514, HPA045471 Approved Vesicles
Intermediate filaments Renal cancer:6.80e-10 (favourable) Mixed Tissue enhanced small intestine: 37.8 duodenum: 32.4 MAS1L dJ994E9.2, MAS-L, MRG ENSG00000204687 MAS1 proto-oncogene like, G protein-coupled receptor 6 29486697-29487956 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA017983 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Not detected Tissue enhanced cervix, uterine: 5.1 epididymis: 2.3 MBD3L1 MBD3L ENSG00000170948 Methyl-CpG binding domain protein 3-like 1 19 8832398-8843340 Predicted intracellular proteins Evidence at protein level HPA043121, HPA046753 Supported Not detected Tissue enriched 5 testis: 34.3 fallopian tube: 6.3 MBD3L2 ENSG00000230522 Methyl-CpG binding domain protein 3-like 2 19 7049321-7051735 Predicted intracellular proteins Evidence at transcript level HPA051259 Uncertain Not detected Not detected testis: 0.3 MBD6 KIAA1887 ENSG00000166987 Methyl-CpG binding domain protein 6 12 57520710-57530148 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA038948, HPA038949 Uncertain Validated Nucleus Expressed in all Expressed in all testis: 66.5 MBOAT2 FLJ14415, FLJ90298, OACT2 ENSG00000143797 Membrane bound O-acyltransferase domain containing 2 2 8852690-9003813 Enzymes, Predicted membrane proteins Evidence at protein level HPA014836 Uncertain Approved Vesicles Endometrial cancer:2.13e-9 (unfavourable), Urothelial cancer:5.32e-4 (unfavourable) Mixed Tissue enhanced parathyroid gland: 49.4 cerebral cortex: 29.8 MCCD1 ENSG00000204511 Mitochondrial coiled-coil domain 1 6 31528717-31530232 Predicted secreted proteins Evidence at transcript level HPA046948 Uncertain Renal cancer:1.73e-4 (favourable) Tissue enhanced Tissue enriched 36 kidney: 3.5 all non-specific tissues: 0.0 MCF2L2 ARHGEF22, KIAA0861 ENSG00000053524 MCF.2 cell line derived transforming sequence-like 2 3 183178043-183428778 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA038946, HPA038947 Uncertain Approved Plasma membrane
Cytosol Not detected Group enriched 8 adrenal gland: 10.3;cerebral cortex: 17.1;parathyroid gland: 7.4;spleen: 3.5;testis: 4.6 prostate: 1.0 MCOLN2 FLJ36691, TRP-ML2, TRPML2 ENSG00000153898 Mucolipin 2 1 84925583-84997113 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level HPA019114, HPA048999 Uncertain Supported Intermediate filaments Lung cancer:2.56e-4 (favourable) Mixed Mixed rectum: 17.6 MCOLN3 FLJ11006, TRP-ML3, TRPML3 ENSG00000055732 Mucolipin 3 1 85018082-85048499 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level HPA018106, HPA062137 Approved Approved Nucleoli
Cytosol Tissue enriched Tissue enhanced adrenal gland: 57.9;parathyroid gland: 42.1 epididymis: 17.3 MCTP1 FLJ22344 ENSG00000175471 Multiple C2 domains, transmembrane 1 5 94703741-95284575 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA019018 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed bone marrow: 29.1 MDH1B FLJ25341, RP11-95H11 ENSG00000138400 Malate dehydrogenase 1B, NAD (soluble) 2 206737763-206765547 Predicted intracellular proteins Evidence at transcript level HPA034741 Uncertain Mixed Group enriched 5 fallopian tube: 34.9;testis: 43.5 parathyroid gland: 7.4 MDS2 ENSG00000197880 Myelodysplastic syndrome 2 translocation associated 1 23581495-23640568 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA052999 Uncertain Tissue enhanced Tissue enhanced lymph node: 7.8;tonsil: 4.1 spleen: 2.9 ME3 ENSG00000151376 Malic enzyme 3, NADP(+)-dependent, mitochondrial 11 86441108-86672636 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA038473 Approved Urothelial cancer:3.86e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 39.0 MEDAG AWMS3, C13orf33, FLJ14834, MEDA-4 ENSG00000102802 Mesenteric estrogen-dependent adipogenesis 13 30906191-30925572 Predicted intracellular proteins Evidence at transcript level Renal cancer:3.29e-5 (unfavourable) Mixed Tissue enhanced adipose tissue: 151.7 smooth muscle: 31.8 MEGF11 DKFZp434L121, KIAA1781 ENSG00000157890 Multiple EGF-like-domains 11 15 65895079-66253747 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA017982 Uncertain Tissue enhanced Group enriched 6 cerebral cortex: 13.0;fallopian tube: 12.2 testis: 1.9 MEGF9 EGFL5 ENSG00000106780 Multiple EGF-like-domains 9 9 120600813-120714470 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA014319, HPA050238 Uncertain Approved Nucleus
Cytosol Renal cancer:5.48e-11 (favourable) Expressed in all Expressed in all thyroid gland: 47.1 MEI1 MGC40042, SPATA38 ENSG00000167077 Meiotic double-stranded break formation protein 1 22 41699499-41799456 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA049240 Approved Uncertain Nucleoplasm
Plasma membrane Cervical cancer:1.59e-6 (favourable) Tissue enhanced Mixed testis: 18.7 MEIKIN ENSG00000239642 Meiotic kinetochore factor 5 131806993-131945698 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 19 testis: 13.3 parathyroid gland: 0.6 MEIOB C16orf73, MGC35212 ENSG00000162039 Meiosis specific with OB domains 16 1833983-1884294 Predicted intracellular proteins Evidence at protein level HPA042547 Approved Nucleus
Nucleoli Not detected Tissue enriched 51 testis: 70.9 kidney: 1.3 MEIS3 DKFZp547H236, MRG2 ENSG00000105419 Meis homeobox 3 19 47403124-47419523 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA046699 Uncertain Approved Nucleoplasm Renal cancer:1.78e-6 (unfavourable) Mixed Tissue enhanced endometrium: 82.2 cerebral cortex: 65.0 MESP1 bHLHc5, MGC10676 ENSG00000166823 Mesoderm posterior bHLH transcription factor 1 15 89748661-89751310 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069981 Supported Nucleus
Nucleoli Group enriched Tissue enhanced adipose tissue: 4.8;prostate: 4.0 cerebral cortex: 1.4 MEST PEG1 ENSG00000106484 Mesoderm specific transcript 7 130486171-130506296 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA005623 Approved Golgi apparatus
Cytosol Renal cancer:6.20e-5 (unfavourable) Expressed in all Tissue enriched 8 placenta: 1079.4 adipose tissue: 131.7 METRN C16orf23, MGC2601 ENSG00000103260 Meteorin, glial cell differentiation regulator 16 715115-719655 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA051164 Approved Approved Nucleoplasm
Nuclear membrane
Cytosol Expressed in all Tissue enhanced cerebral cortex: 64.9 fallopian tube: 37.8 METRNL ENSG00000176845 Meteorin, glial cell differentiation regulator-like 17 83079691-83095119 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA023792 Uncertain Expressed in all Mixed skin: 31.0 METTL12 U99HG ENSG00000214756 Methyltransferase like 12 11 62665309-62668496 Predicted intracellular proteins Evidence at transcript level HPA038115, HPA038533 Uncertain Breast cancer:8.73e-4 (favourable) Expressed in all Not detected duodenum: 0.9 METTL24 C6orf186, dJ71D21.2 ENSG00000053328 Methyltransferase like 24 6 110245928-110358272 Predicted secreted proteins Evidence at transcript level HPA037441, HPA037442 Uncertain Mixed Tissue enhanced smooth muscle: 20.2 endometrium: 12.7 METTL25 C12orf26, FLJ22789 ENSG00000127720 Methyltransferase like 25 12 82358497-82479236 Predicted intracellular proteins Evidence at protein level HPA039534, HPA041207 Uncertain Uncertain Plasma membrane
Mitochondria
Cytosol Expressed in all Mixed testis: 13.3 METTL4 FLJ23017, HsT661 ENSG00000101574 Methyltransferase like 4 18 2537525-2571509 Predicted intracellular proteins Evidence at protein level HPA040061 Approved Approved Mitochondria Expressed in all Expressed in all thyroid gland: 17.2 METTL6 MGC24132 ENSG00000206562 Methyltransferase like 6 3 15381275-15440566 Predicted intracellular proteins Evidence at protein level HPA035166 Uncertain Approved Vesicles Liver cancer:2.66e-6 (unfavourable) Expressed in all Expressed in all testis: 33.7 METTL9 DREV1 ENSG00000197006 Methyltransferase like 9 16 21597218-21657473 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA053588, HPA056347 Uncertain Approved Nucleus
Cell Junctions
Cytosol Liver cancer:8.71e-4 (unfavourable) Expressed in all Expressed in all kidney: 182.7 MFAP2 MAGP, MAGP-1 ENSG00000117122 Microfibrillar-associated protein 2 1 16974502-16980835 Predicted secreted proteins Evidence at protein level HPA007354 Supported Renal cancer:2.52e-8 (unfavourable) Expressed in all Tissue enhanced gallbladder: 101.1 endometrium: 82.2 MFAP3 ENSG00000037749 Microfibrillar-associated protein 3 5 154038906-154220478 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA015883, HPA049198 Approved Approved Nucleoplasm
Golgi apparatus Cervical cancer:4.28e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 73.4 MFAP3L KIAA0626, NYD-sp9 ENSG00000198948 Microfibrillar-associated protein 3-like 4 169986597-170033031 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA017986, HPA077490 Approved Supported Plasma membrane Renal cancer:1.42e-8 (favourable) Expressed in all Tissue enhanced testis: 73.6 epididymis: 46.9 MFSD1 FLJ14153, UG0581B09 ENSG00000118855 Major facilitator superfamily domain containing 1 3 158732198-158829719 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA057924, HPA065858 Approved Approved Nucleus
Nucleoli Renal cancer:5.60e-5 (favourable) Expressed in all Expressed in all spleen: 35.8 MFSD11 FLJ20226, FLJ22196 ENSG00000092931 Major facilitator superfamily domain containing 11 17 76735865-76781449 Predicted membrane proteins Evidence at protein level HPA022001 Uncertain Approved Nuclear speckles Endometrial cancer:7.69e-4 (unfavourable), Urothelial cancer:7.90e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 33.9 MFSD2B ENSG00000205639 Major facilitator superfamily domain containing 2B 2 24010081-24063321 Predicted membrane proteins Evidence at protein level HPA044145 Supported Not detected Tissue enriched 9 bone marrow: 7.2 placenta: 0.7 MFSD3 ENSG00000167700 Major facilitator superfamily domain containing 3 8 144509074-144511213 Predicted membrane proteins Evidence at protein level HPA056013 Uncertain Approved Vesicles Renal cancer:5.44e-7 (favourable), Cervical cancer:5.08e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 14.2 MFSD4 DKFZp761N1114, FLJ25004, FLJ34577, UNQ3064 ENSG00000174514 Major facilitator superfamily domain containing 4 1 205568885-205602918 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Renal cancer:2.27e-13 (favourable), Lung cancer:4.59e-4 (favourable), Cervical cancer:7.54e-4 (favourable) Mixed Tissue enhanced kidney: 75.1;stomach: 108.2 cerebral cortex: 50.8 MFSD6L FLJ35773 ENSG00000185156 Major facilitator superfamily domain containing 6-like 17 8797162-8799349 Predicted membrane proteins, Transporters Evidence at transcript level HPA023164 Uncertain Breast cancer:1.84e-4 (favourable) Mixed Tissue enhanced testis: 29.7 parathyroid gland: 8.3 MFSD7 FLJ22269, LP2561 ENSG00000169026 Major facilitator superfamily domain containing 7 4 681829-689441 Predicted membrane proteins Evidence at transcript level HPA043593 Uncertain Renal cancer:2.66e-5 (favourable) Expressed in all Mixed parathyroid gland: 14.3 MFSD9 MGC11332 ENSG00000135953 Major facilitator superfamily domain containing 9 2 102715840-102736888 Predicted membrane proteins Evidence at protein level HPA055293, HPA061859 Approved Approved Nucleoli Glioma:7.48e-4 (unfavourable) Expressed in all Mixed duodenum: 10.1 MGAM2 ENSG00000257743 Maltase-glucoamylase 2 (putative) 7 142111749-142222324 Enzymes, Predicted membrane proteins Evidence at protein level HPA055697 Supported Approved Vesicles
Cytosol Group enriched Group enriched 5 duodenum: 12.2;small intestine: 10.6 salivary gland: 2.1 MGAT3 GNT-III ENSG00000128268 Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase 22 39457344-39492194 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA017598 Approved Renal cancer:5.04e-8 (unfavourable) Mixed Tissue enhanced cerebral cortex: 38.7 small intestine: 33.2 MGAT4C HGNT-IV-H ENSG00000182050 MGAT4 family, member C 12 85955666-86838904 Enzymes, Predicted membrane proteins Evidence at transcript level Tissue enriched Group enriched 5 cerebral cortex: 11.9;epididymis: 13.6;testis: 11.1;thyroid gland: 31.8 adrenal gland: 3.3 MGAT4D GnT1IP ENSG00000205301 MGAT4 family, member D 4 140442262-140498377 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA036523 Approved Not detected Tissue enriched 67 testis: 48.7 epididymis: 0.7 MGAT5 GNT-V ENSG00000152127 Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase 2 134119983-134454621 Enzymes, Predicted membrane proteins Evidence at protein level HPA010919 Approved Expressed in all Mixed parathyroid gland: 32.0 MICALCL FLJ14966 ENSG00000133808 MICAL C-terminal like 11 12276080-12359144 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA039895, HPA040438 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Mixed Tissue enhanced skin: 17.3;testis: 13.3 lung: 10.3 MICU3 DKFZp313A0139, EFHA2 ENSG00000155970 Mitochondrial calcium uptake family, member 3 8 17027238-17122644 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA024048, HPA024771, HPA024779 Uncertain Mixed Tissue enhanced cerebral cortex: 34.9 parathyroid gland: 13.9 MIDN ENSG00000167470 Midnolin 19 1248553-1259140 Predicted intracellular proteins Evidence at protein level HPA042018, HPA049432 Uncertain Approved Nucleoplasm Expressed in all Expressed in all bone marrow: 51.6 MKX C10orf48, IRXL1, MGC39616 ENSG00000150051 Mohawk homeobox 10 27672875-27746060 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006927 Uncertain Approved Nucleoplasm
Nuclear speckles Mixed Tissue enhanced ovary: 13.6;prostate: 26.1 fallopian tube: 8.1 MLNR GPR38 ENSG00000102539 Motilin receptor 13 49220338-49222377 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enhanced thyroid gland: 2.8 bone marrow: 0.8 MMD MMA, PAQR11 ENSG00000108960 Monocyte to macrophage differentiation-associated 17 55392613-55421992 Predicted membrane proteins, Transporters Evidence at transcript level HPA026978 Approved Vesicles Colorectal cancer:3.52e-5 (favourable), Liver cancer:6.39e-5 (unfavourable), Renal cancer:2.85e-4 (unfavourable), Endometrial cancer:3.88e-4 (unfavourable), Thyroid cancer:8.62e-4 (unfavourable) Expressed in all Tissue enhanced adipose tissue: 141.1 cerebral cortex: 73.3 MMEL1 MMEL2, NEPII, NL1, NL2, SEP ENSG00000142606 Membrane metallo-endopeptidase-like 1 1 2590639-2632990 Enzymes, Predicted intracellular proteins Evidence at protein level HPA007876, HPA008205, CAB020786 Uncertain Mixed Tissue enhanced testis: 5.4 stomach: 2.3 MMP21 ENSG00000154485 Matrix metallopeptidase 21 10 125766453-125775821 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 27 epididymis: 58.2 ovary: 2.1 MMP24 MT5-MMP ENSG00000125966 Matrix metallopeptidase 24 (membrane-inserted) 20 35226654-35277000 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at transcript level HPA049280 Approved Nucleoli
Plasma membrane Renal cancer:8.17e-11 (favourable) Mixed Tissue enhanced cerebral cortex: 10.6 lung: 7.1 MMP26 endometase, MGC126590, MGC126592 ENSG00000167346 Matrix metallopeptidase 26 11 4704927-4992429 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at transcript level Group enriched Tissue enriched 64 endometrium: 23.8 prostate,testis: 0.3 MMP28 EPILYSIN, MM28, MMP-25, MMP-28 ENSG00000271447 Matrix metallopeptidase 28 17 35756249-35795707 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Pancreatic cancer:6.28e-6 (unfavourable) Mixed Tissue enhanced testis: 6.4 adipose tissue: 4.2 MNS1 FLJ11222, SPATA40 ENSG00000138587 Meiosis-specific nuclear structural 1 15 56421544-56465137 Predicted intracellular proteins Evidence at protein level HPA039975, HPA040382 Uncertain Approved Nucleoplasm
Nuclear speckles Expressed in all Group enriched 6 fallopian tube: 34.8;testis: 86.8 kidney: 10.0 MOGAT1 DGAT2L, DGAT2L1, MGAT1 ENSG00000124003 Monoacylglycerol O-acyltransferase 1 2 222671786-222709930 Enzymes, Predicted membrane proteins Evidence at transcript level HPA049944 Uncertain Tissue enhanced Tissue enriched 11 gallbladder: 30.8 parathyroid gland: 2.8 MOK RAGE, RAGE1, STK30 ENSG00000080823 MOK protein kinase 14 102224500-102305200 Enzymes, Predicted intracellular proteins Evidence at protein level HPA027282, HPA027292 Approved Supported Endoplasmic reticulum Mixed Tissue enhanced testis: 71.5 fallopian tube: 33.7 MORC1 CT33, MORC, ZCW6 ENSG00000114487 MORC family CW-type zinc finger 1 3 108958239-109118142 Predicted intracellular proteins Evidence at protein level HPA036413 Supported Not detected Tissue enriched 69 testis: 29.6 epididymis: 0.4 MORN1 FLJ13941 ENSG00000116151 MORN repeat containing 1 1 2321253-2391707 Predicted intracellular proteins Evidence at protein level HPA005858, HPA070703 Uncertain Approved Nucleus
Mitochondria Mixed Tissue enhanced fallopian tube: 17.6 testis: 12.2 MORN5 C9orf113, C9orf18, FLJ46909 ENSG00000185681 MORN repeat containing 5 9 122159908-122200088 Predicted intracellular proteins Evidence at transcript level Endometrial cancer:4.86e-4 (favourable) Tissue enhanced Group enriched 6 fallopian tube: 174.0;testis: 105.8 smooth muscle: 24.5 MOSPD1 dJ473B4 ENSG00000101928 Motile sperm domain containing 1 X 134887626-134915267 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA031158 Approved Approved Nucleoplasm
Vesicles Expressed in all Expressed in all fallopian tube: 41.8 MOSPD3 CDS3, NET30 ENSG00000106330 Motile sperm domain containing 3 7 100612102-100615384 Predicted membrane proteins Evidence at protein level HPA041137, HPA048240 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 29.7 MOV10L1 CHAMP, DJ402G11.8, DKFZp434B0717 ENSG00000073146 Mov10 RISC complex RNA helicase like 1 22 50089879-50161690 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA019034 Approved Mixed Tissue enriched 10 testis: 40.0 endometrium: 4.2 MPEG1 MPG1 ENSG00000197629 Macrophage expressed 1 11 59208510-59212951 Predicted membrane proteins, Transporters Evidence at protein level HPA046801 Approved Expressed in all Tissue enhanced spleen: 287.6 appendix: 156.3 MPPED1 239AB, C22orf1, FAM1A ENSG00000186732 Metallophosphoesterase domain containing 1 22 43411196-43507848 Predicted secreted proteins Evidence at protein level Tissue enhanced Tissue enriched 9 cerebral cortex: 39.5 liver: 4.2 MRGPRD mrgD ENSG00000172938 MAS-related GPR, member D 11 68980021-68980986 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA031346 Uncertain Not detected Not detected seminal vesicle: 0.4 MRGPRE GPR167, mrgE ENSG00000184350 MAS-related GPR, member E 11 3227698-3232386 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA046556 Uncertain Tissue enhanced Tissue enhanced cervix, uterine: 1.0 endometrium,spleen: 0.6 MRGPRF GPR140, GPR168, MGC21621, mrgF ENSG00000172935 MAS-related GPR, member F 11 69004395-69013409 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA028811 Approved Supported Nuclear membrane
Plasma membrane Expressed in all Mixed smooth muscle: 77.8 MRGPRG GPR169, mrgG ENSG00000182170 MAS-related GPR, member G 11 3217944-3218813 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA058909 Uncertain Not detected Tissue enriched 18 testis: 1.7 all non-specific tissues: 0.0 MRGPRX3 MRGX3 ENSG00000179826 MAS-related GPR, member X3 11 18120955-18138480 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced salivary gland: 1.3 testis: 0.9 MRGPRX4 MRGX4 ENSG00000179817 MAS-related GPR, member X4 11 18172837-18197348 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enriched Not detected testis: 0.1 MRO B29, C18orf3, FLJ30140 ENSG00000134042 Maestro 18 50795120-50825402 Predicted intracellular proteins Evidence at transcript level HPA022011 Approved Tissue enriched Tissue enhanced cerebral cortex: 27.6;kidney: 25.3;testis: 54.6 thyroid gland: 10.4 MROH1 HEATR7A, KIAA1833 ENSG00000179832 Maestro heat-like repeat family member 1 8 144148016-144261940 Predicted intracellular proteins Evidence at protein level HPA044465 Approved Renal cancer:3.65e-6 (favourable), Endometrial cancer:6.74e-4 (favourable) Expressed in all Expressed in all thyroid gland: 14.9 MROH2B DKFZp781F0822, FLJ40243, HEATR7B2 ENSG00000171495 Maestro heat-like repeat family member 2B 5 40998017-41071342 Predicted intracellular proteins Evidence at protein level HPA059457 Supported Tissue enriched Tissue enriched 251 testis: 41.6 smooth muscle: 0.1 MROH7 C1orf175, FLJ46354, HEATR8 ENSG00000184313 Maestro heat-like repeat family member 7 1 54641754-54710266 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 30 testis: 49.5 ovary: 1.6 MROH8 C20orf131, C20orf132, dJ621N11.3, dJ621N11.4 ENSG00000101353 Maestro heat-like repeat family member 8 20 37101226-37179588 Predicted intracellular proteins Evidence at transcript level HPA060298 Uncertain Approved Nucleus Mixed Tissue enhanced testis: 41.0 epididymis: 8.6 MROH9 ARMC11, C1orf129, FLJ23550 ENSG00000117501 Maestro heat-like repeat family member 9 1 170935471-171064765 Predicted intracellular proteins Evidence at transcript level HPA028413 Uncertain Not detected Group enriched 7 fallopian tube: 3.9;lung: 1.2;testis: 2.7 endometrium: 0.3 MS4A10 CD20L7, MS4A9 ENSG00000172689 Membrane-spanning 4-domains, subfamily A, member 10 11 60785348-60801305 Predicted membrane proteins, Transporters Evidence at transcript level HPA014778 Uncertain Not detected Group enriched 93 duodenum: 76.3;small intestine: 97.7 parathyroid gland: 0.9 MS4A13 ENSG00000204979 Membrane-spanning 4-domains, subfamily A, member 13 11 60515413-60542721 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA045017, HPA063626 Uncertain Not detected Tissue enriched 54 testis: 5.3 all non-specific tissues: 0.0 MS4A14 DKFZp434H092, FLJ32856, MS4A16, NYD-SP21 ENSG00000166928 Membrane-spanning 4-domains, subfamily A, member 14 11 60378530-60417756 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Mixed Tissue enriched 12 testis: 91.2 spleen: 7.7 MS4A15 ENSG00000166961 Membrane-spanning 4-domains, subfamily A, member 15 11 60756953-60776732 Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enriched 11 lung: 71.5 endometrium: 6.2 MS4A18 ENSG00000214782 Membrane-spanning 4-domains, subfamily A, member 18 11 60729304-60744212 Predicted membrane proteins Evidence at transcript level HPA045121 Approved Not detected Tissue enhanced breast: 10.3;duodenum: 24.5 small intestine: 4.1 MS4A2 APY, FCER1B, IGER, MS4A1 ENSG00000149534 Membrane-spanning 4-domains, subfamily A, member 2 11 60088261-60098466 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA059967 Supported Mixed Tissue enhanced lung: 24.8 gallbladder: 18.5 MS4A4A CD20L1, MS4A4, MS4A7 ENSG00000110079 Membrane-spanning 4-domains, subfamily A, member 4A 11 60280541-60308972 Predicted membrane proteins Evidence at transcript level HPA029323 Approved Expressed in all Tissue enhanced placenta: 101.4 adipose tissue: 62.8 MS4A4E ENSG00000214787 Membrane-spanning 4-domains, subfamily A, member 4E 11 60201253-60243088 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA040075 Uncertain Mixed Mixed adipose tissue,gallbladder: 5.8 MS4A5 CD20L2 ENSG00000166930 Membrane-spanning 4-domains, subfamily A, member 5 11 60429589-60455214 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA043732 Uncertain Not detected Tissue enriched 270 testis: 72.6 duodenum: 0.2 MS4A6A CD20L3, MS4A6 ENSG00000110077 Membrane-spanning 4-domains, subfamily A, member 6A 11 60172014-60184666 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA011391, HPA076623 Approved Approved Vesicles Cervical cancer:6.33e-4 (favourable) Expressed in all Expressed in all lymph node: 115.2 MS4A6E ENSG00000166926 Membrane-spanning 4-domains, subfamily A, member 6E 11 60334831-60396596 Predicted membrane proteins Evidence at transcript level HPA076623 Approved Vesicles Not detected Tissue enriched 36 testis: 61.4 appendix: 1.6 MS4A7 CD20L4, CFFM4, MS4A8 ENSG00000166927 Membrane-spanning 4-domains, subfamily A, member 7 11 60378482-60395951 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017418, CAB026387 Approved Expressed in all Tissue enhanced spleen: 321.1 lung: 125.3 MS4A8 CD20L5, MS4A4, MS4A8B ENSG00000166959 Membrane-spanning 4-domains, subfamily A, member 8 11 60699574-60715811 Predicted membrane proteins Evidence at protein level HPA007318, HPA007319 Supported Tissue enhanced Tissue enhanced duodenum: 191.8;fallopian tube: 223.5;small intestine: 215.2 stomach: 49.6 MSANTD1 C4orf44, LOC345222 ENSG00000188981 Myb/SANT-like DNA-binding domain containing 1 4 3244369-3271738 Predicted intracellular proteins Evidence at transcript level Not detected Group enriched 7 cerebral cortex: 1.9;testis: 2.5 epididymis,lung,spleen: 0.3 MTHFD2L MGC72244 ENSG00000163738 Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like 4 74114174-74303099 Enzymes, Predicted intracellular proteins Evidence at protein level HPA035434 Uncertain Mixed Mixed adrenal gland: 4.9 MTMR11 CRA ENSG00000014914 Myotubularin related protein 11 1 149928651-149936898 Predicted intracellular proteins Evidence at protein level HPA030351 Approved Approved Centrosome Expressed in all Mixed rectum: 27.7 MTRNR2L1 ENSG00000256618 MT-RNR2-like 1 17 22523111-22524663 Predicted intracellular proteins Evidence at transcript level Liver cancer:8.99e-4 (favourable) Expressed in all Expressed in all heart muscle: 1053.3 MTRNR2L10 ENSG00000256045 MT-RNR2-like 10 X 55181391-55182920 Predicted intracellular proteins Evidence at transcript level Mixed Mixed kidney: 68.3 MTRNR2L3 ENSG00000256222 MT-RNR2-like 3 20 57358442-57359980 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.3 MTRNR2L4 ENSG00000232196 MT-RNR2-like 4 16 3370979-3372740 Predicted intracellular proteins Evidence at transcript level Not detected Expressed in all skeletal muscle: 98.2 MTRNR2L5 ENSG00000249860 MT-RNR2-like 5 10 55599303-55600041 Predicted intracellular proteins Evidence at transcript level Not detected Not detected skeletal muscle: 0.3 MTRNR2L6 ENSG00000270672 MT-RNR2-like 6 7 142666272-142667718 Predicted intracellular proteins Evidence at transcript level Mixed Expressed in all skeletal muscle: 131.8 MTRNR2L7 ENSG00000256892 MT-RNR2-like 7 10 37601440-37602974 Predicted intracellular proteins Evidence at transcript level Not detected Not detected adrenal gland,cerebral cortex,heart muscle,kidney,rectum,skeletal muscle,testis: 0.1 MTRNR2L8 ENSG00000255823 MT-RNR2-like 8 11 10507887-10509189 Predicted intracellular proteins Evidence at transcript level Mixed Expressed in all heart muscle: 1840.4 MTURN C7orf41, Ells1, FLJ25903 ENSG00000180354 Maturin, neural progenitor differentiation regulator homolog (Xenopus) 7 30134810-30162762 Predicted intracellular proteins Evidence at protein level HPA029507 Approved Approved Cytosol Renal cancer:7.64e-13 (favourable) Expressed in all Expressed in all cerebral cortex: 352.3 MUC15 ENSG00000169550 Mucin 15, cell surface associated 11 26559033-26572233 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA026110 Approved Tissue enriched Tissue enriched 18 epididymis: 2780.4 thyroid gland: 158.6 MUM1L1 FLJ33516 ENSG00000157502 Melanoma associated antigen (mutated) 1-like 1 X 106168305-106208956 Predicted intracellular proteins Evidence at protein level HPA000168, HPA020464 Supported Thyroid cancer:5.95e-4 (unfavourable) Mixed Tissue enriched 7 ovary: 225.9 testis: 33.8 MXRA5 DKFZp564I1922 ENSG00000101825 Matrix-remodelling associated 5 X 3308565-3346641 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level HPA000508 Uncertain Uncertain Mitochondria Glioma:2.56e-4 (unfavourable), Urothelial cancer:8.94e-4 (unfavourable) Expressed in all Tissue enhanced cervix, uterine: 56.8 skin: 35.3 MYADML2 LOC255275 ENSG00000185105 Myeloid-associated differentiation marker-like 2 17 81939645-81947233 Predicted membrane proteins Evidence at transcript level HPA041856, HPA048476 Uncertain Tissue enhanced Tissue enriched 20 skeletal muscle: 30.9 heart muscle: 1.5 MYEOV OCIM ENSG00000172927 Myeloma overexpressed 11 69294138-69367726 Predicted membrane proteins Evidence at transcript level HPA012949 Uncertain Approved Nucleus
Vesicles Pancreatic cancer:1.54e-7 (unfavourable), Renal cancer:1.48e-5 (unfavourable), Lung cancer:2.00e-4 (unfavourable) Mixed Group enriched 5 adipose tissue: 4.0;breast: 5.8;esophagus: 9.2;skin: 1.8;stomach: 7.0 appendix: 1.0 MYF5 bHLHc2 ENSG00000111049 Myogenic factor 5 12 80716912-80719673 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041691 Supported Nucleoplasm Not detected Tissue enhanced skeletal muscle: 1.9 esophagus,prostate: 0.3 MYH13 MyHC-eo ENSG00000006788 Myosin, heavy chain 13, skeletal muscle 17 10298084-10373130 Plasma proteins, Predicted intracellular proteins Evidence at protein level Not detected Not detected placenta: 0.7 MYL1 ENSG00000168530 Myosin, light chain 1, alkali; skeletal, fast 2 210290150-210315190 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA046859, HPA063034 Uncertain Head and neck cancer:6.59e-4 (unfavourable) Group enriched Tissue enriched 33 skeletal muscle: 7523.2 esophagus: 226.9 MYL10 MGC3479, MYLC2PL, PLRLC ENSG00000106436 Myosin, light chain 10, regulatory 7 101613325-101629296 Predicted intracellular proteins Evidence at protein level HPA019763 Uncertain Uncertain Microtubules Tissue enhanced Not detected cervix, uterine,placenta: 0.7 MYL5 ENSG00000215375 Myosin, light chain 5, regulatory 4 673580-682033 Predicted intracellular proteins Evidence at protein level HPA037381, HPA039262 Uncertain Approved Nucleus
Nucleoli Expressed in all Expressed in all parathyroid gland: 30.3 MYLK3 caMLCK, MLCK ENSG00000140795 Myosin light chain kinase 3 16 46703369-46790407 Enzymes, Predicted membrane proteins Evidence at protein level HPA040258 Uncertain Not detected Tissue enhanced heart muscle: 74.6 skeletal muscle: 16.9 MYLPF HUMMLC2B, MRLC2, MYL11 ENSG00000180209 Myosin light chain, phosphorylatable, fast skeletal muscle 16 30370934-30377991 Predicted intracellular proteins Evidence at protein level HPA039262 Approved Tissue enhanced Tissue enriched 94 skeletal muscle: 6542.5 esophagus: 69.5 MYO16 KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107 ENSG00000041515 Myosin XVI 13 108596152-109208007 Predicted intracellular proteins Evidence at protein level HPA040110, HPA058769, HPA071948 Uncertain Approved Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 2.2 testis: 1.0 MYO1H FLJ37587 ENSG00000174527 Myosin IH 12 109347903-109455523 Predicted intracellular proteins Evidence at protein level HPA039516 Uncertain Not detected Tissue enriched 6 testis: 1.8 thyroid gland: 0.3 MYO3A DFNB30 ENSG00000095777 Myosin IIIA 10 25934267-26212527 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA048951, HPA051893 Approved Supported Plasma membrane
Actin filaments
Cytoplasmic bodies Mixed Tissue enriched 9 testis: 6.8 skin: 0.8 MYO3B ENSG00000071909 Myosin IIIB 2 170178145-170655171 Enzymes, Predicted intracellular proteins Evidence at protein level HPA015745, HPA045483 Uncertain Mixed Group enriched 5 epididymis: 11.2;kidney: 4.6;parathyroid gland: 14.8;urinary bladder: 4.3 thyroid gland: 1.6 MYOM3 FLJ35961 ENSG00000142661 Myomesin 3 1 24056035-24112175 Predicted intracellular proteins Evidence at protein level HPA028132, HPA029752 Uncertain Approved Vesicles Renal cancer:4.28e-6 (favourable) Tissue enhanced Group enriched 5 heart muscle: 68.0;kidney: 31.7;skeletal muscle: 86.6 testis: 12.1 MYPOP P42pop ENSG00000176182 Myb-related transcription factor, partner of profilin 19 45890020-45902604 Predicted intracellular proteins Evidence at protein level HPA065307 Approved Nucleoplasm Ovarian cancer:8.67e-5 (unfavourable), Liver cancer:1.21e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 10.2 MYRFL bcm1377, C12orf15, C12orf28, FLJ25056 ENSG00000166268 Myelin regulatory factor-like 12 69825304-69959097 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA049340 Approved Approved Nucleoli Mixed Group enriched 6 duodenum: 24.4;small intestine: 24.5 testis: 4.3 MYT1L KIAA1106, NZF1, ZC2HC4B ENSG00000186487 Myelin transcription factor 1-like 2 1789113-2331260 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 11 cerebral cortex: 60.2 testis: 5.3 N4BP2L1 CG018 ENSG00000139597 NEDD4 binding protein 2-like 1 13 32400723-32428311 Predicted intracellular proteins Evidence at protein level HPA038971 Approved Uncertain Nucleoplasm
Cytosol Liver cancer:3.11e-4 (favourable) Expressed in all Expressed in all ovary: 47.6 NANOGNB ENSG00000205857 NANOG neighbor homeobox 12 7765216-7774121 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA060371 Uncertain Tissue enriched Not detected testis: 0.5 NAP1L3 MB20, MGC26312, NPL3 ENSG00000186310 Nucleosome assembly protein 1-like 3 X 93670930-93673568 Predicted intracellular proteins Evidence at protein level HPA026075 Approved Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 131.7 testis: 31.0 NAP1L5 DRLM ENSG00000177432 Nucleosome assembly protein 1-like 5 4 88695915-88698235 Predicted intracellular proteins Evidence at protein level HPA058227 Approved Approved Nucleoplasm
Cytosol Expressed in all Tissue enhanced cerebral cortex: 91.4 adrenal gland: 29.6 NAT16 C7orf52, FLJ39237 ENSG00000167011 N-acetyltransferase 16 (GCN5-related, putative) 7 101170493-101180276 Predicted intracellular proteins Evidence at transcript level HPA021918 Uncertain Uncertain Nucleus Tissue enhanced Group enriched 8 cerebral cortex: 5.1;thyroid gland: 3.0 pancreas: 0.5 NAT6 FUS2 ENSG00000243477 N-acetyltransferase 6 (GCN5-related) 3 50296402-50299421 Predicted intracellular proteins Evidence at protein level HPA039576 Approved Renal cancer:1.71e-4 (favourable), Breast cancer:3.62e-4 (favourable) Expressed in all Expressed in all testis: 45.8 NAV1 DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1 ENSG00000134369 Neuron navigator 1 1 201622885-201826969 Predicted intracellular proteins Evidence at protein level CAB012302, HPA018127, HPA027887 Approved Approved Microtubules Renal cancer:3.10e-6 (unfavourable) Mixed Mixed cerebral cortex: 31.8 NBEAL1 ALS2CR16, ALS2CR17, MGC164581 ENSG00000144426 Neurobeachin-like 1 2 203014879-203226378 Predicted intracellular proteins Evidence at protein level HPA049189, HPA049447 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed thyroid gland: 7.6 NBPF11 NBPF24 ENSG00000263956 Neuroblastoma breakpoint family, member 11 1 148102046-148152322 Predicted intracellular proteins Evidence at protein level HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050 Approved Approved Vesicles Urothelial cancer:3.20e-5 (favourable), Lung cancer:6.87e-4 (favourable) Mixed Expressed in all epididymis: 20.4 NBPF15 MGC8902, NBPF16 ENSG00000266338 Neuroblastoma breakpoint family, member 15 1 144421386-144461674 Predicted intracellular proteins Evidence at protein level HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050 Approved Approved Vesicles Renal cancer:4.11e-5 (unfavourable) Expressed in all Expressed in all epididymis: 24.7 NBPF3 AE2 ENSG00000142794 Neuroblastoma breakpoint family, member 3 1 21440128-21485005 Predicted intracellular proteins Evidence at protein level HPA042595, HPA043692, HPA044023, HPA046971, HPA058050 Approved Mixed Tissue enriched 6 testis: 20.4 breast: 3.5 NBPF4 FLJ32833 ENSG00000196427 Neuroblastoma breakpoint family, member 4 1 108223341-108244081 Predicted intracellular proteins Evidence at transcript level HPA045044, HPA046411, HPA047447, HPA058050 Uncertain Tissue enriched Tissue enhanced testis: 6.5 small intestine: 1.4 NBPF6 ENSG00000186086 Neuroblastoma breakpoint family, member 6 1 108375799-108471002 Predicted intracellular proteins Evidence at transcript level HPA045044, HPA046411, HPA047447, HPA058050 Uncertain Tissue enriched Tissue enriched 6 testis: 5.4 small intestine: 0.9 NDN HsT16328, PWCR ENSG00000182636 Necdin, melanoma antigen (MAGE) family member 15 23685400-23687330 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA074457 Approved Nucleoplasm
Cytosol Renal cancer:4.52e-4 (unfavourable) Expressed in all Mixed ovary: 84.9 NDST3 HSST3 ENSG00000164100 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 4 118033618-118258648 Enzymes, Predicted intracellular proteins Evidence at protein level HPA056189 Uncertain Not detected Tissue enhanced cerebral cortex: 3.0;spleen: 2.8 cervix, uterine: 0.7 NDST4 ENSG00000138653 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 4 114827763-115113876 Enzymes, Predicted intracellular proteins Evidence at protein level HPA011129 Uncertain Not detected Tissue enhanced cerebral cortex: 1.4;ovary: 1.8 spleen: 1.0 NEK10 FLJ32685 ENSG00000163491 NIMA-related kinase 10 3 27110085-27369460 Enzymes, Predicted intracellular proteins Evidence at protein level HPA038941 Uncertain Approved Nucleoplasm
Vesicles Breast cancer:4.20e-4 (favourable) Tissue enriched Tissue enhanced testis: 65.6 breast: 18.4 NEK5 ENSG00000197168 NIMA-related kinase 5 13 52033611-52129078 Enzymes, Predicted intracellular proteins Evidence at protein level HPA035565, HPA041399 Supported Mixed Group enriched 8 fallopian tube: 12.1;testis: 18.7 lung: 1.9 NEMP2 TMEM194B ENSG00000189362 Nuclear envelope integral membrane protein 2 2 190504342-190534722 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA057719 Approved Nucleoplasm Renal cancer:6.42e-4 (unfavourable) Expressed in all Mixed testis: 5.8 NETO1 BCTL1, BTCL1 ENSG00000166342 Neuropilin (NRP) and tolloid (TLL)-like 1 18 72742314-72868146 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA064630 Approved Golgi apparatus Tissue enhanced Tissue enriched 15 cerebral cortex: 64.1 spleen: 4.1 NEURL1 h-neu, neu-1, NEURL, RNF67 ENSG00000107954 Neuralized E3 ubiquitin protein ligase 1 10 103493979-103592552 Predicted intracellular proteins Evidence at transcript level HPA044204 Uncertain Mixed Tissue enhanced skeletal muscle: 50.9 cerebral cortex: 30.2 NEURL2 C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3 ENSG00000124257 Neuralized E3 ubiquitin protein ligase 2 20 45888625-45891287 Predicted intracellular proteins Evidence at transcript level HPA043402, HPA059842 Approved Approved Vesicles Mixed Mixed ovary: 8.6 NEURL3 Lincr, LOC93082 ENSG00000163121 Neuralized E3 ubiquitin protein ligase 3 2 96497643-96508109 Predicted intracellular proteins Evidence at transcript level Liver cancer:6.46e-4 (unfavourable) Mixed Tissue enhanced salivary gland: 13.9 pancreas: 4.2 NEUROD2 bHLHa1, NDRF ENSG00000171532 Neuronal differentiation 2 17 39603536-39609777 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Tissue enriched 146 cerebral cortex: 14.9 stomach: 0.1 NEUROD4 ATH-3, Atoh3, bHLHa4, MATH-3 ENSG00000123307 Neuronal differentiation 4 12 55019945-55030014 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015545 Supported Not detected Tissue enhanced adrenal gland: 2.3;testis: 1.0 cerebral cortex: 0.4 NEUROD6 Atoh2, bHLHa2, Math-2, Nex1, NEX1M ENSG00000164600 Neuronal differentiation 6 7 31337461-31340894 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027046 Approved Not detected Tissue enriched 225 cerebral cortex: 22.4 all non-specific tissues: 0.0 NEUROG2 Atoh4, bHLHa8, Math4A, ngn-2, NGN2 ENSG00000178403 Neurogenin 2 4 112513516-112516172 Predicted intracellular proteins, Transcription factors Evidence at transcript level CAB012342 Uncertain Tissue enhanced Tissue enhanced testis: 1.5 cerebral cortex: 0.4 NHLH1 bHLHa35, HEN1, NSCL, NSCL1 ENSG00000171786 Nescient helix loop helix 1 1 160367067-160372848 Predicted intracellular proteins, Transcription factors Evidence at transcript level CAB033854 Uncertain Group enriched Not detected skin: 0.8 NHLRC3 ENSG00000188811 NHL repeat containing 3 13 39038306-39050109 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA013738 Uncertain Expressed in all Expressed in all thyroid gland: 27.8 NHLRC4 ENSG00000257108 NHL repeat containing 4 16 566996-569495 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced fallopian tube: 18.7 parathyroid gland: 6.2 NICN1 MGC12936 ENSG00000145029 Nicolin 1 3 49422946-49429326 Predicted intracellular proteins Evidence at protein level HPA037550, HPA058014 Uncertain Supported Nucleoplasm Renal cancer:8.81e-7 (favourable), Pancreatic cancer:1.11e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 32.0 NIPA2 ENSG00000140157 Non imprinted in Prader-Willi/Angelman syndrome 2 15 22838641-22868384 Predicted membrane proteins, Transporters Evidence at protein level HPA067160, HPA071342 Approved Approved Golgi apparatus Expressed in all Expressed in all appendix: 45.7 NIPAL1 DKFZp686A06115, NPAL1 ENSG00000163293 NIPA-like domain containing 1 4 47914142-48040173 Predicted membrane proteins Evidence at transcript level HPA036765 Uncertain Approved Golgi apparatus Mixed Tissue enhanced esophagus: 24.2;skin: 31.0 rectum: 14.9 NIPAL2 FLJ13955, NPAL2 ENSG00000104361 NIPA-like domain containing 2 8 98189833-98294393 Predicted membrane proteins Evidence at transcript level HPA071759 Uncertain Expressed in all Mixed skin: 62.5 NIPSNAP3B FLJ11275 ENSG00000165028 Nipsnap homolog 3B (C. elegans) 9 104764157-104777457 Predicted intracellular proteins Evidence at protein level HPA042491 Uncertain Mixed Mixed adipose tissue: 15.5 NKAIN1 FAM77C, FLJ12650 ENSG00000084628 Na+/K+ transporting ATPase interacting 1 1 31179745-31239554 Predicted membrane proteins Evidence at transcript level HPA006873 Uncertain Group enriched Tissue enhanced adrenal gland: 13.9;cerebral cortex: 13.1;skeletal muscle: 7.4 epididymis: 4.4 NKAIN2 FAM77B, TCBA1 ENSG00000188580 Na+/K+ transporting ATPase interacting 2 6 123804141-124825657 Disease related genes, Predicted membrane proteins Evidence at transcript level HPA045860 Approved Cytosol Mixed Tissue enriched 44 cerebral cortex: 48.0 adipose tissue,skeletal muscle,testis: 1.0 NKAIN3 FAM77D, FLJ39630 ENSG00000185942 Na+/K+ transporting ATPase interacting 3 8 62248591-62999652 Predicted membrane proteins Evidence at transcript level HPA018833 Uncertain Tissue enhanced Not detected adrenal gland: 0.4 NKAIN4 bA261N11.2, C20orf58, FAM77A ENSG00000101198 Na+/K+ transporting ATPase interacting 4 20 63240784-63272694 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA029876 Approved Endometrial cancer:3.14e-4 (unfavourable) Tissue enriched Tissue enriched 13 cerebral cortex: 71.9 kidney: 5.5 NKAPL bA424I5.1, C6orf194 ENSG00000189134 NFKB activating protein-like 6 28259320-28260958 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enriched 15 testis: 53.3 seminal vesicle: 3.5 NKPD1 FLJ33600 ENSG00000179846 NTPase, KAP family P-loop domain containing 1 19 45149750-45160150 Predicted membrane proteins Evidence at protein level HPA043339 Uncertain Mixed Tissue enriched 18 skin: 13.9 breast,seminal vesicle: 0.7 NKX1-1 HSPX153, SAX2 ENSG00000235608 NK1 homeobox 1 4 1402932-1406331 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029367 Uncertain Not detected Not detected testis: 0.1 NKX1-2 bB238F13.2, C10orf121 ENSG00000229544 NK1 homeobox 2 10 124445239-124450184 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029367 Uncertain Tissue enhanced Not detected cerebral cortex: 0.7 NKX2-2 NKX2.2, NKX2B ENSG00000125820 NK2 homeobox 2 20 21511010-21514026 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003468 Approved Group enriched Tissue enhanced cerebral cortex: 10.0;stomach: 2.6 duodenum: 2.4 NKX2-3 CSX3, NKX2.3, NKX2C, NKX4-3 ENSG00000119919 NK2 homeobox 3 10 99532933-99536524 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047561 Uncertain Uncertain Nucleoli
Cytosol Tissue enhanced Tissue enhanced small intestine: 12.9;spleen: 30.1 duodenum: 11.8 NKX2-8 Nkx2-9, NKX2.8, NKX2H ENSG00000136327 NK2 homeobox 8 14 36580579-36582607 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062879 Uncertain Approved Nucleoplasm
Plasma membrane Mixed Tissue enhanced testis: 3.1 lung: 0.6 NKX3-2 BAPX1, NKX3.2, NKX3B ENSG00000109705 NK3 homeobox 2 4 13540830-13545050 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027564 Approved Approved Nucleoplasm Mixed Tissue enhanced spleen: 2.8 smooth muscle: 1.6 NKX6-1 Nkx6.1, NKX6A ENSG00000163623 NK6 homeobox 1 4 84491987-84498450 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036774, CAB070169 Supported Supported Nucleoplasm Mixed Tissue enhanced esophagus: 6.9;thyroid gland: 2.9 testis: 1.4 NKX6-2 GTX, NKX6.1, NKX6B ENSG00000148826 NK6 homeobox 2 10 132783179-132786052 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Group enriched 26 cerebral cortex: 15.8;stomach: 17.1 testis: 0.6 NKX6-3 FLJ25169 ENSG00000165066 NK6 homeobox 3 8 41645178-41650669 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA042790 Uncertain Group enriched Tissue enhanced duodenum: 17.7;stomach: 51.1 parathyroid gland: 7.8 NLGN4Y KIAA0951 ENSG00000165246 Neuroligin 4, Y-linked Y 14522638-14845650 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA001651 Approved Mixed Tissue enhanced prostate: 11.0;seminal vesicle: 12.3 cerebral cortex: 7.4 NLRC3 CLR16.2, FLJ00348, NOD3 ENSG00000167984 NLR family, CARD domain containing 3 16 3539033-3577400 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA048062 Supported Microtubule organizing center
Cytosol Mixed Tissue enhanced lymph node: 16.7 spleen: 11.8 NLRP11 CLR19.6, NALP11, NOD17, PAN10, PYPAF6 ENSG00000179873 NLR family, pyrin domain containing 11 19 55785397-55836800 Predicted intracellular proteins Evidence at transcript level HPA046402 Uncertain Not detected Tissue enhanced epididymis: 1.2;testis: 1.3 liver,tonsil: 0.4 NLRP13 CLR19.7, NALP13, NOD14, PAN13 ENSG00000173572 NLR family, pyrin domain containing 13 19 55891699-55932336 Predicted intracellular proteins Evidence at protein level HPA060459 Uncertain Not detected Not detected breast: 0.7 NLRP2P NALP2P, NOD24 ENSG00000215174 NLR family, pyrin domain containing 2 pseudogene X 57677067-57680260 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 NLRP5 CLR19.8, MATER, NALP5, PAN11, PYPAF8 ENSG00000171487 NLR family, pyrin domain containing 5 19 55999726-56061813 Predicted secreted proteins Evidence at protein level HPA056271 Uncertain Not detected Tissue enriched 50 parathyroid gland: 22.5 testis: 0.4 NLRP8 CLR19.2, NALP8, NOD16, PAN4 ENSG00000179709 NLR family, pyrin domain containing 8 19 55947832-55988629 Predicted intracellular proteins Evidence at transcript level HPA056989 Uncertain Not detected Not detected breast: 0.5 NLRP9 CLR19.1, NALP9, NOD6, PAN12 ENSG00000185792 NLR family, pyrin domain containing 9 19 55708432-55738402 Predicted intracellular proteins Evidence at transcript level HPA042623 Uncertain Tissue enriched Tissue enhanced prostate: 1.5 testis: 0.6 NME8 CILD6, NM23-H8, SPTRX2, TXNDC3 ENSG00000086288 NME/NM23 family member 8 7 37848597-37900401 Disease related genes, Predicted intracellular proteins Evidence at protein level CAB016416, HPA019259 Supported Mixed Group enriched 14 bone marrow: 8.2;testis: 18.3 appendix,spleen: 0.9 NME9 NM23-H9, TXL-2, TXNDC6 ENSG00000181322 NME/NM23 family member 9 3 138261437-138329886 Predicted intracellular proteins Evidence at protein level HPA040000, HPA043881 Supported Mixed Tissue enhanced fallopian tube: 29.9 testis: 6.9 NMS ENSG00000204640 Neuromedin S 2 100470482-100483280 Predicted secreted proteins Evidence at transcript level HPA035420 Uncertain Not detected Tissue enriched 13 testis: 1.2 all non-specific tissues: 0.0 NMUR1 FM-3, GPC-R, GPR66, NMU1R ENSG00000171596 Neuromedin U receptor 1 2 231523160-231530495 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level HPA027895 Uncertain Mixed Mixed adipose tissue: 5.5 NNAT Peg5 ENSG00000053438 Neuronatin 20 37521215-37523693 Predicted membrane proteins Evidence at transcript level Group enriched Group enriched 5 cerebral cortex: 158.1;placenta: 148.0 adipose tissue: 28.1 NOCT Ccr4c, CCR4L, CCRN4L, NOC ENSG00000151014 Nocturnin 4 139015789-139045939 Enzymes, Predicted intracellular proteins Evidence at protein level HPA012287, HPA053714 Uncertain Supported Nucleoplasm
Nuclear bodies
Cytosol Renal cancer:1.05e-5 (unfavourable), Lung cancer:5.28e-5 (unfavourable), Urothelial cancer:6.23e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 21.2 gallbladder: 8.4 NOTO ENSG00000214513 Notochord homeobox 2 73202258-73212513 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA034660 Uncertain Not detected Not detected skin: 0.4 NOXRED1 C14orf148, FLJ32809 ENSG00000165555 NADP-dependent oxidoreductase domain containing 1 14 77394021-77423517 Predicted intracellular proteins Evidence at transcript level HPA055658 Approved Mixed Tissue enhanced testis: 12.1 parathyroid gland: 2.5 NPAS1 bHLHe11, MOP5, PASD5 ENSG00000130751 Neuronal PAS domain protein 1 19 47019820-47045775 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043364, HPA072259 Approved Approved Nucleoplasm Tissue enhanced Group enriched 5 cerebral cortex: 3.9;skin: 4.4;spleen: 1.9;stomach: 2.7 lymph node: 0.6 NPAS3 bHLHe12, MOP6, PASD6 ENSG00000151322 Neuronal PAS domain protein 3 14 32934933-33804176 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA002892 Approved Approved Nucleoplasm Tissue enhanced Tissue enhanced cerebral cortex: 25.0 cervix, uterine: 10.0 NPFFR1 GPR147, NPFF1R1, OT7T022 ENSG00000148734 Neuropeptide FF receptor 1 10 70247329-70283676 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA037521 Uncertain Tissue enhanced Tissue enhanced testis: 2.1 cerebral cortex,lymph node: 0.8 NPIPA1 morpheus, NPIP ENSG00000183426 Nuclear pore complex interacting protein family, member A1 16 14750813-14952060 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA053611 Supported Approved Nucleoplasm Mixed Mixed ovary: 68.2 NPIPA5 ENSG00000183793 Nuclear pore complex interacting protein family, member A5 16 15363624-15381047 Predicted membrane proteins Evidence at protein level HPA053611 Approved Approved Nucleoplasm Mixed Mixed testis: 17.2 NPIPB3 KIAA0220, NPIPL3 ENSG00000169246 Nuclear pore complex interacting protein family, member B3 16 21402237-21448567 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA053611 Approved Approved Nucleoplasm Mixed Expressed in all skin: 229.8 NPIPB5 ENSG00000243716 Nuclear pore complex interacting protein family, member B5 16 22479121-22536521 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA053611 Approved Approved Nucleoplasm Mixed Expressed in all skin: 271.1 NPNT EGFL6L, POEM ENSG00000168743 Nephronectin 4 105894775-106004027 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA003711, HPA050203 Supported Approved Nucleus
Cell Junctions
Cytosol Renal cancer:8.28e-8 (favourable) Expressed in all Tissue enhanced lung: 168.7;thyroid gland: 274.6 prostate: 126.2 NPTX1 ENSG00000171246 Neuronal pentraxin I 17 80467148-80477843 Predicted secreted proteins Evidence at protein level Tissue enhanced Tissue enriched 28 cerebral cortex: 122.8 adrenal gland: 4.3 NPY4R PP1, PPYR1, Y4 ENSG00000204174 Neuropeptide Y receptor Y4 10 46461099-46465881 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA027863 Approved Tissue enhanced Tissue enhanced colon: 9.0;rectum: 10.5 skin: 6.4 NPY5R NPYR5 ENSG00000164129 Neuropeptide Y receptor Y5 4 163343939-163351934 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced spleen: 12.5;testis: 9.6 adipose tissue: 7.6 NRAP ENSG00000197893 Nebulin-related anchoring protein 10 113588716-113664127 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA037953, HPA037954 Approved Group enriched Group enriched 19 heart muscle: 198.7;skeletal muscle: 814.2 esophagus: 26.5 NRBP2 DKFZp434P086 ENSG00000185189 Nuclear receptor binding protein 2 8 143833594-143840974 Enzymes, Predicted intracellular proteins Evidence at protein level CAB020944, HPA029051, HPA029052 Approved Approved Cytosol Renal cancer:2.01e-5 (unfavourable) Expressed in all Expressed in all cerebral cortex: 55.4 NRN1 NRN ENSG00000124785 Neuritin 1 6 5997999-6007605 Predicted membrane proteins Evidence at protein level Renal cancer:4.79e-5 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 153.0 adipose tissue: 61.4 NRN1L MRCC2446, UNQ2446 ENSG00000188038 Neuritin 1-like 16 67884805-67888855 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA041761 Uncertain Not detected Mixed skin: 3.3 NRSN2 C20orf98, dJ1103G7.6 ENSG00000125841 Neurensin 2 20 346782-359660 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA015967 Approved Approved Nucleoplasm
Vesicles
Cytosol Pancreatic cancer:1.61e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 126.5 parathyroid gland: 68.4 NRXN1 Hs.22998, KIAA0578 ENSG00000179915 Neurexin 1 2 49918505-51225564 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Tissue enriched Tissue enriched 7 cerebral cortex: 83.7 testis: 12.1 NRXN2 ENSG00000110076 Neurexin 2 11 64606174-64723188 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA051470 Approved Nucleus
Nuclear membrane
Cytosol Tissue enhanced Tissue enriched 8 cerebral cortex: 143.0 testis: 17.0 NSUN3 FLJ22609 ENSG00000178694 NOP2/Sun domain family, member 3 3 94062916-94128545 Predicted intracellular proteins Evidence at protein level HPA036181, HPA057979 Uncertain Approved Nucleoplasm
Nuclear membrane Expressed in all Mixed testis: 8.0 NSUN7 FLJ14001 ENSG00000179299 NOP2/Sun domain family, member 7 4 40749897-40809985 Predicted intracellular proteins Evidence at protein level HPA020653 Uncertain Supported Vesicles Renal cancer:2.76e-8 (favourable) Mixed Tissue enhanced testis: 31.4 fallopian tube: 11.4 NT5C1A CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201 ENSG00000116981 5'-nucleotidase, cytosolic IA 1 39659121-39672038 Enzymes, Predicted intracellular proteins Evidence at protein level HPA050283, HPA054158 Supported Not detected Tissue enhanced heart muscle: 8.1;skeletal muscle: 24.9 cerebral cortex: 4.8 NT5C1B AIRP, CN-IB ENSG00000185013 5'-nucleotidase, cytosolic IB 2 18562872-18589572 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at transcript level HPA056683 Uncertain Not detected Tissue enriched 16 testis: 57.8 parathyroid gland: 3.5 NT5DC4 ENSG00000144130 5'-nucleotidase domain containing 4 2 112721486-112742879 Predicted intracellular proteins Evidence at transcript level HPA046856 Uncertain Tissue enhanced Tissue enriched 7 testis: 3.5 lymph node: 0.5 NTN5 ENSG00000142233 Netrin 5 19 48661407-48673081 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Mixed Mixed endometrium,fallopian tube,ovary: 1.5 NUDT13 DKFZp586P2219 ENSG00000166321 Nudix (nucleoside diphosphate linked moiety X)-type motif 13 10 73110375-73131828 Predicted intracellular proteins Evidence at transcript level HPA040636 Approved Approved Nucleus Mixed Mixed epididymis: 6.2 NUDT7 ENSG00000140876 Nudix (nucleoside diphosphate linked moiety X)-type motif 7 16 77722492-77742260 Predicted intracellular proteins Evidence at protein level HPA042042 Supported Renal cancer:5.36e-11 (favourable), Head and neck cancer:1.84e-4 (unfavourable) Expressed in all Expressed in all liver: 35.7 NUGGC C8orf80, HMFN0672, SLIP-GC ENSG00000189233 Nuclear GTPase, germinal center associated 8 28021964-28083871 Predicted intracellular proteins Evidence at protein level Tissue enriched Tissue enhanced lymph node: 23.2;tonsil: 22.4 liver: 11.0 NUP210L ENSG00000143552 Nucleoporin 210kDa-like 1 153992685-154155116 Cancer-related genes, Predicted membrane proteins Evidence at protein level HPA047195, HPA064245, HPA066707 Supported Approved Nuclear bodies Not detected Tissue enriched 93 testis: 47.5 seminal vesicle: 0.5 NUTM2A FAM22A ENSG00000184923 NUT family member 2A 10 87225448-87236908 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA064635 Uncertain Nuclear bodies Not detected Mixed skin: 1.9 NUTM2F DKFZp434I1117, FAM22F ENSG00000130950 NUT family member 2F 9 94318196-94328644 Predicted intracellular proteins Evidence at protein level HPA064635 Uncertain Nuclear bodies Not detected Tissue enriched 12 testis: 1.2 all non-specific tissues: 0.0 NWD2 KIAA1239 ENSG00000174145 NACHT and WD repeat domain containing 2 4 37244220-37449465 Predicted intracellular proteins Evidence at protein level HPA046911 Uncertain Not detected Tissue enhanced cerebral cortex: 6.2 thyroid gland: 1.4 NXF5 ENSG00000126952 Nuclear RNA export factor 5 X 101832112-101857577 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA002079 Uncertain Not detected Not detected cerebral cortex,epididymis,spleen: 0.1 NXNL1 RDCVF, TXNL6 ENSG00000171773 Nucleoredoxin-like 1 19 17455425-17460954 Predicted intracellular proteins Evidence at protein level HPA042010 Approved Not detected Tissue enhanced adipose tissue: 2.0 skin: 1.0 NXNL2 C9orf121 ENSG00000130045 Nucleoredoxin-like 2 9 88535101-88584274 Predicted intracellular proteins Evidence at transcript level HPA045526 Uncertain Approved Cytosol Endometrial cancer:3.83e-8 (favourable), Breast cancer:6.53e-4 (favourable), Renal cancer:9.60e-4 (favourable) Group enriched Mixed adipose tissue: 8.1 NXPE1 FAM55A, MGC34290 ENSG00000095110 Neurexophilin and PC-esterase domain family, member 1 11 114521715-114559895 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA049133 Supported Tissue enriched Group enriched 13 colon: 114.0;rectum: 168.7 appendix: 11.0 NXPE2 FAM55B, FLJ25224 ENSG00000204361 Neurexophilin and PC-esterase domain family, member 2 11 114678386-114706933 Predicted intracellular proteins Evidence at protein level HPA039744, HPA039876 Supported Colorectal cancer:9.29e-5 (favourable) Tissue enhanced Tissue enhanced colon: 9.7;epididymis: 29.8;rectum: 9.9 salivary gland: 8.2 NXPE3 FAM55C, MGC15606 ENSG00000144815 Neurexophilin and PC-esterase domain family, member 3 3 101779202-101828229 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA036259 Uncertain Approved Nucleoplasm
Vesicles Renal cancer:7.76e-6 (unfavourable) Mixed Mixed parathyroid gland: 34.2 NXPE4 C11orf33, FAM55D, FLJ20127 ENSG00000137634 Neurexophilin and PC-esterase domain family, member 4 11 114570591-114595762 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042801 Approved Tissue enriched Group enriched 9 colon: 142.1;rectum: 161.0;salivary gland: 38.4 appendix: 12.4 NXPH1 ENSG00000122584 Neurexophilin 1 7 8433955-8752963 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA020062 Uncertain Group enriched Group enriched 83 adrenal gland: 52.3;cerebral cortex: 47.3 breast,testis: 0.5 NXPH2 NPH2 ENSG00000144227 Neurexophilin 2 2 138670772-138780348 Predicted secreted proteins Evidence at transcript level HPA034759 Approved Mixed Group enriched 9 cerebral cortex: 5.7;kidney: 5.0;ovary: 13.9 endometrium: 0.9 NXPH4 NPH4 ENSG00000182379 Neurexophilin 4 12 57216795-57226449 Predicted secreted proteins Evidence at transcript level Renal cancer:7.68e-6 (unfavourable), Liver cancer:2.57e-4 (unfavourable), Endometrial cancer:6.21e-4 (unfavourable), Glioma:8.20e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 8.3;prostate: 6.7;skin: 12.2 placenta: 3.8 NYAP1 C7orf51, FLJ37538, KIAA1486L ENSG00000166924 Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 7 100483927-100494799 Predicted intracellular proteins Evidence at protein level HPA022251 Uncertain Supported Golgi apparatus
Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 25.2;testis: 7.7 adrenal gland: 3.3 NYNRIN CGIN1, FLJ11811, KIAA1305 ENSG00000205978 NYN domain and retroviral integrase containing 14 24398786-24419288 Predicted intracellular proteins Evidence at protein level HPA018945 Approved Approved Nucleoplasm
Golgi apparatus
Vesicles Expressed in all Mixed ovary: 42.6 OAF MGC52117 ENSG00000184232 Out at first homolog 11 120210767-120230332 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA047412 Uncertain Approved Nucleus Head and neck cancer:5.71e-5 (unfavourable) Expressed in all Expressed in all liver: 80.2 OBP2B hOBPIIb, LCN14 ENSG00000171102 Odorant binding protein 2B 9 133205277-133209250 Predicted secreted proteins Evidence at protein level Group enriched Tissue enhanced breast: 1.8;testis: 6.8 fallopian tube: 1.4 OC90 PLA2L ENSG00000253117 Otoconin 90 8 132024220-132059380 Predicted secreted proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OCEL1 FLJ22709 ENSG00000099330 Occludin/ELL domain containing 1 19 17226204-17229219 Predicted intracellular proteins Evidence at protein level HPA042070, HPA043223 Uncertain Approved Golgi apparatus Expressed in all Expressed in all epididymis: 21.9 OCLM ENSG00000262180 Oculomedin 1 186400572-186401455 Predicted membrane proteins Evidence at transcript level Mixed Mixed epididymis: 2.4 OCSTAMP C20orf123, dJ257E24.3 ENSG00000149635 Osteoclast stimulatory transmembrane protein 20 46540946-46550574 Predicted membrane proteins Evidence at transcript level HPA031116 Uncertain Not detected Not detected testis: 0.2 ODF2L KIAA1229 ENSG00000122417 Outer dense fiber of sperm tails 2-like 1 86346824-86396342 Predicted intracellular proteins Evidence at protein level HPA028020, HPA028095, HPA028333 Uncertain Approved Mitochondria Renal cancer:4.69e-7 (unfavourable) Mixed Expressed in all fallopian tube: 34.0 ODF3 CT135, hSHIPPO, SHIPPO1 ENSG00000177947 Outer dense fiber of sperm tails 3 11 196738-200261 Predicted intracellular proteins Evidence at protein level HPA038919, HPA039241 Uncertain Not detected Tissue enriched 94 testis: 9.3 all non-specific tissues: 0.0 ODF3B ENSG00000177989 Outer dense fiber of sperm tails 3B 22 50529710-50532580 Predicted intracellular proteins Evidence at protein level HPA062837 Approved Renal cancer:2.65e-5 (unfavourable), Endometrial cancer:2.84e-4 (favourable), Head and neck cancer:4.89e-4 (favourable) Expressed in all Tissue enhanced fallopian tube: 74.1 appendix: 37.8 ODF3L1 MGC48986 ENSG00000182950 Outer dense fiber of sperm tails 3-like 1 15 75723977-75727688 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enriched 6 testis: 24.0 gallbladder: 3.9 OGFOD2 FLJ13491, FLJ37501 ENSG00000111325 2-oxoglutarate and iron-dependent oxygenase domain containing 2 12 122974580-122980043 Predicted intracellular proteins Evidence at protein level HPA039448, HPA040306 Approved Supported Nucleoplasm
Nuclear bodies Mixed Expressed in all testis: 23.0 OGFRL1 dJ331H24.1 ENSG00000119900 Opioid growth factor receptor-like 1 6 71288803-71308950 Predicted intracellular proteins Evidence at protein level HPA027122 Approved Nucleoplasm
Golgi apparatus Liver cancer:3.62e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 70.6 OLAH FLJ11106, SAST, THEDC1 ENSG00000152463 Oleoyl-ACP hydrolase 10 15032227-15073852 Enzymes, Predicted intracellular proteins Evidence at protein level HPA037947, HPA037948 Approved Group enriched Tissue enriched 6 testis: 46.1 breast: 7.1 OLFML2A FLJ00237 ENSG00000185585 Olfactomedin-like 2A 9 124777158-124814885 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA021180, HPA022254 Approved Approved Nucleoplasm
Cytosol Renal cancer:3.73e-5 (unfavourable) Expressed in all Mixed spleen: 48.3 OLFML2B DKFZP586L151 ENSG00000162745 Olfactomedin-like 2B 1 161983192-162023854 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA054136, HPA062739 Approved Approved Cytosol Renal cancer:1.01e-12 (unfavourable), Liver cancer:4.67e-4 (unfavourable) Expressed in all Tissue enhanced gallbladder: 77.2 placenta: 58.1 OLFML3 HNOEL-iso, OLF44 ENSG00000116774 Olfactomedin-like 3 1 113979391-114035572 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Renal cancer:3.45e-5 (unfavourable) Expressed in all Mixed cervix, uterine: 265.4 OLIG2 BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17 ENSG00000205927 Oligodendrocyte lineage transcription factor 2 21 33025845-33029196 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003254, CAB019381 Supported Uncertain Nucleoplasm
Plasma membrane Tissue enriched Tissue enriched 239 cerebral cortex: 91.2 duodenum: 0.3 OMP ENSG00000254550 Olfactory marker protein 11 77102840-77103331 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced duodenum: 2.7;small intestine: 2.8 rectum: 2.0 ONECUT1 HNF-6, HNF6, HNF6A ENSG00000169856 One cut homeobox 1 15 52756989-52791078 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003457 Approved Group enriched Group enriched 6 gallbladder: 8.5;liver: 5.9;pancreas: 2.3;testis: 1.8 bone marrow: 0.7 ONECUT2 OC-2 ENSG00000119547 One cut homeobox 2 18 57435685-57491297 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057058 Approved Supported Nucleoplasm
Actin filaments Group enriched Tissue enhanced duodenum: 10.6;gallbladder: 16.4 liver: 4.5 OOEP C6orf156, Em:AC019205.2, KHDC2 ENSG00000203907 Oocyte expressed protein 6 73368555-73395133 Predicted intracellular proteins Evidence at transcript level HPA055165 Approved Tissue enriched Tissue enriched 12 testis: 23.1 placenta: 1.9 OOSP2 FLJ36198, PLAC1L, TMEM122 ENSG00000149507 Oocyte secreted protein 2 11 60040275-60048044 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA050914 Approved Not detected Tissue enriched 485 testis: 48.4 all non-specific tissues: 0.0 OPALIN HTMP10, TMEM10, TMP10 ENSG00000197430 Oligodendrocytic myelin paranodal and inner loop protein 10 96343216-96359365 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014372 Supported Tissue enriched Tissue enriched 866 cerebral cortex: 86.6 all non-specific tissues: 0.0 OR10A2 OR10A2P, OST363 ENSG00000170790 Olfactory receptor, family 10, subfamily A, member 2 11 6869693-6870745 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10A3 HSHTPCRX12, HTPCRX12 ENSG00000170683 Olfactory receptor, family 10, subfamily A, member 3 11 7938534-7939594 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10A4 OR10A4P ENSG00000170782 Olfactory receptor, family 10, subfamily A, member 4 11 6876625-6877619 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.1 OR10A5 JCG6, OR10A1, OR11-403 ENSG00000166363 Olfactory receptor, family 10, subfamily A, member 5 11 6845652-6846705 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10AD1 OR10AD1P ENSG00000172640 Olfactory receptor, family 10, subfamily AD, member 1 12 48202083-48203387 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA049913 Uncertain Not detected Mixed testis: 1.2 OR10AG1 ENSG00000174970 Olfactory receptor, family 10, subfamily AG, member 1 11 55967558-55968463 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10G2 ENSG00000255582 Olfactory receptor, family 10, subfamily G, member 2 14 21633836-21634940 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected lymph node: 0.2 OR10G8 ENSG00000234560 Olfactory receptor, family 10, subfamily G, member 8 11 124029590-124030634 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10H1 ENSG00000186723 Olfactory receptor, family 10, subfamily H, member 1 19 15807003-15808126 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected urinary bladder: 0.7 OR10H2 ENSG00000171942 Olfactory receptor, family 10, subfamily H, member 2 19 15728020-15729060 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10H3 ENSG00000171936 Olfactory receptor, family 10, subfamily H, member 3 19 15741393-15742343 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10H5 ENSG00000172519 Olfactory receptor, family 10, subfamily H, member 5 19 15793951-15795082 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR10J1 HGMP07J, HSHGMP07J ENSG00000196184 Olfactory receptor, family 10, subfamily J, member 1 1 159439722-159440811 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 101 testis: 10.1 all non-specific tissues: 0.0 OR10J5 ENSG00000184155 Olfactory receptor, family 10, subfamily J, member 5 1 159535078-159536007 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected liver: 0.1 OR10K1 ENSG00000173285 Olfactory receptor, family 10, subfamily K, member 1 1 158465562-158466503 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA059125 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR10P1 OR10P1P, OR10P2P, OR10P3P, OST701 ENSG00000175398 Olfactory receptor, family 10, subfamily P, member 1 12 55636860-55637854 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected heart muscle: 0.2 OR10S1 ENSG00000196248 Olfactory receptor, family 10, subfamily S, member 1 11 123976661-123977781 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA019038 Uncertain Not detected Not detected thyroid gland: 0.1 OR10W1 OR10W1P ENSG00000172772 Olfactory receptor, family 10, subfamily W, member 1 11 58266792-58268260 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR11A1 hs6M1-18, OR11A2 ENSG00000204694 Olfactory receptor, family 11, subfamily A, member 1 6 29425504-29457071 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR11H12 ENSG00000257115 Olfactory receptor, family 11, subfamily H, member 12 14 18601045-18602129 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047370 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR11H4 ENSG00000176198 Olfactory receptor, family 11, subfamily H, member 4 14 20242739-20243820 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA052790 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR12D2 hs6M1-20 ENSG00000168787 Olfactory receptor, family 12, subfamily D, member 2 (gene/pseudogene) 6 29396700-29397623 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR12D3 hs6M1-27 ENSG00000112462 Olfactory receptor, family 12, subfamily D, member 3 6 29373423-29375291 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR13A1 ENSG00000256574 Olfactory receptor, family 13, subfamily A, member 1 10 45302654-45315608 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA057237 Uncertain Tissue enhanced Not detected urinary bladder: 0.5 OR13C2 ENSG00000276119 Olfactory receptor, family 13, subfamily C, member 2 9 104604671-104605627 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected cerebral cortex,fallopian tube,thyroid gland: 0.1 OR13C3 ENSG00000204246 Olfactory receptor, family 13, subfamily C, member 3 9 104535749-104536856 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA053978 Uncertain Not detected Not detected testis: 0.7 OR13C5 ENSG00000277556 Olfactory receptor, family 13, subfamily C, member 5 9 104598457-104599413 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected adrenal gland,fallopian tube,seminal vesicle,testis,thyroid gland: 0.1 OR13D1 ENSG00000179055 Olfactory receptor, family 13, subfamily D, member 1 9 104694422-104695462 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA055921 Uncertain Not detected Not detected testis: 0.5 OR13G1 ENSG00000197437 Olfactory receptor, family 13, subfamily G, member 1 1 247672118-247673041 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.4 OR13H1 ENSG00000171054 Olfactory receptor, family 13, subfamily H, member 1 X 131544074-131545000 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR13J1 ENSG00000168828 Olfactory receptor, family 13, subfamily J, member 1 9 35869263-35870601 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected cerebral cortex: 0.3 OR14J1 hs6M1-28, OR5U1 ENSG00000204695 Olfactory receptor, family 14, subfamily J, member 1 6 29306690-29307655 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA045575 Uncertain Not detected Not detected testis: 0.1 OR1A1 OR17-7 ENSG00000172146 Olfactory receptor, family 1, subfamily A, member 1 17 3215621-3216550 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR1A2 OR17-6 ENSG00000172150 Olfactory receptor, family 1, subfamily A, member 2 17 3197519-3198448 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR1C1 HSTPCR27, TPCR27 ENSG00000221888 Olfactory receptor, family 1, subfamily C, member 1 1 247757462-247758406 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 40 testis: 4.0 all non-specific tissues: 0.0 OR1E2 OR17-135, OR17-93, OR1E4 ENSG00000127780 Olfactory receptor, family 1, subfamily E, member 2 17 3432870-3433841 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR1F1 Olfmf, OR16-36, OR16-37, OR16-88, OR16-89, OR16-90, OR1F10, OR1F13P, OR1F4, OR1F5, OR1F6, OR1F7, OR1F8, OR1F9, OR3-145 ENSG00000168124 Olfactory receptor, family 1, subfamily F, member 1 16 3204247-3205188 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.7 OR1G1 OR17-209, OR1G2 ENSG00000183024 Olfactory receptor, family 1, subfamily G, member 1 17 3126584-3127581 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.2 OR1J1 hg32 ENSG00000136834 Olfactory receptor, family 1, subfamily J, member 1 9 122476958-122477926 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected epididymis: 0.2 OR1J2 OR1J3, OR1J5, OST044 ENSG00000197233 Olfactory receptor, family 1, subfamily J, member 2 9 122510802-122511743 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected urinary bladder: 0.2 OR1J4 HSHTPCRX01, HTPCRX01 ENSG00000239590 Olfactory receptor, family 1, subfamily J, member 4 9 122519141-122520082 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected epididymis: 0.2 OR1K1 hg99, MNAB ENSG00000165204 Olfactory receptor, family 1, subfamily K, member 1 9 122800123-122801073 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.2 OR1L3 OR9-D ENSG00000171481 Olfactory receptor, family 1, subfamily L, member 3 9 122675130-122676104 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA058878 Uncertain Not detected Not detected cerebral cortex: 0.1 OR1L8 ENSG00000171496 Olfactory receptor, family 1, subfamily L, member 8 9 122567548-122568477 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced spleen: 1.2;testis: 1.3 fallopian tube: 0.4 OR1M1 OR19-6 ENSG00000170929 Olfactory receptor, family 1, subfamily M, member 1 19 9093179-9094213 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Not detected Not detected fallopian tube: 0.1 OR1N2 ENSG00000171501 Olfactory receptor, family 1, subfamily N, member 2 9 122553112-122555173 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR1Q1 HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106 ENSG00000165202 Olfactory receptor, family 1, subfamily Q, member 1 9 122614738-122615682 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA044828 Uncertain Not detected Not detected epididymis: 0.9 OR2A2 OR2A17P, OR2A2P, OST008 ENSG00000221989 Olfactory receptor, family 2, subfamily A, member 2 7 144109514-144110564 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2A25 OR2A25P, OR2A27 ENSG00000221933 Olfactory receptor, family 2, subfamily A, member 25 7 144074182-144075195 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA058272 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR2A4 OR2A10 ENSG00000180658 Olfactory receptor, family 2, subfamily A, member 4 6 131700469-131701401 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA058272 Uncertain Tissue enriched Not detected testis: 0.2 OR2A5 OR2A26, OR2A8, OR7-138, OR7-141 ENSG00000221836 Olfactory receptor, family 2, subfamily A, member 5 7 144050368-144051380 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected seminal vesicle: 0.1 OR2A7 HSDJ0798C17 ENSG00000243896 Olfactory receptor, family 2, subfamily A, member 7 7 144258607-144259722 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA058272 Uncertain Mixed Mixed thyroid gland: 20.0 OR2AE1 OR2AE2 ENSG00000244623 Olfactory receptor, family 2, subfamily AE, member 1 7 99875987-99877057 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA042957 Uncertain Not detected Not detected parathyroid gland: 0.2 OR2AK2 OR2AK1P ENSG00000187080 Olfactory receptor, family 2, subfamily AK, member 2 1 247965233-247966339 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA052544 Uncertain Not detected Not detected testis: 0.2 OR2AT4 ENSG00000171561 Olfactory receptor, family 2, subfamily AT, member 4 11 75088713-75089754 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA060357 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR2B11 ENSG00000177535 Olfactory receptor, family 2, subfamily B, member 11 1 247451029-247451982 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047459 Uncertain Not detected Not detected adipose tissue: 0.7 OR2B2 hs6M1-10, OR2B2Q, OR2B9, OR6-1 ENSG00000168131 Olfactory receptor, family 2, subfamily B, member 2 6 27911185-27912396 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2B6 dJ408B20.2, OR2B1, OR2B1P, OR2B5, OR2B6P, OR5-40, OR5-41, OR6-31 ENSG00000124657 Olfactory receptor, family 2, subfamily B, member 6 6 27957241-27958182 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Mixed Not detected spleen,testis: 0.3 OR2C1 OLFmf3, OR2C2P ENSG00000168158 Olfactory receptor, family 2, subfamily C, member 1 16 3355889-3357294 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced fallopian tube: 1.1 parathyroid gland: 0.4 OR2C3 OR2C4, OR2C5P, OST742 ENSG00000196242 Olfactory receptor, family 2, subfamily C, member 3 1 247530132-247533839 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA053920, HPA058578 Uncertain Supported Plasma membrane Not detected Expressed in all parathyroid gland: 26.6 OR2D2 hg27, OR11-610, OR2D1 ENSG00000166368 Olfactory receptor, family 2, subfamily D, member 2 11 6891490-6892599 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2D3 ENSG00000178358 Olfactory receptor, family 2, subfamily D, member 3 11 6920974-6922043 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA052551 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR2F2 OR7-1 ENSG00000221910 Olfactory receptor, family 2, subfamily F, member 2 7 143935166-143936279 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2G3 ENSG00000177476 Olfactory receptor, family 2, subfamily G, member 3 1 247605586-247606515 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2G6 ENSG00000188558 Olfactory receptor, family 2, subfamily G, member 6 1 248521647-248522597 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected kidney,testis: 0.1 OR2H1 OR2H6, OR2H8, OR6-2 ENSG00000204688 Olfactory receptor, family 2, subfamily H, member 1 6 29457181-29464328 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.9 OR2H2 hs6M1-12 ENSG00000204657 Olfactory receptor, family 2, subfamily H, member 2 6 29587455-29589038 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2J2 dJ80I19.4, hs6M1-6, OR6-8 ENSG00000204700 Olfactory receptor, family 2, subfamily J, member 2 6 29173303-29174574 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2K2 HSHTPCRH06, HTPCRH06, OR2AR1P ENSG00000171133 Olfactory receptor, family 2, subfamily K, member 2 9 111327483-111328520 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA024261 Uncertain Not detected Not detected testis: 0.3 OR2L13 OR2L14 ENSG00000196071 Olfactory receptor, family 2, subfamily L, member 13 1 247937191-248100922 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced cerebral cortex: 4.0 prostate: 1.1 OR2L2 HSHTPCRH07, HTPCRH07, OR2L12, OR2L4P ENSG00000203663 Olfactory receptor, family 2, subfamily L, member 2 1 248038268-248039206 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 7 testis: 2.5 cerebral cortex,spleen: 0.3 OR2L3 ENSG00000198128 Olfactory receptor, family 2, subfamily L, member 3 1 248060682-248061620 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected thyroid gland: 0.3 OR2M3 OR2M3P, OR2M6, OST003 ENSG00000228198 Olfactory receptor, family 2, subfamily M, member 3 1 248203068-248204006 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2M4 HSHTPCRX18, HTPCRX18, OST710, TPCR100 ENSG00000171180 Olfactory receptor, family 2, subfamily M, member 4 1 248238929-248239864 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA051308 Uncertain Not detected Not detected cerebral cortex: 0.2 OR2M7 ENSG00000177186 Olfactory receptor, family 2, subfamily M, member 7 1 248323630-248324568 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2S2 ENSG00000122718 Olfactory receptor, family 2, subfamily S, member 2 (gene/pseudogene) 9 35957139-35958098 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected lung: 0.1 OR2T10 ENSG00000184022 Olfactory receptor, family 2, subfamily T, member 10 1 248592830-248593768 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA052019 Uncertain Tissue enhanced Tissue enriched 13 kidney: 7.1 prostate: 0.5 OR2T2 OR2T2P ENSG00000196240 Olfactory receptor, family 2, subfamily T, member 2 1 248452798-248453772 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2T3 ENSG00000196539 Olfactory receptor, family 2, subfamily T, member 3 1 248473351-248474307 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2T33 ENSG00000177212 Olfactory receptor, family 2, subfamily T, member 33 1 248272852-248273814 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected bone marrow,testis: 0.2 OR2T34 ENSG00000183310 Olfactory receptor, family 2, subfamily T, member 34 1 248573801-248574757 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2W1 hs6M1-15 ENSG00000204704 Olfactory receptor, family 2, subfamily W, member 1 6 29044213-29045240 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2W3 OR2W3P, OR2W8P, OST718 ENSG00000238243 Olfactory receptor, family 2, subfamily W, member 3 1 247895587-247896531 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA045594 Uncertain Tissue enhanced Tissue enhanced bone marrow: 7.8;thyroid gland: 10.5 cerebral cortex: 2.9 OR2Y1 ENSG00000174339 Olfactory receptor, family 2, subfamily Y, member 1 5 180739042-180740099 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR2Z1 OR2Z2 ENSG00000181733 Olfactory receptor, family 2, subfamily Z, member 1 19 8730954-8732009 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA048760 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR3A1 OLFRA03, OR17-40, OR40 ENSG00000180090 Olfactory receptor, family 3, subfamily A, member 1 17 3291635-3292600 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced testis: 1.7 epididymis: 0.3 OR3A2 OLFRA04, OR17-228, OR228 ENSG00000221882 Olfactory receptor, family 3, subfamily A, member 2 17 3277899-3278974 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enriched 6 testis: 5.3 cerebral cortex,epididymis: 0.8 OR3A3 OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P ENSG00000159961 Olfactory receptor, family 3, subfamily A, member 3 17 3420568-3421533 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected gallbladder,lymph node,placenta,tonsil: 0.1 OR4C11 OR4C11P ENSG00000172188 Olfactory receptor, family 4, subfamily C, member 11 11 55603354-55604398 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4C12 ENSG00000221954 Olfactory receptor, family 4, subfamily C, member 12 11 49981473-49982535 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4C13 ENSG00000258817 Olfactory receptor, family 4, subfamily C, member 13 11 49952391-49953419 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4C3 ENSG00000176547 Olfactory receptor, family 4, subfamily C, member 3 11 48324920-48328471 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA049116 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR4C6 ENSG00000181903 Olfactory receptor, family 4, subfamily C, member 6 11 55665167-55666096 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected lymph node,tonsil: 0.1 OR4D1 OR4D3, TPCR16 ENSG00000141194 Olfactory receptor, family 4, subfamily D, member 1 17 58155133-58156156 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected epididymis,lymph node,testis: 0.1 OR4D10 OR4D10P, OST711 ENSG00000254466 Olfactory receptor, family 4, subfamily D, member 10 11 59477373-59478396 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enriched Not detected all non-specific tissues: 0.0 OR4D2 ENSG00000255713 Olfactory receptor, family 4, subfamily D, member 2 17 58169656-58170579 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4D5 ENSG00000171014 Olfactory receptor, family 4, subfamily D, member 5 11 123939543-123940637 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA045005 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR4D6 ENSG00000166884 Olfactory receptor, family 4, subfamily D, member 6 11 59456938-59457991 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.2 OR4F15 ENSG00000182854 Olfactory receptor, family 4, subfamily F, member 15 15 101805720-101819147 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4F16 ENSG00000273547 Olfactory receptor, family 4, subfamily F, member 16 1 685716-686654 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047705 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR4F17 OR4F11P, OR4F18, OR4F19 ENSG00000176695 Olfactory receptor, family 4, subfamily F, member 17 19 107461-111696 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4F29 ENSG00000278566 Olfactory receptor, family 4, subfamily F, member 29 1 450740-451678 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047705 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR4F3 ENSG00000230178 Olfactory receptor, family 4, subfamily F, member 3 5 181367268-181368262 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047705 Uncertain Not detected Not detected testis: 0.6 OR4F4 OR4F18 ENSG00000177693 Olfactory receptor, family 4, subfamily F, member 4 15 101922042-101923095 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4F6 OR4F12 ENSG00000184140 Olfactory receptor, family 4, subfamily F, member 6 15 101805699-101806686 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4K1 ENSG00000155249 Olfactory receptor, family 4, subfamily K, member 1 14 19935608-19936683 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA028877 Uncertain Not detected Not detected testis: 0.3 OR4K15 OR4K15Q ENSG00000169488 Olfactory receptor, family 4, subfamily K, member 15 14 19975444-19976659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA055732 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR4K2 ENSG00000165762 Olfactory receptor, family 4, subfamily K, member 2 14 19876232-19877309 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR4M1 ENSG00000176299 Olfactory receptor, family 4, subfamily M, member 1 14 19780242-19781357 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA058889 Uncertain Not detected Tissue enriched 10 testis: 1.0 all non-specific tissues: 0.0 OR4M2 ENSG00000274102 Olfactory receptor, family 4, subfamily M, member 2 15 22080527-22081659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA058889 Uncertain Not detected Tissue enriched 10 testis: 1.2 cerebral cortex: 0.1 OR4N4 ENSG00000183706 Olfactory receptor, family 4, subfamily N, member 4 15 22094431-22095556 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA057442 Uncertain Uncertain Centrosome Not detected Tissue enriched 103 testis: 10.3 cervix, uterine: 0.1 OR4X2 ENSG00000279556 Olfactory receptor, family 4, subfamily X, member 2 (gene/pseudogene) 11 48245104-48246015 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA060249 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR51A7 ENSG00000176895 Olfactory receptor, family 51, subfamily A, member 7 11 4907370-4908308 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA061356 Uncertain Not detected Not detected testis: 0.2 OR51B4 ENSG00000183251 Olfactory receptor, family 51, subfamily B, member 4 11 5301014-5301996 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.2 OR51B5 ENSG00000242180 Olfactory receptor, family 51, subfamily B, member 5 11 5342586-5343524 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA063124 Uncertain Not detected Not detected testis: 0.3 OR51D1 OR51D1Q ENSG00000197428 Olfactory receptor, family 51, subfamily D, member 1 11 4639715-4640838 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA061240 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR51E1 GPR136, GPR164, OR51E1P, OR52A3P ENSG00000180785 Olfactory receptor, family 51, subfamily E, member 1 11 4643420-4655488 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level CAB019995, HPA051439 Approved Renal cancer:1.23e-6 (unfavourable) Tissue enriched Tissue enhanced adipose tissue: 6.3;placenta: 9.5;prostate: 8.0 urinary bladder: 1.8 OR51E2 PSGR ENSG00000167332 Olfactory receptor, family 51, subfamily E, member 2 11 4680171-4697854 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enriched 7 prostate: 38.9 placenta: 5.8 OR51F2 ENSG00000176925 Olfactory receptor, family 51, subfamily F, member 2 11 4821386-4822414 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR51G1 OR51G3P ENSG00000176879 Olfactory receptor, family 51, subfamily G, member 1 (gene/pseudogene) 11 4923374-4924339 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA050482 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR51G2 ENSG00000176893 Olfactory receptor, family 51, subfamily G, member 2 11 4914719-4915663 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR51I1 ENSG00000167359 Olfactory receptor, family 51, subfamily I, member 1 11 5440570-5441514 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected epididymis: 0.1 OR51Q1 ENSG00000167360 Olfactory receptor, family 51, subfamily Q, member 1 (gene/pseudogene) 11 5422111-5423206 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA044998 Uncertain Not detected Not detected epididymis: 0.1 OR51S1 ENSG00000176922 Olfactory receptor, family 51, subfamily S, member 1 11 4848237-4849208 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.1 OR52A1 HPFH1OR ENSG00000182070 Olfactory receptor, family 52, subfamily A, member 1 11 5151009-5186382 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR52B2 ENSG00000255307 Olfactory receptor, family 52, subfamily B, member 2 11 6169330-6170408 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR52D1 ENSG00000181609 Olfactory receptor, family 52, subfamily D, member 1 11 5488685-5489749 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA046965 Uncertain Not detected Tissue enriched 6 testis: 2.3 epididymis: 0.3 OR52E8 ENSG00000183269 Olfactory receptor, family 52, subfamily E, member 8 11 5856674-5857734 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR52H1 ENSG00000181616 Olfactory receptor, family 52, subfamily H, member 1 11 5544561-5545523 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR52I2 ENSG00000226288 Olfactory receptor, family 52, subfamily I, member 2 11 4586791-4587905 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA049343 Uncertain Not detected Not detected epididymis: 0.2 OR52K1 ENSG00000196778 Olfactory receptor, family 52, subfamily K, member 1 11 4488879-4489908 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected appendix: 0.1 OR52K2 ENSG00000181963 Olfactory receptor, family 52, subfamily K, member 2 11 4449295-4450361 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected bone marrow: 0.1 OR52L1 ENSG00000183313 Olfactory receptor, family 52, subfamily L, member 1 11 5985892-5986985 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.1 OR52N4 ENSG00000181074 Olfactory receptor, family 52, subfamily N, member 4 (gene/pseudogene) 11 5754693-5755729 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Mixed spleen: 2.5 OR52N5 OR52N5Q ENSG00000181009 Olfactory receptor, family 52, subfamily N, member 5 11 5777634-5778667 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR52W1 OR52W1P ENSG00000175485 Olfactory receptor, family 52, subfamily W, member 1 11 6199146-6200259 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected bone marrow: 0.1 OR56A1 ENSG00000180934 Olfactory receptor, family 56, subfamily A, member 1 11 6026671-6027741 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.6 OR56A4 ENSG00000183389 Olfactory receptor, family 56, subfamily A, member 4 11 6001986-6003194 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR56B1 OR56B1P ENSG00000181023 Olfactory receptor, family 56, subfamily B, member 1 11 5736517-5737491 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA045043 Uncertain Not detected Not detected parathyroid gland: 0.3 OR56B4 ENSG00000180919 Olfactory receptor, family 56, subfamily B, member 4 11 6107684-6108835 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected smooth muscle: 0.2 OR5A1 OR5A1P, OST181 ENSG00000172320 Olfactory receptor, family 5, subfamily A, member 1 11 59443144-59444194 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.1 OR5A2 ENSG00000172324 Olfactory receptor, family 5, subfamily A, member 2 11 59421943-59422976 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047135, HPA049575 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR5AK2 ENSG00000181273 Olfactory receptor, family 5, subfamily AK, member 2 11 56988872-56989867 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 66 spleen: 10.1 lung,placenta: 0.1 OR5AN1 ENSG00000176495 Olfactory receptor, family 5, subfamily AN, member 1 11 59364412-59365448 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5AP2 ENSG00000172464 Olfactory receptor, family 5, subfamily AP, member 2 11 56641466-56642471 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5AU1 ENSG00000169327 Olfactory receptor, family 5, subfamily AU, member 1 14 21154865-21156063 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected seminal vesicle: 0.2 OR5B12 OR5B12P, OR5B16, OST743 ENSG00000172362 Olfactory receptor, family 5, subfamily B, member 12 11 58439120-58440173 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5B2 OST073 ENSG00000172365 Olfactory receptor, family 5, subfamily B, member 2 11 58422265-58423313 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.2 OR5C1 hRPK-465_F_21, OR5C2P, OR9-F ENSG00000148215 Olfactory receptor, family 5, subfamily C, member 1 9 122788933-122789895 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5D18 ENSG00000186119 Olfactory receptor, family 5, subfamily D, member 18 11 55819630-55820571 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5F1 OR11-10 ENSG00000149133 Olfactory receptor, family 5, subfamily F, member 1 11 55993681-55994625 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA059360 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR5H1 HSHTPCRX14, HTPCRX14 ENSG00000231192 Olfactory receptor, family 5, subfamily H, member 1 3 98132698-98133639 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5H14 ENSG00000236032 Olfactory receptor, family 5, subfamily H, member 14 3 98149326-98150405 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.3 OR5H6 ENSG00000230301 Olfactory receptor, family 5, subfamily H, member 6 (gene/pseudogene) 3 98264285-98265262 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5I1 HSOlf1, OLF1 ENSG00000167825 Olfactory receptor, family 5, subfamily I, member 1 11 55935456-55936400 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5K1 HSHTPCRX10, HTPCRX10 ENSG00000232382 Olfactory receptor, family 5, subfamily K, member 1 3 98469480-98470576 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5K2 ENSG00000231861 Olfactory receptor, family 5, subfamily K, member 2 3 98497604-98498663 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected lung,smooth muscle: 0.5 OR5L1 OST262 ENSG00000186117 Olfactory receptor, family 5, subfamily L, member 1 (gene/pseudogene) 11 55811467-55812402 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047524 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR5L2 HSHTPCRX16, HTPCRX16 ENSG00000205030 Olfactory receptor, family 5, subfamily L, member 2 11 55827219-55828154 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047524 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR5M10 ENSG00000254834 Olfactory receptor, family 5, subfamily M, member 10 11 56576774-56577721 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5M11 OR11-199 ENSG00000255223 Olfactory receptor, family 5, subfamily M, member 11 11 56542340-56543257 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.1 OR5M3 ENSG00000174937 Olfactory receptor, family 5, subfamily M, member 3 11 56469574-56470497 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5M8 ENSG00000181371 Olfactory receptor, family 5, subfamily M, member 8 11 56490435-56491370 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.1 OR5P2 JCG3 ENSG00000183303 Olfactory receptor, family 5, subfamily P, member 2 11 7795905-7796973 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected skin: 0.1 OR5P3 JCG1 ENSG00000182334 Olfactory receptor, family 5, subfamily P, member 3 11 7825037-7825972 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA060787 Uncertain Not detected Not detected epididymis,skin: 0.1 OR5T1 OR5T1P ENSG00000181698 Olfactory receptor, family 5, subfamily T, member 1 11 56275639-56276619 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA050952 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR5T2 ENSG00000181718 Olfactory receptor, family 5, subfamily T, member 2 11 56232106-56233185 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR5V1 hs6M1-21 ENSG00000243729 Olfactory receptor, family 5, subfamily V, member 1 6 29355230-29431967 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA046707 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR6A2 OR11-55, OR6A1, OR6A2P ENSG00000184933 Olfactory receptor, family 6, subfamily A, member 2 11 6794627-6795783 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6B1 OR7-3 ENSG00000221813 Olfactory receptor, family 6, subfamily B, member 1 7 144003929-144004983 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA053164 Uncertain Not detected Not detected testis: 0.3 OR6B2 OR6B2P ENSG00000182083 Olfactory receptor, family 6, subfamily B, member 2 2 240028965-240030456 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047529 Uncertain Not detected Not detected testis: 0.6 OR6C1 OST267 ENSG00000205330 Olfactory receptor, family 6, subfamily C, member 1 12 55320561-55321624 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6C4 ENSG00000179626 Olfactory receptor, family 6, subfamily C, member 4 12 55551199-55552244 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6C65 ENSG00000205328 Olfactory receptor, family 6, subfamily C, member 65 12 55400430-55401505 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6F1 OST731 ENSG00000169214 Olfactory receptor, family 6, subfamily F, member 1 1 247711829-247712755 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 22 testis: 2.2 all non-specific tissues: 0.0 OR6K2 ENSG00000196171 Olfactory receptor, family 6, subfamily K, member 2 1 158699678-158700652 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6K6 ENSG00000180433 Olfactory receptor, family 6, subfamily K, member 6 1 158754720-158755891 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6M1 ENSG00000196099 Olfactory receptor, family 6, subfamily M, member 1 11 123805335-123806387 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA048674 Uncertain Not detected Not detected testis: 0.3 OR6Q1 ENSG00000172381 Olfactory receptor, family 6, subfamily Q, member 1 (gene/pseudogene) 11 58030953-58031906 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6T1 ENSG00000181499 Olfactory receptor, family 6, subfamily T, member 1 11 123942785-123943873 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA060893 Uncertain Not detected Not detected testis: 0.6 OR6V1 GPR138 ENSG00000225781 Olfactory receptor, family 6, subfamily V, member 1 7 143052320-143053347 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR6X1 ENSG00000221931 Olfactory receptor, family 6, subfamily X, member 1 11 123753488-123754545 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected epididymis: 0.1 OR7A17 HTPCRX19 ENSG00000185385 Olfactory receptor, family 7, subfamily A, member 17 19 14880426-14881452 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected epididymis: 0.8 OR7A5 HTPCR2 ENSG00000188269 Olfactory receptor, family 7, subfamily A, member 5 19 14792490-14835376 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA053823 Uncertain Tissue enriched Tissue enhanced epididymis: 5.4;parathyroid gland: 5.2;testis: 2.8 breast,seminal vesicle: 0.9 OR7C1 OR19-5, OR7C4 ENSG00000127530 Olfactory receptor, family 7, subfamily C, member 1 19 14799146-14800211 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA047127 Uncertain Tissue enriched Tissue enhanced epididymis: 3.4;parathyroid gland: 4.9;testis: 3.9 seminal vesicle: 1.5 OR7D2 FLJ38149, HTPCRH03, OR19-4 ENSG00000188000 Olfactory receptor, family 7, subfamily D, member 2 19 9185594-9188817 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Mixed testis: 2.0 OR7D4 hg105, OR19-B, OR7D4P ENSG00000174667 Olfactory receptor, family 7, subfamily D, member 4 19 9213850-9214871 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.2 OR7E24 HSHT2, OR19-8, OR7E24P, OR7E24Q ENSG00000237521 Olfactory receptor, family 7, subfamily E, member 24 19 9250930-9252479 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enriched 25 testis: 2.5 all non-specific tissues: 0.0 OR8A1 OST025 ENSG00000196119 Olfactory receptor, family 8, subfamily A, member 1 11 124569997-124571142 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.4 OR8B12 ENSG00000170953 Olfactory receptor, family 8, subfamily B, member 12 11 124542682-124543679 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.8 OR8B4 OR8B4P ENSG00000198657 Olfactory receptor, family 8, subfamily B, member 4 (gene/pseudogene) 11 124423942-124424871 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA049884 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR8B8 TPCR85 ENSG00000197125 Olfactory receptor, family 8, subfamily B, member 8 11 124440126-124441158 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR8D1 OR8D3, OST004 ENSG00000196341 Olfactory receptor, family 8, subfamily D, member 1 11 124309812-124310837 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA059510 Uncertain Not detected Tissue enriched 21 testis: 2.0 all non-specific tissues: 0.0 OR8D2 ENSG00000197263 Olfactory receptor, family 8, subfamily D, member 2 (gene/pseudogene) 11 124319262-124320197 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR8D4 ENSG00000181518 Olfactory receptor, family 8, subfamily D, member 4 11 123906146-123907476 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR8G1 HSTPCR25, OR8G1P, TPCR25 ENSG00000197849 Olfactory receptor, family 8, subfamily G, member 1 (gene/pseudogene) 11 124249676-124250611 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.6 OR8G5 OR8G5P, OR8G6 ENSG00000255298 Olfactory receptor, family 8, subfamily G, member 5 11 124264827-124265867 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 30 testis: 6.1 placenta: 0.2 OR8H1 ENSG00000181693 Olfactory receptor, family 8, subfamily H, member 1 11 56290053-56291090 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR8I2 ENSG00000172154 Olfactory receptor, family 8, subfamily I, member 2 11 56093308-56094240 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR8J1 ENSG00000172487 Olfactory receptor, family 8, subfamily J, member 1 11 56360215-56361288 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR8K1 ENSG00000150261 Olfactory receptor, family 8, subfamily K, member 1 11 56346039-56346998 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA055233 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR9A2 ENSG00000179468 Olfactory receptor, family 9, subfamily A, member 2 7 143026158-143027195 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 OR9A4 ENSG00000258083 Olfactory receptor, family 9, subfamily A, member 4 7 141918817-141919909 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.2 OR9K2 ENSG00000170605 Olfactory receptor, family 9, subfamily K, member 2 12 55129681-55130802 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA015808 Uncertain Not detected Not detected all non-specific tissues: 0.0 OR9Q1 ENSG00000186509 Olfactory receptor, family 9, subfamily Q, member 1 11 58023881-58181616 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Not detected Not detected skeletal muscle,skin,testis: 0.1 OSBPL7 MGC71150, ORP7 ENSG00000006025 Oxysterol binding protein-like 7 17 47807372-47821834 Predicted intracellular proteins Evidence at protein level HPA036076, HPA053083 Uncertain Approved Nucleoplasm
Cytosol Urothelial cancer:1.19e-5 (favourable), Renal cancer:8.30e-4 (unfavourable) Expressed in all Mixed stomach: 33.4 OSCAR ENSG00000170909 Osteoclast associated, immunoglobulin-like receptor 19 54094668-54102692 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA062740 Approved Nucleus
Nuclear membrane
Vesicles Renal cancer:2.71e-5 (unfavourable) Expressed in all Tissue enhanced bone marrow: 9.1;lung: 14.2 appendix: 3.4 OSER1 C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1 ENSG00000132823 Oxidative stress responsive serine-rich 1 20 44196496-44210791 Predicted intracellular proteins Evidence at protein level HPA045125 Approved Approved Nucleoli
Nuclear speckles Endometrial cancer:2.58e-5 (unfavourable) Expressed in all Expressed in all testis: 183.6 OSGEPL1 Qri7 ENSG00000128694 O-sialoglycoprotein endopeptidase-like 1 2 189746660-189763227 Enzymes, Predicted intracellular proteins Evidence at protein level HPA030693 Uncertain Validated Mitochondria Ovarian cancer:3.19e-4 (favourable), Liver cancer:3.71e-4 (unfavourable) Expressed in all Mixed testis: 12.2 OSGIN2 C8orf1, hT41 ENSG00000164823 Oxidative stress induced growth inhibitor family member 2 8 89901859-89927888 Predicted intracellular proteins Evidence at transcript level HPA028515, HPA050595 Approved Approved Nucleoli Liver cancer:3.91e-6 (unfavourable), Lung cancer:2.93e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 88.4 OSR1 ODD ENSG00000143867 Odd-skipped related transciption factor 1 2 19351485-19358653 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA015525 Uncertain Mixed Mixed adipose tissue: 21.9 OSTN ENSG00000188729 Osteocrin 3 191199241-191265615 Predicted secreted proteins Evidence at transcript level CAB024997, CAB025649, HPA030878 Uncertain Not detected Tissue enhanced cerebral cortex: 4.4 epididymis: 2.7 OTOGL C12orf64, FLJ90579 ENSG00000165899 Otogelin-like 12 80209453-80379090 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA040364, HPA053392 Uncertain Approved Cytosol Tissue enhanced Tissue enhanced kidney: 6.1 heart muscle: 1.3 OTOP1 ENSG00000163982 Otopetrin 1 4 4188803-4226889 Predicted membrane proteins Evidence at transcript level HPA035599 Uncertain Not detected Not detected skin: 0.2 OTOP2 ENSG00000183034 Otopetrin 2 17 74924275-74933912 Predicted membrane proteins Evidence at transcript level HPA024524, HPA053090 Uncertain Not detected Tissue enhanced colon: 20.3;rectum: 11.6 testis: 3.9 OTOS OTOSP ENSG00000178602 Otospiralin 2 240139026-240144562 Predicted secreted proteins Evidence at transcript level Group enriched Tissue enriched 16 thyroid gland: 73.9 cerebral cortex: 4.6 OVCH1 OVCH ENSG00000187950 Ovochymase 1 12 29412474-29497686 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA040253 Uncertain Not detected Group enriched 5 lung: 6.9;testis: 5.2;thyroid gland: 1.7 spleen: 0.8 OVGP1 CHIT5, MUC9 ENSG00000085465 Oviductal glycoprotein 1, 120kDa 1 111414314-111427777 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA062205 Supported Urothelial cancer:3.93e-5 (favourable), Endometrial cancer:1.36e-4 (favourable) Group enriched Tissue enriched 117 fallopian tube: 3120.0 endometrium: 26.6 OVOL1 HOVO1 ENSG00000172818 Ovo-like zinc finger 1 11 65787022-65797219 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003984 Uncertain Approved Nucleus Renal cancer:1.00e-13 (favourable), Endometrial cancer:1.87e-4 (unfavourable) Mixed Tissue enhanced esophagus: 37.4;skin: 33.5;testis: 35.3 urinary bladder: 16.0 OXCT2 FKSG25, FLJ00030, SCOT-T ENSG00000198754 3-oxoacid CoA transferase 2 1 39769523-39771348 Enzymes, Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 12 testis: 37.5 heart muscle: 3.2 OXER1 GPCR, GPR170, TG1019 ENSG00000162881 Oxoeicosanoid (OXE) receptor 1 2 42762481-42764261 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA051433 Uncertain Expressed in all Mixed small intestine: 9.3 OXGR1 aKGR, GPR80, GPR99, P2RY15, P2Y15 ENSG00000165621 Oxoglutarate (alpha-ketoglutarate) receptor 1 13 96985719-96994730 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA067673 Supported Plasma membrane Mixed Mixed breast: 5.2 OXLD1 C17orf90, MGC104712 ENSG00000204237 Oxidoreductase-like domain containing 1 17 81665036-81666635 Predicted intracellular proteins Evidence at protein level HPA056878, HPA057019 Uncertain Approved Vesicles
Cytosol Cervical cancer:2.91e-4 (favourable) Expressed in all Mixed testis: 10.7 OXTR ENSG00000180914 Oxytocin receptor 3 8750408-8769628 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Mixed Tissue enriched 11 breast: 65.6 fallopian tube: 6.0 P2RX3 P2X3 ENSG00000109991 Purinergic receptor P2X, ligand gated ion channel, 3 11 57338374-57370600 Predicted membrane proteins, Transporters Evidence at transcript level HPA057776 Uncertain Not detected Tissue enhanced heart muscle: 2.0;testis: 6.1 liver: 0.9 P2RX5 LRH-1, P2X5 ENSG00000083454 Purinergic receptor P2X, ligand gated ion channel, 5 17 3672199-3696404 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA021948, HPA067827 Supported Supported Cytosol Mixed Group enriched 10 appendix: 42.6;lymph node: 90.9;spleen: 75.5;tonsil: 48.4 bone marrow: 6.2 P2RY10 P2Y10 ENSG00000078589 Purinergic receptor P2Y, G-protein coupled, 10 X 78945332-78961954 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA036757, HPA065766 Approved Renal cancer:3.63e-4 (unfavourable) Mixed Tissue enhanced lymph node: 33.5;spleen: 23.0;tonsil: 24.9 appendix: 20.1 P2RY11 P2Y11 ENSG00000244165 Purinergic receptor P2Y, G-protein coupled, 11 19 10111538-10115372 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA014232 Approved Urothelial cancer:1.77e-4 (favourable) Expressed in all Mixed lymph node: 7.3 P2RY13 FKSG77, GPR86, GPR94, P2Y13 ENSG00000181631 Purinergic receptor P2Y, G-protein coupled, 13 3 151326312-151329548 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA049047 Supported Expressed in all Tissue enhanced spleen: 51.9 appendix: 28.7 P2RY14 GPR105, KIAA0001 ENSG00000174944 Purinergic receptor P2Y, G-protein coupled, 14 3 151212117-151278467 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level CAB022646 Uncertain Renal cancer:1.72e-5 (unfavourable) Mixed Tissue enhanced placenta: 45.4 esophagus: 23.4 P2RY2 P2U ENSG00000175591 Purinergic receptor P2Y, G-protein coupled, 2 11 73218298-73236352 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level CAB022642 Uncertain Uncertain Cytosol Pancreatic cancer:2.19e-5 (unfavourable) Mixed Tissue enhanced esophagus: 19.0 skeletal muscle: 14.9 PABPC1L C20orf119, dJ1069P2.3, ePAB, PABPC1L1 ENSG00000101104 Poly(A) binding protein, cytoplasmic 1-like 20 44910062-44959035 Predicted intracellular proteins Evidence at protein level HPA066650 Approved Nuclear bodies
Cytosol Renal cancer:4.00e-15 (unfavourable), Colorectal cancer:3.80e-4 (unfavourable), Urothelial cancer:8.84e-4 (favourable) Expressed in all Mixed thyroid gland: 54.0 PABPC1L2A RBM32A ENSG00000186288 Poly(A) binding protein, cytoplasmic 1-like 2A X 73077276-73079512 Predicted intracellular proteins Evidence at transcript level HPA041573 Approved Tissue enriched Group enriched 5 adrenal gland: 2.0;cerebral cortex: 6.7;prostate: 3.7;testis: 2.8 epididymis: 0.7 PABPC1L2B RBM32B ENSG00000184388 Poly(A) binding protein, cytoplasmic 1-like 2B X 73003517-73005713 Predicted intracellular proteins Evidence at transcript level HPA041573 Approved Tissue enriched Group enriched 5 cerebral cortex: 8.8;prostate: 4.5 testis: 1.2 PABPC4L ENSG00000254535 Poly(A) binding protein, cytoplasmic 4-like 4 134196333-134201748 Predicted intracellular proteins Evidence at protein level Renal cancer:1.11e-5 (favourable) Mixed Tissue enhanced parathyroid gland: 12.6;placenta: 14.5 endometrium: 6.4 PABPC5 PABP5 ENSG00000174740 Poly(A) binding protein, cytoplasmic 5 X 91434595-91438584 Predicted intracellular proteins Evidence at transcript level HPA000164, HPA000165 Approved Mixed Tissue enhanced ovary: 13.3 adrenal gland: 9.7 PABPN1L ePABP2 ENSG00000205022 Poly(A) binding protein, nuclear 1-like (cytoplasmic) 16 88863333-88866660 Predicted intracellular proteins Evidence at transcript level HPA043415 Uncertain Not detected Tissue enhanced adrenal gland: 1.0 bone marrow: 0.5 PADI1 HPAD10, PAD1, PDI, PDI1 ENSG00000142623 Peptidyl arginine deiminase, type I 1 17205126-17246005 Enzymes, Predicted intracellular proteins Evidence at protein level HPA062294 Approved Approved Nucleoplasm
Cytosol Renal cancer:8.34e-11 (unfavourable) Tissue enhanced Tissue enriched 7 esophagus: 37.3 skin: 5.4 PAGE4 CT16.7, GAGEC1, PAGE-4 ENSG00000101951 P antigen family, member 4 (prostate associated) X 49829260-49833973 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA023880 Supported Approved Golgi apparatus
Vesicles Group enriched Group enriched 6 epididymis: 1431.1;placenta: 2026.4 prostate: 279.7 PANO1 PANO ENSG00000274897 Proapoptotic nucleolar protein 1 11 797511-799190 Predicted intracellular proteins Evidence at transcript level Mixed Mixed skin: 1.5 PANX2 hPANX2, PX2 ENSG00000073150 Pannexin 2 22 50170731-50180294 Predicted membrane proteins, Transporters Evidence at transcript level HPA004624, HPA039117 Approved Approved Plasma membrane Mixed Tissue enhanced cerebral cortex: 8.7 seminal vesicle: 2.1 PANX3 Px3 ENSG00000154143 Pannexin 3 11 124611490-124620356 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Not detected testis: 0.5 PAPL ENSG00000183760 Iron/zinc purple acid phosphatase-like protein 19 39083913-39111493 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042005, HPA042613 Uncertain Group enriched Group enriched 6 cerebral cortex: 1.8;skin: 6.9;tonsil: 2.5 epididymis: 0.6 PAPLN MGC50452 ENSG00000100767 Papilin, proteoglycan-like sulfated glycoprotein 14 73237497-73274640 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA048682, HPA053453 Uncertain Approved Nucleoplasm Expressed in all Mixed spleen: 21.0 PAPOLB PAPT ENSG00000218823 Poly(A) polymerase beta (testis specific) 7 4857733-4861994 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 536 testis: 53.6 all non-specific tissues: 0.0 PAQR4 FLJ30002 ENSG00000162073 Progestin and adipoQ receptor family member IV 16 2969245-2973489 Predicted membrane proteins Evidence at protein level HPA068394 Approved Vesicles Renal cancer:3.01e-6 (unfavourable), Stomach cancer:1.70e-4 (favourable), Liver cancer:6.86e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 54.1;parathyroid gland: 64.2 skin: 19.2 PAQR6 FLJ22672, PRdelta ENSG00000160781 Progestin and adipoQ receptor family member VI 1 156243321-156248117 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA073505 Approved Nucleus
Nucleoli Renal cancer:1.58e-8 (unfavourable), Colorectal cancer:1.60e-5 (unfavourable), Urothelial cancer:1.86e-4 (favourable), Prostate cancer:1.99e-4 (unfavourable) Tissue enriched Tissue enriched 9 cerebral cortex: 97.8 skin: 10.8 PAQR7 MPRA, mSR ENSG00000182749 Progestin and adipoQ receptor family member VII 1 25861210-25871253 Predicted membrane proteins Evidence at protein level HPA046936 Approved Approved Cytosol Renal cancer:1.05e-5 (favourable), Liver cancer:1.14e-4 (unfavourable) Expressed in all Mixed testis: 51.0 PAQR8 C6orf33, LMPB1, MPRB ENSG00000170915 Progestin and adipoQ receptor family member VIII 6 52361421-52407777 Predicted membrane proteins Evidence at protein level HPA064625 Supported Golgi apparatus
Plasma membrane Breast cancer:4.61e-4 (favourable), Urothelial cancer:6.40e-4 (favourable) Expressed in all Mixed cerebral cortex: 65.1 PAQR9 FLJ41938 ENSG00000188582 Progestin and adipoQ receptor family member IX 3 142949164-142963682 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA052798 Uncertain Tissue enriched Tissue enhanced liver: 8.3;testis: 19.3 heart muscle: 5.2 PARP6 pART17 ENSG00000137817 Poly (ADP-ribose) polymerase family, member 6 15 72241181-72272999 Enzymes, Predicted intracellular proteins Evidence at protein level HPA026991 Approved Approved Plasma membrane Renal cancer:8.02e-8 (unfavourable), Cervical cancer:3.17e-5 (favourable), Colorectal cancer:3.37e-4 (unfavourable) Expressed in all Expressed in all testis: 46.7 PARP8 FLJ21308, pART16 ENSG00000151883 Poly (ADP-ribose) polymerase family, member 8 5 50665899-50846522 Enzymes, Predicted intracellular proteins Evidence at protein level HPA049183 Approved Approved Nucleoplasm
Cytosol Urothelial cancer:1.12e-4 (favourable) Expressed in all Expressed in all thyroid gland: 72.0 PATE2 C11orf38, LVLF3112, PATE-M, UNQ3112 ENSG00000196844 Prostate and testis expressed 2 11 125776113-125778819 Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 11 epididymis: 541.7 seminal vesicle: 50.3 PATE3 HEL-127, PATE-DJ ENSG00000236027 Prostate and testis expressed 3 11 125788111-125791600 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 28 epididymis: 186.8 seminal vesicle: 6.6 PATE4 FLJ41047, PATE-B ENSG00000237353 Prostate and testis expressed 4 11 125833316-125840069 Predicted secreted proteins Evidence at protein level HPA045632 Approved Not detected Tissue enriched 8 seminal vesicle: 147.1 epididymis: 18.4 PBOV1 UC28, UROC28 ENSG00000254440 Prostate and breast cancer overexpressed 1 6 138215986-138218491 Predicted intracellular proteins Evidence at transcript level HPA063021 Uncertain Not detected Not detected bone marrow,breast,kidney,parathyroid gland,skin,testis: 0.1 PCBP3 ENSG00000183570 Poly(rC) binding protein 3 21 45643694-45942454 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA030247 Approved Mixed Tissue enhanced testis: 21.6 cerebral cortex: 12.8 PCBP4 LIP4, MCG10 ENSG00000090097 Poly(rC) binding protein 4 3 51957454-51974016 Predicted intracellular proteins Evidence at protein level HPA057754 Supported Cytosol Expressed in all Expressed in all cerebral cortex: 125.7 PCDH10 KIAA1400, OL-PCDH ENSG00000138650 Protocadherin 10 4 133149315-133208606 Predicted membrane proteins Evidence at protein level HPA011220, HPA073462 Approved Approved Nucleus
Golgi apparatus
Vesicles Tissue enhanced Group enriched 5 cerebral cortex: 62.2;placenta: 36.4;prostate: 17.0;seminal vesicle: 24.4 adrenal gland: 6.9 PCDH11X PCDH-X, PCDH11, PCDHX, PPP1R119 ENSG00000102290 Protocadherin 11 X-linked X 91779261-92623230 Predicted membrane proteins Evidence at transcript level HPA000432 Approved Not detected Tissue enhanced cerebral cortex: 5.3;ovary: 9.9;parathyroid gland: 4.8 cervix, uterine: 1.7 PCDH17 PCDH68, PCH68 ENSG00000118946 Protocadherin 17 13 57631810-57729311 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA026817 Uncertain Approved Vesicles
Plasma membrane
Cytosol Renal cancer:3.31e-5 (unfavourable) Mixed Tissue enhanced cerebral cortex: 25.8;spleen: 34.3 lung: 18.3 PCDH18 KIAA1562, PCDH68L ENSG00000189184 Protocadherin 18 4 137518918-137532494 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017976 Approved Approved Golgi apparatus
Cytosol Renal cancer:3.21e-4 (unfavourable), Urothelial cancer:4.71e-4 (unfavourable) Mixed Mixed placenta: 64.0 PCDH20 FLJ22218, PCDH13 ENSG00000280165 Protocadherin 20 13 61409685-61415522 Predicted membrane proteins Evidence at protein level Not detected Tissue enhanced cerebral cortex: 14.6;smooth muscle: 12.8 lung: 5.0 PCDH8 ARCADLIN, PAPC ENSG00000136099 Protocadherin 8 13 52842889-52848641 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA010509 Uncertain Tissue enhanced Tissue enriched 8 cerebral cortex: 5.7 testis: 0.7 PCDHA1 ENSG00000204970 Protocadherin alpha 1 5 140786136-141012347 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA035969 Approved Approved Plasma membrane Not detected Tissue enhanced cerebral cortex: 2.8;testis: 1.6 adrenal gland: 0.4 PCDHA10 CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10 ENSG00000250120 Protocadherin alpha 10 5 140855883-141012344 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced cerebral cortex: 17.5 thyroid gland: 4.2 PCDHA11 CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11 ENSG00000249158 Protocadherin alpha 11 5 140868183-141012344 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA077160 Approved Vesicles
Cell Junctions Not detected Tissue enhanced cerebral cortex: 7.6;parathyroid gland: 4.7 testis: 2.3 PCDHA12 PCDH-ALPHA12 ENSG00000251664 Protocadherin alpha 12 5 140875302-141012344 Predicted membrane proteins Evidence at transcript level HPA035812 Approved Approved Cytosol Not detected Tissue enhanced lung: 2.7 cerebral cortex: 1.8 PCDHA13 CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13 ENSG00000239389 Protocadherin alpha 13 5 140882208-141012344 Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 6 parathyroid gland: 6.9 testis: 1.1 PCDHA3 PCDH-ALPHA3 ENSG00000255408 Protocadherin alpha 3 5 140801028-141012344 Predicted membrane proteins Evidence at transcript level HPA035667 Uncertain Not detected Mixed endometrium: 2.5 PCDHA5 CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5 ENSG00000204965 Protocadherin alpha 5 5 140821604-141012344 Predicted membrane proteins Evidence at transcript level HPA044557 Approved Not detected Tissue enriched 10 cerebral cortex: 4.1 endometrium: 0.4 PCDHA6 CNR2, CNRS2, CRNR2, PCDH-ALPHA6 ENSG00000081842 Protocadherin alpha 6 5 140827958-141012344 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA059326 Approved Vesicles Not detected Tissue enhanced cerebral cortex: 4.8 parathyroid gland: 1.9 PCDHA7 CNR4, CNRS4, CRNR4 ENSG00000204963 Protocadherin alpha 7 5 140834248-141012344 Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced cerebral cortex: 1.6;testis: 1.3 endometrium,gallbladder,smooth muscle: 0.3 PCDHA8 ENSG00000204962 Protocadherin alpha 8 5 140841187-141012344 Predicted membrane proteins Evidence at protein level HPA044585 Uncertain Not detected Not detected cerebral cortex: 0.7 PCDHA9 KIAA0345, PCDH-ALPHA9 ENSG00000204961 Protocadherin alpha 9 5 140847463-141012344 Plasma proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced testis: 1.6 cerebral cortex: 0.6 PCDHAC1 ENSG00000248383 Protocadherin alpha subfamily C, 1 5 140926369-141012344 Predicted membrane proteins Evidence at transcript level HPA052775 Approved Nucleus
Nucleoli
Vesicles Not detected Tissue enriched 26 parathyroid gland: 68.4 cerebral cortex: 2.6 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 Protocadherin alpha subfamily C, 2 5 140966235-141012344 Predicted membrane proteins Evidence at transcript level HPA076190 Approved Nucleoplasm
Mitochondria Mixed Tissue enriched 6 parathyroid gland: 90.7 cerebral cortex: 14.2 PCDHB1 PCDH-BETA1 ENSG00000171815 Protocadherin beta 1 5 141051135-141059344 Predicted membrane proteins Evidence at protein level HPA053921 Uncertain Not detected Not detected testis: 0.9 PCDHB11 ME2, PCDH-BETA11 ENSG00000197479 Protocadherin beta 11 5 141199582-141203779 Predicted membrane proteins Evidence at transcript level HPA045042 Uncertain Approved Plasma membrane Mixed Tissue enhanced parathyroid gland: 8.1 endometrium: 2.5 PCDHB12 PCDH-BETA12 ENSG00000120328 Protocadherin beta 12 5 141208697-141212571 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA045042 Uncertain Approved Plasma membrane Mixed Mixed endometrium: 3.6 PCDHB13 PCDH-BETA13 ENSG00000187372 Protocadherin beta 13 5 141213919-141218979 Plasma proteins, Predicted membrane proteins Evidence at transcript level Mixed Mixed endometrium,gallbladder: 2.5 PCDHB15 PCDH-BETA15 ENSG00000113248 Protocadherin beta 15 5 141245349-141249365 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA007172, CAB026471 Uncertain Mixed Mixed cerebral cortex: 12.7 PCDHB3 PCDH-BETA3 ENSG00000113205 Protocadherin beta 3 5 141100473-141103827 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA050296 Uncertain Supported Vesicles Mixed Tissue enhanced testis: 10.4 endometrium,prostate: 2.3 PCDHB4 PCDH-BETA4 ENSG00000081818 Protocadherin beta 4 5 141121799-141125623 Predicted membrane proteins Evidence at transcript level HPA014466 Approved Uncertain Plasma membrane
Intermediate filaments
Cytosol Mixed Mixed endometrium: 8.9 PCDHB5 DKFZp586B0217, PCDH-BETA5 ENSG00000113209 Protocadherin beta 5 5 141135218-141138625 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA013191 Approved Mixed Mixed ovary: 7.3 PCDHB6 PCDH-BETA6 ENSG00000113211 Protocadherin beta 6 5 141150022-141153287 Predicted membrane proteins Evidence at transcript level HPA029566 Uncertain Uncertain Nucleus
Plasma membrane
Cytosol Renal cancer:5.52e-4 (unfavourable) Mixed Tissue enhanced parathyroid gland: 7.1 testis: 3.5 PCDHB7 PCDH-BETA7 ENSG00000113212 Protocadherin beta 7 5 141172619-141176383 Plasma proteins, Predicted membrane proteins Evidence at transcript level HPA059271 Approved Tissue enhanced Tissue enhanced endometrium: 6.6 smooth muscle: 4.4 PCDHB8 PCDH-BETA8, PCDH3I ENSG00000120322 Protocadherin beta 8 5 141177790-141180529 Predicted membrane proteins Evidence at transcript level HPA057773 Uncertain Mixed Mixed endometrium: 2.1 PCDHB9 PCDH-BETA9, PCDH3H ENSG00000177839 Protocadherin beta 9 5 141187127-141191541 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA013445, HPA029441 Uncertain Mixed Tissue enhanced cerebral cortex: 7.9 ovary: 2.5 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 Protocadherin gamma subfamily A, 1 5 141330571-141512981 Predicted membrane proteins Evidence at transcript level HPA008755, HPA036547 Uncertain Mixed Tissue enhanced cerebral cortex: 3.2 testis: 1.4 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 Protocadherin gamma subfamily A, 10 5 141412987-141512979 Predicted membrane proteins Evidence at transcript level HPA008755 Uncertain Mixed Tissue enriched 5 cerebral cortex: 28.1 placenta: 5.1 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 Protocadherin gamma subfamily A, 11 5 141421047-141512979 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA008755 Uncertain Mixed Mixed cerebral cortex: 3.2 PCDHGA12 CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12 ENSG00000253159 Protocadherin gamma subfamily A, 12 5 141430589-141512979 Plasma proteins, Predicted membrane proteins Evidence at transcript level HPA008755 Uncertain Tissue enhanced Mixed cerebral cortex: 8.1 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 Protocadherin gamma subfamily A, 2 5 141338760-141512979 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA008755 Uncertain Mixed Mixed cerebral cortex: 8.5 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 Protocadherin gamma subfamily A, 3 5 141343829-141512979 Predicted membrane proteins Evidence at protein level HPA008755, HPA039295 Uncertain Approved Nucleoplasm
Centrosome Not detected Tissue enhanced cerebral cortex: 6.5 ovary: 3.1 PCDHGA5 CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5 ENSG00000253485 Protocadherin gamma subfamily A, 5 5 141364232-141512979 Plasma proteins, Predicted membrane proteins Evidence at transcript level HPA008755 Uncertain Tissue enhanced Mixed cerebral cortex: 3.8 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 Protocadherin gamma subfamily A, 6 5 141373914-141512979 Predicted membrane proteins Evidence at transcript level HPA008755 Uncertain Mixed Mixed ovary: 3.8 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 Protocadherin gamma subfamily A, 7 5 141382739-141512979 Predicted membrane proteins Evidence at transcript level HPA008755, HPA077995 Uncertain Uncertain Plasma membrane
Cell Junctions Mixed Tissue enhanced cerebral cortex: 7.4 thyroid gland: 3.2 PCDHGA8 KIAA0327, PCDH-GAMMA-A8 ENSG00000253767 Protocadherin gamma subfamily A, 8 5 141390157-141512979 Predicted membrane proteins Evidence at transcript level HPA008755 Uncertain Not detected Not detected thyroid gland: 0.7 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 Protocadherin gamma subfamily A, 9 5 141402932-141512979 Predicted membrane proteins Evidence at protein level HPA008755 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 9.6 endometrium: 4.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 Protocadherin gamma subfamily B, 1 5 141350102-141512979 Predicted membrane proteins Evidence at transcript level HPA008755, HPA076182 Uncertain Approved Plasma membrane
Focal adhesion sites
Midbody Mixed Tissue enriched 12 cerebral cortex: 23.8 endometrium: 2.0 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 Protocadherin gamma subfamily B, 2 5 141360042-141512979 Predicted membrane proteins Evidence at transcript level HPA008755, HPA077526 Uncertain Uncertain Vesicles Tissue enriched Mixed cerebral cortex: 6.5 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 Protocadherin gamma subfamily B, 3 5 141370264-141512979 Plasma proteins, Predicted membrane proteins Evidence at transcript level HPA008755, HPA035823 Uncertain Mixed Mixed endometrium: 1.5 PCDHGB4 CDH20, FIB2, PCDH-GAMMA-B4 ENSG00000253953 Protocadherin gamma subfamily B, 4 5 141387698-141512979 Predicted membrane proteins Evidence at transcript level HPA008755 Uncertain Mixed Mixed placenta: 4.2 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 Protocadherin gamma subfamily B, 5 5 141397987-141512979 Predicted membrane proteins Evidence at transcript level HPA008755 Uncertain Mixed Tissue enhanced parathyroid gland: 19.4 thyroid gland: 7.5 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 Protocadherin gamma subfamily B, 6 5 141408021-141512979 Predicted membrane proteins Evidence at protein level HPA008755 Uncertain Mixed Tissue enhanced cerebral cortex: 20.9 parathyroid gland: 11.7 PCDHGB7 ME6, PCDH-GAMMA-B7 ENSG00000254122 Protocadherin gamma subfamily B, 7 5 141417645-141512979 Predicted membrane proteins Evidence at protein level HPA008755 Uncertain Tissue enhanced Mixed ovary: 10.2 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 Protocadherin gamma subfamily C, 4 5 141484997-141512979 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA008755, HPA078024 Uncertain Approved Golgi apparatus Tissue enriched Tissue enriched 11 cerebral cortex: 16.4 adrenal gland: 1.4 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 Protocadherin gamma subfamily C, 5 5 141489121-141512979 Predicted membrane proteins Evidence at protein level HPA008755, HPA051540 Uncertain Approved Nucleoplasm Group enriched Tissue enriched 44 cerebral cortex: 50.8 smooth muscle: 1.1 PCMTD2 C20orf36, FLJ10883 ENSG00000203880 Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 20 64255695-64287821 Predicted intracellular proteins Evidence at protein level HPA057849 Approved Approved Nucleoplasm
Mitochondria Lung cancer:2.13e-4 (favourable), Renal cancer:3.82e-4 (favourable) Expressed in all Expressed in all skin: 78.8 PCNXL2 FLJ11383, KIAA0435 ENSG00000135749 Pecanex-like 2 (Drosophila) 1 232983435-233295713 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA013815, HPA014427 Uncertain Approved Endoplasmic reticulum Renal cancer:2.27e-5 (unfavourable) Mixed Mixed cerebral cortex: 14.0 PCP2 GPSM4, MGC41903 ENSG00000174788 Purkinje cell protein 2 19 7631611-7633748 Predicted intracellular proteins Evidence at protein level HPA057428 Approved Nuclear speckles
Vesicles Urothelial cancer:2.76e-5 (favourable), Breast cancer:7.93e-4 (favourable) Mixed Tissue enriched 9 testis: 72.6 skin: 8.1 PCSK2 NEC2, PC2, SPC2 ENSG00000125851 Proprotein convertase subtilisin/kexin type 2 20 17226107-17484578 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA049627 Approved Approved Vesicles Group enriched Tissue enhanced adrenal gland: 37.7;cerebral cortex: 31.8 skin: 16.5 PCSK4 DKFZp434B217, MGC34749, PC4, SPC5 ENSG00000115257 Proprotein convertase subtilisin/kexin type 4 19 1481428-1490752 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA005572 Uncertain Endometrial cancer:9.45e-5 (favourable) Expressed in all Tissue enriched 9 testis: 41.3 fallopian tube: 4.7 PDE1A ENSG00000115252 Phosphodiesterase 1A, calmodulin-dependent 2 182140036-182523192 Enzymes, Predicted intracellular proteins Evidence at protein level HPA022151 Approved Approved Nucleoplasm Tissue enhanced Tissue enhanced thyroid gland: 76.2 testis: 62.5 PDP2 KIAA1348, PPM2C2 ENSG00000172840 Pyruvate dehyrogenase phosphatase catalytic subunit 2 16 66878589-66895754 Enzymes, Predicted intracellular proteins Evidence at protein level HPA019950, HPA062059 Approved Supported Mitochondria Renal cancer:9.75e-7 (favourable) Expressed in all Mixed thyroid gland: 15.5 PDZD9 C16orf65, MGC50721 ENSG00000155714 PDZ domain containing 9 16 21983865-22001110 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 39 testis: 20.7 cerebral cortex: 0.5 PDZRN4 DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4 ENSG00000165966 PDZ domain containing ring finger 4 12 41188448-41574590 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039510 Uncertain Tissue enhanced Tissue enhanced seminal vesicle: 19.4 prostate: 8.8 PERM1 C1orf170, MGC13275, Perm1, RP11-54O7.8 ENSG00000187642 PPARGC1 and ESRR induced regulator, muscle 1 1 975204-982093 Predicted intracellular proteins Evidence at protein level HPA031711, HPA031712 Supported Renal cancer:1.95e-4 (unfavourable) Mixed Group enriched 15 heart muscle: 20.6;skeletal muscle: 68.1 esophagus: 3.0 PERP dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW ENSG00000112378 PERP, TP53 apoptosis effector 6 138088505-138107511 Predicted membrane proteins Evidence at protein level HPA022269 Supported Pancreatic cancer:1.05e-5 (unfavourable), Lung cancer:3.73e-4 (unfavourable), Breast cancer:5.46e-4 (unfavourable) Expressed in all Group enriched 6 esophagus: 574.1;skin: 1238.6 breast: 149.6 PFKFB4 ENSG00000114268 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 3 48517684-48562015 Enzymes, Predicted intracellular proteins Evidence at protein level HPA047719, HPA066058 Uncertain Approved Nucleoli Renal cancer:3.91e-8 (unfavourable), Cervical cancer:3.04e-4 (unfavourable) Expressed in all Tissue enhanced testis: 31.7 small intestine: 23.2 PFN3 ENSG00000196570 Profilin 3 5 177400107-177400636 Predicted intracellular proteins Evidence at protein level Not detected Group enriched 22 kidney: 1.1;testis: 3.2 all non-specific tissues: 0.0 PGBD2 ENSG00000185220 PiggyBac transposable element derived 2 1 248906196-248919946 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA029888, HPA029889, HPA029890 Uncertain Supported Vesicles Urothelial cancer:2.05e-4 (favourable), Head and neck cancer:6.08e-4 (favourable), Renal cancer:7.86e-4 (unfavourable) Expressed in all Mixed thyroid gland: 13.5 PGBD3 FLJ90201 ENSG00000243251 PiggyBac transposable element derived 3 10 49515105-49524227 Predicted intracellular proteins Evidence at protein level HPA025825 Uncertain Not detected Mixed parathyroid gland: 2.3 PGBD4 FLJ32638, FLJ37497 ENSG00000182405 PiggyBac transposable element derived 4 15 34102073-34108684 Predicted intracellular proteins Evidence at protein level HPA040896, HPA059823 Uncertain Approved Nucleoplasm
Centrosome Mixed Mixed testis: 3.6 PGPEP1L ENSG00000183571 Pyroglutamyl-peptidase I-like 15 98968230-99007795 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA041781 Uncertain Not detected Group enriched 6 heart muscle: 2.2;skeletal muscle: 9.6;testis: 3.3 breast: 0.8 PGS1 DKFZP762M186 ENSG00000087157 Phosphatidylglycerophosphate synthase 1 17 78378640-78425114 Enzymes, Predicted intracellular proteins Evidence at protein level HPA022526 Approved Approved Vesicles
Cell Junctions
Intermediate filaments Renal cancer:1.16e-5 (unfavourable), Pancreatic cancer:7.33e-5 (favourable), Liver cancer:1.37e-4 (unfavourable), Prostate cancer:9.94e-4 (unfavourable) Expressed in all Expressed in all placenta: 26.5 PHACTR1 dJ257A7.2, KIAA1733, RPEL1 ENSG00000112137 Phosphatase and actin regulator 1 6 12716805-13290484 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA029755, HPA029756, HPA029757 Supported Uncertain Plasma membrane Renal cancer:5.48e-6 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 27.9 bone marrow: 15.6 PHF21B BHC80L, FLJ34161, PHF4 ENSG00000056487 PHD finger protein 21B 22 44881162-45009999 Predicted intracellular proteins Evidence at protein level HPA053834 Uncertain Uncertain Nucleus
Nucleoli fibrillar center Tissue enhanced Tissue enhanced cerebral cortex: 6.7;cervix, uterine: 5.5;testis: 6.4 endometrium: 5.3 PHKG1 PHKG ENSG00000164776 Phosphorylase kinase, gamma 1 (muscle) 7 56080283-56092996 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA012057 Supported Tissue enriched Tissue enriched 7 skeletal muscle: 100.5 cerebral cortex: 14.3 PHLDB3 FLJ40193 ENSG00000176531 Pleckstrin homology-like domain, family B, member 3 19 43474954-43504935 Predicted intracellular proteins Evidence at protein level HPA043425 Approved Approved Nuclear speckles
Plasma membrane
Cytosol Pancreatic cancer:6.36e-6 (favourable), Renal cancer:4.11e-5 (unfavourable), Stomach cancer:5.77e-4 (unfavourable) Expressed in all Expressed in all testis: 24.8 PHTF1 PHTF ENSG00000116793 Putative homeodomain transcription factor 1 1 113696831-113759489 Plasma proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA059486 Approved Nucleoli
Nuclear bodies Renal cancer:1.21e-6 (unfavourable) Expressed in all Tissue enhanced testis: 54.1 parathyroid gland: 18.8 PHTF2 DKFZp434D166 ENSG00000006576 Putative homeodomain transcription factor 2 7 77798792-77957503 Predicted membrane proteins, Transcription factors Evidence at protein level HPA012312 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:3.09e-7 (unfavourable), Thyroid cancer:2.78e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 60.8 PIANP C12orf53, DKFZp547D2210, PANP ENSG00000139200 PILR alpha associated neural protein 12 6693792-6700800 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA010631 Approved Approved Nucleoplasm Tissue enhanced Tissue enhanced cerebral cortex: 64.5 endometrium: 13.5 PIGB ENSG00000069943 Phosphatidylinositol glycan anchor biosynthesis, class B 15 55318960-55355648 Predicted membrane proteins Evidence at protein level HPA039929 Uncertain Uncertain Plasma membrane
Cytosol Expressed in all Mixed parathyroid gland: 22.8 PIGC ENSG00000135845 Phosphatidylinositol glycan anchor biosynthesis, class C 1 172370189-172444086 Enzymes, Predicted membrane proteins Evidence at protein level HPA036663 Uncertain Renal cancer:1.43e-8 (unfavourable), Liver cancer:4.49e-4 (unfavourable) Expressed in all Expressed in all epididymis: 47.0 PIGX FLJ20522 ENSG00000163964 Phosphatidylinositol glycan anchor biosynthesis, class X 3 196639775-196736007 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA029409 Uncertain Approved Nucleoplasm
Cytosol Liver cancer:7.45e-5 (unfavourable), Cervical cancer:2.12e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 28.0 PIGZ FLJ12768, MGC52163, SMP3 ENSG00000119227 Phosphatidylinositol glycan anchor biosynthesis, class Z 3 196946343-196969060 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA058599, HPA059920 Approved Uncertain Vesicles Renal cancer:5.60e-5 (unfavourable) Expressed in all Tissue enhanced colon: 18.8;rectum: 18.4 cerebral cortex: 10.9 PINLYP ENSG00000234465 Phospholipase A2 inhibitor and LY6/PLAUR domain containing 19 43576800-43583964 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA061218 Uncertain Approved Vesicles Mixed Mixed fallopian tube: 27.4 PIP5KL1 bA203J24.5, MGC46424 ENSG00000167103 Phosphatidylinositol-4-phosphate 5-kinase-like 1 9 127920879-127930797 Enzymes, Predicted intracellular proteins Evidence at protein level HPA056240 Uncertain Supported Cytosol Mixed Tissue enhanced parathyroid gland: 3.7 skin: 2.2 PIRT ENSG00000233670 Phosphoinositide-interacting regulator of transient receptor potential channels 17 10822475-10838445 Predicted membrane proteins, Transporters Evidence at transcript level HPA042337 Uncertain Uncertain Plasma membrane
Cytosol Tissue enriched Tissue enhanced adrenal gland: 3.1;cerebral cortex: 2.7;rectum: 2.7 colon: 2.1 PISD dJ858B16.2, PSDC ENSG00000241878 Phosphatidylserine decarboxylase 22 31618491-31662432 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA031090, HPA031091 Approved Approved Golgi apparatus
Cytosol Urothelial cancer:5.27e-5 (favourable) Expressed in all Expressed in all adipose tissue: 35.9 PIWIL3 HIWI3 ENSG00000184571 Piwi-like RNA-mediated gene silencing 3 22 24719034-24774720 Predicted intracellular proteins Evidence at protein level HPA061955 Uncertain Not detected Tissue enriched 13 testis: 1.7 skin: 0.1 PIWIL4 FLJ36156, HIWI2, Miwi2 ENSG00000134627 Piwi-like RNA-mediated gene silencing 4 11 94543840-94621421 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA036588, HPA057508 Approved Mixed Tissue enhanced testis: 24.2 bone marrow: 15.5 PKD2L2 TRPP5 ENSG00000078795 Polycystic kidney disease 2-like 2 5 137887968-137942747 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level HPA041903, HPA043634 Approved Approved Plasma membrane
Cytosol Not detected Tissue enriched 11 testis: 15.6 thyroid gland: 1.4 PKDCC SgK493, Vlk ENSG00000162878 Protein kinase domain containing, cytoplasmic 2 42048020-42058528 Enzymes, Predicted secreted proteins Evidence at protein level HPA026427, HPA026442, HPA026526 Uncertain Expressed in all Mixed adipose tissue: 27.4 PKDREJ ENSG00000130943 Polycystin (PKD) family receptor for egg jelly 22 46255663-46263355 Predicted membrane proteins Evidence at protein level HPA034587 Supported Not detected Tissue enriched 9 testis: 6.2 skin: 0.7 PKHD1L1 ENSG00000205038 Polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 8 109362477-109530330 Predicted membrane proteins Evidence at protein level HPA044458 Uncertain Endometrial cancer:7.61e-4 (favourable) Group enriched Group enriched 6 cervix, uterine: 21.2;fallopian tube: 19.5;thyroid gland: 56.9 endometrium: 5.4 PKIG ENSG00000168734 Protein kinase (cAMP-dependent, catalytic) inhibitor gamma 20 44531785-44624247 Predicted intracellular proteins Evidence at protein level HPA042703, HPA063690 Uncertain Supported Nucleoplasm
Cytosol Pancreatic cancer:4.90e-5 (favourable) Expressed in all Expressed in all heart muscle: 176.3 PKNOX2 ENSG00000165495 PBX/knotted 1 homeobox 2 11 125164687-125433389 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028867, CAB034342, HPA055368, HPA066962 Supported Validated Nucleoplasm Tissue enhanced Mixed thyroid gland: 20.1 PLA1A ps-PLA1 ENSG00000144837 Phospholipase A1 member A 3 119597842-119629811 Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level HPA059740 Approved Nuclear speckles Cervical cancer:2.81e-7 (favourable) Group enriched Tissue enhanced epididymis: 162.2;seminal vesicle: 92.2 parathyroid gland: 38.1 PLA2G4D cPLA2delta ENSG00000159337 Phospholipase A2, group IVD (cytosolic) 15 42067009-42094554 Enzymes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Mixed Group enriched 26 prostate: 30.0;skin: 16.6 esophagus,urinary bladder: 0.8 PLA2G4E FLJ45651 ENSG00000188089 Phospholipase A2, group IVE 15 41981582-42051190 Enzymes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level HPA041105 Supported Tissue enhanced Tissue enriched 10 skin: 20.4 esophagus,tonsil: 2.0 PLA2G4F PLA2G4F/Z ENSG00000168907 Phospholipase A2, group IVF 15 42139034-42156636 Enzymes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level HPA042713, HPA056752 Approved Approved Nucleus
Vesicles Endometrial cancer:2.00e-4 (unfavourable) Mixed Tissue enriched 5 skin: 92.8 lung: 18.4 PLAC1 CT92, OOSP2L ENSG00000170965 Placenta-specific 1 X 134565838-134764322 Predicted secreted proteins Evidence at protein level HPA063425 Supported Mixed Tissue enriched 21 placenta: 37.6 testis: 1.7 PLAC8 C15, onzin ENSG00000145287 Placenta-specific 8 4 83090048-83137075 Predicted intracellular proteins Evidence at protein level HPA040465, HPA077912 Supported Approved Cytosol Cervical cancer:3.03e-4 (favourable) Mixed Mixed bone marrow: 236.4 PLAC8L1 ENSG00000173261 PLAC8-like 1 5 146084386-146104369 Predicted intracellular proteins Evidence at transcript level HPA074266 Approved Nucleus Mixed Tissue enriched 10 testis: 31.1 skin: 3.0 PLAGL2 ZNF900 ENSG00000126003 Pleiomorphic adenoma gene-like 2 20 32192503-32207791 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005900 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 25.7 PLCD4 ENSG00000115556 Phospholipase C, delta 4 2 218607765-218637184 Enzymes, Predicted intracellular proteins Evidence at protein level CAB009914, HPA038139, HPA038140 Approved Approved Nuclear membrane
Plasma membrane
Cytosol Mixed Tissue enhanced skeletal muscle: 38.4 testis: 10.0 PLCH2 KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1 ENSG00000149527 Phospholipase C, eta 2 1 2425980-2505530 Enzymes, Predicted intracellular proteins Evidence at protein level Mixed Tissue enhanced skin: 58.4 esophagus: 14.0 PLCXD1 FLJ11323 ENSG00000182378 Phosphatidylinositol-specific phospholipase C, X domain containing 1 X 276322-303356 Predicted intracellular proteins Evidence at protein level HPA007721 Approved Approved Cytosol Renal cancer:7.82e-14 (unfavourable), Head and neck cancer:2.50e-4 (favourable), Endometrial cancer:8.10e-4 (unfavourable) Expressed in all Expressed in all stomach: 26.3 PLCXD2 FLJ31579 ENSG00000240891 Phosphatidylinositol-specific phospholipase C, X domain containing 2 3 111674676-111846447 Predicted intracellular proteins Evidence at protein level HPA055947 Uncertain Approved Nucleoplasm Renal cancer:1.23e-7 (favourable), Urothelial cancer:2.99e-4 (favourable) Mixed Mixed testis: 3.8 PLCXD3 ENSG00000182836 Phosphatidylinositol-specific phospholipase C, X domain containing 3 5 41306954-41510628 Predicted intracellular proteins Evidence at protein level HPA046849 Uncertain Approved Golgi apparatus Mixed Tissue enhanced adrenal gland: 16.8;heart muscle: 21.1;ovary: 28.3 cerebral cortex: 8.3 PLCZ1 NYD-SP27, PLCzeta ENSG00000139151 Phospholipase C, zeta 1 12 18683169-18738057 Enzymes, Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 22 testis: 48.2 skin: 2.1 PLD4 C14orf175 ENSG00000166428 Phospholipase D family, member 4 14 104924816-104937790 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA051512 Approved Mixed Mixed lymph node: 14.1 PLD5 FLJ40773 ENSG00000180287 Phospholipase D family, member 5 1 242082986-242524696 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA028389, HPA050367 Uncertain Approved Vesicles
Mitochondria
Cytosol Tissue enhanced Mixed cerebral cortex: 4.2 PLEKHD1 UPF0639 ENSG00000175985 Pleckstrin homology domain containing, family D (with coiled-coil domains) member 1 14 69484692-69531551 Predicted intracellular proteins Evidence at protein level HPA051875 Uncertain Mixed Tissue enhanced parathyroid gland: 2.9 thyroid gland: 2.7 PLEKHG4B KIAA1909 ENSG00000153404 Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B 5 140258-189970 Predicted intracellular proteins Evidence at protein level HPA036274, HPA058157 Uncertain Approved Nucleoplasm Lung cancer:3.47e-4 (favourable) Mixed Tissue enhanced thyroid gland: 5.2 testis: 3.2 PLEKHG7 FLJ46688 ENSG00000187510 Pleckstrin homology domain containing, family G (with RhoGef domain) member 7 12 92721505-92772455 Predicted intracellular proteins Evidence at transcript level HPA060632 Uncertain Mixed Tissue enhanced fallopian tube: 6.1 epididymis: 4.2 PLEKHH1 KIAA1200 ENSG00000054690 Pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 14 67533301-67589612 Predicted intracellular proteins Evidence at protein level HPA047707, HPA051964 Uncertain Approved Centrosome Renal cancer:4.03e-7 (favourable), Endometrial cancer:8.03e-5 (favourable), Urothelial cancer:2.26e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 43.4;thyroid gland: 51.0 parathyroid gland: 15.4 PLEKHJ1 FLJ10297 ENSG00000104886 Pleckstrin homology domain containing, family J member 1 19 2230084-2237704 Predicted intracellular proteins Evidence at protein level HPA048989 Approved Approved Mitochondria Renal cancer:1.10e-5 (favourable), Stomach cancer:6.99e-4 (favourable) Expressed in all Expressed in all duodenum: 110.9 PLEKHM3 DAPR, PLEKHM1L ENSG00000178385 Pleckstrin homology domain containing, family M, member 3 2 207828303-208025560 Predicted intracellular proteins Evidence at protein level HPA035046 Uncertain Approved Vesicles
Cytosol Mixed Mixed parathyroid gland: 16.5 PLET1 C11orf34 ENSG00000188771 Placenta expressed transcript 1 11 112248479-112260860 Predicted membrane proteins Evidence at transcript level HPA040237 Uncertain Not detected Not detected skin: 0.4 PLPP7 C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3 ENSG00000160539 Phospholipid phosphatase 7 (inactive) 9 131289694-131309262 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA070252 Uncertain Approved Nucleus
Vesicles Mixed Group enriched 5 heart muscle: 33.8;skeletal muscle: 72.2 cerebral cortex: 10.1 PLPPR1 FLJ20300, LPPR1, MGC26189, PRG-3 ENSG00000148123 Phospholipid phosphatase related 1 9 101028709-101325135 Predicted membrane proteins Evidence at protein level HPA014760, HPA014968, HPA014979 Supported Approved Nucleoplasm Lung cancer:1.37e-4 (favourable) Group enriched Group enriched 6 cerebral cortex: 23.9;kidney: 15.7 epididymis: 3.2 PLPPR2 LPPR2, PRG-4 ENSG00000105520 Phospholipid phosphatase related 2 19 11355386-11365698 Enzymes, Predicted membrane proteins Evidence at protein level HPA048973 Uncertain Approved Nucleoplasm Renal cancer:7.46e-11 (unfavourable), Colorectal cancer:6.45e-4 (unfavourable), Pancreatic cancer:6.82e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 77.4 PLPPR3 FLJ11535, LPPR3, PRG-2, PRG2 ENSG00000129951 Phospholipid phosphatase related 3 19 812488-821977 Enzymes, Predicted membrane proteins Evidence at protein level HPA052293, HPA057034 Uncertain Approved Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced Tissue enhanced bone marrow: 6.1;cerebral cortex: 9.6;fallopian tube: 8.8 testis: 2.1 PLPPR5 LPPR5, PAP2, PAP2D, PRG5 ENSG00000117598 Phospholipid phosphatase related 5 1 98890245-99005032 Predicted membrane proteins Evidence at transcript level HPA018072 Uncertain Approved Nucleus
Plasma membrane
Centrosome Renal cancer:6.22e-4 (unfavourable) Group enriched Group enriched 11 cerebral cortex: 12.0;testis: 4.0 adrenal gland: 0.7 PLSCR5 ENSG00000231213 Phospholipid scramblase family, member 5 3 146576555-146606216 Predicted membrane proteins Evidence at transcript level HPA047249 Uncertain Not detected Tissue enriched 5 parathyroid gland: 1.7 testis: 0.3 PLVAP FELS, gp68, PV-1, PV1 ENSG00000130300 Plasmalemma vesicle associated protein 19 17351448-17377350 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA002279 Supported Uncertain Cytosol Expressed in all Expressed in all thyroid gland: 328.6 PM20D1 Cps1, FLJ32569 ENSG00000162877 Peptidase M20 domain containing 1 1 205828022-205850132 Enzymes, Predicted secreted proteins Evidence at transcript level Tissue enriched Tissue enhanced kidney: 5.9;pancreas: 16.6 skin: 3.9 PMFBP1 ENSG00000118557 Polyamine modulated factor 1 binding protein 1 16 72112157-72176878 Predicted intracellular proteins Evidence at protein level HPA008518, HPA056716 Uncertain Approved Endoplasmic reticulum Mixed Tissue enhanced epididymis: 17.7;testis: 32.3 parathyroid gland: 7.2 PNCK CaMK1b, MGC45419 ENSG00000130822 Pregnancy up-regulated nonubiquitous CaM kinase X 153669730-153689010 Enzymes, Predicted intracellular proteins Evidence at protein level HPA007458 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Renal cancer:1.04e-6 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 40.7;seminal vesicle: 51.7 smooth muscle: 22.1 PNLDC1 dJ195P10.2, FLJ40240 ENSG00000146453 Poly(A)-specific ribonuclease (PARN)-like domain containing 1 6 159800249-159820704 Predicted membrane proteins Evidence at protein level HPA052026 Uncertain Mixed Tissue enriched 5 testis: 12.2 fallopian tube: 2.3 PNLIPRP3 ENSG00000203837 Pancreatic lipase-related protein 3 10 116427867-116477957 Enzymes, Predicted secreted proteins Evidence at transcript level HPA046202, HPA052009 Uncertain Tissue enhanced Tissue enhanced breast: 11.8;skin: 5.4 esophagus: 1.8 PNMA3 MA3, MA5, MGC132756, MGC132758 ENSG00000183837 Paraneoplastic Ma antigen 3 X 153056409-153060467 Predicted intracellular proteins Evidence at transcript level HPA047920 Approved Endometrial cancer:4.14e-5 (unfavourable) Mixed Group enriched 13 cerebral cortex: 15.4;epididymis: 44.8;testis: 12.3 fallopian tube: 1.8 PNMA6A MGC15827, PNMA6C ENSG00000235961 Paraneoplastic Ma antigen family member 6A X 153072482-153075018 Predicted intracellular proteins Evidence at transcript level HPA045007, HPA052115 Uncertain Uncertain Nucleoli
Mitochondria Renal cancer:1.93e-5 (favourable) Mixed Tissue enhanced cerebral cortex: 22.9 epididymis: 9.3 PNMAL2 KIAA1183 ENSG00000204851 Paraneoplastic Ma antigen family-like 2 19 46486906-46496498 Predicted intracellular proteins Evidence at protein level HPA054810 Approved Mixed Group enriched 5 adrenal gland: 12.2;cerebral cortex: 33.0 ovary: 4.3 PNPLA4 DXS1283E, GS2, iPLA2eta ENSG00000006757 Patatin-like phospholipase domain containing 4 X 7898247-7927739 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA003656 Approved Renal cancer:2.23e-12 (favourable), Glioma:4.67e-4 (unfavourable), Head and neck cancer:5.37e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 50.3 PNPLA5 dJ388M5.4, GS2L ENSG00000100341 Patatin-like phospholipase domain containing 5 22 43879678-43892013 Predicted intracellular proteins Evidence at transcript level HPA050409, HPA054211 Uncertain Tissue enhanced Tissue enhanced epididymis: 2.1 cerebral cortex: 1.1 PODNL1 FLJ23447, SLRR5B ENSG00000132000 Podocan-like 1 19 13931187-13953392 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042807 Approved Glioma:2.06e-8 (unfavourable), Urothelial cancer:4.49e-4 (unfavourable) Mixed Tissue enhanced placenta: 12.3 skin: 8.5 POM121L12 DKFZp564N2472 ENSG00000221900 POM121 transmembrane nucleoporin-like 12 7 53035642-53036924 Predicted intracellular proteins Evidence at transcript level HPA027836 Uncertain Not detected Tissue enriched 88 testis: 8.8 all non-specific tissues: 0.0 POMZP3 POM-ZP3, POM121 ENSG00000146707 POM121 and ZP3 fusion 7 76609986-76627261 Predicted intracellular proteins Evidence at transcript level HPA049817 Uncertain Approved Nucleoplasm
Nuclear membrane Liver cancer:3.78e-4 (unfavourable), Cervical cancer:4.34e-4 (favourable), Ovarian cancer:9.31e-4 (favourable) Expressed in all Mixed testis: 13.7 POPDC2 POP2 ENSG00000121577 Popeye domain containing 2 3 119636457-119665324 Predicted membrane proteins Evidence at protein level HPA024255 Supported Mixed Tissue enhanced heart muscle: 191.4;seminal vesicle: 63.4 smooth muscle: 35.0 POPDC3 bA355M14.1, MGC22671, POP3 ENSG00000132429 Popeye domain containing 3 6 105158280-105179995 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA012514 Uncertain Approved Nucleoli
Cytosol Head and neck cancer:4.43e-4 (unfavourable), Lung cancer:5.79e-4 (unfavourable) Mixed Group enriched 6 cerebral cortex: 8.8;heart muscle: 18.4;skeletal muscle: 41.8;testis: 9.7 epididymis: 3.4 POTEB3 ENSG00000278522 POTE ankyrin domain family, member B3 15 21408243-21440451 Predicted intracellular proteins Evidence at transcript level HPA042822 Uncertain Not detected Tissue enriched 22 testis: 2.1 all non-specific tissues: 0.0 POTEC A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18 ENSG00000183206 POTE ankyrin domain family, member C 18 14507339-14543585 Predicted intracellular proteins Evidence at transcript level HPA042822 Uncertain Not detected Tissue enriched 7 testis: 1.4 prostate: 0.2 POTED A26B3, ANKRD21, CT104.1, POTE, POTE-21, POTE21 ENSG00000166351 POTE ankyrin domain family, member D 21 13609858-13641585 Predicted intracellular proteins Evidence at transcript level HPA042822 Uncertain Not detected Tissue enriched 14 testis: 1.3 all non-specific tissues: 0.0 POTEG A26C2, CT104.4, POTE-14, POTE14, POTE14alpha ENSG00000187537 POTE ankyrin domain family, member G 14 19402486-19434341 Predicted intracellular proteins Evidence at transcript level HPA042822 Uncertain Tissue enhanced Tissue enhanced prostate: 3.3 testis: 0.7 POTEH A26C3, ACTBL1, CT104.7, POTE22 ENSG00000198062 POTE ankyrin domain family, member H 22 15690026-15721631 Predicted intracellular proteins Evidence at transcript level HPA042822 Uncertain Tissue enriched Group enriched 36 prostate: 5.7;testis: 1.3 all non-specific tissues: 0.0 POU2F3 Epoc-1, OCT11, PLA-1, Skn-1a ENSG00000137709 POU class 2 homeobox 3 11 120236640-120319944 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA019652 Supported Thyroid cancer:8.14e-4 (favourable) Mixed Group enriched 12 parathyroid gland: 15.3;skin: 72.5 seminal vesicle: 3.8 POU3F1 OCT6, OTF6, SCIP ENSG00000185668 POU class 3 homeobox 1 1 38043827-38046794 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055980, HPA073824 Validated Nucleoplasm Mixed Tissue enriched 18 skin: 38.6 cerebral cortex: 2.1 POU3F3 BRN1, OTF8 ENSG00000198914 POU class 3 homeobox 3 2 104855511-104860471 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052792, HPA056039, HPA067151 Supported Supported Nucleus Endometrial cancer:4.26e-5 (unfavourable) Group enriched Group enriched 51 cerebral cortex: 36.6;epididymis: 34.9;kidney: 28.3;seminal vesicle: 17.2 skin: 0.5 POU4F1 BRN3A, RDC-1 ENSG00000152192 POU class 4 homeobox 1 13 78598362-78603560 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA068024 Supported Mixed Tissue enhanced testis: 2.4 tonsil: 0.7 POU5F2 FLJ25680, SPRM-1 ENSG00000248483 POU domain class 5, transcription factor 2 5 93734806-93741637 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Tissue enriched 158 testis: 15.7 all non-specific tissues: 0.0 PP2D1 C3orf48, FLJ25449 ENSG00000183977 Protein phosphatase 2C-like domain containing 1 3 19979961-20012330 Predicted intracellular proteins Evidence at protein level HPA036870, HPA066083 Supported Uncertain Nucleoplasm
Intermediate filaments Not detected Tissue enriched 11 testis: 12.8 bone marrow: 1.2 PPAN BXDC3, SSF, SSF1, SSF2 ENSG00000130810 Peter pan homolog (Drosophila) 19 10106289-10111634 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA043265 Approved Expressed in all Expressed in all appendix: 20.7 PPFIA4 ENSG00000143847 Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 1 203026498-203078740 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA053419, HPA054132 Supported Renal cancer:1.73e-8 (unfavourable) Mixed Tissue enhanced cerebral cortex: 24.8;heart muscle: 13.3 skeletal muscle: 6.5 PPIAL4A COAS2, PPIAL4, PPIAL4B ENSG00000263353 Peptidylprolyl isomerase A (cyclophilin A)-like 4A 1 120889746-120890405 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA058345 Uncertain Not detected Not detected cerebral cortex: 0.4 PPIAL4C ENSG00000263464 Peptidylprolyl isomerase A (cyclophilin A)-like 4C 1 149583865-149584464 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA058345 Uncertain Not detected Mixed duodenum: 4.0 PPIL6 bA425D10.6, dJ919F19.1, MGC41939, RSPH12 ENSG00000185250 Peptidylprolyl isomerase (cyclophilin)-like 6 6 109390215-109441171 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA036717 Approved Approved Nucleus
Golgi apparatus
Cytosol Mixed Tissue enhanced fallopian tube: 52.8;testis: 32.6 thyroid gland: 17.6 PPM1M FLJ32332, PP2Ceta ENSG00000164088 Protein phosphatase, Mg2+/Mn2+ dependent, 1M 3 52245793-52250597 Enzymes, Predicted intracellular proteins Evidence at protein level HPA036905, HPA062291 Uncertain Approved Nuclear bodies Renal cancer:1.61e-5 (unfavourable), Lung cancer:6.69e-4 (favourable), Cervical cancer:7.73e-4 (favourable) Expressed in all Expressed in all lung: 34.9 PPM1N FLJ40125 ENSG00000213889 Protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) 19 45488777-45502510 Enzymes, Predicted intracellular proteins Evidence at protein level HPA043577 Supported Vesicles Tissue enhanced Tissue enriched 5 skeletal muscle: 69.9 spleen: 13.1 PPP1R42 dtr, LRRC67, TLLR ENSG00000178125 Protein phosphatase 1, regulatory subunit 42 8 66964099-67056604 Predicted intracellular proteins Evidence at transcript level HPA024313, HPA027983, HPA028628 Uncertain Mixed Group enriched 19 fallopian tube: 7.7;testis: 15.5 lung: 0.6 PPP2R2D MDS026 ENSG00000175470 Protein phosphatase 2, regulatory subunit B, delta 10 131900644-131959834 Predicted intracellular proteins Evidence at protein level HPA042122, HPA042770 Approved Approved Cytosol Colorectal cancer:3.14e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 6.7 PPP5D1 ENSG00000230510 PPP5 tetratricopeptide repeat domain containing 1 19 46480796-46601200 Predicted intracellular proteins Evidence at transcript level HPA073186 Uncertain Cytosol Not detected Mixed cerebral cortex: 4.8 PPTC7 TA-PP2C ENSG00000196850 PTC7 protein phosphatase homolog 12 110533245-110583320 Enzymes, Predicted intracellular proteins Evidence at protein level HPA039335, HPA040614 Approved Approved Plasma membrane
Cytosol Ovarian cancer:1.43e-5 (unfavourable), Renal cancer:4.48e-5 (favourable), Pancreatic cancer:6.76e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 33.7 PQLC2L C3orf55 ENSG00000174899 PQ loop repeat containing 2-like 3 157543246-157677749 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA054395 Uncertain Approved Nucleoplasm
Nuclear bodies Mixed Tissue enhanced adipose tissue: 21.5;thyroid gland: 16.0 breast: 6.0 PQLC3 C2orf22, MGC33602 ENSG00000162976 PQ loop repeat containing 3 2 11155198-11178874 Predicted membrane proteins Evidence at protein level HPA061607 Approved Cytosol Expressed in all Expressed in all cervix, uterine: 54.2 PRAC1 C17orf92, PRAC ENSG00000159182 Prostate cancer susceptibility candidate 1 17 48721719-48722522 Predicted intracellular proteins Evidence at transcript level HPA047871 Approved Tissue enriched Group enriched 38 colon: 105.4;prostate: 197.0;rectum: 224.2 urinary bladder: 4.5 PRAMEF1 ENSG00000116721 PRAME family member 1 1 12791397-12796628 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.1 PRAMEF10 ENSG00000187545 PRAME family member 10 1 12892896-12898270 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 12 liver: 1.1 all non-specific tissues: 0.0 PRAMEF15 ENSG00000204501 PRAME family member 15 1 13303509-13322598 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 PRAMEF17 ENSG00000204479 PRAME family member 17 1 13389632-13392629 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 PRAMEF2 FLJ43580 ENSG00000120952 PRAME family member 2 1 12857086-12861909 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.2 PRAMEF4 RP5-845O24.6 ENSG00000243073 PRAME family member 4 1 12879224-12886201 Predicted intracellular proteins Evidence at transcript level Tissue enriched Not detected all non-specific tissues: 0.0 PRAMEF5 PRAMEF23, PRAMEF5L ENSG00000270601 PRAME family member 5 1 13254212-13263314 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 PRAMEF6 ENSG00000232423 PRAME family member 6 1 12938472-13056491 Predicted intracellular proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 PRAMEF7 ENSG00000204510 PRAME family member 7 1 12916610-12920482 Predicted intracellular proteins Evidence at transcript level HPA049887, HPA051704 Uncertain Not detected Not detected all non-specific tissues: 0.0 PRAMEF8 ENSG00000182330 PRAME family member 8 1 13281035-13285174 Predicted intracellular proteins Evidence at transcript level HPA049887, HPA051704 Uncertain Not detected Not detected all non-specific tissues: 0.0 PRDM13 ENSG00000112238 PR domain containing 13 6 99606730-99615578 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA070592 Uncertain Not detected Not detected all non-specific tissues: 0.0 PRDM15 C21orf83, ZNF298 ENSG00000141956 PR domain containing 15 21 41798225-41879482 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024268, HPA029255, HPA029256 Uncertain Supported Nucleoplasm
Nuclear bodies Expressed in all Mixed lymph node: 8.9 PRDM6 ENSG00000061455 PR domain containing 6 5 123089121-123194266 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030322, HPA030324 Uncertain Uncertain Nucleoplasm Mixed Tissue enhanced gallbladder: 5.2;placenta: 5.9 lung: 4.0 PRDM8 ENSG00000152784 PR domain containing 8 4 80183879-80204329 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057253 Approved Nuclear bodies Tissue enhanced Tissue enhanced prostate: 41.3;seminal vesicle: 37.8 cerebral cortex: 23.3 PRELID2 FLJ38376, MGC21644 ENSG00000186314 PRELI domain containing 2 5 145471799-145835369 Predicted intracellular proteins Evidence at transcript level HPA042486 Uncertain Approved Nucleoplasm Renal cancer:9.65e-6 (unfavourable), Pancreatic cancer:3.78e-4 (unfavourable) Mixed Tissue enhanced small intestine: 29.3 rectum: 19.5 PRELID3A C18orf43, FLJ31484, HFL-EDDG1, SLMO1 ENSG00000141391 PRELI domain containing 3A 18 12407896-12432238 Predicted intracellular proteins Evidence at transcript level Endometrial cancer:5.89e-7 (unfavourable) Mixed Mixed seminal vesicle: 16.9 PRELID3B C20orf45, dJ543J19.5, SLMO2 ENSG00000101166 PRELI domain containing 3B 20 59033145-59042909 Predicted intracellular proteins Evidence at protein level HPA047721 Uncertain Approved Nucleus Liver cancer:6.96e-5 (unfavourable), Endometrial cancer:5.04e-4 (unfavourable) Expressed in all Expressed in all duodenum: 90.4 PREX2 DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129 ENSG00000046889 Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 8 67952118-68237030 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA015234, HPA075956 Approved Approved Endoplasmic reticulum Renal cancer:1.61e-7 (unfavourable) Mixed Mixed cerebral cortex: 12.0 PRICKLE4 C6orf49, DKFZp761H221, OEBT ENSG00000124593 Prickle homolog 4 6 41780349-41790141 Predicted intracellular proteins Evidence at transcript level HPA031240 Uncertain Mitotic spindle
Microtubule organizing center Renal cancer:2.47e-4 (unfavourable), Lung cancer:8.24e-4 (favourable) Expressed in all Mixed endometrium: 4.4 PRLH PRH ENSG00000071677 Prolactin releasing hormone 2 237566574-237567175 Predicted secreted proteins Evidence at transcript level HPA014768 Uncertain Tissue enhanced Not detected heart muscle: 0.8 PRMT9 FLJ46629, PRMT10 ENSG00000164169 Protein arginine methyltransferase 9 4 147637785-147684230 Predicted intracellular proteins Evidence at protein level HPA036844, HPA042537 Uncertain Approved Nucleoplasm
Microtubules
Cytosol Renal cancer:3.58e-7 (favourable) Expressed in all Mixed parathyroid gland: 14.5 PROB1 C5orf65 ENSG00000228672 Proline-rich basic protein 1 5 139390592-139395713 Predicted intracellular proteins Evidence at protein level HPA060103 Supported Approved Nucleoplasm Cervical cancer:9.26e-4 (favourable) Mixed Tissue enhanced skeletal muscle: 24.8 heart muscle: 6.3 PROCA1 MGC39650 ENSG00000167525 Protein interacting with cyclin A1 17 28703197-28711854 Predicted intracellular proteins Evidence at transcript level HPA023648 Approved Mixed Tissue enriched 20 testis: 139.6 spleen: 7.0 PRODH2 HSPOX1 ENSG00000250799 Proline dehydrogenase (oxidase) 2 19 35799988-35813299 Enzymes, Predicted intracellular proteins Evidence at protein level HPA051287 Approved Supported Nucleoplasm
Cytosol Group enriched Group enriched 94 kidney: 132.6;liver: 45.0 testis: 0.9 PRORY CYorf17 ENSG00000183146 Proline rich, Y-linked Y 21382954-21386360 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enhanced small intestine: 1.9 colon,rectum: 0.7 PROSER3 C19orf55, FLJ30657 ENSG00000167595 Proline and serine rich 3 19 35758143-35771028 Predicted intracellular proteins Evidence at protein level HPA058492 Approved Approved Golgi apparatus Renal cancer:3.74e-7 (unfavourable) Expressed in all Mixed testis: 14.2 PROX2 FLJ36749 ENSG00000119608 Prospero homeobox 2 14 74852871-74871940 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045057 Uncertain Not detected Mixed skin: 2.5 PRR15 ENSG00000176532 Proline rich 15 7 29563811-29567295 Predicted intracellular proteins Evidence at protein level HPA040996, HPA048121 Supported Uncertain Vesicles
Cell Junctions Renal cancer:1.83e-6 (favourable), Endometrial cancer:6.37e-4 (favourable), Lung cancer:7.23e-4 (unfavourable) Mixed Tissue enhanced cervix, uterine: 91.8 colon,small intestine: 80.6 PRR18 MGC35308 ENSG00000176381 Proline rich 18 6 166305300-166308448 Predicted intracellular proteins Evidence at protein level Tissue enhanced Tissue enriched 10 cerebral cortex: 32.7 fallopian tube: 3.4 PRR20A FLJ40296, PRR20 ENSG00000204919 Proline rich 20A 13 57140918-57143939 Predicted intracellular proteins Evidence at transcript level HPA059485 Uncertain Not detected Not detected testis: 0.1 PRR22 MGC24975 ENSG00000212123 Proline rich 22 19 5782960-5784765 Predicted intracellular proteins Evidence at protein level HPA044157 Approved Approved Nucleus
Vesicles
Cytosol Expressed in all Tissue enhanced testis: 22.0 skin: 4.9 PRR23B FLJ46116 ENSG00000184814 Proline rich 23B 3 139019031-139020926 Predicted intracellular proteins Evidence at transcript level HPA047473 Uncertain Not detected Tissue enriched 16 testis: 1.5 all non-specific tissues: 0.0 PRR23C FLJ46210 ENSG00000233701 Proline rich 23C 3 139042102-139044892 Predicted intracellular proteins Evidence at transcript level HPA047473 Uncertain Not detected Tissue enriched 12 testis: 1.7 adrenal gland,cerebral cortex,skin,spleen: 0.1 PRR26 C10orf108, FLJ38681 ENSG00000180525 Proline rich 26 10 649948-669581 Predicted intracellular proteins Evidence at transcript level HPA066037 Uncertain Mixed Mixed gallbladder: 7.9 PRR27 C4orf40 ENSG00000187533 Proline rich 27 4 70133616-70176799 Predicted secreted proteins Evidence at protein level HPA036150, HPA036151 Supported Tissue enriched Tissue enriched 1046 salivary gland: 405.2 ovary: 0.3 PRR29 C17orf72, DKFZp761M2312, FLJ11724 ENSG00000224383 Proline rich 29 17 63998351-64004304 Predicted intracellular proteins Evidence at transcript level HPA051264 Approved Nucleoli Mixed Tissue enriched 12 fallopian tube: 91.7 testis: 7.9 PRR30 C2orf53, MGC44505 ENSG00000186143 Proline rich 30 2 27136848-27139410 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 1039 testis: 103.8 all non-specific tissues: 0.0 PRR34 C22orf26, FLJ10945 ENSG00000182257 Proline rich 34 22 46049478-46054144 Predicted intracellular proteins Evidence at transcript level Not detected Mixed epididymis,skeletal muscle: 1.7 PRR35 C16orf11 ENSG00000161992 Proline rich 35 16 560422-565528 Predicted intracellular proteins Evidence at transcript level HPA069297 Uncertain Not detected Tissue enhanced kidney: 2.9 testis: 0.8 PRR7 MGC10772 ENSG00000131188 Proline rich 7 (synaptic) 5 177446445-177456286 Predicted intracellular proteins Evidence at transcript level HPA046636 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Liver cancer:1.50e-4 (unfavourable), Renal cancer:1.98e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 8.1 bone marrow: 3.7 PRRG3 TMG3 ENSG00000130032 Proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) X 151695124-151705924 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA060566 Uncertain Mixed Tissue enhanced cerebral cortex: 8.9 cervix, uterine: 7.5 PRRT1 C6orf31, IFITMD7, NG5 ENSG00000204314 Proline-rich transmembrane protein 1 6 32148359-32154373 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA055149 Approved Mixed Tissue enriched 8 cerebral cortex: 4.5 ovary: 0.6 PRRT4 ENSG00000224940 Proline-rich transmembrane protein 4 7 128350325-128361685 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA046373, HPA052681 Uncertain Approved Nucleoplasm
Peroxisomes
Plasma membrane Mixed Group enriched 12 adipose tissue: 15.7;bone marrow: 41.2 cerebral cortex: 2.3 PRRX2 PMX2, PRX2 ENSG00000167157 Paired related homeobox 2 9 129665641-129722674 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006607, HPA026808 Approved Approved Nucleoplasm
Nuclear bodies Mixed Tissue enhanced cervix, uterine: 9.8;skin: 10.7 testis: 6.3 PRSS12 BSSP-3, MRT1 ENSG00000164099 Protease, serine, 12 (neurotrypsin, motopsin) 4 118280038-118353003 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level HPA035054, HPA035055 Uncertain Approved Nucleus
Actin filaments Head and neck cancer:1.03e-4 (favourable), Glioma:1.53e-4 (favourable) Mixed Mixed cervix, uterine: 22.3 PRSS16 TSSP ENSG00000112812 Protease, serine, 16 (thymus) 6 27247701-27256624 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA017743 Uncertain Ovarian cancer:6.46e-5 (favourable) Mixed Tissue enhanced thyroid gland: 21.8 epididymis: 16.0 PRSS35 C6orf158, dJ223E3.1, MGC46520 ENSG00000146250 Protease, serine, 35 6 83512538-83525704 Enzymes, Predicted secreted proteins Evidence at protein level HPA038787, HPA038788 Uncertain Tissue enhanced Tissue enhanced ovary: 12.9 cerebral cortex: 10.0 PRSS37 ENSG00000165076 Protease, serine, 37 7 141836286-141841487 Enzymes, Predicted secreted proteins Evidence at protein level HPA020541 Uncertain Not detected Tissue enriched 155 testis: 55.0 epididymis,skin: 0.3 PRSS38 MPN2 ENSG00000185888 Protease, serine, 38 1 227815693-227846470 Enzymes, Predicted secreted proteins Evidence at protein level HPA028003, HPA055809 Supported Not detected Tissue enriched 21 testis: 4.2 epididymis: 0.2 PRSS42 TESSP2 ENSG00000178055 Protease, serine, 42 3 46829542-46834095 Enzymes, Predicted secreted proteins Evidence at transcript level HPA046925 Uncertain Not detected Group enriched 6 epididymis: 4.7;heart muscle: 7.1;parathyroid gland: 3.1;skeletal muscle: 8.4;testis: 2.0;thyroid gland: 1.8 cervix, uterine: 0.7 PRSS45 TESSP5 ENSG00000188086 Protease, serine, 45 3 46742092-46812558 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA060284 Uncertain Mixed Tissue enhanced epididymis: 4.1 parathyroid gland: 1.5 PRSS48 ESSPL ENSG00000189099 Protease, serine, 48 4 151277171-151291453 Enzymes, Predicted secreted proteins Evidence at transcript level HPA053801 Uncertain Not detected Tissue enhanced testis: 1.4 skin: 0.4 PRSS53 POL3S ENSG00000151006 Protease, serine, 53 16 31083425-31089628 Enzymes, Predicted secreted proteins Evidence at transcript level HPA034955, HPA034956 Uncertain Mixed Tissue enhanced skin: 1.1 endometrium,spleen: 0.4 PRSS54 CT67, FLJ25339, KLKBL4 ENSG00000103023 Protease, serine, 54 16 58279997-58295047 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA041549 Uncertain Not detected Tissue enriched 264 testis: 62.8 fallopian tube: 0.2 PRSS58 TRYX3 ENSG00000258223 Protease, serine, 58 7 142252143-142258058 Enzymes, Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 123 testis: 20.8 cervix, uterine,smooth muscle: 0.1 PRTG FLJ25756, IGDCC5 ENSG00000166450 Protogenin 15 55611546-55743090 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA032138 Uncertain Approved Vesicles
Plasma membrane
Cytosol Mixed Tissue enhanced thyroid gland: 18.2 testis: 6.7 PSAPL1 ENSG00000178597 Prosaposin-like 1 (gene/pseudogene) 4 7432258-7434945 Predicted secreted proteins Evidence at protein level HPA038013, HPA038482 Approved Validated Cytosol Mixed Group enriched 7 skin: 78.5;stomach: 59.0 breast: 10.1 PSD2 DKFZp761B0514, EFA6C ENSG00000146005 Pleckstrin and Sec7 domain containing 2 5 139795821-139844466 Predicted intracellular proteins Evidence at protein level Tissue enriched Tissue enriched 29 cerebral cortex: 58.7 epididymis: 2.0 PSG11 MGC22484, PSG13, PSG14 ENSG00000243130 Pregnancy specific beta-1-glycoprotein 11 19 43007656-43026512 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042240, HPA046327 Supported Not detected Tissue enriched 78 placenta: 73.9 smooth muscle: 0.9 PSG2 CEA, PSBG2, PSG1, PSGGB ENSG00000242221 Pregnancy specific beta-1-glycoprotein 2 19 43064211-43083045 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Not detected Tissue enriched 229 placenta: 342.1 smooth muscle: 1.4 PSG3 ENSG00000221826 Pregnancy specific beta-1-glycoprotein 3 19 42721638-42740569 Predicted secreted proteins Evidence at protein level HPA046327 Approved Not detected Tissue enriched 161 placenta: 188.4 testis: 1.1 PSG4 ENSG00000243137 Pregnancy specific beta-1-glycoprotein 4 19 43192702-43207299 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA046327 Approved Mixed Group enriched 8 parathyroid gland: 240.2;placenta: 192.9 colon: 28.5 PSG6 ENSG00000170848 Pregnancy specific beta-1-glycoprotein 6 19 42902079-42919563 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA046327 Approved Not detected Tissue enriched 75 placenta: 70.1 bone marrow: 0.9 PSG8 ENSG00000124467 Pregnancy specific beta-1-glycoprotein 8 19 42752686-42855691 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA046327 Approved Tissue enriched Tissue enriched 12 placenta: 9.1 parathyroid gland: 0.7 PSG9 PSG11, PSGII ENSG00000183668 Pregnancy specific beta-1-glycoprotein 9 19 43211791-43269530 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA046327 Approved Not detected Tissue enriched 120 placenta: 146.9 smooth muscle: 1.2 PSKH2 ENSG00000147613 Protein serine kinase H2 8 86048373-86088621 Enzymes, Predicted membrane proteins Evidence at protein level HPA015095 Uncertain Tissue enhanced Not detected testis: 0.4 PSMA8 MGC26605, PSMA7L ENSG00000154611 Proteasome subunit alpha 8 18 26133852-26193355 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 19 testis: 38.7 tonsil: 2.0 PSMB11 beta5t ENSG00000222028 Proteasome (prosome, macropain) subunit, beta type, 11 14 23042167-23044276 Enzymes, Predicted intracellular proteins Evidence at protein level Not detected Not detected testis: 0.2 PSMG4 C6orf86, PAC4 ENSG00000180822 Proteasome (prosome, macropain) assembly chaperone 4 6 3231403-3303373 Predicted intracellular proteins Evidence at protein level HPA067652 Approved Nucleus
Mitochondria Renal cancer:7.45e-4 (unfavourable) Expressed in all Expressed in all epididymis: 26.3 PSORS1C1 C6orf16, SEEK1 ENSG00000204540 Psoriasis susceptibility 1 candidate 1 6 31114750-31140092 Predicted intracellular proteins Evidence at transcript level HPA045049 Uncertain Nucleus Mixed Tissue enriched 10 testis: 33.5 epididymis: 3.2 PSORS1C2 C6orf17, SPR1 ENSG00000204538 Psoriasis susceptibility 1 candidate 2 6 31137536-31139350 Predicted secreted proteins Evidence at protein level HPA061228 Supported Tissue enhanced Tissue enriched 57 skin: 24.0 testis: 0.4 PSPN PSP ENSG00000125650 Persephin 19 6375148-6379058 Predicted secreted proteins Evidence at transcript level CAB025366 Approved Expressed in all Mixed cerebral cortex,epididymis,parathyroid gland,thyroid gland: 1.4 PTCD2 FLJ12598 ENSG00000049883 Pentatricopeptide repeat domain 2 5 72320367-72368395 Predicted intracellular proteins Evidence at protein level HPA043686 Approved Expressed in all Mixed cerebral cortex,thyroid gland: 6.5 PTCH2 ENSG00000117425 Patched 2 1 44819844-44843063 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Pancreatic cancer:5.74e-5 (favourable) Tissue enhanced Tissue enriched 6 parathyroid gland: 200.3 salivary gland: 32.3 PTCHD1 FLJ30296 ENSG00000165186 Patched domain containing 1 X 23334015-23404372 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA046110 Uncertain Mixed Tissue enhanced epididymis: 9.6 seminal vesicle: 5.3 PTCHD2 DISP3, KIAA1337 ENSG00000204624 Patched domain containing 2 1 11479166-11537584 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA054579 Uncertain Uncertain Nucleoplasm
Cytosol Tissue enhanced Group enriched 14 cerebral cortex: 8.7;testis: 4.3 adrenal gland: 0.4 PTCHD4 C6orf138, dJ402H5.2, FLJ41841 ENSG00000244694 Patched domain containing 4 6 47878028-48068689 Predicted membrane proteins Evidence at transcript level HPA041276 Uncertain Approved Plasma membrane
Cytosol Renal cancer:1.49e-6 (favourable) Group enriched Mixed seminal vesicle: 2.8 PTGDR DP, DP1, PTGDR1 ENSG00000168229 Prostaglandin D2 receptor (DP) 14 52267713-52276724 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced rectum: 8.7;spleen: 8.9 colon: 5.7 PTGER1 EP1 ENSG00000160951 Prostaglandin E receptor 1 (subtype EP1), 42kDa 19 14472466-14475362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Tissue enhanced Tissue enhanced kidney: 2.9;spleen: 2.6 appendix,lung: 0.7 PTGER2 EP2 ENSG00000125384 Prostaglandin E receptor 2 (subtype EP2), 53kDa 14 52314305-52328606 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Renal cancer:4.16e-4 (unfavourable) Mixed Mixed cervix, uterine: 27.3 PTGER3 EP3 ENSG00000050628 Prostaglandin E receptor 3 (subtype EP3) 1 70852353-71047808 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA010689 Uncertain Renal cancer:3.50e-4 (unfavourable) Group enriched Group enriched 7 adipose tissue: 58.5;endometrium: 114.7;kidney: 87.6;smooth muscle: 103.9 skin: 14.0 PTPDC1 FLJ37312, PTP9Q22 ENSG00000158079 Protein tyrosine phosphatase domain containing 1 9 94030794-94109856 Predicted intracellular proteins Evidence at protein level HPA016747, HPA026832 Uncertain Supported Nucleoplasm Expressed in all Mixed testis: 14.2 PTTG2 ENSG00000250254 Pituitary tumor-transforming 2 4 37960435-37961125 Predicted intracellular proteins Evidence at transcript level HPA008890, HPA045034 Uncertain Approved Nucleoli
Cytosol Not detected Not detected bone marrow: 0.7 PTX4 C16orf38 ENSG00000251692 Pentraxin 4, long 16 1485886-1488981 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA064718 Uncertain Cytosol Not detected Not detected testis: 0.9 PURG PURG-A, PURG-B ENSG00000172733 Purine-rich element binding protein G 8 30995802-31033715 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047746 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 6.6;testis: 4.8 endometrium: 2.6 PVRIG C7orf15, MGC2463 ENSG00000213413 Poliovirus receptor related immunoglobulin domain containing 7 100218241-100221490 Predicted membrane proteins Evidence at transcript level HPA047497 Uncertain Approved Nucleoli
Endoplasmic reticulum Not detected Tissue enhanced lymph node: 20.8;spleen: 11.3 appendix: 8.8 PWP2 EHOC-17, PWP2H, UTP1 ENSG00000241945 PWP2 periodic tryptophan protein homolog (yeast) 21 44107290-44131181 Predicted intracellular proteins Evidence at protein level HPA024573 Uncertain Supported Nucleoli
Cytosol Mixed Mixed skin: 5.4 PXDC1 C6orf145 ENSG00000168994 PX domain containing 1 6 3722614-3752026 Predicted intracellular proteins Evidence at protein level HPA019246 Approved Plasma membrane Endometrial cancer:1.14e-4 (unfavourable), Colorectal cancer:3.64e-4 (unfavourable) Expressed in all Mixed placenta: 82.1 PXT1 STEPP ENSG00000179165 Peroxisomal, testis specific 1 6 36390551-36442889 Predicted intracellular proteins Evidence at transcript level HPA044042 Uncertain Not detected Tissue enriched 7 testis: 3.6 appendix: 0.5 QRFP 26RFa, P518 ENSG00000188710 Pyroglutamylated RFamide peptide 9 130892702-130896812 Predicted secreted proteins Evidence at transcript level HPA043377 Uncertain Mixed Mixed prostate: 1.6 QRFPR GPR103 ENSG00000186867 Pyroglutamylated RFamide peptide receptor 4 121329312-121381059 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA014300 Uncertain Renal cancer:3.09e-4 (favourable) Tissue enriched Not detected heart muscle: 0.6 R3HDML dJ881L22.3 ENSG00000101074 R3H domain containing-like 20 44336986-44351235 Predicted secreted proteins Evidence at protein level HPA070264 Supported Tissue enhanced Tissue enhanced fallopian tube: 4.4;rectum: 6.2 small intestine: 2.8 RAB19 RAB19B ENSG00000146955 RAB19, member RAS oncogene family 7 140404043-140426250 Predicted intracellular proteins Evidence at protein level HPA051077 Uncertain Renal cancer:2.36e-8 (favourable) Mixed Mixed parathyroid gland: 6.1 RAB36 ENSG00000100228 RAB36, member RAS oncogene family 22 23145326-23164350 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA059631 Approved Vesicles Renal cancer:4.55e-4 (favourable) Mixed Tissue enhanced fallopian tube: 52.4;thyroid gland: 29.6 testis: 10.4 RAB3C ENSG00000152932 RAB3C, member RAS oncogene family 5 58582221-58859394 Predicted intracellular proteins Evidence at protein level HPA003160, HPA048156 Supported Approved Cytosol Mixed Group enriched 16 adrenal gland: 12.1;cerebral cortex: 55.5 small intestine: 2.0 RAB40A Rar-2, RAR2A ENSG00000172476 RAB40A, member RAS oncogene family X 103499750-103519489 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced epididymis: 9.2 esophagus: 7.6 RAB40B RAR, SEC4L ENSG00000141542 RAB40B, member RAS oncogene family 17 82654973-82698728 Predicted intracellular proteins Evidence at transcript level Renal cancer:2.95e-6 (favourable), Lung cancer:9.77e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 56.9 epididymis: 17.8 RAB7B MGC16212, MGC9726 ENSG00000276600 RAB7B, member RAS oncogene family 1 205976740-206003461 Predicted intracellular proteins Evidence at protein level Endometrial cancer:4.87e-4 (unfavourable) Expressed in all Tissue enhanced skin: 60.0 gallbladder: 23.0 RABL2B ENSG00000079974 RAB, member of RAS oncogene family-like 2B 22 50767501-50783663 Predicted intracellular proteins Evidence at protein level HPA042700, HPA044007 Approved Uncertain Plasma membrane
Cytosol Liver cancer:4.58e-5 (unfavourable), Endometrial cancer:5.58e-4 (favourable) Expressed in all Expressed in all epididymis: 109.0 RAD21L1 dJ545L17.2, RAD21L ENSG00000244588 RAD21 cohesin complex component like 1 20 1226056-1296421 Predicted intracellular proteins Evidence at transcript level HPA053282 Uncertain Not detected Tissue enriched 78 testis: 21.5 seminal vesicle: 0.2 RAET1L ENSG00000155918 Retinoic acid early transcript 1L 6 150018334-150025532 Predicted membrane proteins Evidence at transcript level Lung cancer:4.09e-4 (unfavourable) Tissue enhanced Tissue enriched 6 esophagus: 39.1 tonsil: 6.1 RANBP17 ENSG00000204764 RAN binding protein 17 5 170861870-171300015 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA029568, HPA029569 Uncertain Approved Nuclear membrane
Nuclear bodies
Cytosol Mixed Tissue enhanced testis: 5.0 thyroid gland: 1.7 RANBP3L FLJ25422 ENSG00000164188 RAN binding protein 3-like 5 36248434-36302114 Predicted intracellular proteins Evidence at transcript level HPA037471, HPA037472, HPA061526 Approved Uncertain Nucleoplasm Tissue enhanced Tissue enhanced cerebral cortex: 31.1;kidney: 28.5;prostate: 21.7 breast: 10.0 RASA4 CAPRI, GAPL, KIAA0538 ENSG00000105808 RAS p21 protein activator 4 7 102573807-102616757 Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at transcript level HPA043010 Uncertain Uncertain Vesicles Not detected Expressed in all skeletal muscle: 84.2 RASGEF1A CG4853, FLJ37817 ENSG00000198915 RasGEF domain family, member 1A 10 43194535-43266919 Predicted intracellular proteins Evidence at transcript level HPA035593 Approved Approved Golgi apparatus Renal cancer:4.11e-7 (unfavourable), Breast cancer:1.86e-5 (favourable), Endometrial cancer:4.28e-4 (unfavourable) Mixed Tissue enhanced cerebral cortex: 22.7 parathyroid gland: 12.5 RASGEF1C FLJ35841 ENSG00000146090 RasGEF domain family, member 1C 5 180100791-180209153 Predicted intracellular proteins Evidence at transcript level HPA028242 Uncertain Approved Mitochondria Tissue enhanced Group enriched 8 cerebral cortex: 16.5;testis: 6.1 seminal vesicle: 1.3 RASL10B RRP17, VTS58635 ENSG00000270885 RAS-like, family 10, member B 17 35731649-35743521 Predicted intracellular proteins Evidence at protein level HPA046842, HPA057092 Approved Approved Vesicles Endometrial cancer:6.38e-6 (unfavourable) Tissue enhanced Tissue enhanced adipose tissue: 15.9;seminal vesicle: 20.7 cerebral cortex,skeletal muscle: 11.1 RASL11A ENSG00000122035 RAS-like, family 11, member A 13 27270327-27273690 Predicted intracellular proteins Evidence at protein level HPA004859, HPA053296 Supported Approved Nuclear bodies Renal cancer:3.52e-4 (unfavourable), Lung cancer:5.43e-4 (favourable) Expressed in all Mixed rectum: 25.4 RASL11B ENSG00000128045 RAS-like, family 11, member B 4 52862290-52866835 Predicted intracellular proteins Evidence at transcript level HPA057803 Approved Approved Nuclear bodies Mixed Tissue enhanced ovary: 25.8;parathyroid gland: 29.9 cerebral cortex: 13.6 RASSF10 ENSG00000189431 Ras association (RalGDS/AF-6) domain family (N-terminal) member 10 11 13009577-13012106 Predicted intracellular proteins Evidence at transcript level Renal cancer:4.12e-5 (favourable), Head and neck cancer:2.76e-4 (favourable) Mixed Tissue enhanced fallopian tube: 5.3 parathyroid gland: 3.8 RASSF9 P-CIP1, PAMCI ENSG00000198774 Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 12 85800697-85836570 Predicted intracellular proteins Evidence at protein level HPA039428, HPA039678 Approved Mixed Mixed fallopian tube: 10.1 RBBP8NL C20orf151, dJ908M14.3 ENSG00000130701 RBBP8 N-terminal like 20 62410237-62427533 Predicted intracellular proteins Evidence at protein level HPA042627 Uncertain Urothelial cancer:6.91e-4 (favourable) Mixed Tissue enhanced small intestine: 5.3 duodenum: 4.6 RBFOX3 FOX-3, HRNBP3, NeuN ENSG00000167281 RNA binding protein, fox-1 homolog (C. elegans) 3 17 79089345-79516148 Predicted intracellular proteins Evidence at protein level HPA030790 Supported Supported Nucleoplasm Tissue enhanced Tissue enhanced cerebral cortex: 62.5;seminal vesicle: 33.0 prostate: 21.5 RBM18 MGC2734 ENSG00000119446 RNA binding motif protein 18 9 122237624-122264839 Predicted intracellular proteins Evidence at protein level HPA057281 Uncertain Approved Nucleus
Nucleoli fibrillar center
Midbody Renal cancer:8.00e-7 (favourable) Expressed in all Expressed in all breast: 20.2 RBM43 C2orf38, FLJ45645 ENSG00000184898 RNA binding motif protein 43 2 151247940-151261879 Predicted intracellular proteins Evidence at protein level HPA038204 Uncertain Approved Nucleus
Nucleoli Expressed in all Mixed thyroid gland: 20.5 RBM44 FLJ40411 ENSG00000177483 RNA binding motif protein 44 2 237798389-237842808 Predicted intracellular proteins Evidence at protein level HPA003298 Supported Not detected Tissue enriched 67 testis: 35.2 lung: 0.5 RBM46 CT68, MGC27016 ENSG00000151962 RNA binding motif protein 46 4 154781213-154828813 Predicted intracellular proteins Evidence at protein level Tissue enriched Tissue enriched 59 testis: 50.0 thyroid gland: 0.8 RBM48 C7orf64, DKFZp564O0523, HSPC304 ENSG00000127993 RNA binding motif protein 48 7 92528773-92538005 Predicted intracellular proteins Evidence at protein level HPA021777, HPA025306 Uncertain Validated Nucleoplasm Liver cancer:3.17e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 21.8 RBMXL3 CXorf55, FLJ40249 ENSG00000175718 RNA binding motif protein, X-linked-like 3 X 115189427-115192868 Predicted intracellular proteins Evidence at protein level HPA051842 Supported Tissue enriched Tissue enriched 26 testis: 2.5 all non-specific tissues: 0.0 RBMY1B ENSG00000242875 RNA binding motif protein, Y-linked, family 1, member B Y 21511338-21549094 Predicted intracellular proteins Evidence at protein level HPA001534, HPA053147 Supported Not detected Tissue enriched 28 testis: 2.8 all non-specific tissues: 0.0 RBMY1D ENSG00000244395 RNA binding motif protein, Y-linked, family 1, member D Y 21880076-21894526 Predicted intracellular proteins Evidence at protein level HPA001534, HPA053147 Supported Not detected Not detected all non-specific tissues: 0.0 RBMY1E ENSG00000242389 RNA binding motif protein, Y-linked, family 1, member E Y 21880076-21918067 Predicted intracellular proteins Evidence at protein level HPA001534, HPA053147 Supported Not detected Tissue enriched 27 testis: 2.6 all non-specific tissues: 0.0 RBPJL RBP-L, RBPSUHL, SUH, SUHL ENSG00000124232 Recombination signal binding protein for immunoglobulin kappa J region-like 20 45306851-45317824 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB006846 Supported Group enriched Tissue enriched 151 pancreas: 205.7 stomach: 1.3 RCAN2 DSCR1L1, ZAKI-4 ENSG00000172348 Regulator of calcineurin 2 6 46220736-46491972 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA053880 Uncertain Approved Nucleoplasm
Mitochondria Renal cancer:1.12e-6 (favourable), Pancreatic cancer:2.48e-4 (favourable) Expressed in all Mixed parathyroid gland: 142.7 RCBTB1 CLLD7, CLLL7, FLJ10716 ENSG00000136144 Regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 13 49531946-49585583 Predicted intracellular proteins Evidence at protein level HPA056783 Approved Nucleoplasm Ovarian cancer:1.21e-5 (unfavourable), Lung cancer:5.51e-5 (favourable), Renal cancer:1.75e-4 (favourable) Expressed in all Expressed in all thyroid gland: 73.7 REC114 C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677 ENSG00000183324 REC114 meiotic recombination protein 15 73443158-73560014 Predicted intracellular proteins Evidence at protein level Tissue enriched Tissue enriched 64 testis: 63.4 heart muscle: 0.9 RERGL FLJ22655 ENSG00000111404 RERG/RAS-like 12 18080869-18320107 Predicted intracellular proteins Evidence at protein level HPA041740 Uncertain Mixed Mixed epididymis: 46.1 RESP18 ENSG00000182698 Regulated endocrine-specific protein 18 2 219327409-219333177 Predicted intracellular proteins Evidence at transcript level HPA045849 Uncertain Not detected Tissue enhanced cerebral cortex: 2.1 testis: 0.6 RETNLB FIZZ2, HXCP2, RELMb ENSG00000163515 Resistin like beta 3 108743424-108757384 Predicted secreted proteins Evidence at transcript level HPA049152 Approved Colorectal cancer:6.86e-5 (favourable) Tissue enriched Tissue enhanced colon: 75.2;rectum: 274.6 small intestine: 37.6 RFNG ENSG00000169733 RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase 17 82047902-82051831 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA011564, HPA031673 Uncertain Supported Nucleus Pancreatic cancer:4.81e-4 (favourable) Expressed in all Expressed in all fallopian tube: 19.4 RFPL1 RNF78 ENSG00000128250 Ret finger protein-like 1 22 29438583-29442455 Predicted intracellular proteins Evidence at transcript level HPA048320, HPA072380 Approved Nuclear speckles
Plasma membrane Not detected Tissue enriched 6 cerebral cortex: 27.3 ovary: 4.4 RFPL2 RNF79 ENSG00000128253 Ret finger protein-like 2 22 32190435-32203477 Predicted intracellular proteins Evidence at transcript level HPA048320, HPA072380 Approved Nuclear speckles
Plasma membrane Prostate cancer:4.16e-4 (favourable) Tissue enriched Tissue enriched 9 prostate: 7.0 cerebral cortex: 0.8 RFPL3S NCRNA00005, RFPL3-AS, RFPL3-AS1 ENSG00000205853 RFPL3 antisense 22 32359906-32382052 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Tissue enriched 24 testis: 98.1 cerebral cortex: 4.1 RFPL4AL1 ENSG00000229292 Ret finger protein-like 4A-like 1 19 55769141-55773179 Predicted intracellular proteins Evidence at transcript level HPA046368 Uncertain Approved Centrosome
Cytosol Not detected Not detected spleen: 0.6 RFPL4B RNF211 ENSG00000251258 Ret finger protein-like 4B 6 112347330-112351296 Predicted intracellular proteins Evidence at transcript level HPA059324, HPA066464 Uncertain Group enriched Tissue enriched 5 testis: 2.9 placenta: 0.5 RFTN2 C2orf11, FLJ30574, Raftlin-2 ENSG00000162944 Raftlin family member 2 2 197568224-197676045 Predicted intracellular proteins Evidence at protein level HPA035232 Approved Group enriched Tissue enhanced cerebral cortex: 31.5 ovary: 8.7 RFX2 FLJ14226 ENSG00000087903 Regulatory factor X, 2 (influences HLA class II expression) 19 5993164-6199572 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048969 Supported Approved Nucleoplasm
Golgi apparatus
Cytosol Endometrial cancer:2.67e-4 (favourable), Cervical cancer:2.80e-4 (favourable), Pancreatic cancer:7.36e-4 (favourable) Mixed Tissue enhanced testis: 93.2 fallopian tube: 32.5 RFX8 FLJ42986 ENSG00000196460 RFX family member 8, lacking RFX DNA binding domain 2 101397361-101474703 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059745 Approved Nucleoplasm
Nuclear bodies Mixed Tissue enhanced bone marrow: 2.6 testis: 1.3 RGAG4 KIAA2001, Mar5, Mart5 ENSG00000242732 Retrotransposon gag domain containing 4 X 72127110-72131901 Predicted intracellular proteins Evidence at transcript level HPA003652 Approved Approved Nucleoplasm Pancreatic cancer:3.41e-4 (favourable), Lung cancer:7.30e-4 (favourable) Expressed in all Mixed thyroid gland: 4.1 RGL4 Rgr ENSG00000159496 Ral guanine nucleotide dissociation stimulator-like 4 22 23688136-23699176 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA035979 Uncertain Not detected Tissue enhanced bone marrow: 107.6 parathyroid gland: 48.1 RGPD1 RGP1 ENSG00000187627 RANBP2-like and GRIP domain containing 1 2 86907953-87013981 Predicted intracellular proteins Evidence at transcript level HPA049497, HPA051675, HPA067564 Uncertain Approved Nuclear membrane
Vesicles Not detected Group enriched 8 cervix, uterine: 12.6;placenta: 14.2;testis: 44.0 bone marrow: 2.8 RGPD2 RANBP2L2, RGP2 ENSG00000185304 RANBP2-like and GRIP domain containing 2 2 87755955-87825952 Predicted intracellular proteins Evidence at transcript level HPA049497, HPA051675, HPA067564 Uncertain Approved Nuclear membrane
Vesicles Not detected Tissue enhanced testis: 13.1 placenta: 8.3 RGPD4 DKFZp686P0288, RGP4 ENSG00000196862 RANBP2-like and GRIP domain containing 4 2 107826937-107890841 Predicted intracellular proteins Evidence at transcript level HPA049497, HPA051675, HPA067564 Uncertain Uncertain Nuclear membrane
Vesicles Not detected Tissue enriched 58 testis: 5.7 all non-specific tissues: 0.0 RGS13 ENSG00000127074 Regulator of G-protein signaling 13 1 192636138-192660306 Predicted intracellular proteins Evidence at protein level HPA044952 Uncertain Mixed Group enriched 6 appendix: 14.8;lymph node: 69.2;tonsil: 38.3 small intestine: 7.3 RGS21 ENSG00000253148 Regulator of G-protein signaling 21 1 192316992-192367285 Predicted intracellular proteins Evidence at transcript level HPA052843 Uncertain Not detected Not detected all non-specific tissues: 0.0 RGS7BP R7BP ENSG00000186479 Regulator of G-protein signaling 7 binding protein 5 64506257-64612312 Predicted intracellular proteins Evidence at protein level HPA039600 Approved Mixed Tissue enhanced cerebral cortex: 39.0 fallopian tube: 13.1 RGS9BP FLJ45744, PERRS, R9AP, RGS9 ENSG00000186326 Regulator of G protein signaling 9 binding protein 19 32675407-32678300 Disease related genes, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 6 skeletal muscle: 2.6 heart muscle,lung: 0.4 RGSL1 RGSL2 ENSG00000121446 Regulator of G-protein signaling like 1 1 182409192-182560599 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 6 testis: 9.1 epididymis: 1.4 RHBDD2 NPD007, RHBDL7 ENSG00000005486 Rhomboid domain containing 2 7 75842602-75888926 Enzymes, Predicted membrane proteins Evidence at protein level HPA045074, HPA051960 Uncertain Validated Golgi apparatus Renal cancer:8.68e-6 (favourable), Colorectal cancer:3.31e-5 (unfavourable), Glioma:1.25e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 253.1 RHBDD3 C22orf3, PTAG ENSG00000100263 Rhomboid domain containing 3 22 29259852-29268209 Predicted membrane proteins Evidence at protein level HPA043979 Approved Approved Microtubules Endometrial cancer:2.67e-6 (favourable), Renal cancer:2.24e-4 (unfavourable) Expressed in all Mixed testis: 10.5 RHBDL1 RHBDL, RRP ENSG00000103269 Rhomboid, veinlet-like 1 (Drosophila) 16 675666-678268 Enzymes, Predicted membrane proteins Evidence at protein level HPA030359, HPA030360, HPA046593 Uncertain Approved Nucleoplasm Breast cancer:8.12e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 8.0 adrenal gland: 3.3 RHBDL3 RHBDL4, VRHO ENSG00000141314 Rhomboid, veinlet-like 3 (Drosophila) 17 32266176-32324661 Enzymes, Predicted membrane proteins Evidence at transcript level HPA059607 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 20.7 adrenal gland: 5.5 RHOBTB1 KIAA0740 ENSG00000072422 Rho-related BTB domain containing 1 10 60869438-61001440 Predicted intracellular proteins Evidence at protein level HPA040205, HPA040226 Approved Approved Nucleoplasm
Cytosol Expressed in all Mixed placenta: 52.1 RHOBTB2 DBC2, KIAA0717 ENSG00000008853 Rho-related BTB domain containing 2 8 22987417-23020199 Predicted intracellular proteins Evidence at transcript level HPA060938 Approved Approved Plasma membrane Renal cancer:2.98e-4 (favourable) Expressed in all Mixed lung: 53.1 RHOXF1 OTEX, PEPP1 ENSG00000101883 Rhox homeobox family, member 1 X 120109053-120115937 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056506 Approved Mixed Tissue enriched 9 testis: 15.5 adipose tissue: 1.6 RHOXF2B ENSG00000203989 Rhox homeobox family, member 2B X 120070672-120077705 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003314 Supported Not detected Tissue enriched 17 testis: 2.7 fallopian tube,ovary,skin,spleen: 0.1 RIMKLA FAM80A, MGC47816, NAAGS-II, RP11-157D18.1 ENSG00000177181 Ribosomal modification protein rimK-like family member A 1 42380795-42422578 Enzymes, Predicted intracellular proteins Evidence at protein level HPA027826 Uncertain Uncertain Nucleoli fibrillar center Lung cancer:1.43e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 10.3 rectum: 3.9 RIMKLB FAM80B, KIAA1238, NAAGS, NAAGS-I ENSG00000166532 Ribosomal modification protein rimK-like family member B 12 8681600-8783095 Enzymes, Predicted intracellular proteins Evidence at protein level HPA059552 Approved Nucleoplasm
Microtubule organizing center Mixed Expressed in all endometrium: 74.3 RINL FLJ45909 ENSG00000187994 Ras and Rab interactor-like 19 38867834-38878279 Predicted intracellular proteins Evidence at protein level HPA042083, HPA042103 Uncertain Approved Nucleoplasm
Vesicles Cervical cancer:6.49e-5 (favourable), Head and neck cancer:1.64e-4 (favourable) Expressed in all Mixed lymph node: 14.2 RIPPLY3 DSCR6 ENSG00000183145 Ripply transcriptional repressor 3 21 37006150-37019659 Predicted intracellular proteins Evidence at transcript level HPA055541 Uncertain Mixed Not detected prostate: 0.2 RLN1 H1 ENSG00000107018 Relaxin 1 9 5334969-5339873 Plasma proteins, Predicted secreted proteins Evidence at transcript level Tissue enriched Tissue enriched 54 prostate: 33.4 testis: 0.6 RNASE10 RAH1, RNASE9 ENSG00000182545 Ribonuclease, RNase A family, 10 (non-active) 14 20505537-20511169 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA052593 Uncertain Group enriched Mixed testis: 4.1 RNASE11 C14orf6, RAJ1 ENSG00000173464 Ribonuclease, RNase A family, 11 (non-active) 14 20583559-20609884 Predicted secreted proteins Evidence at protein level HPA003724 Uncertain Not detected Tissue enriched 7 epididymis: 531.2 testis: 81.5 RNASE12 RAI1 ENSG00000258436 Ribonuclease, RNase A family, 12 (non-active) 14 20590193-20590823 Predicted secreted proteins Evidence at transcript level HPA044175 Uncertain Uncertain Vesicles
Microtubules Not detected Tissue enriched 255 epididymis: 1061.8 seminal vesicle: 4.1 RNASE13 RAL1 ENSG00000206150 Ribonuclease, RNase A family, 13 (non-active) 14 21032820-21034785 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 242 epididymis: 374.0 salivary gland: 1.5 RNASE6 RAD1, RNS6 ENSG00000169413 Ribonuclease, RNase A family, k6 14 20781051-20782467 Predicted secreted proteins Evidence at protein level HPA000698 Approved Expressed in all Mixed lymph node: 91.6 RNASEK MGC71993 ENSG00000219200 Ribonuclease, RNase K 17 7012417-7014532 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA044708 Uncertain Pancreatic cancer:1.92e-4 (favourable) Expressed in all Expressed in all adrenal gland: 470.3 RNF112 BFP, ZNF179 ENSG00000128482 Ring finger protein 112 17 19411125-19417276 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA015970 Approved Approved Nuclear speckles Tissue enriched Tissue enhanced cerebral cortex: 33.0 prostate: 9.6 RNF122 FLJ12526 ENSG00000133874 Ring finger protein 122 8 33547755-33567125 Predicted membrane proteins Evidence at transcript level HPA003888 Uncertain Renal cancer:4.50e-7 (unfavourable), Thyroid cancer:1.88e-4 (unfavourable), Prostate cancer:5.37e-4 (favourable) Expressed in all Expressed in all fallopian tube: 21.4 RNF133 ENSG00000188050 Ring finger protein 133 7 122697712-122699156 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 182 testis: 60.5 lung: 0.3 RNF145 FLJ31951 ENSG00000145860 Ring finger protein 145 5 159157409-159210053 Predicted membrane proteins Evidence at protein level HPA036562 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Liver cancer:1.64e-6 (unfavourable) Expressed in all Expressed in all lung: 109.1 RNF148 MGC35222 ENSG00000235631 Ring finger protein 148 7 122701664-122702967 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 226 testis: 73.0 lung: 0.3 RNF149 FLJ90504 ENSG00000163162 Ring finger protein 149 2 101271219-101308701 Predicted membrane proteins Evidence at protein level HPA011424 Approved Approved Vesicles
Plasma membrane Renal cancer:2.04e-8 (unfavourable), Urothelial cancer:2.91e-4 (favourable) Expressed in all Expressed in all appendix: 69.4 RNF150 KIAA1214 ENSG00000170153 Ring finger protein 150 4 140859807-141212877 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA037987 Uncertain Breast cancer:1.41e-4 (favourable) Mixed Mixed endometrium: 21.2 RNF151 ENSG00000179580 Ring finger protein 151 16 1966823-1968975 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 431 testis: 73.1 appendix,skin,stomach,thyroid gland: 0.1 RNF166 MGC14381, MGC2647 ENSG00000158717 Ring finger protein 166 16 88696495-88706421 Predicted intracellular proteins Evidence at protein level HPA042970 Approved Nucleoplasm
Plasma membrane
Cytosol Renal cancer:9.45e-6 (unfavourable), Pancreatic cancer:1.04e-4 (favourable) Expressed in all Expressed in all bone marrow: 57.2 RNF180 ENSG00000164197 Ring finger protein 180 5 64165844-64372869 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA006897 Approved Approved Cytosol Renal cancer:6.81e-5 (favourable) Tissue enhanced Tissue enhanced parathyroid gland: 62.3 thyroid gland: 24.9 RNF186 FLJ20225 ENSG00000178828 Ring finger protein 186 1 19814029-19815278 Predicted membrane proteins Evidence at protein level HPA034547, HPA035558 Supported Tissue enhanced Tissue enhanced duodenum: 136.0;epididymis: 82.8;small intestine: 47.7 kidney: 26.4 RNF207 C1orf188, FLJ32096, FLJ46380 ENSG00000158286 Ring finger protein 207 1 6205475-6221299 Predicted intracellular proteins Evidence at protein level HPA028378, HPA042535 Uncertain Approved Cytosol Renal cancer:1.92e-4 (unfavourable) Mixed Tissue enhanced heart muscle: 10.4 seminal vesicle: 5.3 RNF212 FLJ38841, LOC285498 ENSG00000178222 Ring finger protein 212 4 1056250-1113562 Predicted intracellular proteins Evidence at transcript level HPA057527 Uncertain Cervical cancer:1.39e-4 (favourable) Mixed Mixed thyroid gland: 5.8 RNF212B C14orf164 ENSG00000215277 Ring finger protein 212B 14 23185316-23273477 Predicted intracellular proteins Evidence at transcript level HPA053574 Uncertain Not detected Group enriched 17 kidney: 26.6;testis: 10.2 epididymis: 1.0 RNF217 C6orf172, dJ84N20.1, IBRDC1, MGC26996 ENSG00000146373 Ring finger protein 217 6 124962545-125092633 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA029598 Uncertain Renal cancer:4.60e-5 (unfavourable), Urothelial cancer:1.92e-4 (unfavourable) Expressed in all Tissue enriched 8 parathyroid gland: 94.6 testis: 12.4 RNF223 ENSG00000237330 Ring finger protein 223 1 1070966-1074307 Predicted membrane proteins Evidence at transcript level Endometrial cancer:8.08e-5 (favourable), Pancreatic cancer:6.53e-4 (unfavourable) Mixed Tissue enhanced esophagus: 5.3;stomach: 3.7 skin: 2.0 RNF26 MGC2642 ENSG00000173456 Ring finger protein 26 11 119334527-119337313 Predicted membrane proteins Evidence at transcript level HPA027620 Uncertain Approved Nucleoplasm
Vesicles
Cytosol Renal cancer:3.45e-6 (favourable), Liver cancer:3.19e-4 (unfavourable), Urothelial cancer:7.73e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 33.3 RNF39 HZFw1, LIRF ENSG00000204618 Ring finger protein 39 6 30070266-30075887 Predicted intracellular proteins Evidence at protein level CAB019278, HPA047115 Uncertain Uncertain Vesicles
Plasma membrane
Centrosome Mixed Tissue enhanced skin: 3.5 breast: 2.1 RNF44 KIAA1100 ENSG00000146083 Ring finger protein 44 5 176526697-176538025 Predicted intracellular proteins Evidence at protein level HPA038981 Uncertain Approved Nucleoplasm Endometrial cancer:2.57e-7 (unfavourable), Liver cancer:8.45e-4 (unfavourable) Expressed in all Expressed in all spleen: 51.0 RNFT1 PTD016 ENSG00000189050 Ring finger protein, transmembrane 1 17 59952240-59964761 Predicted membrane proteins Evidence at protein level HPA013739 Approved Nucleoli Thyroid cancer:2.57e-4 (favourable), Colorectal cancer:6.57e-4 (favourable), Lung cancer:7.48e-4 (favourable) Expressed in all Tissue enriched 9 testis: 113.2 epididymis: 12.3 RNFT2 FLJ14627, TMEM118 ENSG00000135119 Ring finger protein, transmembrane 2 12 116738178-116853631 Predicted membrane proteins Evidence at protein level HPA064161 Approved Approved Nucleoplasm
Cytosol Mixed Tissue enhanced cerebral cortex: 15.4 testis: 6.1 RNPEPL1 ENSG00000142327 Arginyl aminopeptidase (aminopeptidase B)-like 1 2 240565804-240581372 Enzymes, Predicted intracellular proteins Evidence at protein level HPA036772 Uncertain Approved Nucleus
Nucleoli Liver cancer:5.06e-4 (unfavourable), Head and neck cancer:7.43e-4 (favourable) Expressed in all Expressed in all skin: 29.4 RP11-294C11.1 ENSG00000182974 Olfactory receptor 4M2 15 21637909-21638992 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA058889 Uncertain Not detected Tissue enriched 24 testis: 2.3 all non-specific tissues: 0.0 RP11-310K10.1 ENSG00000197991 Protocadherin-20 13 61409858-61427849 Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.5 RP11-723O4.6 ENSG00000187695 Uncharacterized protein FLJ43738 3 128909874-128971330 Predicted intracellular proteins Evidence at transcript level HPA048390 Uncertain Mixed Tissue enhanced fallopian tube: 7.6;testis: 11.9 skin: 2.4 RP5-1187M17.10 ENSG00000088899 Leucine zipper putative tumor suppressor 3 20 3162617-3173592 Predicted intracellular proteins Evidence at protein level HPA031008, HPA031009 Approved Renal cancer:5.92e-8 (favourable), Endometrial cancer:7.26e-4 (unfavourable), Lung cancer:7.98e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 58.7 parathyroid gland: 19.9 RPEL1 ENSG00000235376 Ribulose-5-phosphate-3-epimerase-like 1 10 103245887-103248016 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA036498, HPA036499 Approved Not detected Not detected all non-specific tissues: 0.0 RPL3L ENSG00000140986 Ribosomal protein L3-like 16 1943974-1957606 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA049136 Supported Approved Nuclear speckles Mixed Tissue enriched 6 skeletal muscle: 324.0 heart muscle: 52.6 RPRML MGC43894 ENSG00000179673 Reprimo-like 17 46978156-46979248 Predicted membrane proteins Evidence at transcript level HPA062668 Uncertain Tissue enhanced Tissue enriched 11 cerebral cortex: 8.4 epididymis: 0.7 RPS4Y2 RPS4Y2P ENSG00000280969 Ribosomal protein S4, Y-linked 2 Y 20756164-20781032 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA000857 Uncertain Tissue enriched Group enriched 12 prostate: 3.3;testis: 2.2 tonsil: 0.2 RPS6KL1 MGC11287 ENSG00000198208 Ribosomal protein S6 kinase-like 1 14 74903954-74923396 Enzymes, Predicted intracellular proteins Evidence at protein level HPA027451, HPA027794 Approved Approved Nucleoplasm Mixed Tissue enhanced cerebral cortex: 31.4 testis: 14.6 RRNAD1 C1orf66, CGI-41 ENSG00000143303 Ribosomal RNA adenine dimethylase domain containing 1 1 156728442-156736960 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA047426 Approved Approved Nucleoli
Cytosol Colorectal cancer:5.60e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 49.0 RSAD1 FLJ11164 ENSG00000136444 Radical S-adenosyl methionine domain containing 1 17 50478800-50485975 Predicted intracellular proteins Evidence at protein level HPA022436, HPA022967 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Pancreatic cancer:5.04e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 36.0 RSC1A1 RS1 ENSG00000215695 Regulatory solute carrier protein, family 1, member 1 1 15659869-15661722 Predicted intracellular proteins Evidence at protein level HPA027813, HPA028676 Approved Supported Nucleoplasm
Cell Junctions Not detected Mixed smooth muscle: 5.2 RSPH10B ENSG00000155026 Radial spoke head 10 homolog B (Chlamydomonas) 7 5925550-5970683 Predicted intracellular proteins Evidence at transcript level HPA047076, HPA049181, HPA049182 Uncertain Not detected Group enriched 8 fallopian tube: 13.0;testis: 35.7 parathyroid gland: 2.9 RSPH10B2 ENSG00000169402 Radial spoke head 10 homolog B2 (Chlamydomonas) 7 6754109-6799365 Predicted intracellular proteins Evidence at transcript level HPA047076, HPA049181, HPA049182 Uncertain Not detected Group enriched 7 fallopian tube: 16.2;testis: 35.7 parathyroid gland: 3.8 RSPH6A RSHL1, RSP4, RSP6, RSPH4B ENSG00000104941 Radial spoke head 6 homolog A (Chlamydomonas) 19 45795710-45815319 Predicted intracellular proteins Evidence at protein level HPA045382 Approved Tissue enriched Tissue enriched 7 testis: 30.5 thyroid gland: 4.5 RTBDN FLJ36353 ENSG00000132026 Retbindin 19 12825478-12835428 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA052511 Approved Endoplasmic reticulum Mixed Group enriched 6 adrenal gland: 4.6;cerebral cortex: 14.7;testis: 3.5 stomach: 1.2 RTKN2 bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1 ENSG00000182010 Rhotekin 2 10 62183035-62268707 Predicted intracellular proteins Evidence at protein level HPA037946, HPA038446 Uncertain Approved Nucleoplasm
Mitochondria Mixed Tissue enriched 8 lung: 121.4 testis: 14.7 RTP1 MGC35450, Z3CXXC1 ENSG00000175077 Receptor (chemosensory) transporter protein 1 3 187197486-187201465 Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced cerebral cortex: 1.3 testis: 0.7 RUNDC3B RPIB9, RPIP9 ENSG00000105784 RUN domain containing 3B 7 87627548-87832296 Predicted intracellular proteins Evidence at protein level HPA056968, HPA057155 Uncertain Renal cancer:2.62e-6 (favourable) Mixed Tissue enhanced adrenal gland: 9.7 cerebral cortex: 7.2 S1PR5 Edg-8, EDG8 ENSG00000180739 Sphingosine-1-phosphate receptor 5 19 10512742-10517931 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA029683 Supported Renal cancer:6.71e-7 (unfavourable) Group enriched Tissue enhanced cerebral cortex: 14.9;skin: 22.1 spleen: 12.2 SAMD10 C20orf136 ENSG00000130590 Sterile alpha motif domain containing 10 20 63974113-63980008 Predicted intracellular proteins Evidence at protein level HPA040973 Approved Approved Nucleoplasm Liver cancer:4.60e-4 (unfavourable) Expressed in all Mixed lymph node: 7.7 SAMD11 MGC45873 ENSG00000187634 Sterile alpha motif domain containing 11 1 924880-944581 Predicted intracellular proteins Evidence at protein level HPA030110 Approved Nucleoplasm
Vesicles Renal cancer:3.35e-5 (unfavourable) Expressed in all Tissue enhanced seminal vesicle: 37.6 fallopian tube: 29.0 SAMD12 FLJ39458 ENSG00000177570 Sterile alpha motif domain containing 12 8 118189459-118621995 Predicted intracellular proteins Evidence at protein level HPA024634 Uncertain Approved Golgi apparatus
Cytosol Renal cancer:1.52e-6 (favourable), Endometrial cancer:1.11e-4 (unfavourable) Mixed Mixed thyroid gland: 14.0 SAMD13 ENSG00000203943 Sterile alpha motif domain containing 13 1 84298366-84389957 Predicted intracellular proteins Evidence at protein level HPA058929 Supported Approved Mitochondria Glioma:2.06e-8 (favourable) Mixed Tissue enhanced rectum: 26.5;testis: 28.8 colon: 21.2 SAMD14 FLJ36890 ENSG00000167100 Sterile alpha motif domain containing 14 17 50110040-50129882 Predicted intracellular proteins Evidence at protein level HPA051916 Uncertain Approved Nucleus
Nucleoli fibrillar center Tissue enhanced Tissue enhanced cerebral cortex: 6.3 testis: 1.8 SAMD15 C14orf174, FAM15A, FLJ35963 ENSG00000100583 Sterile alpha motif domain containing 15 14 77376689-77391497 Predicted intracellular proteins Evidence at protein level HPA030673, HPA030677 Approved Approved Nucleus
Nuclear membrane
Nucleoli Mixed Tissue enhanced testis: 31.9 fallopian tube: 7.3 SAMD7 DKFZp686E1583 ENSG00000187033 Sterile alpha motif domain containing 7 3 169911572-169939175 Predicted intracellular proteins Evidence at protein level HPA044187 Uncertain Not detected Not detected parathyroid gland: 0.5 SAPCD1 C6orf26, NG23 ENSG00000228727 Suppressor APC domain containing 1 6 31762799-31764851 Predicted intracellular proteins Evidence at transcript level HPA071699 Approved Vesicles
Cell Junctions Mixed Tissue enhanced skin: 3.2 bone marrow: 1.0 SAPCD2 C9orf140, p42.3 ENSG00000186193 Suppressor APC domain containing 2 9 137062124-137070588 Predicted intracellular proteins Evidence at protein level HPA044154 Approved Supported Nucleus
Nucleoli
Cytosol Lung cancer:5.88e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 12.9 small intestine: 4.9 SATL1 ENSG00000184788 Spermidine/spermine N1-acetyl transferase-like 1 X 85092287-85109048 Predicted intracellular proteins Evidence at transcript level HPA060369 Uncertain Not detected Tissue enhanced testis: 1.3 cerebral cortex: 0.4 SAXO2 DKFZp666G057, FAM154B ENSG00000188659 Stabilizer of axonemal microtubules 2 15 82262810-82284930 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA040487, HPA040833 Supported Approved Nucleoplasm
Golgi apparatus Mixed Tissue enhanced fallopian tube: 94.7 testis: 28.9 SAYSD1 C6orf64, FLJ11101 ENSG00000112167 SAYSVFN motif domain containing 1 6 39104064-39115189 Predicted membrane proteins Evidence at protein level HPA007959 Approved Validated Vesicles Expressed in all Tissue enriched 6 testis: 85.5 prostate: 14.9 SBK1 Sbk ENSG00000188322 SH3 domain binding kinase 1 16 28292519-28323849 Enzymes, Predicted membrane proteins Evidence at transcript level Cervical cancer:6.88e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 10.9;skeletal muscle: 12.0 parathyroid gland: 4.0 SBNO2 FLJ00173, KIAA0963, Sno, Stno ENSG00000064932 Strawberry notch homolog 2 (Drosophila) 19 1107636-1174283 Predicted intracellular proteins Evidence at protein level HPA041867 Approved Renal cancer:7.98e-8 (unfavourable) Expressed in all Mixed adipose tissue: 14.1 SCAMP4 FLJ33847 ENSG00000227500 Secretory carrier membrane protein 4 19 1905214-1926013 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA043284 Approved Approved Golgi apparatus
Vesicles
Lipid droplets
Plasma membrane Endometrial cancer:4.40e-6 (favourable), Liver cancer:1.92e-5 (unfavourable), Renal cancer:3.56e-4 (favourable) Expressed in all Expressed in all fallopian tube: 58.6 SCARA5 FLJ23907, MGC45780, NET33 ENSG00000168079 Scavenger receptor class A, member 5 8 27869882-27992727 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA024661 Approved Mixed Mixed adipose tissue: 65.7 SCGB1D2 LIPB, LPHB ENSG00000124935 Secretoglobin, family 1D, member 2 11 62242210-62244808 Cancer-related genes, Predicted secreted proteins Evidence at protein level HPA035318 Approved Endometrial cancer:3.46e-6 (favourable), Renal cancer:8.03e-6 (favourable) Group enriched Group enriched 9 breast: 1426.3;cervix, uterine: 5141.6 epididymis: 377.9 SCGB3A2 LU103, PNSP1, UGRP1 ENSG00000164265 Secretoglobin, family 3A, member 2 5 147870682-147882191 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Tissue enriched Tissue enriched 187 lung: 1862.5 thyroid gland: 9.9 SCGN CALBL, DJ501N12.8, SECRET, SEGN ENSG00000079689 Secretagogin, EF-hand calcium binding protein 6 25652201-25701783 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB004005, HPA006641, CAB044060, CAB062563, CAB068232 Supported Supported Tissue enhanced Tissue enhanced rectum: 21.8;stomach: 20.7 colon: 17.3 SCP2D1 C20orf79, dJ1068E13.2, HSD22 ENSG00000132631 SCP2 sterol-binding domain containing 1 20 18813726-18814392 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 588 testis: 58.7 all non-specific tissues: 0.0 SCRT2 ZNF898B ENSG00000215397 Scratch family zinc finger 2 20 661596-676179 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA067697 Approved Nucleoplasm Tissue enriched Not detected cerebral cortex: 0.7 SCTR ENSG00000080293 Secretin receptor 2 119439843-119525301 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level HPA007269 Uncertain Tissue enhanced Tissue enhanced duodenum: 27.4;lung: 13.0;pancreas: 14.3 stomach: 4.2 SCUBE2 Cegb1, Cegf1, FLJ16792 ENSG00000175356 Signal peptide, CUB domain, EGF-like 2 11 9020391-9138114 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA006353, HPA029871 Uncertain Breast cancer:2.41e-4 (favourable) Expressed in all Mixed epididymis: 62.1 SDK1 FLJ31425 ENSG00000146555 Sidekick cell adhesion molecule 1 7 3301448-4269000 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA011392 Approved Approved Cytosol Pancreatic cancer:4.08e-4 (favourable) Mixed Tissue enhanced cervix, uterine: 14.9 spleen: 6.1 SDR16C5 RDH-E2, RDHE2 ENSG00000170786 Short chain dehydrogenase/reductase family 16C, member 5 8 56300010-56320776 Enzymes, Predicted membrane proteins Evidence at protein level HPA025224 Supported Head and neck cancer:7.88e-4 (favourable) Mixed Group enriched 6 breast: 14.9;esophagus: 36.4;lung: 40.3;skin: 73.0;small intestine: 22.1;stomach: 21.3;tonsil: 26.3 cervix, uterine: 5.6 SDR42E1 HSPC105 ENSG00000184860 Short chain dehydrogenase/reductase family 42E, member 1 16 81988855-82011488 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA014388 Uncertain Mixed Mixed skin: 10.7 SEC14L5 KIAA0420, PRELID4B ENSG00000103184 SEC14-like lipid binding 5 16 4958317-5019158 Predicted intracellular proteins Evidence at protein level HPA041492, HPA041825 Uncertain Uncertain Golgi apparatus
Cytosol Mixed Tissue enriched 7 cerebral cortex: 17.2 heart muscle: 2.4 SEC61A2 FLJ10578 ENSG00000065665 Sec61 translocon alpha 2 subunit 10 12129637-12169961 Predicted membrane proteins, Transporters Evidence at protein level Renal cancer:2.22e-16 (unfavourable), Pancreatic cancer:1.08e-5 (favourable), Urothelial cancer:8.75e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 51.4 testis: 32.3 SEMA3B LUCA-1, SemA, sema5, SEMAA, semaV ENSG00000012171 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B 3 50267558-50277546 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Breast cancer:1.27e-4 (favourable) Expressed in all Mixed adrenal gland: 75.9 SEMA3C SEMAE, SemE ENSG00000075223 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C 7 80742538-80922359 Predicted secreted proteins Evidence at protein level HPA042418 Uncertain Approved Golgi apparatus
Plasma membrane
Cytosol Pancreatic cancer:4.08e-5 (unfavourable), Head and neck cancer:5.72e-5 (unfavourable) Mixed Mixed prostate: 98.7 SEMA3D coll-2, Sema-Z2 ENSG00000153993 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D 7 84995553-85186855 Predicted intracellular proteins Evidence at protein level HPA037522 Uncertain Approved Golgi apparatus
Plasma membrane Mixed Group enriched 5 spleen: 67.1;thyroid gland: 76.0 prostate: 13.5 SEMA3F Sema4, SEMAK ENSG00000001617 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F 3 50155045-50189075 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA035008 Approved Liver cancer:5.15e-4 (unfavourable) Expressed in all Expressed in all skin: 89.3 SEMA3G FLJ00014, sem2 ENSG00000010319 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G 3 52433053-52445085 Predicted secreted proteins Evidence at protein level HPA001761 Uncertain Renal cancer:8.86e-5 (favourable) Expressed in all Tissue enhanced adipose tissue: 82.0 placenta: 42.0 SEMA4F SEMAM, SEMAW ENSG00000135622 Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F 2 74654228-74683853 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA065969 Approved Nucleus
Plasma membrane
Centrosome Renal cancer:9.74e-6 (unfavourable), Endometrial cancer:5.94e-5 (unfavourable), Glioma:3.18e-4 (unfavourable), Thyroid cancer:6.94e-4 (favourable) Expressed in all Mixed cerebral cortex: 14.2 SEMA5B FLJ10372, KIAA1445, SEMAG, SemG ENSG00000082684 Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B 3 122909193-123028605 Predicted membrane proteins Evidence at protein level HPA017084, HPA066548 Uncertain Approved Cytosol Renal cancer:7.57e-4 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 11.5 heart muscle: 4.2 SEMA6C KIAA1869 ENSG00000143434 Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C 1 151131685-151146664 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA071220 Approved Endoplasmic reticulum Pancreatic cancer:3.06e-5 (favourable), Endometrial cancer:3.27e-4 (unfavourable) Expressed in all Tissue enhanced skeletal muscle: 111.3 testis: 33.9 SEMA6D FLJ11598, KIAA1479 ENSG00000137872 Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D 15 47184101-47774223 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA043109 Approved Golgi apparatus
Plasma membrane Renal cancer:5.96e-5 (favourable) Tissue enhanced Tissue enhanced placenta: 64.3 small intestine: 45.7 SERF1A 4F5, FAM2A, H4F5, SERF1, SMAM1 ENSG00000172058 Small EDRK-rich factor 1A (telomeric) 5 70900665-70918530 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA075271 Approved Nuclear bodies Not detected Mixed cerebral cortex: 9.2 SERF1B FAM2B, H4F5C ENSG00000205572 Small EDRK-rich factor 1B (centromeric) 5 70025247-70043113 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA075271 Approved Nuclear bodies Mixed Tissue enhanced testis: 48.1 epididymis: 31.6 SERHL2 ENSG00000183569 Serine hydrolase-like 2 22 42553617-42574382 Plasma proteins, Predicted intracellular proteins Evidence at transcript level Group enriched Tissue enriched 12 breast: 546.8 epididymis: 46.2 SERINC2 FKSG84, PRO0899, TDE2, TDE2L ENSG00000168528 Serine incorporator 2 1 31409565-31434680 Predicted membrane proteins Evidence at protein level HPA005974 Approved Endometrial cancer:1.69e-7 (favourable), Liver cancer:2.11e-4 (unfavourable), Lung cancer:5.70e-4 (unfavourable) Expressed in all Mixed urinary bladder: 138.8 SERINC3 AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1 ENSG00000132824 Serine incorporator 3 20 44496221-44522109 Predicted membrane proteins Evidence at protein level HPA048116 Uncertain Cervical cancer:1.01e-4 (unfavourable) Expressed in all Expressed in all testis: 200.8 SERINC4 FLJ40363 ENSG00000184716 Serine incorporator 4 15 43794162-43800221 Predicted membrane proteins Evidence at transcript level HPA018526 Uncertain Not detected Tissue enriched 10 testis: 2.2 endometrium: 0.2 SERINC5 C5orf12, TPO1 ENSG00000164300 Serine incorporator 5 5 80111651-80256079 Predicted membrane proteins Evidence at protein level HPA037898, HPA037899 Supported Uncertain Nucleus
Golgi apparatus
Vesicles Expressed in all Mixed testis: 55.9 SERPINA11 ENSG00000186910 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 14 94442464-94452790 Plasma proteins, Predicted secreted proteins Evidence at protein level Endometrial cancer:6.30e-4 (favourable) Tissue enriched Tissue enriched 30 liver: 255.3 cervix, uterine: 8.6 SERPINB11 EPIPIN ENSG00000206072 Serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene) 18 63647579-63726432 Plasma proteins, Predicted intracellular proteins Evidence at transcript level Tissue enhanced Group enriched 6 esophagus: 28.8;prostate: 65.8 tonsil: 7.5 SERPINE3 ENSG00000253309 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 3 13 51335773-51364735 Predicted secreted proteins Evidence at protein level HPA051904, HPA055804 Uncertain Not detected Mixed skin: 1.0 SERTAD4 DJ667H12.2 ENSG00000082497 SERTA domain containing 4 1 210232799-210246631 Predicted intracellular proteins Evidence at protein level HPA027344, HPA028514 Uncertain Supported Nucleoplasm Mixed Mixed breast: 4.6 SESN3 MGC29667, SEST3 ENSG00000149212 Sestrin 3 11 95165513-95232541 Predicted intracellular proteins Evidence at protein level HPA037935 Approved Nucleoplasm
Cytosol Expressed in all Tissue enhanced testis: 104.4 parathyroid gland: 54.5 SETD4 C21orf18, C21orf27 ENSG00000185917 SET domain containing 4 21 36034541-36079389 Predicted intracellular proteins Evidence at protein level HPA024073, HPA035405 Approved Approved Nuclear speckles Expressed in all Expressed in all testis: 41.7 SETD9 C5orf35, MGC33648 ENSG00000155542 SET domain containing 9 5 56909260-56925532 Predicted intracellular proteins Evidence at protein level HPA049936 Approved Nucleoplasm Expressed in all Tissue enriched 6 testis: 27.0 thyroid gland: 4.3 SFRP5 SARP3 ENSG00000120057 Secreted frizzled-related protein 5 10 97766751-97771952 Predicted secreted proteins Evidence at protein level Tissue enhanced Tissue enhanced duodenum: 31.7;pancreas: 31.2;small intestine: 30.0 adrenal gland: 13.0 SFT2D3 MGC5391 ENSG00000173349 SFT2 domain containing 3 2 127701508-127705242 Predicted membrane proteins Evidence at protein level Not detected Not detected epididymis: 0.8 SGCZ ZSG1 ENSG00000185053 Sarcoglycan, zeta 8 14089864-15238339 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA017585 Uncertain Not detected Tissue enhanced cerebral cortex: 1.3;ovary: 3.4 breast: 0.7 SGPP2 FLJ39004, SPP2 ENSG00000163082 Sphingosine-1-phosphate phosphatase 2 2 222424517-222560948 Predicted membrane proteins Evidence at transcript level Renal cancer:1.28e-4 (favourable) Expressed in all Tissue enhanced parathyroid gland: 58.4 thyroid gland: 33.8 SH2D4B ENSG00000178217 SH2 domain containing 4B 10 80537902-80646560 Predicted intracellular proteins Evidence at protein level HPA040022 Uncertain Not detected Not detected epididymis: 0.6 SH2D6 FLJ35993 ENSG00000152292 SH2 domain containing 6 2 85418721-85437029 Predicted intracellular proteins Evidence at transcript level HPA053873 Uncertain Mixed Tissue enhanced duodenum: 4.1;testis: 4.7;thyroid gland: 3.9 small intestine: 2.7 SH3BGR 21-GARP ENSG00000185437 SH3 domain binding glutamate-rich protein 21 39445855-39515506 Predicted intracellular proteins Evidence at protein level CAB003685, HPA030690 Supported Approved Plasma membrane
Cytosol Expressed in all Group enriched 7 heart muscle: 89.7;skeletal muscle: 436.1 prostate: 40.2 SH3D21 C1orf113, FLJ22938 ENSG00000214193 SH3 domain containing 21 1 36306387-36324886 Predicted intracellular proteins Evidence at protein level HPA042212, HPA042456, HPA066168 Approved Approved Nucleus
Plasma membrane Renal cancer:1.76e-6 (unfavourable), Breast cancer:2.60e-4 (favourable) Mixed Tissue enhanced small intestine: 28.3 skin: 17.8 SHISA4 C1orf40, hShisa4, TMEM58 ENSG00000198892 Shisa family member 4 1 201888680-201892306 Predicted membrane proteins Evidence at protein level HPA061273 Uncertain Expressed in all Group enriched 5 adrenal gland: 23.6;cerebral cortex: 45.5;skeletal muscle: 94.5 heart muscle: 10.8 SHISA6 FLJ45455 ENSG00000188803 Shisa family member 6 17 11241263-11564063 Predicted membrane proteins Evidence at transcript level HPA023440 Uncertain Mixed Tissue enhanced cervix, uterine: 24.6 seminal vesicle: 10.2 SHISA7 ENSG00000187902 Shisa family member 7 19 55428740-55442863 Predicted membrane proteins Evidence at protein level HPA058935 Uncertain Tissue enriched Tissue enriched 11 cerebral cortex: 18.3 testis: 1.7 SHISA9 ENSG00000237515 Shisa family member 9 16 12901620-13240413 Predicted membrane proteins Evidence at transcript level HPA072399 Approved Endoplasmic reticulum Renal cancer:1.53e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 23.0 prostate: 7.7 SHOX2 OG12, OG12X, SHOT ENSG00000168779 Short stature homeobox 2 3 158095954-158106503 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced adipose tissue: 4.1;testis: 3.3 cervix, uterine: 2.8 SIAH3 FLJ39203 ENSG00000215475 Siah E3 ubiquitin protein ligase family member 3 13 45777243-45851736 Predicted intracellular proteins Evidence at transcript level HPA060576 Uncertain Tissue enhanced Tissue enhanced fallopian tube: 5.0 cerebral cortex,cervix, uterine: 1.4 SIDT1 FLJ20174, SID-1 ENSG00000072858 SID1 transmembrane family, member 1 3 113532296-113629578 Predicted membrane proteins, Transporters Evidence at protein level HPA035862 Approved Urothelial cancer:4.09e-5 (favourable), Cervical cancer:3.78e-4 (favourable) Mixed Mixed cerebral cortex,rectum: 10.7 SIGLEC12 S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG ENSG00000254521 Sialic acid binding Ig-like lectin 12 (gene/pseudogene) 19 51491357-51501789 Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced appendix: 6.6;spleen: 13.0 smooth muscle: 3.6 SIGLECL1 C19orf75, FLJ40235, SIGLEC23P, SIGLECP7 ENSG00000179213 SIGLEC family like 1 19 51246348-51269330 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 81 testis: 40.0 cervix, uterine: 0.4 SIM1 bHLHe14 ENSG00000112246 Single-minded family bHLH transcription factor 1 6 100385015-100464929 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA024385 Approved Nuclear speckles Renal cancer:5.32e-7 (favourable) Tissue enhanced Tissue enhanced epididymis: 3.4;kidney: 11.1;seminal vesicle: 3.1 skeletal muscle: 1.2 SIRPB2 dJ776F14.2, PTPN1L, PTPNS1L3 ENSG00000196209 Signal-regulatory protein beta 2 20 1470741-1491587 Predicted membrane proteins Evidence at protein level HPA011548, HPA048032 Uncertain Approved Nuclear bodies Mixed Tissue enhanced appendix: 17.4 lung,placenta: 10.8 SIRPD dJ576H24.4, PTPNS1L2 ENSG00000125900 Signal-regulatory protein delta 20 1534251-1558843 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042663 Supported Not detected Tissue enriched 18 testis: 72.3 appendix: 4.0 SLAMF9 CD2F-10, CD84-H1, SF2001 ENSG00000162723 SLAM family member 9 1 159951492-159954254 Predicted membrane proteins Evidence at transcript level HPA035153 Uncertain Mixed Tissue enhanced testis: 1.3 appendix: 0.6 SLC10A3 DXS253E, P3 ENSG00000126903 Solute carrier family 10, member 3 X 154487306-154490690 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA021656 Approved Approved Intermediate filaments Colorectal cancer:4.15e-5 (unfavourable), Cervical cancer:4.53e-4 (favourable), Pancreatic cancer:7.22e-4 (unfavourable) Expressed in all Expressed in all gallbladder: 33.2 SLC10A5 ENSG00000253598 Solute carrier family 10, member 5 8 81693607-81696174 Predicted membrane proteins, Transporters Evidence at protein level HPA025966 Uncertain Approved Plasma membrane Mixed Mixed liver: 3.0 SLC10A7 C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043 ENSG00000120519 Solute carrier family 10, member 7 4 146253975-146521964 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA039996, HPA057906 Uncertain Approved Nucleoli Expressed in all Mixed epididymis: 16.0 SLC11A1 LSH, NRAMP, NRAMP1 ENSG00000018280 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 2 218382029-218396894 Predicted membrane proteins, Transporters Evidence at protein level HPA029590 Uncertain Renal cancer:2.58e-8 (unfavourable) Mixed Tissue enhanced appendix: 9.3;lung: 13.2 spleen: 4.8 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021690-46060152 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA072058 Supported Glioma:8.45e-4 (unfavourable) Mixed Tissue enriched 8 cerebral cortex: 94.5 adrenal gland: 12.0 SLC12A8 CCC9 ENSG00000221955 Solute carrier family 12, member 8 3 125082636-125212864 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA031123 Uncertain Supported Nucleoplasm Renal cancer:5.56e-4 (unfavourable) Expressed in all Tissue enhanced thyroid gland: 39.4 gallbladder: 16.3 SLC13A2 NaDC-1 ENSG00000007216 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 17 28473293-28497781 Predicted membrane proteins, Transporters Evidence at protein level HPA014963 Supported Renal cancer:9.00e-4 (favourable) Mixed Tissue enhanced duodenum: 70.6;small intestine: 55.4 kidney: 19.6 SLC13A4 SUT-1, SUT1 ENSG00000164707 Solute carrier family 13 (sodium/sulfate symporter), member 4 7 135681237-135729258 Predicted membrane proteins, Transporters Evidence at transcript level HPA048582 Approved Mixed Tissue enriched 10 placenta: 76.2 testis: 7.3 SLC15A1 HPECT1, HPEPT1, PEPT1 ENSG00000088386 Solute carrier family 15 (oligopeptide transporter), member 1 13 98683801-98752654 Predicted membrane proteins, Transporters Evidence at protein level HPA002827 Uncertain Approved Nucleoplasm
Cytosol Mixed Group enriched 5 duodenum: 157.7;gallbladder: 68.0;small intestine: 230.1 skin: 27.9 SLC15A2 PEPT2 ENSG00000163406 Solute carrier family 15 (oligopeptide transporter), member 2 3 121894089-121944102 Predicted membrane proteins, Transporters Evidence at protein level Cervical cancer:2.37e-4 (favourable), Lung cancer:6.74e-4 (favourable), Endometrial cancer:6.96e-4 (favourable) Mixed Tissue enhanced cervix, uterine: 77.7;prostate: 66.0 epididymis: 47.2 SLC15A3 hPTR3, PHT2 ENSG00000110446 Solute carrier family 15 (oligopeptide transporter), member 3 11 60937083-60952530 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA047880, HPA057642 Approved Supported Vesicles Cervical cancer:4.07e-5 (favourable) Expressed in all Expressed in all lung: 102.3 SLC15A4 PHT1, PTR4 ENSG00000139370 Solute carrier family 15 (oligopeptide transporter), member 4 12 128793191-128823983 Predicted membrane proteins, Transporters Evidence at protein level HPA016713 Approved Renal cancer:7.56e-6 (unfavourable), Liver cancer:6.78e-4 (unfavourable), Head and neck cancer:8.45e-4 (unfavourable) Expressed in all Expressed in all lymph node: 27.7 SLC16A11 FLJ90193, MCT11 ENSG00000174326 Solute carrier family 16, member 11 17 7041630-7043923 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Renal cancer:3.19e-7 (favourable), Pancreatic cancer:1.45e-5 (favourable), Liver cancer:2.56e-4 (favourable) Tissue enhanced Tissue enhanced fallopian tube: 8.8;parathyroid gland: 11.2 seminal vesicle: 3.8 SLC16A13 MCT13 ENSG00000174327 Solute carrier family 16, member 13 17 7036075-7040121 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA065245 Supported Golgi apparatus Pancreatic cancer:1.50e-4 (favourable) Expressed in all Mixed liver: 15.4 SLC16A14 FLJ30794, MCT14 ENSG00000163053 Solute carrier family 16, member 14 2 230034974-230068999 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA040518 Uncertain Approved Cytosol Mixed Mixed parathyroid gland: 14.6 SLC16A4 MCT4, MCT5 ENSG00000168679 Solute carrier family 16, member 4 1 110362848-110391082 Predicted membrane proteins Evidence at transcript level HPA046986, HPA060163 Approved Approved Microtubules
Cytokinetic bridge
Cytosol Renal cancer:1.69e-4 (favourable) Expressed in all Tissue enhanced kidney: 124.3 placenta: 39.9 SLC16A5 MCT5, MCT6 ENSG00000170190 Solute carrier family 16 (monocarboxylate transporter), member 5 17 75087727-75106162 Predicted membrane proteins, Transporters Evidence at transcript level Expressed in all Mixed duodenum: 35.5 SLC16A8 MCT3, REMP ENSG00000100156 Solute carrier family 16 (monocarboxylate transporter), member 8 22 38078134-38084093 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level HPA075017 Approved Intermediate filaments
Focal adhesion sites Mixed Mixed prostate: 5.7 SLC17A1 NAPI-1, NPT1 ENSG00000124568 Solute carrier family 17 (organic anion transporter), member 1 6 25782897-25832059 Predicted membrane proteins, Transporters Evidence at protein level HPA050513 Approved Golgi apparatus Group enriched Tissue enriched 7 kidney: 173.1 liver: 25.2 SLC17A2 NPT3 ENSG00000112337 Solute carrier family 17, member 2 6 25912754-25930726 Predicted membrane proteins, Transporters Evidence at protein level HPA038270 Uncertain Liver cancer:8.54e-4 (favourable) Tissue enriched Tissue enriched 85 liver: 40.9 kidney,testis: 0.4 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level HPA055564 Approved Group enriched Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 SLC17A6 DNPI, VGLUT2 ENSG00000091664 Solute carrier family 17 (vesicular glutamate transporter), member 6 11 22338097-22379503 Predicted membrane proteins, Transporters Evidence at protein level CAB037130, HPA039226 Supported Supported Not detected Tissue enriched 65 cerebral cortex: 6.5 all non-specific tissues: 0.0 SLC17A7 BNPI, VGLUT1 ENSG00000104888 Solute carrier family 17 (vesicular glutamate transporter), member 7 19 49429401-49442360 Predicted membrane proteins, Transporters Evidence at protein level CAB037183, HPA050458, HPA063679 Supported Tissue enriched Tissue enriched 178 cerebral cortex: 586.2 adipose tissue: 3.2 SLC18A1 CGAT, VAT1, VMAT1 ENSG00000036565 Solute carrier family 18 (vesicular monoamine transporter), member 1 8 20144855-20183206 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA006877, HPA063797 Supported Tissue enhanced Tissue enriched 10 adrenal gland: 32.8 rectum: 3.1 SLC18A3 VACHT ENSG00000187714 Solute carrier family 18 (vesicular acetylcholine transporter), member 3 10 49610301-49612720 Predicted membrane proteins, Transporters Evidence at transcript level CAB037102 Uncertain Mixed Not detected placenta: 0.6 SLC1A6 EAAT4 ENSG00000105143 Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19 14950034-15022990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA041505, HPA044066 Supported Uncertain Intermediate filaments Urothelial cancer:6.88e-6 (unfavourable) Tissue enriched Group enriched 6 cerebral cortex: 16.2;skin: 8.9;testis: 36.8 epididymis: 3.7 SLC1A7 EAAT5 ENSG00000162383 Solute carrier family 1 (glutamate transporter), member 7 1 53087179-53142632 Predicted membrane proteins, Transporters Evidence at protein level Tissue enhanced Tissue enhanced gallbladder: 8.5 fallopian tube: 4.4 SLC22A10 hOAT5, OAT5 ENSG00000184999 Solute carrier family 22, member 10 11 63137867-63369718 Predicted membrane proteins, Transporters Evidence at transcript level Tissue enriched Tissue enriched 108 liver: 36.1 epididymis: 0.3 SLC22A13 OAT10, OCTL1, OCTL3, ORCTL3 ENSG00000172940 Solute carrier family 22 (organic anion/urate transporter), member 13 3 38265812-38278315 Predicted membrane proteins, Transporters Evidence at protein level HPA035603, HPA035962 Supported Tissue enriched Tissue enriched 39 kidney: 10.6 testis: 0.2 SLC22A14 OCTL2, ORCTL4 ENSG00000144671 Solute carrier family 22, member 14 3 38282294-38318575 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Tissue enriched 20 testis: 13.4 kidney: 0.6 SLC22A15 FLIPT1 ENSG00000163393 Solute carrier family 22, member 15 1 115976498-116070054 Predicted membrane proteins, Transporters Evidence at protein level HPA019785 Approved Approved Vesicles Expressed in all Tissue enhanced bone marrow: 20.5 skin: 11.1 SLC22A17 BOCT, BOIT, NGALR ENSG00000092096 Solute carrier family 22, member 17 14 23346306-23352912 Predicted membrane proteins, Transporters Evidence at protein level HPA002728 Uncertain Pancreatic cancer:1.73e-4 (favourable), Stomach cancer:5.95e-4 (unfavourable) Expressed in all Tissue enriched 6 cerebral cortex: 229.2 prostate: 38.6 SLC22A18AS BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS ENSG00000254827 Solute carrier family 22 (organic cation transporter), member 18 antisense 11 2887780-2903740 Predicted intracellular proteins Evidence at protein level HPA068288 Supported Supported Nucleoplasm Mixed Tissue enhanced colon: 14.7;duodenum: 13.9 rectum,small intestine: 11.2 SLC22A24 MGC34821, NET46 ENSG00000197658 Solute carrier family 22, member 24 11 63079940-63144221 Predicted membrane proteins, Transporters Evidence at transcript level HPA045015 Uncertain Tissue enriched Tissue enriched 46 kidney: 4.6 all non-specific tissues: 0.0 SLC22A25 HIMTP, MGC120420, UST6 ENSG00000196600 Solute carrier family 22, member 25 11 63163776-63229652 Predicted membrane proteins, Transporters Evidence at transcript level HPA039390 Uncertain Liver cancer:7.04e-4 (favourable) Tissue enriched Tissue enriched 57 liver: 5.7 all non-specific tissues: 0.0 SLC23A3 FLJ31168, SVCT3, Yspl1 ENSG00000213901 Solute carrier family 23, member 3 2 219161465-219170095 Predicted membrane proteins, Transporters Evidence at protein level HPA019059 Approved Nucleus
Cell Junctions Tissue enriched Tissue enhanced kidney: 52.7;small intestine: 23.3 duodenum: 9.0 SLC24A3 ENSG00000185052 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 20 19212646-19722937 Predicted membrane proteins, Transporters Evidence at protein level HPA043400, HPA045497 Uncertain Thyroid cancer:6.08e-4 (unfavourable) Mixed Mixed endometrium: 47.4 SLC25A14 BMCP1, UCP5 ENSG00000102078 Solute carrier family 25 (mitochondrial carrier, brain), member 14 X 130339888-130373361 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA060316 Approved Mitochondria Renal cancer:5.52e-6 (unfavourable), Urothelial cancer:1.39e-5 (favourable), Cervical cancer:1.72e-5 (favourable), Pancreatic cancer:1.78e-4 (favourable) Expressed in all Mixed cerebral cortex: 20.5 SLC25A26 ENSG00000144741 Solute carrier family 25 (S-adenosylmethionine carrier), member 26 3 66133610-66388116 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA026887 Supported Supported Mitochondria Renal cancer:1.73e-5 (favourable) Expressed in all Expressed in all thyroid gland: 17.4 SLC25A27 FLJ33552, UCP4 ENSG00000153291 Solute carrier family 25, member 27 6 46652915-46678193 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level HPA069732 Supported Mitochondria Pancreatic cancer:6.16e-4 (favourable) Expressed in all Mixed epididymis: 83.8 SLC25A28 MRS3/4, MRS4L ENSG00000155287 Solute carrier family 25 (mitochondrial iron transporter), member 28 10 99610522-99620609 Predicted intracellular proteins, Transporters Evidence at protein level Cervical cancer:2.18e-6 (favourable), Renal cancer:7.28e-5 (unfavourable) Expressed in all Expressed in all testis: 93.2 SLC25A31 ANT4, DKFZP434N1235 ENSG00000151475 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 4 127730378-127774299 Predicted membrane proteins, Transporters Evidence at protein level HPA015064, HPA016841, HPA046835, HPA071684 Uncertain Validated Mitochondria Not detected Tissue enriched 849 testis: 84.9 all non-specific tissues: 0.0 SLC25A34 DKFZp781A10161 ENSG00000162461 Solute carrier family 25, member 34 1 15736405-15741396 Predicted membrane proteins, Transporters Evidence at protein level HPA069806 Supported Mitochondria Mixed Tissue enhanced duodenum: 14.9;small intestine: 15.5 skeletal muscle: 8.2 SLC25A35 FLJ40217 ENSG00000125434 Solute carrier family 25, member 35 17 8287763-8295343 Predicted membrane proteins, Transporters Evidence at protein level HPA051720 Uncertain Approved Vesicles
Mitochondria Endometrial cancer:3.37e-7 (favourable), Renal cancer:1.14e-6 (favourable), Urothelial cancer:1.91e-5 (favourable) Expressed in all Mixed testis: 19.6 SLC25A37 MFRN, MFRN1, MSCP ENSG00000147454 Solute carrier family 25 (mitochondrial iron transporter), member 37 8 23528805-23575463 Predicted intracellular proteins, Transporters Evidence at protein level HPA045680 Uncertain Renal cancer:4.37e-6 (unfavourable) Expressed in all Expressed in all bone marrow: 80.2 SLC25A39 CGI-69, FLJ22407 ENSG00000013306 Solute carrier family 25, member 39 17 44319625-44324870 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level HPA026785 Approved Renal cancer:3.58e-5 (favourable), Liver cancer:5.90e-5 (unfavourable) Expressed in all Expressed in all bone marrow: 181.5 SLC25A41 APC4, FLJ40442, MGC34725 ENSG00000181240 Solute carrier family 25, member 41 19 6426037-6433779 Predicted intracellular proteins, Transporters Evidence at transcript level HPA043591 Uncertain Not detected Tissue enhanced cerebral cortex: 1.0;testis: 1.9 esophagus: 0.4 SLC25A42 MGC26694 ENSG00000181035 Solute carrier family 25, member 42 19 19063999-19112888 Predicted membrane proteins, Transporters Evidence at protein level HPA049449 Approved Supported Mitochondria Lung cancer:4.11e-4 (favourable), Cervical cancer:5.04e-4 (favourable) Expressed in all Expressed in all kidney: 28.7 SLC25A43 ENSG00000077713 Solute carrier family 25, member 43 X 119399060-119454478 Predicted membrane proteins, Transporters Evidence at transcript level HPA035188 Uncertain Approved Nucleus Renal cancer:5.06e-8 (unfavourable), Endometrial cancer:3.76e-5 (unfavourable) Expressed in all Mixed esophagus: 20.6 SLC25A44 FLJ90431, KIAA0446 ENSG00000160785 Solute carrier family 25, member 44 1 156193932-156212796 Predicted membrane proteins, Transporters Evidence at protein level HPA065411 Approved Nucleus
Mitochondria Pancreatic cancer:2.49e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 43.1 SLC25A45 ENSG00000162241 Solute carrier family 25, member 45 11 65375192-65383701 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA050821 Uncertain Approved Nucleoplasm
Cytosol Pancreatic cancer:2.83e-4 (favourable) Expressed in all Expressed in all spleen: 12.6 SLC25A47 C14orf68 ENSG00000140107 Solute carrier family 25, member 47 14 100323337-100330378 Predicted membrane proteins, Transporters Evidence at transcript level Tissue enriched Tissue enriched 166 liver: 101.0 duodenum: 0.6 SLC25A51 CG7943, MCART1, MGC14836 ENSG00000122696 Solute carrier family 25, member 51 9 37879400-37904353 Predicted membrane proteins, Transporters Evidence at protein level HPA046388, HPA058261 Uncertain Approved Mitochondria Liver cancer:5.67e-5 (unfavourable), Renal cancer:1.52e-4 (favourable), Thyroid cancer:2.21e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 16.4 SLC25A53 MCART6 ENSG00000269743 Solute carrier family 25, member 53 X 104099214-104157027 Predicted membrane proteins Evidence at protein level HPA034959 Uncertain Mixed Mixed cerebral cortex: 2.6 SLC26A10 ENSG00000135502 Solute carrier family 26, member 10 12 57619527-57626151 Predicted membrane proteins, Transporters Evidence at transcript level HPA044719 Uncertain Tissue enhanced Not detected endometrium: 0.5 SLC26A11 ENSG00000181045 Solute carrier family 26 (anion exchanger), member 11 17 80219699-80253500 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA029893 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Liver cancer:1.82e-6 (unfavourable), Pancreatic cancer:1.43e-5 (favourable), Endometrial cancer:1.55e-5 (unfavourable) Expressed in all Expressed in all adrenal gland: 34.5 SLC26A5 DFNB61, PRES ENSG00000170615 Solute carrier family 26 (anion exchanger), member 5 7 103352730-103446177 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Mixed Mixed breast: 1.2 SLC26A7 SUT2 ENSG00000147606 Solute carrier family 26 (anion exchanger), member 7 8 91209494-91398152 Predicted membrane proteins Evidence at transcript level Group enriched Tissue enriched 21 thyroid gland: 548.4 kidney: 26.1 SLC27A1 ACSVL5, FATP, FATP1, FLJ00336, MGC71751 ENSG00000130304 Solute carrier family 27 (fatty acid transporter), member 1 19 17468769-17506168 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Renal cancer:4.70e-4 (favourable) Expressed in all Mixed parathyroid gland: 34.3 SLC27A3 ACSVL3, FATP3, MGC4365 ENSG00000143554 Solute carrier family 27 (fatty acid transporter), member 3 1 153774354-153780157 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA006935, HPA067508 Uncertain Supported Endoplasmic reticulum Pancreatic cancer:5.23e-4 (favourable), Renal cancer:6.33e-4 (unfavourable) Expressed in all Tissue enhanced epididymis: 43.7 lung: 20.9 SLC27A6 ACSVL2, FACVL2, FATP6, VLCS-H1 ENSG00000113396 Solute carrier family 27 (fatty acid transporter), member 6 5 128538013-129033642 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA008987 Approved Approved Nuclear bodies Tissue enriched Tissue enhanced adrenal gland: 32.7;fallopian tube: 33.7 testis: 24.1 SLC28A2 CNT2, HCNT2, HsT17153, SPNT1 ENSG00000137860 Solute carrier family 28 (concentrative nucleoside transporter), member 2 15 45252230-45277845 Predicted membrane proteins, Transporters Evidence at protein level HPA046068, HPA055623 Supported Tissue enhanced Tissue enhanced duodenum: 66.8;rectum: 37.9;small intestine: 100.1 stomach: 21.4 SLC2A11 GLUT10, GLUT11 ENSG00000133460 Solute carrier family 2 (facilitated glucose transporter), member 11 22 23856703-23886309 Predicted membrane proteins, Transporters Evidence at transcript level HPA042960, HPA071184 Uncertain Uncertain Nucleus
Cell Junctions Renal cancer:5.77e-7 (favourable), Pancreatic cancer:3.83e-4 (favourable) Mixed Mixed parathyroid gland: 10.7 SLC2A12 GLUT12, GLUT8 ENSG00000146411 Solute carrier family 2 (facilitated glucose transporter), member 12 6 133988697-134052636 Predicted membrane proteins, Transporters Evidence at protein level HPA031593, HPA031594 Approved Validated Plasma membrane
Cell Junctions Tissue enriched Tissue enhanced prostate: 38.8 endometrium: 15.7 SLC2A14 GLUT14, SLC2A3P3 ENSG00000173262 Solute carrier family 2 (facilitated glucose transporter), member 14 12 7812512-7891148 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA006539 Approved Approved Plasma membrane Tissue enriched Tissue enriched 9 testis: 151.1 breast: 17.2 SLC2A7 GLUT7 ENSG00000197241 Solute carrier family 2 (facilitated glucose transporter), member 7 1 9003300-9026345 Predicted membrane proteins, Transporters Evidence at protein level HPA039931 Uncertain Not detected Group enriched 9 duodenum: 3.1;small intestine: 3.1 epididymis,testis: 0.3 SLC30A4 ZNT4 ENSG00000104154 Solute carrier family 30 (zinc transporter), member 4 15 45479611-45522807 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA018178 Uncertain Pancreatic cancer:6.02e-4 (favourable) Tissue enriched Tissue enriched 5 prostate: 64.1 testis: 11.8 SLC30A7 ZNT7, ZnTL2 ENSG00000162695 Solute carrier family 30 (zinc transporter), member 7 1 100896076-100981753 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA018034 Uncertain Supported Golgi apparatus Expressed in all Mixed parathyroid gland: 20.6 SLC32A1 bA122O1.1, VGAT, VIAAT ENSG00000101438 Solute carrier family 32 (GABA vesicular transporter), member 1 20 38724462-38729372 Predicted membrane proteins, Transporters Evidence at protein level CAB037156, HPA058859, HPA059985 Supported Tissue enhanced Tissue enriched 34 cerebral cortex: 15.9 testis: 0.4 SLC35A1 CMPST, hCST ENSG00000164414 Solute carrier family 35 (CMP-sialic acid transporter), member A1 6 87470623-87512336 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Renal cancer:2.70e-6 (unfavourable) Expressed in all Expressed in all prostate: 59.9 SLC35A4 ENSG00000176087 Solute carrier family 35, member A4 5 140564456-140569103 Predicted membrane proteins, Transporters Evidence at protein level HPA062210 Approved Nucleoplasm Renal cancer:4.56e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 110.8 SLC35D3 FRCL1 ENSG00000182747 Solute carrier family 35, member D3 6 136922264-136925639 Predicted membrane proteins, Transporters Evidence at protein level HPA030431, HPA067497 Uncertain Approved Microtubule organizing center Tissue enhanced Tissue enhanced adrenal gland: 1.2 lung,stomach: 0.6 SLC35E2 KIAA0447 ENSG00000215790 Solute carrier family 35, member E2 1 1724838-1745992 Predicted membrane proteins Evidence at transcript level HPA062711 Uncertain Uncertain Nucleus Mixed Mixed thyroid gland: 7.5 SLC35E2B ENSG00000189339 Solute carrier family 35, member E2B 1 1659529-1692728 Predicted membrane proteins, Transporters Evidence at protein level HPA045641, HPA062711 Uncertain Uncertain Nucleus Urothelial cancer:5.15e-4 (favourable), Head and neck cancer:7.64e-4 (favourable) Expressed in all Expressed in all smooth muscle: 47.0 SLC35E3 BLOV1 ENSG00000175782 Solute carrier family 35, member E3 12 68746106-68793964 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level HPA049403 Uncertain Endometrial cancer:1.78e-4 (favourable) Expressed in all Mixed skin: 6.1 SLC35E4 ENSG00000100036 Solute carrier family 35, member E4 22 30635652-30669016 Predicted membrane proteins, Transporters Evidence at transcript level HPA049558 Approved Approved Cytosol Mixed Tissue enhanced testis: 17.6 cerebral cortex: 5.1 SLC35F1 C6orf169, dJ230I3.1 ENSG00000196376 Solute carrier family 35, member F1 6 117907526-118317676 Predicted membrane proteins, Transporters Evidence at protein level HPA019576 Approved Approved Nucleoplasm
Microtubule organizing center
Cytosol Group enriched Tissue enriched 12 cerebral cortex: 45.6 epididymis: 3.7 SLC35F3 FLJ37712 ENSG00000183780 Solute carrier family 35, member F3 1 233904933-234324516 Predicted membrane proteins, Transporters Evidence at protein level HPA051327, HPA061582 Uncertain Approved Nucleoli
Golgi apparatus Mixed Tissue enhanced cerebral cortex: 10.2 breast: 3.0 SLC35F4 C14orf36, FLJ37712 ENSG00000151812 Solute carrier family 35, member F4 14 57563922-57982194 Predicted membrane proteins, Transporters Evidence at transcript level HPA043853 Uncertain Approved Nucleoli fibrillar center Not detected Tissue enhanced prostate: 1.9;seminal vesicle: 4.9;testis: 1.8 thyroid gland: 1.0 SLC35F5 FLJ22004 ENSG00000115084 Solute carrier family 35, member F5 2 113705011-113756823 Predicted membrane proteins, Transporters Evidence at transcript level HPA034828, HPA049229 Uncertain Uncertain Plasma membrane Renal cancer:1.71e-5 (favourable), Cervical cancer:2.60e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 65.7 SLC35G3 AMAC1, FLJ40154, TMEM21A ENSG00000164729 Solute carrier family 35, member G3 17 35192520-35194523 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Tissue enriched 15 testis: 1.6 lymph node,skeletal muscle,spleen: 0.1 SLC35G5 AMAC, AMAC1L2 ENSG00000177710 Solute carrier family 35, member G5 8 11330888-11332208 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Tissue enhanced testis: 1.5 appendix,epididymis,skin,spleen: 0.4 SLC35G6 AMAC1L3, TMEM21B ENSG00000259224 Solute carrier family 35, member G6 17 7481332-7483496 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Tissue enriched 19 testis: 3.7 bone marrow,epididymis,parathyroid gland,skeletal muscle,thyroid gland: 0.1 SLC36A3 PAT3, TRAMD2, tramdorin2 ENSG00000186334 Solute carrier family 36, member 3 5 151276762-151303766 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Tissue enriched 57 testis: 14.4 epididymis: 0.2 SLC37A1 ENSG00000160190 Solute carrier family 37 (glucose-6-phosphate transporter), member 1 21 42496008-42581440 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA030418, CAB034154 Approved Approved Nucleus Thyroid cancer:3.43e-5 (favourable), Endometrial cancer:9.22e-5 (favourable) Expressed in all Mixed duodenum: 46.9 SLC37A2 FLJ00171 ENSG00000134955 Solute carrier family 37 (glucose-6-phosphate transporter), member 2 11 125063067-125090312 Predicted membrane proteins, Transporters Evidence at protein level HPA014948 Uncertain Expressed in all Mixed adrenal gland: 24.8 SLC37A3 DKFZp761N0624 ENSG00000157800 Solute carrier family 37, member 3 7 140293693-140404433 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA014713, HPA061841 Supported Cytosol Liver cancer:4.78e-5 (unfavourable), Cervical cancer:9.54e-4 (unfavourable) Expressed in all Expressed in all endometrium: 72.5 SLC38A11 AVT2, FLJ39822 ENSG00000169507 Solute carrier family 38, member 11 2 164896186-164955525 Predicted membrane proteins, Transporters Evidence at transcript level HPA043432 Uncertain Renal cancer:2.00e-8 (favourable) Tissue enriched Tissue enhanced epididymis: 47.1;gallbladder: 28.3 seminal vesicle: 23.3 SLC39A11 C17orf26 ENSG00000133195 Solute carrier family 39, member 11 17 72645949-73092712 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA021455 Approved Nucleoplasm Expressed in all Expressed in all thyroid gland: 60.0 SLC39A12 FLJ30499 ENSG00000148482 Solute carrier family 39 (zinc transporter), member 12 10 17951839-18043292 Predicted membrane proteins, Transporters Evidence at protein level Tissue enriched Tissue enriched 28 cerebral cortex: 25.4 breast: 0.8 SLC39A8 BIGM103 ENSG00000138821 Solute carrier family 39 (zinc transporter), member 8 4 102251041-102431258 Predicted membrane proteins, Transporters Evidence at protein level HPA038832, HPA038833 Approved Renal cancer:6.34e-6 (favourable), Colorectal cancer:1.34e-4 (favourable), Breast cancer:6.69e-4 (favourable) Expressed in all Tissue enhanced lung: 257.1 cervix, uterine: 128.6 SLC39A9 FLJ11274 ENSG00000029364 Solute carrier family 39, member 9 14 69398015-69462388 Predicted membrane proteins, Transporters Evidence at protein level HPA007921, HPA075390 Approved Approved Endoplasmic reticulum Renal cancer:1.05e-6 (favourable) Expressed in all Expressed in all parathyroid gland,thyroid gland: 44.1 SLC41A1 MgtE ENSG00000133065 Solute carrier family 41 (magnesium transporter), member 1 1 205789093-205813748 Predicted membrane proteins, Transporters Evidence at protein level HPA014721, HPA015138 Uncertain Approved Mitochondria Cervical cancer:1.48e-4 (unfavourable) Expressed in all Tissue enhanced heart muscle: 72.6 testis: 37.3 SLC44A4 C6orf29, CTL4, FLJ14491, NG22, TPPT ENSG00000204385 Solute carrier family 44, member 4 6 31863192-31879046 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA046977, HPA054176 Approved Renal cancer:1.06e-6 (favourable), Head and neck cancer:3.54e-4 (favourable), Urothelial cancer:6.06e-4 (favourable) Tissue enhanced Tissue enhanced duodenum: 36.0 prostate: 30.1 SLC44A5 CTL5, MGC34032 ENSG00000137968 Solute carrier family 44, member 5 1 75202131-75611116 Predicted membrane proteins, Transporters Evidence at protein level HPA047455, HPA051011 Uncertain Approved Cytosol Renal cancer:6.52e-4 (unfavourable) Mixed Tissue enhanced skin: 12.6 parathyroid gland,testis: 8.0 SLC45A1 DNB5 ENSG00000162426 Solute carrier family 45, member 1 1 8317826-8344167 Predicted membrane proteins, Transporters Evidence at transcript level Mixed Tissue enhanced cerebral cortex: 11.7 endometrium: 3.2 SLC45A3 IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein ENSG00000158715 Solute carrier family 45, member 3 1 205657851-205680459 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level HPA019073, HPA019075 Supported Approved Nucleoplasm
Vesicles Endometrial cancer:4.04e-5 (unfavourable), Urothelial cancer:7.33e-5 (favourable) Tissue enriched Tissue enriched 25 prostate: 430.6 stomach: 16.9 SLC46A2 Ly110, TSCOT ENSG00000119457 Solute carrier family 46, member 2 9 112878920-112890913 Predicted membrane proteins, Transporters Evidence at transcript level HPA020098 Approved Tissue enhanced Group enriched 6 cervix, uterine: 23.0;endometrium: 5.5;epididymis: 5.4;lung: 15.2;skin: 11.3 seminal vesicle: 2.0 SLC46A3 DKFZp686A1775, FLJ42613 ENSG00000139508 Solute carrier family 46, member 3 13 28700064-28718970 Predicted membrane proteins, Transporters Evidence at protein level HPA039930 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Lung cancer:7.09e-4 (favourable) Expressed in all Expressed in all small intestine: 89.4 SLC4A10 NBCn2, NCBE ENSG00000144290 Solute carrier family 4, sodium bicarbonate transporter, member 10 2 161424332-161985282 Predicted membrane proteins, Transporters Evidence at protein level HPA034755 Supported Tissue enhanced Tissue enriched 22 cerebral cortex: 57.7 adrenal gland: 2.6 SLC4A3 AE3, SLC2C ENSG00000114923 Solute carrier family 4 (anion exchanger), member 3 2 219627327-219641980 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA063498 Approved Nucleoplasm Urothelial cancer:4.12e-4 (unfavourable) Expressed in all Group enriched 6 cerebral cortex: 30.1;heart muscle: 125.7;ovary: 47.6 testis: 10.9 SLC4A5 NBC4 ENSG00000188687 Solute carrier family 4 (sodium bicarbonate cotransporter), member 5 2 74216242-74343414 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036621 Approved Tissue enriched Group enriched 9 testis: 25.5;thyroid gland: 40.5 skin: 3.7 SLC4A9 AE4 ENSG00000113073 Solute carrier family 4, sodium bicarbonate cotransporter, member 9 5 140360202-140375143 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level HPA051307 Uncertain Tissue enriched Tissue enriched 17 kidney: 12.1 testis: 0.6 SLC50A1 HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1 ENSG00000169241 Solute carrier family 50 (sugar efflux transporter), member 1 1 155135344-155138857 Predicted membrane proteins, Transporters Evidence at protein level HPA018095 Approved Renal cancer:3.88e-7 (unfavourable) Expressed in all Expressed in all epididymis: 133.2 SLC51A OSTalpha ENSG00000163959 Solute carrier family 51, alpha subunit 3 196211487-196243178 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level HPA039123 Approved Liver cancer:7.54e-4 (favourable) Tissue enriched Tissue enhanced duodenum: 30.1;liver: 35.2;small intestine: 72.7 colon: 10.2 SLC51B OSTbeta ENSG00000186198 Solute carrier family 51, beta subunit 15 65045370-65053396 Predicted membrane proteins, Transporters Evidence at protein level HPA008398, HPA008533 Supported Approved Vesicles
Mitochondria Renal cancer:8.46e-5 (favourable) Tissue enhanced Tissue enhanced duodenum: 87.8;small intestine: 120.6 cervix, uterine: 63.7 SLC5A12 MGC52019, SMCT2 ENSG00000148942 Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 11 26667019-26723427 Predicted membrane proteins, Transporters Evidence at protein level HPA060904 Supported Tissue enriched Tissue enhanced epididymis: 57.8;kidney: 172.6 small intestine: 34.0 SLC5A4 DJ90G24.4, SAAT1, SGLT3 ENSG00000100191 Solute carrier family 5 (glucose activated ion channel), member 4 22 32218476-32255341 Predicted membrane proteins, Transporters Evidence at transcript level Tissue enriched Group enriched 9 duodenum: 18.5;small intestine: 21.8 lung: 2.3 SLC5A6 SMVT ENSG00000138074 Solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 2 27199587-27212958 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA036958 Approved Approved Cell Junctions Renal cancer:3.60e-7 (unfavourable) Expressed in all Expressed in all epididymis: 82.1 SLC6A11 GAT3 ENSG00000132164 Solute carrier family 6 (neurotransmitter transporter), member 11 3 10816200-10940733 Predicted membrane proteins, Transporters Evidence at protein level HPA037981 Supported Supported Tissue enhanced Tissue enhanced cerebral cortex: 18.2;skin: 6.7 esophagus: 5.5 SLC6A14 ENSG00000268104 Solute carrier family 6 (amino acid transporter), member 14 X 116436622-116461458 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level HPA003193 Uncertain Approved Vesicles Pancreatic cancer:9.74e-4 (unfavourable) Mixed Tissue enhanced cervix, uterine: 11.0;lung: 23.9 breast: 9.2 SLC6A16 NTT5 ENSG00000063127 Solute carrier family 6, member 16 19 49289638-49325225 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level HPA076812 Approved Golgi apparatus Mixed Tissue enriched 18 testis: 161.8 lymph node: 9.0 SLC6A18 FLJ31236, Xtrp2 ENSG00000164363 Solute carrier family 6 (neutral amino acid transporter), member 18 5 1225355-1246189 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA011885 Supported Tissue enriched Tissue enriched 83 kidney: 8.2 all non-specific tissues: 0.0 SLC6A7 PROT ENSG00000011083 Solute carrier family 6 (neurotransmitter transporter), member 7 5 150189957-150222788 Predicted membrane proteins, Transporters Evidence at protein level HPA028907 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 17.0;rectum: 4.3 colon: 2.9 SLC6A9 GLYT1 ENSG00000196517 Solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1 43991500-44031467 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA013977 Uncertain Approved Nucleus
Golgi apparatus Renal cancer:5.93e-4 (unfavourable), Endometrial cancer:9.50e-4 (unfavourable) Expressed in all Tissue enhanced skin: 49.8 adrenal gland: 31.0 SLC7A10 asc-1 ENSG00000130876 Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19 33208664-33225850 Predicted membrane proteins, Transporters Evidence at transcript level HPA041884, HPA057036 Uncertain Uncertain Nucleus
Nucleoli Mixed Group enriched 23 adipose tissue: 31.5;cerebral cortex: 6.6 breast: 0.8 SLC7A13 AGT-1, XAT2 ENSG00000164893 Solute carrier family 7 (anionic amino acid transporter), member 13 8 86214052-86321146 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Tissue enriched 102 kidney: 42.6 testis: 0.4 SLC7A14 KIAA1613, PPP1R142 ENSG00000013293 Solute carrier family 7, member 14 3 170459584-170586074 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA045929 Approved Group enriched Tissue enriched 8 cerebral cortex: 26.8 adrenal gland: 3.1 SLC7A4 CAT-4, HCAT3, VH ENSG00000099960 Solute carrier family 7, member 4 22 21028718-21032840 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA031023 Approved Mixed Tissue enhanced testis: 22.5 esophagus: 6.0 SLC8A2 KIAA1087, NCX2 ENSG00000118160 Solute carrier family 8 (sodium/calcium exchanger), member 2 19 47428017-47472168 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA050818, HPA054671 Supported Mixed Tissue enriched 11 cerebral cortex: 68.4 endometrium: 6.2 SLC9A2 NHE2 ENSG00000115616 Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 2 102619707-102711318 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA035121, HPA035122 Approved Approved Cell Junctions Mixed Tissue enhanced colon: 20.9;rectum: 23.7;stomach: 25.8 testis: 10.6 SLC9B1 NHA1, NHEDC1 ENSG00000164037 Solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 4 102885048-103019739 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA035435, HPA058971, HPA065520 Uncertain Approved Mitochondria Mixed Tissue enriched 25 testis: 73.9 epididymis: 2.9 SLC9C1 NHE, SLC9A10 ENSG00000172139 Solute carrier family 9, subfamily C (Na+-transporting carboxylic acid decarboxylase), member 1 3 112140887-112294258 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Group enriched 9 skin: 2.9;testis: 14.1 thyroid gland: 0.9 SLC9C2 MGC43026, SLC9A11 ENSG00000162753 Solute carrier family 9, member C2 (putative) 1 173500464-173603094 Predicted membrane proteins, Transporters Evidence at transcript level Not detected Tissue enriched 12 testis: 10.6 fallopian tube: 0.8 SLCO1A2 OATP, OATP-A, OATP1A2, SLC21A3 ENSG00000084453 Solute carrier organic anion transporter family, member 1A2 12 21264600-21419594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA071152 Approved Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 28.8 salivary gland: 6.6 SLCO1C1 OATP-F, OATP1, OATP1C1, SLC21A14 ENSG00000139155 Solute carrier organic anion transporter family, member 1C1 12 20695355-20753386 Predicted membrane proteins, Transporters Evidence at transcript level Tissue enriched Tissue enriched 10 cerebral cortex: 27.6 testis: 2.6 SLCO5A1 OATP-J, OATP5A1, OATPRP4, SLC21A15 ENSG00000137571 Solute carrier organic anion transporter family, member 5A1 8 69667047-69835064 Predicted membrane proteins, Transporters Evidence at transcript level HPA025062 Uncertain Mixed Tissue enhanced prostate: 3.6 skeletal muscle: 2.6 SLCO6A1 CT48, MGC26949, OATP6A1, OATPY ENSG00000205359 Solute carrier organic anion transporter family, member 6A1 5 102371782-102499016 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA054126 Supported Not detected Tissue enriched 136 testis: 53.7 placenta: 0.3 SLFN12 FLJ10260 ENSG00000172123 Schlafen family member 12 17 35411060-35433283 Predicted intracellular proteins Evidence at protein level HPA022523 Uncertain Renal cancer:4.14e-5 (unfavourable) Mixed Mixed spleen: 13.4 SLFN12L ENSG00000205045 Schlafen family member 12-like 17 35464249-35537861 Predicted membrane proteins Evidence at protein level HPA024447 Uncertain Mixed Mixed spleen: 7.5 SLFN13 FLJ31952 ENSG00000154760 Schlafen family member 13 17 35435096-35448837 Predicted intracellular proteins Evidence at protein level HPA022532, HPA023064 Uncertain Approved Cytokinetic bridge Cervical cancer:3.82e-4 (favourable) Mixed Mixed parathyroid gland: 40.4 SLFN14 ENSG00000236320 Schlafen family member 14 17 35548125-35558098 Predicted intracellular proteins Evidence at protein level HPA022994, HPA023065 Uncertain Not detected Tissue enhanced bone marrow: 2.5 lymph node,spleen: 0.6 SLFNL1 FLJ23878 ENSG00000171790 Schlafen-like 1 1 41015597-41023237 Predicted intracellular proteins Evidence at protein level HPA054956 Approved Cytosol Not detected Tissue enriched 16 testis: 47.7 lung: 3.0 SLIT1 MEGF4, SLIL1, Slit-1, slit1, SLIT3 ENSG00000187122 Slit guidance ligand 1 10 96998038-97185920 Predicted secreted proteins Evidence at protein level Group enriched Tissue enriched 14 cerebral cortex: 60.2 thyroid gland: 4.1 SLIT3 MEGF5, SLIL2, Slit-3, SLIT1, slit2 ENSG00000184347 Slit guidance ligand 3 5 168661733-169301129 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA051630 Approved Approved Cell Junctions Renal cancer:2.45e-5 (unfavourable) Mixed Mixed parathyroid gland: 98.0 SLITRK2 CXorf2, KIAA1854, SLITL1 ENSG00000185985 SLIT and NTRK-like family, member 2 X 145817832-145825842 Predicted membrane proteins Evidence at protein level Tissue enhanced Tissue enhanced cerebral cortex: 25.7 seminal vesicle: 7.3 SLITRK3 KIAA0848 ENSG00000121871 SLIT and NTRK-like family, member 3 3 165186720-165197109 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA017636 Approved Mitochondria Tissue enriched Tissue enhanced cerebral cortex: 17.4;endometrium: 12.4 fallopian tube: 9.7 SLITRK4 DKFZp547M2010 ENSG00000179542 SLIT and NTRK-like family, member 4 X 143622790-143635777 Predicted membrane proteins Evidence at protein level HPA000431 Approved Uncertain Microtubules Tissue enhanced Tissue enhanced adrenal gland: 14.0;cerebral cortex: 12.8 cervix, uterine: 8.3 SLITRK5 bA364G4.2, KIAA0918, LRRC11 ENSG00000165300 SLIT and NTRK-like family, member 5 13 87672615-87696272 Predicted membrane proteins Evidence at protein level HPA013843 Uncertain Supported Nucleoplasm
Golgi apparatus Not detected Tissue enhanced cerebral cortex: 4.9;fallopian tube: 4.7 seminal vesicle: 1.8 SLITRK6 FLJ22774 ENSG00000184564 SLIT and NTRK-like family, member 6 13 85792790-85799488 Disease related genes, Predicted membrane proteins Evidence at protein level HPA014491, HPA014513 Uncertain Supported Plasma membrane Head and neck cancer:8.52e-4 (unfavourable) Tissue enhanced Tissue enhanced urinary bladder: 20.4 salivary gland: 11.8 SMC1B bK268H5, SMC1L2 ENSG00000077935 Structural maintenance of chromosomes 1B 22 45344063-45413619 Predicted intracellular proteins Evidence at protein level HPA001500 Supported Supported Nucleoplasm
Cytosol Tissue enriched Tissue enriched 115 testis: 57.1 parathyroid gland: 0.4 SMCO1 C3orf43, DKFZp313B0440, FLJ41923 ENSG00000214097 Single-pass membrane protein with coiled-coil domains 1 3 196506877-196515366 Predicted intracellular proteins Evidence at transcript level HPA061937 Uncertain Not detected Group enriched 15 heart muscle: 23.7;skeletal muscle: 51.1 esophagus: 2.5 SMCO2 C12orf70, LOC341346 ENSG00000165935 Single-pass membrane protein with coiled-coil domains 2 12 27466810-27502185 Predicted membrane proteins Evidence at protein level HPA014366 Uncertain Mixed Tissue enhanced testis: 1.3 skin: 0.6 SMIM11A C21orf51, FAM165B, SMIM11 ENSG00000205670 Small integral membrane protein 11A 21 34375480-34407866 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA051321 Uncertain Approved Focal adhesion sites Not detected Mixed thyroid gland: 32.0 SMIM11B ENSG00000273590 Small integral membrane protein 11B 21 7744962-7777853 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA051321 Uncertain Approved Focal adhesion sites Not detected Expressed in all epididymis: 25.9 SMIM22 ENSG00000267795 Small integral membrane protein 22 16 4788397-4796491 Predicted membrane proteins Evidence at transcript level HPA077331 Approved Nucleoplasm
Cytosol Mixed Mixed colon: 229.8 SMIM23 C5orf50, LOC644994 ENSG00000185662 Small integral membrane protein 23 5 171785872-171794598 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 37 testis: 40.0 epididymis: 1.0 SMIM24 C19orf77, HSPC323 ENSG00000095932 Small integral membrane protein 24 19 3473986-3480542 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA045046, HPA056027 Supported Approved Nucleoplasm
Cytosol Renal cancer:4.13e-10 (favourable) Tissue enhanced Group enriched 8 duodenum: 780.7;epididymis: 1898.5;kidney: 832.6;small intestine: 696.9 stomach: 139.3 SMOC2 SMAP2 ENSG00000112562 SPARC related modular calcium binding 2 6 168441151-168673445 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level CAB033979 Uncertain Renal cancer:1.16e-6 (unfavourable) Expressed in all Mixed endometrium: 182.8 SMPDL3B ASML3B ENSG00000130768 Sphingomyelin phosphodiesterase, acid-like 3B 1 27934993-27959157 Predicted secreted proteins Evidence at protein level HPA030561 Approved Golgi apparatus
Cytosol Mixed Mixed rectum: 26.0 SMPX DFN6, DFNX4 ENSG00000091482 Small muscle protein, X-linked X 21705972-21758163 Disease related genes, Predicted intracellular proteins Evidence at protein level Head and neck cancer:3.04e-5 (unfavourable) Tissue enhanced Group enriched 21 heart muscle: 422.6;skeletal muscle: 383.2 esophagus: 19.5 SMTNL2 FLJ42461 ENSG00000188176 Smoothelin-like 2 17 4583999-4608319 Predicted intracellular proteins Evidence at protein level Renal cancer:1.28e-4 (favourable) Tissue enhanced Tissue enriched 5 skeletal muscle: 133.8 kidney: 26.7 SMYD4 KIAA1936, ZMYND21 ENSG00000186532 SET and MYND domain containing 4 17 1779485-1830634 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA030059 Uncertain Approved Nucleoplasm
Golgi apparatus
Vesicles
Cytosol Expressed in all Expressed in all testis: 10.9 SNAI3 SMUC, Zfp293, ZNF293 ENSG00000185669 Snail family zinc finger 3 16 88677682-88686493 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA016757, HPA071127 Uncertain Approved Nucleoplasm Cervical cancer:1.39e-4 (favourable), Pancreatic cancer:3.58e-4 (favourable) Mixed Tissue enhanced skeletal muscle: 10.9 lymph node: 4.4 SNED1 FLJ00133, Snep, SST3 ENSG00000162804 Sushi, nidogen and EGF-like domains 1 2 240998838-241095568 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA036414, HPA036415 Uncertain Mixed Mixed endometrium: 30.0 SNTN FLJ44379, S100AL ENSG00000188817 Sentan, cilia apical structure protein 3 63652668-63679020 Predicted intracellular proteins Evidence at protein level HPA043322, HPA058399 Supported Group enriched Tissue enriched 11 fallopian tube: 344.9 thyroid gland: 32.3 SNX21 C20orf161, dJ337O18.4, SNX-L ENSG00000124104 Sorting nexin family member 21 20 45833810-45843275 Predicted intracellular proteins Evidence at protein level HPA046359 Approved Approved Vesicles
Microtubule organizing center Expressed in all Mixed skin: 25.3 SOAT2 ACAT2 ENSG00000167780 Sterol O-acyltransferase 2 12 53103518-53124538 Enzymes, Predicted membrane proteins Evidence at protein level HPA062409 Uncertain Group enriched Tissue enhanced duodenum: 12.4;small intestine: 22.4 spleen: 3.5 SOHLH2 bHLHe81, FLJ20449, SPATA28, TEB1 ENSG00000120669 Spermatogenesis and oogenesis specific basic helix-loop-helix 2 13 36168208-36214615 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029182, HPA029183 Uncertain Vesicles Mixed Tissue enriched 13 testis: 46.0 prostate: 3.5 SORCS3 KIAA1059, SORCS ENSG00000156395 Sortilin-related VPS10 domain containing receptor 3 10 104641101-105265235 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Renal cancer:5.72e-4 (unfavourable) Group enriched Tissue enhanced cerebral cortex: 11.9 adrenal gland: 2.6 SOWAHD ANKRD58 ENSG00000187808 Sosondowah ankyrin repeat domain family member D X 119758613-119760164 Predicted intracellular proteins Evidence at protein level HPA065955 Uncertain Tissue enriched Tissue enhanced spleen: 5.2 testis: 3.6 SOX12 SOX22 ENSG00000177732 SRY (sex determining region Y)-box 12 20 325401-330224 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055052, HPA061627 Supported Nucleoplasm Liver cancer:6.64e-5 (unfavourable) Expressed in all Mixed cerebral cortex: 10.3 SOX21 SOX25 ENSG00000125285 SRY (sex determining region Y)-box 21 13 94709622-94712399 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA064084 Approved Nucleus Glioma:1.34e-4 (favourable), Cervical cancer:7.60e-4 (favourable) Tissue enhanced Group enriched 6 cerebral cortex: 18.0;esophagus: 6.9;skin: 19.4;stomach: 33.9 tonsil: 3.2 SOX8 ENSG00000005513 SRY (sex determining region Y)-box 8 16 981808-986979 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041640, HPA058665 Approved Supported Nucleus Tissue enriched Tissue enriched 29 cerebral cortex: 110.2 salivary gland: 3.8 SP140L ENSG00000185404 SP140 nuclear body protein-like 2 230327184-230403732 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055864 Uncertain Approved Nucleoplasm Renal cancer:5.09e-10 (unfavourable) Expressed in all Mixed spleen: 29.2 SP5 ENSG00000204335 Sp5 transcription factor 2 170715351-170718078 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074123 Approved Nucleus
Nucleoli Mixed Tissue enhanced endometrium: 3.9 stomach: 2.4 SP6 Epfn, KLF14 ENSG00000189120 Sp6 transcription factor 17 47844908-47855874 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024516, HPA044469 Supported Nucleoplasm
Mitotic spindle
Centrosome Lung cancer:2.11e-6 (unfavourable), Urothelial cancer:5.72e-4 (favourable), Stomach cancer:6.39e-4 (favourable) Mixed Tissue enhanced placenta: 32.3;seminal vesicle: 14.6 skin: 7.2 SP8 ENSG00000164651 Sp8 transcription factor 7 20782283-20786886 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA054006 Uncertain Approved Nucleus Tissue enhanced Tissue enriched 12 prostate: 9.8 skin: 0.8 SPACA5 dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288 ENSG00000171489 Sperm acrosome associated 5 X 48004336-48009729 Enzymes, Predicted secreted proteins Evidence at protein level HPA044747, HPA047149 Supported Not detected Group enriched 6 epididymis: 2.7;testis: 13.7 thyroid gland: 1.4 SPACA5B ENSG00000171478 Sperm acrosome associated 5B X 48130657-48132613 Enzymes, Predicted secreted proteins Evidence at protein level HPA044747, HPA047149 Supported Not detected Tissue enriched 148 testis: 16.4 fallopian tube: 0.1 SPACA7 C13orf28 ENSG00000153498 Sperm acrosome associated 7 13 112376319-112434689 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 43 testis: 50.1 liver: 1.1 SPAG11A EDDM2A, HE2 ENSG00000178287 Sperm associated antigen 11A 8 7847876-7868867 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 10595 epididymis: 6163.8 seminal vesicle: 0.5 SPAG11B EDDM2B, EP2, EP2C, EP2D, HE2 ENSG00000164871 Sperm associated antigen 11B 8 7442684-7463674 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at transcript level Not detected Tissue enriched 5396 epididymis: 6639.3 seminal vesicle: 1.2 SPAG16 DKFZp666P1710, FLJ22724, PF20, WDR29 ENSG00000144451 Sperm associated antigen 16 2 213284379-214410501 Predicted intracellular proteins Evidence at protein level HPA037542 Uncertain Approved Plasma membrane
Cytosol Renal cancer:3.82e-4 (favourable), Prostate cancer:4.90e-4 (unfavourable) Expressed in all Expressed in all testis: 83.8 SPAG17 CT143, FLJ34497, PF6, RP4-776P7.2 ENSG00000155761 Sperm associated antigen 17 1 117953861-118185223 Predicted intracellular proteins Evidence at protein level HPA028597, HPA028666 Supported Validated Nucleoplasm Mixed Tissue enhanced fallopian tube: 13.2;testis: 27.4 esophagus: 6.8 SPAG6 CT141, pf16, Repro-SA-1 ENSG00000077327 Sperm associated antigen 6 10 22345445-22454224 Predicted intracellular proteins Evidence at protein level HPA038440 Supported Mixed Group enriched 12 fallopian tube: 76.6;testis: 171.7 lung: 10.7 SPANXB1 CT11.2, SPANXB2, SPANXF1, SPANXF2 ENSG00000227234 SPANX family, member B1 X 141002591-141003706 Predicted intracellular proteins Evidence at transcript level HPA046423 Uncertain Approved Nucleoplasm
Vesicles Mixed Tissue enriched 369 testis: 42.3 kidney: 0.1 SPANXN2 CT11.7, SPANX-N2 ENSG00000268988 SPANX family, member N2 X 143711955-143721423 Predicted intracellular proteins Evidence at transcript level HPA045652 Approved Nucleus
Nucleoli fibrillar center Not detected Tissue enriched 7 testis: 2.5 epididymis: 0.3 SPANXN3 CT11.8, SPANX-N3 ENSG00000189252 SPANX family, member N3 X 143508735-143517475 Predicted intracellular proteins Evidence at transcript level HPA045652 Approved Nucleus
Nucleoli fibrillar center Not detected Tissue enriched 26 testis: 51.9 epididymis: 2.0 SPATA12 ENSG00000186451 Spermatogenesis associated 12 3 57060441-57075432 Predicted intracellular proteins Evidence at transcript level HPA043323 Approved Nucleoplasm
Plasma membrane
Cytosol Mixed Tissue enriched 54 testis: 22.9 fallopian tube,lung: 0.4 SPATA17 IQCH ENSG00000162814 Spermatogenesis associated 17 1 217631324-217871696 Predicted intracellular proteins Evidence at transcript level HPA030099 Approved Approved Nucleus
Nucleoli Mixed Tissue enhanced testis: 18.1 fallopian tube: 6.5 SPATA19 CT132, FLJ25851, SPAS1, spergen1 ENSG00000166118 Spermatogenesis associated 19 11 133840631-133845538 Predicted intracellular proteins Evidence at protein level HPA040082 Supported Not detected Tissue enriched 503 testis: 141.9 esophagus: 0.2 SPATA20 FLJ21347, SSP411, Tisp78 ENSG00000006282 Spermatogenesis associated 20 17 50543058-50555852 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA022023, HPA027144, HPA031442 Approved Approved Nucleoplasm Urothelial cancer:9.69e-5 (favourable) Expressed in all Expressed in all testis: 97.7 SPATA21 spergen-2, spergen2 ENSG00000187144 Spermatogenesis associated 21 1 16387117-16437424 Predicted intracellular proteins Evidence at transcript level HPA032080 Approved Vesicles
Cytosol Not detected Tissue enriched 14 testis: 8.3 skin: 0.6 SPATA2L C16orf76, MGC26885, tamo ENSG00000158792 Spermatogenesis associated 2-like 16 89696343-89701705 Predicted intracellular proteins Evidence at protein level HPA041182, HPA042453 Uncertain Approved Nucleoplasm
Mitochondria
Cytosol Expressed in all Mixed cerebral cortex: 9.2 SPATA3 TSARG1 ENSG00000173699 Spermatogenesis associated 3 2 230996121-231025055 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA018254 Supported Not detected Tissue enriched 445 testis: 159.4 cerebral cortex: 0.3 SPATA31A3 DKFZp434B204, FAM75A3 ENSG00000275969 SPATA31 subfamily A, member 3 9 66986304-66992583 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 52 testis: 5.1 all non-specific tissues: 0.0 SPATA31A7 FAM75A4, FAM75A7, SPATA31A4 ENSG00000276040 SPATA31 subfamily A, member 7 9 61190003-61196280 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 26 testis: 2.5 all non-specific tissues: 0.0 SPATA31D1 FAM75D1, FLJ46321 ENSG00000214929 SPATA31 subfamily D, member 1 9 81988772-81995256 Predicted membrane proteins Evidence at transcript level HPA047897 Uncertain Not detected Tissue enriched 95 testis: 9.5 all non-specific tissues: 0.0 SPATA31E1 C9orf79, FAM75E1, FLJ35866 ENSG00000177992 SPATA31 subfamily E, member 1 9 87882826-87888899 Predicted membrane proteins Evidence at protein level HPA024253 Supported Not detected Tissue enriched 100 testis: 9.9 all non-specific tissues: 0.0 SPATA33 C16orf55, FLJ31606 ENSG00000167523 Spermatogenesis associated 33 16 89657802-89671272 Predicted intracellular proteins Evidence at protein level HPA045648, HPA073096 Approved Approved Nucleoplasm
Vesicles Cervical cancer:1.06e-4 (favourable) Expressed in all Tissue enhanced testis: 77.1 fallopian tube: 25.5 SPATA6L C9orf68, FLJ10058 ENSG00000106686 Spermatogenesis associated 6-like 9 4553386-4666674 Predicted intracellular proteins Evidence at protein level HPA039585 Supported Mixed Tissue enhanced fallopian tube: 5.7;testis: 6.3 gallbladder,lung: 2.3 SPATA9 FLJ35906, NYD-SP16 ENSG00000145757 Spermatogenesis associated 9 5 95652181-95698711 Predicted membrane proteins Evidence at protein level HPA010848 Uncertain Approved Mitochondria Not detected Tissue enriched 39 testis: 53.1 adipose tissue: 1.3 SPATC1 MGC61633, SPATA15, SPERIOLIN ENSG00000186583 Spermatogenesis and centriole associated 1 8 144012414-144047085 Predicted intracellular proteins Evidence at protein level HPA039590, HPA040220 Uncertain Not detected Group enriched 5 bone marrow: 6.2;testis: 21.8 appendix: 2.6 SPATS1 FLJ25442, SPATA8, SRSP1 ENSG00000249481 Spermatogenesis associated, serine-rich 1 6 44342660-44377167 Predicted intracellular proteins Evidence at transcript level HPA030897, HPA046230, HPA049722 Approved Approved Nucleoplasm Not detected Group enriched 6 fallopian tube: 13.9;testis: 45.0 epididymis: 4.9 SPDYE1 Ringo1, SPDYE, WBSCR19 ENSG00000136206 Speedy/RINGO cell cycle regulator family member E1 7 44000889-44010122 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA044799, HPA051750 Uncertain Mixed Tissue enriched 6 testis: 8.2 skin: 1.2 SPDYE3 ENSG00000214300 Speedy/RINGO cell cycle regulator family member E3 7 100307702-100322196 Predicted intracellular proteins Evidence at protein level HPA044799, HPA051750 Uncertain Endometrial cancer:2.00e-6 (unfavourable), Breast cancer:8.73e-4 (favourable) Expressed in all Tissue enriched 11 testis: 2.3 skin: 0.2 SPDYE4 ENSG00000183318 Speedy/RINGO cell cycle regulator family member E4 17 8753106-8758559 Predicted intracellular proteins Evidence at protein level HPA025704, HPA051750 Uncertain Not detected Tissue enriched 21 testis: 10.9 bone marrow,epididymis: 0.5 SPEM1 C17orf83, FLJ40081 ENSG00000181323 Spermatid maturation 1 17 7420360-7421632 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 641 testis: 64.0 all non-specific tissues: 0.0 SPIC MGC40611, SPI-C ENSG00000166211 Spi-C transcription factor (Spi-1/PU.1 related) 12 101475421-101486997 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enriched 12 spleen: 47.3 lymph node: 4.0 SPIN2B SPIN-2, TDRD26 ENSG00000186787 Spindlin family, member 2B X 57118551-57121547 Predicted intracellular proteins Evidence at transcript level HPA000162, HPA069835 Uncertain Approved Nucleoplasm Renal cancer:1.78e-5 (favourable), Pancreatic cancer:3.39e-4 (favourable), Ovarian cancer:3.43e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 14.9 SPNS3 MGC29671 ENSG00000182557 Spinster homolog 3 (Drosophila) 17 4433688-4488208 Predicted membrane proteins Evidence at protein level HPA023928 Uncertain Renal cancer:8.09e-4 (unfavourable) Mixed Tissue enriched 6 bone marrow: 12.4 spleen: 2.1 SPO11 CT35, SPATA43, TOPVIA ENSG00000054796 SPO11 meiotic protein covalently bound to DSB 20 57329759-57343994 Plasma proteins, Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 153 testis: 15.3 all non-specific tissues: 0.0 SPOCD1 FLJ25348, PPP1R146 ENSG00000134668 SPOC domain containing 1 1 31790422-31816051 Predicted intracellular proteins Evidence at protein level HPA031713, HPA031714, HPA031715 Approved Approved Nucleus
Nucleoli
Cytosol Urothelial cancer:4.05e-5 (favourable) Group enriched Tissue enhanced testis: 14.1;urinary bladder: 10.3 appendix: 4.5 SPRED3 ENSG00000188766 Sprouty-related, EVH1 domain containing 3 19 38388421-38399587 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA071521 Uncertain Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced Tissue enhanced cerebral cortex: 6.6 parathyroid gland: 2.6 SPRN bA108K14.1, FLJ41197, Shadoo, Sprn ENSG00000203772 Shadow of prion protein homolog (zebrafish) 10 133420666-133424572 Predicted secreted proteins Evidence at transcript level Urothelial cancer:1.58e-7 (favourable), Pancreatic cancer:1.54e-6 (favourable), Renal cancer:3.95e-4 (unfavourable) Expressed in all Tissue enriched 8 cerebral cortex: 24.9 testis: 3.0 SPRR2B ENSG00000196805 Small proline-rich protein 2B 1 153070224-153070840 Predicted intracellular proteins Evidence at transcript level Tissue enriched Group enriched 18 esophagus: 30.4;skin: 17.1;testis: 8.2;tonsil: 14.7 ovary: 0.9 SPRR2D ENSG00000163216 Small proline-rich protein 2D 1 153039725-153041931 Predicted intracellular proteins Evidence at protein level Urothelial cancer:1.62e-4 (unfavourable) Group enriched Tissue enriched 6 esophagus: 2283.1 tonsil: 361.4 SPRR2E ENSG00000203785 Small proline-rich protein 2E 1 153093135-153106184 Predicted intracellular proteins Evidence at transcript level Urothelial cancer:9.47e-4 (unfavourable) Tissue enhanced Group enriched 18 esophagus: 2014.8;skin: 804.5;tonsil: 477.6 breast: 60.5 SPRR4 ENSG00000184148 Small proline-rich protein 4 1 152970666-152972574 Predicted intracellular proteins Evidence at protein level HPA055963 Supported Tissue enhanced Tissue enriched 6 skin: 48.3 breast: 7.8 SPRY3 HSPRY3 ENSG00000168939 Sprouty RTK signaling antagonist 3 X 155767812-155782459 Predicted membrane proteins Evidence at transcript level CAB013505 Uncertain Approved Nucleoli
Cytosol Mixed Mixed epididymis: 2.6 SRL ENSG00000185739 Sarcalumenin 16 4189374-4242080 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA041535, HPA045520 Supported Group enriched Group enriched 16 heart muscle: 161.3;skeletal muscle: 178.9 esophagus: 10.3 SRRD HC/HCC, SRR1L ENSG00000100104 SRR1 domain containing 22 26483877-26494658 Predicted intracellular proteins Evidence at protein level HPA002945 Uncertain Approved Cytosol Liver cancer:2.16e-6 (unfavourable) Expressed in all Expressed in all thyroid gland: 29.9 SRSF12 SFRS13B, SFRS19, SRrp35 ENSG00000154548 Serine/arginine-rich splicing factor 12 6 89095959-89118081 Predicted intracellular proteins Evidence at protein level HPA049782 Approved Mixed Group enriched 6 cerebral cortex: 6.9;testis: 20.9 thyroid gland: 2.2 SSC4D S4D-SRCRB, SRCRB-S4D, SRCRB4D ENSG00000146700 Scavenger receptor cysteine rich family, 4 domains 7 76389334-76409695 Predicted secreted proteins Evidence at transcript level HPA062611 Uncertain Endometrial cancer:2.83e-6 (unfavourable), Renal cancer:4.71e-4 (unfavourable), Glioma:6.31e-4 (unfavourable) Mixed Group enriched 5 kidney: 1.4;parathyroid gland: 4.1;thyroid gland: 2.0 cervix, uterine: 0.5 SSMEM1 C7orf45, FLJ40316 ENSG00000165120 Serine-rich single-pass membrane protein 1 7 130207860-130216843 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 200 testis: 56.6 lung,placenta: 0.2 SSPN KRAG, SPN1, SPN2 ENSG00000123096 Sarcospan 12 26121991-26299290 Predicted membrane proteins Evidence at protein level HPA066432 Approved Nucleus
Nuclear membrane Renal cancer:2.77e-5 (unfavourable) Mixed Mixed cervix, uterine: 64.1 SSTR4 ENSG00000132671 Somatostatin receptor 4 20 23035386-23036812 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA064252 Uncertain Not detected Not detected cerebral cortex: 0.8 SSX4 CT5.4 ENSG00000268009 Synovial sarcoma, X breakpoint 4 X 48383516-48393347 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level HPA045683 Approved Not detected Tissue enriched 15 testis: 3.8 fallopian tube: 0.2 SSX4B OTTHUMT00000056510 ENSG00000269791 Synovial sarcoma, X breakpoint 4B X 48402078-48411910 Predicted intracellular proteins Evidence at transcript level HPA045683 Approved Not detected Tissue enriched 15 testis: 3.8 fallopian tube: 0.2 SSX7 ENSG00000187754 Synovial sarcoma, X breakpoint 7 X 52644090-52654900 Predicted intracellular proteins Evidence at transcript level HPA045683 Uncertain Not detected Not detected epididymis: 0.7 ST20 HCCS-1 ENSG00000180953 Suppressor of tumorigenicity 20 15 79898840-79923702 Predicted intracellular proteins Evidence at transcript level Renal cancer:7.69e-8 (unfavourable) Expressed in all Mixed spleen: 11.6 ST3GAL1 SIAT4A, SIATFL, ST3GalA.1, ST3O ENSG00000008513 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 8 133454848-133571940 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA040466 Approved Expressed in all Expressed in all thyroid gland: 115.4 ST3GAL2 SIAT4B, ST3GalA.2, ST3GALII ENSG00000157350 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 16 70375978-70439237 Enzymes, Predicted membrane proteins Evidence at protein level HPA017270 Approved Approved Vesicles Renal cancer:3.34e-6 (unfavourable), Pancreatic cancer:2.33e-4 (favourable), Liver cancer:2.79e-4 (unfavourable) Expressed in all Mixed appendix: 15.7 ST3GAL4 CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ ENSG00000110080 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 11 126355640-126440344 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA049827 Approved Expressed in all Mixed adrenal gland: 105.8 ST6GALNAC1 SIAT7A, ST6GalNAcI ENSG00000070526 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 17 76624761-76643838 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014975 Uncertain Head and neck cancer:2.54e-5 (favourable) Mixed Tissue enhanced colon: 166.2;rectum: 239.7 cervix, uterine: 90.8 ST6GALNAC3 SIAT7C ENSG00000184005 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 1 76074719-76634601 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA054566, HPA055399 Uncertain Supported Nucleoplasm Mixed Tissue enhanced thyroid gland: 22.3 parathyroid gland: 11.0 ST6GALNAC4 SIAT3C, SIAT7D, ST6GALNACIV ENSG00000136840 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 9 127907886-127917038 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA009042 Approved Nucleus
Golgi apparatus Liver cancer:8.63e-7 (unfavourable), Ovarian cancer:5.12e-4 (unfavourable), Renal cancer:8.39e-4 (unfavourable) Expressed in all Mixed bone marrow: 24.5 ST6GALNAC5 MGC3184, SIAT7E, ST6GalNAcV ENSG00000117069 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 1 76867441-77065711 Predicted secreted proteins Evidence at protein level HPA065593, HPA070354 Uncertain Approved Vesicles Tissue enhanced Mixed lung: 8.8 ST7L FAM4B, FLJ20284, ST7R, STLR ENSG00000007341 Suppression of tumorigenicity 7 like 1 112523518-112620825 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA042324, HPA075418 Uncertain Approved Centrosome Ovarian cancer:3.04e-5 (favourable), Colorectal cancer:8.34e-5 (favourable), Melanoma:5.16e-4 (unfavourable), Endometrial cancer:8.96e-4 (unfavourable) Expressed in all Tissue enriched 5 testis: 64.6 thyroid gland: 12.3 ST8SIA2 HsT19690, SIAT8B, ST8SIA-II, STX ENSG00000140557 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 15 92393828-92468728 Predicted secreted proteins Evidence at protein level HPA054518 Approved Approved Microtubule organizing center Mixed Tissue enhanced cerebral cortex: 2.1;heart muscle: 1.9 cervix, uterine: 1.2 ST8SIA6 SIAT8F ENSG00000148488 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 10 17318383-17454330 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA011635, HPA072708 Uncertain Uncertain Endoplasmic reticulum Tissue enhanced Tissue enhanced breast: 13.3;lung: 18.3 epididymis: 9.4 STARD4 ENSG00000164211 StAR-related lipid transfer (START) domain containing 4 5 111496033-111512590 Predicted intracellular proteins Evidence at protein level HPA046177, HPA048081 Approved Approved Plasma membrane Liver cancer:4.80e-5 (unfavourable), Renal cancer:5.89e-5 (unfavourable), Urothelial cancer:2.84e-4 (unfavourable) Expressed in all Mixed duodenum: 42.6 STEAP1 PRSS24, STEAP ENSG00000164647 Six transmembrane epithelial antigen of the prostate 1 7 90154375-90164829 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level HPA030985 Uncertain Tissue enriched Tissue enhanced prostate: 124.2 appendix: 41.5 STEAP1B ENSG00000105889 STEAP family member 1B 7 22419444-22632925 Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced testis: 5.3 spleen: 3.5 STK31 SgK396, TDRD8 ENSG00000196335 Serine/threonine kinase 31 7 23710167-23832513 Enzymes, Predicted intracellular proteins Evidence at protein level HPA023194 Supported Mixed Tissue enriched 285 testis: 111.9 duodenum,lung: 0.3 STK32B HSA250839, STK32, STKG6, YANK2 ENSG00000152953 Serine/threonine kinase 32B 4 5051442-5500998 Enzymes, Predicted intracellular proteins Evidence at protein level HPA015820, HPA058536 Uncertain Approved Microtubules Renal cancer:1.63e-8 (favourable) Mixed Tissue enhanced kidney: 15.7 testis: 8.6 STKLD1 C9orf96, MGC43306, SGK071 ENSG00000198870 Serine/threonine kinase-like domain containing 1 9 133376367-133406096 Enzymes, Predicted membrane proteins Evidence at transcript level HPA029902 Uncertain Mixed Tissue enriched 14 testis: 5.7 cerebral cortex,endometrium,epididymis,fallopian tube,ovary: 0.3 STMN4 RB3 ENSG00000015592 Stathmin-like 4 8 27235323-27258420 Predicted intracellular proteins Evidence at protein level HPA027765 Uncertain Golgi apparatus
Vesicles Tissue enriched Tissue enriched 25 cerebral cortex: 339.4 adrenal gland: 13.4 STMND1 FLJ23152 ENSG00000230873 Stathmin domain containing 1 6 17102258-17131372 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA067970 Approved Actin filaments Group enriched Tissue enhanced fallopian tube: 33.3;testis: 12.3 gallbladder: 9.4 STOML3 Epb7.2l, SRO ENSG00000133115 Stomatin (EPB72)-like 3 13 38965925-38991066 Predicted membrane proteins Evidence at protein level HPA012892, CAB014880 Approved Endometrial cancer:1.49e-4 (favourable) Tissue enhanced Tissue enriched 17 fallopian tube: 49.7 lung: 2.8 STOX2 DKFZp762K222 ENSG00000173320 Storkhead box 2 4 183853431-184023526 Predicted intracellular proteins Evidence at protein level HPA049776, HPA065002 Uncertain Uncertain Nucleoplasm
Actin filaments
Cytosol Mixed Tissue enhanced cerebral cortex: 15.4 parathyroid gland: 9.1 STPG2 C4orf37, MGC46496 ENSG00000163116 Sperm-tail PG-rich repeat containing 2 4 97184093-98143240 Predicted intracellular proteins Evidence at protein level Not detected Tissue enhanced testis: 3.9 thyroid gland: 0.9 STRA8 ENSG00000146857 Stimulated by retinoic acid 8 7 135231979-135258492 Predicted intracellular proteins Evidence at protein level Mixed Tissue enhanced testis: 1.7 skin: 0.7 STRC DFNB16 ENSG00000242866 Stereocilin 15 43599398-43618800 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA015731 Uncertain Not detected Tissue enhanced cerebral cortex: 1.4;epididymis: 1.5;testis: 1.7 skin: 0.8 STX2 EPIM, EPM, STX2A, STX2B, STX2C ENSG00000111450 Syntaxin 2 12 130789600-130839266 Cancer-related genes, Predicted membrane proteins Evidence at protein level HPA038189, HPA069176 Uncertain Approved Nucleus
Cytosol Renal cancer:5.15e-5 (unfavourable) Expressed in all Expressed in all testis: 35.1 STYXL1 DUSP24, MK-STYX ENSG00000127952 Serine/threonine/tyrosine interacting-like 1 7 75996338-76048004 Predicted intracellular proteins Evidence at transcript level HPA050261 Uncertain Approved Nuclear speckles Urothelial cancer:8.22e-4 (favourable) Expressed in all Expressed in all fallopian tube: 45.5 SULT6B1 ENSG00000138068 Sulfotransferase family, cytosolic, 6B, member 1 2 37167820-37196598 Enzymes, Predicted intracellular proteins Evidence at protein level Not detected Tissue enhanced testis: 4.3 fallopian tube: 0.9 SUN3 MGC33329, SUNC1 ENSG00000164744 Sad1 and UNC84 domain containing 3 7 47987148-48029119 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA008344 Approved Golgi apparatus Tissue enhanced Tissue enriched 153 testis: 74.2 placenta: 0.4 SUN5 dJ726C3.1, SPAG4L, TSARG4 ENSG00000167098 Sad1 and UNC84 domain containing 5 20 32983773-33004433 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA048529 Supported Not detected Tissue enriched 409 testis: 40.8 all non-specific tissues: 0.0 SUSD3 MGC26847 ENSG00000157303 Sushi domain containing 3 9 93058688-93085138 Predicted membrane proteins Evidence at protein level HPA042310 Uncertain Approved Nucleus Breast cancer:5.13e-4 (favourable) Expressed in all Tissue enhanced testis: 91.7 lymph node: 67.3 SUSD4 FLJ10052 ENSG00000143502 Sushi domain containing 4 1 223220819-223364202 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA058296 Uncertain Approved Vesicles Endometrial cancer:4.28e-4 (unfavourable) Mixed Tissue enhanced esophagus: 42.6 cerebral cortex: 38.6 SVOP DKFZp761H039 ENSG00000166111 SV2 related protein 12 108907741-109021240 Predicted membrane proteins Evidence at protein level HPA016573 Uncertain Group enriched Tissue enriched 15 cerebral cortex: 32.4 adrenal gland: 2.1 SVOPL MGC46715 ENSG00000157703 SVOP-like 7 138594285-138701352 Predicted membrane proteins Evidence at transcript level HPA018035 Uncertain Mixed Tissue enriched 5 parathyroid gland: 14.0 fallopian tube: 2.6 SWT1 C1orf26, FLJ20121, HsSwt1 ENSG00000116668 SWT1 RNA endoribonuclease homolog 1 185157080-185291765 Predicted intracellular proteins Evidence at protein level HPA024214, HPA027334 Uncertain Approved Cytosol Renal cancer:5.63e-4 (favourable) Expressed in all Tissue enriched 8 testis: 69.0 thyroid gland: 8.7 SYCE1L MRP2 ENSG00000205078 Synaptonemal complex central element protein 1-like 16 77199397-77213215 Predicted intracellular proteins Evidence at protein level HPA062464, HPA066691 Validated Intermediate filaments Renal cancer:2.11e-5 (unfavourable), Endometrial cancer:6.65e-4 (favourable) Mixed Tissue enriched 6 testis: 23.7 prostate: 3.9 SYCE2 CESC1 ENSG00000161860 Synaptonemal complex central element protein 2 19 12898786-12919276 Predicted intracellular proteins Evidence at protein level HPA042080, HPA062919 Supported Supported Nucleus Cervical cancer:3.85e-5 (favourable), Endometrial cancer:9.91e-4 (unfavourable) Mixed Tissue enriched 15 testis: 38.8 cerebral cortex: 2.5 SYCN FLJ27441, INSSA1, SYL ENSG00000179751 Syncollin 19 39202831-39204266 Predicted secreted proteins Evidence at protein level HPA047654 Supported Tissue enriched Tissue enriched 400 pancreas: 6058.1 ovary: 15.1 SYCP2 SCP2 ENSG00000196074 Synaptonemal complex protein 2 20 59863563-59933655 Predicted intracellular proteins Evidence at protein level HPA062401, HPA065613 Supported Nucleoplasm
Plasma membrane
Cytosol Group enriched Group enriched 8 breast: 17.5;testis: 76.3 prostate,stomach: 5.8 SYNGR4 ENSG00000105467 Synaptogyrin 4 19 48364395-48376376 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA030075, HPA059286 Approved Approved Golgi apparatus Mixed Tissue enriched 11 testis: 46.8 parathyroid gland: 4.4 SYNPO2L FLJ12921 ENSG00000166317 Synaptopodin 2-like 10 73644881-73663803 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA055192, HPA057142 Supported Approved Nuclear speckles
Cell Junctions
Cytosol Group enriched Group enriched 11 heart muscle: 158.4;skeletal muscle: 96.0 esophagus: 11.2 SYPL2 Mg29 ENSG00000143028 Synaptophysin-like 2 1 109466628-109482137 Predicted membrane proteins Evidence at protein level HPA018032 Approved Nucleoplasm Renal cancer:3.05e-4 (favourable) Mixed Tissue enriched 8 skeletal muscle: 129.4 parathyroid gland: 17.1 SYT10 ENSG00000110975 Synaptotagmin X 12 33374238-33439819 Predicted membrane proteins Evidence at transcript level HPA055426 Uncertain Approved Nucleoplasm
Vesicles Tissue enriched Tissue enhanced fallopian tube: 3.5 seminal vesicle: 1.1 SYT15 CHR10SYT ENSG00000204176 Synaptotagmin XV 10 46578217-46594173 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA036971, HPA036972, HPA064559 Uncertain Approved Golgi apparatus Not detected Mixed lung: 21.5 SYT3 ENSG00000213023 Synaptotagmin III 19 50621307-50668394 Predicted membrane proteins Evidence at protein level Mixed Tissue enriched 10 cerebral cortex: 17.1 testis: 1.7 SYT5 ENSG00000129990 Synaptotagmin V 19 55171199-55180441 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Pancreatic cancer:5.54e-4 (favourable), Glioma:8.26e-4 (unfavourable) Mixed Tissue enriched 10 cerebral cortex: 131.7 adrenal gland: 12.8 SYT8 DKFZp434K0322 ENSG00000149043 Synaptotagmin VIII 11 1828307-1837521 Predicted membrane proteins Evidence at transcript level HPA052700 Uncertain Approved Nucleoplasm
Cell Junctions Tissue enhanced Group enriched 5 gallbladder: 26.7;skin: 80.3;urinary bladder: 25.5 seminal vesicle: 8.5 SYT9 ENSG00000170743 Synaptotagmin IX 11 7238778-7469042 Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced cerebral cortex: 6.1;seminal vesicle: 5.1 adrenal gland: 2.8 SYTL3 exophilin-6, SLP3 ENSG00000164674 Synaptotagmin-like 3 6 158650014-158764876 Predicted intracellular proteins Evidence at protein level HPA030584, HPA030585, HPA030586 Approved Approved Nucleoli fibrillar center
Vesicles Cervical cancer:8.84e-5 (favourable) Mixed Tissue enhanced thyroid gland: 44.4 fallopian tube: 22.6 TAAR1 TA1, TAR1, TRAR1 ENSG00000146399 Trace amine associated receptor 1 6 132644984-132646003 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA055614 Approved Tissue enhanced Group enriched 17 fallopian tube: 2.2;stomach: 7.9 duodenum,endometrium,prostate,urinary bladder: 0.2 TAAR2 GPR58 ENSG00000146378 Trace amine associated receptor 2 6 132617022-132624275 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected testis: 0.4 TAAR5 PNR ENSG00000135569 Trace amine associated receptor 5 6 132588673-132589686 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA051703 Uncertain Not detected Not detected all non-specific tissues: 0.0 TAAR6 TA4, TRAR4 ENSG00000146383 Trace amine associated receptor 6 6 132570322-132571359 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected kidney: 0.1 TAAR8 GPR102, TA5, TAR5, TRAR5 ENSG00000146385 Trace amine associated receptor 8 6 132552693-132553721 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 TAAR9 TA3, TAR3, TRAR3 ENSG00000237110 Trace amine associated receptor 9 (gene/pseudogene) 6 132538290-132539336 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 TAF7L CT40, TAF2Q ENSG00000102387 TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa X 101268253-101293057 Predicted intracellular proteins Evidence at protein level HPA001879 Approved Approved Nucleoplasm Cervical cancer:8.71e-4 (favourable) Tissue enhanced Tissue enriched 14 testis: 62.4 parathyroid gland: 4.5 TANGO2 C22orf25, DKFZp761P1121 ENSG00000183597 Transport and golgi organization 2 homolog 22 20017014-20065926 Predicted intracellular proteins Evidence at protein level HPA003080 Approved Approved Pancreatic cancer:3.01e-4 (favourable) Expressed in all Expressed in all heart muscle: 46.6 TARM1 ENSG00000248385 T cell-interacting, activating receptor on myeloid cells 1 19 54069895-54081365 Predicted membrane proteins Evidence at transcript level HPA051022, HPA054401 Uncertain Not detected Not detected gallbladder,spleen: 0.2 TAS1R1 GPR70, T1R1, TR1 ENSG00000173662 Taste receptor, type 1, member 1 1 6555181-6579757 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level HPA034579, HPA034580 Approved Mixed Tissue enriched 7 testis: 4.2 gallbladder,skin: 0.5 TAS2R19 T2R19, T2R23, TAS2R23, TAS2R48 ENSG00000212124 Taste receptor, type 2, member 19 12 11021619-11022620 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Tissue enhanced Not detected ovary: 0.2 TAS2R20 T2R20, T2R56, TAS2R49 ENSG00000255837 Taste receptor, type 2, member 20 12 10996495-10997875 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Mixed Not detected skin: 0.8 TAS2R3 T2R3 ENSG00000127362 Taste receptor, type 2, member 3 7 141764097-141765197 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected ovary: 0.5 TAS2R30 T2R30, TAS2R47 ENSG00000256188 Taste receptor, type 2, member 30 12 11132958-11134644 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected endometrium,ovary,parathyroid gland,testis,thyroid gland: 0.2 TAS2R31 T2R31, T2R53, TAS2R44 ENSG00000256436 Taste receptor, type 2, member 31 12 11030387-11031407 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Mixed Not detected parathyroid gland: 0.3 TAS2R38 PTC, T2R61 ENSG00000257138 Taste receptor, type 2, member 38 7 141972631-141973773 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA043862, HPA054366 Uncertain Not detected Not detected rectum,small intestine: 0.3 TAS2R39 ENSG00000236398 Taste receptor, type 2, member 39 7 143183419-143184435 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA053456, HPA060680 Uncertain Not detected Not detected all non-specific tissues: 0.0 TAS2R40 GPR60 ENSG00000221937 Taste receptor, type 2, member 40 7 143222037-143223079 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced appendix: 1.0 spleen: 0.3 TAS2R41 T2R59 ENSG00000221855 Taste receptor, type 2, member 41 7 143477873-143478796 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA057063 Uncertain Not detected Not detected all non-specific tissues: 0.0 TAS2R42 hT2R55, T2R24, T2R55, TAS2R55 ENSG00000186136 Taste receptor, type 2, member 42 12 11185993-11186937 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA036149 Uncertain Approved Nucleoplasm
Actin filaments
Focal adhesion sites Not detected Not detected all non-specific tissues: 0.0 TAS2R43 T2R52 ENSG00000255374 Taste receptor, type 2, member 43 12 11091287-11134244 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 TAS2R46 T2R54 ENSG00000226761 Taste receptor, type 2, member 46 12 11061365-11062294 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 TAS2R50 T2R51 ENSG00000212126 Taste receptor, type 2, member 50 12 10985913-10986912 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Not detected Not detected all non-specific tissues: 0.0 TAS2R60 T2R60 ENSG00000185899 Taste receptor, type 2, member 60 7 143443453-143444409 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA030416 Uncertain Not detected Not detected appendix,bone marrow,liver,parathyroid gland,placenta: 0.1 TATDN2 KIAA0218 ENSG00000157014 TatD DNase domain containing 2 3 10248023-10281218 Predicted intracellular proteins Evidence at protein level HPA036822, HPA058001 Approved Supported Nucleus
Nuclear speckles
Cytosol Pancreatic cancer:4.66e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 37.6 TBATA C10orf27, FLJ32820, spatial ENSG00000166220 Thymus, brain and testes associated 10 70771239-70785401 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 26 testis: 31.9 spleen: 1.2 TBC1D16 FLJ20748, MGC25062 ENSG00000167291 TBC1 domain family, member 16 17 79932343-80035848 Predicted intracellular proteins Evidence at protein level HPA024482, HPA065839 Approved Approved Intermediate filaments Expressed in all Mixed adipose tissue: 40.6 TBC1D21 MGC34741, MgcRabGAP ENSG00000167139 TBC1 domain family, member 21 15 73873608-73889214 Predicted intracellular proteins Evidence at protein level HPA043319 Uncertain Supported Not detected Tissue enriched 600 testis: 61.6 fallopian tube,small intestine: 0.1 TBC1D26 MGC51025 ENSG00000214946 TBC1 domain family, member 26 17 15732247-15749192 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 11 testis: 3.9 lung: 0.3 TBC1D28 FLJ40244 ENSG00000189375 TBC1 domain family, member 28 17 18635006-18661950 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 69 testis: 18.3 spleen,tonsil: 0.2 TBC1D29 DKFZP434O047 ENSG00000266733 TBC1 domain family, member 29 17 30557112-30563493 Predicted intracellular proteins Evidence at transcript level HPA059178 Uncertain Not detected Tissue enriched 11 testis: 10.6 epididymis: 0.9 TBC1D31 Gm85, MGC21654, WDR67 ENSG00000156787 TBC1 domain family, member 31 8 123041968-123152153 Predicted intracellular proteins Evidence at protein level HPA023710 Approved Approved Centrosome Lung cancer:2.91e-4 (unfavourable) Mixed Mixed testis: 8.4 TBC1D32 bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235 ENSG00000146350 TBC1 domain family, member 32 6 121079494-121334745 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA013413 Uncertain Approved Mitochondria Mixed Mixed testis: 6.0 TBC1D3B PRC17, TBC1D3I ENSG00000274808 TBC1 domain family, member 3B 17 36165624-36264527 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA046969, HPA047745, HPA052553 Uncertain Uncertain Vesicles Not detected Tissue enhanced skin: 6.3 testis: 5.9 TBC1D3C MGC44903 ENSG00000278299 TBC1 domain family, member 3C 17 37978470-38068592 Predicted membrane proteins Evidence at protein level HPA046969, HPA047745, HPA052553 Approved Uncertain Vesicles Not detected Tissue enhanced testis: 4.2 skin: 3.0 TBC1D3D ENSG00000274419 TBC1 domain family, member 3D 17 38003976-38139051 Predicted membrane proteins Evidence at protein level HPA046969, HPA047745, HPA052553 Uncertain Uncertain Vesicles Not detected Tissue enhanced skin: 4.7;small intestine: 5.6 testis: 3.3 TBC1D3E ENSG00000278599 TBC1 domain family, member 3E 17 38005561-38138862 Predicted membrane proteins Evidence at protein level HPA046969, HPA047745, HPA052553 Uncertain Uncertain Vesicles Not detected Tissue enhanced bone marrow: 1.8;gallbladder: 2.7;testis: 3.8 lymph node: 0.9 TBC1D3G ENSG00000260287 TBC1 domain family, member 3G 17 36323884-36334759 Predicted membrane proteins Evidence at protein level HPA046969, HPA047745, HPA052553 Uncertain Approved Vesicles Not detected Tissue enriched 60 testis: 6.0 all non-specific tissues: 0.0 TBC1D3H ENSG00000274226 TBC1 domain family, member 3H 17 36377531-36388423 Predicted membrane proteins Evidence at protein level HPA046969, HPA047745, HPA052553 Uncertain Approved Vesicles Not detected Tissue enhanced testis: 2.7;urinary bladder: 1.1 cervix, uterine: 0.6 TBC1D3L ENSG00000274512 TBC1 domain family, member 3L 17 37977972-38068651 Predicted membrane proteins Evidence at protein level HPA046969, HPA047745, HPA052553 Uncertain Uncertain Vesicles Mixed Mixed skin: 41.4 TBC1D8 AD3, HBLP1, VRP ENSG00000204634 TBC1 domain family, member 8 (with GRAM domain) 2 101007617-101252866 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB015211, HPA037496 Uncertain Supported Nucleus Colorectal cancer:6.73e-4 (unfavourable) Expressed in all Expressed in all seminal vesicle: 44.7 TBC1D9 KIAA0882, MDR1 ENSG00000109436 TBC1 domain family, member 9 (with GRAM domain) 4 140620765-140756120 Predicted intracellular proteins Evidence at protein level HPA000262, HPA006317, HPA006503 Uncertain Supported Approved Nucleoplasm
Cytosol Renal cancer:1.61e-6 (favourable) Tissue enriched Mixed breast: 64.9 TBCCD1 FLJ10560 ENSG00000113838 TBCC domain containing 1 3 186546073-186570543 Predicted intracellular proteins Evidence at protein level Liver cancer:1.87e-4 (unfavourable) Expressed in all Expressed in all testis: 35.4 TBL1Y TBL1 ENSG00000092377 Transducin (beta)-like 1, Y-linked Y 6910686-7091683 Predicted intracellular proteins Evidence at protein level HPA060073 Uncertain Tissue enriched Tissue enhanced prostate: 2.5;thyroid gland: 1.4 testis: 0.5 TBPL2 TBP2, TRF3 ENSG00000182521 TATA box binding protein like 2 14 55413541-55456726 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA056241 Uncertain Tissue enriched Mixed testis: 2.1 TBR1 ENSG00000136535 T-box, brain, 1 2 161416094-161425870 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051256 Approved Not detected Tissue enriched 29 cerebral cortex: 30.7 testis: 1.0 TBX10 TBX13, TBX7 ENSG00000167800 T-box 10 11 67631303-67639560 Predicted secreted proteins, Transcription factors Evidence at protein level HPA047881 Uncertain Group enriched Group enriched 27 colon: 9.0;duodenum: 6.0;rectum: 8.8;small intestine: 10.8 appendix,testis: 0.3 TBX21 T-bet, TBLYM ENSG00000073861 T-box 21 17 47733244-47746119 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009524, CAB030043 Supported Mixed Tissue enhanced lymph node: 8.6;spleen: 11.2 bone marrow: 6.4 TCAIM C3orf23, DKFZp313N0621, TOAG-1 ENSG00000179152 T cell activation inhibitor, mitochondrial 3 44338119-44409451 Predicted intracellular proteins Evidence at transcript level Renal cancer:2.19e-7 (favourable), Urothelial cancer:2.81e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 22.6 TCEAL2 my048, MY0876G05, WEX1 ENSG00000184905 Transcription elongation factor A (SII)-like 2 X 102125688-102127711 Predicted intracellular proteins Evidence at protein level HPA076317 Approved Nuclear speckles
Cytosol Tissue enhanced Tissue enhanced cerebral cortex: 192.2 ovary: 77.9 TCEAL6 WEX2 ENSG00000204071 Transcription elongation factor A (SII)-like 6 X 102140476-102142970 Predicted intracellular proteins Evidence at protein level HPA045564, HPA058982 Uncertain Tissue enriched Group enriched 6 adrenal gland: 15.0;cerebral cortex: 65.3;testis: 35.6 endometrium: 6.2 TCEAL7 MGC23947, WEX5 ENSG00000182916 Transcription elongation factor A (SII)-like 7 X 103330196-103332326 Predicted intracellular proteins Evidence at protein level HPA051507, HPA065080 Supported Supported Nucleus Stomach cancer:3.53e-4 (unfavourable), Renal cancer:4.31e-4 (unfavourable) Tissue enriched Tissue enhanced cerebral cortex: 146.0 endometrium: 76.6 TCEB3CL HsT828 ENSG00000275553 Transcription elongation factor B polypeptide 3C-like 18 46968695-47029842 Predicted intracellular proteins Evidence at transcript level HPA048971, HPA049178, HPA050086 Uncertain Not detected Not detected epididymis: 0.1 TCERG1L FLJ38950 ENSG00000176769 Transcription elongation regulator 1-like 10 131092391-131311721 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 6 thyroid gland: 25.1 cerebral cortex: 4.1 TCF15 bHLHa40, EC2, PARAXIS ENSG00000125878 Transcription factor 15 (basic helix-loop-helix) 20 603797-610398 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050998, HPA060221 Uncertain Supported Nuclear speckles Ovarian cancer:3.25e-4 (unfavourable) Mixed Group enriched 5 adipose tissue: 9.0;heart muscle: 5.5;placenta: 8.0;skeletal muscle: 7.2;testis: 2.2 lung: 1.2 TCF21 bHLHa23, POD1 ENSG00000118526 Transcription factor 21 6 133889138-133895553 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA013189 Uncertain Mixed Tissue enhanced placenta: 62.1;spleen: 47.8 ovary: 32.1 TCF23 bHLHa24, OUT ENSG00000163792 Transcription factor 23 2 27149004-27156974 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced endometrium: 33.7;ovary: 22.6;smooth muscle: 30.5 fallopian tube: 13.9 TCF7L1 TCF3 ENSG00000152284 Transcription factor 7-like 1 (T-cell specific, HMG-box) 2 85133410-85310388 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071298 Supported Nucleoplasm
Cytosol Liver cancer:6.16e-5 (unfavourable), Endometrial cancer:1.70e-4 (unfavourable), Renal cancer:2.06e-4 (unfavourable), Stomach cancer:2.72e-4 (unfavourable), Urothelial cancer:5.38e-4 (unfavourable) Expressed in all Mixed adipose tissue,endometrium: 22.8 TCFL5 bHLHe82, CHA, E2BP-1, Figlb ENSG00000101190 Transcription factor-like 5 (basic helix-loop-helix) 20 62841115-62861763 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055223 Approved Supported Nucleoplasm Endometrial cancer:3.24e-4 (unfavourable) Expressed in all Expressed in all testis: 143.8 TCHHL1 S100A17, THHL1 ENSG00000182898 Trichohyalin-like 1 1 152084144-152089064 Predicted intracellular proteins Evidence at protein level HPA042579, HPA063483 Supported Approved Nuclear membrane
Nucleoli Not detected Not detected epididymis: 0.1 TCP10 ENSG00000203690 T-complex 10 6 167357031-167384510 Predicted intracellular proteins Evidence at transcript level HPA044709 Approved Not detected Tissue enriched 14 testis: 14.2 small intestine: 1.0 TCP11 D6S230E, FPPR, KIAA0229 ENSG00000124678 T-complex 11, testis-specific 6 35118071-35148610 Predicted intracellular proteins Evidence at protein level HPA048311 Supported Cervical cancer:5.02e-4 (favourable) Tissue enhanced Tissue enriched 331 testis: 558.6 ovary: 1.6 TCP11L2 MGC40368 ENSG00000166046 T-complex 11, testis-specific-like 2 12 106301929-106347015 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA039483, HPA042188 Uncertain Supported Nuclear speckles Head and neck cancer:9.52e-4 (favourable) Mixed Expressed in all fallopian tube: 26.2 TCTE1 D6S46, DRC5, FAP155, MGC33600 ENSG00000146221 T-complex-associated-testis-expressed 1 6 44278743-44297688 Predicted intracellular proteins Evidence at transcript level HPA031739 Uncertain Uncertain Vesicles Tissue enhanced Group enriched 13 fallopian tube: 22.8;testis: 35.3 lung: 2.2 TCTN1 FLJ21127, JBTS13, TECT1 ENSG00000204852 Tectonic family member 1 12 110614027-110649430 Disease related genes, Predicted secreted proteins Evidence at protein level HPA039687, HPA040036 Approved Approved Nucleoplasm
Actin filaments Endometrial cancer:1.13e-5 (favourable) Expressed in all Mixed fallopian tube: 43.7 TCTN2 C12orf38, FLJ12975, MKS8, TECT2 ENSG00000168778 Tectonic family member 2 12 123671113-123708403 Disease related genes, Predicted membrane proteins Evidence at protein level HPA039900 Approved Approved Golgi apparatus
Vesicles Expressed in all Mixed fallopian tube: 46.1 TDRD10 DKFZp434M202 ENSG00000163239 Tudor domain containing 10 1 154502219-154548147 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level HPA054327 Approved Vesicles Thyroid cancer:8.04e-5 (favourable) Tissue enhanced Tissue enriched 12 testis: 76.9 lung: 6.3 TDRD12 ECAT8, FLJ13072 ENSG00000173809 Tudor domain containing 12 19 32719753-32829580 Enzymes, Predicted intracellular proteins Evidence at protein level Tissue enriched Tissue enriched 7 testis: 25.3 epididymis: 3.6 TDRD15 ENSG00000218819 Tudor domain containing 15 2 21123917-21143272 Predicted intracellular proteins Evidence at transcript level HPA051770, HPA054675 Uncertain Not detected Tissue enriched 77 testis: 9.9 liver: 0.1 TDRD6 bA446F17.4, CT41.2, NY-CO-45, SPATA36 ENSG00000180113 Tudor domain containing 6 6 46687875-46704319 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Tissue enhanced Tissue enhanced testis: 42.6;thyroid gland: 20.3 spleen: 7.2 TDRD9 C14orf75, DKFZp434N0820, FLJ36164, NET54 ENSG00000156414 Tudor domain containing 9 14 103928462-104052667 Enzymes, Predicted intracellular proteins Evidence at protein level Thyroid cancer:5.52e-4 (unfavourable) Mixed Group enriched 6 parathyroid gland: 39.0;testis: 74.7 thyroid gland: 9.1 TECRL DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL ENSG00000205678 Trans-2,3-enoyl-CoA reductase-like 4 64275257-64409468 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 18 heart muscle: 361.1 skeletal muscle: 20.5 TECTB ENSG00000119913 Tectorin beta 10 112283735-112305035 Predicted membrane proteins Evidence at transcript level Not detected Tissue enhanced epididymis: 1.5 thyroid gland: 0.3 TEDDM1 EDDM9, Epdd1, HE9, TMEM45C ENSG00000203730 Transmembrane epididymal protein 1 1 182398117-182400616 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 422 epididymis: 705.5 seminal vesicle: 1.6 TENM3 KIAA1455, ODZ3, Ten-M3 ENSG00000218336 Teneurin transmembrane protein 3 4 182143987-182803024 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA047043 Approved Approved Nucleoplasm Mixed Tissue enhanced placenta: 18.7 parathyroid gland: 13.8 TEPP ENSG00000159648 Testis, prostate and placenta expressed 16 57976435-57988116 Predicted secreted proteins Evidence at protein level HPA062092 Supported Tissue enhanced Tissue enriched 9 testis: 7.3 thyroid gland: 0.7 TEX101 CT131, MGC4766, SGRG, SPATA44 ENSG00000131126 Testis expressed 101 19 43401496-43418597 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA041915, HPA042513 Supported Mixed Tissue enriched 107 testis: 173.0 skin: 1.6 TEX12 ENSG00000150783 Testis expressed 12 11 112167372-112172559 Predicted intracellular proteins Evidence at protein level HPA038289, HPA038290 Supported Not detected Tissue enriched 38 testis: 32.4 skin: 0.8 TEX13B TGC3B, TSGA5 ENSG00000170925 Testis expressed 13B X 107980864-107982370 Predicted intracellular proteins Evidence at transcript level HPA011283 Uncertain Not detected Not detected testis: 0.8 TEX15 CT42 ENSG00000133863 Testis expressed 15 8 30831544-30890606 Predicted intracellular proteins Evidence at transcript level HPA036799, HPA036800 Approved Approved Nuclear speckles Not detected Group enriched 31 endometrium: 10.9;smooth muscle: 8.2;testis: 22.2 cerebral cortex,gallbladder: 0.4 TEX19 FLJ35767 ENSG00000182459 Testis expressed 19 17 82359247-82363776 Predicted intracellular proteins Evidence at protein level HPA054577 Supported Not detected Tissue enriched 265 testis: 27.2 cerebral cortex: 0.1 TEX22 ENSG00000226174 Testis expressed 22 14 105398579-105450106 Predicted intracellular proteins Evidence at transcript level HPA065576 Uncertain Mixed Tissue enhanced testis: 2.1 cerebral cortex: 0.8 TEX26 C13orf26, MGC40178 ENSG00000175664 Testis expressed 26 13 30932703-30975502 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 30 testis: 40.4 cervix, uterine: 1.3 TEX261 MGC32043, TEG-261 ENSG00000144043 Testis expressed 261 2 70985938-70994945 Predicted membrane proteins Evidence at transcript level HPA016631 Approved Approved Nucleoplasm
Cytosol Liver cancer:4.23e-4 (unfavourable), Endometrial cancer:6.17e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 91.4 TEX28 CXorf2, fTEX ENSG00000278057 Testis expressed 28 X 154271265-154295853 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 33 testis: 6.2 bone marrow,skin: 0.1 TEX29 bA474D23.1, C13orf16, MGC35169 ENSG00000153495 Testis expressed 29 13 111316184-111344249 Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 15 testis: 46.7 cerebral cortex: 3.0 TEX30 C13orf27 ENSG00000151287 Testis expressed 30 13 102765990-102773811 Predicted intracellular proteins Evidence at protein level HPA053545 Supported Prostate cancer:2.10e-6 (unfavourable), Cervical cancer:2.09e-5 (favourable) Expressed in all Group enriched 7 epididymis: 87.5;testis: 223.0 placenta: 22.2 TEX33 C22orf33, EAN57, MGC35206 ENSG00000185264 Testis expressed 33 22 36991120-37007841 Predicted intracellular proteins Evidence at protein level HPA005998 Supported Not detected Tissue enriched 569 testis: 86.6 cerebral cortex: 0.1 TEX35 C1orf49, DKFZP564J047, TSC24 ENSG00000240021 Testis expressed 35 1 178513077-178548602 Predicted intracellular proteins Evidence at protein level HPA039190 Approved Not detected Tissue enriched 28 testis: 174.3 epididymis: 6.1 TEX36 bA383C5.1, C10orf122 ENSG00000175018 Testis expressed 36 10 125576522-125683144 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 55 testis: 47.2 endometrium,smooth muscle: 0.8 TEX38 ATPAF1-AS1, C1orf223, LOC374973, THEG4 ENSG00000186118 Testis expressed 38 1 46668855-46673594 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 127 testis: 260.0 parathyroid gland: 2.0 TEX43 C5orf48, FLJ27505, MGC163367, MGC163369, Tseg7 ENSG00000196900 Testis expressed 43 5 126631722-126636287 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 13 testis: 35.2 rectum: 2.7 TEX9 ENSG00000151575 Testis expressed 9 15 56244009-56445997 Predicted intracellular proteins Evidence at protein level HPA039415 Uncertain Approved Plasma membrane
Cytosol Mixed Mixed fallopian tube: 44.1 TFAP2D TFAP2BL1 ENSG00000008197 Transcription factor AP-2 delta (activating enhancer binding protein 2 delta) 6 50713828-50772988 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048962 Uncertain Tissue enriched Not detected cerebral cortex,testis: 0.1 TFAP2E AP2E ENSG00000116819 Transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon) 1 35573370-35595328 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced skin: 7.2 lymph node: 2.1 TFCP2L1 CRTR1, LBP-9 ENSG00000115112 Transcription factor CP2-like 1 2 121216587-121285207 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029708 Uncertain Supported Nucleoli fibrillar center Renal cancer:7.72e-6 (favourable) Mixed Tissue enhanced kidney: 48.7 thyroid gland: 45.6 TGFBR3L ENSG00000260001 Transforming growth factor, beta receptor III-like 19 7916145-7919097 Predicted membrane proteins Evidence at transcript level HPA074356 Approved Vesicles Mixed Tissue enhanced duodenum: 1.8;small intestine: 1.8 kidney: 1.2 TGM7 TGMZ ENSG00000159495 Transglutaminase 7 15 43276280-43302255 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at transcript level Tissue enriched Group enriched 6 testis: 1.5;tonsil: 1.5 esophagus: 0.2 THEGL ENSG00000249693 Theg spermatid protein-like 4 56530609-56603507 Predicted intracellular proteins Evidence at protein level HPA068093 Uncertain Not detected Tissue enriched 7 testis: 5.6 smooth muscle: 0.8 THNSL2 FLJ10916, SOFAT, TSH2 ENSG00000144115 Threonine synthase-like 2 2 88170295-88186636 Predicted intracellular proteins Evidence at protein level HPA035395 Approved Expressed in all Tissue enhanced parathyroid gland: 72.9 thyroid gland: 38.0 THSD1 TMTSP ENSG00000136114 Thrombospondin, type I, domain containing 1 13 52377167-52406494 Predicted membrane proteins Evidence at protein level HPA012611, CAB020796 Uncertain Validated Cytosol Expressed in all Mixed lung: 16.6 THSD4 ADAMTSL6, FLJ13710, FVSY9334, PRO34005 ENSG00000187720 Thrombospondin, type I, domain containing 4 15 71096952-71783383 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA026845 Approved Nucleus
Nucleoli Mixed Tissue enhanced cervix, uterine: 159.1 fallopian tube: 58.5 THSD7B KIAA1679 ENSG00000144229 Thrombospondin, type I, domain containing 7B 2 136765545-137677717 Predicted membrane proteins Evidence at transcript level HPA051416, HPA056745 Uncertain Approved Nucleoplasm
Cytosol Mixed Tissue enhanced epididymis: 5.0 adipose tissue: 2.0 THUMPD2 C2orf8, MGC2454 ENSG00000138050 THUMP domain containing 2 2 39736060-39779267 Predicted intracellular proteins Evidence at protein level HPA043042, HPA058025 Approved Uncertain Nucleoplasm Renal cancer:7.27e-5 (unfavourable), Liver cancer:6.05e-4 (unfavourable) Expressed in all Mixed ovary,thyroid gland: 3.8 TIAF1 ENSG00000221995 TGFB1-induced anti-apoptotic factor 1 17 29073521-29078857 Predicted intracellular proteins Evidence at transcript level HPA051129 Uncertain Mixed Mixed skin: 4.8 TIAM2 STEF ENSG00000146426 T-cell lymphoma invasion and metastasis 2 6 154832697-155257723 Predicted intracellular proteins Evidence at protein level HPA011134, HPA013903 Approved Supported Nucleoplasm
Nucleoli fibrillar center
Cytosol Mixed Tissue enhanced cerebral cortex: 18.1;testis: 24.4 thyroid gland: 10.4 TIGD3 ENSG00000173825 Tigger transposable element derived 3 11 65354767-65357613 Predicted intracellular proteins Evidence at transcript level HPA040016 Uncertain Approved Nucleoplasm
Nuclear membrane Mixed Tissue enhanced small intestine: 2.4;testis: 3.9 cerebral cortex: 1.7 TIGD4 ENSG00000169989 Tigger transposable element derived 4 4 152769354-152779764 Predicted intracellular proteins Evidence at protein level HPA035649 Approved Approved Nucleoplasm
Cytosol Mixed Tissue enhanced testis: 8.5 fallopian tube: 3.2 TIGD6 DKFZp761E2110 ENSG00000164296 Tigger transposable element derived 6 5 149993118-150001167 Predicted intracellular proteins Evidence at protein level HPA044599 Uncertain Approved Nucleoplasm
Vesicles
Actin filaments Colorectal cancer:5.35e-4 (favourable), Pancreatic cancer:5.88e-4 (favourable) Expressed in all Tissue enhanced parathyroid gland: 21.1 testis: 6.7 TIMD4 ENSG00000145850 T-cell immunoglobulin and mucin domain containing 4 5 156919282-156963255 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA015625, CAB026027 Approved Approved Plasma membrane
Cytosol Renal cancer:3.37e-4 (favourable) Tissue enriched Group enriched 6 lymph node: 64.4;testis: 161.6 adipose tissue: 17.7 TIMP4 ENSG00000157150 TIMP metallopeptidase inhibitor 4 3 12153051-12159351 Plasma proteins, Predicted secreted proteins Evidence at transcript level Tissue enriched Tissue enhanced adipose tissue: 138.3 cerebral cortex: 27.6 TINAG ENSG00000137251 Tubulointerstitial nephritis antigen 6 54307859-54390152 Enzymes, Predicted intracellular proteins Evidence at protein level HPA035427, HPA041055 Approved Approved Vesicles Liver cancer:2.05e-5 (unfavourable), Renal cancer:8.75e-5 (favourable) Tissue enhanced Tissue enriched 7 kidney: 112.9 small intestine: 16.0 TIPARP DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1 ENSG00000163659 TCDD-inducible poly(ADP-ribose) polymerase 3 156673235-156706770 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA036796, HPA049230 Uncertain Uncertain Nucleoplasm
Microtubules
Microtubule organizing center Breast cancer:2.00e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 228.1 TKTL2 DKFZP434L1717, FLJ32975 ENSG00000151005 Transketolase-like 2 4 163471093-163473746 Enzymes, Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 483 testis: 103.2 spleen: 0.2 TLCD1 ENSG00000160606 TLC domain containing 1 17 28724348-28727935 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA042366 Approved Renal cancer:9.05e-5 (unfavourable), Liver cancer:3.28e-4 (unfavourable) Expressed in all Mixed fallopian tube: 23.1 TLDC2 C20orf118, dJ132F21.2 ENSG00000101342 TBC/LysM-associated domain containing 2 20 36876121-36894235 Predicted intracellular proteins Evidence at protein level HPA047468 Approved Renal cancer:9.97e-5 (unfavourable) Tissue enhanced Mixed small intestine: 20.5 TLE6 FLJ14009, GRG6 ENSG00000104953 Transducin-like enhancer of split 6 19 2977446-2995184 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced thyroid gland: 9.7 placenta: 6.5 TLR7 ENSG00000196664 Toll-like receptor 7 X 12867083-12890380 FDA approved drug targets, Predicted membrane proteins Evidence at protein level HPA059613 Supported Mixed Mixed placenta: 9.1 TM2D2 BLP1 ENSG00000169490 TM2 domain containing 2 8 38988808-38996824 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA047152, HPA050547 Approved Approved Nucleoplasm
Vesicles
Plasma membrane Colorectal cancer:1.71e-4 (favourable), Breast cancer:7.49e-4 (unfavourable) Expressed in all Expressed in all testis: 51.1 TM2D3 BLP2, FLJ22604 ENSG00000184277 TM2 domain containing 3 15 101621444-101652391 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA054064 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Expressed in all cerebral cortex: 97.5 TM4SF18 L6D ENSG00000163762 Transmembrane 4 L six family member 18 3 149318498-149334414 Predicted membrane proteins Evidence at transcript level HPA053639, HPA069378 Approved Uncertain Nucleoli
Vesicles Liver cancer:8.63e-4 (favourable) Expressed in all Mixed spleen: 47.6 TM4SF19 ENSG00000145107 Transmembrane 4 L six family member 19 3 196319342-196338503 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Tissue enhanced Tissue enhanced testis: 11.3 esophagus,lung: 3.1 TM4SF20 FLJ22800, TCCE518 ENSG00000168955 Transmembrane 4 L six family member 20 2 227362156-227381995 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA051838, HPA063184, HPA065531 Uncertain Supported Plasma membrane
Focal adhesion sites Group enriched Group enriched 36 duodenum: 285.0;small intestine: 167.3 testis: 6.3 TM4SF5 ENSG00000142484 Transmembrane 4 L six family member 5 17 4771884-4783213 Predicted membrane proteins Evidence at protein level HPA055674 Uncertain Nucleoplasm
Plasma membrane
Cell Junctions Tissue enriched Group enriched 5 duodenum: 181.8;small intestine: 172.8 liver: 33.2 TM7SF2 ANG1, DHCR14A, NET47 ENSG00000149809 Transmembrane 7 superfamily member 2 11 65111845-65116384 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA030691, HPA072704 Approved Supported Endoplasmic reticulum
Vesicles Renal cancer:8.49e-8 (favourable) Expressed in all Expressed in all adrenal gland: 161.3 TM7SF3 ENSG00000064115 Transmembrane 7 superfamily member 3 12 26973195-27014434 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA041097, HPA057640 Uncertain Approved Nucleus
Cytosol Renal cancer:1.32e-4 (favourable) Expressed in all Expressed in all kidney: 189.4 TM9SF1 HMP70, MP70 ENSG00000100926 Transmembrane 9 superfamily member 1 14 24189143-24195687 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA059249 Supported Approved Golgi apparatus Lung cancer:2.04e-4 (unfavourable), Cervical cancer:8.94e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 71.2 TMC2 C20orf145, dJ686C3.3 ENSG00000149488 Transmembrane channel-like 2 20 2536607-2641784 Predicted membrane proteins Evidence at transcript level HPA046350 Uncertain Not detected Tissue enhanced testis: 1.0 lung: 0.8 TMC3 ENSG00000188869 Transmembrane channel-like 3 15 81331217-81374213 Predicted membrane proteins Evidence at protein level HPA040265, HPA040510 Approved Supported Cytosol Tissue enhanced Tissue enriched 79 parathyroid gland: 248.1 epididymis: 3.1 TMC5 FLJ13593 ENSG00000103534 Transmembrane channel-like 5 16 19410496-19499113 Predicted membrane proteins Evidence at protein level HPA040810, HPA042037 Approved Approved Nucleus
Plasma membrane Liver cancer:7.96e-4 (unfavourable) Mixed Tissue enhanced small intestine: 60.2 duodenum: 46.6 TMC6 EVER1, EVIN1, LAK-4P ENSG00000141524 Transmembrane channel-like 6 17 78110458-78132407 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA051430 Uncertain Stomach cancer:1.82e-4 (favourable), Urothelial cancer:3.20e-4 (favourable) Expressed in all Expressed in all spleen: 84.5 TMC7 FLJ21240 ENSG00000170537 Transmembrane channel-like 7 16 18983934-19063942 Predicted membrane proteins Evidence at protein level HPA029465 Uncertain Approved Vesicles Lung cancer:3.20e-4 (unfavourable), Pancreatic cancer:7.64e-4 (unfavourable), Urothelial cancer:9.20e-4 (favourable) Mixed Tissue enhanced testis: 17.7 cerebral cortex: 10.7 TMCC3 KIAA1145 ENSG00000057704 Transmembrane and coiled-coil domain family 3 12 94567124-94650562 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014272 Approved Approved Cytosol Endometrial cancer:4.87e-4 (unfavourable) Expressed in all Mixed placenta: 25.5 TMCO2 dJ39G22.2 ENSG00000188800 Transmembrane and coiled-coil domains 2 1 40245947-40251691 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 742 testis: 187.0 urinary bladder: 0.2 TMCO3 C13orf11, FLJ20623 ENSG00000150403 Transmembrane and coiled-coil domains 3 13 113490995-113554590 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039561, HPA048126 Uncertain Approved Cytosol Liver cancer:1.14e-5 (unfavourable), Urothelial cancer:4.10e-4 (unfavourable), Cervical cancer:5.80e-4 (unfavourable) Expressed in all Expressed in all cervix, uterine: 49.2 TMCO4 DKFZp686C23231 ENSG00000162542 Transmembrane and coiled-coil domains 4 1 19682213-19799945 Predicted membrane proteins Evidence at protein level HPA014601, HPA014620 Uncertain Approved Endoplasmic reticulum Renal cancer:4.12e-11 (favourable), Liver cancer:1.12e-4 (unfavourable), Urothelial cancer:3.64e-4 (favourable), Endometrial cancer:3.71e-4 (favourable) Expressed in all Mixed parathyroid gland: 36.3 TMCO5A MGC35118, TMCO5 ENSG00000166069 Transmembrane and coiled-coil domains 5A 15 37921939-37967724 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA056530 Supported Not detected Tissue enriched 177 testis: 122.1 fallopian tube: 0.6 TMED6 MGC23911, p24g5, p24gamma5 ENSG00000157315 Transmembrane p24 trafficking protein 6 16 69343248-69351809 Predicted membrane proteins Evidence at protein level HPA012532 Approved Endometrial cancer:7.74e-5 (favourable) Mixed Tissue enhanced fallopian tube: 35.5;pancreas: 61.2;stomach: 36.5 epididymis: 21.9 TMEM105 FLJ38792 ENSG00000185332 Transmembrane protein 105 17 81311270-81330674 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Mixed Mixed thyroid gland: 1.0 TMEM106A MGC20235 ENSG00000184988 Transmembrane protein 106A 17 43211835-43220041 Predicted membrane proteins Evidence at transcript level Colorectal cancer:9.61e-5 (unfavourable) Expressed in all Mixed kidney: 23.1 TMEM107 MGC10744 ENSG00000179029 Transmembrane protein 107 17 8173237-8176399 Predicted membrane proteins Evidence at transcript level HPA052555, HPA059653 Approved Approved Nucleoplasm
Midbody
Midbody ring
Cytosol Endometrial cancer:9.39e-5 (favourable) Expressed in all Mixed fallopian tube: 71.3 TMEM108 CT124, MGC3040 ENSG00000144868 Transmembrane protein 108 3 133038391-133397792 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA063350 Uncertain Approved Nucleoli
Vesicles
Cytosol Tissue enhanced Tissue enhanced testis: 25.8 cerebral cortex: 22.0 TMEM114 ENSG00000232258 Transmembrane protein 114 16 8537605-8590193 Disease related genes, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 62 seminal vesicle: 28.3 epididymis: 0.4 TMEM116 FLJ90167 ENSG00000198270 Transmembrane protein 116 12 111931282-112013185 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA040720 Approved Approved Nucleoplasm
Microtubules Renal cancer:1.08e-4 (favourable) Expressed in all Tissue enhanced parathyroid gland: 56.1 testis: 47.8 TMEM117 DKFZp434K2435 ENSG00000139173 Transmembrane protein 117 12 43835967-44389762 Predicted membrane proteins Evidence at transcript level HPA046223 Uncertain Melanoma:3.94e-4 (unfavourable) Expressed in all Mixed seminal vesicle: 7.2 TMEM121 hole, MGC4659 ENSG00000184986 Transmembrane protein 121 14 105526603-105530202 Predicted membrane proteins Evidence at transcript level HPA049857 Uncertain Approved Cytosol Thyroid cancer:5.87e-4 (unfavourable) Mixed Tissue enhanced cerebral cortex: 4.8 spleen: 2.4 TMEM125 MGC17299 ENSG00000179178 Transmembrane protein 125 1 43269994-43274002 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA015796 Approved Midbody
Cytosol Renal cancer:2.91e-9 (favourable), Lung cancer:5.11e-5 (favourable) Mixed Tissue enhanced lung: 113.9 thyroid gland: 51.5 TMEM130 DKFZp761L1417, FLJ42643 ENSG00000166448 Transmembrane protein 130 7 98846488-98870771 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA012928 Uncertain Supported Golgi apparatus Lung cancer:7.84e-4 (favourable) Tissue enhanced Group enriched 9 adrenal gland: 49.3;cerebral cortex: 183.7;testis: 70.8 epididymis: 11.5 TMEM132B KIAA1786, KIAA1906 ENSG00000139364 Transmembrane protein 132B 12 125186836-125662377 Predicted membrane proteins Evidence at protein level HPA035661, HPA035662 Uncertain Tissue enriched Tissue enriched 7 cerebral cortex: 21.9 thyroid gland: 3.1 TMEM132C DKFZp761O2018, PPP1R152 ENSG00000181234 Transmembrane protein 132C 12 128267403-128707915 Predicted membrane proteins Evidence at protein level HPA015633, HPA015984 Uncertain Supported Centrosome
Cytosol Tissue enhanced Tissue enhanced adipose tissue: 34.7;cervix, uterine: 23.9 fallopian tube: 15.8 TMEM133 AD031 ENSG00000170647 Transmembrane protein 133 11 100991989-100993941 Predicted membrane proteins Evidence at protein level HPA060528, HPA065742 Uncertain Approved Endoplasmic reticulum
Golgi apparatus Pancreatic cancer:1.76e-4 (unfavourable) Expressed in all Mixed placenta: 18.2 TMEM134 FLJ21749 ENSG00000172663 Transmembrane protein 134 11 67461710-67469272 Predicted membrane proteins Evidence at protein level HPA043744 Approved Supported Cytosol Expressed in all Expressed in all skin: 38.4 TMEM135 FLJ22104 ENSG00000166575 Transmembrane protein 135 11 87037844-87323758 Predicted membrane proteins Evidence at protein level HPA056685, HPA069473 Uncertain Supported Vesicles Renal cancer:9.02e-4 (favourable) Expressed in all Expressed in all adipose tissue: 31.8 TMEM136 MGC17839 ENSG00000181264 Transmembrane protein 136 11 120325129-120333682 Predicted membrane proteins Evidence at transcript level HPA074432 Approved Vesicles
Cytosol Endometrial cancer:6.65e-4 (unfavourable) Expressed in all Mixed adrenal gland: 12.7 TMEM143 FLJ10922 ENSG00000161558 Transmembrane protein 143 19 48332356-48364237 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014476 Uncertain Approved Nucleoli fibrillar center Renal cancer:1.53e-7 (favourable) Expressed in all Tissue enhanced skeletal muscle: 32.5 heart muscle: 15.9 TMEM144 FLJ11155 ENSG00000164124 Transmembrane protein 144 4 158201604-158255411 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA043767, HPA063554 Uncertain Approved Mitochondria Endometrial cancer:2.89e-4 (favourable), Pancreatic cancer:8.48e-4 (unfavourable) Mixed Tissue enhanced cerebral cortex: 90.8 testis: 46.6 TMEM145 FLJ90805 ENSG00000167619 Transmembrane protein 145 19 42313325-42325062 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA060462 Supported Approved Vesicles Tissue enhanced Tissue enriched 6 cerebral cortex: 38.4 adrenal gland: 6.0 TMEM14EP TMEM14E ENSG00000221962 Transmembrane protein 14E, pseudogene 3 152340527-152340904 Predicted membrane proteins Evidence at transcript level HPA014550 Uncertain Not detected Tissue enhanced skin: 1.0 bone marrow: 0.9 TMEM150B TMEM224 ENSG00000180061 Transmembrane protein 150B 19 55312801-55334048 Predicted membrane proteins Evidence at transcript level Renal cancer:6.14e-6 (unfavourable) Tissue enhanced Tissue enhanced duodenum: 71.8;small intestine: 67.8 lung: 18.9 TMEM150C FLJ12993 ENSG00000249242 Transmembrane protein 150C 4 82483170-82562357 Predicted membrane proteins Evidence at protein level HPA052921 Supported Renal cancer:4.59e-6 (favourable), Pancreatic cancer:5.68e-4 (favourable), Head and neck cancer:7.87e-4 (favourable) Expressed in all Tissue enhanced epididymis: 179.7 ovary: 43.5 TMEM151A MGC33486, TMEM151 ENSG00000179292 Transmembrane protein 151A 11 66291870-66296664 Predicted membrane proteins Evidence at transcript level HPA041035 Uncertain Approved Nucleoli
Cytosol Tissue enhanced Tissue enriched 24 cerebral cortex: 45.4 adrenal gland: 1.8 TMEM151B bA444E17.5, C6orf137, TMEM193 ENSG00000178233 Transmembrane protein 151B 6 44270466-44307506 Predicted membrane proteins Evidence at transcript level HPA055167 Uncertain Tissue enhanced Tissue enriched 10 cerebral cortex: 40.1 adrenal gland: 4.0 TMEM154 FLJ32028 ENSG00000170006 Transmembrane protein 154 4 152618632-152680165 Predicted membrane proteins Evidence at protein level HPA019184, HPA055411 Uncertain Approved Nucleoplasm
Nuclear membrane Mixed Tissue enhanced esophagus: 64.6;skin: 69.4 tonsil: 25.3 TMEM155 FLJ30834 ENSG00000164112 Transmembrane protein 155 4 121758933-121765427 Predicted secreted proteins Evidence at transcript level Mixed Group enriched 5 cerebral cortex: 27.7;placenta: 5.7 lymph node: 3.0 TMEM156 FLJ23235 ENSG00000121895 Transmembrane protein 156 4 38966744-39032922 Predicted membrane proteins Evidence at transcript level Breast cancer:4.09e-4 (favourable) Mixed Group enriched 6 appendix: 12.2;lymph node: 28.1;spleen: 15.4;tonsil: 25.3;urinary bladder: 5.9 gallbladder: 3.1 TMEM158 p40BBp, RIS1 ENSG00000249992 Transmembrane protein 158 (gene/pseudogene) 3 45224466-45226278 Predicted membrane proteins Evidence at transcript level Renal cancer:5.42e-9 (unfavourable), Prostate cancer:6.43e-5 (favourable) Mixed Tissue enhanced endometrium: 32.5;seminal vesicle: 31.8 smooth muscle: 25.4 TMEM161A FLJ20422, FLJ39645 ENSG00000064545 Transmembrane protein 161A 19 19119169-19138513 Predicted membrane proteins Evidence at protein level HPA043365 Approved Approved Cytosol Stomach cancer:2.99e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 20.9 TMEM161B MGC33214 ENSG00000164180 Transmembrane protein 161B 5 88189633-88269476 Predicted membrane proteins Evidence at protein level HPA044562 Uncertain Expressed in all Expressed in all parathyroid gland: 58.9 TMEM163 DKFZP566N034, SV31 ENSG00000152128 Transmembrane protein 163 2 134455759-134719000 Predicted membrane proteins, Transporters Evidence at protein level HPA007224 Uncertain Urothelial cancer:3.15e-4 (favourable), Lung cancer:7.94e-4 (favourable) Mixed Mixed lung: 21.5 TMEM164 FLJ22679, RP13-360B22.2 ENSG00000157600 Transmembrane protein 164 X 110002631-110182734 Predicted membrane proteins Evidence at protein level HPA038784 Approved Approved Vesicles
Cell Junctions Liver cancer:8.17e-6 (unfavourable), Stomach cancer:3.14e-4 (favourable) Expressed in all Expressed in all lung: 26.7 TMEM168 DKFZp564C012, FLJ13576 ENSG00000146802 Transmembrane protein 168 7 112762382-112790592 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA020389 Approved Lung cancer:4.07e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 43.5 TMEM169 FLJ34263 ENSG00000163449 Transmembrane protein 169 2 216081866-216102783 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA070657 Uncertain Approved Focal adhesion sites Mixed Tissue enhanced cerebral cortex: 12.0 thyroid gland: 4.8 TMEM17 FLJ34583 ENSG00000186889 Transmembrane protein 17 2 62500221-62511894 Predicted membrane proteins Evidence at protein level HPA018100 Uncertain Approved Actin filaments Expressed in all Mixed testis: 8.1 TMEM170A FLJ37611, TMEM170 ENSG00000166822 Transmembrane protein 170A 16 75443054-75465497 Predicted membrane proteins Evidence at transcript level HPA055071 Uncertain Renal cancer:2.36e-9 (favourable) Expressed in all Expressed in all testis: 32.6 TMEM176A HCA112, MS4B1 ENSG00000002933 Transmembrane protein 176A 7 150800403-150805120 Predicted membrane proteins Evidence at protein level HPA008770 Approved Approved Mitochondria Expressed in all Expressed in all liver: 579.4 TMEM177 MGC10993 ENSG00000144120 Transmembrane protein 177 2 119679167-119686507 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA036689, HPA053816 Uncertain Approved Nucleus
Nucleoli fibrillar center Expressed in all Mixed duodenum: 16.9 TMEM178A MGC33926, TMEM178 ENSG00000152154 Transmembrane protein 178A 2 39664982-39717963 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level HPA052128, HPA058560 Uncertain Approved Nucleus
Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 55.6 kidney: 19.1 TMEM178B DKFZp547G036 ENSG00000261115 Transmembrane protein 178B 7 141074232-141480380 Predicted membrane proteins Evidence at protein level HPA048771 Uncertain Uncertain Nucleoli
Vesicles Renal cancer:4.10e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 19.4;parathyroid gland: 28.5;thyroid gland: 14.3 heart muscle: 7.4 TMEM179 C14orf90, FLJ42486, TMEM179A ENSG00000258986 Transmembrane protein 179 14 104474678-104605647 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA002942 Uncertain Mitochondria Mixed Group enriched 8 adrenal gland: 14.7;cerebral cortex: 28.0 testis: 2.5 TMEM180 bA18I14.8, C10orf77, FLJ22529 ENSG00000138111 Transmembrane protein 180 10 102461395-102477045 Predicted membrane proteins, Transporters Evidence at protein level HPA018031 Uncertain Approved Golgi apparatus
Cytosol Cervical cancer:8.29e-4 (favourable), Renal cancer:8.51e-4 (unfavourable) Expressed in all Mixed skin: 8.8 TMEM184A MGC9712 ENSG00000164855 Transmembrane protein 184A 7 1542235-1560821 Predicted membrane proteins Evidence at protein level HPA053790, HPA071312 Uncertain Approved Nucleoplasm Colorectal cancer:1.12e-4 (unfavourable), Thyroid cancer:9.94e-4 (unfavourable) Mixed Tissue enhanced skin: 33.5 esophagus: 26.7 TMEM184C FLJ10846, TMEM34 ENSG00000164168 Transmembrane protein 184C 4 147617383-147672044 Predicted membrane proteins Evidence at protein level HPA054013 Uncertain Approved Nucleoplasm
Vesicles Renal cancer:2.31e-7 (favourable), Pancreatic cancer:6.37e-4 (unfavourable) Expressed in all Group enriched 5 parathyroid gland: 253.7;thyroid gland: 54.5 placenta: 28.5 TMEM186 C16orf51, DKFZP564K2062 ENSG00000184857 Transmembrane protein 186 16 8780384-8797648 Predicted membrane proteins Evidence at protein level HPA018226, HPA063559 Uncertain Approved Cell Junctions Renal cancer:1.93e-8 (favourable) Expressed in all Expressed in all parathyroid gland: 22.5 TMEM187 CXorf12, DXS9878E, ITBA1 ENSG00000177854 Transmembrane protein 187 X 153972327-153983195 Predicted membrane proteins Evidence at transcript level HPA038134 Uncertain Approved Nucleoli
Cytosol Renal cancer:9.14e-8 (favourable) Expressed in all Expressed in all fallopian tube: 11.2 TMEM196 MGC42090 ENSG00000173452 Transmembrane protein 196 7 19719310-19773598 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA043163 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 9.2 endometrium: 2.1 TMEM200B TTMB ENSG00000253304 Transmembrane protein 200B 1 29119428-29123935 Predicted membrane proteins Evidence at transcript level HPA055254 Uncertain Mixed Tissue enhanced endometrium: 68.0 seminal vesicle: 52.6 TMEM200C TTMA ENSG00000206432 Transmembrane protein 200C 18 5882072-5895955 Predicted membrane proteins Evidence at protein level HPA047253, HPA050490 Uncertain Approved Microtubules Tissue enhanced Tissue enhanced adrenal gland: 3.1;cerebral cortex: 3.5 salivary gland: 1.8 TMEM204 C16orf30, CLP24, FLJ20898 ENSG00000131634 Transmembrane protein 204 16 1528688-1555580 Predicted membrane proteins Evidence at transcript level HPA014028 Approved Liver cancer:4.76e-4 (favourable), Melanoma:7.89e-4 (unfavourable) Expressed in all Mixed adipose tissue: 40.6 TMEM211 bA9F11.1 ENSG00000206069 Transmembrane protein 211 22 24935110-24946695 Predicted membrane proteins Evidence at transcript level HPA066784 Uncertain Tissue enhanced Tissue enhanced cervix, uterine: 4.5;stomach: 3.4 salivary gland: 1.9 TMEM212 FLJ23172 ENSG00000186329 Transmembrane protein 212 3 171843349-171938715 Predicted membrane proteins Evidence at transcript level HPA045736, HPA053134 Uncertain Approved Nucleoli fibrillar center
Endoplasmic reticulum Not detected Tissue enriched 6 fallopian tube: 47.9 lung: 7.7 TMEM215 ENSG00000188133 Transmembrane protein 215 9 32783499-32787399 Predicted membrane proteins Evidence at transcript level HPA052804 Uncertain Tissue enriched Group enriched 5 cervix, uterine: 1.0;endometrium: 4.8;testis: 4.2;thyroid gland: 1.8 cerebral cortex: 0.5 TMEM217 C6orf128, dJ355M6.2 ENSG00000172738 Transmembrane protein 217 6 37212180-37258155 Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 14 testis: 14.1 adrenal gland: 1.0 TMEM220 ENSG00000187824 Transmembrane protein 220 17 10699015-10730316 Predicted membrane proteins Evidence at protein level Liver cancer:2.23e-5 (favourable), Pancreatic cancer:1.72e-4 (favourable), Glioma:9.39e-4 (unfavourable) Expressed in all Expressed in all liver: 53.9 TMEM225 PMP22CD, PPP1R154 ENSG00000204300 Transmembrane protein 225 11 123882926-123885642 Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 395 testis: 39.4 all non-specific tissues: 0.0 TMEM229A ENSG00000234224 Transmembrane protein 229A 7 124030916-124033023 Predicted membrane proteins Evidence at protein level HPA056391 Uncertain Approved Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 7.1;duodenum: 8.9;testis: 10.4 small intestine: 4.4 TMEM229B C14orf83, FLJ33387 ENSG00000198133 Transmembrane protein 229B 14 67447084-67533739 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA046562 Approved Endometrial cancer:1.21e-5 (favourable), Urothelial cancer:1.79e-5 (favourable), Breast cancer:5.38e-4 (favourable) Expressed in all Mixed duodenum: 16.2 TMEM232 FLJ43080 ENSG00000186952 Transmembrane protein 232 5 110289233-110738956 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA049386 Uncertain Not detected Tissue enhanced fallopian tube: 26.1;testis: 35.3 thyroid gland: 7.3 TMEM235 ENSG00000204278 Transmembrane protein 235 17 78231310-78240987 Predicted membrane proteins Evidence at transcript level HPA053939 Uncertain Tissue enriched Tissue enriched 101 cerebral cortex: 15.7 placenta,testis: 0.1 TMEM236 bA162I21.2, bA16O1.2, FAM23A, FAM23B ENSG00000148483 Transmembrane protein 236 10 17752252-17800868 Predicted membrane proteins Evidence at transcript level Tissue enhanced Group enriched 9 colon: 14.7;duodenum: 22.7;rectum: 15.8;small intestine: 38.4 appendix: 2.4 TMEM241 C18orf45, FLJ44259, MGC11386 ENSG00000134490 Transmembrane protein 241 18 23197144-23437961 Predicted membrane proteins Evidence at protein level HPA029489, HPA059922 Uncertain Approved Golgi apparatus
Vesicles Urothelial cancer:5.80e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 4.3 TMEM249 C8orfK29 ENSG00000261587 Transmembrane protein 249 8 144352219-144354914 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Not detected Tissue enriched 27 testis: 9.4 epididymis: 0.3 TMEM251 C14orf109, DKFZP564F1123 ENSG00000153485 Transmembrane protein 251 14 93184951-93187089 Predicted membrane proteins Evidence at transcript level HPA048559 Uncertain Approved Golgi apparatus
Cell Junctions Liver cancer:6.14e-7 (unfavourable), Renal cancer:1.10e-4 (favourable) Expressed in all Expressed in all prostate: 27.9 TMEM252 C9orf71, MGC34760 ENSG00000181778 Transmembrane protein 252 9 68536580-68540867 Predicted membrane proteins Evidence at transcript level Renal cancer:1.75e-7 (favourable) Tissue enriched Tissue enhanced kidney: 37.5;small intestine: 26.2 seminal vesicle: 15.4 TMEM255A FAM70A, FLJ20716 ENSG00000125355 Transmembrane protein 255A X 120258650-120311556 Predicted membrane proteins Evidence at transcript level HPA048470 Uncertain Uncertain Nucleus
Nuclear bodies Group enriched Tissue enhanced ovary: 23.4 cervix, uterine: 10.4 TMEM255B FAM70B, MGC20579 ENSG00000184497 Transmembrane protein 255B 13 113759240-113816995 Predicted membrane proteins Evidence at protein level HPA043334 Approved Approved Nucleoplasm Renal cancer:4.12e-5 (unfavourable) Expressed in all Mixed lung: 8.3 TMEM257 CXorf1 ENSG00000221870 Transmembrane protein 257 X 145827410-145829850 Predicted membrane proteins Evidence at transcript level Tissue enriched Tissue enriched 10 cerebral cortex: 4.2 seminal vesicle: 0.4 TMEM260 C14orf101, FLJ20392 ENSG00000070269 Transmembrane protein 260 14 56488354-56650606 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA003502 Uncertain Approved Nucleus
Focal adhesion sites
Cytosol Lung cancer:7.11e-4 (favourable) Expressed in all Tissue enhanced cervix, uterine: 63.2 thyroid gland: 14.0 TMEM266 C15orf27, FLJ38190 ENSG00000169758 Transmembrane protein 266 15 76059837-76229121 Predicted membrane proteins Evidence at protein level HPA041921 Uncertain Supported Plasma membrane
Cytosol Tissue enhanced Tissue enhanced cerebral cortex: 1.9;skeletal muscle: 1.5 placenta: 1.1 TMEM35 FLJ14084 ENSG00000126950 Transmembrane protein 35 X 101078720-101096364 Predicted membrane proteins Evidence at protein level HPA048583 Supported Tissue enhanced Tissue enhanced cerebral cortex: 42.5;seminal vesicle: 64.8 prostate: 34.0 TMEM37 PR, PR1 ENSG00000171227 Transmembrane protein 37 2 119429901-119438520 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA053794 Approved Approved Nucleus
Nucleoli fibrillar center
Cytosol Expressed in all Mixed kidney: 107.7 TMEM39A FLJ10902 ENSG00000176142 Transmembrane protein 39A 3 119429500-119468830 Predicted membrane proteins Evidence at protein level HPA039140 Approved Approved Nucleoplasm
Vesicles Renal cancer:1.00e-5 (unfavourable), Liver cancer:3.26e-4 (unfavourable) Expressed in all Expressed in all cervix, uterine: 32.9 TMEM39B FLJ10315 ENSG00000121775 Transmembrane protein 39B 1 32072031-32102866 Predicted membrane proteins Evidence at protein level HPA040191, HPA040224 Approved Approved Vesicles Renal cancer:5.11e-9 (unfavourable), Liver cancer:2.82e-6 (unfavourable), Endometrial cancer:3.00e-4 (unfavourable) Expressed in all Mixed cervix, uterine: 9.7 TMEM42 MGC29956 ENSG00000169964 Transmembrane protein 42 3 44861869-44865670 Predicted membrane proteins Evidence at transcript level HPA052569 Uncertain Renal cancer:1.10e-5 (favourable), Breast cancer:5.23e-4 (favourable) Expressed in all Expressed in all epididymis: 12.5 TMEM44 DKFZp686O18124 ENSG00000145014 Transmembrane protein 44 3 194587673-194633689 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA043718 Uncertain Approved Cytosol Renal cancer:6.55e-13 (unfavourable) Expressed in all Mixed epididymis: 15.8 TMEM45A DERP7, FLJ10134 ENSG00000181458 Transmembrane protein 45A 3 100492619-100577444 Predicted membrane proteins Evidence at protein level HPA024082, HPA062101 Uncertain Approved Intermediate filaments
Microtubules Renal cancer:6.18e-11 (unfavourable), Lung cancer:7.42e-4 (unfavourable) Expressed in all Tissue enriched 10 skin: 563.8 placenta: 58.1 TMEM52 ENSG00000178821 Transmembrane protein 52 1 1917590-1919273 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Mixed Tissue enhanced pancreas: 38.8;skeletal muscle: 105.7 adrenal gland: 24.5 TMEM52B C12orf59, FLJ31166 ENSG00000165685 Transmembrane protein 52B 12 10170542-10191801 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA058096 Supported Approved Focal adhesion sites Tissue enriched Tissue enriched 21 kidney: 182.6 placenta: 8.7 TMEM53 FLJ22353, NET4 ENSG00000126106 Transmembrane protein 53 1 44635238-44674555 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA021134 Approved Approved Golgi apparatus
Focal adhesion sites Renal cancer:1.02e-5 (favourable), Ovarian cancer:6.96e-4 (favourable) Expressed in all Mixed testis: 23.3 TMEM54 CAC-1 ENSG00000121900 Transmembrane protein 54 1 32894594-32901438 Predicted membrane proteins Evidence at transcript level HPA061992 Approved Vesicles Liver cancer:3.08e-4 (unfavourable) Expressed in all Mixed colon: 226.8 TMEM59L BSMAP, C19orf4 ENSG00000105696 Transmembrane protein 59-like 19 18607430-18621039 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA010661, HPA070701 Approved Approved Nucleoplasm
Actin filaments Endometrial cancer:1.62e-4 (unfavourable), Pancreatic cancer:8.80e-4 (favourable) Tissue enriched Tissue enriched 16 cerebral cortex: 367.2 adrenal gland: 22.3 TMEM60 C7orf35, DC32 ENSG00000135211 Transmembrane protein 60 7 77793728-77798580 Predicted membrane proteins Evidence at transcript level HPA062625 Approved Breast cancer:3.09e-4 (favourable), Glioma:8.70e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 55.3 TMEM61 ENSG00000143001 Transmembrane protein 61 1 54980792-54992293 Predicted membrane proteins Evidence at transcript level HPA030614 Uncertain Renal cancer:1.78e-7 (favourable), Colorectal cancer:1.07e-4 (favourable) Mixed Tissue enhanced parathyroid gland: 11.0;salivary gland: 10.2 seminal vesicle: 8.1 TMEM63C C14orf171, CSC1, DKFZp434P0111, hsCSC1 ENSG00000165548 Transmembrane protein 63C 14 77116568-77259495 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA030657 Uncertain Approved Centrosome Mixed Tissue enhanced adrenal gland: 12.9;cerebral cortex: 18.6;testis: 13.8 epididymis: 5.5 TMEM64 DKFZp762C1112 ENSG00000180694 Transmembrane protein 64 8 90621995-90791632 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level CAB034221 Uncertain Expressed in all Expressed in all epididymis: 173.0 TMEM68 FLJ32370 ENSG00000167904 Transmembrane protein 68 8 55696424-55773407 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA018216, HPA019173 Uncertain Approved Vesicles Expressed in all Expressed in all fallopian tube: 36.6 TMEM69 C1orf154, FLJ21029 ENSG00000159596 Transmembrane protein 69 1 45687214-45694443 Predicted membrane proteins Evidence at transcript level HPA026993 Approved Approved Nucleoplasm Liver cancer:3.66e-8 (unfavourable), Breast cancer:2.24e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 21.9 TMEM71 FLJ33069 ENSG00000165071 Transmembrane protein 71 8 132685007-132760712 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA058401, HPA070655 Uncertain Validated Mitochondria Mixed Mixed bone marrow,heart muscle: 24.2 TMEM72 bA285G1.3, C10orf127, KSP37 ENSG00000187783 Transmembrane protein 72 10 44911200-44937002 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039894, HPA062907 Supported Renal cancer:1.01e-4 (favourable) Tissue enriched Tissue enriched 7 kidney: 54.0 rectum: 8.0 TMEM74B C20orf46, FLJ11190 ENSG00000125895 Transmembrane protein 74B 20 1180561-1185415 Predicted membrane proteins Evidence at transcript level HPA045213 Approved Approved Nucleoplasm
Golgi apparatus Renal cancer:2.55e-7 (unfavourable), Pancreatic cancer:3.07e-5 (favourable) Mixed Mixed small intestine: 28.0 TMEM78 FLJ40168 ENSG00000177800 Transmembrane protein 78 1 229249636-229251810 Predicted membrane proteins Evidence at transcript level HPA042351 Uncertain Not detected Not detected epididymis: 0.5 TMEM80 FLJ38216 ENSG00000177042 Transmembrane protein 80 11 695428-705028 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA059592, HPA067046 Uncertain Approved Golgi apparatus Renal cancer:2.47e-4 (favourable) Expressed in all Expressed in all thyroid gland: 43.4 TMEM81 HC3107, KVLA2788, MGC75217, UNQ2788 ENSG00000174529 Transmembrane protein 81 1 205083129-205084460 Predicted membrane proteins Evidence at protein level HPA052515 Approved Intermediate filaments Renal cancer:6.65e-9 (unfavourable), Liver cancer:3.25e-6 (unfavourable), Urothelial cancer:2.67e-4 (favourable) Expressed in all Mixed testis: 6.7 TMEM82 ENSG00000162460 Transmembrane protein 82 1 15742422-15747982 Predicted membrane proteins Evidence at protein level HPA060282 Uncertain Renal cancer:3.80e-7 (favourable) Tissue enhanced Tissue enhanced duodenum: 23.7;liver: 9.0;small intestine: 19.8 kidney: 7.6 TMEM86A FLJ90119 ENSG00000151117 Transmembrane protein 86A 11 18693122-18704785 Predicted membrane proteins Evidence at transcript level HPA057119 Uncertain Expressed in all Mixed skin: 13.3 TMEM89 ENSG00000183396 Transmembrane protein 89 3 48620759-48621855 Predicted membrane proteins Evidence at protein level HPA053577 Uncertain Not detected Tissue enriched 10 testis: 9.4 bone marrow: 0.9 TMEM91 FLJ27310, IFITMD6 ENSG00000142046 Transmembrane protein 91 19 41350911-41384083 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA053240 Uncertain Renal cancer:3.52e-7 (unfavourable), Pancreatic cancer:3.54e-5 (favourable) Expressed in all Expressed in all skin: 31.0 TMEM92 FLJ33318 ENSG00000167105 Transmembrane protein 92 17 50271406-50281485 Predicted membrane proteins Evidence at protein level HPA063009, HPA069820 Approved Supported Nucleoplasm Renal cancer:1.14e-6 (unfavourable), Head and neck cancer:8.35e-4 (unfavourable) Mixed Tissue enhanced duodenum: 41.4;small intestine: 51.6 gallbladder: 21.9 TMEM95 MGC129793, UNQ9390 ENSG00000182896 Transmembrane protein 95 17 7355123-7357219 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 48 testis: 9.9 gallbladder: 0.2 TMEM99 MGC21518 ENSG00000167920 Transmembrane protein 99 17 40819106-40836274 Predicted membrane proteins Evidence at transcript level HPA076359 Approved Cytosol Expressed in all Tissue enhanced testis: 175.7 epididymis: 52.1 TMIGD1 TMIGD, UNQ9372 ENSG00000182271 Transmembrane and immunoglobulin domain containing 1 17 30316333-30334059 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA021946 Approved Mitochondria Tissue enhanced Group enriched 24 colon: 83.2;rectum: 111.5;small intestine: 165.6 kidney: 5.0 TMIGD3 AD026 ENSG00000121933 Transmembrane and immunoglobulin domain containing 3 1 111483348-111563962 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Breast cancer:3.58e-4 (unfavourable) Tissue enriched Tissue enriched 15 testis: 98.4 placenta: 6.5 TMOD4 Sk-Tmod ENSG00000163157 Tropomodulin 4 (muscle) 1 151169986-151176284 Predicted intracellular proteins Evidence at protein level HPA028203 Supported Not detected Tissue enriched 30 skeletal muscle: 378.9 esophagus: 12.6 TMPPE FLJ45032 ENSG00000188167 Transmembrane protein with metallophosphoesterase domain 3 33090421-33096801 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA027019 Uncertain Approved Nucleoplasm
Mitochondria Mixed Mixed parathyroid gland: 4.0 TMPRSS11B ENSG00000185873 Transmembrane protease, serine 11B 4 68226653-68245720 Enzymes, Predicted membrane proteins Evidence at protein level Head and neck cancer:6.91e-4 (favourable) Group enriched Group enriched 169 esophagus: 312.7;tonsil: 77.9 cervix, uterine: 1.1 TMPRSS11F FLJ16046 ENSG00000198092 Transmembrane protease, serine 11F 4 68053198-68129880 Enzymes, Predicted membrane proteins Evidence at transcript level HPA026911 Uncertain Group enriched Group enriched 7 esophagus: 16.8;skin: 11.0;tonsil: 3.8 breast: 1.5 TMPRSS13 MSPL, TMPRSS11 ENSG00000137747 Transmembrane protease, serine 13 11 117900643-117929459 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Mixed Tissue enhanced skin: 35.1 cervix, uterine,esophagus: 10.0 TMPRSS7 ENSG00000176040 Transmembrane protease, serine 7 3 112034843-112081269 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA040630 Uncertain Not detected Tissue enhanced testis: 2.5 fallopian tube: 0.5 TMTC2 DKFZp762A217 ENSG00000179104 Transmembrane and tetratricopeptide repeat containing 2 12 82686880-83134870 Predicted membrane proteins Evidence at protein level HPA026954, HPA026955 Uncertain Approved Actin filaments
Cytosol Renal cancer:2.84e-5 (favourable) Mixed Mixed cerebral cortex: 16.4 TMTC4 FLJ14624, FLJ22153 ENSG00000125247 Transmembrane and tetratricopeptide repeat containing 4 13 100603927-100675093 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA016489 Uncertain Approved Vesicles Expressed in all Expressed in all cerebral cortex: 26.5 TNFAIP2 B94, EXOC3L3 ENSG00000185215 Tumor necrosis factor, alpha-induced protein 2 14 103123442-103137439 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level CAB004598, HPA030624 Supported Approved Nucleus
Nuclear membrane
Golgi apparatus
Cytosol Stomach cancer:2.79e-5 (favourable), Urothelial cancer:7.17e-5 (favourable), Renal cancer:4.10e-4 (unfavourable) Expressed in all Expressed in all urinary bladder: 211.4 TNFSF8 CD153, CD30LG ENSG00000106952 Tumor necrosis factor (ligand) superfamily, member 8 9 114893343-114930595 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced lymph node: 34.8;tonsil: 27.8 appendix: 25.1 TOMM20L UNQ9438 ENSG00000196860 Translocase of outer mitochondrial membrane 20 homolog (yeast)-like 14 58395916-58408701 Predicted membrane proteins Evidence at transcript level HPA044997 Uncertain Mixed Tissue enriched 10 testis: 13.1 parathyroid gland: 1.3 TOPAZ1 C3orf77, FLJ36157 ENSG00000173769 Testis and ovary specific PAZ domain containing 1 3 44241886-44332098 Predicted intracellular proteins Evidence at protein level HPA047431, HPA051034 Uncertain Not detected Tissue enriched 65 testis: 6.5 all non-specific tissues: 0.0 TOR2A FLJ14771, TORP1 ENSG00000160404 Torsin family 2, member A 9 127731524-127735317 Predicted secreted proteins Evidence at protein level Stomach cancer:7.51e-4 (favourable) Expressed in all Mixed bone marrow: 16.6 TOX KIAA0808, TOX1 ENSG00000198846 Thymocyte selection-associated high mobility group box 8 58805418-59119208 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018322, HPA073241 Supported Approved Nucleus
Nucleoli fibrillar center Renal cancer:1.90e-7 (unfavourable), Lung cancer:5.20e-4 (favourable) Expressed in all Mixed lymph node: 21.3 TOX2 C20orf100, dJ1108D11.2, GCX-1 ENSG00000124191 TOX high mobility group box family member 2 20 43914864-44069616 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049900, HPA058396 Approved Supported Nucleoplasm Renal cancer:7.45e-8 (unfavourable), Endometrial cancer:2.60e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 19.5 TP53AIP1 p53AIP1 ENSG00000120471 Tumor protein p53 regulated apoptosis inducing protein 1 11 128934731-128943399 Predicted intracellular proteins Evidence at transcript level HPA044300, HPA048797 Approved Tissue enhanced Tissue enhanced esophagus: 6.3;skin: 22.2 fallopian tube: 4.0 TP53I13 DSCP1 ENSG00000167543 Tumor protein p53 inducible protein 13 17 29566052-29573157 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Renal cancer:2.10e-6 (unfavourable), Pancreatic cancer:3.13e-5 (favourable) Expressed in all Expressed in all spleen: 54.3 TP53TG3 P53TG3, TP53TG3A ENSG00000183632 TP53 target 3 16 32673528-32676732 Predicted intracellular proteins Evidence at transcript level Not detected Not detected placenta: 0.4 TP53TG3B ENSG00000261509 TP53 target 3B 16 33360274-33363478 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 15 epididymis: 21.9 testis: 1.4 TP53TG3C ENSG00000205457 TP53 target 3C 16 33193659-33306938 Predicted intracellular proteins Evidence at transcript level Not detected Group enriched 28 epididymis: 5.5;testis: 3.3 adrenal gland,placenta: 0.1 TP53TG3D ENSG00000205456 TP53 target 3D 16 32252719-32255922 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enhanced epididymis: 4.4;testis: 4.7 placenta: 1.2 TPGS1 C19orf20, GTRGEO22, PGs1 ENSG00000141933 Tubulin polyglutamylase complex subunit 1 19 507497-519654 Predicted intracellular proteins Evidence at protein level Endometrial cancer:2.24e-4 (favourable), Pancreatic cancer:8.82e-4 (favourable) Expressed in all Mixed cerebral cortex: 6.6 TPGS2 C18orf10, DKFZP586M1523, HsT3006 ENSG00000134779 Tubulin polyglutamylase complex subunit 2 18 36777647-36829216 Predicted intracellular proteins Evidence at protein level HPA040596, HPA040617, HPA061753 Uncertain Supported Nucleoli Liver cancer:1.24e-5 (unfavourable), Ovarian cancer:1.93e-5 (favourable), Cervical cancer:4.09e-4 (favourable), Testis cancer:7.74e-4 (favourable) Expressed in all Expressed in all testis: 364.7 TPRA1 FLJ32197, GPR175, TMEM227, TPRA40 ENSG00000163870 Transmembrane protein, adipocyte asscociated 1 3 127573069-127598251 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA019784 Approved Approved Vesicles Liver cancer:6.46e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 38.1 TPRG1 FAM79B, FLJ41238, FLJ43694 ENSG00000188001 Tumor protein p63 regulated 1 3 188947214-189325304 Predicted intracellular proteins Evidence at protein level HPA044751, HPA060187 Uncertain Supported Nucleoplasm Breast cancer:5.43e-4 (favourable) Tissue enhanced Tissue enhanced esophagus: 49.2 breast: 29.2 TPRX1 FLJ40321 ENSG00000178928 Tetra-peptide repeat homeobox 1 19 47801243-47819051 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044922 Uncertain Not detected Tissue enriched 13 testis: 1.3 all non-specific tissues: 0.0 TPSD1 ENSG00000095917 Tryptase delta 1 16 1256059-1258998 Enzymes, Predicted secreted proteins Evidence at protein level CAB002215, CAB032871, HPA040182, HPA049554 Supported Mixed Tissue enhanced lung: 26.9 gallbladder: 20.5 TPSG1 PRSS31, TMT ENSG00000116176 Tryptase gamma 1 16 1221651-1225257 Enzymes, Predicted membrane proteins Evidence at transcript level HPA060458 Approved Renal cancer:1.76e-8 (unfavourable) Tissue enhanced Tissue enhanced colon: 15.2;duodenum: 14.7;small intestine: 10.7 rectum: 9.8 TPST1 TANGO13A ENSG00000169902 Tyrosylprotein sulfotransferase 1 7 66205199-66420543 Enzymes, Predicted secreted proteins Evidence at protein level HPA047415 Approved Approved Cytosol Renal cancer:8.16e-6 (unfavourable), Urothelial cancer:3.73e-5 (unfavourable), Stomach cancer:8.78e-4 (unfavourable) Expressed in all Mixed gallbladder: 55.8 TPTE CT44, PTEN2 ENSG00000274391 Transmembrane phosphatase with tensin homology 21 10521553-10606140 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA049690, HPA068342 Supported Approved Endoplasmic reticulum
Cytosol Tissue enriched Tissue enriched 225 testis: 198.9 epididymis,placenta: 0.8 TRABD2A C2orf89, TIKI1 ENSG00000186854 TraB domain containing 2A 2 84821650-84907008 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA045817 Approved Group enriched Tissue enhanced colon: 35.8;ovary: 30.5;rectum: 43.4 lymph node: 11.8 TRAM1L1 MGC26568 ENSG00000174599 Translocation associated membrane protein 1-like 1 4 117083554-117085576 Predicted membrane proteins Evidence at transcript level HPA044560 Uncertain Approved Mitochondria Mixed Mixed cerebral cortex: 14.2 TRANK1 KIAA0342, LBA1 ENSG00000168016 Tetratricopeptide repeat and ankyrin repeat containing 1 3 36826820-36945057 Predicted intracellular proteins Evidence at protein level HPA035508 Approved Approved Nucleoplasm Renal cancer:2.52e-5 (unfavourable) Expressed in all Mixed endometrium: 38.8 TREML4 TLT4 ENSG00000188056 Triggering receptor expressed on myeloid cells-like 4 6 41228324-41238882 Predicted membrane proteins Evidence at transcript level HPA065044 Uncertain Not detected Not detected spleen: 0.5 TRHDE PAP-II, PGPEP2, TRH-DE ENSG00000072657 Thyrotropin-releasing hormone degrading enzyme 12 72087266-72670757 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Renal cancer:1.53e-7 (favourable) Tissue enhanced Mixed cerebral cortex: 8.0 TRIB2 GS3955, TRB2 ENSG00000071575 Tribbles pseudokinase 2 2 12716889-12742734 Enzymes, Predicted membrane proteins Evidence at protein level HPA001305 Approved Approved Nucleoplasm
Cytosol Expressed in all Expressed in all ovary: 116.8 TRIM14 KIAA0129 ENSG00000106785 Tripartite motif containing 14 9 98069275-98119212 Predicted intracellular proteins Evidence at protein level HPA053217 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Mixed parathyroid gland: 37.0 TRIM16L TRIM70 ENSG00000108448 Tripartite motif containing 16-like 17 18697998-18736118 Predicted intracellular proteins Evidence at protein level HPA066431 Approved Plasma membrane
Cytosol Thyroid cancer:2.29e-5 (unfavourable), Liver cancer:2.87e-4 (unfavourable) Expressed in all Mixed gallbladder: 22.7 TRIM46 FLJ23229, TRIFIC ENSG00000163462 Tripartite motif containing 46 1 155173787-155184971 Predicted intracellular proteins Evidence at protein level HPA030389 Uncertain Approved Intermediate filaments
Cytosol Endometrial cancer:2.61e-7 (unfavourable) Mixed Tissue enhanced cerebral cortex: 7.9 epididymis: 1.8 TRIM48 RNF101 ENSG00000150244 Tripartite motif containing 48 11 55262182-55271119 Predicted intracellular proteins Evidence at transcript level Tissue enhanced Not detected skin: 0.3 TRIM49 RNF18, TRIM49A ENSG00000168930 Tripartite motif containing 49 11 89797655-89808575 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.3 TRIM49B ENSG00000182053 Tripartite motif containing 49B 11 49027501-49038451 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.1 TRIM49C TRIM49L2 ENSG00000204449 Tripartite motif containing 49C 11 90031106-90042025 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.2 TRIM49D1 TRIM49D, TRIM49D1P, TRIM49DP ENSG00000223417 Tripartite motif containing 49D1 11 89911111-89921767 Predicted intracellular proteins Evidence at transcript level Not detected Not detected prostate,testis: 0.1 TRIM49D2 TRIM49D2P, TRIM49L, TRIM49L1 ENSG00000233802 Tripartite motif containing 49D2 11 89924064-89933063 Predicted intracellular proteins Evidence at transcript level Not detected Not detected testis: 0.2 TRIM51 SPRYD5, TRIM51A ENSG00000124900 Tripartite motif-containing 51 11 55883297-55891810 Predicted intracellular proteins Evidence at transcript level HPA044988 Uncertain Tissue enriched Not detected testis: 0.4 TRIM58 BIA2 ENSG00000162722 Tripartite motif containing 58 1 247857199-247878205 Predicted intracellular proteins Evidence at protein level HPA023637 Uncertain Mixed Group enriched 6 bone marrow: 16.2;placenta: 6.8;testis: 6.6;thyroid gland: 21.9 prostate: 2.0 TRIM60 FLJ35882, RNF129, RNF33 ENSG00000176979 Tripartite motif containing 60 4 165031953-165041744 Predicted intracellular proteins Evidence at transcript level HPA035809, HPA035810, HPA061496 Uncertain Tissue enriched Group enriched 13 placenta: 2.1;testis: 2.7 skin: 0.1 TRIM61 RNF35 ENSG00000183439 Tripartite motif containing 61 4 164954446-164977668 Predicted intracellular proteins Evidence at transcript level HPA049109 Uncertain Approved Nucleoli fibrillar center
Endoplasmic reticulum Tissue enhanced Tissue enhanced testis: 10.5 thyroid gland: 4.3 TRIM64 C11orf28, TRIM64A ENSG00000204450 Tripartite motif containing 64 11 89968502-89975228 Predicted intracellular proteins Evidence at transcript level HPA045370 Approved Not detected Tissue enriched 11 placenta: 1.1 all non-specific tissues: 0.0 TRIM66 C11orf29, KIAA0298, TIF1D ENSG00000166436 Tripartite motif containing 66 11 8612037-8671866 Predicted intracellular proteins Evidence at protein level HPA027420 Approved Supported Nucleoplasm Renal cancer:3.96e-4 (unfavourable), Pancreatic cancer:8.89e-4 (favourable) Expressed in all Mixed testis: 14.1 TRIM67 TNL ENSG00000119283 Tripartite motif containing 67 1 231162112-231221556 Predicted intracellular proteins Evidence at protein level HPA034776 Uncertain Not detected Tissue enriched 28 cerebral cortex: 10.3 adrenal gland,testis: 0.3 TRIM73 TRIM50B ENSG00000178809 Tripartite motif containing 73 7 75395063-75410996 Predicted intracellular proteins Evidence at transcript level HPA047843, HPA051845 Uncertain Uncertain Cytosol Not detected Mixed stomach: 8.6 TRIM77 TRIM77P ENSG00000214414 Tripartite motif containing 77 11 89710299-89717872 Predicted intracellular proteins Evidence at transcript level HPA039896 Uncertain Not detected Not detected all non-specific tissues: 0.0 TRIML1 FLJ36180, RNF209 ENSG00000184108 Tripartite motif family-like 1 4 188139419-188147743 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 147 testis: 14.7 all non-specific tissues: 0.0 TRIML2 FLJ25801, SPRYD6 ENSG00000179046 Tripartite motif family-like 2 4 188091273-188109603 Predicted intracellular proteins Evidence at protein level HPA043838 Uncertain Approved Plasma membrane
Cytosol Tissue enriched Group enriched 25 placenta: 5.9;testis: 3.4 cerebral cortex,lung: 0.1 TRMT10B bA3J10.9, FLJ31455, RG9MTD3 ENSG00000165275 TRNA methyltransferase 10B 9 37753803-37778972 Predicted intracellular proteins Evidence at transcript level HPA021800 Uncertain Approved Nucleoplasm
Plasma membrane Lung cancer:3.91e-4 (favourable), Pancreatic cancer:5.34e-4 (favourable) Expressed in all Mixed skin: 13.0 TRMT44 C4orf23, FLJ35725, METTL19, TRM44 ENSG00000155275 TRNA methyltransferase 44 homolog (S. cerevisiae) 4 8436140-8493531 Enzymes, Predicted intracellular proteins Evidence at protein level HPA045461 Uncertain Approved Nucleoplasm Expressed in all Mixed endometrium: 9.9 TRNP1 C1orf225, LOC388610 ENSG00000253368 TMF1-regulated nuclear protein 1 1 26993707-27000898 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Liver cancer:1.90e-6 (unfavourable), Renal cancer:7.72e-4 (unfavourable) Expressed in all Tissue enhanced stomach: 118.0 esophagus: 49.8 TRPM3 GON-2, KIAA1616, LTRPC3 ENSG00000083067 Transient receptor potential cation channel, subfamily M, member 3 9 70529063-71446904 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Tissue enhanced Tissue enhanced kidney: 17.5 testis: 6.3 TRPM5 LTRPC5, MTR1 ENSG00000070985 Transient receptor potential cation channel, subfamily M, member 5 11 2404515-2423045 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level HPA042115, HPA043315 Approved Tissue enhanced Group enriched 5 colon: 1.0;duodenum: 3.0;epididymis: 2.2;seminal vesicle: 2.5;small intestine: 2.9 testis,thyroid gland: 0.4 TSGA13 ENSG00000213265 Testis specific, 13 7 130668648-130687432 Predicted intracellular proteins Evidence at transcript level HPA022968 Uncertain Not detected Group enriched 59 placenta: 5.5;testis: 21.0 epididymis: 0.2 TSHZ1 NY-CO-33, SDCCAG33, TSH1 ENSG00000179981 Teashirt zinc finger homeobox 1 18 75210755-75289950 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006982 Approved Approved Nucleoplasm Thyroid cancer:1.71e-5 (unfavourable) Expressed in all Expressed in all ovary: 46.3 TSKU E2IG4, LRRC54, TSK ENSG00000182704 Tsukushi, small leucine rich proteoglycan 11 76782251-76798154 Predicted secreted proteins Evidence at protein level HPA008164 Approved Approved Nucleus
Nuclear bodies Renal cancer:2.80e-8 (unfavourable), Prostate cancer:1.66e-4 (favourable), Pancreatic cancer:2.87e-4 (unfavourable), Endometrial cancer:3.66e-4 (favourable) Expressed in all Expressed in all liver: 114.5 TSNARE1 FLJ31164 ENSG00000171045 T-SNARE domain containing 1 8 142212080-142403240 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA015890 Approved Nucleus Urothelial cancer:7.33e-4 (favourable) Expressed in all Expressed in all skin: 29.2 TSNAXIP1 TXI1 ENSG00000102904 Translin-associated factor X interacting protein 1 16 67806765-67832148 Predicted intracellular proteins Evidence at protein level HPA053516 Approved Nucleus
Cytosol Endometrial cancer:2.22e-4 (favourable) Mixed Group enriched 10 fallopian tube: 15.4;testis: 40.0 parathyroid gland: 2.7 TSPAN11 ENSG00000110900 Tetraspanin 11 12 30926428-30996599 Predicted membrane proteins Evidence at protein level HPA066789 Approved Vesicles Lung cancer:3.43e-4 (favourable), Head and neck cancer:5.28e-4 (favourable) Mixed Mixed cerebral cortex: 18.0 TSPAN13 NET-6, TM4SF13 ENSG00000106537 Tetraspanin 13 7 16753535-16784536 Predicted membrane proteins Evidence at protein level HPA007426 Uncertain Approved Nucleus Glioma:5.27e-5 (unfavourable), Ovarian cancer:2.20e-4 (favourable), Renal cancer:2.43e-4 (unfavourable), Liver cancer:2.94e-4 (unfavourable) Expressed in all Expressed in all lung: 246.3 TSPAN16 TM-8, TM4-B, TM4SF16 ENSG00000130167 Tetraspanin 16 19 11296139-11326996 Predicted membrane proteins Evidence at protein level HPA041579 Approved Not detected Tissue enriched 32 testis: 153.1 bone marrow: 4.8 TSPAN17 FBX23, FBXO23, TM4SF17 ENSG00000048140 Tetraspanin 17 5 176647387-176659054 Predicted membrane proteins Evidence at transcript level HPA030447 Approved Nucleoplasm Expressed in all Expressed in all bone marrow: 34.8 TSPAN18 TSPAN ENSG00000157570 Tetraspanin 18 11 44726465-44932421 Predicted membrane proteins Evidence at protein level Expressed in all Mixed smooth muscle: 68.4 TSPAN3 TM4-A, TM4SF8, TSPAN-3 ENSG00000140391 Tetraspanin 3 15 77041404-77083984 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA015996 Uncertain Approved Nucleoplasm
Golgi apparatus Expressed in all Expressed in all epididymis: 519.8 TSPAN31 SAS ENSG00000135452 Tetraspanin 31 12 57738013-57750211 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA057489 Approved Renal cancer:9.91e-5 (favourable), Head and neck cancer:1.09e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 73.1 TSPAN32 PHEMX, TSSC6 ENSG00000064201 Tetraspanin 32 11 2301997-2318200 Predicted membrane proteins Evidence at protein level HPA024135 Uncertain Mixed Tissue enhanced bone marrow: 12.0 heart muscle: 6.8 TSPAN33 MGC50844, Penumbra ENSG00000158457 Tetraspanin 33 7 129144892-129169697 Predicted membrane proteins, Transporters Evidence at protein level HPA020357 Approved Approved Microtubules Renal cancer:8.74e-5 (favourable), Pancreatic cancer:8.88e-4 (favourable) Expressed in all Expressed in all kidney: 126.4 TSPAN5 NET-4, TM4SF9, Tspan-5 ENSG00000168785 Tetraspanin 5 4 98470367-98658629 Predicted membrane proteins Evidence at transcript level Renal cancer:7.83e-5 (unfavourable), Stomach cancer:8.56e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 76.1 ovary: 57.0 TSPEAR C21orf29, DFNB98, MGC11251, TSP-EAR ENSG00000175894 Thrombospondin-type laminin G domain and EAR repeats 21 44497892-44711580 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB034203, CAB034204, HPA052995 Approved Mixed Tissue enhanced testis: 3.1 parathyroid gland: 2.6 TSPO2 BZRPL1, dJ34B21.2 ENSG00000112212 Translocator protein 2 6 41042554-41044337 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA066996 Uncertain Mixed Tissue enriched 16 bone marrow: 30.9 placenta: 1.8 TSPYL6 ENSG00000178021 TSPY-like 6 2 54253184-54256272 Predicted intracellular proteins Evidence at protein level HPA034699, HPA034700 Supported Approved Nucleoli
Centrosome
Cytosol Tissue enriched Tissue enriched 389 testis: 38.8 all non-specific tissues: 0.0 TTC13 FLJ22584 ENSG00000143643 Tetratricopeptide repeat domain 13 1 230906243-230978875 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA018022, HPA051558 Uncertain Approved Nucleoplasm Renal cancer:1.60e-11 (unfavourable), Pancreatic cancer:4.59e-5 (favourable), Head and neck cancer:7.66e-4 (favourable) Expressed in all Expressed in all lymph node: 23.3 TTC16 FLJ32780 ENSG00000167094 Tetratricopeptide repeat domain 16 9 127716066-127731600 Predicted intracellular proteins Evidence at transcript level Not detected Group enriched 12 fallopian tube: 10.8;testis: 18.3 lung: 1.1 TTC21A IFT139A, STI2 ENSG00000168026 Tetratricopeptide repeat domain 21A 3 39107704-39138903 Predicted intracellular proteins Evidence at protein level HPA035510, HPA035511 Approved Supported Nucleoplasm Endometrial cancer:1.79e-4 (favourable) Mixed Tissue enriched 26 testis: 39.3 fallopian tube: 1.4 TTC22 FLJ20619 ENSG00000006555 Tetratricopeptide repeat domain 22 1 54779712-54801267 Predicted intracellular proteins Evidence at protein level HPA035072 Uncertain Breast cancer:2.06e-4 (favourable), Liver cancer:7.73e-4 (unfavourable) Mixed Tissue enhanced esophagus: 40.8 skin: 22.8 TTC26 dyf-13, DYF13, FLJ12571, IFT56 ENSG00000105948 Tetratricopeptide repeat domain 26 7 139133744-139191986 Predicted intracellular proteins Evidence at protein level HPA036338, HPA036339 Supported Approved Nuclear speckles
Intermediate filaments
Cytosol Expressed in all Tissue enhanced fallopian tube: 22.4;testis: 22.0 parathyroid gland: 13.3 TTC29 NYD-SP14 ENSG00000137473 Tetratricopeptide repeat domain 29 4 146706638-146945882 Predicted intracellular proteins Evidence at protein level HPA037006, HPA061473 Uncertain Tissue enhanced Group enriched 27 fallopian tube: 33.8;testis: 150.4 lung: 3.4 TTC30A FLJ13946, IFT70A ENSG00000197557 Tetratricopeptide repeat domain 30A 2 177612992-177618966 Predicted intracellular proteins Evidence at protein level HPA051714, HPA052100, HPA052487 Supported Approved Nucleus
Centrosome Glioma:9.98e-4 (unfavourable) Expressed in all Mixed testis: 17.2 TTC31 FLJ12788 ENSG00000115282 Tetratricopeptide repeat domain 31 2 74483073-74494886 Predicted intracellular proteins Evidence at protein level HPA041783 Uncertain Approved Nucleoplasm
Cytosol Urothelial cancer:2.49e-4 (favourable), Endometrial cancer:6.70e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 11.6 TTC34 ENSG00000215912 Tetratricopeptide repeat domain 34 1 2635976-2789755 Predicted intracellular proteins Evidence at transcript level HPA066832 Uncertain Not detected Group enriched 5 fallopian tube: 2.1;testis: 3.7;thyroid gland: 1.1 endometrium,epididymis,ovary,spleen: 0.4 TTC39A C1orf34, DEME-6, KIAA0452 ENSG00000085831 Tetratricopeptide repeat domain 39A 1 51287258-51345116 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA028098, HPA043440 Uncertain Approved Centrosome Liver cancer:5.05e-5 (unfavourable) Mixed Tissue enhanced testis: 87.2 breast: 58.0 TTC39C C18orf17, FLJ33761, HsT2697 ENSG00000168234 Tetratricopeptide repeat domain 39C 18 23992773-24135610 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA065705, HPA065713 Approved Approved Nucleoplasm Renal cancer:2.60e-5 (unfavourable), Breast cancer:1.48e-4 (favourable) Expressed in all Expressed in all liver: 47.6 TTC6 C14orf25, NCRNA00291 ENSG00000139865 Tetratricopeptide repeat domain 6 14 37595847-38041442 Predicted intracellular proteins Evidence at protein level HPA069293 Uncertain Approved Centrosome Group enriched Group enriched 6 breast: 10.4;prostate: 26.3;testis: 10.4 stomach: 2.6 TTC9 KIAA0227, TTC9A ENSG00000133985 Tetratricopeptide repeat domain 9 14 70641787-70675360 Predicted intracellular proteins Evidence at protein level Renal cancer:2.10e-8 (favourable), Endometrial cancer:1.82e-5 (favourable) Expressed in all Tissue enhanced esophagus: 44.8 fallopian tube: 15.7 TTC9B FLJ30373 ENSG00000174521 Tetratricopeptide repeat domain 9B 19 40216058-40218399 Predicted secreted proteins Evidence at protein level HPA042496 Uncertain Tissue enriched Tissue enriched 66 cerebral cortex: 57.7 adrenal gland: 0.8 TTLL1 C22orf7 ENSG00000100271 Tubulin tyrosine ligase-like family member 1 22 43039644-43089428 Predicted intracellular proteins Evidence at transcript level HPA048392 Approved Approved Nucleoli
Mitochondria Liver cancer:2.34e-5 (unfavourable), Renal cancer:1.68e-4 (favourable), Endometrial cancer:1.85e-4 (favourable) Expressed in all Mixed testis: 20.2 TTLL8 ENSG00000138892 Tubulin tyrosine ligase-like family member 8 22 50015123-50056935 Predicted intracellular proteins Evidence at transcript level HPA016882 Uncertain Not detected Tissue enriched 42 testis: 4.2 all non-specific tissues: 0.0 TTLL9 C20orf125, dJ310O13.1 ENSG00000131044 Tubulin tyrosine ligase-like family member 9 20 31870702-31944963 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level HPA041772, HPA055676 Uncertain Uncertain Nucleoplasm
Microtubules Tissue enhanced Tissue enhanced fallopian tube: 6.4;testis: 5.8 epididymis: 2.8 TTYH1 ENSG00000167614 Tweety family member 1 19 54415219-54436900 Predicted membrane proteins, Transporters Evidence at protein level HPA023617, HPA050655 Approved Breast cancer:3.64e-4 (favourable) Tissue enriched Tissue enriched 27 cerebral cortex: 57.9 testis: 2.1 TUBD1 FLJ12709, TUBD ENSG00000108423 Tubulin, delta 1 17 59859482-59892945 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level CAB004609, HPA023980, HPA027090 Approved Validated Nucleoplasm
Cytosol Liver cancer:1.00e-5 (unfavourable), Colorectal cancer:2.04e-4 (favourable), Renal cancer:6.06e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 12.7 TUBE1 dJ142L7.2, FLJ22589, TUBE ENSG00000074935 Tubulin, epsilon 1 6 112070777-112087529 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level HPA032073, HPA032074 Approved Expressed in all Expressed in all testis: 54.9 TUBG2 ENSG00000037042 Tubulin, gamma 2 17 42659305-42667006 Predicted intracellular proteins Evidence at protein level CAB011495 Approved Supported Microtubule organizing center Liver cancer:4.68e-5 (unfavourable), Renal cancer:3.49e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 77.6 TULP2 CT65, TUBL2 ENSG00000104804 Tubby like protein 2 19 48880965-48898733 Predicted intracellular proteins Evidence at transcript level Tissue enriched Tissue enriched 12 testis: 40.9 bone marrow: 3.4 TULP4 KIAA1397, TUSP ENSG00000130338 Tubby like protein 4 6 158232236-158511828 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA005445 Approved Expressed in all Mixed cerebral cortex: 12.6 TUSC5 IFITMD3, LOST1 ENSG00000184811 Tumor suppressor candidate 5 17 1279663-1300987 Predicted membrane proteins Evidence at protein level HPA050825 Approved Tissue enhanced Tissue enriched 18 adipose tissue: 109.9 breast: 6.0 TVP23A FAM18A, YDR084C ENSG00000166676 Trans-golgi network vesicle protein 23 homolog A (S. cerevisiae) 16 10760919-10818794 Predicted membrane proteins Evidence at transcript level HPA060582 Uncertain Approved Vesicles Tissue enhanced Tissue enhanced cerebral cortex: 6.3 ovary: 3.2 TXNDC16 KIAA1344 ENSG00000087301 Thioredoxin domain containing 16 14 52430590-52552522 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA002543 Approved Approved Mitochondria Renal cancer:6.79e-4 (favourable) Expressed in all Tissue enhanced prostate: 41.9 seminal vesicle: 18.2 TXNDC2 SPTRX1 ENSG00000168454 Thioredoxin domain containing 2 (spermatozoa) 18 9885726-9889275 Predicted intracellular proteins Evidence at protein level CAB016414, HPA018817 Supported Validated Nucleus
Cytosol Not detected Tissue enriched 476 testis: 142.8 bone marrow,cerebral cortex,cervix, uterine,parathyroid gland,smooth muscle: 0.2 TXNRD3NB TR2IT1, TXNRD3IT1, TXNRD3NT1 ENSG00000206483 Thioredoxin reductase 3 neighbor 3 126571789-126572636 Predicted intracellular proteins Evidence at transcript level HPA058257 Uncertain Not detected Not detected ovary,testis: 0.2 TYW1 FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W ENSG00000198874 TRNA-yW synthesizing protein 1 homolog (S. cerevisiae) 7 66995173-67239519 Enzymes, Predicted membrane proteins Evidence at protein level HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097 Approved Approved Nucleus
Nucleoli Ovarian cancer:1.73e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 22.9 TYW3 C1orf171, FLJ40918 ENSG00000162623 TRNA-yW synthesizing protein 3 homolog (S. cerevisiae) 1 74733152-74766678 Enzymes, Predicted intracellular proteins Evidence at protein level HPA029641 Approved Approved Plasma membrane
Cytosol Liver cancer:1.49e-7 (unfavourable) Expressed in all Expressed in all ovary: 32.6 UBALD1 FAM100A ENSG00000153443 UBA-like domain containing 1 16 4608883-4615027 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA066771 Approved Approved Nucleus
Cell Junctions
Cytosol Expressed in all Expressed in all cerebral cortex: 23.9 UBAP1L ENSG00000246922 Ubiquitin associated protein 1-like 15 65092770-65115197 Predicted intracellular proteins Evidence at protein level HPA065334, HPA067923 Uncertain Uncertain Nuclear bodies Mixed Mixed cerebral cortex: 1.8 UBQLNL MGC20470, MGC26958 ENSG00000175518 Ubiquilin-like 11 5514393-5516705 Predicted intracellular proteins Evidence at transcript level Not detected Tissue enriched 30 testis: 39.9 epididymis: 1.3 UBR3 DKFZp434P117, FLJ37422, KIAA2024, ZNF650 ENSG00000144357 Ubiquitin protein ligase E3 component n-recognin 3 (putative) 2 169827458-170084131 Plasma proteins, Predicted membrane proteins Evidence at protein level HPA035390 Approved Approved Nucleus
Nucleoli Expressed in all Expressed in all parathyroid gland: 38.9 UBXN10 FLJ25429, UBXD3 ENSG00000162543 UBX domain protein 10 1 20186085-20196048 Predicted intracellular proteins Evidence at protein level HPA028555, HPA028564 Uncertain Uncertain Nucleoplasm
Plasma membrane
Cell Junctions Glioma:1.64e-4 (unfavourable), Endometrial cancer:2.02e-4 (favourable) Mixed Tissue enhanced fallopian tube: 78.2 testis: 25.4 UBXN2A UBXD4 ENSG00000173960 UBX domain protein 2A 2 23927285-24004909 Predicted intracellular proteins Evidence at protein level HPA065482, HPA069096 Supported Approved Centrosome Liver cancer:1.39e-5 (unfavourable) Expressed in all Mixed parathyroid gland: 15.7 UCMA C10orf49 ENSG00000165623 Upper zone of growth plate and cartilage matrix associated 10 13221767-13234334 Predicted secreted proteins Evidence at transcript level HPA046718 Uncertain Tissue enhanced Tissue enhanced ovary: 1.4 heart muscle: 0.3 UCP1 SLC25A7, UCP ENSG00000109424 Uncoupling protein 1 (mitochondrial, proton carrier) 4 140559434-140568805 Predicted membrane proteins, Transporters Evidence at protein level Tissue enhanced Tissue enhanced adrenal gland: 3.7 breast: 0.9 UFSP1 UFSP ENSG00000176125 UFM1-specific peptidase 1 (non-functional) 7 100888723-100889718 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA027099 Uncertain Expressed in all Mixed adipose tissue: 2.0 UGT1A5 UGT1E ENSG00000240224 UDP glucuronosyltransferase 1 family, polypeptide A5 2 233712992-233773299 Enzymes, Predicted membrane proteins Evidence at transcript level Not detected Group enriched 7 duodenum: 7.7;gallbladder: 3.9;small intestine: 6.9 liver: 0.9 UGT2A3 FLJ21934 ENSG00000135220 UDP glucuronosyltransferase 2 family, polypeptide A3 4 68928463-68951791 Enzymes, Predicted membrane proteins Evidence at protein level HPA045108 Supported Renal cancer:6.07e-7 (favourable), Colorectal cancer:3.31e-4 (favourable) Tissue enriched Tissue enhanced duodenum: 84.3;gallbladder: 46.5;kidney: 46.4;small intestine: 87.8 rectum: 24.3 UGT2B11 ENSG00000213759 UDP glucuronosyltransferase 2 family, polypeptide B11 4 69004618-69214731 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA045108 Uncertain Group enriched Tissue enriched 16 breast: 314.2 gallbladder: 19.0 UGT3A1 FLJ34658 ENSG00000145626 UDP glycosyltransferase 3 family, polypeptide A1 5 35951010-36001028 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA047697, HPA056290 Uncertain Approved Vesicles
Cytosol Group enriched Tissue enhanced kidney: 52.9;liver: 29.1 duodenum: 9.7 UGT3A2 ENSG00000168671 UDP glycosyltransferase 3 family, polypeptide A2 5 36035017-36071358 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA059475 Uncertain Approved Nucleus
Cytosol Tissue enriched Tissue enhanced skin: 11.9;testis: 4.6 bone marrow: 3.3 UGT8 CGT ENSG00000174607 UDP glycosyltransferase 8 4 114598455-114678224 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA014405, HPA065785 Approved Approved Mitochondria Renal cancer:8.55e-5 (favourable) Mixed Tissue enhanced cerebral cortex: 101.6 kidney: 29.8 UMODL1 ENSG00000177398 Uromodulin-like 1 21 42062959-42143453 Predicted membrane proteins Evidence at protein level HPA067245 Uncertain Group enriched Group enriched 7 fallopian tube: 1.9;testis: 1.7 small intestine: 0.2 UNC13A KIAA1032, Munc13-1 ENSG00000130477 Unc-13 homolog A (C. elegans) 19 17601328-17688365 Predicted intracellular proteins Evidence at protein level HPA041418 Uncertain Tissue enhanced Tissue enriched 16 cerebral cortex: 53.7 adrenal gland: 3.4 UNC13C DKFZp547H074, Munc13-3 ENSG00000137766 Unc-13 homolog C (C. elegans) 15 54012904-54633414 Predicted intracellular proteins Evidence at protein level HPA041516 Uncertain Not detected Group enriched 15 cerebral cortex: 17.4;testis: 15.2 ovary,thyroid gland: 1.1 UNC5C ENSG00000182168 Unc-5 netrin receptor C 4 95162504-95549206 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Tissue enhanced Tissue enhanced thyroid gland: 19.9 adrenal gland: 11.7 UNC79 KIAA1409 ENSG00000133958 Unc-79 homolog (C. elegans) 14 93333219-93707876 Predicted membrane proteins Evidence at protein level Mixed Tissue enhanced cerebral cortex: 5.2;testis: 3.0 adrenal gland: 1.0 UNC80 C2orf21, FLJ33496, KIAA1843, UNC-80 ENSG00000144406 Unc-80 homolog (C. elegans) 2 209771993-209999300 Predicted intracellular proteins Evidence at protein level HPA042472 Approved Approved Vesicles Tissue enhanced Tissue enhanced adrenal gland: 5.1;cerebral cortex: 15.8;testis: 5.2 gallbladder: 1.9 UNC93A dJ366N23.1, dJ366N23.2 ENSG00000112494 Unc-93 homolog A (C. elegans) 6 167271169-167316019 Predicted membrane proteins Evidence at protein level HPA035729 Uncertain Tissue enhanced Tissue enhanced duodenum: 9.9;skin: 17.9 liver: 7.1 UPK1A TSPAN21 ENSG00000105668 Uroplakin 1A 19 35666516-35678483 Predicted membrane proteins Evidence at protein level HPA049879 Supported Tissue enriched Tissue enhanced esophagus: 27.0;urinary bladder: 112.9 skin: 15.6 UPK1B TSPAN20, UPK1 ENSG00000114638 Uroplakin 1B 3 119173517-119205153 Predicted membrane proteins Evidence at protein level HPA031799, HPA031800 Supported Endometrial cancer:3.87e-5 (favourable), Stomach cancer:7.76e-4 (unfavourable) Tissue enhanced Tissue enhanced stomach: 33.2;urinary bladder: 37.5 tonsil: 16.0 UPK3BL UPLP ENSG00000267368 Uroplakin 3B-like 7 102637025-102642791 Predicted membrane proteins Evidence at protein level HPA011403 Supported Mixed Expressed in all esophagus: 139.3 URB2 KIAA0133, NET10, NPA2 ENSG00000135763 URB2 ribosome biogenesis 2 homolog (S. cerevisiae) 1 229626234-229660199 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA008902, HPA046788 Uncertain Validated Nucleoli Expressed in all Mixed testis: 10.6 USP27X USP27 ENSG00000273820 Ubiquitin specific peptidase 27, X-linked X 49879948-49882565 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA077264 Approved Vesicles Liver cancer:6.14e-4 (unfavourable), Pancreatic cancer:9.31e-4 (favourable) Expressed in all Tissue enhanced placenta: 19.6 cerebral cortex: 10.4 USP29 ENSG00000131864 Ubiquitin specific peptidase 29 19 57119138-57131926 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA021064 Uncertain Not detected Tissue enriched 5 testis: 9.1 skin: 1.7 USP31 KIAA1203 ENSG00000103404 Ubiquitin specific peptidase 31 16 23061406-23149270 Enzymes, Predicted intracellular proteins Evidence at protein level HPA006937 Uncertain Approved Cytosol Renal cancer:4.41e-5 (unfavourable) Expressed in all Mixed testis: 22.2 USP41 ENSG00000161133 Ubiquitin specific peptidase 41 22 20350578-20390758 Enzymes, Predicted intracellular proteins Evidence at transcript level Not detected Not detected cerebral cortex: 0.3 USP50 ENSG00000170236 Ubiquitin specific peptidase 50 15 50500562-50546708 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA039470 Uncertain Not detected Tissue enriched 17 testis: 1.9 parathyroid gland: 0.1 USP51 ENSG00000247746 Ubiquitin specific peptidase 51 X 55484616-55489202 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA001942 Uncertain Renal cancer:2.63e-5 (favourable), Ovarian cancer:5.70e-4 (favourable) Mixed Tissue enriched 7 epididymis: 60.9 parathyroid gland: 9.0 USP53 KIAA1350 ENSG00000145390 Ubiquitin specific peptidase 53 4 119212587-119295517 Enzymes, Predicted intracellular proteins Evidence at protein level HPA035844, HPA035845 Uncertain Approved Nucleoplasm
Golgi apparatus Renal cancer:3.58e-8 (favourable), Colorectal cancer:3.15e-6 (favourable), Prostate cancer:7.54e-6 (unfavourable) Expressed in all Mixed fallopian tube: 48.4 USP9Y DFFRY ENSG00000114374 Ubiquitin specific peptidase 9, Y-linked Y 12701231-12860839 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA057687 Uncertain Vesicles Tissue enhanced Tissue enhanced prostate: 10.1 epididymis,seminal vesicle: 6.7 UST 2OST ENSG00000111962 Uronyl-2-sulfotransferase 6 148747328-149076990 Predicted membrane proteins Evidence at protein level HPA032022 Approved Approved Mitochondria Expressed in all Tissue enhanced thyroid gland: 49.6 adrenal gland: 17.0 UTP6 C17orf40, HCA66 ENSG00000108651 UTP6, small subunit (SSU) processome component, homolog (yeast) 17 31860899-31901765 Predicted intracellular proteins Evidence at protein level HPA025936, HPA055806 Supported Validated Nucleoli Renal cancer:1.16e-6 (unfavourable), Liver cancer:1.86e-5 (unfavourable) Expressed in all Expressed in all epididymis: 15.3 VCX VCX-10r, VCX-B1, VCX1, VCX10R ENSG00000182583 Variable charge, X-linked X 7842262-7844143 Predicted intracellular proteins Evidence at protein level HPA044996, HPA049357 Supported Mixed Tissue enriched 155 testis: 39.2 duodenum: 0.2 VCX2 VCX-2r ENSG00000177504 Variable charge, X-linked 2 X 8169944-8171267 Predicted intracellular proteins Evidence at transcript level HPA044642, HPA044996, HPA049357 Uncertain Tissue enhanced Tissue enriched 32 testis: 3.2 all non-specific tissues: 0.0 VCX3A VCX-8r, VCX-A, VCX3 ENSG00000169059 Variable charge, X-linked 3A X 6533618-6535118 Predicted intracellular proteins Evidence at protein level HPA044996, HPA049357 Supported Mixed Tissue enriched 207 testis: 27.5 placenta: 0.1 VCX3B VCX-C ENSG00000205642 Variable charge, X-linked 3B X 8464830-8466510 Predicted intracellular proteins Evidence at protein level HPA044996, HPA049357 Supported Tissue enhanced Tissue enriched 84 testis: 32.7 breast: 0.3 VCY BPY1, VCY1, VCY1A ENSG00000129864 Variable charge, Y-linked Y 13985772-13986513 Predicted intracellular proteins Evidence at protein level HPA044996, HPA049357 Supported Not detected Tissue enriched 73 testis: 27.2 placenta: 0.3 VCY1B BPY1B ENSG00000129862 Variable charge, Y-linked 1B Y 14056217-14056958 Predicted intracellular proteins Evidence at protein level HPA044996, HPA049357 Supported Not detected Tissue enriched 73 testis: 27.2 placenta: 0.3 VEPH1 FLJ12604, KIAA1692 ENSG00000197415 Ventricular zone expressed PH domain-containing 1 3 157259742-157533619 Predicted intracellular proteins Evidence at protein level HPA026645 Uncertain Approved Nucleus
Nucleoli
Cytosol Renal cancer:7.75e-9 (favourable) Mixed Tissue enhanced adrenal gland: 26.8;kidney: 28.5;lung: 43.9 epididymis: 21.0 VGLL3 VGL-3 ENSG00000206538 Vestigial-like family member 3 3 86937969-86991119 Predicted intracellular proteins Evidence at protein level HPA054983 Approved Approved Nucleoli
Cytosol Tissue enhanced Tissue enhanced placenta: 57.4 adipose tissue: 24.2 VILL ENSG00000136059 Villin-like 3 37988059-38007188 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA035675 Supported Glioma:1.16e-4 (unfavourable), Head and neck cancer:1.75e-4 (favourable) Tissue enhanced Tissue enhanced stomach: 94.8 small intestine: 69.1 VIT ENSG00000205221 Vitrin 2 36696690-36814792 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Mixed Tissue enhanced ovary: 35.7 adipose tissue: 18.4 VMAC ENSG00000187650 Vimentin-type intermediate filament associated coiled-coil protein 19 5904858-5910853 Predicted intracellular proteins Evidence at protein level Endometrial cancer:5.67e-6 (favourable), Urothelial cancer:7.24e-4 (favourable), Head and neck cancer:8.20e-4 (favourable) Expressed in all Mixed spleen: 7.8 VN1R1 V1RL1, VNR19I1, ZVNH1, ZVNR1 ENSG00000178201 Vomeronasal 1 receptor 1 19 57454790-57457142 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level HPA062209 Uncertain Nucleus
Vesicles Mixed Mixed epididymis: 2.8 VN1R2 V1RL2 ENSG00000196131 Vomeronasal 1 receptor 2 19 53258292-53261837 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA044551 Uncertain Not detected Mixed small intestine: 2.5 VN1R4 V1RL4 ENSG00000228567 Vomeronasal 1 receptor 4 19 53266676-53267723 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA027018 Uncertain Not detected Not detected testis: 0.5 VNN3 HSA238982 ENSG00000093134 Vanin 3 6 132722787-132734765 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA010818 Uncertain Tissue enhanced Tissue enhanced bone marrow: 35.4;liver: 15.2 spleen: 9.6 VOPP1 DKFZp564K0822, ECop, FLJ20532, GASP ENSG00000154978 Vesicular, overexpressed in cancer, prosurvival protein 1 7 55436056-55572988 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Renal cancer:6.99e-8 (unfavourable), Liver cancer:4.35e-5 (unfavourable) Expressed in all Expressed in all lymph node: 111.8 VPREB3 8HS20 ENSG00000128218 Pre-B lymphocyte 3 22 23752743-23754468 Predicted secreted proteins Evidence at protein level HPA003041 Supported Expressed in all Tissue enhanced lymph node: 119.1;tonsil: 99.5 spleen: 62.3 VPS9D1 ATP-BL, C16orf7 ENSG00000075399 VPS9 domain containing 1 16 89707134-89720986 Predicted intracellular proteins Evidence at protein level HPA007847, HPA023620 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:2.91e-5 (favourable) Expressed in all Expressed in all cerebral cortex: 26.5 VSIG10 ENSG00000176834 V-set and immunoglobulin domain containing 10 12 118063593-118136026 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA014526 Approved Cytosol Liver cancer:1.76e-4 (unfavourable), Melanoma:7.53e-4 (unfavourable) Expressed in all Mixed small intestine: 28.3 VSIG10L ENSG00000186806 V-set and immunoglobulin domain containing 10 like 19 51331536-51342124 Predicted membrane proteins Evidence at protein level HPA060453, HPA066745 Uncertain Validated Nucleus Liver cancer:8.75e-4 (unfavourable) Expressed in all Tissue enhanced esophagus: 31.5;salivary gland: 9.3 tonsil: 6.0 VSIG8 ENSG00000243284 V-set and immunoglobulin domain containing 8 1 159854316-159862657 Predicted membrane proteins Evidence at protein level HPA023219 Uncertain Group enriched Tissue enhanced skin: 13.6;tonsil: 6.1 fallopian tube: 2.1 VSTM2A MGC33530, VSTM2 ENSG00000170419 V-set and transmembrane domain containing 2A 7 54542325-54571080 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA021404, HPA024134 Uncertain Renal cancer:5.34e-4 (favourable) Tissue enhanced Tissue enhanced adrenal gland: 12.7;cerebral cortex: 40.9;prostate: 13.4 stomach: 4.8 VSTM4 C10orf72, FLJ31737 ENSG00000165633 V-set and transmembrane domain containing 4 10 49014245-49115509 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level HPA017279 Uncertain Approved Nucleus
Vesicles Urothelial cancer:4.25e-4 (unfavourable) Tissue enriched Mixed adrenal gland: 55.1 VWA3A FLJ40941, FLJ46765 ENSG00000175267 Von Willebrand factor A domain containing 3A 16 22092538-22156966 Predicted intracellular proteins Evidence at protein level HPA041696, HPA042044 Uncertain Endometrial cancer:8.15e-4 (favourable) Tissue enhanced Tissue enhanced fallopian tube: 52.4 lung: 11.6 VWA3B DKFZp686F2227, MGC26733 ENSG00000168658 Von Willebrand factor A domain containing 3B 2 98087116-98313299 Predicted intracellular proteins Evidence at protein level HPA036700, HPA036701 Approved Approved Nucleus Tissue enhanced Group enriched 9 fallopian tube: 40.6;testis: 36.3 lung: 4.3 VWA5A BCSC-1, LOH11CR2A ENSG00000110002 Von Willebrand factor A domain containing 5A 11 124115362-124147721 Predicted intracellular proteins Evidence at protein level HPA037813, HPA037814, HPA061500 Uncertain Validated Nucleus Renal cancer:1.55e-5 (favourable) Expressed in all Expressed in all gallbladder: 48.9 VWA5B2 DKFZp761K032, LOC90113 ENSG00000145198 Von Willebrand factor A domain containing 5B2 3 184230429-184242329 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA036823, HPA036824, HPA061412 Approved Approved Nucleus
Golgi apparatus Mixed Tissue enriched 10 adrenal gland: 53.7 cerebral cortex: 5.4 VWA7 C6orf27, G7c, NG37 ENSG00000204396 Von Willebrand factor A domain containing 7 6 31765590-31777294 Predicted secreted proteins Evidence at transcript level HPA046954, HPA054262, HPA055033 Approved Approved Plasma membrane
Cytosol Renal cancer:4.35e-8 (favourable) Mixed Tissue enhanced fallopian tube: 9.0 parathyroid gland: 1.9 VWC2 PSST739, UNQ739 ENSG00000188730 Von Willebrand factor C domain containing 2 7 49773661-49921950 Predicted secreted proteins Evidence at protein level HPA055243 Approved Not detected Tissue enhanced heart muscle: 3.0;ovary: 6.1 cerebral cortex: 1.8 VWC2L ENSG00000174453 Von Willebrand factor C domain containing protein 2-like 2 214411065-214578959 Predicted secreted proteins Evidence at transcript level HPA044815, HPA059414 Uncertain Not detected Tissue enriched 31 cerebral cortex: 3.1 all non-specific tissues: 0.0 VWCE FLJ32009, URG11, VWC1 ENSG00000167992 Von Willebrand factor C and EGF domains 11 61258286-61295424 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA040401, HPA043921 Uncertain Supported Nucleus
Vesicles
Cytosol Group enriched Tissue enhanced fallopian tube: 5.1;ovary: 5.8 liver: 3.7 VWDE FLJ14712 ENSG00000146530 Von Willebrand factor D and EGF domains 7 12330885-12403941 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA026619, HPA036044 Uncertain Approved Nucleoplasm
Cytosol Mixed Tissue enhanced thyroid gland: 3.9 heart muscle: 1.5 WBP2NL FLJ26145, MGC26816, PAWP ENSG00000183066 WBP2 N-terminal like 22 41998725-42058456 Predicted intracellular proteins Evidence at protein level HPA048557 Supported Not detected Tissue enriched 8 testis: 11.6 epididymis: 1.5 WBSCR17 GalNAc-T5L, GALNTL3 ENSG00000185274 Williams-Beuren syndrome chromosome region 17 7 71132169-71713600 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA013624, HPA047986 Approved Uncertain Nucleus
Nucleoli
Nuclear bodies
Golgi apparatus Testis cancer:3.91e-4 (favourable), Ovarian cancer:4.60e-4 (favourable) Mixed Tissue enhanced cerebral cortex: 76.7 ovary: 28.9 WBSCR28 MGC26719 ENSG00000175877 Williams-Beuren syndrome chromosome region 28 7 73861159-73865893 Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 97 testis: 36.2 duodenum: 0.3 WDR17 ENSG00000150627 WD repeat domain 17 4 176065834-176182818 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA042766 Uncertain Approved Nuclear speckles Mixed Tissue enhanced cerebral cortex: 25.3;parathyroid gland: 19.0 thyroid gland: 11.0 WDR31 FLJ35921 ENSG00000148225 WD repeat domain 31 9 113313222-113340298 Predicted intracellular proteins Evidence at transcript level HPA019340, HPA019347 Approved Approved Nuclear bodies
Cytosol Renal cancer:1.90e-9 (favourable), Endometrial cancer:1.85e-4 (favourable) Expressed in all Tissue enhanced parathyroid gland: 16.3 testis: 9.2 WDR38 ENSG00000136918 WD repeat domain 38 9 124853417-124857890 Predicted intracellular proteins Evidence at transcript level HPA056607 Uncertain Endometrial cancer:3.97e-4 (favourable) Tissue enhanced Tissue enriched 17 fallopian tube: 123.5 lung: 7.3 WDR41 FLJ10904 ENSG00000164253 WD repeat domain 41 5 77425970-77620611 Predicted intracellular proteins Evidence at protein level HPA043124 Approved Approved Nucleus
Golgi apparatus
Cytosol Liver cancer:4.47e-4 (unfavourable) Expressed in all Expressed in all testis: 51.4 WDR45 JM5, NBIA5, WDRX1, WIPI4 ENSG00000196998 WD repeat domain 45 X 49071470-49101170 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA027562 Uncertain Approved Nucleoli Cervical cancer:1.21e-4 (favourable), Head and neck cancer:1.61e-4 (favourable) Expressed in all Expressed in all epididymis: 133.5 WDR45B WDR45L, WIPI3 ENSG00000141580 WD repeat domain 45B 17 82614562-82648553 Predicted intracellular proteins Evidence at protein level HPA017886 Approved Nucleus
Golgi apparatus
Cytosol Liver cancer:2.98e-5 (unfavourable) Expressed in all Expressed in all testis: 82.9 WDR49 FLJ33620 ENSG00000174776 WD repeat domain 49 3 167478684-167653983 Predicted intracellular proteins Evidence at protein level HPA036225, HPA036226 Uncertain Tissue enhanced Tissue enhanced fallopian tube: 18.2 small intestine: 5.1 WDR53 MGC12928, MGC64882 ENSG00000185798 WD repeat domain 53 3 196554177-196568674 Predicted intracellular proteins Evidence at protein level HPA016420, HPA019332 Approved Approved Plasma membrane
Cytosol Liver cancer:1.57e-6 (unfavourable), Melanoma:3.09e-4 (unfavourable) Expressed in all Tissue enriched 6 testis: 112.1 parathyroid gland: 19.5 WDR5B FLJ11287 ENSG00000196981 WD repeat domain 5B 3 122412332-122416051 Predicted intracellular proteins Evidence at transcript level HPA042994 Approved Expressed in all Mixed epididymis: 13.3 WDR63 DIC3, FLJ30067, NYD-SP29 ENSG00000162643 WD repeat domain 63 1 84999147-85133138 Predicted intracellular proteins Evidence at protein level HPA038526 Supported Tissue enhanced Tissue enhanced adrenal gland: 28.4;fallopian tube: 22.8;testis: 33.4 parathyroid gland: 6.1 WDR64 FLJ32978 ENSG00000162843 WD repeat domain 64 1 241652278-241802133 Predicted intracellular proteins Evidence at protein level HPA046186 Uncertain Not detected Tissue enriched 10 testis: 5.5 placenta: 0.5 WDR66 CaM-IP4, MGC33630 ENSG00000158023 WD repeat domain 66 12 121917862-122003927 Predicted intracellular proteins Evidence at protein level HPA039902, HPA040005 Supported Uncertain Plasma membrane
Cytosol Endometrial cancer:3.11e-4 (favourable) Mixed Tissue enhanced fallopian tube: 32.2;testis: 30.6 thyroid gland: 7.4 WDR72 FLJ38736 ENSG00000166415 WD repeat domain 72 15 53513741-53762878 Disease related genes, Predicted intracellular proteins Evidence at transcript level HPA048212, HPA057410, HPA059819 Uncertain Approved Vesicles Renal cancer:3.33e-16 (favourable), Thyroid cancer:1.80e-4 (unfavourable) Mixed Group enriched 6 kidney: 103.9;thyroid gland: 91.7 liver: 17.1 WDR78 DIC4, FLJ23129 ENSG00000152763 WD repeat domain 78 1 66812885-66924887 Predicted intracellular proteins Evidence at protein level HPA045793 Uncertain Renal cancer:9.60e-5 (favourable) Mixed Group enriched 5 fallopian tube: 43.2;testis: 62.6 parathyroid gland: 9.7 WDR86 ENSG00000187260 WD repeat domain 86 7 151375909-151410727 Predicted intracellular proteins Evidence at transcript level HPA021086 Uncertain Tissue enhanced Tissue enhanced parathyroid gland: 23.6;spleen: 14.6 endometrium,fallopian tube: 7.5 WDR88 PQWD ENSG00000166359 WD repeat domain 88 19 33132090-33175795 Predicted intracellular proteins Evidence at protein level HPA041916, HPA050336 Uncertain Approved Nucleoplasm
Golgi apparatus Mixed Tissue enriched 6 testis: 11.3 fallopian tube,thyroid gland: 1.9 WDR89 C14orf150, MGC9907 ENSG00000140006 WD repeat domain 89 14 63597039-63641861 Predicted intracellular proteins Evidence at protein level HPA000813 Uncertain Approved Intermediate filaments
Cytosol Liver cancer:3.26e-4 (unfavourable), Breast cancer:3.37e-4 (favourable) Expressed in all Expressed in all thyroid gland: 20.6 WDR93 ENSG00000140527 WD repeat domain 93 15 89690797-89743638 Predicted intracellular proteins Evidence at transcript level HPA046196, HPA048112 Uncertain Uncertain Actin filaments Mixed Tissue enhanced fallopian tube: 14.1;testis: 21.1 epididymis: 5.7 WDR97 KIAA1875 ENSG00000179698 WD repeat domain 97 8 144107726-144118315 Predicted intracellular proteins Evidence at transcript level HPA059409 Uncertain Mixed Tissue enriched 9 testis: 1.2 adrenal gland,skin: 0.1 WEE2 FLJ16107 ENSG00000214102 WEE1 homolog 2 (S. pombe) 7 141708353-141731271 Enzymes, Predicted intracellular proteins Evidence at protein level HPA027418 Uncertain Supported Nucleoplasm
Cytosol Not detected Mixed epididymis: 1.8 WFDC1 PS20 ENSG00000103175 WAP four-disulfide core domain 1 16 84294646-84329851 Predicted secreted proteins Evidence at transcript level HPA031411 Uncertain Mixed Tissue enhanced placenta: 120.9;seminal vesicle: 134.0 prostate: 85.3 WFDC10B WAP12 ENSG00000182931 WAP four-disulfide core domain 10B 20 45684653-45705019 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Tissue enhanced Tissue enriched 12 epididymis: 32.7 testis: 2.7 WFDC12 C20orf122, dJ211D12.4, WAP2 ENSG00000168703 WAP four-disulfide core domain 12 20 45123425-45124465 Predicted secreted proteins Evidence at transcript level Renal cancer:5.65e-4 (unfavourable) Group enriched Tissue enriched 9 skin: 49.9 seminal vesicle: 5.3 WFDC3 dJ447F3.3, WAP14 ENSG00000124116 WAP four-disulfide core domain 3 20 45747944-45791932 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Mixed Tissue enriched 19 testis: 31.8 breast: 1.6 WFDC5 dJ211D12.5, WAP1 ENSG00000175121 WAP four-disulfide core domain 5 20 45109452-45115172 Predicted secreted proteins Evidence at transcript level Renal cancer:2.32e-5 (unfavourable) Tissue enhanced Tissue enriched 36 skin: 469.0 breast: 13.0 WFDC6 C20orf171, dJ461P17.11, WAP6 ENSG00000243543 WAP four-disulfide core domain 6 20 45534196-45539495 Predicted secreted proteins Evidence at transcript level Tissue enhanced Group enriched 16 epididymis: 317.8;testis: 83.3 fallopian tube: 12.4 WFDC8 C20orf170, dJ461P17.1, WAP8 ENSG00000158901 WAP four-disulfide core domain 8 20 45551153-45579326 Predicted secreted proteins Evidence at transcript level Not detected Tissue enriched 409 epididymis: 479.0 seminal vesicle: 1.1 WIPF3 CR16, FLJ36931 ENSG00000122574 WAS/WASL interacting protein family, member 3 7 29806486-29917066 Predicted intracellular proteins Evidence at protein level HPA041145, HPA041211 Uncertain Uncertain Mitochondria Breast cancer:7.93e-4 (favourable) Mixed Tissue enhanced ovary: 52.7;testis: 37.2 epididymis: 24.7 WNT16 ENSG00000002745 Wingless-type MMTV integration site family, member 16 7 121325367-121341104 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA027030 Uncertain Mixed Group enriched 5 cervix, uterine: 8.6;skin: 24.4 seminal vesicle: 3.1 WNT2 INT1L1, IRP ENSG00000105989 Wingless-type MMTV integration site family member 2 7 117276631-117323289 Cancer-related genes, Predicted secreted proteins Evidence at protein level HPA020920 Approved Vesicles Mixed Group enriched 6 endometrium: 23.6;placenta: 92.5 lung: 9.2 WNT5B ENSG00000111186 Wingless-type MMTV integration site family, member 5B 12 1529891-1647243 Predicted secreted proteins Evidence at protein level HPA061991 Approved Vesicles Expressed in all Tissue enhanced prostate: 33.3 seminal vesicle: 27.6 WNT7B ENSG00000188064 Wingless-type MMTV integration site family, member 7B 22 45920362-45977129 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Mixed Tissue enhanced skin: 21.4 urinary bladder: 8.2 WNT8A WNT8D ENSG00000061492 Wingless-type MMTV integration site family, member 8A 5 138083892-138092365 Predicted secreted proteins Evidence at transcript level HPA038539 Uncertain Uncertain Plasma membrane
Cytosol Tissue enriched Not detected testis: 0.7 WNT8B ENSG00000075290 Wingless-type MMTV integration site family, member 8B 10 100463041-100483744 Predicted secreted proteins Evidence at transcript level HPA036570 Uncertain Not detected Tissue enhanced adrenal gland: 1.1;parathyroid gland: 1.5;testis: 1.6 kidney: 0.6 WNT9A WNT14 ENSG00000143816 Wingless-type MMTV integration site family, member 9A 1 227918656-227947898 Plasma proteins, Predicted secreted proteins Evidence at transcript level Ovarian cancer:1.06e-4 (unfavourable) Mixed Mixed endometrium: 7.1 WRAP73 WDR8 ENSG00000116213 WD repeat containing, antisense to TP73 1 3630767-3652761 Predicted intracellular proteins Evidence at protein level HPA026893 Uncertain Approved Nucleoplasm
Cell Junctions Liver cancer:1.37e-4 (unfavourable), Renal cancer:1.42e-4 (unfavourable), Pancreatic cancer:3.49e-4 (favourable) Expressed in all Expressed in all lymph node: 20.7 WSB2 MGC10210, SBA2 ENSG00000176871 WD repeat and SOCS box containing 2 12 118032694-118062430 Predicted intracellular proteins Evidence at protein level HPA052606 Uncertain Liver cancer:2.42e-5 (unfavourable) Expressed in all Expressed in all cerebral cortex: 193.8 WSCD1 KIAA0523 ENSG00000179314 WSC domain containing 1 17 5772234-6124427 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA015919 Uncertain Approved Nucleoplasm
Golgi apparatus Group enriched Tissue enhanced cerebral cortex: 30.4;spleen: 19.2 testis: 15.3 WSCD2 KIAA0789 ENSG00000075035 WSC domain containing 2 12 108129471-108250537 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA013346, HPA048133 Approved Approved Nucleoplasm Tissue enhanced Tissue enhanced seminal vesicle: 18.7;thyroid gland: 28.7 cerebral cortex: 14.2 XG PBDX ENSG00000124343 Xg blood group X 2752050-2815927 Blood group antigen proteins, Predicted membrane proteins Evidence at transcript level Breast cancer:4.25e-4 (unfavourable) Mixed Tissue enhanced skin: 41.1 breast: 15.6 XKR3 MGC57211, XTES ENSG00000172967 XK, Kell blood group complex subunit-related family, member 3 22 16783412-16821699 Predicted membrane proteins, Transporters Evidence at transcript level HPA003379, HPA035081 Uncertain Not detected Tissue enriched 80 testis: 14.3 cerebral cortex: 0.1 XKR4 KIAA1889 ENSG00000206579 XK, Kell blood group complex subunit-related family, member 4 8 55102389-55542054 Predicted membrane proteins, Transporters Evidence at protein level HPA025072, HPA028083 Uncertain Not detected Tissue enriched 6 cerebral cortex: 4.7 seminal vesicle: 0.8 XKR6 C8orf21, C8orf5, C8orf7 ENSG00000171044 XK, Kell blood group complex subunit-related family, member 6 8 10896045-11201366 Predicted membrane proteins Evidence at transcript level HPA024828 Uncertain Mixed Mixed testis: 1.8 XKR7 C20orf159, dJ310O13.4 ENSG00000260903 XK, Kell blood group complex subunit-related family, member 7 20 31968002-32003387 Predicted membrane proteins Evidence at protein level HPA040854 Uncertain Not detected Tissue enriched 10 cerebral cortex: 3.6 adrenal gland,testis: 0.3 XKR9 ENSG00000221947 XK, Kell blood group complex subunit-related family, member 9 8 70669365-70790371 Predicted membrane proteins, Transporters Evidence at transcript level HPA044430 Uncertain Approved Mitochondria Pancreatic cancer:7.20e-4 (unfavourable) Mixed Tissue enhanced testis: 14.1 small intestine: 6.2 XKRX XKR2, XPLAC ENSG00000182489 XK, Kell blood group complex subunit-related, X-linked X 100913445-100929433 Predicted membrane proteins, Transporters Evidence at transcript level Thyroid cancer:3.52e-4 (favourable) Mixed Tissue enhanced skin: 9.5 tonsil: 3.3 XPNPEP2 ENSG00000122121 X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound X 129738974-129769538 Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins Evidence at protein level HPA000339, CAB025136, CAB025269 Supported Approved Golgi apparatus Group enriched Group enriched 13 duodenum: 131.6;kidney: 174.6;small intestine: 236.2 liver: 14.3 XRRA1 FLJ00225 ENSG00000166435 X-ray radiation resistance associated 1 11 74807739-74949200 Predicted intracellular proteins Evidence at protein level HPA039263 Supported Nucleoplasm
Nuclear bodies Expressed in all Tissue enhanced testis: 35.7 thyroid gland: 11.7 YAE1D1 C7orf36, GK003 ENSG00000241127 Yae1 domain containing 1 7 39566376-39610320 Predicted intracellular proteins Evidence at protein level HPA019226, HPA031249 Uncertain Approved Cytosol Liver cancer:1.64e-4 (unfavourable) Expressed in all Expressed in all testis: 34.3 YIPF7 FinGER9, FLJ39576 ENSG00000177752 Yip1 domain family, member 7 4 44622065-44678556 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA030642 Uncertain Not detected Tissue enriched 42 skeletal muscle: 29.6 esophagus: 0.7 YPEL3 MGC10500 ENSG00000090238 Yippee-like 3 16 30092314-30096915 Predicted intracellular proteins Evidence at transcript level HPA030501, HPA045621 Uncertain Head and neck cancer:1.09e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 117.3 YPEL4 FLJ30213 ENSG00000166793 Yippee-like 4 11 57645087-57649944 Predicted intracellular proteins Evidence at transcript level HPA045621 Uncertain Mixed Tissue enhanced cerebral cortex: 19.0 ovary: 4.0 YY2 ZNF631 ENSG00000230797 YY2 transcription factor X 21855987-21858727 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001119, HPA030335 Approved Approved Nuclear bodies Mixed Tissue enhanced testis: 10.9 endometrium: 2.8 ZAR1 Z3CXXC6 ENSG00000182223 Zygote arrest 1 4 48490252-48494389 Plasma proteins, Predicted intracellular proteins Evidence at protein level Not detected Tissue enhanced testis: 1.1 bone marrow: 0.2 ZAR1L Z3CXXC7 ENSG00000189167 Zygote arrest 1-like 13 32303700-32315344 Predicted intracellular proteins Evidence at transcript level HPA041319 Uncertain Not detected Not detected testis: 0.7 ZBBX FLJ23049 ENSG00000169064 Zinc finger, B-box domain containing 3 167240287-167381346 Predicted intracellular proteins Evidence at protein level HPA036327, HPA036328 Supported Tissue enhanced Group enriched 9 fallopian tube: 37.7;testis: 67.4 lung: 5.5 ZBED5 Buster1 ENSG00000236287 Zinc finger, BED-type containing 5 11 10812074-10858796 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048472, HPA050994 Uncertain Approved Nucleus
Nucleoli fibrillar center
Golgi apparatus Liver cancer:2.19e-5 (unfavourable), Urothelial cancer:3.87e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 94.8 ZBED6CL C7orf29 ENSG00000188707 ZBED6 C-terminal like 7 150329789-150332721 Predicted intracellular proteins Evidence at transcript level HPA019724, HPA055805 Approved Approved Nuclear membrane
Vesicles Renal cancer:1.38e-5 (unfavourable), Pancreatic cancer:2.44e-5 (favourable), Glioma:5.65e-5 (unfavourable), Breast cancer:9.48e-5 (favourable) Expressed in all Tissue enhanced adrenal gland: 31.9;parathyroid gland: 30.0 lymph node: 10.0 ZBED9 Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452 ENSG00000232040 Zinc finger, BED-type containing 9 6 28571630-28616212 Predicted intracellular proteins Evidence at protein level HPA007246 Uncertain Approved Nucleus
Nucleoli
Golgi apparatus Mixed Tissue enhanced testis: 18.7 epididymis: 4.5 ZBTB34 KIAA1993, MGC24652, ZNF918 ENSG00000177125 Zinc finger and BTB domain containing 34 9 126860665-126885878 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023893 Approved Supported Nucleoplasm Expressed in all Mixed placenta: 9.5 ZBTB37 MGC2629, ZNF908 ENSG00000185278 Zinc finger and BTB domain containing 37 1 173868082-173903549 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023438 Approved Approved Nucleus
Nucleoli fibrillar center
Cytosol Mixed Tissue enhanced testis: 17.3 spleen: 5.5 ZBTB39 KIAA0352, ZNF922 ENSG00000166860 Zinc finger and BTB domain containing 39 12 56998834-57006446 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016866, HPA020306 Uncertain Approved Vesicles Expressed in all Mixed testis: 13.4 ZBTB45 FLJ14486, ZNF499 ENSG00000119574 Zinc finger and BTB domain containing 45 19 58513530-58538911 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035754 Uncertain Approved Cytosol Renal cancer:5.38e-4 (favourable) Expressed in all Expressed in all cerebral cortex,thyroid gland: 10.6 ZBTB47 DKFZp434N0615, KIAA1190, ZNF651 ENSG00000114853 Zinc finger and BTB domain containing 47 3 42653684-42665854 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074057 Approved Nucleoplasm Renal cancer:7.96e-5 (favourable) Expressed in all Expressed in all cerebral cortex: 48.0 ZBTB7C ZBTB36, ZNF857C ENSG00000184828 Zinc finger and BTB domain containing 7C 18 48026673-48410752 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA014433 Uncertain Colorectal cancer:1.59e-4 (favourable) Mixed Mixed esophagus: 31.9 ZBTB8B DKFZp547H154, RP1-27O5.1, ZNF916B ENSG00000273274 Zinc finger and BTB domain containing 8B 1 32465069-32496686 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027818, HPA028690, HPA055553 Approved Tissue enhanced Not detected cerebral cortex: 0.6 ZC2HC1B C6orf94, dJ468K18.5, FAM164B ENSG00000118491 Zinc finger, C2HC-type containing 1B 6 143864436-143938356 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 74 testis: 23.2 skin: 0.3 ZC3H12B CXorf32, MCPIP2 ENSG00000102053 Zinc finger CCCH-type containing 12B X 65366638-65507887 Predicted intracellular proteins Evidence at transcript level HPA000836 Uncertain Approved Endoplasmic reticulum
Golgi apparatus
Vesicles Mixed Mixed cerebral cortex: 4.6 ZC3H12D C6orf95, dJ281H8.1, MCPIP4 ENSG00000178199 Zinc finger CCCH-type containing 12D 6 149446795-149485061 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA036897 Uncertain Supported Nucleoplasm
Cytoplasmic bodies Mixed Tissue enhanced appendix: 9.9;lymph node: 11.7;tonsil: 12.1 spleen: 6.1 ZC3H6 FLJ41410, FLJ45877, KIAA2035, ZC3HDC6 ENSG00000188177 Zinc finger CCCH-type containing 6 2 112275594-112340063 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036019, HPA036020 Uncertain Expressed in all Mixed ovary: 7.6 ZCCHC14 BDG29, MGC14139 ENSG00000140948 Zinc finger, CCHC domain containing 14 16 87406246-87492045 Predicted intracellular proteins Evidence at protein level HPA014122 Uncertain Nuclear membrane Renal cancer:1.47e-14 (favourable) Expressed in all Expressed in all testis: 61.6 ZCCHC16 FLJ46608, Mar4, Mart4 ENSG00000187823 Zinc finger, CCHC domain containing 16 X 112454500-112457112 Predicted intracellular proteins Evidence at transcript level HPA003272 Uncertain Approved Nucleus
Plasma membrane
Cytosol Group enriched Not detected kidney: 0.8 ZCCHC5 FLJ38865, Mar3, Mart3, ZHC5 ENSG00000179300 Zinc finger, CCHC domain containing 5 X 78656069-78659328 Predicted intracellular proteins Evidence at transcript level HPA051991, HPA053174, HPA075136 Uncertain Approved Nucleoplasm
Golgi apparatus
Plasma membrane Not detected Not detected endometrium,smooth muscle: 0.7 ZCCHC9 DKFZp761J139, PPP1R41 ENSG00000131732 Zinc finger, CCHC domain containing 9 5 81301590-81313297 Predicted intracellular proteins Evidence at protein level HPA038404, HPA057521 Uncertain Approved Intermediate filaments Expressed in all Expressed in all placenta: 27.3 ZDHHC1 C16orf1, HSU90653, ZNF377 ENSG00000159714 Zinc finger, DHHC-type containing 1 16 67394419-67416833 Enzymes, Predicted membrane proteins Evidence at transcript level HPA042531, HPA048659 Uncertain Approved Cytosol Endometrial cancer:1.25e-6 (favourable), Renal cancer:1.55e-6 (favourable), Pancreatic cancer:5.99e-4 (favourable) Expressed in all Mixed fallopian tube: 31.4 ZDHHC11 FLJ13153, ZNF399 ENSG00000188818 Zinc finger, DHHC-type containing 11 5 795606-850986 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA057886, HPA069008 Uncertain Approved Lipid droplets Mixed Mixed fallopian tube: 10.7 ZDHHC12 FLJ14524, ZNF400 ENSG00000160446 Zinc finger, DHHC-type containing 12 9 128720869-128724127 Enzymes, Predicted membrane proteins Evidence at transcript level HPA059339 Uncertain Approved Nucleoplasm Expressed in all Expressed in all small intestine: 36.5 ZDHHC15 FLJ31812, MRX91 ENSG00000102383 Zinc finger, DHHC-type containing 15 X 75368427-75523502 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at transcript level HPA003618 Uncertain Approved Nuclear speckles
Cytosol Tissue enhanced Mixed cerebral cortex: 4.8 ZDHHC16 APH2 ENSG00000171307 Zinc finger, DHHC-type containing 16 10 97446131-97457370 Enzymes, Predicted membrane proteins Evidence at protein level HPA039893, HPA040214 Uncertain Supported Nucleus
Nuclear membrane
Cytosol Expressed in all Expressed in all placenta: 31.3 ZDHHC18 DKFZp667O2416 ENSG00000204160 Zinc finger, DHHC-type containing 18 1 26826710-26857602 Enzymes, Predicted membrane proteins Evidence at protein level HPA040234 Approved Approved Microtubules Renal cancer:1.36e-10 (unfavourable), Liver cancer:7.42e-7 (unfavourable), Glioma:9.53e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 75.3 ZDHHC19 MGC33345 ENSG00000163958 Zinc finger, DHHC-type containing 19 3 196197449-196211437 Enzymes, Predicted membrane proteins Evidence at transcript level Mixed Tissue enriched 44 testis: 29.2 adrenal gland: 0.6 ZDHHC2 ZNF372 ENSG00000104219 Zinc finger, DHHC-type containing 2 8 17156029-17224799 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA023331 Uncertain Renal cancer:3.24e-4 (favourable) Expressed in all Expressed in all thyroid gland: 53.5 ZDHHC21 DNZ1, HSPC097 ENSG00000175893 Zinc finger, DHHC-type containing 21 9 14611071-14693471 Enzymes, Predicted membrane proteins Evidence at protein level HPA065254 Approved Approved Golgi apparatus
Cytosol Urothelial cancer:9.28e-6 (favourable), Renal cancer:1.29e-4 (favourable) Expressed in all Mixed cerebral cortex: 16.0 ZDHHC4 FLJ10479, ZNF374 ENSG00000136247 Zinc finger, DHHC-type containing 4 7 6577434-6589374 Enzymes, Predicted membrane proteins Evidence at protein level HPA032124, HPA064358 Approved Approved Nuclear bodies Renal cancer:1.18e-7 (favourable), Head and neck cancer:3.95e-6 (unfavourable), Urothelial cancer:8.94e-4 (unfavourable), Cervical cancer:9.35e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 77.5 ZFAND2A AIRAP ENSG00000178381 Zinc finger, AN1-type domain 2A 7 1152071-1160759 Predicted intracellular proteins Evidence at transcript level HPA019469 Approved Renal cancer:5.47e-7 (unfavourable) Expressed in all Expressed in all bone marrow: 50.1 ZFAND4 ANUBL1, FLJ40185 ENSG00000172671 Zinc finger, AN1-type domain 4 10 45615501-45672780 Predicted intracellular proteins Evidence at transcript level HPA037839, HPA057543 Uncertain Approved Golgi apparatus Expressed in all Tissue enriched 12 testis: 94.8 lymph node: 7.6 ZFHX2 KIAA1056, KIAA1762, ZFH-5, ZNF409 ENSG00000136367 Zinc finger homeobox 2 14 23520855-23556192 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000720, HPA005146 Uncertain Approved Nucleus
Nucleoli fibrillar center Mixed Tissue enhanced testis: 13.1 parathyroid gland: 4.0 ZFP14 KIAA1559, ZNF531 ENSG00000142065 ZFP14 zinc finger protein 19 36334453-36379199 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030637 Uncertain Approved Nuclear speckles Urothelial cancer:2.75e-5 (favourable) Expressed in all Mixed parathyroid gland: 8.6 ZFP3 FLJ30726, ZNF752 ENSG00000180787 ZFP3 zinc finger protein 17 5078248-5096374 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053085, HPA057290 Approved Approved Nucleoplasm
Cytosol Renal cancer:7.69e-7 (favourable), Pancreatic cancer:1.07e-4 (favourable), Lung cancer:1.38e-4 (favourable), Cervical cancer:5.68e-4 (favourable) Mixed Mixed parathyroid gland: 12.8 ZFP30 KIAA0961, ZNF745 ENSG00000120784 ZFP30 zinc finger protein 19 37613749-37692337 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030606 Uncertain Approved Cytosol Renal cancer:3.86e-4 (favourable) Expressed in all Mixed testis: 14.2 ZFP37 ZNF906 ENSG00000136866 ZFP37 zinc finger protein 9 113038380-113056759 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049112 Uncertain Approved Nucleus
Vesicles Glioma:9.22e-5 (favourable) Mixed Mixed ovary: 8.8 ZFP69 FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A ENSG00000187815 ZFP69 zinc finger protein 1 40477215-40496343 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027808, HPA054942 Uncertain Approved Nucleus Renal cancer:5.00e-6 (unfavourable), Head and neck cancer:9.31e-4 (favourable) Expressed in all Mixed testis: 6.8 ZFP82 KIAA1948, MGC45380, ZNF545 ENSG00000181007 ZFP82 zinc finger protein 19 36383120-36418656 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA060470 Uncertain Mixed Mixed thyroid gland: 8.8 ZFP92 ZNF897 ENSG00000189420 ZFP92 zinc finger protein X 153418322-153426481 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003030 Uncertain Tissue enhanced Mixed fallopian tube: 5.2 ZFR2 KIAA1086 ENSG00000105278 Zinc finger RNA binding protein 2 19 3804024-3869032 Predicted intracellular proteins Evidence at protein level HPA043275, HPA055678 Uncertain Uncertain Nucleoplasm Tissue enhanced Group enriched 9 adrenal gland: 3.8;cerebral cortex: 12.7;testis: 19.0 fallopian tube: 1.3 ZFX ZNF926 ENSG00000005889 Zinc finger protein, X-linked X 24149173-24216255 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001748, HPA003877, HPA071863 Supported Approved Nucleoplasm
Nucleoli Expressed in all Expressed in all parathyroid gland: 32.5 ZGLP1 GATAD3, GLP-1, GLP1 ENSG00000220201 Zinc finger, GATA-like protein 1 19 10304803-10309880 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049855 Uncertain Approved Nucleus
Vesicles Mixed Mixed testis: 3.1 ZGRF1 C4orf21, FLJ11331 ENSG00000138658 Zinc finger, GRF-type containing 1 4 112539333-112636995 Predicted intracellular proteins Evidence at protein level HPA030704, HPA030706 Uncertain Approved Cytosol Mixed Mixed testis: 6.7 ZHX1-C8orf76 ENSG00000259305 ZHX1-C8orf76 readthrough 8 123226189-123274284 Predicted intracellular proteins Evidence at transcript level HPA023708 Uncertain Uncertain Nucleoplasm
Cytosol Mixed Mixed bone marrow: 5.3 ZIC1 ZIC, ZNF201 ENSG00000152977 Zic family member 1 3 147393422-147510293 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004098 Supported Supported Nucleoplasm Tissue enhanced Tissue enriched 9 cerebral cortex: 23.8 skin: 2.5 ZIC4 ENSG00000174963 Zic family member 4 3 147386046-147406860 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at transcript level HPA030194 Uncertain Approved Nucleus
Cytosol Mixed Tissue enhanced cerebral cortex: 4.3;skin: 1.4 testis: 0.7 ZIK1 ZNF762 ENSG00000171649 Zinc finger protein interacting with K protein 1 19 57578456-57593777 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059975 Uncertain Approved Intermediate filaments Mixed Mixed parathyroid gland: 12.0 ZIM2 ZNF656 ENSG00000269699 Zinc finger, imprinted 2 19 56774552-56840729 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA071856 Approved Nuclear speckles
Cytosol Not detected Group enriched 6 adrenal gland: 5.8;cerebral cortex: 5.1;ovary: 10.0;placenta: 6.8;testis: 7.8 endometrium: 1.1 ZIM3 ZNF657 ENSG00000141946 Zinc finger, imprinted 3 19 57134096-57145202 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA034575 Uncertain Not detected Not detected testis: 0.8 ZMAT1 KIAA1789 ENSG00000166432 Zinc finger, matrin-type 1 X 101882288-101932031 Predicted intracellular proteins Evidence at protein level HPA012827 Uncertain Approved Nucleoplasm Pancreatic cancer:1.72e-5 (favourable) Mixed Tissue enhanced epididymis: 25.5 parathyroid gland: 12.0 ZMYM1 FLJ23151, MYM ENSG00000197056 Zinc finger, MYM-type 1 1 35059786-35115859 Predicted intracellular proteins Evidence at protein level HPA064019 Approved Microtubule organizing center Liver cancer:3.21e-6 (unfavourable) Expressed in all Mixed testis: 6.9 ZMYM6 Buster2, MYM, ZBED7, ZNF198L4, ZNF258 ENSG00000163867 Zinc finger, MYM-type 6 1 34986165-35031968 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA011004, HPA071865 Approved Supported Nucleoplasm Breast cancer:1.30e-5 (favourable) Expressed in all Mixed testis: 18.9 ZMYND12 DKFZp434N2435 ENSG00000066185 Zinc finger, MYND-type containing 12 1 42430329-42456267 Predicted intracellular proteins Evidence at transcript level Renal cancer:1.11e-5 (favourable) Mixed Tissue enhanced fallopian tube: 23.1;testis: 51.6 epididymis: 8.6 ZMYND15 DKFZp434N127 ENSG00000141497 Zinc finger, MYND-type containing 15 17 4740015-4746119 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA023286 Approved Nuclear speckles
Cytosol Expressed in all Tissue enhanced parathyroid gland: 15.6;testis: 29.5 lung: 7.6 ZNF100 ENSG00000197020 Zinc finger protein 100 19 21722766-21767628 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059135 Uncertain Urothelial cancer:5.47e-4 (favourable) Mixed Mixed testis: 11.9 ZNF107 smap-7, ZFD25, ZNF588 ENSG00000196247 Zinc finger protein 107 7 64666083-64711582 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:2.62e-4 (unfavourable) Expressed in all Mixed lymph node: 19.7 ZNF112 ZFP112, ZNF228 ENSG00000062370 Zinc finger protein 112 19 44326555-44367217 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023856 Approved Approved Centrosome Renal cancer:1.54e-5 (favourable) Mixed Mixed testis: 13.7 ZNF117 H-plk, HPF9 ENSG00000152926 Zinc finger protein 117 7 64971776-65006684 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031148 Approved Nucleoli fibrillar center
Cytosol Renal cancer:2.17e-11 (unfavourable) Expressed in all Mixed adrenal gland: 25.2 ZNF132 pHZ-12 ENSG00000131849 Zinc finger protein 132 19 58432814-58440222 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA008726 Uncertain Approved Vesicles
Intermediate filaments Renal cancer:7.26e-13 (favourable), Pancreatic cancer:1.92e-4 (favourable) Mixed Mixed parathyroid gland: 10.6 ZNF134 pHZ-15 ENSG00000213762 Zinc finger protein 134 19 57614233-57624723 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009064 Supported Approved Nucleoplasm Cervical cancer:1.03e-4 (unfavourable), Renal cancer:2.61e-4 (favourable), Head and neck cancer:5.21e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 25.2 ZNF135 pHZ-17, ZNF61, ZNF78L1 ENSG00000176293 Zinc finger protein 135 19 58059239-58086310 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006961 Approved Approved Cytosol Renal cancer:3.93e-5 (favourable) Mixed Mixed parathyroid gland: 24.5 ZNF14 GIOT-4, KOX6 ENSG00000105708 Zinc finger protein 14 19 19710471-19733097 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049863 Uncertain Approved Nucleus
Cytosol Renal cancer:8.09e-6 (favourable), Lung cancer:7.96e-4 (favourable) Expressed in all Mixed thyroid gland: 13.3 ZNF140 pHZ-39 ENSG00000196387 Zinc finger protein 140 12 133079838-133107544 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048332 Uncertain Expressed in all Expressed in all endometrium: 14.5 ZNF154 pHZ-92 ENSG00000179909 Zinc finger protein 154 19 57697367-57709194 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed parathyroid gland: 9.6 ZNF157 HZF22 ENSG00000147117 Zinc finger protein 157 X 47370583-47414305 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003319 Uncertain Tissue enhanced Mixed fallopian tube: 2.1 ZNF160 F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18 ENSG00000170949 Zinc finger protein 160 19 53066606-53103436 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023599 Uncertain Approved Nuclear speckles
Cytosol Urothelial cancer:2.67e-5 (favourable) Expressed in all Expressed in all spleen: 38.0 ZNF17 FLJ40864, FLJ46058, FLJ46615, HPF3, KIAA1947, KOX10 ENSG00000186272 Zinc finger protein 17 19 57411163-57421939 Predicted intracellular proteins, Transcription factors Evidence at transcript level Pancreatic cancer:6.03e-4 (favourable) Expressed in all Mixed parathyroid gland: 9.0 ZNF182 HHZ150, KOX14, Zfp182, ZNF21 ENSG00000147118 Zinc finger protein 182 X 47974851-48003978 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059574 Uncertain Approved Nucleus Urothelial cancer:1.55e-7 (favourable), Renal cancer:2.42e-5 (unfavourable), Liver cancer:3.73e-4 (unfavourable) Expressed in all Mixed thyroid gland: 9.5 ZNF19 KOX12, MGC51021 ENSG00000157429 Zinc finger protein 19 16 71464555-71565089 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA053189, HPA063685 Uncertain Approved Mitochondria Mixed Expressed in all testis: 32.3 ZNF197 D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41 ENSG00000186448 Zinc finger protein 197 3 44584888-44648471 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054567 Uncertain Approved Nucleoplasm Prostate cancer:6.78e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 9.2 ZNF200 ENSG00000010539 Zinc finger protein 200 16 3222325-3236221 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018981, HPA059310 Uncertain Approved Mitochondria Expressed in all Tissue enhanced testis: 31.5 placenta: 8.7 ZNF208 PMIDP, ZNF95 ENSG00000160321 Zinc finger protein 208 19 21932958-22010949 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Mixed testis: 16.8 ZNF211 CH2H2-25, ZNF-25 ENSG00000121417 Zinc finger protein 211 19 57630395-57642779 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA011340, HPA049967 Approved Approved Mitochondria
Rods & Rings Expressed in all Expressed in all parathyroid gland: 32.1 ZNF213 CR53, ZKSCAN21, ZSCAN53 ENSG00000085644 Zinc finger protein 213 16 3129777-3142805 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035000, HPA056750 Uncertain Approved Nucleus
Nuclear membrane
Vesicles
Cytosol Liver cancer:6.74e-4 (unfavourable) Expressed in all Mixed testis: 16.9 ZNF214 ENSG00000149050 Zinc finger protein 214 11 6999318-7020368 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055391 Uncertain Mixed Mixed fallopian tube: 6.8 ZNF215 ZKSCAN11, ZSCAN43 ENSG00000149054 Zinc finger protein 215 11 6926404-6984632 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047243, HPA051010 Approved Approved Nucleoplasm
Vesicles Mixed Mixed lymph node: 4.8 ZNF222 ENSG00000159885 Zinc finger protein 222 19 44025342-44033112 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004086 Approved Approved Nucleoplasm
Nuclear bodies Pancreatic cancer:5.56e-7 (favourable) Expressed in all Mixed testis: 16.8 ZNF225 ENSG00000256294 Zinc finger protein 225 19 44112181-44134816 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA073778 Approved Nucleoplasm Mixed Tissue enhanced testis: 22.7 breast: 10.5 ZNF226 ENSG00000167380 Zinc finger protein 226 19 44165073-44178381 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006145, CAB034353 Uncertain Approved Nuclear bodies Urothelial cancer:2.37e-5 (favourable), Pancreatic cancer:8.34e-4 (favourable) Expressed in all Expressed in all thyroid gland: 39.7 ZNF229 ENSG00000278318 Zinc finger protein 229 19 44417519-44448578 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA001494 Uncertain Approved Vesicles
Plasma membrane Renal cancer:8.43e-5 (favourable) Mixed Tissue enhanced parathyroid gland: 6.5 fallopian tube,thyroid gland: 3.1 ZNF23 KOX16, Zfp612, ZNF359, ZNF612 ENSG00000167377 Zinc finger protein 23 16 71447597-71463095 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023534 Uncertain Approved Cytosol Not detected Mixed cerebral cortex: 12.2 ZNF233 FLJ38032 ENSG00000159915 Zinc finger protein 233 19 44259880-44275317 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA020975 Uncertain Approved Nucleoplasm Mixed Tissue enhanced testis: 26.5 cerebral cortex: 5.9 ZNF234 HZF4, ZNF269 ENSG00000263002 Zinc finger protein 234 19 44141557-44160309 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001664 Approved Approved Nuclear bodies Urothelial cancer:4.34e-5 (favourable) Expressed in all Mixed parathyroid gland: 9.1 ZNF235 ANF270, HZF6, ZFP93, ZNF270 ENSG00000159917 Zinc finger protein 235 19 44228729-44305046 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045582 Uncertain Supported Nucleoplasm Mixed Mixed parathyroid gland: 6.2 ZNF236 ENSG00000130856 Zinc finger protein 236 18 76822607-76970727 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008600 Uncertain Approved Nucleoplasm
Cell Junctions
Cytosol Expressed in all Mixed testis: 13.2 ZNF248 bA162G10.3 ENSG00000198105 Zinc finger protein 248 10 37776526-37858106 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018237, HPA018287, HPA018455 Uncertain Approved Nucleoplasm Lung cancer:1.04e-4 (favourable), Pancreatic cancer:1.22e-4 (favourable), Renal cancer:2.25e-4 (unfavourable), Prostate cancer:6.71e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 25.3 ZNF25 FLJ31890, KOX19, Zfp9 ENSG00000175395 Zinc finger protein 25 10 37949572-37976633 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030190 Uncertain Approved Nucleoplasm
Golgi apparatus Expressed in all Mixed cerebral cortex: 27.0 ZNF251 ENSG00000198169 Zinc finger protein 251 8 144720907-144756417 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA018290 Approved Approved Nucleoplasm Renal cancer:1.42e-9 (unfavourable) Expressed in all Mixed thyroid gland: 13.7 ZNF253 BMZF-1, FLJ90391, ZNF411 ENSG00000256771 Zinc finger protein 253 19 19865886-19894674 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:9.69e-5 (favourable), Glioma:1.11e-4 (favourable), Ovarian cancer:2.19e-4 (favourable) Expressed in all Mixed thyroid gland: 25.8 ZNF254 BMZF-5, HD-ZNF1, ZNF539, ZNF91L ENSG00000213096 Zinc finger protein 254 19 24033405-24129961 Predicted intracellular proteins, Transcription factors Evidence at transcript level Lung cancer:8.60e-4 (favourable), Urothelial cancer:9.96e-4 (favourable) Expressed in all Mixed thyroid gland: 29.2 ZNF257 BMZF-4 ENSG00000197134 Zinc finger protein 257 19 22052452-22091480 Predicted intracellular proteins, Transcription factors Evidence at transcript level Ovarian cancer:2.05e-4 (favourable) Tissue enhanced Mixed testis: 4.3 ZNF267 HZF2 ENSG00000185947 Zinc finger protein 267 16 31873758-31917357 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003866 Approved Approved Nucleoplasm Renal cancer:1.58e-6 (unfavourable) Expressed in all Mixed appendix: 25.6 ZNF275 ENSG00000063587 Zinc finger protein 275 X 153334155-153360110 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA000566 Approved Approved Nucleoli Expressed in all Expressed in all adrenal gland: 79.7 ZNF28 DKFZp781D0275, KOX24 ENSG00000198538 Zinc finger protein 28 19 52797409-52857600 Predicted intracellular proteins, Transcription factors Evidence at transcript level Breast cancer:9.29e-4 (unfavourable) Expressed in all Mixed thyroid gland: 17.9 ZNF280A 3'OY11.1, SUHW1, ZNF280, ZNF636 ENSG00000169548 Zinc finger protein 280A 22 22513736-22520270 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044475 Uncertain Uncertain Nucleoplasm Tissue enhanced Not detected adrenal gland: 0.3 ZNF282 HUB1 ENSG00000170265 Zinc finger protein 282 7 149195485-149226248 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024374 Supported Approved Nucleoplasm
Cytosol Liver cancer:3.03e-5 (unfavourable) Expressed in all Expressed in all cervix, uterine: 14.8 ZNF283 ENSG00000167637 Zinc finger protein 283 19 43827292-43852017 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA072977 Approved Nucleoplasm Mixed Mixed parathyroid gland: 10.0 ZNF284 DKFZp781F1775 ENSG00000186026 Zinc finger protein 284 19 44072144-44089613 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed skin: 3.6 ZNF285 ZNF285A ENSG00000267508 Zinc finger protein 285 19 44382298-44401608 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046100, HPA049212 Uncertain Mixed Mixed ovary: 7.8 ZNF287 ZKSCAN13, ZSCAN45 ENSG00000141040 Zinc finger protein 287 17 16551387-16569206 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029290 Uncertain Approved Golgi apparatus Renal cancer:5.28e-5 (favourable) Mixed Mixed parathyroid gland: 12.8 ZNF296 ZNF342 ENSG00000170684 Zinc finger protein 296 19 45071500-45076588 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046940, HPA049576 Uncertain Approved Nucleoplasm
Centrosome Head and neck cancer:5.24e-4 (favourable) Expressed in all Mixed spleen: 3.9 ZNF30 DKFZp686N19164, FLJ20562, KOX28 ENSG00000168661 Zinc finger protein 30 19 34926903-34945170 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030400 Uncertain Approved Nucleoplasm
Cytosol Pancreatic cancer:1.16e-4 (favourable) Expressed in all Mixed fallopian tube: 5.0 ZNF304 ENSG00000131845 Zinc finger protein 304 19 57351307-57359898 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050531 Approved Approved Nuclear speckles Renal cancer:1.52e-7 (favourable), Melanoma:4.95e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 15.6 ZNF311 ENSG00000197935 Zinc finger protein 311 6 28994785-29005316 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050541 Uncertain Mixed Not detected fallopian tube: 0.4 ZNF324 ZF5128, ZNF324A ENSG00000083812 Zinc finger protein 324 19 58467045-58475436 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039774 Uncertain Approved Nucleus
Nuclear membrane
Cytosol Renal cancer:1.34e-7 (favourable), Pancreatic cancer:4.74e-5 (favourable), Thyroid cancer:6.99e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 8.6 ZNF333 KIAA1806 ENSG00000160961 Zinc finger protein 333 19 14689801-14733746 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA043973, HPA054680 Uncertain Approved Nucleoplasm Mixed Mixed endometrium: 11.2 ZNF334 bA179N14.1 ENSG00000198185 Zinc finger protein 334 20 46499630-46513559 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050022 Uncertain Approved Nucleus
Cytosol Mixed Mixed ovary: 19.3 ZNF345 HZF10 ENSG00000251247 Zinc finger protein 345 19 36850361-36913029 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA025816 Uncertain Mixed Mixed testis: 18.4 ZNF35 HF.10, HF10, Zfp105 ENSG00000169981 Zinc finger protein 35 3 44648727-44660791 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051859, HPA054738 Uncertain Approved Nucleoplasm Expressed in all Mixed testis: 9.2 ZNF354A EZNF, HKL1, KID-1, KID1, TCF17 ENSG00000169131 Zinc finger protein 354A 5 178711592-178730702 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052043 Approved Supported Nucleus
Nucleoli
Cytosol Renal cancer:3.45e-6 (unfavourable), Ovarian cancer:8.28e-4 (favourable) Expressed in all Expressed in all testis: 16.7 ZNF354B FLJ25008, KID2 ENSG00000178338 Zinc finger protein 354B 5 178859953-178888122 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029056 Approved Approved Nucleoplasm Renal cancer:1.30e-5 (unfavourable), Head and neck cancer:9.52e-4 (favourable) Expressed in all Expressed in all placenta: 19.7 ZNF354C KID3 ENSG00000177932 Zinc finger protein 354C 5 179060415-179083537 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030904 Uncertain Supported Nuclear membrane
Cytosol Mixed Mixed ovary: 9.2 ZNF365 KIAA0844, UAN ENSG00000138311 Zinc finger protein 365 10 62374192-62672011 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA052446 Approved Supported Vesicles
Microtubule organizing center Mixed Tissue enriched 5 cerebral cortex: 54.6 parathyroid gland: 10.7 ZNF37A KOX21, ZNF37 ENSG00000075407 Zinc finger protein 37A 10 38094336-38125544 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003172 Approved Approved Vesicles Renal cancer:2.31e-4 (unfavourable), Liver cancer:2.83e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 18.1 ZNF382 FLJ14686, KS1 ENSG00000161298 Zinc finger protein 382 19 36604817-36634113 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049259 Approved Approved Nuclear speckles Mixed Mixed cerebral cortex: 10.9 ZNF383 FLJ35863 ENSG00000188283 Zinc finger protein 383 19 37217926-37248738 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063945 Approved Supported Nucleus
Nuclear membrane Urothelial cancer:3.71e-4 (favourable), Pancreatic cancer:9.97e-4 (favourable) Expressed in all Mixed thyroid gland: 9.3 ZNF385D FLJ22419, ZNF659 ENSG00000151789 Zinc finger protein 385D 3 21412222-22373321 Predicted intracellular proteins Evidence at protein level HPA036190 Uncertain Mixed Tissue enhanced cerebral cortex: 4.8 adipose tissue: 3.0 ZNF391 dJ153G14.3 ENSG00000124613 Zinc finger protein 391 6 27374615-27403904 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050886 Uncertain Ovarian cancer:1.89e-4 (favourable) Mixed Mixed testis: 8.9 ZNF416 FLJ20557 ENSG00000083817 Zinc finger protein 416 19 57571566-57578927 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063318 Approved Nuclear bodies
Cytosol Renal cancer:1.20e-5 (favourable) Expressed in all Mixed testis: 7.8 ZNF429 ENSG00000197013 Zinc finger protein 429 19 21496682-21556270 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004139 Approved Nucleus Ovarian cancer:1.96e-8 (favourable), Pancreatic cancer:7.30e-4 (favourable) Mixed Mixed thyroid gland: 17.1 ZNF43 HTF6, KOX27, ZNF39L1 ENSG00000198521 Zinc finger protein 43 19 21804949-21852125 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050271 Uncertain Ovarian cancer:3.16e-5 (favourable) Mixed Mixed testis: 17.0 ZNF431 KIAA1969 ENSG00000196705 Zinc finger protein 431 19 21142024-21196053 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059135 Uncertain Mixed Mixed ovary: 26.7 ZNF438 bA330O11.1 ENSG00000183621 Zinc finger protein 438 10 30820207-31031937 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039843 Uncertain Supported Nucleoplasm
Cytosol Expressed in all Mixed thyroid gland: 16.2 ZNF44 KOX7, ZNF504, ZNF55, ZNF58 ENSG00000197857 Zinc finger protein 44 19 12224686-12294887 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003146 Supported Approved Nucleoplasm
Microtubules
Cytosol Urothelial cancer:9.21e-6 (favourable), Lung cancer:7.54e-4 (favourable), Head and neck cancer:8.74e-4 (favourable) Expressed in all Mixed skin: 8.6 ZNF441 FLJ38637 ENSG00000197044 Zinc finger protein 441 19 11767000-11784078 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA063338 Approved Nuclear speckles Expressed in all Mixed thyroid gland: 12.1 ZNF442 FLJ14356 ENSG00000198342 Zinc finger protein 442 19 12345949-12365905 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA045738, HPA053407 Uncertain Approved Nuclear membrane
Vesicles Mixed Mixed ovary: 6.0 ZNF443 ZK1 ENSG00000180855 Zinc finger protein 443 19 12429707-12441112 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003150, HPA018683 Supported Uncertain Nucleoplasm
Microtubule organizing center Renal cancer:2.74e-7 (favourable), Urothelial cancer:3.91e-4 (favourable) Expressed in all Mixed parathyroid gland: 6.9 ZNF45 ZNF13 ENSG00000124459 Zinc finger protein 45 19 43912629-43935278 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038611, HPA075124 Uncertain Supported Nucleoplasm Expressed in all Mixed parathyroid gland: 18.1 ZNF454 FLJ37444 ENSG00000178187 Zinc finger protein 454 5 178941191-178966433 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA024556 Uncertain Mixed Mixed testis: 4.0 ZNF461 GIOT-1, MGC33911 ENSG00000197808 Zinc finger protein 461 19 36637192-36666853 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA021139 Uncertain Approved Nucleus
Nucleoli
Golgi apparatus Endometrial cancer:3.64e-4 (unfavourable) Expressed in all Mixed thyroid gland: 6.1 ZNF467 EZI, Zfp467 ENSG00000181444 Zinc finger protein 467 7 149764182-149773479 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042907 Uncertain Approved Mitochondria Pancreatic cancer:4.56e-4 (favourable) Expressed in all Mixed spleen: 14.4 ZNF468 ENSG00000204604 Zinc finger protein 468 19 52838008-52857649 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:3.94e-7 (favourable), Breast cancer:6.87e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 20.3 ZNF469 KIAA1858 ENSG00000225614 Zinc finger protein 469 16 88427471-88440757 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069784 Approved Vesicles Mixed Mixed cervix, uterine: 2.3 ZNF470 CZF-1, FLJ26175 ENSG00000197016 Zinc finger protein 470 19 56567511-56588911 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029000 Uncertain Supported Nucleoplasm
Nuclear bodies Mixed Mixed cerebral cortex: 5.8 ZNF471 KIAA1396, Z1971 ENSG00000196263 Zinc finger protein 471 19 56507843-56530221 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA066695 Uncertain Supported Nucleus Renal cancer:2.37e-4 (favourable) Mixed Mixed ovary: 28.0 ZNF474 4933409D10Rik, FLJ32921 ENSG00000164185 Zinc finger protein 474 5 122129513-122179617 Predicted intracellular proteins Evidence at transcript level HPA036595 Uncertain Mixed Group enriched 8 fallopian tube: 26.3;testis: 13.5 lung: 2.6 ZNF479 KR19 ENSG00000185177 Zinc finger protein 479 7 57119614-57139864 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Tissue enriched 42 testis: 4.2 all non-specific tissues: 0.0 ZNF485 ENSG00000198298 Zinc finger protein 485 10 43606407-43617903 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059356 Uncertain Breast cancer:5.24e-4 (unfavourable) Expressed in all Mixed testis: 7.1 ZNF486 KRBO2, MGC2396 ENSG00000256229 Zinc finger protein 486 19 20167228-20200490 Predicted intracellular proteins Evidence at transcript level Mixed Tissue enhanced thyroid gland: 63.3 urinary bladder: 17.8 ZNF491 FLJ34791 ENSG00000177599 Zinc finger protein 491 19 11797667-11809622 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed parathyroid gland: 3.5 ZNF492 KIAA1473, ZNF115 ENSG00000229676 Zinc finger protein 492 19 22634324-22667670 Predicted intracellular proteins, Transcription factors Evidence at transcript level Group enriched Tissue enhanced testis: 3.6 bone marrow: 1.6 ZNF493 FLJ36504 ENSG00000196268 Zinc finger protein 493 19 21397119-21427573 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Expressed in all thyroid gland: 34.6 ZNF497 FLJ44773 ENSG00000174586 Zinc finger protein 497 19 58354357-58362848 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047872 Uncertain Approved Nucleus
Cell Junctions Mixed Mixed fallopian tube: 10.7 ZNF500 KIAA0557, ZKSCAN18, ZSCAN50 ENSG00000103199 Zinc finger protein 500 16 4748239-4767624 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035498, HPA057963 Supported Validated Nucleoplasm
Cytosol Stomach cancer:3.41e-4 (favourable) Expressed in all Mixed testis: 8.2 ZNF501 MGC21738, ZNF52 ENSG00000186446 Zinc finger protein 501 3 44729596-44737083 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044161 Uncertain Approved Endoplasmic reticulum Mixed Mixed testis: 2.7 ZNF506 DKFZp761G1812 ENSG00000081665 Zinc finger protein 506 19 19785839-19821751 Predicted intracellular proteins, Transcription factors Evidence at transcript level Expressed in all Expressed in all thyroid gland: 16.2 ZNF510 KIAA0972 ENSG00000081386 Zinc finger protein 510 9 96755865-96778129 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049139 Uncertain Approved Nucleoplasm
Plasma membrane Renal cancer:5.94e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 12.2 ZNF514 FLJ14457 ENSG00000144026 Zinc finger protein 514 2 95147330-95165413 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028974 Approved Approved Nucleoplasm
Nuclear bodies Expressed in all Expressed in all epididymis: 32.4 ZNF517 ENSG00000197363 Zinc finger protein 517 8 144798876-144811169 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055337 Approved Nucleoplasm Pancreatic cancer:1.66e-4 (favourable) Expressed in all Mixed skin: 7.5 ZNF518B KIAA1729 ENSG00000178163 Zinc finger protein 518B 4 10439874-10457410 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031215, HPA031216 Approved Approved Nucleus Mixed Mixed testis: 16.9 ZNF519 FLJ36809, HsT2362 ENSG00000175322 Zinc finger protein 519 18 14057457-14132490 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028982 Uncertain Approved Nucleoli Mixed Mixed endometrium: 4.0 ZNF526 KIAA1951, MGC4267 ENSG00000167625 Zinc finger protein 526 19 42220271-42228201 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023070, HPA056609 Uncertain Approved Nucleus
Golgi apparatus
Vesicles Expressed in all Mixed skin: 6.2 ZNF527 KIAA1829 ENSG00000189164 Zinc finger protein 527 19 37371061-37393066 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA037740, HPA037741 Uncertain Approved Nuclear speckles
Golgi apparatus Mixed Mixed parathyroid gland: 4.5 ZNF528 KIAA1827 ENSG00000167555 Zinc finger protein 528 19 52397849-52418412 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065435 Approved Nuclear speckles
Cytosol Expressed in all Expressed in all thyroid gland: 31.1 ZNF529 KIAA1615 ENSG00000186020 Zinc finger protein 529 19 36534774-36605276 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA031311 Uncertain Approved Nucleoplasm Urothelial cancer:1.39e-5 (favourable) Expressed in all Mixed testis: 18.2 ZNF530 KIAA1508 ENSG00000183647 Zinc finger protein 530 19 57599885-57612722 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045868 Uncertain Approved Vesicles Mixed Mixed spleen: 3.2 ZNF534 FLJ25344, KRBO3 ENSG00000198633 Zinc finger protein 534 19 52429187-52452315 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enhanced testis: 2.4 cerebral cortex: 0.9 ZNF541 DKFZp434I1930 ENSG00000118156 Zinc finger protein 541 19 47520685-47555856 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA058541 Approved Nucleoplasm
Cytosol Cervical cancer:2.94e-4 (favourable) Tissue enhanced Tissue enriched 11 testis: 19.2 ovary: 1.7 ZNF546 MGC43537, ZNF49 ENSG00000187187 Zinc finger protein 546 19 39984134-40021041 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030838 Approved Nucleus
Cytosol Mixed Tissue enhanced testis: 14.4 parathyroid gland: 3.3 ZNF547 FLJ31100 ENSG00000152433 Zinc finger protein 547 19 57363477-57379565 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA056001 Uncertain Mixed Mixed thyroid gland: 5.2 ZNF548 FLJ32932 ENSG00000188785 Zinc finger protein 548 19 57389850-57402992 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA066042 Uncertain Approved Nucleus Breast cancer:7.85e-4 (favourable) Expressed in all Expressed in all lymph node: 33.1 ZNF549 FLJ34917 ENSG00000121406 Zinc finger protein 549 19 57527325-57557542 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039511 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed parathyroid gland: 10.2 ZNF551 DKFZp686H1038 ENSG00000204519 Zinc finger protein 551 19 57681969-57717301 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038187, HPA038188 Uncertain Approved Nucleoplasm
Nuclear speckles Melanoma:7.68e-5 (unfavourable), Renal cancer:1.32e-4 (favourable) Expressed in all Mixed testis: 8.1 ZNF554 FLJ34817 ENSG00000172006 Zinc finger protein 554 19 2819874-2835773 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060247, HPA063358 Uncertain Supported Nucleoplasm
Nucleoli Renal cancer:1.99e-5 (favourable), Pancreatic cancer:4.69e-4 (favourable), Urothelial cancer:5.00e-4 (favourable), Lung cancer:9.31e-4 (favourable) Expressed in all Mixed cerebral cortex: 7.5 ZNF556 FLJ11637 ENSG00000172000 Zinc finger protein 556 19 2867335-2883445 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA060593 Approved Nucleus Mixed Tissue enhanced fallopian tube: 3.3;ovary: 6.5 testis: 1.3 ZNF557 MGC4054 ENSG00000130544 Zinc finger protein 557 19 7069444-7087968 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003151, HPA029291 Uncertain Approved Nucleus
Intermediate filaments
Cytosol Head and neck cancer:3.67e-6 (favourable), Pancreatic cancer:1.51e-4 (favourable), Lung cancer:2.62e-4 (favourable), Endometrial cancer:5.70e-4 (favourable) Expressed in all Mixed testis: 5.6 ZNF558 FLJ30932 ENSG00000167785 Zinc finger protein 558 19 8806170-8832328 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003151 Uncertain Renal cancer:1.23e-6 (unfavourable), Urothelial cancer:9.30e-5 (favourable), Head and neck cancer:1.04e-4 (favourable) Expressed in all Mixed parathyroid gland: 18.7 ZNF560 FLJ31986 ENSG00000198028 Zinc finger protein 560 19 9466507-9498607 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enriched 9 testis: 11.9 placenta: 1.2 ZNF561 MGC45408 ENSG00000171469 Zinc finger protein 561 19 9604680-9621399 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055332, HPA062397 Uncertain Approved Nucleoplasm Renal cancer:1.16e-4 (favourable), Ovarian cancer:1.31e-4 (favourable) Expressed in all Expressed in all smooth muscle: 37.6 ZNF562 FLJ20079 ENSG00000171466 Zinc finger protein 562 19 9641808-9675086 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055332, HPA062397 Uncertain Approved Nucleoplasm Head and neck cancer:4.17e-4 (favourable) Expressed in all Expressed in all esophagus: 19.1 ZNF563 FLJ34797 ENSG00000188868 Zinc finger protein 563 19 12317477-12333720 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042136 Uncertain Expressed in all Tissue enhanced testis: 25.5 thyroid gland: 8.5 ZNF565 FLJ36991 ENSG00000196357 Zinc finger protein 565 19 36182060-36246257 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044123 Uncertain Approved Nucleoplasm
Nuclear bodies Expressed in all Mixed testis: 11.5 ZNF566 FLJ14779, MGC12515 ENSG00000186017 Zinc finger protein 566 19 36445119-36489902 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023456 Uncertain Approved Nucleus Endometrial cancer:1.86e-4 (unfavourable) Expressed in all Mixed thyroid gland: 8.0 ZNF568 DKFZp686B0797 ENSG00000198453 Zinc finger protein 568 19 36916329-36998700 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052061 Uncertain Mixed Mixed parathyroid gland: 14.1 ZNF57 ZNF424 ENSG00000171970 Zinc finger protein 57 19 2900898-2918476 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA061915 Approved Nucleoli Renal cancer:4.11e-9 (favourable), Lung cancer:6.26e-4 (favourable), Pancreatic cancer:7.72e-4 (favourable) Expressed in all Tissue enriched 5 testis: 58.4 skin: 11.6 ZNF570 FLJ30791 ENSG00000171827 Zinc finger protein 570 19 37467585-37488652 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at transcript level HPA028881 Uncertain Approved Nucleoplasm Renal cancer:4.06e-5 (favourable) Expressed in all Mixed testis: 10.7 ZNF571 HSPC059 ENSG00000180479 Zinc finger protein 571 19 37554782-37594790 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA054762 Approved Nucleus
Nucleoli
Plasma membrane Mixed Tissue enriched 5 thyroid gland: 130.2 testis: 25.9 ZNF573 FLJ30921 ENSG00000189144 Zinc finger protein 573 19 37735833-37817300 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA042776 Uncertain Approved Intermediate filaments
Cytosol Mixed Mixed testis: 4.5 ZNF575 FLJ32567 ENSG00000176472 Zinc finger protein 575 19 43525497-43536130 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051865 Approved Approved Nucleus
Nucleoli fibrillar center
Cytosol Expressed in all Mixed colon: 4.5 ZNF577 MGC4400 ENSG00000161551 Zinc finger protein 577 19 51855802-51890950 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041499, HPA046761 Uncertain Supported Nucleus
Nucleoli Urothelial cancer:2.03e-4 (favourable) Mixed Expressed in all testis: 42.1 ZNF578 FLJ31384 ENSG00000258405 Zinc finger protein 578 19 52453576-52512154 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 5 testis: 14.0 thyroid gland: 2.7 ZNF582 FLJ30927 ENSG00000018869 Zinc finger protein 582 19 56375846-56393545 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028858 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed thyroid gland: 13.4 ZNF583 FLJ31030 ENSG00000198440 Zinc finger protein 583 19 56397966-56436035 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023805, HPA023957 Uncertain Approved Nucleoli
Cytosol Mixed Mixed testis: 13.7 ZNF584 FLJ39899 ENSG00000171574 Zinc finger protein 584 19 58401504-58418327 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at transcript level HPA043408, HPA048075 Uncertain Approved Nuclear speckles Expressed in all Mixed fallopian tube: 9.9 ZNF585A FLJ23765 ENSG00000196967 Zinc finger protein 585A 19 37106734-37172741 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Expressed in all thyroid gland: 17.7 ZNF585B FLJ14928, SZFP41 ENSG00000245680 Zinc finger protein 585B 19 37181579-37218153 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA075556 Approved Nucleoplasm
Cytoplasmic bodies Expressed in all Mixed parathyroid gland: 19.6 ZNF586 FLJ20070 ENSG00000083828 Zinc finger protein 586 19 57769655-57819939 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030306, HPA060782 Approved Approved Nucleoli fibrillar center
Vesicles Breast cancer:9.83e-5 (favourable), Urothelial cancer:5.36e-4 (favourable) Expressed in all Expressed in all bone marrow: 16.3 ZNF594 KIAA1871 ENSG00000180626 Zinc finger protein 594 17 5179536-5191883 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA067178 Approved Nucleus Mixed Mixed ovary: 13.8 ZNF596 ENSG00000172748 Zinc finger protein 596 8 232137-247342 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055463 Uncertain Approved Nucleoli
Mitochondria Mixed Tissue enhanced testis: 27.3 parathyroid gland: 12.9 ZNF597 FLJ33071, HIT-4 ENSG00000167981 Zinc finger protein 597 16 3432422-3443542 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA001556 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all Mixed testis: 7.3 ZNF605 ENSG00000196458 Zinc finger protein 605 12 132918308-132956306 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA061970, HPA062655 Uncertain Approved Nucleoplasm
Vesicles Expressed in all Mixed parathyroid gland,thyroid gland: 11.1 ZNF606 FLJ14260, KIAA1852, ZNF328 ENSG00000166704 Zinc finger protein 606 19 57977053-58003349 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041712, HPA043584 Uncertain Supported Nucleoplasm Urothelial cancer:4.75e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 18.9 ZNF610 FLJ36040 ENSG00000167554 Zinc finger protein 610 19 52336245-52367778 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055771 Approved Renal cancer:1.05e-7 (favourable), Ovarian cancer:3.38e-4 (favourable) Mixed Tissue enhanced testis: 22.1 ovary: 10.4 ZNF611 MGC5384 ENSG00000213020 Zinc finger protein 611 19 52702813-52735073 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:3.33e-4 (favourable) Mixed Mixed fallopian tube: 10.5 ZNF613 FLJ13590 ENSG00000176024 Zinc finger protein 613 19 51879872-51948759 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA026833 Uncertain Approved Nucleoplasm
Vesicles Urothelial cancer:1.92e-6 (favourable) Expressed in all Tissue enhanced prostate: 25.7 parathyroid gland: 8.5 ZNF615 FLJ33710 ENSG00000197619 Zinc finger protein 615 19 51991332-52008230 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA052422 Uncertain Approved Nucleoli
Mitochondria Urothelial cancer:2.98e-4 (favourable) Expressed in all Mixed prostate: 28.6 ZNF616 MGC45556 ENSG00000204611 Zinc finger protein 616 19 52113091-52139922 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062639, HPA071539 Approved Approved Centrosome Expressed in all Expressed in all adrenal gland: 17.4 ZNF619 FLJ90764 ENSG00000177873 Zinc finger protein 619 3 40477113-40490236 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045094 Uncertain Approved Nucleoplasm
Intermediate filaments Expressed in all Mixed parathyroid gland: 7.7 ZNF620 MGC50836 ENSG00000177842 Zinc finger protein 620 3 40505992-40518736 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031452 Uncertain Approved Plasma membrane Mixed Mixed thyroid gland: 6.0 ZNF621 FLJ45246 ENSG00000172888 Zinc finger protein 621 3 40524878-40574685 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065518, HPA071440 Supported Nuclear speckles Expressed in all Expressed in all parathyroid gland: 22.9 ZNF623 KIAA0628 ENSG00000183309 Zinc finger protein 623 8 143636013-143656418 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044372 Uncertain Approved Nucleus Endometrial cancer:2.94e-4 (unfavourable) Expressed in all Mixed endometrium: 6.1 ZNF626 ENSG00000188171 Zinc finger protein 626 19 20620061-20661596 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA045631 Uncertain Approved Nucleoplasm
Nuclear membrane
Vesicles Mixed Expressed in all parathyroid gland: 52.0 ZNF628 ZEC, Zfp628 ENSG00000197483 Zinc finger protein 628 19 55476332-55484487 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044451 Uncertain Approved Nucleoplasm Expressed in all Tissue enhanced testis: 7.3 spleen: 2.8 ZNF630 BC037316, dJ54B20.2, FLJ20573, MGC138344 ENSG00000221994 Zinc finger protein 630 X 47983356-48071658 Predicted intracellular proteins Evidence at transcript level HPA001053, HPA068130 Approved Approved Nucleus
Cytosol Mixed Mixed parathyroid gland: 7.4 ZNF645 CT138, FLJ25735, HAKAIL ENSG00000175809 Zinc finger protein 645 X 22272943-22274461 Predicted intracellular proteins Evidence at protein level Not detected Tissue enriched 140 testis: 14.0 all non-specific tissues: 0.0 ZNF648 FLJ46813 ENSG00000179930 Zinc finger protein 648 1 182054570-182061712 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA053897 Uncertain Not detected Not detected ovary,testis: 0.6 ZNF654 FLJ10997, FLJ21142 ENSG00000175105 Zinc finger protein 654 3 88139104-88144665 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036172, HPA036173 Uncertain Approved Nucleus
Microtubules Prostate cancer:9.97e-6 (unfavourable) Expressed in all Mixed testis: 12.3 ZNF658 DKFZp572C163, FLJ32813, MGC35232 ENSG00000274349 Zinc finger protein 658 9 66856426-66932141 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047730, HPA048668 Uncertain Approved Nucleoplasm Mixed Mixed skin: 9.7 ZNF664 DKFZp761B128, ZFOC1, ZNF176 ENSG00000179195 Zinc finger protein 664 12 123971845-124015439 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047846 Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 231.9 ZNF665 FLJ14345 ENSG00000197497 Zinc finger protein 665 19 53159213-53193386 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023437 Uncertain Approved Nuclear membrane Mixed Mixed ovary: 3.8 ZNF667 FLJ14011 ENSG00000198046 Zinc finger protein 667 19 56439325-56478065 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030731, HPA046673 Uncertain Approved Nucleus Mixed Mixed cerebral cortex: 18.3 ZNF669 FLJ12606 ENSG00000188295 Zinc finger protein 669 1 247099962-247104372 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044043 Uncertain Approved Nucleoli Renal cancer:4.59e-7 (favourable) Expressed in all Mixed testis: 8.7 ZNF671 FLJ23506 ENSG00000083814 Zinc finger protein 671 19 57719751-57727624 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046099 Uncertain Approved Nucleoplasm Breast cancer:2.20e-4 (favourable), Pancreatic cancer:3.57e-4 (favourable) Mixed Mixed parathyroid gland: 16.4 ZNF672 FLJ22301 ENSG00000171161 Zinc finger protein 672 1 248838210-248849517 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055779, HPA062506 Approved Validated Nucleoplasm Urothelial cancer:1.79e-5 (favourable), Pancreatic cancer:7.51e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 24.3 ZNF674 MRX92, ZNF673B ENSG00000251192 Zinc finger protein 674 X 46497727-46545457 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031026, HPA065295 Uncertain Validated Nucleoplasm Mixed Mixed prostate: 3.2 ZNF676 ENSG00000196109 Zinc finger protein 676 19 22179091-22196951 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enhanced parathyroid gland: 4.3;testis: 4.0 thyroid gland: 3.0 ZNF677 MGC48625 ENSG00000197928 Zinc finger protein 677 19 53235381-53254898 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023106, HPA024796 Approved Approved Nucleus
Centrosome Mixed Expressed in all testis: 71.0 ZNF678 MGC42493 ENSG00000181450 Zinc finger protein 678 1 227563543-227677443 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028507 Uncertain Approved Nucleoli
Mitochondria
Cytosol Expressed in all Mixed thyroid gland: 9.0 ZNF680 FLJ90430 ENSG00000173041 Zinc finger protein 680 7 64519884-64563106 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003173 Approved Nucleus Expressed in all Expressed in all thyroid gland: 42.3 ZNF681 FLJ31526 ENSG00000196172 Zinc finger protein 681 19 23739195-23758891 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed testis: 4.7 ZNF682 BC39498_3 ENSG00000197124 Zinc finger protein 682 19 19997058-20039506 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055998 Uncertain Uncertain Golgi apparatus Urothelial cancer:3.51e-4 (favourable) Tissue enhanced Mixed thyroid gland: 13.3 ZNF683 Hobit, MGC33414 ENSG00000176083 Zinc finger protein 683 1 26361634-26374522 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023865 Uncertain Endometrial cancer:2.90e-5 (favourable), Urothelial cancer:3.45e-5 (favourable) Mixed Tissue enriched 11 testis: 78.7 lung: 7.1 ZNF684 MGC27466 ENSG00000117010 Zinc finger protein 684 1 40531561-40548169 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059153 Uncertain Approved Nucleus
Cytosol Renal cancer:4.89e-10 (favourable) Expressed in all Mixed kidney: 6.8 ZNF688 ENSG00000229809 Zinc finger protein 688 16 30569346-30572734 Predicted intracellular proteins Evidence at transcript level HPA048922 Uncertain Approved Nucleoplasm
Plasma membrane
Cell Junctions Endometrial cancer:4.58e-5 (favourable), Lung cancer:3.24e-4 (favourable), Breast cancer:5.90e-4 (favourable), Pancreatic cancer:6.61e-4 (favourable), Cervical cancer:7.74e-4 (favourable) Expressed in all Expressed in all testis: 23.9 ZNF689 FLJ90415 ENSG00000156853 Zinc finger protein 689 16 30602558-30624012 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054095, HPA055385 Approved Approved Nucleus
Nucleoli fibrillar center Pancreatic cancer:9.89e-4 (favourable) Expressed in all Expressed in all testis: 35.3 ZNF696 FLJ14129 ENSG00000185730 Zinc finger protein 696 8 143289676-143298061 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057855, HPA072473 Uncertain Approved Nucleus
Nucleoli Endometrial cancer:3.52e-5 (unfavourable), Cervical cancer:6.63e-5 (unfavourable), Pancreatic cancer:1.41e-4 (favourable) Expressed in all Mixed cerebral cortex: 9.8 ZNF697 MGC45731 ENSG00000143067 Zinc finger protein 697 1 119619422-119647773 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049933 Uncertain Approved Nucleoplasm Renal cancer:6.20e-5 (favourable) Expressed in all Mixed placenta: 10.8 ZNF70 Cos17, MGC48959 ENSG00000187792 Zinc finger protein 70 22 23738678-23751092 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018821 Uncertain Supported Cytosol Mixed Mixed ovary: 4.9 ZNF700 DKFZp434I1610 ENSG00000196757 Zinc finger protein 700 19 11925068-11950773 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047845 Uncertain Uncertain Nucleus Renal cancer:2.01e-5 (unfavourable), Urothelial cancer:2.53e-5 (favourable), Head and neck cancer:1.27e-4 (favourable), Prostate cancer:1.75e-4 (unfavourable), Melanoma:2.58e-4 (unfavourable) Expressed in all Expressed in all skin: 19.1 ZNF701 FLJ10891 ENSG00000167562 Zinc finger protein 701 19 52555822-52587174 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005532 Uncertain Approved Nucleoplasm
Microtubule organizing center Urothelial cancer:4.89e-5 (favourable) Mixed Mixed thyroid gland: 10.0 ZNF705A FLJ16353 ENSG00000196946 Zinc finger protein 705A 12 8138137-8188537 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Mixed cerebral cortex: 9.1 ZNF705D ENSG00000215343 Zinc finger protein 705D 8 12104389-12115516 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Tissue enriched 6 epididymis: 4.5 testis: 0.7 ZNF705G ENSG00000215372 Zinc finger protein 705G 8 7355517-7385558 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Not detected testis: 0.9 ZNF709 FLJ38281 ENSG00000242852 Zinc finger protein 709 19 12461184-12513854 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA045573, HPA053153 Uncertain Approved Nucleoplasm Not detected Tissue enhanced testis: 13.9 thyroid gland: 4.8 ZNF71 Cos26, EZFIT ENSG00000197951 Zinc finger protein 71 19 56595264-56626481 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA018124 Uncertain Approved Nucleus
Nucleoli Expressed in all Mixed cerebral cortex: 5.4 ZNF710 DKFZp547K1113, FLJ00306, FLJ37393 ENSG00000140548 Zinc finger protein 710 15 90001392-90082206 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030226, HPA030227, HPA030228 Supported Approved Nucleoplasm
Mitochondria Expressed in all Expressed in all appendix: 20.9 ZNF713 FLJ39963 ENSG00000178665 Zinc finger protein 713 7 55887475-55942225 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059425, HPA062887 Uncertain Approved Nucleoli Mixed Mixed testis: 8.4 ZNF716 FLJ46189 ENSG00000182111 Zinc finger protein 716 7 57450177-57473546 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enriched 6 testis: 1.1 bone marrow,cerebral cortex,duodenum,epididymis,gallbladder,lymph node,skin,thyroid gland: 0.1 ZNF720 ENSG00000197302 Zinc finger protein 720 16 31713229-31794869 Predicted intracellular proteins Evidence at transcript level HPA041570 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 15.4 ZNF721 KIAA1982 ENSG00000182903 Zinc finger protein 721 4 425815-499156 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065313 Approved Microtubule organizing center
Cytosol Urothelial cancer:2.76e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 30.9 ZNF726 ENSG00000213967 Zinc finger protein 726 19 23914876-23945159 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed breast: 7.3 ZNF729 ENSG00000196350 Zinc finger protein 729 19 22286408-22317176 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 22 testis: 3.8 breast,cerebral cortex,endometrium,parathyroid gland: 0.1 ZNF730 ENSG00000183850 Zinc finger protein 730 19 23075210-23147219 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced testis: 9.5 ovary: 3.1 ZNF732 FLJ59067 ENSG00000186777 Zinc finger protein 732 4 270675-305321 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced testis: 2.7 breast,skin: 0.8 ZNF736 ENSG00000234444 Zinc finger protein 736 7 64307459-64354860 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051027, HPA061215 Uncertain Uncertain Nucleoplasm Endometrial cancer:3.03e-4 (unfavourable), Prostate cancer:5.01e-4 (unfavourable), Urothelial cancer:8.65e-4 (favourable) Mixed Mixed testis: 15.6 ZNF737 ZNF102 ENSG00000237440 Zinc finger protein 737 19 20535825-20565809 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed thyroid gland: 66.8 ZNF738 ENSG00000172687 Zinc finger protein 738 19 21358930-21379302 Predicted intracellular proteins Evidence at protein level HPA059135 Uncertain Ovarian cancer:2.27e-4 (favourable) Mixed Mixed ovary: 11.8 ZNF74 Cos52, Zfp520, ZNF520 ENSG00000185252 Zinc finger protein 74 22 20394115-20408461 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003354 Approved Supported Nucleoplasm
Actin filaments Expressed in all Mixed ovary: 4.9 ZNF75A FLJ31529 ENSG00000162086 Zinc finger protein 75a 16 3305406-3318852 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001665 Uncertain Approved Nucleoplasm
Nucleoli fibrillar center Expressed in all Expressed in all parathyroid gland: 45.5 ZNF75D D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28 ENSG00000186376 Zinc finger protein 75D X 135248920-135344087 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004705 Supported Approved Nucleoplasm
Golgi apparatus Urothelial cancer:7.42e-5 (favourable), Renal cancer:1.31e-4 (favourable) Expressed in all Expressed in all prostate: 16.1 ZNF76 D6S229E, Zfp523, ZNF523 ENSG00000065029 Zinc finger protein 76 6 35258909-35295985 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030090, HPA030091 Approved Approved Nucleoplasm
Cytosol Ovarian cancer:1.18e-4 (favourable), Pancreatic cancer:5.09e-4 (favourable) Expressed in all Expressed in all thyroid gland: 34.5 ZNF763 ZNF440L ENSG00000197054 Zinc finger protein 763 19 11965037-11980381 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047845 Uncertain Uncertain Nucleus Mixed Mixed parathyroid gland: 11.4 ZNF764 MGC13138 ENSG00000169951 Zinc finger protein 764 16 30553764-30558498 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003203 Uncertain Approved Cytosol Endometrial cancer:6.84e-4 (favourable) Expressed in all Mixed testis: 6.0 ZNF766 ENSG00000196214 Zinc finger protein 766 19 52269571-52296046 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044882, HPA063496 Uncertain Supported Centrosome Expressed in all Expressed in all testis: 43.5 ZNF77 pT1 ENSG00000175691 Zinc finger protein 77 19 2933218-2944971 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023397 Uncertain Approved Nucleus
Nucleoli Lung cancer:6.79e-6 (favourable), Endometrial cancer:6.65e-5 (favourable), Cervical cancer:8.49e-4 (favourable) Expressed in all Mixed breast: 5.7 ZNF770 FLJ20582, PRO1914 ENSG00000198146 Zinc finger protein 770 15 34978341-34988287 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024518 Approved Expressed in all Expressed in all thyroid gland: 73.3 ZNF773 MGC4728, ZNF419B ENSG00000152439 Zinc finger protein 773 19 57499915-57518404 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003152 Uncertain Approved Nucleus
Nucleoli fibrillar center Mixed Mixed parathyroid gland: 13.2 ZNF775 MGC33584 ENSG00000196456 Zinc finger protein 775 7 150368790-150410597 Predicted intracellular proteins, Transcription factors Evidence at transcript level Pancreatic cancer:1.35e-5 (favourable), Renal cancer:2.84e-4 (favourable), Head and neck cancer:3.48e-4 (favourable) Expressed in all Mixed cerebral cortex: 7.7 ZNF780A ZNF780 ENSG00000197782 Zinc finger protein 780A 19 40069152-40090938 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003311 Uncertain Approved Nucleus
Centrosome Urothelial cancer:9.30e-4 (favourable) Expressed in all Mixed parathyroid gland: 8.5 ZNF780B ZNF779 ENSG00000128000 Zinc finger protein 780B 19 40028260-40056209 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003311 Uncertain Approved Nucleus
Centrosome Expressed in all Mixed thyroid gland: 8.0 ZNF781 FLJ37549 ENSG00000196381 Zinc finger protein 781 19 37667751-37692322 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062512 Uncertain Approved Nucleoplasm Mixed Mixed smooth muscle: 3.6 ZNF782 FLJ16636 ENSG00000196597 Zinc finger protein 782 9 96816472-96875623 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA011013 Approved Approved Nucleus
Mitochondria Expressed in all Mixed testis: 10.3 ZNF786 DKFZp762I137 ENSG00000197362 Zinc finger protein 786 7 149069643-149090782 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021518, HPA053459 Uncertain Approved Nucleoplasm
Nuclear speckles Liver cancer:1.09e-4 (unfavourable), Pancreatic cancer:2.01e-4 (favourable) Expressed in all Mixed skin: 7.2 ZNF789 ENSG00000198556 Zinc finger protein 789 7 99472841-99503650 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029500, HPA050793 Uncertain Validated Nucleoplasm Urothelial cancer:5.31e-6 (favourable), Renal cancer:3.56e-4 (unfavourable), Pancreatic cancer:7.14e-4 (favourable) Expressed in all Mixed prostate: 13.7 ZNF790 FLJ20350, MGC62100 ENSG00000197863 Zinc finger protein 790 19 36817428-36850787 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA056134, HPA060288 Uncertain Approved Nucleoli Endometrial cancer:7.66e-4 (unfavourable) Expressed in all Mixed testis: 21.0 ZNF791 FLJ90396 ENSG00000173875 Zinc finger protein 791 19 12610918-12633840 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021537 Uncertain Approved Nucleus Urothelial cancer:1.39e-5 (favourable), Lung cancer:9.07e-4 (favourable) Expressed in all Expressed in all thyroid gland: 25.0 ZNF793 ENSG00000188227 Zinc finger protein 793 19 37506939-37548762 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA034781 Uncertain Approved Nucleus
Nucleoli
Cytosol Mixed Mixed testis: 16.8 ZNF799 HIT-40, MGC71805, ZNF842 ENSG00000196466 Zinc finger protein 799 19 12390016-12401271 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003150, HPA018683 Supported Uncertain Nucleoplasm
Microtubule organizing center Endometrial cancer:2.39e-4 (favourable) Mixed Mixed ovary: 7.6 ZNF8 HF.18, Zfp128 ENSG00000278129 Zinc finger protein 8 19 58278951-58302805 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034797, HPA034798 Uncertain Approved Nucleoplasm
Nuclear bodies Mixed Mixed parathyroid gland: 4.7 ZNF80 pT17 ENSG00000174255 Zinc finger protein 80 3 114234631-114237578 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065484 Uncertain Not detected Tissue enhanced breast: 6.4 lymph node: 2.7 ZNF804B FLJ32110 ENSG00000182348 Zinc finger protein 804B 7 88759368-89337057 Predicted intracellular proteins Evidence at protein level HPA026702 Uncertain Not detected Tissue enriched 7 thyroid gland: 7.3 kidney: 0.9 ZNF805 ENSG00000204524 Zinc finger protein 805 19 57240685-57255135 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA057665, HPA058895 Uncertain Mixed Mixed parathyroid gland: 5.0 ZNF808 ENSG00000198482 Zinc finger protein 808 19 52527652-52564464 Predicted intracellular proteins, Transcription factors Evidence at protein level Urothelial cancer:3.88e-4 (favourable), Thyroid cancer:7.82e-4 (unfavourable) Expressed in all Mixed thyroid gland: 15.1 ZNF813 FLJ16542 ENSG00000198346 Zinc finger protein 813 19 53467735-53496255 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056406 Uncertain Approved Vesicles Expressed in all Mixed prostate: 8.8 ZNF816 ZNF816A ENSG00000180257 Zinc finger protein 816 19 52949379-52962911 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA042466 Uncertain Uncertain Nucleoli Expressed in all Mixed prostate: 20.4 ZNF823 HSZFP36 ENSG00000197933 Zinc finger protein 823 19 11721265-11739009 Predicted intracellular proteins, Transcription factors Evidence at transcript level Head and neck cancer:6.76e-5 (favourable), Renal cancer:4.49e-4 (favourable), Stomach cancer:5.05e-4 (favourable) Expressed in all Mixed parathyroid gland: 12.3 ZNF829 DKFZp779O175 ENSG00000185869 Zinc finger protein 829 19 36888124-36916291 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA073073 Approved Nucleus
Nuclear bodies Mixed Tissue enriched 5 testis: 18.3 ovary: 3.3 ZNF83 FLJ11015, HPF1, ZNF816B ENSG00000167766 Zinc finger protein 83 19 52594060-52690496 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA025970 Approved Approved Nucleoplasm Urothelial cancer:6.92e-6 (favourable), Renal cancer:3.13e-5 (unfavourable), Head and neck cancer:3.83e-4 (favourable), Ovarian cancer:9.06e-4 (favourable), Melanoma:9.20e-4 (unfavourable) Expressed in all Expressed in all epididymis: 110.8 ZNF831 C20orf174, dJ492J12.1 ENSG00000124203 Zinc finger protein 831 20 59191020-59259113 Predicted intracellular proteins Evidence at protein level HPA016839 Uncertain Not detected Tissue enhanced lymph node: 7.3 spleen,tonsil: 3.7 ZNF835 BC37295_3 ENSG00000127903 Zinc finger protein 835 19 56661981-56671783 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA051136, HPA055356 Uncertain Approved Actin filaments Mixed Mixed ovary: 5.3 ZNF836 FLJ16287 ENSG00000196267 Zinc finger protein 836 19 52153864-52171643 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:3.77e-4 (favourable), Cervical cancer:5.11e-4 (favourable) Expressed in all Mixed adrenal gland: 34.9 ZNF837 ENSG00000152475 Zinc finger protein 837 19 58367618-58381060 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA042833 Uncertain Approved Nucleoli Renal cancer:1.76e-5 (favourable), Endometrial cancer:1.27e-4 (favourable) Expressed in all Mixed skin,spleen: 1.4 ZNF839 C14orf131 ENSG00000022976 Zinc finger protein 839 14 102317377-102342702 Predicted intracellular proteins Evidence at protein level HPA020434 Uncertain Approved Nucleoplasm
Plasma membrane Pancreatic cancer:4.57e-4 (favourable), Renal cancer:5.00e-4 (favourable) Expressed in all Expressed in all testis: 36.9 ZNF841 LOC284371 ENSG00000197608 Zinc finger protein 841 19 52064466-52095765 Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:3.56e-6 (unfavourable), Urothelial cancer:8.92e-5 (favourable), Head and neck cancer:2.93e-4 (favourable) Expressed in all Mixed endometrium: 21.4 ZNF845 ENSG00000213799 Zinc finger protein 845 19 53333749-53354869 Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:3.98e-4 (favourable) Expressed in all Mixed thyroid gland: 8.2 ZNF852 ENSG00000178917 Zinc finger protein 852 3 44498970-44510640 Predicted intracellular proteins Evidence at protein level HPA048312, HPA049885, HPA071850 Uncertain Mixed Mixed parathyroid gland: 2.5 ZNF853 DKFZp434J1015 ENSG00000236609 Zinc finger protein 853 7 6615617-6624290 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067690 Approved Approved Nucleoli Renal cancer:2.30e-6 (favourable) Mixed Mixed cerebral cortex: 17.4 ZNF860 ENSG00000197385 Zinc finger protein 860 3 31981771-31991628 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA063386 Uncertain Approved Nucleus
Nucleoli Mixed Mixed prostate: 4.5 ZNF862 ENSG00000106479 Zinc finger protein 862 7 149838367-149867479 Predicted intracellular proteins Evidence at protein level HPA024154 Uncertain Approved Mitochondria Urothelial cancer:8.66e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 23.5 ZNF879 DKFZp686E2433 ENSG00000234284 Zinc finger protein 879 5 179023752-179035064 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA068608 Uncertain Approved Nucleus Mixed Mixed testis: 11.2 ZNF880 ENSG00000221923 Zinc finger protein 880 19 52369917-52385795 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA077316 Approved Intermediate filaments Renal cancer:4.33e-8 (favourable) Expressed in all Expressed in all thyroid gland: 31.2 ZNF891 ENSG00000214029 Zinc finger protein 891 12 133106817-133130473 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA040301 Uncertain Mixed Mixed testis: 2.2 ZNF90 HTF9 ENSG00000213988 Zinc finger protein 90 19 20077994-20127076 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003227 Uncertain Approved Nucleus
Golgi apparatus Tissue enhanced Tissue enhanced parathyroid gland: 8.5 thyroid gland: 3.6 ZNF91 HPF7, HTF10 ENSG00000167232 Zinc finger protein 91 19 23304991-23395560 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Urothelial cancer:3.48e-4 (favourable), Renal cancer:7.58e-4 (favourable) Expressed in all Mixed thyroid gland: 17.5 ZNF92 HPF12, TF12 ENSG00000146757 Zinc finger protein 92 7 65373799-65401135 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003173 Approved Nucleus Liver cancer:6.56e-4 (unfavourable) Expressed in all Mixed breast: 13.1 ZNF93 FLJ12488, HPF34, TF34, ZNF505 ENSG00000184635 Zinc finger protein 93 19 19900913-19935575 Predicted intracellular proteins, Transcription factors Evidence at protein level Ovarian cancer:9.31e-6 (favourable) Mixed Mixed thyroid gland: 14.2 ZNF98 F7175, ZNF739 ENSG00000197360 Zinc finger protein 98 19 22391019-22532485 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced ovary: 14.3;testis: 14.2 pancreas,thyroid gland: 7.8 ZNF99 C19orf9, MGC24986 ENSG00000213973 Zinc finger protein 99 19 22752183-22784107 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enriched 7 testis: 3.0 cerebral cortex: 0.4 ZNFX1 FLJ11277, KIAA1404 ENSG00000124201 Zinc finger, NFX1-type containing 1 20 49237946-49278426 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046629 Approved Approved Mitochondria Expressed in all Expressed in all lung: 27.1 ZNRD1 HTEX-6, hZR14, RPA12, tctex-6 ENSG00000066379 Zinc ribbon domain containing 1 6 30058899-30064909 Predicted intracellular proteins, RNA polymerase related proteins Evidence at protein level HPA055074 Supported Nucleoli fibrillar center Renal cancer:2.17e-7 (unfavourable), Urothelial cancer:2.75e-5 (favourable) Expressed in all Mixed lymph node: 6.0 ZNRF4 RNF204, spzn, Ssrzf1 ENSG00000105428 Zinc and ring finger 4 19 5455431-5456856 Predicted membrane proteins Evidence at protein level Not detected Tissue enriched 495 testis: 49.4 all non-specific tissues: 0.0 ZP1 ENSG00000149506 Zona pellucida glycoprotein 1 (sperm receptor) 11 60867562-60875693 Disease related genes, Predicted membrane proteins Evidence at transcript level Mixed Not detected epididymis: 0.4 ZP2 ZPA ENSG00000103310 Zona pellucida glycoprotein 2 (sperm receptor) 16 21197450-21214510 Predicted membrane proteins Evidence at protein level HPA011296 Approved Not detected Not detected placenta: 0.7 ZP4 ZPB ENSG00000116996 Zona pellucida glycoprotein 4 1 237877864-237890922 Predicted membrane proteins Evidence at protein level HPA008547 Supported Not detected Not detected tonsil: 0.2 ZPBP SP38, ZPBP1 ENSG00000042813 Zona pellucida binding protein 7 49850421-50121329 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA058673 Supported Not detected Tissue enriched 270 testis: 251.1 epididymis: 0.9 ZPBP2 MGC41930, ZPBPL ENSG00000186075 Zona pellucida binding protein 2 17 39868164-39877896 Predicted secreted proteins Evidence at protein level HPA027997, HPA053070 Supported Not detected Tissue enriched 214 testis: 208.2 lymph node,tonsil: 0.9 ZPLD1 ENSG00000170044 Zona pellucida-like domain containing 1 3 102099244-102479841 Predicted membrane proteins Evidence at transcript level Mixed Tissue enhanced gallbladder: 3.5;testis: 1.3 duodenum: 0.9 ZRSR1 U2AF1-RS1, U2AF1L1, U2AF1P, U2AF1RS1, U2AFBPL, ZC3H21 ENSG00000212643 Zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 1 5 112891422-112893094 Predicted intracellular proteins Evidence at transcript level Not detected Mixed epididymis: 1.9 ZSCAN18 FLJ12895, ZNF447 ENSG00000121413 Zinc finger and SCAN domain containing 18 19 58083838-58118427 Predicted intracellular proteins Evidence at protein level HPA024318 Supported Approved Nucleoplasm Renal cancer:3.95e-7 (favourable) Expressed in all Expressed in all cerebral cortex: 78.9 ZSCAN2 FLJ20595, ZFP29, ZNF854 ENSG00000176371 Zinc finger and SCAN domain containing 2 15 84600986-84627796 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007296, HPA024331 Supported Approved Nucleoplasm
Cytosol Urothelial cancer:4.16e-5 (favourable), Pancreatic cancer:3.52e-4 (favourable), Renal cancer:7.46e-4 (favourable) Expressed in all Expressed in all testis: 14.0 ZSCAN20 KOX29, ZNF31, ZNF360 ENSG00000121903 Zinc finger and SCAN domain containing 20 1 33472645-33496507 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA017933 Uncertain Approved Nucleoplasm Mixed Mixed parathyroid gland: 5.4 ZSCAN23 dJ29K1.3.1, ZNF390, ZNF453 ENSG00000187987 Zinc finger and SCAN domain containing 23 6 28431930-28443502 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035959, HPA035960 Uncertain Not detected Mixed parathyroid gland: 2.1 ZSCAN25 FLJ32468, ZNF498 ENSG00000197037 Zinc finger and SCAN domain containing 25 7 99616946-99632407 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055127, HPA057173 Uncertain Approved Nucleus
Nucleoli fibrillar center Expressed in all Mixed parathyroid gland: 9.8 ZSCAN4 FLJ35105, ZNF494 ENSG00000180532 Zinc finger and SCAN domain containing 4 19 57668935-57679152 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006491 Uncertain Tissue enhanced Tissue enhanced stomach: 2.4 placenta: 1.2 ZSCAN5A MGC4161, ZNF495, ZSCAN5 ENSG00000131848 Zinc finger and SCAN domain containing 5A 19 56219670-56368383 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041263, HPA043123, HPA046836, HPA060667 Uncertain Uncertain Nuclear speckles Mixed Tissue enhanced testis: 34.3 fallopian tube: 11.3 ZSWIM1 C20orf162, dJ337O18.5 ENSG00000168612 Zinc finger, SWIM-type containing 1 20 45881227-45885266 Predicted intracellular proteins Evidence at protein level HPA041147, HPA046751 Uncertain Approved Plasma membrane
Cytosol Pancreatic cancer:1.77e-4 (favourable), Liver cancer:5.47e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 10.6 ZSWIM3 C20orf164, dJ337O18.7, PPP1R174 ENSG00000132801 Zinc finger, SWIM-type containing 3 20 45857617-45879122 Predicted intracellular proteins Evidence at protein level HPA055692, HPA060508 Uncertain Approved Nucleoli fibrillar center
Vesicles
Cytosol Breast cancer:9.32e-5 (unfavourable), Endometrial cancer:4.21e-4 (unfavourable) Expressed in all Mixed testis: 5.2 ZSWIM4 FLJ12221 ENSG00000132003 Zinc finger, SWIM-type containing 4 19 13795460-13832230 Plasma proteins, Predicted intracellular proteins Evidence at transcript level HPA042084 Uncertain Renal cancer:7.85e-5 (unfavourable) Expressed in all Mixed appendix: 5.9 ZSWIM5 KIAA1511 ENSG00000162415 Zinc finger, SWIM-type containing 5 1 45016399-45306209 Predicted intracellular proteins Evidence at transcript level HPA018211 Uncertain Approved Nuclear speckles Expressed in all Mixed parathyroid gland: 15.5 ZXDB ZNF905 ENSG00000198455 Zinc finger, X-linked, duplicated B X 57591652-57597545 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043789 Approved Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 9.9 ZYG11A ZYG11 ENSG00000203995 Zyg-11 family member A, cell cycle regulator 1 52842511-52894998 Predicted intracellular proteins Evidence at protein level HPA030378, HPA030379 Uncertain Approved Nucleus Tissue enriched Tissue enhanced testis: 7.2;thyroid gland: 4.1 kidney: 3.1